Chemical,SMILES,Identificador,Results,Type
"(-)-EPIGALLOCATECHIN GALLATE (85% (-)-EPIGALLOCATECHIN GALLATE, 10% (-)-EPIGALLOCATECHIN, 5% (-)-EPICATECHIN GALLATE)",C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,989-51-5,Negative,In vivo
"(+-)-(4)-(2-CHLOROPHENYL)-2-[2-(4-ISOBUTYLPHENYL)ETHYL]-6,9-DIMETHYL-6H-THIENO[3,2-f][1,2,4]TRIAZOLO[4,3-a][1,4]DIAZEPINE",CC1C2=NN=C(N2C3=C(C=C(S3)CCC4=CC=C(C=C4)CC(C)C)C(=N1)C5=CC=CC=C5Cl)C,117279-73-9,Negative,In vivo
"(+-)-7-(3,5,6-TRIMETHYL-1,4-BENZOQUINON-2-YL)-7-PHENYLHEPTANOIC ACID",CC1=C(C(=O)C(=C(C1=O)C)C(CCCCCC(=O)O)C2=CC=CC=C2)C,112665-43-7,Negative,In vivo
(1-methyl-5-nitroimidazol-2-yl)methyl carbamate,CN1C(=CN=C1COC(=O)N)[N+](=O)[O-],7681-76-7,Negative,in vivo
(1-methyl-5-nitroimidazol-2-yl)methyl carbamate,CN1C(=CN=C1COC(=O)N)[N+](=O)[O-],7681-76-7,Positive,in vitro
"(1-methylindol-3-yl)-[(5R)-4,5,6,7-tetrahydro-3H-benzimidazol-5-yl]methanone;hydrochloride",CN1C=C(C2=CC=CC=C21)C(=O)[C@@H]3CCC4=C(C3)NC=N4.Cl,107999,Negative,In Vivo
(1-methylpyrrol-2-yl)methanol,CN1C=CC=C1CO,52160-51-7,Positive,in vitro
(1-methylpyrrol-3-yl)methanol,CN1C=CC(=C1)CO,68384-83-8,Positive,in vitro
"(10R,11R)-10,11-dihydrobenzo[a]anthracene-10,11-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)[C@H]([C@@H](C=C4)O)O,,Positive,in vitro
"(10S,11S)-10,11-dihydrobenzo[b]triphenylene-10,11-diol",C1=CC=C2C(=C1)C3=CC=CC=C3C4=C2C=C5C=C[C@@H]([C@H](C5=C4)O)O,,Positive,in vitro
"(10S,11S)-10,11-dihydronaphtho[1,2-b]quinoline-10,11-diol",C1=CC=C2C(=C1)C=CC3=CC4=C([C@@H]([C@H](C=C4)O)O)N=C32,56842959,Positive,In Vivo
"(11R,12R)-11,12-dihydrobenzo[a]pyrene-11,12-diol",C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2[C@H]([C@@H](C5=CC=C4)O)O,60657-27-4,Positive,in vitro
"(11S,12R)-11,12-dihydrobenzo[a]pyrene-11,12-diol",C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2[C@@H]([C@@H](C5=CC=C4)O)O,64283-13-2,Negative,in vitro
"(11S,12R)-3-methyl-1,2,11,12-tetrahydrobenzo[j]aceanthrylene-11,12-diol",CC1=C2CCC3=C2C(=CC4=C3[C@H]([C@H](C5=CC=CC=C54)O)O)C=C1,,Positive,in vitro
"(11S,12S)-3-methyl-1,2,11,12-tetrahydrobenzo[j]aceanthrylene-11,12-diol",CC1=C2CCC3=C2C(=CC4=C3[C@@H]([C@H](C5=CC=CC=C54)O)O)C=C1,,Negative,in vitro
(12-methylbenzo[a]anthracen-7-yl)methanol,CC1=C2C(=C(C3=CC=CC=C13)CO)C=CC4=CC=CC=C42,11285,Positive,In Vivo
(12-methylbenzo[a]anthracen-7-yl)methanol,CC1=C2C(=C(C3=CC=CC=C13)CO)C=CC4=CC=CC=C42,568-75-2,Positive,in vivo
(12-methylbenzo[a]anthracen-7-yl)methanol,CC1=C2C(=C(C3=CC=CC=C13)CO)C=CC4=CC=CC=C42,11285,Negative,In Vivo
(12-methylbenzo[a]anthracen-7-yl)methanol,CC1=C2C(=C(C3=CC=CC=C13)CO)C=CC4=CC=CC=C42,568-75-2,Negative,in vitro
"(17R,19S)-18-oxahexacyclo[10.7.2.02,7.09,20.016,21.017,19]henicosa-1(20),2,4,6,8,10,12(21),13,15-nonaene",C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2[C@H]6[C@@H](C5=CC=C4)O6,,Positive,in vitro
"(17S,18S)-pentacyclo[10.7.1.02,11.03,8.016,20]icosa-1(19),2(11),3,5,7,9,12(20),13,15-nonaene-17,18-diol",C1=CC=C2C(=C1)C=CC3=C2C4=C[C@@H]([C@H](C5=CC=CC3=C54)O)O,163759,Positive,In Vivo
"(18R,19S,20R,22S)-21-oxa-2-azahexacyclo[12.9.0.03,12.04,9.017,23.020,22]tricosa-1(14),2,4,6,8,10,12,15,17(23)-nonaene-18,19-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C5=C(C=C4)[C@H]([C@@H]([C@@H]6[C@H]5O6)O)O)N=C32,151982,Positive,In Vivo
"(18R,19S,20S,22R)-21-oxa-2-azahexacyclo[12.9.0.03,12.04,9.017,23.020,22]tricosa-1(14),2,4,6,8,10,12,15,17(23)-nonaene-18,19-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C5=C(C=C4)[C@H]([C@@H]([C@H]6[C@@H]5O6)O)O)N=C32,151977,Positive,In Vivo
"(18S,19R,20R,22S)-21-oxa-2-azahexacyclo[12.9.0.03,12.04,9.017,23.020,22]tricosa-1(14),2,4,6,8,10,12,15,17(23)-nonaene-18,19-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C5=C(C=C4)[C@@H]([C@H]([C@@H]6[C@H]5O6)O)O)N=C32,151979,Negative,In Vivo
"(18S,19R,20S,22R)-21-oxa-2-azahexacyclo[12.9.0.03,12.04,9.017,23.020,22]tricosa-1(14),2,4,6,8,10,12,15,17(23)-nonaene-18,19-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C5=C(C=C4)[C@@H]([C@H]([C@H]6[C@@H]5O6)O)O)N=C32,151984,Positive,In Vivo
"(1aS,2S,3R,7bR)-1a,2,3,7b-tetrahydronaphtho[3,4-b]oxirene-2,3-diol",C1=CC=C2[C@@H]3[C@@H](O3)[C@H]([C@@H](C2=C1)O)O,,Positive,in vitro
"(1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione",COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O,969516,Negative,In Vivo
"(1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione",COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O,458-37-7,Negative,in vitro
"(1E)-1-chlorobuta-1,3-diene",C=C/C=C/Cl,627-22-5,Positive,in vitro
"(1R,10R,12R,21R,22S,23R,24R)-23-(dimethylamino)-4,8,12,22,24-pentahydroxy-10-methoxy-1,12-dimethyl-20,25-dioxahexacyclo[19.3.1.02,19.05,18.07,16.09,14]pentacosa-2,4,7(16),8,14,18-hexaene-6,17-dione",C[C@@]1(C[C@H](C2=C(C3=C(C=C2C1)C(=O)C4=C5C(=CC(=C4C3=O)O)[C@@]6([C@@H]([C@H]([C@@H]([C@H](O5)O6)O)N(C)C)O)C)O)OC)O,71628-96-1,Positive,in vitro
"(1R,2R,3R,6S,7S,8S,9S,11R)-3,4,5,6,13,13-hexachloro-10-oxapentacyclo[6.3.1.13,6.02,7.09,11]tridec-4-ene",C1[C@@H]2[C@@H]3[C@H]([C@H]1[C@H]4[C@@H]2O4)[C@@]5(C(=C([C@]3(C5(Cl)Cl)Cl)Cl)Cl)Cl,12358480,Negative,In Vivo
"(1R,2R,3R,6S,7S,8S,9S,11R)-3,4,5,6,13,13-hexachloro-10-oxapentacyclo[6.3.1.13,6.02,7.09,11]tridec-4-ene",C1[C@@H]2[C@@H]3[C@H]([C@H]1[C@H]4[C@@H]2O4)[C@@]5(C(=C([C@]3(C5(Cl)Cl)Cl)Cl)Cl)Cl,72-20-8,Negative,in vivo
"(1R,2R,3R,6S,7S,8S,9S,11R)-3,4,5,6,13,13-hexachloro-10-oxapentacyclo[6.3.1.13,6.02,7.09,11]tridec-4-ene",C1[C@@H]2[C@@H]3[C@H]([C@H]1[C@H]4[C@@H]2O4)[C@@]5(C(=C([C@]3(C5(Cl)Cl)Cl)Cl)Cl)Cl,72-20-8,Negative,in vitro
"(1R,2R,3S,6S)-7-oxabicyclo[4.1.0]hept-4-ene-2,3-diol",C1=C[C@H]2[C@H](O2)[C@@H]([C@H]1O)O,147504,Positive,In Vivo
"(1R,2R,3S,7R,9R,10R,12S)-3,10-dihydroxy-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-4-one",CC1=C[C@@H]2[C@]([C@@H](C1=O)O)([C@]3(C[C@H]([C@H]([C@@]34CO4)O2)O)C)CO,40024,Negative,In Vivo
"(1R,2R,5S,8S,9S,10R,11S,12S)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylic acid",C[C@@]12[C@H](C=C[C@@]3([C@@H]1[C@@H]([C@]45[C@H]3CC[C@](C4)(C(=C)C5)O)C(=O)O)OC2=O)O,6466,Positive,In Vivo
"(1R,2R,5S,8S,9S,10R,11S,12S)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylic acid",C[C@@]12[C@H](C=C[C@@]3([C@@H]1[C@@H]([C@]45[C@H]3CC[C@](C4)(C(=C)C5)O)C(=O)O)OC2=O)O,77-06-5,Negative,in vitro
"(1R,2R,6R,7R,9S,12R,15R)-13-hydroxy-2,7,12,13-tetramethyl-10,14-dioxatetracyclo[7.5.1.02,6.012,15]pentadec-4-ene-3,11-dione",C[C@@H]1C[C@H]2[C@@H]3[C@H]([C@]4([C@H]1C=CC4=O)C)OC([C@@]3(C(=O)O2)C)(C)O,19202-92-7,Negative,in vitro
"(1R,2R)-1,2-dihydrobenzo[a]anthracene-1,2-diol",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3[C@H]([C@@H](C=C4)O)O,,Negative,in vitro
"(1R,2R)-11-methyl-1,2-dihydrochrysene-1,2-diol",CC1=CC2=C(C=C[C@H]([C@@H]2O)O)C3=C1C4=CC=CC=C4C=C3,57137,Positive,In Vivo
"(1R,2R)-5-methyl-1,2-dihydrochrysene-1,2-diol",CC1=CC2=CC=CC=C2C3=C1C4=C(C=C3)[C@H]([C@@H](C=C4)O)O,57136,Positive,In Vivo
"(1R,2R)-7-methyl-1,2-dihydrobenzo[a]anthracene-1,2-diol",CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)[C@H]([C@@H](C=C3)O)O,,Positive,in vitro
"(1R,2R)-cyclohexa-3,5-diene-1,2-diol",C1=C[C@H]([C@@H](C=C1)O)O,149186,Negative,In Vivo
"(1R,2S,3R,4S)-7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid",C1C[C@H]2[C@@H]([C@@H]([C@@H]1O2)C(=O)O)C(=O)O,28871-63-8,Positive,in vitro
"(1R,2S,3S,4R,5R)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol",C1[C@@H]2[C@H]([C@@H]([C@H]([C@H](O1)O2)O)O)O,2724705,Negative,In Vivo
"(1R,2S,3S,4S,7S,11S,13R)-3,4,5,6,6,7-hexachloro-12-oxahexacyclo[6.5.0.02,10.03,7.05,9.011,13]tridecane",[C@@H]12[C@@H]3[C@@H](O3)C4[C@@H]1[C@@]5([C@@H](C6(C4C2[C@]5(C6(Cl)Cl)Cl)Cl)Cl)Cl,122361661,Negative,In Vivo
"(1R,2S,3S,6R,7R,8S,9S,11R)-3,4,5,6,13,13-hexachloro-10-oxapentacyclo[6.3.1.13,6.02,7.09,11]tridec-4-ene",C1[C@@H]2[C@H]3[C@@H]([C@H]1[C@H]4[C@@H]2O4)[C@]5(C(=C([C@@]3(C5(Cl)Cl)Cl)Cl)Cl)Cl,969491,Negative,In Vivo
"(1R,2S,3S,6R,7R,8S,9S,11R)-3,4,5,6,13,13-hexachloro-10-oxapentacyclo[6.3.1.13,6.02,7.09,11]tridec-4-ene",C1[C@@H]2[C@H]3[C@@H]([C@H]1[C@H]4[C@@H]2O4)[C@]5(C(=C([C@@]3(C5(Cl)Cl)Cl)Cl)Cl)Cl,969491,Positive,In Vivo
"(1R,2S,3S,6R,7R,8S,9S,11R)-3,4,5,6,13,13-hexachloro-10-oxapentacyclo[6.3.1.13,6.02,7.09,11]tridec-4-ene",C1[C@@H]2[C@H]3[C@@H]([C@H]1[C@H]4[C@@H]2O4)[C@]5(C(=C([C@@]3(C5(Cl)Cl)Cl)Cl)Cl)Cl,60-57-1,Negative,in vivo
"(1R,2S,3S,6R,7R,8S,9S,11R)-3,4,5,6,13,13-hexachloro-10-oxapentacyclo[6.3.1.13,6.02,7.09,11]tridec-4-ene",C1[C@@H]2[C@H]3[C@@H]([C@H]1[C@H]4[C@@H]2O4)[C@]5(C(=C([C@@]3(C5(Cl)Cl)Cl)Cl)Cl)Cl,60-57-1,Negative,in vitro
"(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexan-1-ol",C[C@@H]1CC[C@H]([C@@H](C1)O)C(C)C,16666,Negative,In Vivo
"(1R,2S)-2-(methylamino)-1-phenylpropan-1-ol;sulfuric acid",C[C@@H]([C@@H](C1=CC=CC=C1)O)NC.C[C@@H]([C@@H](C1=CC=CC=C1)O)NC.OS(=O)(=O)O,5359318,Negative,In Vivo
"(1R,3'S,4S,6R,7R,17R)-7-hydroxy-3',6,7-trimethylspiro[2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-4,2'-oxirane]-3,8-dione",C[C@@H]1C[C@]2([C@@H](O2)C)C(=O)O[C@@H]3CCN4[C@@H]3C(=CC4)COC(=O)[C@]1(C)O,6870-67-3,Positive,in vitro
"(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid",C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O,1397-89-3,Positive,in vitro
"(1R,3S)-2-oxapentacyclo[8.6.1.01,3.06,17.011,16]heptadeca-6,8,10(17),11,13,15-hexaene-4,5-diol",C1=CC=C2C(=C1)C3=C4[C@@]25[C@@H](O5)C(C(C4=CC=C3)O)O,157895,Positive,In Vivo
"(1R,4R,5R,6R,16R)-5,6-dihydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.013,16]hexadec-10-ene-3,7-dione",C[C@H]1C(=O)O[C@@H]2CCN3[C@@H]2C(=CC3)COC(=O)[C@]([C@]1(C)O)(C)O,315-22-0,Positive,in vivo
"(1R,4R,5R,6R,16R)-5,6-dihydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.013,16]hexadec-10-ene-3,7-dione",C[C@H]1C(=O)O[C@@H]2CCN3[C@@H]2C(=CC3)COC(=O)[C@]([C@]1(C)O)(C)O,9415,Positive,In Vivo
"(1R,4R,5R,6R,16R)-5,6-dihydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.013,16]hexadec-10-ene-3,7-dione",C[C@H]1C(=O)O[C@@H]2CCN3[C@@H]2C(=CC3)COC(=O)[C@]([C@]1(C)O)(C)O,315-22-0,Negative,in vitro
"(1R,4S,5S,6S,16R)-5-hydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.013,16]hexadec-10-ene-3,7-dione",C[C@@H]1C(=O)OCC2=CCN3[C@H]2[C@@H](CC3)OC(=O)[C@H]([C@@]1(C)O)C,6029-87-4,Positive,in vivo
"(1R,4S,5S,6S,16R)-5-hydroxy-4,5,6-trimethyl-2,8-dioxa-13-azatricyclo[8.5.1.013,16]hexadec-10-ene-3,7-dione",C[C@@H]1C(=O)OCC2=CCN3[C@H]2[C@@H](CC3)OC(=O)[C@H]([C@@]1(C)O)C,6029-87-4,Positive,in vitro
"(1R,4Z,6R,7R,11Z)-4-ethylidene-7-hydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione",C/C=C\1/C[C@H]([C@@](C(=O)OC/C/2=C/CN(CC[C@H](C2=O)OC1=O)C)(C)O)C,5281752,Positive,In Vivo
"(1R,4Z,6R,7R,11Z)-4-ethylidene-7-hydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione",C/C=C\1/C[C@H]([C@@](C(=O)OC/C/2=C/CN(CC[C@H](C2=O)OC1=O)C)(C)O)C,2318-18-5,Positive,in vitro
"(1R,4Z,6R,7R,17R)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione",C/C=C\1/C[C@H]([C@@](C(=O)OCC2=CCN3[C@H]2[C@@H](CC3)OC1=O)(C)O)C,0130-01-08,Positive,in vitro
"(1R,4Z,6R,7S,17R)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione",C/C=C\1/C[C@H]([C@@](C(=O)OCC2=CCN3[C@H]2[C@@H](CC3)OC1=O)(CO)O)C,480-54-6,Positive,in vitro
"(1R,4Z,7R,17R)-4-ethylidene-7-hydroxy-7-methyl-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione",C/C=C\1/CC(=C)[C@@](C(=O)OCC2=CCN3[C@H]2[C@@H](CC3)OC1=O)(C)O,480-81-9,Positive,in vitro
"(1R,4Z,7S,17R)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione",C/C=C\1/CC(=C)[C@@](C(=O)OCC2=CCN3[C@H]2[C@@H](CC3)OC1=O)(CO)O,5281744,Positive,In Vivo
"(1R,4Z,7S,17R)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione",C/C=C\1/CC(=C)[C@@](C(=O)OCC2=CCN3[C@H]2[C@@H](CC3)OC1=O)(CO)O,5281744,Negative,In Vivo
"(1R,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-butan-2-yl-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one;(1R,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethyl-6'-propan-2-ylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",CCC(C)[C@@H]1[C@H](CC[C@@]2(O1)CC3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)OC7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C.C[C@H]1CC[C@]2(CC3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)OC7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)O[C@@H]1C(C)C,6435110,Negative,In Vivo
"(1R,6S)-7-oxabicyclo[4.1.0]heptane",C1CC[C@H]2[C@@H](C1)O2,,Positive,in vitro
"(1R,7S)-1,3,4,7,8,9,10,10-octachlorotricyclo[5.2.1.02,6]dec-8-ene",C1C2C(C(C1Cl)Cl)[C@]3(C(=C([C@@]2(C3(Cl)Cl)Cl)Cl)Cl)Cl,11954021,Positive,In Vivo
"(1R,7S)-1,3,4,7,8,9,10,10-octachlorotricyclo[5.2.1.02,6]dec-8-ene",C1C2C(C(C1Cl)Cl)[C@]3(C(=C([C@@]2(C3(Cl)Cl)Cl)Cl)Cl)Cl,57-74-9,Positive,in vivo
"(1R,7S)-1,3,4,7,8,9,10,10-octachlorotricyclo[5.2.1.02,6]dec-8-ene",C1C2C(C(C1Cl)Cl)[C@]3(C(=C([C@@]2(C3(Cl)Cl)Cl)Cl)Cl)Cl,11954021,Negative,In Vivo
"(1R,7S)-1,3,4,7,8,9,10,10-octachlorotricyclo[5.2.1.02,6]dec-8-ene",C1C2C(C(C1Cl)Cl)[C@]3(C(=C([C@@]2(C3(Cl)Cl)Cl)Cl)Cl)Cl,57-74-9,Positive,in vitro
"(1R)-4-[(2S,6R)-2,6-dimethylpiperidin-1-yl]-1-phenyl-1-pyridin-2-ylbutan-1-ol;hydrochloride",C[C@@H]1CCC[C@@H](N1CCC[C@@](C2=CC=CC=C2)(C3=CC=CC=N3)O)C.Cl,76962233,Negative,In Vivo
"(1R)-7-(hydroxymethyl)-2,3-dihydro-1H-pyrrolizin-1-ol",C1CN2C=CC(=C2[C@@H]1O)CO,105037,Positive,In Vivo
"(1R)-7-(hydroxymethyl)-2,3-dihydro-1H-pyrrolizin-1-ol",C1CN2C=CC(=C2[C@@H]1O)CO,23107-12-2,Positive,in vitro
"(1S,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E)-33-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid",C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/C(CC2C(C(C[C@](O2)(CC(C(CCC(CC(CC(CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O,1400-61-9,Negative,in vitro
"(1S,17S,18S,19S)-5,7-dioxa-12-azapentacyclo[10.6.1.02,10.04,8.015,19]nonadeca-2,4(8),9,15-tetraene-17,18-diol",C1CN2CC3=CC4=C(C=C3[C@H]5[C@H]2C1=C[C@@H]([C@H]5O)O)OCO4,476-28-8,Positive,in vitro
"(1S,2R,3S,5S,6R,7S,8R)-1,6,8,9,10,11,11-heptachloro-4-oxatetracyclo[6.2.1.02,7.03,5]undec-9-ene",[C@@H]12[C@@H]([C@H]([C@@H]3[C@H]1O3)Cl)[C@]4(C(=C([C@@]2(C4(Cl)Cl)Cl)Cl)Cl)Cl,,Negative,in vivo
"(1S,2R,3S,6R)-7-oxabicyclo[4.1.0]hept-4-ene-2,3-diol",C1=C[C@@H]2[C@@H](O2)[C@@H]([C@H]1O)O,152006,Negative,In Vivo
"(1S,2R,3S,7R,9R,10R,11S,12S)-3,10,11-trihydroxy-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-4-one",CC1=C[C@@H]2[C@]([C@@H](C1=O)O)([C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)O)O)C)CO,5284433,Negative,In Vivo
"(1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol",C[C@]12CC[C@H](C1(C)C)C[C@H]2O,464-45-9,Negative,in vitro
"(1S,2R,5S,6S,8R,9S,10R,12S,15R,16S,25R,27S,28R)-21-chloro-15,16,33,33-tetramethyl-24-methylidene-10-prop-1-en-2-yl-7,11,32-trioxa-18-azadecacyclo[25.4.2.02,16.05,15.06,8.06,12.017,31.019,30.022,29.025,28]tritriaconta-17(31),19,21,29-tetraene-5,9,28-triol",CC(=C)[C@@H]1[C@@H]([C@@H]2[C@@]3(O2)[C@@H](O1)CC[C@]4([C@]3(CC[C@@H]5[C@@]4(C6=C7[C@H]5OC([C@H]8C[C@H]9[C@@]8(C1=C7C(=CC(=C1CC9=C)Cl)N6)O)(C)C)C)O)C)O,12627-35-9,Negative,in vitro
"(1S,2R,5S,7R,9R,10S,14R,15S,19S)-15-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-14-methyl-7-[(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione",CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3[C@@H]2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C,443059,Negative,In Vivo
"(1S,2R,5S,7R,9S,11S,12S,15R,16R)-2,16-dimethyl-15-[(2R)-6-methylheptan-2-yl]-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-ol",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H]4[C@@]5([C@@]3(CC[C@@H](C5)O)C)O4)C,227037,Negative,In Vivo
"(1S,2R,5S,7R,9S,11S,12S,15R,16R)-2,16-dimethyl-15-[(2R)-6-methylheptan-2-yl]-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-ol",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H]4[C@@]5([C@@]3(CC[C@@H](C5)O)C)O4)C,1250-95-9,Positive,in vitro
"(1S,2R,5S,7S,9R,11S,12S,15R,16R)-2,16-dimethyl-15-[(2R)-6-methylheptan-2-yl]-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-ol",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@@H]4[C@]5([C@@]3(CC[C@@H](C5)O)C)O4)C,108109,Negative,In Vivo
"(1S,2S,3R,6R)-7-oxabicyclo[4.1.0]hept-4-ene-2,3-diol",C1=C[C@@H]2[C@@H](O2)[C@H]([C@@H]1O)O,147652,Positive,In Vivo
"(1S,2S,3S,6R,7R,8R)-1,8,9,10,11,11-hexachlorotetracyclo[6.2.1.13,6.02,7]dodeca-4,9-diene",C1[C@@H]2C=C[C@H]1[C@H]3[C@@H]2[C@]4(C(=C([C@@]3(C4(Cl)Cl)Cl)Cl)Cl)Cl,12310947,Negative,In Vivo
"(1S,2S,3S,6R,7R,8R)-1,8,9,10,11,11-hexachlorotetracyclo[6.2.1.13,6.02,7]dodeca-4,9-diene",C1[C@@H]2C=C[C@H]1[C@H]3[C@@H]2[C@]4(C(=C([C@@]3(C4(Cl)Cl)Cl)Cl)Cl)Cl,12310947,Positive,In Vivo
"(1S,2S,3S,6R,7R,8R)-1,8,9,10,11,11-hexachlorotetracyclo[6.2.1.13,6.02,7]dodeca-4,9-diene",C1[C@@H]2C=C[C@H]1[C@H]3[C@@H]2[C@]4(C(=C([C@@]3(C4(Cl)Cl)Cl)Cl)Cl)Cl,309-00-2,Positive,in vivo
"(1S,2S,3S,6R,7R,8R)-1,8,9,10,11,11-hexachlorotetracyclo[6.2.1.13,6.02,7]dodeca-4,9-diene",C1[C@@H]2C=C[C@H]1[C@H]3[C@@H]2[C@]4(C(=C([C@@]3(C4(Cl)Cl)Cl)Cl)Cl)Cl,309-00-2,Negative,in vitro
"(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one",C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O,67-73-2,Positive,in vitro
"(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one",C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CCC5=CC(=O)C=C[C@@]53C)F)O,6436,Positive,In Vivo
"(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one",CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,5281004,Positive,In Vivo
"(1S,2S,5R,6R,7R,10S,12R,13R)-6,13-bis(hydroxymethyl)-2,6-dimethyltetracyclo[10.3.1.01,10.02,7]hexadecane-5,13-diol",C[C@]12CC[C@H]([C@@]([C@@H]1CC[C@@H]3[C@@]24CC[C@@]([C@H](C3)C4)(CO)O)(C)CO)O,38966-21-1,Positive,in vitro
"(1S,2S,6R,10S,11R,13S,14R,15R)-1,6,13,14-tetrahydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyltetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dien-5-one",C[C@@H]1[C@H]([C@@]2([C@@H](C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@]4(CC(=C3)CO)O)C)O)O)O,17673-25-5,Negative,in vitro
"(1S,2S)-1,2-dihydrobenzo[c]acridine-1,2-diol",C1=CC=C2C(=C1)C=C3C=CC4=C(C3=N2)[C@@H]([C@H](C=C4)O)O,56841464,Negative,In Vivo
"(1S,2S)-1,2-dihydronaphtho[1,2-b]phenanthrene-1,2-diol",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)[C@@H]([C@H](C=C5)O)O,,Positive,in vitro
"(1S,2S)-6-amino-1,2-dihydrochrysene-1,2-diol",C1=CC=C2C(=C1)C3=C(C=C2N)C4=C(C=C3)[C@@H]([C@H](C=C4)O)O,107900,Positive,In Vivo
"(1S,2S)-6-nitro-1,2-dihydrochrysene-1,2-diol",C1=CC=C2C(=C1)C3=C(C=C2[N+](=O)[O-])C4=C(C=C3)[C@@H]([C@H](C=C4)O)O,115211,Positive,In Vivo
"(1S,2S)-cyclohexa-3,5-diene-1,2-diol",C1=C[C@@H]([C@H](C=C1)O)O,152287,Negative,In Vivo
"(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C,57363,Positive,In Vivo
"(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol",C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8O)O)CO)CO)CO)CO)CO)CO)O)O)O,444041,Negative,In Vivo
"(1S,3R,7R,9R,10S,12R,14R)-12,14-dihydroxy-1,9-dimethyl-4-methylidene-6,13-dioxatricyclo[8.4.0.03,7]tetradecan-5-one",C[C@@H]1C[C@@H]2[C@H](C[C@]3([C@H]1C[C@@H](O[C@H]3O)O)C)C(=C)C(=O)O2,57074-51-8,Positive,in vitro
"(1S,4E,6R,10R,12E,14S,15S,17S,18S,19S)-19-benzyl-6,15-dihydroxy-10,17-dimethyl-16-methylidene-2-oxa-20-azatricyclo[12.7.0.01,18]henicosa-4,12-diene-3,21-dione",C[C@@H]1CCC[C@H](/C=C/C(=O)O[C@]23[C@@H](/C=C/C1)[C@@H](C(=C)[C@H]([C@H]2[C@@H](NC3=O)CC4=CC=CC=C4)C)O)O,14930-96-2,Negative,in vitro
"(1S,5E,16S,17R,18S,22R,27R,28R)-8-[(1Z)-buta-1,3-dienyl]-22,27-dihydroxy-20-(hydroxymethyl)-16,24,28-trimethyl-10-[(1E,3E,5E)-nona-1,3,5-trienyl]-2,14-dioxaheptacyclo[14.13.0.01,17.07,12.09,11.018,27.022,26]nonacosa-5,19,24-triene-3,13,23-trione",CCC/C=C/C=C/C=C/C1C2C1C3C(C2/C=C\C=C)/C=C/CC(=O)O[C@@]45C[C@H]([C@]6([C@H]([C@@H]4[C@]5(COC3=O)C)C=C(C[C@]7(C6C=C(C7=O)C)O)CO)O)C,6440822,Negative,In Vivo
"(1S,5R)-6,8-dioxabicyclo[3.2.1]oct-2-en-4-one",C1[C@@H]2C=CC(=O)[C@H](O1)O2,699486,Negative,In Vivo
"(1S,6R,13S)-16,17-dimethoxy-6-prop-1-en-2-yl-2,7,20-trioxapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one",CC(=C)[C@H]1CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@H]4C3=O)OC)OC,6758,Negative,In Vivo
"(1S,6R)-2,5-dichloro-3-(2,5-dichlorophenyl)-7-oxabicyclo[4.1.0]hepta-2,4-diene",C1=CC(=C(C=C1Cl)C2=C([C@@H]3[C@@H](O3)C(=C2)Cl)Cl)Cl,121489661,Negative,In Vivo
"(2-butan-2-yl-4,6-dinitrophenyl) acetate",CCC(C)C1=C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])OC(=O)C,2813-95-8,Negative,in vitro
(2-butan-2-ylphenyl) N-methyl-N-nitrosocarbamate,CCC(C)C1=CC=CC=C1OC(=O)N(C)N=O,,Positive,in vitro
(2-butan-2-ylphenyl) N-methylcarbamate,CCC(C)C1=CC=CC=C1OC(=O)NC,3766-81-2,Negative,in vitro
(2-chloro-2-naphthalen-2-ylethyl)-propan-2-ylazanium;chloride,CC(C)[NH2+]CC(C1=CC2=CC=CC=C2C=C1)Cl.[Cl-],20794-96-1,Positive,in vivo
(2-chlorophenyl) N-methyl-N-nitrosocarbamate,CN(C(=O)OC1=CC=CC=C1Cl)N=O,,Positive,in vitro
(2-chlorophenyl) N-methylcarbamate,CNC(=O)OC1=CC=CC=C1Cl,3942-54-9,Negative,in vitro
(2-chlorophenyl)-(4-chlorophenyl)-pyrimidin-5-ylmethanol,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)(C3=CN=CN=C3)O)Cl,43226,Negative,In Vivo
(2-hydroxynaphthalen-1-yl)azanium;chloride,C1=CC=C2C(=C1)C=CC(=C2[NH3+])O.[Cl-],,Positive,in vitro
"(2-methyl-3-phenylphenyl)methyl (1R,3R)-3-[(Z)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylate",CC1=C(C=CC=C1C2=CC=CC=C2)COC(=O)[C@@H]3[C@@H](C3(C)C)/C=C(/C(F)(F)F)\Cl,6442842,Negative,In Vivo
"(2-methyl-3-phenylphenyl)methyl (1R,3R)-3-[(Z)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylate",CC1=C(C=CC=C1C2=CC=CC=C2)COC(=O)[C@@H]3[C@@H](C3(C)C)/C=C(/C(F)(F)F)\Cl,6442842,Positive,In Vivo
"(2-methyl-4-oxo-3-prop-2-enylcyclopent-2-en-1-yl) (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate",CC1=C(C(=O)CC1OC(=O)[C@@H]2[C@H](C2(C)C)C=C(C)C)CC=C,260359-57-7,Negative,in vitro
"(2-methylsulfanyl-1,3-dioxoinden-2-yl) N,N-diethylcarbamate",CCN(CC)C(=O)OC1(C(=O)C2=CC=CC=C2C1=O)SC,,Positive,in vitro
(2-propan-2-yloxyphenyl) N-methyl-N-nitrosocarbamate,CC(C)OC1=CC=CC=C1OC(=O)N(C)N=O,38777-13-8,Positive,in vitro
(2-propan-2-yloxyphenyl) N-methylcarbamate,CC(C)OC1=CC=CC=C1OC(=O)NC,4944,Negative,In Vivo
(2-propan-2-yloxyphenyl) N-methylcarbamate,CC(C)OC1=CC=CC=C1OC(=O)NC,114-26-1,Negative,in vitro
(2-propan-2-ylphenyl) N-methyl-N-nitrosocarbamate,CC(C)C1=CC=CC=C1OC(=O)N(C)N=O,,Positive,in vitro
(2-propan-2-ylphenyl) N-methylcarbamate,CC(C)C1=CC=CC=C1OC(=O)NC,2631-40-5,Negative,in vitro
"(2-tert-butyl-4,6-dinitrophenyl) methanesulfonate",CC(C)(C)C1=C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])OS(=O)(=O)C,147300,Negative,In Vivo
"(2,2-dimethyl-1,3-benzodioxol-4-yl) N-methylcarbamate",CC1(OC2=C(O1)C(=CC=C2)OC(=O)NC)C,2314,Negative,In Vivo
"(2,2-dimethyl-1,3-benzodioxol-4-yl) N-methylcarbamate",CC1(OC2=C(O1)C(=CC=C2)OC(=O)NC)C,22781-23-3,Negative,in vitro
"(2,2-dimethyl-3H-1-benzofuran-7-yl) N-methyl-N-nitrosocarbamate",CC1(CC2=C(O1)C(=CC=C2)OC(=O)N(C)N=O)C,62593-23-1,Positive,in vitro
"(2,2-dimethyl-3H-1-benzofuran-7-yl) N-methylcarbamate",CC1(CC2=C(O1)C(=CC=C2)OC(=O)NC)C,2566,Negative,In Vivo
"(2,2-dimethyl-3H-1-benzofuran-7-yl) N-methylcarbamate",CC1(CC2=C(O1)C(=CC=C2)OC(=O)NC)C,1563-66-2,Negative,in vitro
"(2,3-dihydroxy-4-methylsulfonyloxybutyl) methanesulfonate",CS(=O)(=O)OCC(C(COS(=O)(=O)C)O)O,21106-06-09,Positive,in vitro
"(2,3,5-trimethylphenyl) N-methyl-N-nitrosocarbamate",CC1=CC(=C(C(=C1)OC(=O)N(C)N=O)C)C,,Positive,in vitro
"(2,4-diamino-5-methylphenyl)-[3-(2,4-diamino-5-methylphenyl)iminoazaniumyl-4-methylphenyl]iminoazanium;dichloride",CC1=C(C=C(C=C1)N=[NH+]C2=C(C=C(C(=C2)C)N)N)[NH+]=NC3=C(C=C(C(=C3)C)N)N.[Cl-].[Cl-],,Negative,in vitro
"(2,4-dichlorophenoxy)-diethoxy-sulfanylidene-lambda5-phosphane",CCOP(=S)(OCC)OC1=C(C=C(C=C1)Cl)Cl,97-17-6,Positive,in vitro
"(2,4-dimethoxyphenyl)azanium;chloride",COC1=CC(=C(C=C1)[NH3+])OC.[Cl-],41023,Negative,In Vivo
"(2,4-dimethoxyphenyl)azanium;chloride",COC1=CC(=C(C=C1)[NH3+])OC.[Cl-],54150-69-5,Negative,in vivo
"(2,4-dinitrophenyl) thiocyanate",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])SC#N,1594-56-5,Negative,in vitro
"(2,4-dinitrophenyl)hydrazine",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NN,119-26-6,Positive,in vitro
"(2,5-dioxo-3-prop-2-ynylimidazolidin-1-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate",CC(=CC1C(C1(C)C)C(=O)OCN2C(=O)CN(C2=O)CC#C)C,123622,Negative,In Vivo
"(2,5-dioxoimidazolidin-4-yl)urea",C1(C(=O)NC(=O)N1)NC(=O)N,204,Negative,In Vivo
"(2,6-dimethyl-1,3-dioxan-4-yl) acetate",CC1CC(OC(O1)C)OC(=O)C,13232,Negative,In Vivo
"(2,6-dimethyl-1,3-dioxan-4-yl) acetate",CC1CC(OC(O1)C)OC(=O)C,13232,Positive,In Vivo
"(2,6-dimethyl-4-nitrosopiperazin-1-yl)-phenylmethanone",CC1CN(CC(N1C(=O)C2=CC=CC=C2)C)N=O,149740,Positive,In Vivo
"(20R,22S)-21-oxa-2-azahexacyclo[12.9.0.03,12.04,9.017,23.020,22]tricosa-1(14),2,4,6,8,10,12,15,17(23)-nonaene",C1CC2=C([C@H]3[C@@H]1O3)C4=C(C=C2)C=C5C=CC6=CC=CC=C6C5=N4,151985,Negative,In Vivo
"(20S,22R)-21-oxa-2-azahexacyclo[12.9.0.03,12.04,9.017,23.020,22]tricosa-1(14),2,4,6,8,10,12,15,17(23)-nonaene",C1CC2=C([C@@H]3[C@H]1O3)C4=C(C=C2)C=C5C=CC6=CC=CC=C6C5=N4,151986,Positive,In Vivo
"(2aS,3R)-3-methyl-1,2-dihydrobenzo[j]aceanthrylene-2a,3-diol",C[C@]1(C=CC2=CC3=C(C=CC4=CC=CC=C43)C5=C2[C@]1(CC5)O)O,68688-84-6,Negative,in vitro
"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol",CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C,68-26-8,Negative,in vivo
"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid",CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C,302-79-4,Positive,in vitro
"(2E,4E,6E,8E)-N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenamide",CCNC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C,56281-36-8,Negative,in vitro
"(2E,4E)-hexa-2,4-dienal",C/C=C/C=C/C=O,637564,Positive,In Vivo
"(2E,4E)-N-(2-methylpropyl)deca-2,4-dienamide",CCCCC/C=C/C=C/C(=O)NCC(C)C,18836-52-7,Positive,in vitro
"(2E)-3-methoxy-5-methyl-4-oxohexa-2,5-dienoic acid",CC(=C)C(=O)/C(=C\C(=O)O)/OC,90-65-3,Positive,in vivo
"(2E)-3-methoxy-5-methyl-4-oxohexa-2,5-dienoic acid",CC(=C)C(=O)/C(=C\C(=O)O)/OC,90-65-3,Negative,in vitro
"(2E)-3,7-dimethylocta-2,6-dienal",CC(=CCC/C(=C/C=O)/C)C,638011,Negative,In Vivo
(2E)-6-chloro-2-(6-chloro-4-methyl-3-oxo-1-benzothiophen-2-ylidene)-4-methyl-1-benzothiophen-3-one,CC1=CC(=CC2=C1C(=O)/C(=C\3/C(=O)C4=C(S3)C=C(C=C4C)Cl)/S2)Cl,2379-74-0,Negative,in vitro
"(2R,3aR,7S,7aR)-7-hydroxy-2,5,7-trimethyl-3a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[3,7a-dihydro-2H-indene-6,1'-cyclopropane]-1-one",C[C@@H]1C[C@]2(C=C(C3(CC3)[C@@]([C@H]2C1=O)(C)O)C)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,13962857,Positive,In Vivo
"(2R,3R,4R,5R,6R)-2-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-5-chloro-6-(hydroxymethyl)oxane-3,4-diol",C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CCl)O)O)CCl)O)O)Cl)O,71485,Negative,In Vivo
"(2R,3R,4R,5R,6S)-2-[[(2R,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-methyloxane-3,4,5-triol;chloride",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC4=C(C=C(C=C4[O+]=C3C5=CC(=C(C=C5)O)O)O)O)O)O)O)O)O)O.[Cl-],29231,Negative,In Vivo
"(2R,3R,4R,5R)-1,6-bis(2-chloroethylamino)hexane-2,3,4,5-tetrol",C(CCl)NC[C@H]([C@H]([C@@H]([C@@H](CNCCCl)O)O)O)O,3033867,Positive,In Vivo
"(2R,3R,4R,5R)-1,6-bis(2-chloroethylamino)hexane-2,3,4,5-tetrol;dihydrochloride",C(CCl)NC[C@H]([C@H]([C@@H]([C@@H](CNCCCl)O)O)O)O.Cl.Cl,551-74-6,Positive,in vitro
"(2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal",C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)O)O)O)O)O)O,3037558,Negative,In Vivo
"(2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal",C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)O)O)O)O)O)O,3037558,Positive,In Vivo
"(2R,3R,4R,5R)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,4,5-pentol",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O)O)O)O,88735,Negative,In Vivo
"(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol",C([C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O,6251,Negative,In Vivo
"(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol",C([C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O,69-65-8,Negative,in vivo
"(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol",C([C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O,69-65-8,Negative,in vitro
"(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol",C([C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O)O,50-70-4,Negative,in vivo
"(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol",C([C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O)O,50-70-4,Negative,in vitro
"(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)oxolane-3,4-diol",C1=CN(C2=NC=NC(=C21)N)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,69-33-0,Negative,in vitro
"(2R,3R,4S,5R)-2,3,4,6-tetrahydroxy-5-sulfanylhexanal",C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)S)O,20408-97-3,Negative,in vivo
"(2R,3R,4S,5S,6R)-2-[(1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",C1[C@@H]([C@H]([C@@H]([C@H]([C@H]1N[C@H]2C=C([C@H]([C@@H]([C@H]2O)O)O)CO)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)CO,37248-47-8,Negative,in vitro
"(2R,3R,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolan-3-ol",C1[C@H](O[C@H]([C@@H]1O)N2C=NC3=C(N=CN=C32)N)CO,73-03-0,Negative,in vitro
"(2R,3R)-2-chloro-3-(chloromethyl)oxirane",C([C@@H]1[C@H](O1)Cl)Cl,149399,Positive,In Vivo
"(2R,3R)-2-chloro-3-methyloxirane",C[C@@H]1[C@H](O1)Cl,155623,Positive,In Vivo
"(2R,3S,10S)-2-hydroxy-3-[(1R)-1-hydroxyheptyl]-10-[(S)-hydroxy-[(2S)-6-oxo-2,3-dihydropyran-2-yl]methyl]-6,14-dioxatricyclo[10.3.0.04,8]pentadeca-1(12),4(8)-diene-5,7,13,15-tetrone",CCCCCC[C@H]([C@H]1[C@H](C2=C(C[C@H](CC3=C1C(=O)OC3=O)[C@@H]([C@@H]4CC=CC(=O)O4)O)C(=O)OC2=O)O)O,21794-01-04,Positive,in vivo
"(2R,3S,10S)-2-hydroxy-3-[(1R)-1-hydroxyheptyl]-10-[(S)-hydroxy-[(2S)-6-oxo-2,3-dihydropyran-2-yl]methyl]-6,14-dioxatricyclo[10.3.0.04,8]pentadeca-1(12),4(8)-diene-5,7,13,15-tetrone",CCCCCC[C@H]([C@H]1[C@H](C2=C(C[C@H](CC3=C1C(=O)OC3=O)[C@@H]([C@@H]4CC=CC(=O)O4)O)C(=O)OC2=O)O)O,21794-01-04,Negative,in vitro
"(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol",C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)O)N,25546-65-0,Negative,in vitro
"(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol;sulfuric acid",C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)OC4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,1405-10-3,Positive,in vivo
"(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol",C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)N)N,4696-76-8,Negative,in vitro
"(2R,3S,4R,5R)-2-(hydroxymethyl)-5-purin-9-yloxolane-3,4-diol",C1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,550-33-4,Negative,in vitro
"(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal",C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)O,50-99-7,Negative,in vivo
"(2R,3S,4R)-2,3,4,5-tetrahydroxypentanal",C([C@H]([C@@H]([C@H](C=O)O)O)O)O,644160,Negative,In Vivo
"(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol",C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N,59-01-8,Negative,in vitro
"(2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N,5536-17-4,Positive,in vitro
"(2R,3S,4S,5S)-2-[(2R,3R,4R,5S,6R)-5-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@H]([C@@H]([C@@H]([C@@H](C(=O)O)O)OP(=O)(O)O)O)C(=O)O)CO)O)O)N,23526-02-05,Positive,in vitro
"(2R,3S,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)CO)O,0958-09-08,Negative,in vitro
"(2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol",C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,9064,Positive,In Vivo
"(2R,3S)-2-(4-methoxyphenyl)-3-methyloxirane",C[C@H]1[C@H](O1)C2=CC=C(C=C2)OC,11819368,Positive,In Vivo
"(2R,3S)-2-chloro-3-(chloromethyl)oxirane",C([C@H]1[C@H](O1)Cl)Cl,119516,Positive,In Vivo
"(2R,3S)-2-chloro-3-methyloxirane",C[C@H]1[C@H](O1)Cl,3036756,Positive,In Vivo
"(2R,4S)-12,19-dimethyl-3-oxapentacyclo[9.8.0.02,4.05,10.013,18]nonadeca-1(19),5,7,9,11,13,15,17-octaene",CC1=C2[C@@H]3[C@@H](O3)C4=CC=CC=C4C2=C(C5=CC=CC=C15)C,,Positive,in vitro
"(2R,4S)-3-oxapentacyclo[9.8.0.02,4.05,10.013,18]nonadeca-1(19),5,7,9,11,13,15,17-octaene",C1=CC=C2C=C3C4=CC=CC=C4[C@H]5[C@@H](C3=CC2=C1)O5,,Positive,in vivo
"(2R,4S)-3-oxapentacyclo[9.8.0.02,4.05,10.013,18]nonadeca-1(19),5,7,9,11,13,15,17-octaene",C1=CC=C2C=C3C4=CC=CC=C4[C@H]5[C@@H](C3=CC2=C1)O5,,Positive,in vitro
(2R)-1-amino-3-chloropropan-2-ol;hydrochloride,C([C@H](CCl)O)N.Cl,34839-14-0,Negative,in vivo
"(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one",C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O,54670067,Negative,In Vivo
"(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one",C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O,50-81-7,Negative,in vivo
"(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one",C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O,50-81-7,Positive,in vitro
"(2R)-2-[2-[(5R,6R,7S,9S,11R,16R,18S,19S)-19-amino-6-[(3R)-3,4-dicarboxybutanoyl]oxy-11,16,18-trihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid",CCCC[C@@H](C)[C@H]([C@H](C[C@@H](C)C[C@@H](CCCC[C@H](C[C@@H]([C@H](C)N)O)O)O)OC(=O)C[C@@H](CC(=O)O)C(=O)O)OC(=O)C[C@@H](CC(=O)O)C(=O)O,2733487,Negative,In Vivo
"(2R)-2-[2-[(5R,6R,7S,9S,11R,16R,18S,19S)-19-amino-6-[(3R)-3,4-dicarboxybutanoyl]oxy-11,16,18-trihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid",CCCC[C@@H](C)[C@H]([C@H](C[C@@H](C)C[C@@H](CCCC[C@H](C[C@@H]([C@H](C)N)O)O)O)OC(=O)C[C@@H](CC(=O)O)C(=O)O)OC(=O)C[C@@H](CC(=O)O)C(=O)O,2733487,Positive,In Vivo
(2R)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,C1=CC(=CC=C1C[C@H](C(=O)O)N)N(CCCl)CCCl,13045-94-8,Positive,in vitro
(2R)-2-amino-3-sulfanylpropanoic acid,C([C@@H](C(=O)O)N)S,52-90-4,Negative,in vitro
(2R)-2-amino-3-sulfanylpropanoic acid;hydrochloride,C([C@@H](C(=O)O)N)S.Cl,60960,Negative,In Vivo
(2R)-2-amino-5-[[(1R)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-5-oxopentanoic acid,C1=CC=C2C(=C1)C(=CN2)C[C@H](C(=O)O)NC(=O)CC[C@H](C(=O)O)N,7275810,Negative,In Vivo
"(2R)-2-hydroxy-3-[(1R)-1-hydroxyheptyl]-10-[(S)-hydroxy-(6-oxooxan-2-yl)methyl]-6,14-dioxatricyclo[10.3.0.04,8]pentadeca-1(12),4(8)-diene-5,7,13,15-tetrone",CCCCCC[C@H](C1[C@H](C2=C(CC(CC3=C1C(=O)OC3=O)[C@@H](C4CCCC(=O)O4)O)C(=O)OC2=O)O)O,,Negative,in vivo
(2R)-2-methyl-1-nitrosopiperidine,C[C@@H]1CCCCN1N=O,14026-03-0,Positive,in vivo
"(2S,3R,4R,5R)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,5,6-pentol",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O,585-88-6,Negative,in vitro
"(2S,3R,4R,5R)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,5,6-pentol",C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O,157355,Negative,In Vivo
"(2S,3R,4R,5R)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,5,6-pentol",C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O,157355,Positive,In Vivo
"(2S,3R,4R,5R)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,5,6-pentol;dihydrate",C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O.O.O,157354,Negative,In Vivo
"(2S,3R,4S,5R)-oxane-2,3,4,5-tetrol",C1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)O,6027,Negative,In Vivo
"(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol",C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N,32986-56-4,Negative,in vitro
"(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol",C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N)N)N,34493-98-6,Negative,in vitro
"(2S,3R,5R,9R,10R,13R,14S,17R)-17-[(2S,3R)-3,6-dihydroxy-6-methylheptan-2-yl]-2,3,14-trihydroxy-10,13-dimethyl-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one",C[C@@H]([C@H]1CC[C@@]2([C@@]1(CC[C@H]3C2=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)C)O)[C@@H](CCC(C)(C)O)O,19212,Positive,In Vivo
"(2S,3R)-butane-1,2,3,4-tetrol",C([C@H]([C@H](CO)O)O)O,222285,Negative,In Vivo
"(2S,3S,4S,5R,6R)-6-(9H-fluoren-2-ylamino)-3,4,5-trihydroxyoxane-2-carboxylic acid",C1C2=CC=CC=C2C3=C1C=C(C=C3)N[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,126308,Negative,In Vivo
"(2S,3S,4S,5R,6R)-6-[9H-fluoren-2-yl(hydroxy)amino]-3,4,5-trihydroxyoxane-2-carboxylic acid",C1C2=CC=CC=C2C3=C1C=C(C=C3)N([C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)O,128980,Positive,In Vivo
"(2S,3S,4S,5R,6S)-6-[acetyl(9H-fluoren-2-yl)amino]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid",CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,92183,Negative,In Vivo
"(2S,3S,4S,5S)-1,6-dibromohexane-2,3,4,5-tetrol",C([C@H]([C@H]([C@@H]([C@@H](CBr)O)O)O)O)Br,488-41-5,Positive,in vivo
"(2S,3S)-2-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4-[(2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-6-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-8,9-dihydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one",C[C@@H]1[C@H]([C@@H](C[C@@H](O1)O[C@@H]2C[C@@H](O[C@@H]([C@H]2O)C)OC3=CC4=CC5=C(C(=O)[C@H]([C@@H](C5)[C@@H](C(=O)[C@H]([C@@H](C)O)O)OC)O[C@H]6C[C@H]([C@@H]([C@H](O6)C)O)O[C@H]7C[C@H]([C@H]([C@H](O7)C)O)O[C@H]8C[C@]([C@@H]([C@H](O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,,Positive,in vitro
"(2S,3S)-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-2-[(2R,4S,5S,6S)-4-[(4S,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-8,9-dihydroxy-6-[(2S,4R,5S,6R)-5-hydroxy-4-[(2S,4S,5S,6S)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-3,4-dihydro-2H-anthracen-1-one",C[C@@H]1[C@@H]([C@@H](C[C@@H](O1)OC2=CC(=C3C(=C2)C=C4C[C@H]([C@@H](C(=O)C4=C3O)O[C@@H]5C[C@@H]([C@H]([C@@H](O5)C)O)OC6C[C@@H]([C@H]([C@@H](O6)C)O)O)[C@@H](C(=O)[C@H]([C@@H](C)O)O)OC)O)O[C@H]7C[C@@H]([C@@H]([C@@H](O7)C)OC)O)O,11006-70-5,Positive,in vitro
"(2S,4R)-8-nitro-3-oxapentacyclo[7.6.2.02,4.05,17.012,16]heptadeca-1(15),5(17),6,8,10,12(16),13-heptaene",C1=CC2=C3C(=C1)[C@H]4[C@H](O4)C5=C3C(=C(C=C5)[N+](=O)[O-])C=C2,121492632,Negative,In Vivo
"(2S,4R)-pentane-1,2,3,4,5-pentol",C([C@H](C([C@H](CO)O)O)O)O,488-81-3,Negative,in vitro
"(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methylspiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione",C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC,441140,Positive,In Vivo
"(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methylspiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione",C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC,0126-07-08,Positive,in vivo
"(2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methylspiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione",C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC,0126-07-08,Negative,in vitro
"(2S,5R,6R)-6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3=C(C=CC=C3OC)OC)C(=O)O)C,61-32-5,Negative,in vitro
"(2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C,69-53-4,Negative,in vitro
"(2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;trihydrate",CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C.O.O.O,23565,Negative,In Vivo
"(2S,5R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol",C(C1[C@@H](C(C([C@H](O1)O)N)O)O)O,,Negative,in vitro
(2S)-1-amino-3-chloropropan-2-ol;hydrochloride,C([C@@H](CCl)O)N.Cl,34839-13-9,Positive,in vivo
(2S)-1-amino-3-chloropropan-2-ol;hydrochloride,C([C@@H](CCl)O)N.Cl,34839-13-9,Negative,in vivo
"(2S)-1a,2,3,7b-tetrahydronaphtho[3,4-b]oxirene-2,3-diol",C1=CC=C2C3C(O3)[C@H](C(C2=C1)O)O,,Positive,in vitro
"(2S)-2-(3,4-dimethoxyphenyl)-5-hydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=O)C[C@H](OC4=C3)C5=CC(=C(C=C5)OC)OC)O)O)O)O)O)O)O,5284419,Negative,In Vivo
(2S)-2-[(2R)-oxiran-2-yl]oxirane,C1[C@@H](O1)[C@@H]2CO2,233706,Positive,In Vivo
(2S)-2-[(2R)-oxiran-2-yl]oxirane,C1[C@@H](O1)[C@@H]2CO2,30419-67-1,Positive,in vitro
(2S)-2-[(2S)-oxiran-2-yl]oxirane,C1[C@H](O1)[C@@H]2CO2,30031-64-2,Positive,in vitro
(2S)-2-[[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamoylamino]-3-phenylpropanoic acid,CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O,37691-11-5,Negative,in vitro
(2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]-nitrosoamino]pentanedioic acid,C1=CC(=CC=C1C(=O)N([C@@H](CCC(=O)O)C(=O)O)N=O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N,135565414,Positive,In Vivo
"(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid",CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,59-05-2,Positive,in vivo
"(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid",CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,59-05-2,Negative,in vivo
"(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid",CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,59-05-2,Negative,in vitro
"(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=NC(=N3)N)N,54-62-6,Positive,in vivo
"(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid",C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=NC(=N3)N)N,54-62-6,Negative,in vitro
(2S)-2-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol;dihydrochloride,CC[C@@H](CO)NCCN[C@@H](CC)CO.Cl.Cl,1070-11-7,Positive,in vitro
(2S)-2-amino-1-phenylpropan-1-one,C[C@@H](C(=O)C1=CC=CC=C1)N,71031-15-7,Positive,in vitro
(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)N,6305,Negative,In Vivo
(2S)-2-amino-3-(2-diazoacetyl)oxypropanoic acid,C([C@@H](C(=O)O)N)OC(=O)C=[N+]=[N-],0115-02-06,Positive,in vivo
(2S)-2-amino-3-(2-diazoacetyl)oxypropanoic acid,C([C@@H](C(=O)O)N)OC(=O)C=[N+]=[N-],460129,Positive,In Vivo
(2S)-2-amino-3-(2-diazoacetyl)oxypropanoic acid,C([C@@H](C(=O)O)N)OC(=O)C=[N+]=[N-],0115-02-06,Positive,in vitro
"(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid;trihydrate",C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N.C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N.O.O.O,38852,Negative,In Vivo
(2S)-2-amino-3-[2-[methyl(nitroso)amino]acetyl]oxypropanoic acid,CN(CC(=O)OC[C@@H](C(=O)O)N)N=O,,Positive,in vitro
(2S)-2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid,C1=CC(=CC(=C1)N(CCCl)CCCl)C[C@@H](C(=O)O)N,1088-80-8,Positive,in vitro
(2S)-2-amino-3-[3-[methyl(nitroso)amino]propanoyloxy]propanoic acid,CN(CCC(=O)OC[C@@H](C(=O)O)N)N=O,52977-61-4,Positive,in vitro
(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl,460612,Positive,In Vivo
(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl,148-82-3,Positive,in vivo
(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl,148-82-3,Positive,in vitro
(2S)-2-amino-3-[4-[methyl(nitroso)amino]butoxy]propanoic acid,CN(CCCCOC[C@@H](C(=O)O)N)N=O,,Negative,in vitro
(2S)-2-amino-4-ethylsulfanylbutanoic acid,CCSCC[C@@H](C(=O)O)N,13073-35-3,Positive,in vivo
(2S)-2-amino-4-ethylsulfanylbutanoic acid,CCSCC[C@@H](C(=O)O)N,25674,Negative,In Vivo
(2S)-2-amino-4-ethylsulfanylbutanoic acid,CCSCC[C@@H](C(=O)O)N,25674,Positive,In Vivo
(2S)-2-amino-4-ethylsulfanylbutanoic acid,CCSCC[C@@H](C(=O)O)N,13073-35-3,Negative,in vitro
(2S)-2-amino-4-methylsulfanylbutanoic acid,CSCC[C@@H](C(=O)O)N,63-68-3,Negative,in vivo
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid,C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,70-18-8,Positive,in vitro
"(2S)-2-amino-5-[[(2R)-3-[3,4-bis[[(2R)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-3-(carboxymethylamino)-3-oxopropyl]sulfanyl]-2,5-dihydroxyphenyl]sulfanyl-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid",C1=C(C(=C(C(=C1SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)O)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)O,101644674,Positive,In Vivo
(2S)-2-amino-5-[[methyl(nitroso)carbamoyl]amino]pentanoic acid,CN(C(=O)NCCC[C@@H](C(=O)O)N)N=O,107919,Positive,In Vivo
(2S)-2-amino-5-[2-[4-(hydroxymethyl)phenyl]hydrazinyl]-5-oxopentanoic acid,C1=CC(=CC=C1CO)NNC(=O)CC[C@@H](C(=O)O)N,439517,Negative,In Vivo
(2S)-2-amino-5-[carbamoyl(nitroso)amino]pentanoic acid,C(C[C@@H](C(=O)O)N)CN(C(=O)N)N=O,,Positive,in vitro
"(2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide",CN(C)C1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)NC(=O)[C@H](CC4=CC=C(C=C4)OC)N)O,53-79-2,Negative,in vivo
"(2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide",CN(C)C1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)NC(=O)[C@H](CC4=CC=C(C=C4)OC)N)O,53-79-2,Negative,in vitro
(2S)-2-aminobutanedioic acid,C([C@@H](C(=O)O)N)C(=O)O,56-84-8,Positive,in vivo
(2S)-2-aminobutanedioic acid,C([C@@H](C(=O)O)N)C(=O)O,56-84-8,Positive,in vitro
(2S)-2-methoxy-3-[4-[3-(4-phenoxyphenoxy)propoxy]phenyl]propanoic acid,CO[C@@H](CC1=CC=C(C=C1)OCCCOC2=CC=C(C=C2)OC3=CC=CC=C3)C(=O)O,9888484,Negative,In Vivo
(2S)-2-methoxy-3-[4-[3-(4-phenoxyphenoxy)propoxy]phenyl]propanoic acid,CO[C@@H](CC1=CC=C(C=C1)OCCCOC2=CC=C(C=C2)OC3=CC=CC=C3)C(=O)O,9888484,Positive,In Vivo
(2S)-2-methyl-1-nitrosopiperidine,C[C@H]1CCCCN1N=O,36702-44-0,Positive,in vivo
"(2S)-2,5-diaminopentanoic acid",C(C[C@@H](C(=O)O)N)CN,70-26-8,Negative,in vivo
"(2S)-2,6-diaminohexanoic acid",C(CCN)C[C@@H](C(=O)O)N,56-87-1,Negative,in vivo
"(2S)-3-[(1E,3E,5E,7E,9E)-dodeca-1,3,5,7,9-pentaenoxy]propane-1,2-diol",CC/C=C/C=C/C=C/C=C/C=C/OC[C@H](CO)O,6437067,Negative,In Vivo
"(2S)-3-[(1E,3E,5E,7E,9E)-dodeca-1,3,5,7,9-pentaenoxy]propane-1,2-diol",CC/C=C/C=C/C=C/C=C/C=C/OC[C@H](CO)O,6437067,Positive,In Vivo
"(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide",C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N,37517-28-5,Negative,in vitro
"(2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=C4C(=O)C[C@H](OC4=C3)C5=CC(=C(C=C5)OC)O)O)CO)O)O)O)O)O,13241-33-3,Negative,in vitro
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8,,Positive,in vivo
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,50225,Negative,In Vivo
(2S)-pyrrolidine-2-carboxylic acid,C1C[C@H](NC1)C(=O)O,147-85-3,Negative,in vitro
"(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid",CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C,4759-48-2,Positive,in vitro
"(2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylidene)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(C/C(=C/O)/C(=O)C4)C,5281034,Positive,In Vivo
"(3-((IMINO((2,2,2-TRIFLUOROETHYL)AMINO)METHYL)AMINO)-1H-PYRAZOLE-1-PENTAMIDE)",C1=CN(N=C1NC(=NCC(F)(F)F)N)CCCCC(=O)N,84545-30-2,Positive,In vivo
"(3-diethoxyphosphinothioylsulfanyl-1,4-dioxan-2-yl)sulfanyl-diethoxy-sulfanylidene-lambda5-phosphane",CCOP(=S)(OCC)SC1C(OCCO1)SP(=S)(OCC)OCC,6531,Negative,In Vivo
"(3-diethoxyphosphinothioylsulfanyl-1,4-dioxan-2-yl)sulfanyl-diethoxy-sulfanylidene-lambda5-phosphane",CCOP(=S)(OCC)SC1C(OCCO1)SP(=S)(OCC)OCC,78-34-2,Negative,in vivo
"(3-hydrazinyl-7,8-dihydro-5H-pyrido[4,3-c]pyridazin-6-yl)-phenylmethanone;methanesulfonic acid",CS(=O)(=O)O.C1CN(CC2=CC(=NN=C21)NN)C(=O)C3=CC=CC=C3,65322-72-7,Positive,in vivo
(3-methoxy-4-nitrophenyl)-phenyldiazene,COC1=C(C=CC(=C1)N=NC2=CC=CC=C2)[N+](=O)[O-],,Positive,in vitro
"(3-methyl-1,2-dihydrobenzo[j]aceanthrylen-1-yl) hydrogen sulfate",CC1=C2CC(C3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1)OS(=O)(=O)O,154823,Positive,In Vivo
(3-methylphenyl) N-methyl-N-nitrosocarbamate,CC1=CC(=CC=C1)OC(=O)N(C)N=O,,Positive,in vitro
(3-methylphenyl) N-methylcarbamate,CC1=CC(=CC=C1)OC(=O)NC,1129-41-5,Negative,in vitro
(3-pentan-3-ylphenyl) N-methyl-N-nitrosocarbamate,CCC(CC)C1=CC(=CC=C1)OC(=O)N(C)N=O,,Positive,in vitro
"(3-phenoxyphenyl)methyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate",CC(=CC1C(C1(C)C)C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C,26002-80-2,Negative,in vitro
"(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,52645-53-1,Negative,in vitro
"(3,4-dimethylphenyl) N-methyl-N-nitrosocarbamate",CC1=C(C=C(C=C1)OC(=O)N(C)N=O)C,,Positive,in vitro
"(3,4-dimethylphenyl) N-methylcarbamate",CC1=C(C=C(C=C1)OC(=O)NC)C,2425-10-7,Negative,in vitro
"(3,5-dimethylphenyl) N-methyl-N-nitrosocarbamate",CC1=CC(=CC(=C1)OC(=O)N(C)N=O)C,,Positive,in vitro
"(3,5-dimethylphenyl) N-methylcarbamate",CC1=CC(=CC(=C1)OC(=O)NC)C,2655-14-3,Negative,in vitro
"(3'S,4'S,6S,9'S)-3',4',8',9',12',14'-hexahydroxy-16'-methoxy-1,5,5-trimethyl-6',10'-dioxospiro[cyclohexene-6,18'-pentacyclo[11.6.1.02,11.04,9.017,20]icosa-1(20),2(11),7,12,14,16-hexaene]-7'-carboxamide",CC1=CCCC([C@@]12CC3=C4C2=C(C=C(C4=C(C5=C3[C@@H]([C@]6(CC(=O)C(=C([C@]6(C5=O)O)O)C(=O)N)O)O)O)O)OC)(C)C,39277-41-3,Positive,in vitro
"(3aR,5R,5aR,8aR,9S,9aS)-9-hydroxy-5,8a-dimethyl-1-methylidene-3a,4,5,5a,9,9a-hexahydroazuleno[6,7-b]furan-2,8-dione",C[C@@H]1C[C@@H]2[C@H]([C@@H]([C@]3([C@H]1C=CC3=O)C)O)C(=C)C(=O)O2,6754-13-8,Negative,in vitro
"(3aR,7aS)-2-(1,1,2,2-tetrachloroethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione",C1C=CC[C@H]2[C@@H]1C(=O)N(C2=O)SC(C(Cl)Cl)(Cl)Cl,16760159,Positive,In Vivo
"(3aR,7aS)-2-(1,1,2,2-tetrachloroethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione",C1C=CC[C@H]2[C@@H]1C(=O)N(C2=O)SC(C(Cl)Cl)(Cl)Cl,2939-80-2,Negative,in vitro
"(3aR,7aS)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione",C1C=CC[C@H]2[C@@H]1C(=O)N(C2=O)SC(Cl)(Cl)Cl,133-06-2,Positive,in vitro
"(3aS,7aR)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione",C1C=CC[C@H]2[C@@H]1C(=O)N(C2=O)SC(Cl)(Cl)Cl,18594026,Negative,In Vivo
"(3aS,7aR)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione",C1C=CC[C@H]2[C@@H]1C(=O)N(C2=O)SC(Cl)(Cl)Cl,,Negative,in vivo
"(3aS,7aR)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione",C1C=CC[C@H]2[C@@H]1C(=O)N(C2=O)SC(Cl)(Cl)Cl,18594026,Positive,In Vivo
"(3aS,7aR)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione",C1C=CC[C@H]2[C@@H]1C(=O)N(C2=O)SC(Cl)(Cl)Cl,,Positive,in vivo
"(3aS,7aR)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione",C1C=CC[C@H]2[C@@H]1C(=O)N(C2=O)SC(Cl)(Cl)Cl,,Negative,in vitro
"(3E)-3-(6H-benzo[c][1]benzothiepin-11-ylidene)-N,N-dimethylpropan-1-amine",CN(C)CC/C=C/1\C2=CC=CC=C2CSC3=CC=CC=C31,113-53-1,Negative,in vivo
"(3R,4R)-12-(hydroxymethyl)-7-methyl-3,4-dihydrobenzo[a]anthracene-3,4-diol",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)CO)C=C[C@H]([C@@H]3O)O,,Positive,in vivo
"(3R,4R)-12-(hydroxymethyl)-7-methyl-3,4-dihydrobenzo[a]anthracene-3,4-diol",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)CO)C=C[C@H]([C@@H]3O)O,,Positive,in vitro
"(3R,4R)-3,4-dihydrobenzo[a]anthracene-3,4-diol",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3C=C[C@H]([C@@H]4O)O,,Positive,in vivo
"(3R,4R)-3,4-dihydrobenzo[a]anthracene-3,4-diol",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3C=C[C@H]([C@@H]4O)O,,Positive,in vitro
"(3R,4R)-3,4-dihydrobenzo[c]acridine-3,4-diol",C1=CC=C2C(=C1)C=C3C=CC4=C(C3=N2)C=C[C@H]([C@@H]4O)O,53653,Positive,In Vivo
"(3R,4R)-3,4-dihydronaphtho[1,2-b]phenanthrene-3,4-diol",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)C=C[C@H]([C@@H]5O)O,66267-19-4,Positive,in vivo
"(3R,4R)-3,4-dihydronaphtho[1,2-b]phenanthrene-3,4-diol",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=C(C4=C3)C=C[C@H]([C@@H]5O)O,66267-19-4,Positive,in vitro
"(3R,4R)-7-(hydroxymethyl)-12-methyl-3,4-dihydrobenzo[a]anthracene-3,4-diol",CC1=C2C3=C(C=CC2=C(C4=CC=CC=C14)CO)[C@H]([C@@H](C=C3)O)O,,Positive,in vivo
"(3R,4R)-7-methyl-3,4-dihydrobenzo[a]anthracene-3,4-diol",CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)C=C[C@H]([C@@H]3O)O,,Positive,in vivo
"(3R,4R)-7-methyl-3,4-dihydrobenzo[a]anthracene-3,4-diol",CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)C=C[C@H]([C@@H]3O)O,,Positive,in vitro
"(3R,4S,5R,7S)-6-oxahexacyclo[11.6.2.02,8.05,7.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-3,4-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@H]([C@@H]([C@@H]6[C@H]5O6)O)O)C=C2,,Positive,in vitro
"(3R,4S,5R)-3,4,5-trihydroxycyclohexene-1-carboxylic acid",C1[C@H]([C@@H]([C@@H](C=C1C(=O)O)O)O)O,138-59-0,Negative,in vitro
"(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,0114-07-08,Negative,in vitro
"(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;octadecanoic acid",CCCCCCCCCCCCCCCCCC(=O)O.CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,12559,Negative,In Vivo
"(3R,4S,5S,7R)-6-oxahexacyclo[11.6.2.02,8.05,7.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-3,4-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@H]([C@@H]([C@H]6[C@@H]5O6)O)O)C=C2,,Positive,in vitro
"(3R,4S)-6-hydroxy-3,4,5-trimethyl-8-oxo-3,4-dihydroisochromene-7-carboxylic acid",C[C@@H]1[C@H](OC=C2C1=C(C(=C(C2=O)C(=O)O)O)C)C,54680783,Negative,In Vivo
"(3R,4S)-6-hydroxy-3,4,5-trimethyl-8-oxo-3,4-dihydroisochromene-7-carboxylic acid",C[C@@H]1[C@H](OC=C2C1=C(C(=C(C2=O)C(=O)O)O)C)C,54680783,Positive,In Vivo
"(3R,4S)-6-hydroxy-3,4,5-trimethyl-8-oxo-3,4-dihydroisochromene-7-carboxylic acid",C[C@@H]1[C@H](OC=C2C1=C(C(=C(C2=O)C(=O)O)O)C)C,518-75-2,Negative,in vitro
"(3R,5R)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid",C1[C@H](C([C@@H](CC1(C(=O)O)O)O)O)O,77-95-2,Negative,in vitro
"(3R,5S,6R,7S)-4-oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-6,7-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]6[C@@H](O6)[C@@H]([C@H]5O)O)C=C2,,Positive,in vitro
"(3R,5S,6S,7R)-18,19-dimethyl-4-oxapentacyclo[9.8.0.02,8.03,5.012,17]nonadeca-1(11),2(8),9,12,14,16,18-heptaene-6,7-diol",CC1=C(C2=C(C=CC3=C2[C@@H]4[C@@H](O4)[C@H]([C@@H]3O)O)C5=CC=CC=C15)C,91827184,Positive,In Vivo
"(3R,5S,6S,7R)-4-oxaheptacyclo[11.10.2.02,8.03,5.010,24.017,25.018,23]pentacosa-1(24),2(8),9,11,13(25),14,16,18,20,22-decaene-6,7-diol",C1=CC=C2C(=C1)C3=CC=CC4=C3C5=C2C6=C(C=C5C=C4)[C@H]([C@@H]([C@H]7[C@@H]6O7)O)O,164497,Positive,In Vivo
"(3R,5S,6S,7R)-4-oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-6,7-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]6[C@@H](O6)[C@H]([C@@H]5O)O)C=C2,44461,Positive,In Vivo
"(3R,5S,6S,7R)-4-oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-6,7-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]6[C@@H](O6)[C@H]([C@@H]5O)O)C=C2,58917-67-2,Positive,in vivo
"(3R,5S,6S,7R)-4-oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-6,7-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]6[C@@H](O6)[C@H]([C@@H]5O)O)C=C2,58917-67-2,Positive,in vitro
"(3R,5S,6S,7R)-4-oxapentacyclo[9.8.0.02,8.03,5.012,17]nonadeca-1(11),2(8),9,12,14,16,18-heptaene-6,7-diol",C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3[C@@H]5[C@@H](O5)[C@H]([C@@H]4O)O,51545,Negative,In Vivo
"(3R,5S,6S,7R)-4-oxapentacyclo[9.8.0.02,8.03,5.012,17]nonadeca-1(11),2(8),9,12,14,16,18-heptaene-6,7-diol",C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3[C@@H]5[C@@H](O5)[C@H]([C@@H]4O)O,51545,Positive,In Vivo
"(3R,5S,6S,7S)-19-methyl-4-oxapentacyclo[9.8.0.02,8.03,5.012,17]nonadeca-1(11),2(8),9,12,14,16,18-heptaene-6,7-diol",CC1=CC2=CC=CC=C2C3=C1C4=C(C=C3)[C@@H]([C@@H]([C@H]5[C@@H]4O5)O)O,57175,Positive,In Vivo
"(3R,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one",C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O,53-41-8,Negative,in vivo
"(3R,5S)-4-oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene",C1CC2=C([C@@H]3[C@H]1O3)C4=C5C(=C2)C=CC6=C5C(=CC=C6)C=C4,,Negative,in vitro
"(3R,7R,10S,13R,16R,17S,18R)-17,18-dichloro-13-ethyl-3,10-bis(hydroxymethyl)-7-phenyl-1,4,8,11,14-pentazabicyclo[14.3.0]nonadecane-2,5,9,12,15-pentone",CC[C@@H]1C(=O)N[C@H](C(=O)N[C@H](CC(=O)N[C@@H](C(=O)N2C[C@H]([C@H]([C@H]2C(=O)N1)Cl)Cl)CO)C3=CC=CC=C3)CO,77098495,Positive,In Vivo
"(3R,7R)-3-hydroxy-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaene-16,18-dione",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C(=C1)O[C@@H]5[C@]4(C=CO5)O,15558498,Positive,In Vivo
"(3R,7R)-3-hydroxy-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaene-16,18-dione",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C(=C1)O[C@@H]5[C@]4(C=CO5)O,6795-23-9,Positive,in vitro
"(3R)-3,4-dihydrobenzo[h]triphenylene-3,4-diol",C1=CC=C2C=C3C4=CC=CC=C4C5=C(C3=CC2=C1)C=C[C@H](C5O)O,,Positive,in vitro
"(3S,4R,5R)-1,3,4,5,6-pentahydroxyhexan-2-one",C([C@H]([C@H]([C@@H](C(=O)CO)O)O)O)O,5984,Negative,In Vivo
"(3S,4R,5R)-6-oxahexacyclo[11.6.2.02,8.05,7.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-3,4-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]([C@H]([C@@H]6C5O6)O)O)C=C2,66212-61-1,Positive,in vitro
"(3S,4R,5S,7R)-6-oxahexacyclo[11.6.2.02,8.05,7.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-3,4-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]([C@H]([C@H]6[C@@H]5O6)O)O)C=C2,,Negative,in vitro
"(3S,4R,5S,7S)-4,5-dichloro-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,9,11,13(17)-tetraene-16,18-dione",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5[C@H]([C@@H](O[C@@H]5OC4=C1)Cl)Cl,,Positive,in vitro
"(3S,4S)-7,12-dimethyl-3,4-dihydrobenzo[a]anthracene-3,4-diol",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C=C[C@@H]([C@H]3O)O,68162-13-0,Positive,in vivo
"(3S,4S)-7,12-dimethyl-3,4-dihydrobenzo[a]anthracene-3,4-diol",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C=C[C@@H]([C@H]3O)O,156317,Positive,In Vivo
"(3S,4S)-7,12-dimethyl-3,4-dihydrobenzo[a]anthracene-3,4-diol",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C=C[C@@H]([C@H]3O)O,68162-13-0,Positive,in vitro
"(3S,5R,6R,7S)-10-methyl-4-oxapentacyclo[9.8.0.02,8.03,5.012,17]nonadeca-1(11),2(8),9,12,14,16,18-heptaene-6,7-diol",CC1=CC2=C([C@H]3[C@H](O3)[C@@H]([C@H]2O)O)C4=C1C5=CC=CC=C5C=C4,119140,Negative,In Vivo
"(3S,5R,6R,7S)-10-methyl-4-oxapentacyclo[9.8.0.02,8.03,5.012,17]nonadeca-1(11),2(8),9,12,14,16,18-heptaene-6,7-diol",CC1=CC2=C([C@H]3[C@H](O3)[C@@H]([C@H]2O)O)C4=C1C5=CC=CC=C5C=C4,119140,Positive,In Vivo
"(3S,5R,6R,7S)-19-ethyl-4-oxapentacyclo[9.8.0.02,8.03,5.012,17]nonadeca-1(11),2(8),9,12,14,16,18-heptaene-6,7-diol",CCC1=CC2=CC=CC=C2C3=C1C4=C(C=C3)[C@@H]([C@H]([C@@H]5[C@H]4O5)O)O,147468,Negative,In Vivo
"(3S,5R,6R,7S)-19-methyl-4-oxapentacyclo[9.8.0.02,8.03,5.012,17]nonadeca-1(11),2(8),9,12,14,16,18-heptaene-6,7-diol",CC1=CC2=CC=CC=C2C3=C1C4=C(C=C3)[C@@H]([C@H]([C@@H]5[C@H]4O5)O)O,57139,Positive,In Vivo
"(3S,5R,6R,7S)-4-oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-6,7-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@H]6[C@H](O6)[C@@H]([C@H]5O)O)C=C2,63323-30-8,Positive,in vitro
"(3S,5R,6S,7R)-4-oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-6,7-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@H]6[C@H](O6)[C@H]([C@@H]5O)O)C=C2,63357-09-05,Positive,in vitro
"(3S,5R)-4-oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),6,9,11,13(21),14,16,18-nonaene",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@H]6[C@H](O6)C=C5)C=C2,,Negative,in vitro
"(3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-3-[(4R,6R)-4-methoxy-6-methyl-5-[(1S,2S,3R,4S,5S)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyoxan-2-yl]oxy-8,9,13-trimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde",C[C@@H]1C([C@@H](CC(O1)O[C@H]2CC[C@@]3([C@]4(CC[C@@]5([C@H](CC[C@]5([C@@]4(CC[C@@]3(C2)O)C)O)C6=CC(=O)OC6)C)C)C=O)OC)O[C@H]7C[C@H]([C@@H]([C@H]([C@@H]7O)O)O)CO,11005-63-3,Negative,in vitro
"(3S,6R,7R)-4-oxapentacyclo[9.8.0.02,8.03,5.013,18]nonadeca-1(19),2(8),9,11,13,15,17-heptaene-6,7-diol",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3[C@H]5C(O5)[C@@H]([C@@H]4O)O,,Positive,in vitro
"(3S,6R,7S)-4-oxapentacyclo[9.8.0.02,8.03,5.013,18]nonadeca-1(19),2(8),9,11,13,15,17-heptaene-6,7-diol",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3[C@H]5C(O5)[C@@H]([C@H]4O)O,,Positive,in vitro
"(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,5284373,Negative,In Vivo
"(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,59865-13-3,Negative,in vitro
"(3S,7R,14S)-14-hydroxy-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaene-16,18-dione",COC1=C2C3=C(C(=O)C[C@@H]3O)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,52819-96-2,Positive,in vitro
"(3S,7R,16S)-16-hydroxy-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaen-18-one",COC1=C2C3=C([C@H](CC3)O)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,104744,Positive,In Vivo
"(3S,7R,16S)-16-hydroxy-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaen-18-one",COC1=C2C3=C([C@H](CC3)O)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,29611-03-08,Positive,in vitro
"(3S,7R)-11-methoxy-6,8,16,20-tetraoxapentacyclo[10.8.0.02,9.03,7.013,18]icosa-1,4,9,11,13(18)-pentaene-17,19-dione",COC1=C2C3=C(C(=O)OCC3)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,2724361,Positive,In Vivo
"(3S,7R)-11-methoxy-6,8,16,20-tetraoxapentacyclo[10.8.0.02,9.03,7.013,18]icosa-1,4,9,11,13(18)-pentaene-17,19-dione",COC1=C2C3=C(C(=O)OCC3)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,,Positive,in vivo
"(3S,7R)-11-methoxy-6,8,16,20-tetraoxapentacyclo[10.8.0.02,9.03,7.013,18]icosa-1,4,9,11,13(18)-pentaene-17,19-dione",COC1=C2C3=C(C(=O)OCC3)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,,Negative,in vitro
"(3S,7R)-11-methoxy-6,8,16,20-tetraoxapentacyclo[10.8.0.02,9.03,7.013,18]icosa-1,9,11,13(18)-tetraene-17,19-dione",COC1=C2C3=C(C(=O)OCC3)C(=O)OC2=C4[C@@H]5CCO[C@@H]5OC4=C1,7241-98-7,Negative,in vitro
"(3S,7R)-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaene-16,18-dione",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,186907,Negative,In Vivo
"(3S,7R)-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaene-16,18-dione",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,186907,Positive,In Vivo
"(3S,7R)-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaene-16,18-dione",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,1162-65-8,Negative,in vivo
"(3S,7R)-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaene-16,18-dione",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,1162-65-8,Positive,in vivo
"(3S,7R)-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaene-16,18-dione",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,1162-65-8,Positive,in vitro
"(3S,7R)-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,9,11,13(17)-tetraene-16,18-dione",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5CCO[C@@H]5OC4=C1,2724360,Positive,In Vivo
"(3S,7R)-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,9,11,13(17)-tetraene-16,18-dione",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5CCO[C@@H]5OC4=C1,7220-81-7,Positive,in vivo
"(3S,7R)-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,9,11,13(17)-tetraene-16,18-dione",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5CCO[C@@H]5OC4=C1,7220-81-7,Negative,in vitro
"(3S,7R)-14,16-dihydroxy-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaen-18-one",COC1=C2C3=C(C(CC3O)O)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,,Positive,in vitro
"(3S,7R)-15-hydroxy-11-methoxy-6,8,20-trioxapentacyclo[10.8.0.02,9.03,7.014,19]icosa-1,4,9,11,14,16,18-heptaen-13-one",COC1=C2C(=C3[C@@H]4C=CO[C@@H]4OC3=C1)OC5=CC=CC(=C5C2=O)O,5280389,Positive,In Vivo
"(3S,7R)-15-hydroxy-11-methoxy-6,8,20-trioxapentacyclo[10.8.0.02,9.03,7.014,19]icosa-1,4,9,11,14,16,18-heptaen-13-one",COC1=C2C(=C3[C@@H]4C=CO[C@@H]4OC3=C1)OC5=CC=CC(=C5C2=O)O,10048-13-2,Positive,in vivo
"(3S,7R)-15-hydroxy-11-methoxy-6,8,20-trioxapentacyclo[10.8.0.02,9.03,7.014,19]icosa-1,4,9,11,14,16,18-heptaen-13-one",COC1=C2C(=C3[C@@H]4C=CO[C@@H]4OC3=C1)OC5=CC=CC(=C5C2=O)O,10048-13-2,Positive,in vitro
"(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O)C,5881,Positive,In Vivo
"(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,57-88-5,Negative,in vitro
(3S)-3-amino-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid,COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N,134601,Negative,In Vivo
"(3Z)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine",CN(C)CC/C=C\1/C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,113-59-7,Positive,in vitro
"(3Z)-3-[(2E,4E,6E,8E,10E)-1-hydroxy-11-(6-hydroxy-2-methyl-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-5-yl)undeca-2,4,6,8,10-pentaenylidene]-1-methyl-5-propan-2-ylpyrrolidine-2,4-dione",CC1CC2C(O1)C(C(O2)/C=C/C=C/C=C/C=C/C=C/C(=C/3\C(=O)C(N(C3=O)C)C(C)C)/O)O,,Negative,in vitro
"(4-bromo-2,5-dichlorophenoxy)-methoxy-phenyl-sulfanylidene-lambda5-phosphane",COP(=S)(C1=CC=CC=C1)OC2=CC(=C(C=C2Cl)Br)Cl,21609-90-5,Positive,in vitro
(4-chlorophenyl)sulfanylmethylsulfanyl-diethoxy-sulfanylidene-lambda5-phosphane,CCOP(=S)(OCC)SCSC1=CC=C(C=C1)Cl,786-19-6,Positive,in vitro
(4-hydrazinylphthalazin-1-yl)hydrazine;sulfuric acid,C1=CC=C2C(=C1)C(=NN=C2NN)NN.OS(=O)(=O)O,7327-87-9,Positive,in vivo
(4-hydroxy-3-nitrophenyl)arsonic acid,C1=CC(=C(C=C1[As](=O)(O)O)[N+](=O)[O-])O,5104,Negative,In Vivo
(4-methyl-7-oxabicyclo[4.1.0]heptan-3-yl)methyl 4-methyl-7-oxabicyclo[4.1.0]heptane-3-carboxylate,CC1CC2C(O2)CC1COC(=O)C3CC4C(O4)CC3C,61094,Positive,In Vivo
(4-nitrophenyl)-phenyldiazene,C1=CC=C(C=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-],2491-52-3,Positive,in vitro
(4-phenylphenyl)azanium;chloride,C1=CC=C(C=C1)C2=CC=C(C=C2)[NH3+].[Cl-],,Positive,in vitro
(4-phenylphenyl)carbamic acid,C1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)O,54159,Negative,In Vivo
(4-phenylphenyl)methanol,C1=CC=C(C=C1)C2=CC=C(C=C2)CO,3597-91-9,Positive,in vitro
"(4aR,5S,9bR)-2-ethyl-7-methyl-5-(4-methylphenyl)-1,3,4,4a,5,9b-hexahydroindeno[1,2-c]pyridine;hydrochloride",CCN1CC[C@H]2[C@@H](C1)C3=C([C@@H]2C4=CC=C(C=C4)C)C=C(C=C3)C.Cl,,Negative,in vivo
"(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol;hydrochloride",CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O.Cl,52-26-6,Negative,in vivo
"(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol",CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,5284371,Negative,In Vivo
"(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol;phosphoric acid",CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O.OP(=O)(O)O,52-28-8,Negative,in vivo
"(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,16590-41-3,Negative,in vivo
"(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,16590-41-3,Positive,in vitro
"(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride",C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O.Cl,16676-29-2,Negative,in vitro
"(4R,5R)-4,5-dihydrobenzo[a]pyrene-4,5-diol",C1=CC=C2C3=C4C(=CC2=C1)[C@H]([C@@H](C5=CC=CC(=C54)C=C3)O)O,37571-88-3,Positive,in vivo
"(4R,5R)-4,5-dihydrobenzo[a]pyrene-4,5-diol",C1=CC=C2C3=C4C(=CC2=C1)[C@H]([C@@H](C5=CC=CC(=C54)C=C3)O)O,37571-88-3,Negative,in vitro
"(4R,6S,7S,8R)-5-oxapentacyclo[9.8.0.03,9.04,6.014,19]nonadeca-1,3(9),10,12,14,16,18-heptaene-7,8-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)[C@@H]5[C@@H](O5)[C@H]([C@@H]4O)O,64937-40-2,Positive,in vitro
"(4R,8R)-2,4,18-trihydroxy-15-(3-hydroxy-3-methylbutyl)-7,9,13-trioxapentacyclo[10.8.0.03,10.04,8.014,19]icosa-1,3(10),5,11,14,16,18-heptaen-20-one",CC(C)(CCC1=C2C(=C(C=C1)O)C(=O)C3=C(C4=C(C=C3O2)O[C@@H]5[C@]4(C=CO5)O)O)O,55256-53-6,Positive,in vitro
(4R)-1-methyl-4-prop-1-en-2-ylcyclohexene,CC1=CC[C@@H](CC1)C(=C)C,440917,Negative,In Vivo
(4R)-1-methyl-4-prop-1-en-2-ylcyclohexene,CC1=CC[C@@H](CC1)C(=C)C,440917,Positive,In Vivo
"(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3-sulfooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)OS(=O)(=O)O)C)C,34669-57-3,Negative,in vitro
"(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,9903,Negative,In Vivo
"(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,434-13-9,Positive,in vitro
"(4R)-4-amino-1,2-oxazolidin-3-one",C1[C@H](C(=O)NO1)N,68-41-7,Negative,in vitro
"(4S,12E)-16,18-dihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraene-2,8-dione",C[C@H]1CCCC(=O)CCC/C=C/C2=C(C(=CC(=C2)O)O)C(=O)O1,5281576,Positive,In Vivo
"(4S,12E)-16,18-dihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraene-2,8-dione",C[C@H]1CCCC(=O)CCC/C=C/C2=C(C(=CC(=C2)O)O)C(=O)O1,5281576,Negative,In Vivo
"(4S,12E)-16,18-dihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraene-2,8-dione",C[C@H]1CCCC(=O)CCC/C=C/C2=C(C(=CC(=C2)O)O)C(=O)O1,17924-92-4,Negative,in vitro
"(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride",C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O.Cl,54680782,Negative,In Vivo
"(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide",C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,60-54-8,Negative,in vitro
"(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride",C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl,54704426,Negative,In Vivo
"(4S,4aS,8aR)-4,8a-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-4a-ol",C[C@H]1CCC[C@@]2([C@@]1(CCCC2)O)C,19700-21-1,Negative,in vitro
"(4S,5R)-4,5,6-trihydroxy-2-oxohexanal",C([C@@H]([C@@H](CO)O)O)C(=O)C=O,114839,Negative,In Vivo
"(4S,5R)-8-chloro-3'-methyl-4-(methylamino)spiro[3,4-dihydro-1H-benzo[cd]indole-5,5'-furan]-2'-one",CC1=C[C@@]2([C@H](CC3=CNC4=C(C=CC2=C34)Cl)NC)OC1=O,59787-45-0,Negative,in vitro
"(4S,5S)-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-1,3-thiazolidine-3-carboxamide",C[C@H]1[C@@H](SC(=O)N1C(=O)NC2CCCCC2)C3=CC=C(C=C3)Cl,13218777,Negative,In Vivo
"(4S,5S)-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-1,3-thiazolidine-3-carboxamide",C[C@H]1[C@@H](SC(=O)N1C(=O)NC2CCCCC2)C3=CC=C(C=C3)Cl,13218777,Positive,In Vivo
"(4S,6R,7S,8R)-5-oxapentacyclo[9.8.0.03,9.04,6.012,17]nonadeca-1,3(9),10,12,14,16,18-heptaene-7,8-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)[C@H]([C@@H]([C@@H]5[C@H]4O5)O)O,,Positive,in vitro
"(4S,6R,7S,8R)-5-oxapentacyclo[9.8.0.03,9.04,6.014,19]nonadeca-1,3(9),10,12,14,16,18-heptaene-7,8-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)[C@H]5[C@H](O5)[C@H]([C@@H]4O)O,64937-39-9,Positive,in vitro
"(4S,6S,7R,8S)-11-amino-8-(hydroxymethyl)-7-methoxy-12-methyl-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-diene-10,13-dione",CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2CO)OC)N4)N,26909-37-5,Positive,in vitro
"(4S,7S,8R)-2,10-dimethyl-5-oxapentacyclo[9.8.0.03,9.04,6.014,19]nonadeca-1,3(9),10,12,14,16,18-heptaene-7,8-diol",CC1=C2C=CC3=CC=CC=C3C2=C(C4=C1[C@H]([C@@H](C5[C@H]4O5)O)O)C,,Positive,in vitro
"(4S,8R)-17-chloro-2,18-dimethoxy-7,9,13-trioxapentacyclo[10.8.0.03,10.04,8.014,19]icosa-1,3(10),5,11,14(19),15,17-heptaen-20-one",COC1=C(C=CC2=C1C(=O)C3=C(C4=C(C=C3O2)O[C@@H]5[C@H]4C=CO5)OC)Cl,55256-58-1,Positive,in vitro
"(4S,8R)-2,16,18-trihydroxy-7,9-dioxapentacyclo[10.8.0.03,10.04,8.014,19]icosa-1,3(10),5,11,14(19),15,17-heptaene-13,20-dione",C1=CO[C@H]2[C@@H]1C3=C(O2)C=C4C(=C3O)C(=O)C5=C(C4=O)C=C(C=C5O)O,6807-96-1,Positive,in vitro
"(4S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide",CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,114750,Negative,In Vivo
(5-amino-10-methylbenzo[a]phenoxazin-9-ylidene)-dimethylazanium;chloride,CC1=CC2=NC3=C(C=C(C4=CC=CC=C43)N)OC2=CC1=[N+](C)C.[Cl-],18472-89-4,Negative,in vitro
"(5-benzylfuran-3-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate",CC(=CC1C(C1(C)C)C(=O)OCC2=COC(=C2)CC3=CC=CC=C3)C,10453-86-8,Negative,in vitro
"(5-chloro-1-propan-2-yl-1,2,4-triazol-3-yl)oxy-diethoxy-sulfanylidene-lambda5-phosphane",CCOP(=S)(OCC)OC1=NN(C(=N1)Cl)C(C)C,39223,Negative,In Vivo
"(5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate",CC1=C(C(=NC=C1COP(=O)([O-])[O-])C)O,8059-24-3,Positive,in vitro
"(5R,6R)-5,6-dihydrobenzo[c]acridine-5,6-diol",C1=CC=C2C(=C1)C=C3[C@H]([C@@H](C4=CC=CC=C4C3=N2)O)O,150735,Negative,In Vivo
"(5R,6R)-5,6-dihydronaphtho[1,2-b]phenanthrene-5,6-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)[C@H]([C@@H](C5=CC=CC=C54)O)O,,Negative,in vitro
"(5R,6S)-5,6-dihydronaphtho[1,2-b]phenanthrene-5,6-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)[C@@H]([C@@H](C5=CC=CC=C54)O)O,,Negative,in vitro
"(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one",C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,33419-42-0,Positive,in vitro
"(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@H](O7)C8=CC=CS8)O)O,29767-20-2,Positive,in vitro
"(5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O,23363-35-1,Positive,in vitro
"(5S,6S)-5,6-dihydrobenzo[c]anthracene-5,6-diol",C1=CC=C2C=C3C4=CC=CC=C4[C@@H]([C@H](C3=CC2=C1)O)O,,Negative,in vitro
"(5S,6S)-5,6-dihydroxy-5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide",C1=CC=C2C(=C1)[C@@H]([C@H](C3=CC=CC=C3N2C(=O)N)O)O,58955-93-4,Positive,in vitro
"(5S,6S)-7-(hydroxymethyl)-12-methyl-5,6-dihydrobenzo[a]anthracene-5,6-diol",CC1=C2C3=CC=CC=C3[C@@H]([C@H](C2=C(C4=CC=CC=C14)CO)O)O,,Negative,in vitro
(5S)-2-methyl-5-prop-1-en-2-ylcyclohex-2-en-1-one,CC1=CC[C@@H](CC1=O)C(=C)C,16724,Negative,In Vivo
(5S)-3-anilino-5-methyl-2-methylsulfanyl-5-phenylimidazol-4-one,C[C@@]1(C(=O)N(C(=N1)SC)NC2=CC=CC=C2)C3=CC=CC=C3,10403199,Negative,In Vivo
"(5S)-5-(morpholin-4-ylmethyl)-3-[(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one",C1COCCN1C[C@H]2CN(C(=O)O2)N=CC3=CC=C(O3)[N+](=O)[O-],3005839,Positive,In Vivo
"(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol",CCCCCC1=CC(=C2[C@@H]3CC(=CC[C@H]3C(OC2=C1)(C)C)C)O,5957-75-5,Negative,in vitro
"(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol",CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O,1972-08-03,Positive,in vivo
"(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol",CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O,16078,Negative,In Vivo
"(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol",CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O,1972-08-03,Negative,in vitro
"(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol",CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)CO)O,36557-05-08,Negative,in vitro
"(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,25614-03-03,Negative,in vivo
"(6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;(2R,3R)-2,3-dihydroxybutanedioic acid",C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C.C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,Positive,in vivo
"(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide;(Z)-but-2-enedioic acid",CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C.C(=C\C(=O)O)\C(=O)O,129-49-7,Positive,in vivo
"(6aR,9R)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CCN(CC)C(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C,50-37-3,Negative,in vivo
"(6aR,9R)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CCN(CC)C(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C,50-37-3,Negative,in vitro
"(6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene",CC(=CCC/C(=C/C=C/C(=C/C=C/C(=C/C=C/C=C(/C=C/C=C(/C=C/C=C(/CCC=C(C)C)\C)\C)\C)/C)/C)/C)C,446925,Negative,In Vivo
"(6R,6aS)-2-[(2S,3R,4R,5S,6S)-3,4-dihydroxy-4,6-dimethyl-5-(methylamino)oxan-2-yl]oxy-4,6-dihydroxy-3-methyl-8-[(E)-prop-1-enyl]-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-11-one",C/C=C/C1=CN2[C@@H](C1)[C@H](NC3=C(C(=C(C=C3C2=O)O[C@H]4[C@@H]([C@]([C@H]([C@@H](O4)C)NC)(C)O)O)C)O)O,12684-33-2,Positive,in vitro
"(6R,7S)-4-oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-6,7-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C6C(O6)[C@@H]([C@H]5O)O)C=C2,60268-85-1,Positive,in vitro
"(6S,7S)-4-oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-6,7-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C6C(O6)[C@H]([C@H]5O)O)C=C2,60268-86-2,Positive,in vitro
"(6S,7S)-pentacyclo[10.7.1.02,11.03,8.016,20]icosa-1(19),2(11),3(8),4,9,12,14,16(20),17-nonaene-6,7-diol",C1=CC2=C3C(=C1)C4=C(C3=CC=C2)C5=C(C=C4)[C@@H]([C@H](C=C5)O)O,115326,Positive,In Vivo
(7-aminophenothiazin-3-ylidene)azanium;chloride,C1=CC2=C(C=C1N)SC3=CC(=[NH2+])C=CC3=N2.[Cl-],581-64-6,Negative,in vitro
(7-methylbenzo[a]anthracen-12-yl)methanol,CC1=C2C=CC3=CC=CC=C3C2=C(C4=CC=CC=C14)CO,,Positive,in vivo
(7-methylbenzo[a]anthracen-12-yl)methanol,CC1=C2C=CC3=CC=CC=C3C2=C(C4=CC=CC=C14)CO,,Positive,in vitro
"(7R,8R)-2-azapentacyclo[12.8.0.03,12.04,9.017,22]docosa-1,3(12),4(9),5,10,13,15,17,19,21-decaene-7,8-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C5=C(C=C4)[C@H]([C@@H](C=C5)O)O)N=C32,12628781,Positive,In Vivo
"(7R,8R)-7,8-dihydrobenzo[a]pyrene-7,8-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=C[C@H]([C@@H]5O)O)C=C2,104889,Positive,In Vivo
"(7R,8R)-7,8-dihydrobenzo[a]pyrene-7,8-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=C[C@H]([C@@H]5O)O)C=C2,60864-95-1,Positive,in vivo
"(7R,8R)-7,8-dihydrobenzo[a]pyrene-7,8-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=C[C@H]([C@@H]5O)O)C=C2,60864-95-1,Positive,in vitro
"(7R,8S,9S,10S)-7,8,9,10-tetrahydrobenzo[a]pyrene-7,8,9,10-tetrol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]([C@@H]([C@H]([C@@H]5O)O)O)O)C=C2,61490-69-5,Negative,in vitro
"(7R,8S)-7,8-dihydroxy-3,7-dimethyl-6-oxo-8H-isochromene-5-carbaldehyde",CC1=CC2=C(C(=O)[C@]([C@H](C2=CO1)O)(C)O)C=O,53043-28-0,Positive,in vitro
"(7S,8R,9R,10S)-7,8,9,10-tetrahydrobenzo[a]pyrene-7,8,9,10-tetrol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]([C@H]([C@@H]([C@H]5O)O)O)O)C=C2,61490-67-3,Negative,in vitro
"(7S,8R,9S,10S)-7,8,9,10-tetrahydrobenzo[a]pyrene-7,8,9,10-tetrol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]([C@@H]([C@@H]([C@H]5O)O)O)O)C=C2,61490-68-4,Negative,in vitro
"(7S,8S,9S)-7,8,9,10-tetrahydrobenzo[a]pyrene-7,8,9-triol",C1[C@@H]([C@@H]([C@H](C2=C1C3=C4C(=C2)C=CC5=C4C(=CC=C5)C=C3)O)O)O,61176-59-8,Negative,in vitro
"(7S,8S)-2-azapentacyclo[12.8.0.03,12.04,9.017,22]docosa-1,3(12),4(9),10,13,15,17,19,21-nonaene-7,8-diol",C1CC2=C(C=CC3=C2N=C4C(=C3)C=CC5=CC=CC=C54)[C@@H]([C@H]1O)O,180266,Negative,In Vivo
"(7S,8S)-3-methyl-1,2,7,8-tetrahydrobenzo[j]aceanthrylene-7,8-diol",CC1=C2CCC3=C2C(=CC4=C3C=CC5=C4[C@@H]([C@H](C=C5)O)O)C=C1,68688-86-8,Positive,in vitro
"(7S,8S)-7,8-dihydrobenzo[a]pyrene-7,8-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=C[C@@H]([C@H]5O)O)C=C2,104853,Positive,In Vivo
"(7S,8S)-7,8-dihydrobenzo[a]pyrene-7,8-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=C[C@@H]([C@H]5O)O)C=C2,57404-88-3,Positive,in vivo
"(7S,8S)-7,8-dihydrobenzo[a]pyrene-7,8-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=C[C@@H]([C@H]5O)O)C=C2,57404-88-3,Positive,in vitro
"(7S,8S)-7,8-dihydrobenzo[f]quinoline-7,8-diol",C1=CC2=C(C=CC3=C2C=C[C@@H]([C@H]3O)O)N=C1,163926,Negative,In Vivo
"(7S,8S)-7,8-dihydrobenzo[h]quinoline-7,8-diol",C1=CC2=C(C3=C(C=C2)[C@@H]([C@H](C=C3)O)O)N=C1,150583,Negative,In Vivo
"(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,23214-92-8,Positive,in vivo
"(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,31703,Positive,In Vivo
"(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,23214-92-8,Positive,in vitro
"(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl,25316-40-9,Positive,in vitro
"(7S,9S)-9-acetyl-6,9,11-trihydroxy-7-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC)O,,Positive,in vitro
"(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,20830-81-3,Positive,in vivo
"(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,30323,Positive,In Vivo
"(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,20830-81-3,Positive,in vitro
"(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride",C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.Cl,20830-81-3,Positive,in vitro
"(7S)-1,2,3,10-tetramethoxy-7-(methylamino)-6,7-dihydro-5H-benzo[a]heptalen-9-one",CN[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,477-30-5,Positive,in vitro
"(8R,9R)-7-methyl-8,9-dihydrobenzo[a]anthracene-8,9-diol",CC1=C2[C@H]([C@@H](C=CC2=CC3=C1C=CC4=CC=CC=C43)O)O,,Positive,in vitro
"(8R,9R)-7,12-dimethyl-8,9-dihydrobenzo[a]anthracene-8,9-diol",CC1=C2C=CC3=CC=CC=C3C2=C(C4=C1[C@H]([C@@H](C=C4)O)O)C,,Positive,in vitro
"(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,68-22-4,Positive,in vivo
"(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,6230,Positive,In Vivo
"(8R,9S,10R,13S,14S,17S)-17-ethyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one",CC[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)O,52-78-8,Positive,in vivo
"(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C,58-22-0,Positive,in vivo
"(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C,58-22-0,Negative,in vivo
"(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C,6013,Positive,In Vivo
"(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C,58-18-4,Negative,in vivo
"(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CCC4=CC(=O)C=C[C@]34C,72-63-9,Positive,in vivo
"(8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,6128,Positive,In Vivo
"(8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,6128,Negative,In Vivo
"(8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol",C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=C3C=CC(=C4)O,5756,Positive,In Vivo
"(8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol",C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=C3C=CC(=C4)O,50-27-1,Positive,in vitro
"(8R,9S,13S,14S,16R,17R)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-16,17-diol",C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=C3C=CC(=C4)OC,1474-53-9,Positive,in vivo
"(8R,9S,13S,14S,16R)-3,16-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one",C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H](C2=O)O)CCC4=C3C=CC(=C4)O,115116,Positive,In Vivo
"(8R,9S,13S,14S,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@H]2O)CCC4=C3C=CC(=C4)O,68570,Negative,In Vivo
"(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O,5991,Positive,In Vivo
"(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O,57-63-6,Positive,in vivo
"(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O,5991,Negative,In Vivo
"(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O,57-63-6,Negative,in vitro
"(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol;[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate",CC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)C#C.C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O,8015-12-1,Negative,in vivo
"(8R,9S,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3CCC(=O)C4,6231,Positive,In Vivo
"(8R,9S,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one;(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3CCC(=O)C4.C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)OC,,Positive,in vivo
"(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)OC,6291,Positive,In Vivo
"(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)OC,72-33-3,Positive,in vivo
"(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-2,3,17-triol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=C(C=C34)O)O,247304,Positive,In Vivo
"(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O,5757,Positive,In Vivo
"(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O,50-28-2,Positive,in vivo
"(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O,50-28-2,Negative,in vitro
"(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,4,17-triol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4O)O,5282360,Negative,In Vivo
"(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,4,17-triol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4O)O,5282360,Positive,In Vivo
"(8R,9S,13S,14S)-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,4,17-trione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=O)C4=O,114862,Negative,In Vivo
"(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O,5870,Positive,In Vivo
"(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O,53-16-7,Positive,in vivo
"(8R)-7,8-dihydrobenzo[n]triphenylene-7,8-diol",C1=CC=C2C=C3C(=CC2=C1)C4=CC=CC=C4C5=C3[C@H](C(C=C5)O)O,,Positive,in vitro
"(8S,9R,10S,13R,14R,17S)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one",CC[C@@]12CC[C@@H]3[C@@H]([C@H]1CC[C@@]2(C#C)O)CCC4=CC(=O)CC[C@@H]34,797-64-8,Negative,in vivo
"(8S,9R,10S,13S,14R)-11-methyl-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17-hexadecahydro-1H-cyclopenta[a]phenanthrene",CC1C[C@@H]2CCC[C@H]2[C@H]3[C@H]1[C@H]4CCCCC4CC3,,Positive,in vitro
"(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one",C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O,50-24-8,Positive,in vivo
"(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one",C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O,5755,Negative,In Vivo
"(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one",C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O,5755,Positive,In Vivo
"(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione",C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C,5865,Negative,In Vivo
"(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,57-83-0,Positive,in vivo
"(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,57-83-0,Negative,in vivo
"(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,5994,Positive,In Vivo
"(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,57-83-0,Negative,in vitro
"(8S,9S,11S,13S,14S,17R)-17-ethynyl-11-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O)OC,11954041,Positive,In Vivo
"(8S,9S,11S,13S,14S,17S)-11-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O)OC,68568,Positive,In Vivo
"(8S,9S,11S,13S,14S,17S)-11,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",C[C@H]1C[C@]2([C@@H](CC[C@@H]2O)[C@H]3[C@H]1C4=C(CC3)C=C(C=C4)O)C,23619914,Negative,In Vivo
"(8S,9S,13S,14S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-ol",C[C@@]12CCC[C@H]1[C@@H]3CCC4=C([C@H]3CC2)C=CC(=C4)O,5888,Negative,In Vivo
"(8S,9S)-12-(hydroxymethyl)-7-methyl-8,9-dihydrobenzo[a]anthracene-8,9-diol",CC1=C2C=CC3=CC=CC=C3C2=C(C4=C1[C@@H]([C@H](C=C4)O)O)CO,,Negative,in vitro
"(8S,9S)-7-(hydroxymethyl)-12-methyl-8,9-dihydrobenzo[a]anthracene-8,9-diol",CC1=C2C=C[C@@H]([C@H](C2=C(C3=C1C4=CC=CC=C4C=C3)CO)O)O,,Positive,in vitro
"(8S,9S)-8,9-dihydrobenzo[a]anthracene-8,9-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C[C@@H]([C@H]4O)O)C=C32,,Negative,in vitro
"(8S,9S)-8,9-dihydronaphtho[1,2-b]quinoline-8,9-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C[C@@H]([C@H]4O)O)N=C32,56842958,Positive,In Vivo
(9-ethylcarbazol-3-yl)azanium;chloride,CCN1C2=C(C=C(C=C2)[NH3+])C3=CC=CC=C31.[Cl-],22487,Positive,In Vivo
"(9R,10R)-9,10-dihydrobenzo[a]pyrene-9,10-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@H]([C@@H](C=C5)O)O)C=C2,,Negative,in vitro
"(9R,10S)-9,10-dihydrobenzo[a]pyrene-9,10-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]([C@@H](C=C5)O)O)C=C2,56484-47-0,Negative,in vitro
"(9R,14S,17S,23R,24S)-23,24-dihydroxy-5-methoxy-12,12-dimethyl-9-(2-methylprop-1-enyl)-10,11-dioxa-8,15,21-triazahexacyclo[12.10.1.02,7.08,25.015,23.017,21]pentacosa-1(25),2(7),3,5-tetraene-16,22-dione",CC(=C[C@@H]1N2C3=C(C=CC(=C3)OC)C4=C2[C@H](CC(OO1)(C)C)N5C(=O)[C@@H]6CCCN6C(=O)[C@@]5([C@H]4O)O)C,12771-72-1,Negative,in vitro
(carbamothioylamino)thiourea,C(=S)(N)NNC(=S)N,2724564,Negative,In Vivo
"(E)-1-[2-[6-(2-chlorophenoxy)-5-fluoropyrimidin-4-yl]oxyphenyl]-1-(5,6-dihydro-1,4,2-dioxazin-3-yl)-N-methoxymethanimine",CO/N=C(\C1=CC=CC=C1OC2=C(C(=NC=N2)OC3=CC=CC=C3Cl)F)/C4=NOCCO4,11048796,Negative,In Vivo
"(E)-1-[2-[6-(2-chlorophenoxy)-5-fluoropyrimidin-4-yl]oxyphenyl]-1-(5,6-dihydro-1,4,2-dioxazin-3-yl)-N-methoxymethanimine",CO/N=C(\C1=CC=CC=C1OC2=C(C(=NC=N2)OC3=CC=CC=C3Cl)F)/C4=NOCCO4,11048796,Positive,In Vivo
(E)-1-chloroprop-1-ene,C/C=C/Cl,5284364,Positive,In Vivo
"(E)-1,3-dichloroprop-1-ene",C(/C=C/Cl)Cl,24726,Negative,In Vivo
"(E)-1,3-dichloroprop-1-ene",C(/C=C/Cl)Cl,24726,Positive,In Vivo
"(E)-1,3-dichloroprop-1-ene",C(/C=C/Cl)Cl,10061-02-06,Positive,in vitro
"(E)-1,4-dichlorobut-2-ene",C(/C=C/CCl)Cl,642197,Positive,In Vivo
"(E)-1,4-dichlorobut-2-ene",C(/C=C/CCl)Cl,110-57-6,Positive,in vitro
"(E)-3-(1,3-benzodioxol-5-yl)prop-1-en-1-ol",C1OC2=C(O1)C=C(C=C2)C/C=C/O,,Positive,in vitro
"(E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid",C1=CC(=C(C=C1/C=C/C(=O)O)O)O,689043,Negative,In Vivo
"(E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid",C1=CC(=C(C=C1/C=C/C(=O)O)O)O,689043,Positive,In Vivo
(E)-3-(5-nitrofuran-2-yl)-N-propan-2-ylprop-2-enamide,CC(C)NC(=O)/C=C/C1=CC=C(O1)[N+](=O)[O-],1951-56-0,Positive,in vitro
(E)-3-(5-nitrofuran-2-yl)prop-2-enamide,C1=C(OC(=C1)[N+](=O)[O-])/C=C/C(=O)N,710-25-8,Positive,in vitro
(E)-3-(5-nitrofuran-2-yl)prop-2-enoic acid,C1=C(OC(=C1)[N+](=O)[O-])/C=C/C(=O)O,6281-23-8,Positive,in vitro
"(E)-3-[(6R,6aS)-4,6-dihydroxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]prop-2-enamide",CC1=C(C2=C(C=C1)C(=O)N3C=C(C[C@H]3[C@H](N2)O)/C=C/C(=O)N)O,4803-27-4,Positive,in vitro
(E)-3-Chloro-4'-nitrostilbene,C1=CC(=CC(=C1)Cl)C=CC2=CC=C(C=C2)[N+](=O)[O-],7297-53-2,Positive,in vitro
(E)-3-Cyano-4'-nitrostilbene,C1=CC(=CC(=C1)C#N)C=CC2=CC=C(C=C2)[N+](=O)[O-],159394-71-5,Positive,in vitro
(E)-3-phenylprop-2-enal,C1=CC=C(C=C1)/C=C/C=O,637511,Negative,In Vivo
(E)-4-Chloro-4'-nitrostilbene,C1=CC(=CC=C1C=CC2=CC=C(C=C2)Cl)[N+](=O)[O-],14064-55-2,Positive,in vitro
(E)-4-Cyano-4'-nitrostilbene,C1=CC(=CC=C1C=CC2=CC=C(C=C2)[N+](=O)[O-])C#N,74518-94-8,Positive,in vitro
(E)-4-hydroxynon-2-enal,CCCCCC(/C=C/C=O)O,5283344,Negative,In Vivo
(E)-4-Methoxy-4'-nitrostilbene,COC1=CC=C(C=C1)C=CC2=CC=C(C=C2)[N+](=O)[O-],4648-33-3,Positive,in vitro
(E)-4-Methyl-4'-nitrostilbene,CC1=CC=C(C=C1)C=CC2=CC=C(C=C2)[N+](=O)[O-],24325-70-0,Positive,in vitro
(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)O)O,24280-93-1,Negative,in vitro
(E)-7-PHENYL-7-(3-PYRIDYL)-6-HEPTENOIC ACID,C1=CC=C(C=C1)C(=CCCCCC(=O)O)C2=CN=CC=C2,89667-40-3,Negative,In vivo
(E)-7-phenyl-7-pyridin-3-ylhept-6-enoic acid,C1=CC=C(C=C1)/C(=C\CCCCC(=O)O)/C2=CN=CC=C2,5284442,Negative,In Vivo
(E)-but-2-enal,C/C=C/C=O,447466,Negative,In Vivo
"(E)-but-2-enedioic acid;N-[3-(diethylamino)propyl]-2-(4,5-diphenylpyrazol-1-yl)acetamide",CCN(CC)CCCNC(=O)CN1C(=C(C=N1)C2=CC=CC=C2)C3=CC=CC=C3.C(=C/C(=O)O)\C(=O)O,5284403,Negative,In Vivo
"(E)-N-(3-methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitrofuran-2-yl)methanimine",CC1CS(=O)(=O)CCN1/N=C/C2=CC=C(O2)[N+](=O)[O-],6842999,Positive,In Vivo
"(E)-N-(3-methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitrofuran-2-yl)methanimine",CC1CS(=O)(=O)CCN1/N=C/C2=CC=C(O2)[N+](=O)[O-],23256-30-6,Positive,in vitro
(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC,404-86-4,Positive,in vitro
(E)-N-cyclohexyl-3-(5-nitrofuran-2-yl)prop-2-enamide,C1CCC(CC1)NC(=O)/C=C/C2=CC=C(O2)[N+](=O)[O-],,Negative,in vitro
(E)-stilbene,C1=CC=C(C=C1)/C=C/C2=CC=CC=C2,103-30-0,Negative,in vitro
(N-6)-(METHYLNITROSO)ADENINE,CN(C1=NC=NC2=C1NC=N2)N=O,---,Positive,In vivo
(N-6)-(METHYLNITROSO)ADENOSINE,CN(C1=NC=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N=O,21928-82-5,Positive,In vivo
(N-6)-METHYLADENINE,CNC1=NC=NC2=C1NC=N2,443-72-1,Negative,In vivo
(N-6)-METHYLADENOSINE,CNC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O,1867-73-8,Negative,In vivo
(N-acetyl-4-phenylanilino) acetate,CC(=O)N(C1=CC=C(C=C1)C2=CC=CC=C2)OC(=O)C,,Positive,in vitro
(N-methyl-4-phenyldiazenylanilino) acetate,CC(=O)ON(C)C1=CC=C(C=C1)N=NC2=CC=CC=C2,55936-77-1,Positive,in vitro
(N-nitrosoanilino)methyl acetate,CC(=O)OCN(C1=CC=CC=C1)N=O,133796,Negative,In Vivo
(N-nitrosoanilino)methyl acetate,CC(=O)OCN(C1=CC=CC=C1)N=O,133796,Positive,In Vivo
(naphthalene-2-carbonylamino) acetate,CC(=O)ONC(=O)C1=CC2=CC=CC=C2C=C1,,Positive,in vitro
(naphthalene-2-carbonylamino) formate,C1=CC=C2C=C(C=CC2=C1)C(=O)NOC=O,,Positive,in vitro
(naphthalene-2-carbonylamino) propanoate,CCC(=O)ONC(=O)C1=CC2=CC=CC=C2C=C1,,Positive,in vitro
(naphthalene-2-carbonylamino) sulfate;pyridin-1-ium,C1=CC=[NH+]C=C1.C1=CC=C2C=C(C=CC2=C1)C(=O)NOS(=O)(=O)[O-],,Positive,in vitro
(NE)-N-(1-hydroxyquinolin-4-ylidene)hydroxylamine;hydrochloride,C1=CC=C2C(=C1)/C(=N/O)/C=CN2O.Cl,9571066,Positive,In Vivo
"(NE)-N-[3-[(2-chloro-1,3-thiazol-5-yl)methyl]-5-methyl-1,3,5-oxadiazinan-4-ylidene]nitramide",CN\1COCN(/C1=N/[N+](=O)[O-])CC2=CN=C(S2)Cl,5821911,Negative,In Vivo
(NE)-N-prop-2-enylidenehydroxylamine,C=C/C=N/O,9577004,Negative,In Vivo
(NZ)-N-[(5-nitrofuran-2-yl)methylidene]hydroxylamine,C1=C(OC(=C1)[N+](=O)[O-])/C=N\O,6236-05-01,Negative,in vitro
(NZ)-N-butan-2-ylidenehydroxylamine,CC/C(=N\O)/C,5324276,Negative,In Vivo
(NZ)-N-butan-2-ylidenehydroxylamine,CC/C(=N\O)/C,5324276,Positive,In Vivo
"(R,R)-DILEVALOL.HCl",CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl,75659-08-4,Negative,In vivo
"(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;hydrochloride",COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O.Cl,130-89-2,Positive,in vivo
"(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;hydrochloride",COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O.Cl,130-89-2,Positive,in vitro
(R)-Glycidyl 1-naphthyl ether,C1[C@@H](O1)COC2=CC=CC3=CC=CC=C32,56715-28-7,Positive,in vitro
(S)-Glycidyl 1-naphthyl ether,C1[C@H](O1)COC2=CC=CC3=CC=CC=C32 ,61249-00-1,Positive,in vitro
"(Z,12R)-12-hydroxyoctadec-9-enoic acid;propane-1,2,3-triol",CCCCCC[C@H](C/C=C\CCCCCCCC(=O)O)O.C(C(CO)O)O,6441835,Negative,In Vivo
"(Z)-1,2,3,3-tetrachloroprop-1-ene",C(=C(/C(Cl)Cl)\Cl)\Cl,20589-85-9,Positive,in vitro
"(Z)-1,3-dichloroprop-1-ene",C(/C=C\Cl)Cl,5280970,Positive,In Vivo
"(Z)-1,3-dichloroprop-1-ene",C(/C=C\Cl)Cl,10061-01-05,Positive,in vitro
(Z)-2-(furan-2-yl)-3-(5-nitrofuran-2-yl)prop-2-enamide,C1=COC(=C1)/C(=C/C2=CC=C(O2)[N+](=O)[O-])/C(=O)N,5280707,Positive,In Vivo
(Z)-2-(furan-2-yl)-3-(5-nitrofuran-2-yl)prop-2-enamide,C1=COC(=C1)/C(=C/C2=CC=C(O2)[N+](=O)[O-])/C(=O)N,3688-53-7,Negative,in vivo
(Z)-2-(furan-2-yl)-3-(5-nitrofuran-2-yl)prop-2-enamide,C1=COC(=C1)/C(=C/C2=CC=C(O2)[N+](=O)[O-])/C(=O)N,3688-53-7,Positive,in vivo
(Z)-2-(furan-2-yl)-3-(5-nitrofuran-2-yl)prop-2-enamide,C1=COC(=C1)/C(=C/C2=CC=C(O2)[N+](=O)[O-])/C(=O)N,3688-53-7,Positive,in vitro
(Z)-2-bromo-3-phenylprop-2-enal,C1=CC=C(C=C1)/C=C(/C=O)\Br,5369403,Negative,In Vivo
(Z)-3-Cyano-4'-nitrostilbene,C1=CC(=CC(=C1)C#N)C=CC2=CC=C(C=C2)[N+](=O)[O-],159394-72-6,Positive,in vitro
(Z)-4-Cyano-4'-nitrostilbene,C1=CC(=CC=C1C=CC2=CC=C(C=C2)[N+](=O)[O-])C#N,159394-73-7,Positive,in vitro
"(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid",CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O)O,0551-11-1,Positive,in vivo
(Z)-acetyloxymethylimino-methyl-oxidoazanium,CC(=O)OC/N=[N+](/C)\[O-],5363199,Positive,In Vivo
(Z)-acetyloxymethylimino-methyl-oxidoazanium,CC(=O)OC/N=[N+](/C)\[O-],592-62-1,Negative,in vivo
(Z)-acetyloxymethylimino-methyl-oxidoazanium,CC(=O)OC/N=[N+](/C)\[O-],592-62-1,Positive,in vivo
(Z)-acetyloxymethylimino-methyl-oxidoazanium,CC(=O)OC/N=[N+](/C)\[O-],592-62-1,Positive,in vitro
"(Z)-but-2-enedioic acid;3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine",CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=C\C(=O)O)\C(=O)O,5281068,Negative,In Vivo
"(Z)-but-2-enedioic acid;N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine",CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2.C(=C\C(=O)O)\C(=O)O,5284451,Negative,In Vivo
(Z)-hydroxymethylimino-methyl-oxidoazanium,C/[N+](=N/CO)/[O-],6433205,Positive,In Vivo
(Z)-hydroxymethylimino-methyl-oxidoazanium,C/[N+](=N/CO)/[O-],590-96-5,Positive,in vivo
(Z)-hydroxymethylimino-methyl-oxidoazanium,C/[N+](=N/CO)/[O-],590-96-5,Positive,in vitro
"(Z)-methyl-oxido-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylimino]azanium",C/[N+](=N/CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)/[O-],5459896,Positive,In Vivo
"(Z)-methyl-oxido-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylimino]azanium",C/[N+](=N/CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)/[O-],14901-08-07,Positive,in vivo
"(Z)-methyl-oxido-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylimino]azanium",C/[N+](=N/CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)/[O-],14901-08-07,Negative,in vitro
"[(1aR,2R,3R,3'S,3aR,5R,7bS)-3'-formyl-3,3',3a-trimethyl-6-oxospiro[2,3,4,7b-tetrahydro-1aH-naphtho[1,2-b]oxirene-5,2'-oxirane]-2-yl] acetate",C[C@H]1[C@H]([C@@H]2[C@@H](O2)C3=CC(=O)[C@@]4(C[C@]13C)[C@@](O4)(C)C=O)OC(=O)C,56299-00-4,Positive,in vitro
"[(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;trihydrate;hydrobromide",CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4.O.O.O.Br,20055509,Negative,In Vivo
"[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate",CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,174174,Negative,In Vivo
[(1R)-2-[bis(2-methoxy-2-oxoethyl)azaniumyl]cyclopropyl]-bis(2-methoxy-2-oxoethyl)azanium;dichloride,COC(=O)C[NH+](CC(=O)OC)[C@@H]1CC1[NH+](CC(=O)OC)CC(=O)OC.[Cl-].[Cl-],,Positive,in vitro
"[(1S,2R,3S,7R,9R,10R,11S,12S)-3,10-dihydroxy-2-(hydroxymethyl)-1,5-dimethyl-4-oxospiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-11-yl] acetate",CC1=C[C@@H]2[C@]([C@@H](C1=O)O)([C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)O)OC(=O)C)C)CO,304599,Negative,In Vivo
"[(1S,2R,3S,7R,9R,10R,11S,12S)-3,10-dihydroxy-2-(hydroxymethyl)-1,5-dimethyl-4-oxospiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-11-yl] acetate",CC1=C[C@@H]2[C@]([C@@H](C1=O)O)([C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)O)OC(=O)C)C)CO,23255-69-8,Negative,in vitro
"[(1S,2R,4S,7R,9R,10R,11S,12S)-11-acetyloxy-2-(acetyloxymethyl)-10-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-4-yl] 3-methylbutanoate",CC1=C[C@@H]2[C@](C[C@@H]1OC(=O)CC(C)C)([C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)O)OC(=O)C)C)COC(=O)C,21259-20-1,Negative,in vitro
"[(1S,2R,7R,9R,10R,11S,12S)-11-acetyloxy-10-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-2-yl]methyl acetate",CC1=C[C@@H]2[C@](CC1)([C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)O)OC(=O)C)C)COC(=O)C,2270-40-8,Negative,in vitro
"[(1S,2S,3S,5R,11R,12S,15R,16S)-15-acetyl-9-chloro-2,16-dimethyl-6-oxo-15-pentacyclo[9.7.0.02,8.03,5.012,16]octadeca-7,9-dienyl] acetate",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C,427-51-0,Positive,in vivo
"[(1S,2S,3S,5R,11R,12S,15R,16S)-15-acetyl-9-chloro-2,16-dimethyl-6-oxo-15-pentacyclo[9.7.0.02,8.03,5.012,16]octadeca-7,9-dienyl] acetate",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C,9880,Positive,In Vivo
"[(1S,2S,3S,5R,11R,12S,15R,16S)-15-acetyl-9-chloro-2,16-dimethyl-6-oxo-15-pentacyclo[9.7.0.02,8.03,5.012,16]octadeca-7,9-dienyl] acetate",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C,9880,Negative,In Vivo
"[(1S,2S,6R,10S,11R,13S,14R,15R)-13-acetyloxy-1-hydroxy-8-(hydroxymethyl)-6-methoxy-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate",CCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)OC)CO)[C@H]4[C@@]1(C4(C)C)OC(=O)C)O)C,57716-89-9,Negative,in vitro
"[(1S,2S,6R,10S,11R,13S,14R,15R)-13-acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate",CCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)OC(=O)C)O)C,27924,Negative,In Vivo
"[(1S,2S,6R,10S,11R,13S,14R,15R)-13-acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate",CCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)OC(=O)C)O)C,27924,Positive,In Vivo
"[(1S,2S,6R,10S,11R,13S,14R,15R)-13-acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate",CCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)OC(=O)C)O)C,16561-29-8,Negative,in vitro
"[(1S,3R,6S,8R,11S,12S,15R,16R)-7,7,12,16-tetramethyl-15-[(2R)-6-methylhept-5-en-2-yl]-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate",C[C@H](CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CC[C@]34[C@H]2CC[C@@H]5[C@]3(C4)CC[C@@H](C5(C)C)OC(=O)/C=C/C6=CC(=C(C=C6)O)OC)C)C,5282164,Negative,In Vivo
"[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;sulfuric acid",CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(=O)(=O)O,55-48-1,Negative,in vitro
[(2-methyl-2-methylsulfanylpropylidene)amino] N-methylcarbamate,CC(C)(C=NOC(=O)NC)SC,2086,Negative,In Vivo
[(2-methyl-2-methylsulfanylpropylidene)amino] N-methylcarbamate,CC(C)(C=NOC(=O)NC)SC,0116-06-03,Negative,in vivo
[(2-methyl-2-methylsulfanylpropylidene)amino] N-methylcarbamate,CC(C)(C=NOC(=O)NC)SC,0116-06-03,Positive,in vitro
"[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoxy]benzene",CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/COC2=CC=CC=C2)/C)/C,,Positive,in vitro
"[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate",CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/COC(=O)C)/C)/C,638034,Positive,In Vivo
"[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate",CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/COC(=O)C)/C)/C,127-47-9,Positive,in vitro
"[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate",CCCCCCCCCCCCCCCC(=O)OC/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(CCCC1(C)C)C,79-81-2,Positive,in vitro
"[(2E)-3,7-dimethylocta-2,6-dienyl] acetate",CC(=CCC/C(=C/COC(=O)C)/C)C,1549026,Negative,In Vivo
"[(2R,3R,4R,5R)-2,3,4,5-tetrahydroxy-6-methylsulfonyloxyhexyl] methanesulfonate",CS(=O)(=O)OC[C@H]([C@H]([C@@H]([C@@H](COS(=O)(=O)C)O)O)O)O,1187-00-4,Positive,in vitro
"[(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-(8-hydroxy-9,10-dioxoanthracen-1-yl)oxyoxan-2-yl]methyl acetate",CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=CC=CC3=C2C(=O)C4=C(C3=O)C=CC=C4O)OC(=O)C)OC(=O)C)OC(=O)C,,Positive,in vitro
"[(2R,3R,4S,5S)-5-(acetyloxymethyl)-5-[(2R,3R,4S,5R,6R)-6-(acetyloxymethyl)-3,4,5-tris(2-methylpropanoyloxy)oxan-2-yl]oxy-3,4-bis(2-methylpropanoyloxy)oxolan-2-yl]methyl 2-methylpropanoate",CC(C)C(=O)OC[C@@H]1[C@H]([C@@H]([C@](O1)(COC(=O)C)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC(=O)C)OC(=O)C(C)C)OC(=O)C(C)C)OC(=O)C(C)C)OC(=O)C(C)C)OC(=O)C(C)C,31339,Negative,In Vivo
"[(2R,3R)-2,3-dihydroxy-4-methylsulfonyloxybutyl] methanesulfonate",CS(=O)(=O)OC[C@H]([C@@H](COS(=O)(=O)C)O)O,1947-62-2,Positive,in vitro
"[(2R,3S,4R,5R)-3,4,6-triacetyloxy-5-[[methyl(nitroso)carbamoyl]amino]oxan-2-yl]methyl acetate",CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H](C(O1)OC(=O)C)NC(=O)N(C)N=O)OC(=O)C)OC(=O)C,18977-95-2,Positive,in vitro
"[(2R,3S,4R,6S)-6-[[(6S,7S)-6-[(2S,4R,5R,6R)-4-[(2S,4R,5R,6R)-4-[(2S,4S,5S,6S)-5-acetyloxy-4-hydroxy-4,6-dimethyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-7-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-4,10-dihydroxy-3-methyl-5-oxo-7,8-dihydro-6H-anthracen-2-yl]oxy]-4-[(2R,4R,5R,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-2-methyloxan-3-yl] acetate",C[C@@H]1[C@H]([C@@H](C[C@@H](O1)O[C@H]2[C@@H](CC3=C(C2=O)C(=C4C(=C3)C=C(C(=C4O)C)O[C@H]5C[C@H]([C@H]([C@H](O5)C)OC(=O)C)O[C@@H]6C[C@H]([C@H]([C@H](O6)C)OC)O)O)[C@@H](C(=O)[C@H]([C@@H](C)O)O)OC)O[C@H]7C[C@H]([C@@H]([C@H](O7)C)O)O[C@H]8C[C@]([C@H]([C@@H](O8)C)OC(=O)C)(C)O)O,,Positive,in vitro
"[(2R,3S,4S,5R,6R)-2-[(2R,3S,4S,5S,6S)-2-[(1R,2S)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[[(2R,3S,4S)-3-hydroxy-5-[[(2S,3R)-3-hydroxy-1-oxo-1-[2-[4-[4-[3-[[(1S)-1-phenylethyl]amino]propylcarbamoyl]-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]ethylamino]butan-2-yl]amino]-4-methyl-5-oxopentan-2-yl]amino]-1-(1H-imidazol-5-yl)-3-oxopropoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] carbamate;sulfuric acid",CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCCN[C@@H](C)C7=CC=CC=C7)O.OS(=O)(=O)O,6321297,Positive,In Vivo
"[(2R,3S,5R)-3-hydroxy-5-(5-nitro-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)[N+](=O)[O-])COP(=O)(O)O)O,63689-79-2,Positive,in vitro
"[(2R,5S)-5-methylsulfonyloxyhexan-2-yl] methanesulfonate",C[C@H](CC[C@H](C)OS(=O)(=O)C)OS(=O)(=O)C,,Positive,in vivo
"[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate",C[C@@]12CCC[C@@]([C@H]1CC[C@]34[C@H]2CC[C@](C3)(C(=C)C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)(C)C(=O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O,442089,Negative,In Vivo
"[(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate",C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O,5282165,Negative,In Vivo
"[(2S,3S,4S,6S)-6-[(2S,3S,4S,6R)-6-[(1'R,2R,3S,4'S,6S,8'R,10'E,12'S,13'S,14'E,16'E,20'R,21'R,24'S)-2-[(2S)-butan-2-yl]-21',24'-dihydroxy-3,11',13',22'-tetramethyl-2'-oxospiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-12'-yl]oxy-4-methoxy-2-methyloxan-3-yl]oxy-4-methoxy-2-methyloxan-3-yl]-methylazanium;benzoate",CC[C@H](C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)[NH2+]C)OC)OC)\C)C.C1=CC=C(C=C1)C(=O)[O-],22833503,Negative,In Vivo
"[(2S,3S)-2,3-dihydroxy-4-methylsulfonyloxybutyl] methanesulfonate",CS(=O)(=O)OC[C@@H]([C@H](COS(=O)(=O)C)O)O,299-75-2,Positive,in vitro
"[(2S,5S)-5-methylsulfonyloxyhexan-2-yl] methanesulfonate",C[C@@H](CC[C@H](C)OS(=O)(=O)C)OS(=O)(=O)C,,Positive,in vivo
[(2S)-2-hydroxy-2-[(2S)-oxiran-2-yl]ethyl] methanesulfonate,CS(=O)(=O)OC[C@@H]([C@@H]1CO1)O,,Positive,in vitro
"[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate",C[C@@]12CCN([C@@H]1N(C3=C2C=C(C=C3)OC(=O)NC)C)C,5983,Positive,In Vivo
"[(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate",CC1=C(C=CC2=C1OC(=O)C(=C2O)NC(=O)C3=CC(=C(C=C3)O)CC=C(C)C)O[C@H]4[C@@H]([C@@H]([C@H](C(O4)(C)C)OC)OC(=O)N)O,303-81-1,Positive,in vitro
"[(3S,6S)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate;hydrochloride",CC[C@@H](C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C.Cl,39371,Negative,In Vivo
"[(3S,6S)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate;hydrochloride",CC[C@@H](C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C.Cl,39371,Positive,In Vivo
"[(3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate",CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C#C)OC(=O)C)C,9270,Positive,In Vivo
"[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-[bis(2-chloroethyl)amino]phenyl]acetate",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)CC5=CC=C(C=C5)N(CCCl)CCCl)C)C,266461,Positive,In Vivo
"[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-[bis(2-chloroethyl)amino]phenyl]acetate",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)CC5=CC=C(C=C5)N(CCCl)CCCl)C)C,3546-10-9,Positive,in vivo
"[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-[bis(2-chloroethyl)amino]phenyl]acetate",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)CC5=CC=C(C=C5)N(CCCl)CCCl)C)C,266461,Negative,In Vivo
"[(3S)-4-oxo-3-(1,3,6,8-tetrahydroxy-9,10-dioxoanthracen-2-yl)butyl] acetate",CC(=O)OCC[C@H](C=O)C1=C(C=C2C(=C1O)C(=O)C3=C(C2=O)C=C(C=C3O)O)O,52021-61-1,Positive,in vitro
"[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate",C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)/C)OC)OC(=O)N)\C)C)O)OC,30562-34-6,Negative,in vitro
"[(4R,4aR,7S,7aR,12bS)-9-acetyloxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] acetate",CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,561-27-3,Positive,in vivo
"[(4S,11R,12R)-11-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-6-methyl-3-(methylamino)oxan-2-yl]oxy-4-(2-oxo-1,3-dioxolan-4-yl)-5-oxatricyclo[8.3.0.04,6]tridec-1(13)-en-2,7-diyn-12-yl] 2-hydroxy-7-methoxy-5-methylnaphthalene-1-carboxylate",C[C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@H]2[C@@H](C=C3C2CC#CC4[C@@](O4)(C#C3)C5COC(=O)O5)OC(=O)C6=C(C=CC7=C6C=C(C=C7C)OC)O)NC)O)O,9014-02-02,Positive,in vitro
"[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate",CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N,50-07-7,Positive,in vivo
"[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate",CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N,5746,Positive,In Vivo
"[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate",CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N,50-07-7,Negative,in vitro
"[(4S,6S,7R,8S)-11-amino-7-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate",CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4C)N,801-52-5,Positive,in vitro
"[(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-yl] 4-morpholin-4-ylbutanoate;hydrobromide",CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)OC(=O)CCCN4CCOCC4.Br,,Negative,in vitro
"[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,6279,Positive,In Vivo
"[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,71-58-9,Positive,in vivo
"[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,6279,Negative,In Vivo
"[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,71-58-9,Positive,in vitro
"[(7R,8R)-7-(1,3-benzodioxole-5-carbonyloxy)-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl 1,3-benzodioxole-5-carboxylate",C1CN2CC=C([C@@H]2[C@@H]1OC(=O)C3=CC4=C(C=C3)OCO4)COC(=O)C5=CC6=C(C=C5)OCO6,,Positive,in vitro
"[(7R,8R)-7-(4-chlorobenzoyl)oxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl 4-chlorobenzoate",C1CN2CC=C([C@@H]2[C@@H]1OC(=O)C3=CC=C(C=C3)Cl)COC(=O)C4=CC=C(C=C4)Cl,,Positive,in vitro
"[(7R,8R)-7-(4-nitrobenzoyl)oxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl 4-nitrobenzoate",C1CN2CC=C([C@@H]2[C@@H]1OC(=O)C3=CC=C(C=C3)[N+](=O)[O-])COC(=O)C4=CC=C(C=C4)[N+](=O)[O-],,Positive,in vitro
"[(7R,8R)-7-[(Z)-2-methylbut-2-enoyl]oxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2R)-2,3-dihydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate",C/C=C(/C)\C(=O)O[C@@H]1CCN2[C@@H]1C(=CC2)COC(=O)[C@@]([C@H](C)O)(C(C)(C)O)O,520-68-3,Positive,in vitro
"[(7S,8R)-7-[(Z)-2-methylbut-2-enoyl]oxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2R)-2,3-dihydroxy-2-[(1S)-1-methoxyethyl]-3-methylbutanoate",C/C=C(/C)\C(=O)O[C@H]1CCN2[C@@H]1C(=CC2)COC(=O)[C@@]([C@H](C)OC)(C(C)(C)O)O,303-34-4,Positive,in vivo
"[(7S,8R)-7-[(Z)-2-methylbut-2-enoyl]oxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2R)-2,3-dihydroxy-2-[(1S)-1-methoxyethyl]-3-methylbutanoate",C/C=C(/C)\C(=O)O[C@H]1CCN2[C@@H]1C(=CC2)COC(=O)[C@@]([C@H](C)OC)(C(C)(C)O)O,5281735,Positive,In Vivo
"[(7S,8R)-7-[(Z)-2-methylbut-2-enoyl]oxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2R)-2,3-dihydroxy-2-[(1S)-1-methoxyethyl]-3-methylbutanoate",C/C=C(/C)\C(=O)O[C@H]1CCN2[C@@H]1C(=CC2)COC(=O)[C@@]([C@H](C)OC)(C(C)(C)O)O,303-34-4,Positive,in vitro
"[(7S,8R)-7-hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-[(1R)-1-methoxyethyl]-3-methylbutanoate",C[C@H]([C@@](C(C)C)(C(=O)OCC1=CCN2[C@H]1[C@H](CC2)O)O)OC,303-33-3,Positive,in vitro
"[(7S,8S)-7-hydroxy-4-oxido-5,6,7,8-tetrahydro-3H-pyrrolizin-4-ium-1-yl]methyl 2-hydroxy-2-(1-methoxyethyl)-3-methylbutanoate",CC(C)C(C(C)OC)(C(=O)OCC1=CC[N+]2([C@@H]1[C@H](CC2)O)[O-])O,6209-65-0,Positive,in vitro
"[(7S,8S)-7-hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl 2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoate",C[C@@H](C(C(C)C)(C(=O)OCC1=CCN2[C@@H]1[C@H](CC2)O)O)O,,Positive,in vitro
"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(Z)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate",C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N\N5CCN(CC5)C)/C,135550179,Positive,In Vivo
"[(8R,9S,10R,13S,14S,17R)-17-acetyl-6-chloro-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@]34C)Cl)C)OC(=O)C,9324,Positive,In Vivo
"[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,11683,Positive,In Vivo
"[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate",CC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)C#C,5832,Positive,In Vivo
"[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4CCCC4)CCC5=CC(=O)CC[C@]35C,58-20-8,Positive,in vivo
"[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate",CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,315-37-7,Positive,in vivo
"[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate",CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,9416,Negative,In Vivo
"[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate",CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,9416,Positive,In Vivo
"[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,57-85-2,Positive,in vivo
"[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,5995,Positive,In Vivo
"[(8R,9S,13S,14S,17S)-13-methyl-3-propanoyloxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C3C=CC(=C4)OC(=O)CC)C,8225,Positive,In Vivo
"[(8R,9S,13S,14S,17S)-13-methyl-3-propanoyloxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] propanoate",CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C3C=CC(=C4)OC(=O)CC)C,113-38-2,Positive,in vivo
"[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] benzoate",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5,222757,Positive,In Vivo
"[(8R,9S,13S,14S,17S)-3-[2-[4-[bis(2-chloroethyl)amino]phenyl]acetyl]oxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 2-[4-[bis(2-chloroethyl)amino]phenyl]acetate",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CC4=CC=C(C=C4)N(CCCl)CCCl)CCC5=C3C=CC(=C5)OC(=O)CC6=CC=C(C=C6)N(CCCl)CCCl,31586,Positive,In Vivo
"[(8R,9S,13S,14S,17S)-3-[2-[4-[bis(2-chloroethyl)amino]phenyl]acetyl]oxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 2-[4-[bis(2-chloroethyl)amino]phenyl]acetate",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CC4=CC=C(C=C4)N(CCCl)CCCl)CCC5=C3C=CC(=C5)OC(=O)CC6=CC=C(C=C6)N(CCCl)CCCl,31586,Negative,In Vivo
"[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate",CCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C3C=CC(=C4)O)C,13791,Positive,In Vivo
"[(8S)-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl (2S)-2-hydroxy-2-[(1R)-1-hydroxyethyl]-3-methylbutanoate",C[C@H]([C@@](C(C)C)(C(=O)OCC1=CCN2[C@H]1CCC2)O)O,551-58-6,Positive,in vitro
[(E)-(5-nitrofuran-2-yl)methylideneamino]urea,C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)N,5447130,Negative,In Vivo
[(E)-(5-nitrofuran-2-yl)methylideneamino]urea,C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)N,59-87-0,Negative,in vivo
[(E)-(5-nitrofuran-2-yl)methylideneamino]urea,C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)N,5447130,Positive,In Vivo
[(E)-(5-nitrofuran-2-yl)methylideneamino]urea,C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)N,59-87-0,Positive,in vivo
[(E)-(5-nitrofuran-2-yl)methylideneamino]urea,C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)N,59-87-0,Negative,in vitro
[(E)-2-nitroethenyl]benzene,C1=CC=C(C=C1)/C=C/[N+](=O)[O-],5153-67-3,Negative,in vitro
"[(E)-3-(1,3-benzodioxol-5-yl)prop-1-enyl] acetate",CC(=O)O/C=C/CC1=CC2=C(C=C1)OCO2,,Positive,in vitro
[(E)-3-phenylprop-2-enyl] 2-aminobenzoate,C1=CC=C(C=C1)/C=C/COC(=O)C2=CC=CC=C2N,5284369,Positive,In Vivo
[(E)-3-phenylprop-2-enyl] 2-aminobenzoate,C1=CC=C(C=C1)/C=C/COC(=O)C2=CC=CC=C2N,87-29-6,Positive,in vivo
[(E)-3-phenylprop-2-enyl] 2-aminobenzoate,C1=CC=C(C=C1)/C=C/COC(=O)C2=CC=CC=C2N,5284369,Negative,In Vivo
[(E)-3-phenylprop-2-enyl] 2-aminobenzoate,C1=CC=C(C=C1)/C=C/COC(=O)C2=CC=CC=C2N,87-29-6,Negative,in vitro
[(E)-4-(dimethylamino)-4-oxobut-2-en-2-yl] dimethyl phosphate,C/C(=C\C(=O)N(C)C)/OP(=O)(OC)OC,141-66-2,Positive,in vitro
[(E)-4-methylsulfonyloxybut-2-enyl] methanesulfonate,CS(=O)(=O)OC/C=C/COS(=O)(=O)C,1953-56-6,Positive,in vitro
[(E)-furan-2-ylmethylideneamino]urea,C1=COC(=C1)/C=N/NC(=O)N,2411-74-7,Negative,in vitro
[(E)-prop-1-enyl]benzene,C/C=C/C1=CC=CC=C1,873-66-5,Positive,in vitro
"[(S)-cyano-(3-phenoxyphenyl)methyl] (1R,3R)-3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1([C@H]([C@H]1C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Br)Br)C,40585,Negative,In Vivo
"[(S)-cyano-(3-phenoxyphenyl)methyl] (1R,3R)-3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1([C@H]([C@H]1C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Br)Br)C,40585,Positive,In Vivo
"[(S)-cyano-(3-phenoxyphenyl)methyl] (1R,3R)-3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1([C@H]([C@H]1C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Br)Br)C,52918-63-5,Negative,in vitro
"[(S)-cyano-(3-phenoxyphenyl)methyl] (1R,3S)-2,2-dimethyl-3-(1,2,2,2-tetrabromoethyl)cyclopropane-1-carboxylate",CC1([C@H]([C@H]1C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C(C(Br)(Br)Br)Br)C,48132,Negative,In Vivo
[(S)-cyano-(3-phenoxyphenyl)methyl] (2S)-2-(4-chlorophenyl)-3-methylbutanoate,CC(C)[C@@H](C1=CC=C(C=C1)Cl)C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3,10342051,Negative,In Vivo
[(Z)-[1-(5-nitrofuran-2-yl)-3-piperidin-1-ylpropylidene]amino]urea;hydrochloride,C1CCN(CC1)CC/C(=N/NC(=O)N)/C2=CC=C(O2)[N+](=O)[O-].Cl,,Positive,in vitro
[(Z)-3-chloro-4-(diethylamino)-4-oxobut-2-en-2-yl] dimethyl phosphate,CCN(CC)C(=O)/C(=C(\C)/OP(=O)(OC)OC)/Cl,3032604,Negative,In Vivo
[(Z)-3-chloro-4-(diethylamino)-4-oxobut-2-en-2-yl] dimethyl phosphate,CCN(CC)C(=O)/C(=C(\C)/OP(=O)(OC)OC)/Cl,13171-21-6,Positive,in vitro
[(Z)-4-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-benzoylsulfanylpent-3-enyl] benzoate;hydrochloride,CC1=NC=C(C(=N1)N)CN(C=O)/C(=C(/CCOC(=O)C2=CC=CC=C2)\SC(=O)C3=CC=CC=C3)/C.Cl,3036234,Negative,In Vivo
[(Z)-4-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-benzoylsulfanylpent-3-enyl] benzoate;hydrochloride,CC1=NC=C(C(=N1)N)CN(C=O)/C(=C(/CCOC(=O)C2=CC=CC=C2)\SC(=O)C3=CC=CC=C3)/C.Cl,2105-44-4,Negative,in vitro
"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,56-65-5,Negative,in vitro
[[2-(4-butoxyphenyl)acetyl]amino] acetate,CCCCOC1=CC=C(C=C1)CC(=O)NOC(=O)C,,Positive,in vitro
[[2-(4-butoxyphenyl)acetyl]amino] formate,CCCCOC1=CC=C(C=C1)CC(=O)NOC=O,,Positive,in vitro
[[2-(4-butoxyphenyl)acetyl]amino] propanoate,CCCCOC1=CC=C(C=C1)CC(=O)NOC(=O)CC,,Positive,in vitro
[[2-(4-butoxyphenyl)acetyl]amino] sulfate;pyridin-1-ium,CCCCOC1=CC=C(C=C1)CC(=O)NOS(=O)(=O)[O-].C1=CC=[NH+]C=C1,,Positive,in vitro
"[[4,6-bis(hydroxymethylamino)-1,3,5-triazin-2-yl]amino]methanol",C(NC1=NC(=NC(=N1)NCO)NCO)O,1017-56-7,Positive,in vitro
[[methyl(nitroso)amino]-phenylmethyl] acetate,CC(=O)OC(C1=CC=CC=C1)N(C)N=O,53198-46-2,Positive,in vitro
"[1-(3,4-dimethylphenyl)-1-phenylprop-2-ynyl] N-cyclohexylcarbamate",CC1=C(C=C(C=C1)C(C#C)(C2=CC=CC=C2)OC(=O)NC3CCCCC3)C,,Positive,in vitro
[1-[2-(diethylamino)ethylamino]-9-oxothioxanthen-4-yl]methyl furan-2-carboxylate,CCN(CC)CCNC1=C2C(=C(C=C1)COC(=O)C3=CC=CO3)SC4=CC=CC=C4C2=O,,Positive,in vitro
"[1,3-benzodioxol-5-yl(oxiran-2-yl)methyl] acetate",CC(=O)OC(C1CO1)C2=CC3=C(C=C2)OCO3,,Positive,in vitro
[12-(hydroxymethyl)benzo[a]anthracen-7-yl]methanol,C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C(=C32)CO)CO,,Negative,in vitro
"[14-[2-(diethylamino)ethyl]-8-thia-14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9,11,13(16)-heptaen-10-yl]methanol",CCN(CC)CCN1C2=C3C(=C(C=C2)CO)SC4=CC=CC=C4C3=N1,,Positive,in vitro
"[2-(1-iodoethyl)-1,3-dioxolan-4-yl]methanol",CC(C1OCC(O1)CO)I,21852,Negative,In Vivo
"[2-(1-iodoethyl)-1,3-dioxolan-4-yl]methanol",CC(C1OCC(O1)CO)I,21852,Positive,In Vivo
[2-(carbamoyloxymethyl)-2-methylpentyl] carbamate,CCCC(C)(COC(=O)N)COC(=O)N,57-53-4,Negative,in vitro
"[2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl] N,N-dimethylcarbamate",CC1=C(N=C(N=C1OC(=O)N(C)C)N(C)C)C,23103-98-2,Negative,in vitro
[2-(dimethylamino)ethyl-formylcarbamoyl]-ethylazanium;nitrite,CC[NH2+]C(=O)N(CCN(C)C)C=O.N(=O)[O-],44146708,Negative,In Vivo
[2-(dimethylamino)ethyl-formylcarbamoyl]-ethylazanium;nitrite,CC[NH2+]C(=O)N(CCN(C)C)C=O.N(=O)[O-],44146708,Positive,In Vivo
[2-(hydroxymethyl)-1-methylpyrrol-3-yl]methanol,CN1C=CC(=C1CO)CO,53365-77-8,Positive,in vitro
"[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoate",C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COC(=O)CCCC4=CC=C(C=C4)N(CCCl)CCCl)O)CCC5=CC(=O)C=C[C@]35C)O,34457,Positive,In Vivo
"[2-acetyloxy-4-(3,5,7-triacetyloxy-4-oxochromen-2-yl)phenyl] acetate",CC(=O)OC1=C(C=C(C=C1)C2=C(C(=O)C3=C(O2)C=C(C=C3OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,1064-06-08,Positive,in vitro
"[2-chloro-1-(2,4,5-trichlorophenyl)ethenyl] dimethyl phosphate",COP(=O)(OC)OC(=CCl)C1=CC(=C(C=C1Cl)Cl)Cl,13745,Positive,In Vivo
"[2-chloro-1-(2,4,5-trichlorophenyl)ethenyl] dimethyl phosphate",COP(=O)(OC)OC(=CCl)C1=CC(=C(C=C1Cl)Cl)Cl,13745,Negative,In Vivo
[2-methylpropyl(nitroso)amino]methyl acetate,CC(C)CN(COC(=O)C)N=O,51153,Positive,In Vivo
"[2,3-dihydroxy-5-[[(2S,3S,4R,5S,6R)-3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy]oxan-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate",C1=C(C=C(C(=C1O)O)O)C(=O)OC2=CC(=CC(=C2O)O)C(=O)OC[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)OC(=O)C4=CC(=C(C(=C4)OC(=O)C5=CC(=C(C(=C5)O)O)O)O)O)OC(=O)C6=CC(=C(C(=C6)OC(=O)C7=CC(=C(C(=C7)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8)OC(=O)C9=CC(=C(C(=C9)O)O)O)O)O)OC(=O)C1=CC(=C(C(=C1)OC(=O)C1=CC(=C(C(=C1)O)O)O)O)O,16133892,Positive,In Vivo
"[2,3-dihydroxy-5-[[(2S,3S,4R,5S,6R)-3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy]oxan-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate",C1=C(C=C(C(=C1O)O)O)C(=O)OC2=CC(=CC(=C2O)O)C(=O)OC[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)OC(=O)C4=CC(=C(C(=C4)OC(=O)C5=CC(=C(C(=C5)O)O)O)O)O)OC(=O)C6=CC(=C(C(=C6)OC(=O)C7=CC(=C(C(=C7)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8)OC(=O)C9=CC(=C(C(=C9)O)O)O)O)O)OC(=O)C1=CC(=C(C(=C1)OC(=O)C1=CC(=C(C(=C1)O)O)O)O)O,,Positive,in vivo
"[2,3-dihydroxy-5-[[(2S,3S,4R,5S,6R)-3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy]oxan-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate",C1=C(C=C(C(=C1O)O)O)C(=O)OC2=CC(=CC(=C2O)O)C(=O)OC[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)OC(=O)C4=CC(=C(C(=C4)OC(=O)C5=CC(=C(C(=C5)O)O)O)O)O)OC(=O)C6=CC(=C(C(=C6)OC(=O)C7=CC(=C(C(=C7)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8)OC(=O)C9=CC(=C(C(=C9)O)O)O)O)O)OC(=O)C1=CC(=C(C(=C1)OC(=O)C1=CC(=C(C(=C1)O)O)O)O)O,16133892,Negative,In Vivo
[3-(dimethylaminomethylideneamino)phenyl] N-methylcarbamate;hydrochloride,CNC(=O)OC1=CC=CC(=C1)N=CN(C)C.Cl,31899,Negative,In Vivo
[3-(ethoxycarbonylamino)phenyl] N-phenylcarbamate,CCOC(=O)NC1=CC(=CC=C1)OC(=O)NC2=CC=CC=C2,24743,Negative,In Vivo
[3-(methoxycarbonylamino)phenyl] N-(3-methylphenyl)carbamate,CC1=CC(=CC=C1)NC(=O)OC2=CC=CC(=C2)NC(=O)OC,13684-63-4,Negative,in vitro
[3-methyl-4-(3-methylphenyl)phenyl]azanium;chloride,CC1=CC(=CC=C1)C2=C(C=C(C=C2)[NH3+])C.[Cl-],,Positive,in vitro
"[3-nitrooxy-2,2-bis(nitrooxymethyl)propyl] nitrate",C(C(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-])O[N+](=O)[O-],6518,Negative,In Vivo
[4-(4-azaniumyl-3-methylphenyl)-2-methylphenyl]azanium;dichloride,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)[NH3+])C)[NH3+].[Cl-].[Cl-],11932,Negative,In Vivo
[4-(4-azaniumyl-3-methylphenyl)-2-methylphenyl]azanium;dichloride,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)[NH3+])C)[NH3+].[Cl-].[Cl-],11932,Positive,In Vivo
"[4-(5-nitrofuran-2-yl)-1,3-thiazol-2-yl]hydrazine",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NN,4021704,Positive,In Vivo
"[4-(dimethylamino)-3,5-dimethylphenyl] N-methylcarbamate",CC1=CC(=CC(=C1N(C)C)C)OC(=O)NC,9414,Negative,In Vivo
"[4-(dimethylamino)-3,5-dimethylphenyl] N-methylcarbamate",CC1=CC(=CC(=C1N(C)C)C)OC(=O)NC,315-18-4,Negative,in vivo
[4-[(E)-4-(4-phosphonooxyphenyl)hex-3-en-3-yl]phenyl] dihydrogen phosphate,CC/C(=C(/CC)\C1=CC=C(C=C1)OP(=O)(O)O)/C2=CC=C(C=C2)OP(=O)(O)O,522-40-7,Negative,in vivo
[4-[(E)-4-(4-phosphonooxyphenyl)hex-3-en-3-yl]phenyl] dihydrogen phosphate,CC/C(=C(/CC)\C1=CC=C(C=C1)OP(=O)(O)O)/C2=CC=C(C=C2)OP(=O)(O)O,522-40-7,Negative,in vitro
[4-[(E)-4-(4-propanoyloxyphenyl)hex-3-en-3-yl]phenyl] propanoate,CC/C(=C(/CC)\C1=CC=C(C=C1)OC(=O)CC)/C2=CC=C(C=C2)OC(=O)CC,657220,Positive,In Vivo
[4-[(E)-4-(4-propanoyloxyphenyl)hex-3-en-3-yl]phenyl] propanoate,CC/C(=C(/CC)\C1=CC=C(C=C1)OC(=O)CC)/C2=CC=C(C=C2)OC(=O)CC,130-80-3,Positive,in vitro
[4-[(Z)-2-nitroprop-1-enyl]phenyl] thiocyanate,C/C(=C/C1=CC=C(C=C1)SC#N)/[N+](=O)[O-],,Positive,in vitro
"[4-[[4-(dimethylamino)phenyl]-[4-(methylamino)phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium",CNC1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C,765266-81-7,Negative,in vitro
"[4-[[4-(dimethylamino)phenyl]-phenylmethylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium;chloride",CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=CC=C3.[Cl-],11294,Negative,In Vivo
"[4-[bis[4-(dimethylamino)phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium;chloride",CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-],11057,Positive,In Vivo
"[4-[bis[4-(dimethylamino)phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium;chloride",CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-],,Negative,in vitro
"[4-CHLORO-6-(2,3-XYLIDINO)-2-PYRIMIDINYLTHIO]ACETIC ACID",CC1=C(C(=CC=C1)NC2=CC(=NC(=N2)SCC(=O)O)Cl)C,50892-23-4,Negative,In vivo
"[4-CHLORO-6-(2,3-XYLIDINO)-2-PYRIMIDINYLTHIO]ACETIC ACID",CC1=C(C(=CC=C1)NC2=CC(=NC(=N2)SCC(=O)O)Cl)C,50892-23-4,Positive,In vivo
[5-(diethylamino)-2-methylpent-3-yn-2-yl] 2-cyclohexyl-2-hydroxy-2-phenylacetate;hydrochloride,CCN(CC)CC#CC(C)(C)OC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl,148165,Negative,In Vivo
"[5-chloro-14-[2-(diethylamino)ethyl]-15-oxido-8-thia-14-aza-15-azoniatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-10-yl]methanol",CCN(CC)CCN1C2=C3C(=C(C=C2)CO)SC4=C(C3=[N+]1[O-])C=CC(=C4)Cl,54484-91-2,Positive,in vitro
"[5-chloro-14-[2-(diethylamino)ethyl]-8-thia-14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-10-yl]methanol",CCN(CC)CCN1C2=C3C(=C(C=C2)CO)SC4=C(C3=N1)C=CC(=C4)Cl,,Positive,in vitro
[6-(diethylamino)xanthen-3-ylidene]-diethylazanium;chloride,CCN(CC)C1=CC2=C(C=C1)C=C3C=CC(=[N+](CC)CC)C=C3O2.[Cl-],2150-48-3,Positive,in vitro
[6-(dimethylamino)thioxanthen-3-ylidene]-dimethylazanium;chloride,CN(C)C1=CC2=C(C=C1)C=C3C=CC(=[N+](C)C)C=C3S2.[Cl-],2412-14-8,Negative,in vitro
[6-(dimethylamino)xanthen-3-ylidene]-dimethylazanium;chloride,CN(C)C1=CC2=C(C=C1)C=C3C=CC(=[N+](C)C)C=C3O2.[Cl-],92-32-0,Positive,in vitro
[6-[(E)-2-(5-nitrofuran-2-yl)ethenyl]pyridin-2-yl]methanol,C1=CC(=NC(=C1)/C=C/C2=CC=C(O2)[N+](=O)[O-])CO,13411-16-0,Positive,in vitro
"[6-hydroxy-3'-(hydroxymethyl)-3,3',3a-trimethylspiro[1a,2,3,4,6,7b-hexahydronaphtho[1,2-b]oxirene-5,2'-oxirane]-2-yl] acetate",CC1C(C2C(O2)C3=CC(C4(CC13C)C(O4)(C)CO)O)OC(=O)C,,Negative,in vitro
"[7-(4-nitrobenzoyl)oxy-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl]methyl 4-nitrobenzoate",C1CN2CCC(C2C1COC(=O)C3=CC=C(C=C3)[N+](=O)[O-])OC(=O)C4=CC=C(C=C4)[N+](=O)[O-],,Negative,in vitro
[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride,CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-],61-73-4,Negative,in vitro
[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride;trihydrate,CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.O.O.O.[Cl-],104827,Positive,In Vivo
[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride;trihydrate,CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.O.O.O.[Cl-],104827,Negative,In Vivo
"[7-nitro-2-[(propan-2-ylamino)methyl]-1,2,3,4-tetrahydroquinolin-6-yl]methanol",CC(C)NCC1CCC2=CC(=C(C=C2N1)[N+](=O)[O-])CO,21738-42-1,Negative,in vivo
"[7-nitro-2-[(propan-2-ylamino)methyl]-1,2,3,4-tetrahydroquinolin-6-yl]methanol",CC(C)NCC1CCC2=CC(=C(C=C2N1)[N+](=O)[O-])CO,21738-42-1,Positive,in vitro
[9-(2-carboxyphenyl)-6-(diethylamino)xanthen-3-ylidene]-diethylazanium;chloride,CCN(CC)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](CC)CC)C=C3O2)C4=CC=CC=C4C(=O)O.[Cl-],6694,Negative,In Vivo
[9-(2-carboxyphenyl)-6-(diethylamino)xanthen-3-ylidene]-diethylazanium;chloride,CCN(CC)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](CC)CC)C=C3O2)C4=CC=CC=C4C(=O)O.[Cl-],81-88-9,Negative,in vitro
"[9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium;chloride",CCNC1=CC2=C(C=C1C)C(=C3C=C(C(=[NH+]CC)C=C3O2)C)C4=CC=CC=C4C(=O)OCC.[Cl-],13806,Negative,In Vivo
[9H-fluoren-2-yl(tetradecanoyl)amino] acetate,CCCCCCCCCCCCCC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)OC(=O)C,,Positive,in vitro
[9H-fluoren-2-yl(tetradecanoyl)amino] tetradecanoate,CCCCCCCCCCCCCC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)OC(=O)CCCCCCCCCCCCC,63224-46-4,Positive,in vitro
[acetyl-(7-iodo-9H-fluoren-2-yl)amino] tetradecanoate,CCCCCCCCCCCCCC(=O)ON(C1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)I)C(=O)C,54345,Positive,In Vivo
[acetyl(9H-fluoren-2-yl)amino] acetate,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)OC(=O)C,6098-44-8,Positive,in vivo
[acetyl(9H-fluoren-2-yl)amino] acetate,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)OC(=O)C,6098-44-8,Positive,in vitro
[acetyl(9H-fluoren-2-yl)amino] tetradecanoate,CCCCCCCCCCCCCC(=O)ON(C1=CC2=C(C=C1)C3=CC=CC=C3C2)C(=O)C,44437,Positive,In Vivo
[acetyl(9H-fluoren-2-yl)amino] tetradecanoate,CCCCCCCCCCCCCC(=O)ON(C1=CC2=C(C=C1)C3=CC=CC=C3C2)C(=O)C,,Positive,in vitro
[acetyl(ethoxycarbonyl)amino] acetate,CCOC(=O)N(C(=O)C)OC(=O)C,,Positive,in vitro
[acetyloxy-(5-nitrofuran-2-yl)methyl] acetate,CC(=O)OC(C1=CC=C(O1)[N+](=O)[O-])OC(=O)C,92-55-7,Positive,in vitro
[acetyloxy(dibutyl)stannyl] acetate,CCCC[Sn](CCCC)(OC(=O)C)OC(=O)C,16682740,Negative,In Vivo
[butyl(nitroso)amino]methyl acetate,CCCCN(COC(=O)C)N=O,42095,Positive,In Vivo
[butyl(nitroso)amino]methyl acetate,CCCCN(COC(=O)C)N=O,56986-36-8,Positive,in vitro
[cyano-(3-phenoxyphenyl)methyl] 2-(4-chlorophenyl)-3-methylbutanoate,CC(C)C(C1=CC=C(C=C1)Cl)C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3,3347,Negative,In Vivo
"[cyano-(3-phenoxyphenyl)methyl] 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate",CC(=CC1C(C1(C)C)C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C,38283,Negative,In Vivo
"[cyano-(3-phenoxyphenyl)methyl] 2,2,3,3-tetramethylcyclopropane-1-carboxylate",CC1(C(C1(C)C)C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C,47326,Negative,In Vivo
"[cyano-(3-phenoxyphenyl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,52315-07-08,Negative,in vitro
"[cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1(C(C1C(=O)OC(C#N)C2=CC(=C(C=C2)F)OC3=CC=CC=C3)C=C(Cl)Cl)C,104926,Negative,In Vivo
[ethyl(nitroso)amino]methyl acetate,CCN(COC(=O)C)N=O,47793,Positive,In Vivo
"[hydroxymethyl-[6-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-1,2,4-triazin-3-yl]amino]methanol",C1=C(OC(=C1)[N+](=O)[O-])/C=C/C2=CN=C(N=N2)N(CO)CO,794-93-4,Positive,in vivo
"[hydroxymethyl-[6-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-1,2,4-triazin-3-yl]amino]methanol",C1=C(OC(=C1)[N+](=O)[O-])/C=C/C2=CN=C(N=N2)N(CO)CO,6414792,Positive,In Vivo
[methoxy(methyl)phosphoryl]oxymethane,COP(=O)(C)OC,12958,Negative,In Vivo
[methoxy(methyl)phosphoryl]oxymethane,COP(=O)(C)OC,12958,Positive,In Vivo
[methyl(nitroso)amino]methyl acetate,CC(=O)OCN(C)N=O,42016,Negative,In Vivo
[methyl(nitroso)amino]methyl acetate,CC(=O)OCN(C)N=O,42016,Positive,In Vivo
[methyl(nitroso)amino]methyl acetate,CC(=O)OCN(C)N=O,56856-83-8,Positive,in vitro
[methyl(thiocyanato)arsanyl] thiocyanate,C[As](SC#N)SC#N,,Positive,in vitro
[N-acetyl-4-[(E)-2-phenylethenyl]anilino] acetate,CC(=O)N(C1=CC=C(C=C1)/C=C/C2=CC=CC=C2)OC(=O)C,26488-34-6,Positive,in vitro
[N-acetyl-4-[(Z)-2-phenylethenyl]anilino] acetate,CC(=O)N(C1=CC=C(C=C1)/C=C\C2=CC=CC=C2)OC(=O)C,,Positive,in vivo
[N-acetyl-4-[(Z)-2-phenylethenyl]anilino] acetate,CC(=O)N(C1=CC=C(C=C1)/C=C\C2=CC=CC=C2)OC(=O)C,,Positive,in vitro
[nitroso(propyl)amino]methyl acetate,CCCN(COC(=O)C)N=O,47807,Positive,In Vivo
1-(1-NAPHTHYL)-2-THIOUREA,C1=CC=C2C(=C1)C=CC=C2NC(=S)N,86-88-4,Negative,In vivo
"1-(1,3-benzodioxol-5-yl)-3-(dimethylamino)propan-1-one",CN(C)CCC(=O)C1=CC2=C(C=C1)OCO2,30418-50-9,Negative,in vitro
"1-(1,3-benzodioxol-5-yl)-3-piperidin-1-ylpropan-1-one",C1CCN(CC1)CCC(=O)C2=CC3=C(C=C2)OCO3,30418-51-0,Positive,in vitro
"1-(1,3-benzodioxol-5-yl)-3-pyrrolidin-1-ylpropan-1-one",C1CCN(C1)CCC(=O)C2=CC3=C(C=C2)OCO3,,Negative,in vitro
"1-(1,3-benzodioxol-5-yl)prop-2-en-1-ol",C=CC(C1=CC2=C(C=C1)OCO2)O,21268,Positive,In Vivo
"1-(1,3-benzodioxol-5-yl)prop-2-en-1-ol",C=CC(C1=CC2=C(C=C1)OCO2)O,5208-87-7,Positive,in vivo
"1-(1,3-benzodioxol-5-yl)prop-2-en-1-ol",C=CC(C1=CC2=C(C=C1)OCO2)O,5208-87-7,Negative,in vitro
"1-(1,3-benzodioxol-5-yl)prop-2-enyl acetate",CC(=O)OC(C=C)C1=CC2=C(C=C1)OCO2,,Positive,in vitro
"1-(1,3-benzothiazol-2-yl)-3-methylurea",CNC(=O)NC1=NC2=CC=CC=C2S1,1929-88-0,Negative,in vitro
"1-(1,3-benzothiazol-2-yl)-3-methylurea;3-cyclohexyl-1,5,6,7-tetrahydrocyclopenta[d]pyrimidine-2,4-dione",CNC(=O)NC1=NC2=CC=CC=C2S1.C1CCC(CC1)N2C(=O)C3=C(CCC3)NC2=O,,Negative,in vitro
"1-(2-chloroethyl)-1-nitroso-3-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]urea",C(CCl)N(C(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O)N=O,54749-90-5,Positive,in vivo
"1-(2-chloroethyl)-1-nitroso-3-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]urea",C(CCl)N(C(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O)N=O,54749-90-5,Positive,in vitro
1-(2-chloroethyl)-1-nitrosourea,C(CCl)N(C(=O)N)N=O,2365-30-2,Positive,in vitro
1-(2-chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea,C(CO)NC(=O)N(CCCl)N=O,60784-46-5,Positive,in vitro
1-(2-chloroethyl)-3-(2-hydroxypropyl)-1-nitrosourea,CC(CNC(=O)N(CCCl)N=O)O,129381,Negative,In Vivo
1-(2-chloroethyl)-3-(2-hydroxypropyl)-1-nitrosourea,CC(CNC(=O)N(CCCl)N=O)O,129381,Positive,In Vivo
1-(2-chloroethyl)-3-(3-hydroxypropyl)-1-nitrosourea,C(CNC(=O)N(CCCl)N=O)CO,60784-47-6,Positive,in vitro
1-(2-chloroethyl)-3-(4-hydroxybutyl)-1-nitrosourea,C(CCO)CNC(=O)N(CCCl)N=O,60784-48-7,Positive,in vitro
1-(2-chloroethyl)-3-[[[2-chloroethyl(nitroso)carbamoyl]amino]-diphenylmethyl]-1-nitrosourea,C1=CC=C(C=C1)C(C2=CC=CC=C2)(NC(=O)N(CCCl)N=O)NC(=O)N(CCCl)N=O,,Positive,in vitro
1-(2-chloroethyl)-3-[1-[[2-chloroethyl(nitroso)carbamoyl]amino]propan-2-yl]-1-nitrosourea,CC(CNC(=O)N(CCCl)N=O)NC(=O)N(CCCl)N=O,,Positive,in vitro
1-(2-chloroethyl)-3-[2-[[2-chloroethyl(nitroso)carbamoyl]amino]ethyl]-1-nitrosourea,C(CNC(=O)N(CCCl)N=O)NC(=O)N(CCCl)N=O,,Positive,in vitro
1-(2-chloroethyl)-3-[3-[[2-chloroethyl(nitroso)carbamoyl]amino]-4-methylphenyl]-1-nitrosourea,CC1=C(C=C(C=C1)NC(=O)N(CCCl)N=O)NC(=O)N(CCCl)N=O,,Positive,in vitro
1-(2-chloroethyl)-3-[4-[[2-chloroethyl(nitroso)carbamoyl]amino]butyl]-1-nitrosourea,C(CCNC(=O)N(CCCl)N=O)CNC(=O)N(CCCl)N=O,,Positive,in vitro
1-(2-chloroethyl)-3-[5-[[2-chloroethyl(nitroso)carbamoyl]amino]pentyl]-1-nitrosourea,C(CCNC(=O)N(CCCl)N=O)CCNC(=O)N(CCCl)N=O,,Positive,in vitro
1-(2-chloroethyl)-3-[6-[[2-chloroethyl(nitroso)carbamoyl]amino]hexyl]-1-nitrosourea,C(CCCNC(=O)N(CCCl)N=O)CCNC(=O)N(CCCl)N=O,,Positive,in vitro
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea,C1CCC(CC1)NC(=O)N(CCCl)N=O,13010-47-4,Positive,in vivo
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea,C1CCC(CC1)NC(=O)N(CCCl)N=O,13010-47-4,Positive,in vitro
1-(2-chloroethylsulfanyl)-2-[2-(2-chloroethylsulfanyl)ethoxy]ethane,C(CSCCCl)OCCSCCCl,,Positive,in vitro
"1-(2-chloroimidazo[1,2-a]pyridin-3-yl)sulfonyl-3-(4,6-dimethoxypyrimidin-2-yl)urea",COC1=CC(=NC(=N1)NC(=O)NS(=O)(=O)C2=C(N=C3N2C=CC=C3)Cl)OC,92433,Negative,In Vivo
"1-(2-chlorophenyl)sulfonyl-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea",CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=CC=CC=C2Cl,47491,Negative,In Vivo
1-(2-chloropyridin-4-yl)-3-phenylurea,C1=CC=C(C=C1)NC(=O)NC2=CC(=NC=C2)Cl,93379,Negative,In Vivo
1-(2-fluoroethyl)-1-nitrosourea,C(CF)N(C(=O)N)N=O,135419,Negative,In Vivo
1-(2-fluoroethyl)-1-nitrosourea,C(CF)N(C(=O)N)N=O,135419,Positive,In Vivo
"1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1,2,4-triazol-1-yl)ethanol",C1=CC=C(C(=C1)C(CN2C=NC=N2)(C3=CC=C(C=C3)F)O)F,91727,Negative,In Vivo
1-(2-hydroxyethyl)-1-nitrosourea,C(CO)N(C(=O)N)N=O,83695,Positive,In Vivo
1-(2-HYDROXYETHYL)-1-NITROSOUREA,C(CO)N(C(=O)N)N=O,13743-07-2,Positive,In vivo
1-(2-HYDROXYETHYL)-1-NITROSOUREA,C(CO)N(C(=O)N)N=O,13743-07-2,Negative,In vivo
1-(2-Hydroxyethyl)-1-nitrosourea,C(CO)N(C(=O)N)N=O,138-89-6,Positive,in vitro
1-(2-HYDROXYETHYL)-3-[(5-NITROFURFURYLIDENE)AMINO]-2-IMIDAZOLIDINONE,C1CN(C(=O)N1CCO)N=CC2=CC=C(O2)[N+](=O)[O-],5036-03-3,Positive,In vivo
1-(2-hydroxyethyl)-3-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidin-2-one,C1CN(C(=O)N1CCO)/N=C/C2=CC=C(O2)[N+](=O)[O-],,Positive,in vitro
1-(2-HYDROXYETHYL)-NITROSO-3-ETHYLUREA,CCNC(=O)N(CCO)N=O,96724-45-7,Positive,In vivo
1-(2-hydroxypropyl)-1-nitrosourea,CC(CN(C(=O)N)N=O)O,114735,Positive,In Vivo
1-(2-methoxyethyl)-1-nitrosourea,COCCN(C(=O)N)N=O,130063,Positive,In Vivo
1-(2-methylcyclohexyl)-3-phenylurea,CC1CCCCC1NC(=O)NC2=CC=CC=C2,1982-49-6,Negative,in vitro
1-(2-methylpropyl)-1-nitrosourea,CC(C)CN(C(=O)N)N=O,69800,Positive,In Vivo
1-(2-methylpropyl)-1-nitrosourea,CC(C)CN(C(=O)N)N=O,760-60-1,Positive,in vitro
1-(2-methylpropyl)-2-nitro-1-nitrosoguanidine,CC(C)CN(/C(=N/[N+](=O)[O-])/N)N=O,,Positive,in vitro
1-(2-OXOPROPYL)NITROSO-3-(2-CHLOROETHYL)UREA,CC(=O)CN(C(=O)NCCCl)N=O,110559-85-8,Positive,In vivo
"1-(2,4,6-Trichlorophenyl)-3,3-dimethyltriazene",CN(C)N=NC1=C(C=C(C=C1Cl)Cl)Cl,50355-74-3,Positive,in vitro
"1-(2,6-dimethyl-4-nitrosopiperazin-1-yl)ethanone",CC1CN(CC(N1C(=O)C)C)N=O,135652,Positive,In Vivo
1-(3-hydroxypropyl)-1-nitrosourea,C(CN(C(=O)N)N=O)CO,123019,Negative,In Vivo
1-(3-hydroxypropyl)-1-nitrosourea,C(CN(C(=O)N)N=O)CO,123019,Positive,In Vivo
1-(3-HYDROXYPROPYL)-1-NITROSOUREA,C(CN(C(=O)N)N=O)CO,71752-70-0,Positive,In vivo
1-(3-methoxy-4-nitrosophenyl)-2-phenylhydrazine;hydrochloride,COC1=C(C=CC(=C1)NNC2=CC=CC=C2)N=O.Cl,,Positive,in vitro
1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2,1989,Negative,In Vivo
1-(4-Bromophenyl)-3-3'-dimethyltriazene,CN(C)N=NC1=CC=C(C=C1)Br,7239-21-6,Positive,in vitro
1-(4-CHLOROPHENYL)-1-PHENYL-2-PROPYNYL CARBAMATE,C#CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OC(=O)N,10473-70-8,Positive,In vivo
"1-(4-Chlorophenyl)-3,3-dimethyltriazene",CN(C)N=NC1=CC=C(C=C1)Cl,7203-90-9,Positive,in vitro
1-(4-chlorophenyl)sulfonyl-3-propylurea,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,2727,Negative,In Vivo
1-(4-chlorophenyl)sulfonyl-3-propylurea,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,94-20-2,Positive,in vivo
1-(4-chlorophenyl)sulfonyl-3-propylurea,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,94-20-2,Positive,in vitro
1-(4-hydroxy-3-methoxyphenyl)-3-piperidin-1-ylpropan-1-one,COC1=C(C=CC(=C1)C(=O)CCN2CCCCC2)O,,Negative,in vitro
1-(4-methoxynaphthalen-1-yl)prop-2-enyl acetate,CC(=O)OC(C=C)C1=CC=C(C2=CC=CC=C21)OC,,Positive,in vitro
1-(4-methoxyphenyl)prop-2-en-1-ol,COC1=CC=C(C=C1)C(C=C)O,40003,Positive,In Vivo
1-(4-methoxyphenyl)prop-2-enyl acetate,CC(=O)OC(C=C)C1=CC=C(C=C1)OC,,Positive,in vitro
1-(4-nitrosophenyl)-2-phenylhydrazine,C1=CC=C(C=C1)NNC2=CC=C(C=C2)N=O,6530-27-4,Positive,in vitro
1-(4-tert-butylphenoxy)propan-2-yl 2-chloroethyl sulfite,CC(COC1=CC=C(C=C1)C(C)(C)C)OS(=O)OCCCl,8809,Positive,In Vivo
1-(4-tert-butylphenoxy)propan-2-yl 2-chloroethyl sulfite,CC(COC1=CC=C(C=C1)C(C)(C)C)OS(=O)OCCCl,140-57-8,Positive,in vivo
1-(5-hydroxy-4-methyloxolan-3-yl)ethanone,CC1C(COC1O)C(=O)C,27098-03-09,Positive,in vitro
"1-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one",C1CN(C(=O)N1)C2=NC=C(S2)[N+](=O)[O-],6093,Positive,In Vivo
"1-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one",C1CN(C(=O)N1)C2=NC=C(S2)[N+](=O)[O-],61-57-4,Negative,in vivo
"1-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one",C1CN(C(=O)N1)C2=NC=C(S2)[N+](=O)[O-],61-57-4,Positive,in vivo
"1-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one",C1CN(C(=O)N1)C2=NC=C(S2)[N+](=O)[O-],61-57-4,Positive,in vitro
1-(5-nitro-1H-pyrrol-2-yl)ethanone,CC(=O)C1=CC=C(N1)[N+](=O)[O-],32116-25-9,Positive,in vitro
1-(5-nitrofuran-2-yl)ethanone,CC(=O)C1=CC=C(O1)[N+](=O)[O-],5275-69-4,Positive,in vitro
1-(5-nitrothiophen-2-yl)ethanone,CC(=O)C1=CC=C(S1)[N+](=O)[O-],39565-00-9,Positive,in vitro
1-(AMINOMETHYL)CYCLOHEXANEACETIC ACID,C1CCC(CC1)(CC(=O)O)CN,60142-96-3,Negative,In vivo
1-(AMINOMETHYL)CYCLOHEXANEACETIC ACID,C1CCC(CC1)(CC(=O)O)CN,60142-96-3,Positive,In vivo
1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2,5503,Negative,In Vivo
1-(aziridin-1-yl)ethanone,CC(=O)N1CC1,0460-07-01,Positive,in vitro
1-(chloromethyl)-4-phenylbenzene,C1=CC=C(C=C1)C2=CC=C(C=C2)CCl,1667-11-4,Negative,in vitro
1-(diaminomethylidene)-2-(2-phenylethyl)guanidine,C1=CC=C(C=C1)CCN=C(N)N=C(N)N,8249,Negative,In Vivo
"1-(morpholin-4-ylmethyl)pyrrolidine-2,5-dione",C1CC(=O)N(C1=O)CN2CCOCC2,13314-97-1,Negative,in vitro
1-(nitrosomethylamino)butan-2-one,CCC(=O)CNCN=O,128951,Positive,In Vivo
1-(piperidin-1-ylmethyl)benzimidazole,C1CCN(CC1)CN2C=NC3=CC=CC=C32,19213-19-5,Negative,in vitro
1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol;hydrochloride,CC(C)NCC(COC1=CC=CC=C1OCC=C)O.Cl,6452-73-9,Positive,in vitro
"1-(propan-2-ylamino)anthracene-9,10-dione",CC(C)NC1=CC=CC2=C1C(=O)C3=CC=CC=C3C2=O,27354-18-3,Positive,in vitro
1-(tert-butylamino)-3-(3-methyl-2-nitrophenoxy)propan-2-ol,CC1=C(C(=CC=C1)OCC(CNC(C)(C)C)O)[N+](=O)[O-],51665,Positive,In Vivo
"1-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-3-nitroguanidine",CN=C(NCC1=CN=C(S1)Cl)N[N+](=O)[O-],213027,Negative,In Vivo
1-[(2-chloro-4-nitrophenyl)diazenyl]naphthalen-2-ol,C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C=C3)[N+](=O)[O-])Cl)O,17778,Negative,In Vivo
1-[(2-chloro-4-nitrophenyl)diazenyl]naphthalen-2-ol,C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C=C3)[N+](=O)[O-])Cl)O,2814-77-9,Positive,in vitro
1-[(2-methylphenyl)diazenyl]naphthalen-2-ol,CC1=CC=CC=C1N=NC2=C(C=CC3=CC=CC=C32)O,2646-17-5,Positive,in vivo
1-[(2-methylpropan-2-yl)oxy]propan-2-ol,CC(COC(C)(C)C)O,92629,Positive,In Vivo
1-[(2-methylpropan-2-yl)oxy]propan-2-ol,CC(COC(C)(C)C)O,92629,Negative,In Vivo
"1-[(2,3-dihydroxy-3-nitrosopropyl)amino]propan-2-one",CC(=O)CNCC(C(N=O)O)O,151884,Positive,In Vivo
"1-[(2,4-dichlorophenyl)methyl]indazole-3-carboxylic acid",C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,39562,Negative,In Vivo
"1-[(2,4-dimethylphenyl)diazenyl]naphthalen-2-ol",CC1=CC(=C(C=C1)N=NC2=C(C=CC3=CC=CC=C32)O)C,3118-97-6,Positive,in vitro
"1-[(2,4-dinitrophenyl)diazenyl]naphthalen-2-ol",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-])O,18981,Negative,In Vivo
"1-[(2,4-dinitrophenyl)diazenyl]naphthalen-2-ol",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-])O,3468-63-1,Positive,in vitro
"1-[(2,5-dimethoxyphenyl)diazenyl]naphthalen-2-ol",COC1=CC(=C(C=C1)OC)N=NC2=C(C=CC3=CC=CC=C32)O,22830,Positive,In Vivo
"1-[(2,5-dimethoxyphenyl)diazenyl]naphthalen-2-ol",COC1=CC(=C(C=C1)OC)N=NC2=C(C=CC3=CC=CC=C32)O,6358-53-8,Positive,in vivo
"1-[(2,5-dimethoxyphenyl)diazenyl]naphthalen-2-ol",COC1=CC(=C(C=C1)OC)N=NC2=C(C=CC3=CC=CC=C32)O,6358-53-8,Negative,in vitro
"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)pyrimidin-2-one",C1=CN(C(=O)N=C1NO)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,3258-02-04,Positive,in vitro
"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide",C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)N,50924-49-7,Positive,in vitro
"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidine-5-carbaldehyde",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C=O)CO)O,4494-26-2,Positive,in vitro
"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(hydroxymethyl)pyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)CO)CO)O,5116-24-5,Positive,in vitro
"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,70-00-8,Negative,in vitro
"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[(E)-2-iodoethenyl]pyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)/C=C/I)CO)O,,Positive,in vitro
"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[(E)-3,3,3-trifluoroprop-1-enyl]pyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)/C=C/C(F)(F)F)CO)O,,Positive,in vitro
"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[(E)-prop-1-enyl]pyrimidine-2,4-dione",C/C=C/C1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,66270-29-9,Positive,in vitro
"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)I)CO)O,54-42-2,Positive,in vivo
"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)I)CO)O,54-42-2,Negative,in vitro
"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,50-89-5,Negative,in vitro
"1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],35370,Negative,In Vivo
"1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],35370,Positive,In Vivo
1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl]benzimidazol-2-amine,COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F,2247,Negative,In Vivo
1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl]benzimidazol-2-amine,COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F,68844-77-9,Negative,in vitro
1-[(4-methoxyphenyl)methyl]-2-[(E)-2-(5-nitrofuran-2-yl)ethenyl]imidazole,COC1=CC=C(C=C1)CN2C=CN=C2/C=C/C3=CC=C(O3)[N+](=O)[O-],,Positive,in vitro
1-[(4-methyl-2-nitrophenyl)diazenyl]naphthalen-2-ol,CC1=CC(=C(C=C1)N=NC2=C(C=CC3=CC=CC=C32)O)[N+](=O)[O-],17047,Negative,In Vivo
1-[(4-methyl-2-nitrophenyl)diazenyl]naphthalen-2-ol,CC1=CC(=C(C=C1)N=NC2=C(C=CC3=CC=CC=C32)O)[N+](=O)[O-],17047,Positive,In Vivo
1-[(4-phenyldiazenylphenyl)diazenyl]naphthalen-2-ol,C1=CC=C(C=C1)N=NC2=CC=C(C=C2)N=NC3=C(C=CC4=CC=CC=C43)O,62331,Negative,In Vivo
1-[(4-tert-butylphenyl)methylsulfanyl]-1-butylsulfanyl-N-pyridin-3-ylmethanimine,CCCCSC(=NC1=CN=CC=C1)SCC2=CC=C(C=C2)C(C)(C)C,51308-54-4,Negative,in vitro
1-[(5-NITROFURFURYLIDENE)AMINO]-2-IMIDAZOLIDINONE,C1CN(C(=O)N1)N=CC2=CC=C(O2)[N+](=O)[O-],555-84-0,Positive,In vivo
1-[(5-NITROFURFURYLIDENE)AMINO]HYDANTOIN,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],67-20-9,Negative,In vivo
"1-[(5-Nitrofurfurylidene)amino]hydantoin 
(AKA Nitrofurantoin)",C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],67-20-9,Positive,in vitro
1-[(6-chloro-2-methoxyacridin-9-yl)amino]-3-(diethylamino)propan-2-ol;dihydrochloride,CCN(CC)CC(CNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC)O.Cl.Cl,1684-42-0,Positive,in vitro
1-[(6-hydrazinylpyridazin-3-yl)-methylamino]propan-2-ol;dihydrochloride,CC(CN(C)C1=NN=C(C=C1)NN)O.Cl.Cl,151324,Negative,In Vivo
1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidin-2-one,C1CN(C(=O)N1)/N=C/C2=CC=C(O2)[N+](=O)[O-],555-84-0,Positive,in vivo
1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidin-2-one,C1CN(C(=O)N1)/N=C/C2=CC=C(O2)[N+](=O)[O-],9568055,Positive,In Vivo
"1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione",C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-],6604200,Negative,In Vivo
"1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione",C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-],67-20-9,Negative,in vivo
"1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione",C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-],6604200,Positive,In Vivo
"1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione",C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-],67-20-9,Positive,in vivo
"1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione",C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-],67-20-9,Negative,in vitro
"1-[(E)-[(E)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]imidazolidine-2,4-dione",C1C(=O)NC(=O)N1/N=C/C=C/C2=CC=C(O2)[N+](=O)[O-],1672-88-4,Negative,in vitro
1-[(E)-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]amino]-3-[4-(trifluoromethoxy)phenyl]urea,C1=CC(=CC(=C1)C(F)(F)F)/C(=N/NC(=O)NC2=CC=C(C=C2)OC(F)(F)F)/CC3=CC=C(C=C3)C#N,11614934,Negative,In Vivo
1-[(E)-2-chloroethenyl]-4-methoxybenzene,COC1=CC=C(C=C1)/C=C/Cl,18684-94-1,Positive,in vitro
1-[[2-methyl-4-[(2-methylphenyl)diazenyl]phenyl]diazenyl]naphthalen-2-ol,CC1=CC=CC=C1N=NC2=CC(=C(C=C2)N=NC3=C(C=CC4=CC=CC=C43)O)C,85-83-6,Positive,in vitro
1-[2-(2-ethylpiperidin-1-yl)ethylamino]-4-(hydroxymethyl)thioxanthen-9-one,CCC1CCCCN1CCNC2=C3C(=C(C=C2)CO)SC4=CC=CC=C4C3=O,,Positive,in vitro
1-[2-(2-prop-2-enoyloxypropoxy)propoxy]propan-2-yl prop-2-enoate,CC(COCC(C)OC(=O)C=C)OCC(C)OC(=O)C=C,93414,Positive,In Vivo
"1-[2-(2,4-dichlorophenyl)-2-prop-2-enoxyethyl]imidazole",C=CCOC(CN1C=CN=C1)C2=C(C=C(C=C2)Cl)Cl,37175,Positive,In Vivo
"1-[2-(2,4-dichlorophenyl)-2-prop-2-enoxyethyl]imidazole",C=CCOC(CN1C=CN=C1)C2=C(C=C(C=C2)Cl)Cl,37175,Negative,In Vivo
"1-[2-(2,6-dioxopiperazin-1-yl)cyclopropyl]piperazine-2,6-dione",C1C(C1N2C(=O)CNCC2=O)N3C(=O)CNCC3=O,62490-99-7,Negative,in vitro
1-[2-(diethylamino)ethylamino]-4-(hydroxymethyl)thioxanthen-9-one,CCN(CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O,3105-97-3,Negative,in vivo
1-[2-(diethylamino)ethylamino]-4-(hydroxymethyl)thioxanthen-9-one,CCN(CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O,3105-97-3,Positive,in vivo
1-[2-(diethylamino)ethylamino]-4-(hydroxymethyl)thioxanthen-9-one,CCN(CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O,3105-97-3,Negative,in vitro
1-[2-(diethylamino)ethylamino]-4-hydroxy-10-oxothioxanthen-9-one,CCN(CC)CCNC1=C2C(=C(C=C1)O)S(=O)C3=CC=CC=C3C2=O,,Positive,in vitro
1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one,CCN(CC)CCNC1=C2C(=C(C=C1)C)SC3=CC=CC=C3C2=O,479-50-5,Negative,in vitro
1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one;hydrochloride,CCN(CC)CCNC1=C2C(=C(C=C1)C)SC3=CC=CC=C3C2=O.Cl,548-57-2,Positive,in vitro
1-[2-(diethylamino)ethylamino]-9-oxothioxanthene-4-carboxylic acid,CCN(CC)CCNC1=C2C(=C(C=C1)C(=O)O)SC3=CC=CC=C3C2=O,,Positive,in vitro
1-[2-(ethylamino)ethylamino]-4-(hydroxymethyl)thioxanthen-9-one,CCNCCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O,13479-19-1,Positive,in vitro
"1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole",C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,27220-47-9,Positive,in vitro
1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,54063-53-5,Positive,in vivo
"1-[2-[4-(6-methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine;hydrochloride",COC1=CC2=C(C=C1)C(=C(CC2)C3=CC=CC=C3)C4=CC=C(C=C4)OCCN5CCCC5.Cl,1847-63-8,Positive,in vivo
1-[2-[ethyl-(2-hydroxy-2-methylpropyl)amino]ethylamino]-4-(hydroxymethyl)thioxanthen-9-one,CCN(CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O)CC(C)(C)O,57292-31-6,Positive,in vitro
"1-[2,2-dichloro-1-(4-ethylphenyl)ethyl]-4-ethylbenzene",CCC1=CC=C(C=C1)C(C2=CC=C(C=C2)CC)C(Cl)Cl,6295,Negative,In Vivo
1-[3-(diethylamino)propyl]-3-[(E)-(5-nitrofuran-2-yl)methylideneamino]urea;hydrochloride,CCN(CC)CCCNC(=O)N/N=C/C1=CC=C(O1)[N+](=O)[O-].Cl,,Positive,in vitro
"1-[4-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,6-dihydroxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)propan-1-one",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=C(C(=C3)O)C(=O)CCC4=CC(=C(C=C4)OC)O)O)CO)O)O)O)O)O,20702-77-6,Negative,in vitro
1-[amino(aziridin-1-yl)phosphinothioyl]aziridine,C1CN1P(=S)(N)N2CC2,14465-96-4,Positive,in vitro
1-[benzyl-(2-methylaziridin-1-yl)phosphoryl]-2-methylaziridine,CC1CN1P(=O)(CC2=CC=CC=C2)N3CC3C,,Positive,in vitro
"1-[bis(2,4-dinitrophenyl)methyl]-2,4-dinitrobenzene",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])C(C2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])C3=C(C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-],3626-18-4,Positive,in vitro
"1-[bis(aziridin-1-yl)phosphoryl]-3-(2,4-dichlorophenyl)urea",C1CN1P(=O)(NC(=O)NC2=C(C=C(C=C2)Cl)Cl)N3CC3,,Positive,in vitro
1-[bis(aziridin-1-yl)phosphoryl]aziridine,C1CN1P(=O)(N2CC2)N3CC3,545-55-1,Positive,in vivo
1-[bis(aziridin-1-yl)phosphoryl]aziridine,C1CN1P(=O)(N2CC2)N3CC3,545-55-1,Positive,in vitro
1-[butyl(nitroso)amino]butyl acetate,CCCCN(C(CCC)OC(=O)C)N=O,42094,Positive,In Vivo
1-[butyl(nitroso)amino]butyl acetate,CCCCN(C(CCC)OC(=O)C)N=O,56986-35-7,Positive,in vitro
1-[ethoxy(propylsulfanyl)phosphoryl]sulfanylpropane,CCCSP(=O)(OCC)SCCC,3289,Negative,In Vivo
1-ACETYL-2-ISONICOTINOYLHYDRAZINE,CC(=O)NNC(=O)C1=CC=NC=C1,1078-38-2,Negative,In vivo
1-ACETYL-2-ISONICOTINOYLHYDRAZINE,CC(=O)NNC(=O)C1=CC=NC=C1,1078-38-2,Positive,In vivo
1-ACETYL-2-PHENYLHYDRAZINE,CC(=O)NNC1=CC=CC=C1,114-83-0,Negative,In vivo
1-ACETYL-2-PHENYLHYDRAZINE,CC(=O)NNC1=CC=CC=C1,114-83-0,Positive,In vivo
1-Acetyl-2-phenylhydrazine,CC(=O)NNC1=CC=CC=C1,114-83-0,Positive,in vitro
1-ALLYL-1-NITROSOUREA,C=CCN(C(=O)N)N=O,760-56-5,Positive,In vivo
1-amino-1-phenylurea,C1=CC=C(C=C1)N(C(=O)N)N,170220,Positive,In Vivo
"1-amino-2-methylanthracene-9,10-dione",CC1=C(C2=C(C=C1)C(=O)C3=CC=CC=C3C2=O)N,6702,Negative,In Vivo
"1-amino-2-methylanthracene-9,10-dione",CC1=C(C2=C(C=C1)C(=O)C3=CC=CC=C3C2=O)N,6702,Positive,In Vivo
"1-amino-2-methylanthracene-9,10-dione",CC1=C(C2=C(C=C1)C(=O)C3=CC=CC=C3C2=O)N,82-28-0,Positive,in vivo
"1-amino-2,4-dibromoanthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3Br)Br)N,6681,Positive,In Vivo
"1-Amino-2,4-dibromoanthraquinone",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3Br)Br)N,81-49-2,Negative,in vitro
1-amino-3-(hydrazinecarbonyl)urea,C(=O)(NC(=O)NN)NN,,Positive,in vitro
1-amino-3-chloropropan-2-ol;hydrochloride,C(C(CCl)O)N.Cl,62037-46-1,Negative,in vivo
"1-amino-4-hydroxyanthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)O)N,116-85-8,Positive,in vitro
"1-amino-4-methoxyanthracene-9,10-dione",COC1=C2C(=C(C=C1)N)C(=O)C3=CC=CC=C3C2=O,116-83-6,Positive,in vitro
1-Aminoanthraquinone,C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=CC=C3)N,82-45-1,Negative,in vitro
1-AMYL-1-NITROSOUREA,CCCCCN(C(=O)N)N=O,10589-74-9,Positive,In vivo
1-AZOXYPROPANE,CCCN=[N+](CCC)[O-],17697-55-1,Positive,In vivo
1-benzofuran,C1=CC=C2C(=C1)C=CO2,9223,Positive,In Vivo
1-benzofuran,C1=CC=C2C(=C1)C=CO2,9223,Negative,In Vivo
"1-benzoyl-5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione",CCC1(C(=O)NC(=O)N(C1=O)C(=O)C2=CC=CC=C2)C3=CC=CC=C3,744-80-9,Negative,in vitro
1-benzyl-2-[(E)-2-(5-nitrofuran-2-yl)ethenyl]imidazole,C1=CC=C(C=C1)CN2C=CN=C2/C=C/C3=CC=C(O3)[N+](=O)[O-],,Positive,in vitro
1-bis(2-methylaziridin-1-yl)phosphoryl-2-methylaziridine,CC1CN1P(=O)(N2CC2C)N3CC3C,57-39-6,Positive,in vivo
1-bis(2-methylaziridin-1-yl)phosphoryl-2-methylaziridine,CC1CN1P(=O)(N2CC2C)N3CC3C,57-39-6,Positive,in vitro
1-bis(butylsulfanyl)phosphorylsulfanylbutane,CCCCSP(=O)(SCCCC)SCCCC,78-48-8,Negative,in vitro
1-bromo-2-chloroethane,C(CBr)Cl,107-04-0,Positive,in vitro
1-bromo-2-methylpropane,CC(C)CBr,6555,Positive,In Vivo
"1-bromo-2,5-dichloro-4-[methoxy(phenyl)phosphoryl]oxybenzene",COP(=O)(C1=CC=CC=C1)OC2=CC(=C(C=C2Cl)Br)Cl,25006-32-0,Positive,in vitro
1-bromo-3-chlorobenzene,C1=CC(=CC(=C1)Br)Cl,108-37-2,Negative,in vitro
1-Bromo-3-chloropropane,C(CCl)CBr,109-70-6,Positive,in vitro
1-bromo-4-chlorobenzene,C1=CC(=CC=C1Cl)Br,106-39-8,Negative,in vitro
1-Bromopropane,CCCBr,106-94-5,Positive,in vitro
1-but-3-yn-2-yl-3-(4-chlorophenyl)-1-methylurea,CC(C#C)N(C)C(=O)NC1=CC=C(C=C1)Cl,3766-60-7,Negative,in vitro
1-butyl-1-nitrosourea,CCCCN(C(=O)N)N=O,13362,Positive,In Vivo
1-butyl-1-nitrosourea,CCCCN(C(=O)N)N=O,0869-01-02,Positive,in vivo
1-butyl-1-nitrosourea,CCCCN(C(=O)N)N=O,0869-01-02,Negative,in vivo
1-butyl-1-nitrosourea,CCCCN(C(=O)N)N=O,0869-01-02,Negative,in vitro
1-butyl-2-nitro-1-nitrosoguanidine,CCCCN(/C(=N/[N+](=O)[O-])/N)N=O,,Positive,in vitro
1-butyl-3-(4-methylphenyl)sulfonylurea,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,5505,Negative,In Vivo
1-butyl-3-(4-methylphenyl)sulfonylurea,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,64-77-7,Positive,in vivo
1-butyl-3-(4-methylphenyl)sulfonylurea,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,64-77-7,Positive,in vitro
1-butylaziridine,CCCCN1CC1,1120-85-0,Positive,in vitro
1-CARBAMYL-2-PHENYLHYDRAZINE,C1=CC=C(C=C1)NNC(=O)N,103-03-7,Negative,In vivo
1-CARBAMYL-2-PHENYLHYDRAZINE,C1=CC=C(C=C1)NNC(=O)N,103-03-7,Positive,In vivo
1-chloro-2-(1-chloropropan-2-yloxy)propane,CC(CCl)OC(C)CCl,7944,Positive,In Vivo
1-chloro-2-(1-chloropropan-2-yloxy)propane,CC(CCl)OC(C)CCl,7944,Negative,In Vivo
1-chloro-2-(2-chloroethoxy)ethane,C(CCl)OCCCl,8115,Positive,In Vivo
1-chloro-2-(2-chloroethoxy)ethane,C(CCl)OCCCl,8115,Negative,In Vivo
1-chloro-2-(2-chloroethylsulfanyl)ethane,C(CCl)SCCCl,505-60-2,Positive,in vivo
1-chloro-2-(2-chloroethylsulfanyl)ethane,C(CCl)SCCCl,10461,Positive,In Vivo
1-chloro-2-(2-chloroethylsulfanyl)ethane,C(CCl)SCCCl,505-60-2,Positive,in vitro
1-Chloro-2-(chloromethyl)benzene,C1=CC=C(C(=C1)CCl)Cl,611-19-8,Positive,in vitro
"1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethenyl]benzene",C1=CC=C(C(=C1)C(=C(Cl)Cl)C2=CC=C(C=C2)Cl)Cl,3424-82-6,Negative,in vitro
"1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene",C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,53-19-0,Positive,in vitro
"1-chloro-2-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene",C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,0789-02-06,Positive,in vitro
"1-chloro-2-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene;1-chloro-4-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene",C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl.C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,91560,Positive,In Vivo
1-chloro-2-ethylsulfanylethane,CCSCCCl,0693-07-02,Positive,in vitro
1-chloro-2-isocyanatoethane,C(CCl)N=C=O,1943-83-5,Negative,in vitro
1-chloro-2-methylprop-1-ene,CC(=CCl)C,10555,Positive,In Vivo
1-CHLORO-2-NITROBENZENE,C1=CC=C(C(=C1)[N+](=O)[O-])Cl,88-73-3,Negative,In vivo
1-chloro-2-nitrobenzene,C1=CC=C(C(=C1)[N+](=O)[O-])Cl,6945,Positive,In Vivo
1-CHLORO-2-NITROBENZENE,C1=CC=C(C(=C1)[N+](=O)[O-])Cl,88-73-3,Positive,In vivo
1-Chloro-2-nitrobenzene,C1=CC=C(C(=C1)[N+](=O)[O-])Cl,88-73-3,Positive,in vitro
1-Chloro-2-propanol,CC(CCl)O,127-00-4,Positive,in vitro
"1-CHLORO-2,4-DINITROBENZENE",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])Cl,97-00-7,Negative,In vivo
1-chloro-3-(3-chlorophenyl)benzene,C1=CC(=CC(=C1)Cl)C2=CC(=CC=C2)Cl,16307,Negative,In Vivo
1-chloro-4-(4-chlorophenyl)sulfonylbenzene,C1=CC(=CC=C1S(=O)(=O)C2=CC=C(C=C2)Cl)Cl,6625,Negative,In Vivo
"1-chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethenyl]benzene",C1=CC(=CC=C1C(=C(Cl)Cl)C2=CC=C(C=C2)Cl)Cl,3035,Positive,In Vivo
"1-chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethenyl]benzene",C1=CC(=CC=C1C(=C(Cl)Cl)C2=CC=C(C=C2)Cl)Cl,72-55-9,Positive,in vivo
"1-chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethenyl]benzene",C1=CC(=CC=C1C(=C(Cl)Cl)C2=CC=C(C=C2)Cl)Cl,3035,Negative,In Vivo
"1-chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethenyl]benzene",C1=CC(=CC=C1C(=C(Cl)Cl)C2=CC=C(C=C2)Cl)Cl,72-55-9,Negative,in vitro
"1-chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,6294,Negative,In Vivo
"1-chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,6294,Positive,In Vivo
"1-chloro-4-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,72-54-8,Positive,in vitro
"1-chloro-4-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,3036,Negative,In Vivo
"1-chloro-4-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,50-29-3,Negative,in vivo
"1-chloro-4-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,3036,Positive,In Vivo
"1-chloro-4-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,50-29-3,Positive,in vivo
"1-chloro-4-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,50-29-3,Negative,in vitro
1-chloro-4-methylbenzene,CC1=CC=C(C=C1)Cl,106-43-4,Negative,in vitro
1-CHLORO-4-NITROBENZENE,C1=CC(=CC=C1[N+](=O)[O-])Cl,100-00-5,Negative,In vivo
1-chloro-4-nitrobenzene,C1=CC(=CC=C1[N+](=O)[O-])Cl,7474,Positive,In Vivo
1-CHLORO-4-NITROBENZENE,C1=CC(=CC=C1[N+](=O)[O-])Cl,100-00-5,Positive,In vivo
1-Chloro-4-nitrobenzene,C1=CC(=CC=C1[N+](=O)[O-])Cl,100-00-5,Positive,in vitro
1-chloroaziridine,C1CN1Cl,10165-13-6,Positive,in vitro
1-chlorobutane,CCCCCl,8005,Negative,In Vivo
1-Chloromethylpyrene,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)CCl,1086-00-6,Positive,in vitro
1-chloropiperidine,C1CCN(CC1)Cl,2156-71-0,Negative,in vitro
1-chloropropan-2-ol,CC(CCl)O,31370,Negative,In Vivo
1-chloropropan-2-one,CC(=O)CCl,78-95-5,Positive,in vitro
1-CHLOROPROPENE,CC=CCl,590-21-6,Positive,In vivo
1-cyano-2-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]-3-prop-2-ynylguanidine;hydrochloride,CC1=C(N=CN1)CSCCN=C(NCC#C)NC#N.Cl,,Negative,in vitro
1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,2756,Negative,In Vivo
1-dimethoxyphosphorylsulfanyl-2-ethylsulfinylethane,CCS(=O)CCSP(=O)(OC)OC,0301-12-2,Positive,in vitro
1-ethenoxy-4-nitrobenzene,C=COC1=CC=C(C=C1)[N+](=O)[O-],119042,Positive,In Vivo
1-ethenyl-2-methylbenzene,CC1=CC=CC=C1C=C,611-15-4,Positive,in vitro
1-ethenyl-3-methylbenzene,CC1=CC(=CC=C1)C=C,100-80-1,Positive,in vitro
"1-ethenyl-3,5-dimethylbenzene",CC1=CC(=CC(=C1)C=C)C,5379-20-4,Positive,in vitro
1-ethenyl-4-methylbenzene,CC1=CC=C(C=C1)C=C,12161,Negative,In Vivo
1-ethenyl-4-methylbenzene,CC1=CC=C(C=C1)C=C,622-97-9,Positive,in vitro
1-ethenylpyrrolidin-2-one,C=CN1CCCC1=O,6917,Positive,In Vivo
1-ethoxy-2-nitrobenzene,CCOC1=CC=CC=C1[N+](=O)[O-],610-67-3,Positive,in vitro
1-ethyl-1-nitroso-3-(2-oxopropyl)urea,CCN(C(=O)NCC(=O)C)N=O,154041,Positive,In Vivo
1-ethyl-1-nitroso-3-phenylurea,CCN(C(=O)NC1=CC=CC=C1)N=O,54680-35-2,Positive,in vitro
1-ethyl-1-nitrosourea,CCN(C(=O)N)N=O,12967,Positive,In Vivo
1-ethyl-1-nitrosourea,CCN(C(=O)N)N=O,759-73-9,Positive,in vivo
1-Ethyl-1-nitrosourea,CCN(C(=O)N)N=O,759-73-9,Positive,in vitro
1-ethyl-2-(4-hydroxyphenyl)-3-methyl-1H-inden-5-ol,CCC1C2=C(C=C(C=C2)O)C(=C1C3=CC=C(C=C3)O)C,114716,Positive,In Vivo
"1-ethyl-2-(4-hydroxyphenyl)-3-methyl-2,3-dihydro-1H-inden-5-ol",CCC1C(C(C2=C1C=CC(=C2)O)C)C3=CC=C(C=C3)O,156224,Negative,In Vivo
1-ethyl-2-nitro-1-nitrosoguanidine,CCN(/C(=N\[N+](=O)[O-])/N)N=O,5473908,Positive,In Vivo
1-ethyl-2-nitro-1-nitrosoguanidine,CCN(/C(=N\[N+](=O)[O-])/N)N=O,,Positive,in vivo
1-ethyl-2-nitro-1-nitrosoguanidine,CCN(/C(=N\[N+](=O)[O-])/N)N=O,,Positive,in vitro
1-ethyl-3-(2-hydroxyethyl)-1-nitrosourea,CCN(C(=O)NCCO)N=O,124535,Positive,In Vivo
"1-ethyl-3-(5-nitro-1,3-thiazol-2-yl)urea",CCNC(=O)NC1=NC=C(S1)[N+](=O)[O-],8776,Positive,In Vivo
"1-ethyl-3-(5-nitro-1,3-thiazol-2-yl)urea",CCNC(=O)NC1=NC=C(S1)[N+](=O)[O-],139-94-6,Positive,in vivo
"1-ethyl-3-(5-nitro-1,3-thiazol-2-yl)urea",CCNC(=O)NC1=NC=C(S1)[N+](=O)[O-],8776,Negative,In Vivo
1-ethyl-3-methyl-1-nitrosourea,CCN(C(=O)NC)N=O,126434,Positive,In Vivo
"1-ethyl-3-methyl-8-phenyl-4,6-dihydropyrazolo[4,3-e][1,4]diazepin-5-one",CCN1C2=C(C(=N1)C)NC(=O)CN=C2C3=CC=CC=C3,33474,Negative,In Vivo
"1-ethyl-3-methyl-8-phenyl-4,6-dihydropyrazolo[4,3-e][1,4]diazepin-5-one",CCN1C2=C(C(=N1)C)NC(=O)CN=C2C3=CC=CC=C3,33474,Positive,In Vivo
1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,4539,Negative,In Vivo
"1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid",CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,4421,Negative,In Vivo
"1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid",CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,4421,Positive,In Vivo
"1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid",CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,0389-08-02,Positive,in vitro
"1-ETHYLENEOXY-3,4-EPOXYCYCLOHEXANE",C1CC2C(O2)CC1C3CO3,106-87-6,Negative,In vivo
1-ETHYLNITROSO-3-(2-HYDROXYETHYL)-UREA,CCN(C(=O)NCCO)N=O,96724-44-6,Positive,In vivo
1-ETHYLNITROSO-3-(2-OXOPROPYL)-UREA,CCN(C(=O)NCC(=O)C)N=O,110559-84-7,Positive,In vivo
"1-fluoro-2,4-dinitrobenzene",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])F,70-34-8,Negative,in vitro
1-fluoro-3-(2-nitroimidazol-1-yl)propan-2-ol,C1=CN(C(=N1)[N+](=O)[O-])CC(CF)O,13551-89-8,Positive,in vitro
"1-fluoro-7,12-dimethylbenzo[a]anthracene",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C(=CC=C3)F,,Negative,in vitro
1-FORMYL-3-THIOSEMICARBAZIDE,C(=O)NNC(=S)N,2302-84-3,Negative,In vivo
1-hexyl-1-nitrosourea,CCCCCCN(C(=O)N)N=O,146461,Positive,In Vivo
1-hexyl-1-nitrosourea,CCCCCCN(C(=O)N)N=O,18774-85-1,Positive,in vitro
"1-hydroperoxy-1,2,3,4-tetrahydronaphthalene",C1CC(C2=CC=CC=C2C1)OO,771-29-9,Negative,in vitro
"1-hydroxy-2-(hydroxymethyl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione",C1[C@H]([C@@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)OC3=C(C(=C4C(=C3)C(=O)C5=CC=CC=C5C4=O)O)CO)O)O)O)O)O)O,,Positive,in vitro
"1-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,31297-82-2,Positive,in vitro
"1-hydroxy-4-(4-methylanilino)anthracene-9,10-dione",CC1=CC=C(C=C1)NC2=C3C(=C(C=C2)O)C(=O)C4=CC=CC=C4C3=O,6680,Negative,In Vivo
"1-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,,Positive,in vitro
"1-hydroxy-4-[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)O)NCCNCCO,69895-67-6,Positive,in vitro
"1-hydroxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione",C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=CC=C3O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,Positive,in vitro
"1-hydroxyanthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=CC=C3)O,8512,Positive,In Vivo
1-HYDROXYANTHRAQUINONE,C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=CC=C3)O,129-43-1,Positive,In vivo
1-hydroxypropan-2-yl methanesulfonate,CC(CO)OS(=O)(=O)C,24590-49-6,Positive,in vitro
1-hydroxyquinolin-4-imine,C1=CC=C2C(=C1)C(=N)C=CN2O,2508-86-3,Negative,in vitro
1-iodopropane,CCCI,33643,Positive,In Vivo
1-isocyanato-4-(4-isocyanato-3-methoxyphenyl)-2-methoxybenzene,COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=C=O)OC)N=C=O,7069,Negative,In Vivo
1-isocyanato-4-(4-isocyanato-3-methoxyphenyl)-2-methoxybenzene,COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=C=O)OC)N=C=O,7069,Positive,In Vivo
1-ISOPROPYL-3-METHYL-s-PYRAZOLYLDIMETHYL CARBAMATE,CC1=NN(C(=C1)OC(=O)N(C)C)C(C)C,119-38-0,Negative,In vivo
1-isothiocyanatonaphthalene,C1=CC=C2C(=C1)C=CC=C2N=C=S,0551-06-04,Negative,in vitro
1-methoxy-2-nitrobenzene,COC1=CC=CC=C1[N+](=O)[O-],7048,Positive,In Vivo
1-methoxy-2-nitrobenzene,COC1=CC=CC=C1[N+](=O)[O-],7048,Negative,In Vivo
1-methoxy-2-phenylbenzene,COC1=CC=CC=C1C2=CC=CC=C2,86-26-0,Negative,in vitro
"1-methoxy-2,4-dinitrobenzene",COC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],119-27-7,Positive,in vitro
1-methoxy-3-(2-nitroimidazol-1-yl)propan-2-ol,COCC(CN1C=CN=C1[N+](=O)[O-])O,13551-87-6,Positive,in vitro
1-methoxy-4-[(E)-prop-1-enyl]benzene,C/C=C/C1=CC=C(C=C1)OC,637563,Negative,In Vivo
1-methoxy-4-[(E)-prop-1-enyl]benzene,C/C=C/C1=CC=C(C=C1)OC,637563,Positive,In Vivo
"1-methoxy-4-[2,2,2-trichloro-1-(4-methoxyphenyl)ethyl]benzene",COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)C(Cl)(Cl)Cl,4115,Negative,In Vivo
"1-methoxy-4-[2,2,2-trichloro-1-(4-methoxyphenyl)ethyl]benzene",COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)C(Cl)(Cl)Cl,4115,Positive,In Vivo
"1-methoxy-4-[2,2,2-trichloro-1-(4-methoxyphenyl)ethyl]benzene",COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)C(Cl)(Cl)Cl,72-43-5,Negative,in vivo
"1-methoxy-4-[2,2,2-trichloro-1-(4-methoxyphenyl)ethyl]benzene",COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)C(Cl)(Cl)Cl,72-43-5,Negative,in vitro
1-methoxy-4-nitrobenzene,COC1=CC=C(C=C1)[N+](=O)[O-],100-17-4,Positive,in vitro
1-methoxy-4-prop-2-enylbenzene,COC1=CC=C(C=C1)CC=C,8815,Positive,In Vivo
1-methoxypropan-1-ol,CCC(O)OC,3032390,Negative,In Vivo
1-methoxypropan-2-yl methanesulfonate,CC(COC)OS(=O)(=O)C,24590-51-0,Positive,in vitro
"1-methyl-1-nitroso-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]urea",CN(C(=O)N[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)N=O,,Positive,in vitro
"1-methyl-1-nitroso-3-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]urea",CN(C(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O)N=O,23615975,Positive,In Vivo
"1-methyl-1-nitroso-3-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]urea",CN(C(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O)N=O,,Positive,in vivo
"1-methyl-1-nitroso-3-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]urea",CN(C(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O)N=O,,Positive,in vitro
"1-methyl-1-nitroso-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]urea",CN(C(=O)NC1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)N=O,37793-17-2,Positive,in vitro
1-methyl-1-nitroso-3-phenylurea,CN(C(=O)NC1=CC=CC=C1)N=O,21561-99-9,Positive,in vitro
1-methyl-1-nitrosourea,CN(C(=O)N)N=O,684-93-5,Positive,in vivo
1-methyl-1-nitrosourea,CN(C(=O)N)N=O,12699,Positive,In Vivo
1-methyl-1-nitrosourea,CN(C(=O)N)N=O,12699,Negative,In Vivo
1-methyl-1-nitrosourea,CN(C(=O)N)N=O,684-93-5,Negative,in vivo
1-methyl-1-nitrosourea,CN(C(=O)N)N=O,684-93-5,Positive,in vitro
"1-methyl-1,2-dinitroguanidine",CN(/C(=N/[N+](=O)[O-])/N)[N+](=O)[O-],9570246,Negative,In Vivo
"1-METHYL-1,4-DIHYDRO-7-[2-(5-NITROFURYL)VINYL]-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLATE, POTASSIUM",CN1C=C(C(=O)C2=C1N=C(C=C2)C=CC3=CC=C(O3)[N+](=O)[O-])C(=O)[O-].[K+],29676-95-7,Positive,In vivo
1-methyl-2-nitro-1-nitrosoguanidine,CN(/C(=N/[N+](=O)[O-])/N)N=O,9562060,Positive,In Vivo
1-methyl-2-nitro-1-nitrosoguanidine,CN(/C(=N/[N+](=O)[O-])/N)N=O,,Positive,in vivo
1-methyl-2-nitro-1-nitrosoguanidine,CN(/C(=N/[N+](=O)[O-])/N)N=O,,Negative,in vivo
1-methyl-2-nitro-1-nitrosoguanidine,CN(/C(=N/[N+](=O)[O-])/N)N=O,,Negative,in vitro
1-methyl-2-nitrobenzene,CC1=CC=CC=C1[N+](=O)[O-],6944,Positive,In Vivo
1-methyl-2-nitrosobenzene,CC1=CC=CC=C1N=O,11909,Positive,In Vivo
"1-methyl-2,4-dinitrobenzene",CC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],8461,Negative,In Vivo
"1-methyl-2,4-dinitrobenzene",CC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],8461,Positive,In Vivo
"1-methyl-2,4-dinitrobenzene",CC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],121-14-2,Negative,in vitro
"1-methyl-3-(4-phenyl-1,3-thiazol-2-yl)urea",CNC(=O)NC1=NC(=CS1)C2=CC=CC=C2,52968-02-02,Positive,in vitro
1-methyl-3-phenyl-5-[3-(trifluoromethyl)phenyl]pyridin-4-one,CN1C=C(C(=O)C(=C1)C2=CC(=CC=C2)C(F)(F)F)C3=CC=CC=C3,43079,Negative,In Vivo
1-methyl-4-(1-methylpyridin-1-ium-4-yl)pyridin-1-ium,C[N+]1=CC=C(C=C1)C2=CC=[N+](C=C2)C,4685-14-7,Negative,in vivo
1-methyl-4-(1-methylpyridin-1-ium-4-yl)pyridin-1-ium,C[N+]1=CC=C(C=C1)C2=CC=[N+](C=C2)C,4685-14-7,Negative,in vitro
1-methyl-4-(1-methylpyridin-1-ium-4-yl)pyridin-1-ium;dichloride,C[N+]1=CC=C(C=C1)C2=CC=[N+](C=C2)C.[Cl-].[Cl-],1910-42-5,Positive,in vitro
1-methyl-4-(1-methylpyridin-1-ium-4-yl)pyridin-1-ium;methyl sulfate,C[N+]1=CC=C(C=C1)C2=CC=[N+](C=C2)C.COS(=O)(=O)[O-].COS(=O)(=O)[O-],2074-50-2,Positive,in vitro
1-methyl-4-nitrobenzene,CC1=CC=C(C=C1)[N+](=O)[O-],7473,Negative,In Vivo
1-methyl-4-nitrobenzene,CC1=CC=C(C=C1)[N+](=O)[O-],7473,Positive,In Vivo
1-methyl-4-nitrosobenzene,CC1=CC=C(C=C1)N=O,623-11-0,Positive,in vitro
1-methyl-4-nitrosopiperazine,CN1CCN(CC1)N=O,27826,Positive,In Vivo
1-methyl-4-nitrosopiperazine,CN1CCN(CC1)N=O,16339-07-04,Positive,in vitro
1-methyl-5-nitroimidazole,CN1C=NC=C1[N+](=O)[O-],3034-42-2,Positive,in vitro
"1-methyl-5H-pyrido[4,3-b]indol-3-amine",CC1=C2C3=CC=CC=C3NC2=CC(=N1)N,5284476,Positive,In Vivo
"1-methyl-5H-pyrido[4,3-b]indol-3-amine",CC1=C2C3=CC=CC=C3NC2=CC(=N1)N,62450-07-01,Positive,in vivo
"1-methyl-5H-pyrido[4,3-b]indol-3-amine",CC1=C2C3=CC=CC=C3NC2=CC(=N1)N,62450-07-01,Positive,in vitro
"1-methyl-6-phenylimidazo[4,5-b]pyridin-2-amine",CN1C2=C(N=CC(=C2)C3=CC=CC=C3)N=C1N,1530,Negative,In Vivo
"1-methyl-6-phenylimidazo[4,5-b]pyridin-2-amine",CN1C2=C(N=CC(=C2)C3=CC=CC=C3)N=C1N,1530,Positive,In Vivo
"1-methyl-9H-pyrido[3,4-b]indol-3-amine",CC1=C2C(=CC(=N1)N)C3=CC=CC=C3N2,84872-35-5,Positive,in vitro
"1-methyl-9H-pyrido[3,4-b]indole",CC1=NC=CC2=C1NC3=CC=CC=C23,486-84-0,Positive,in vitro
"1-methyl-9H-pyrido[3,4-b]indole;hydrochloride",CC1=NC=CC2=C1NC3=CC=CC=C23.Cl,21655-84-5,Positive,in vitro
1-methylbenzo[a]anthracene,CC1=C2C(=CC=C1)C=CC3=CC4=CC=CC=C4C=C32,2498-77-3,Positive,in vitro
1-methylchrysene,CC1=C2C=CC3=C(C2=CC=C1)C=CC4=CC=CC=C43,3351-28-8,Positive,in vitro
1-Methylcyclopropene,CC1=CC1,3100-04-7,Negative,in vivo
1-Methylcyclopropene,CC1=CC1,3100-04-07,Negative,in vitro
1-methylnaphthalene,CC1=CC=CC2=CC=CC=C12,7002,Negative,In Vivo
1-methylnaphthalene,CC1=CC=CC2=CC=CC=C12,7002,Positive,In Vivo
1-methylpyrrolidin-2-one,CN1CCCC1=O,13387,Positive,In Vivo
1-methylpyrrolidin-2-one,CN1CCCC1=O,13387,Negative,In Vivo
"1-N,1-N-bis(2-chloroethyl)-4-N-(6-chloro-2-methoxyacridin-9-yl)pentane-1,4-diamine;dihydrochloride",CC(CCCN(CCCl)CCCl)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC.Cl.Cl,4213-45-0,Positive,in vitro
"1-N,1-N-dimethyl-2-N-(1-nitroacridin-9-yl)propane-1,2-diamine;dihydrochloride",CC(CN(C)C)NC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-].Cl.Cl,65094-73-7,Positive,in vitro
"1-N,4-N-dimethyl-1-N,4-N-dinitrosobenzene-1,4-dicarboxamide",CN(C(=O)C1=CC=C(C=C1)C(=O)N(C)N=O)N=O,133-55-1,Negative,in vitro
"1-N,4-N-diphenylbenzene-1,4-diamine",C1=CC=C(C=C1)NC2=CC=C(C=C2)NC3=CC=CC=C3,6319,Negative,In Vivo
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;hydrochloride,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl,318-98-9,Positive,in vitro
1-naphthalen-2-yl-2-(propan-2-ylamino)ethanol,CC(C)NCC(C1=CC2=CC=CC=C2C=C1)O,54-80-8,Negative,in vivo
1-naphthalen-2-yl-2-(propan-2-ylamino)ethanol;hydrochloride,CC(C)NCC(C1=CC2=CC=CC=C2C=C1)O.Cl,60975,Positive,In Vivo
1-NAPHTHALENE ACETAMIDE,C1=CC=C2C(=C1)C=CC=C2CC(=O)N,86-86-2,Negative,In vivo
1-NAPHTHALENE ACETIC ACID,C1=CC=C2C(=C1)C=CC=C2CC(=O)O,86-87-3,Negative,In vivo
1-Naphthyl gylcidyl ether,C1C(O1)COC2=CC=CC3=CC=CC=C32,2461-42-9,Positive,in vitro
1-Naphthylacetic acid,C1=CC=C2C(=C1)C=CC=C2CC(=O)O,86-87-3,Negative,in vivo
1-Naphthylacetic acid,C1=CC=C2C(=C1)C=CC=C2CC(=O)O,86-87-3,Negative,in vitro
1-NAPHTHYLAMINE,C1=CC=C2C(=C1)C=CC=C2N,134-32-7,Positive,In vivo
1-Naphthylamine [Japan],C1=CC=C2C(=C1)C=CC=C2N,134-32-7,Positive,in vitro
1-Naphthylpropylene oxide,C1C(O1)CC2=CC=CC3=CC=CC=C32,68884-32-2,Positive,in vitro
1-nitro-4-[(4-nitrophenyl)disulfanyl]benzene,C1=CC(=CC=C1[N+](=O)[O-])SSC2=CC=C(C=C2)[N+](=O)[O-],100-32-3,Positive,in vitro
1-nitro-4-phenylbenzene,C1=CC=C(C=C1)C2=CC=C(C=C2)[N+](=O)[O-],7114,Positive,In Vivo
1-nitro-4-phenylbenzene,C1=CC=C(C=C1)C2=CC=C(C=C2)[N+](=O)[O-],92-93-3,Positive,in vivo
1-nitro-4-phenylbenzene,C1=CC=C(C=C1)C2=CC=C(C=C2)[N+](=O)[O-],7114,Negative,In Vivo
1-nitro-4-phenylbenzene,C1=CC=C(C=C1)C2=CC=C(C=C2)[N+](=O)[O-],92-93-3,Negative,in vitro
1-nitro-6-nitrosopyrene,C1=CC2=C(C=CC3=C2C4=C1C=CC(=C4C=C3)[N+](=O)[O-])N=O,101043-65-6,Positive,in vitro
1-nitro-8-nitrosopyrene,C1=CC2=C3C(=C(C=C2)[N+](=O)[O-])C=CC4=C(C=CC1=C43)N=O,100593-23-5,Positive,in vitro
1-nitrobenzo[a]pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=C(C=C5)[N+](=O)[O-])C=C3,50958,Negative,In Vivo
1-nitrobenzo[a]pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=C(C=C5)[N+](=O)[O-])C=C3,70021-99-7,Positive,in vitro
1-nitrobutane,CCCC[N+](=O)[O-],12302,Negative,In Vivo
1-NITROBUTANE,CCCC[N+](=O)[O-],627-05-4,Negative,In vivo
1-nitrochrysene,C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3C=CC=C4[N+](=O)[O-],44334,Negative,In Vivo
1-nitronaphthalen-2-ol,C1=CC=C2C(=C1)C=CC(=C2[N+](=O)[O-])O,550-60-7,Positive,in vitro
1-nitronaphthalene,C1=CC=C2C(=C1)C=CC=C2[N+](=O)[O-],6849,Negative,In Vivo
1-nitronaphthalene,C1=CC=C2C(=C1)C=CC=C2[N+](=O)[O-],86-57-7,Negative,in vivo
1-Nitronaphthalene,C1=CC=C2C(=C1)C=CC=C2[N+](=O)[O-],86-57-7,Positive,in vitro
1-NITROPROPANE,CCC[N+](=O)[O-],108-03-2,Negative,In vivo
1-nitropyrene,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)[N+](=O)[O-],21694,Negative,In Vivo
1-nitropyrene,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)[N+](=O)[O-],21694,Positive,In Vivo
1-NITROPYRENE,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)[N+](=O)[O-],5522-43-0,Positive,In vivo
1-Nitropyrene,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)[N+](=O)[O-],5522-43-0,Positive,in vitro
1-NITROSO-1-(2-HYDROXYPROPYL)-3-CHLOROETHYLUREA,CC(CN(C(=O)NCCCl)N=O)O,96806-35-8,Positive,In vivo
1-nitroso-1-(2-oxopropyl)urea,CC(=O)CN(C(=O)N)N=O,119557,Positive,In Vivo
1-nitroso-1-(2-phenylethyl)urea,C1=CC=C(C=C1)CCN(C(=O)N)N=O,96395,Positive,In Vivo
1-NITROSO-1-HYDROXYETHYL-3-CHLOROETHYLUREA,C(CCl)NC(=O)N(CCO)N=O,96806-34-7,Positive,In vivo
1-nitroso-1-pentylurea,CCCCCN(C(=O)N)N=O,82746,Positive,In Vivo
1-nitroso-1-prop-2-enylurea,C=CCN(C(=O)N)N=O,96019,Positive,In Vivo
1-nitroso-1-prop-2-enylurea,C=CCN(C(=O)N)N=O,,Positive,in vitro
1-nitroso-1-propylurea,CCCN(C(=O)N)N=O,13157,Positive,In Vivo
1-nitroso-1-propylurea,CCCN(C(=O)N)N=O,816-57-9,Positive,in vivo
1-nitroso-1-propylurea,CCCN(C(=O)N)N=O,816-57-9,Negative,in vitro
"1-nitroso-1,3-diazinan-2-one",C1CNC(=O)N(C1)N=O,,Positive,in vitro
"1-nitroso-1,3-diazinane-2,4-dione",C1CN(C(=O)NC1=O)N=O,85598,Positive,In Vivo
"1-nitroso-1,3-diazinane-2,4-dione",C1CN(C(=O)NC1=O)N=O,16813-36-8,Positive,in vitro
"1-NITROSO-3,4,5-TRIMETHYLPIPERAZINE",CC1CN(CC(N1C)C)N=O,75881-18-4,Positive,In vivo
"1-NITROSO-3,5-DIMETHYL-4-BENZOYLPIPERAZINE",CC1CN(CC(N1C(=O)C2=CC=CC=C2)C)N=O,61034-40-0,Positive,In vivo
"1-nitroso-3,6-dihydro-2H-pyridine",C1CN(CC=C1)N=O,55556-92-8,Positive,in vitro
1-nitroso-4-phenylbenzene,C1=CC=C(C=C1)C2=CC=C(C=C2)N=O,10125-76-5,Positive,in vitro
1-nitroso-4-phenylpiperidine,C1CN(CCC1C2=CC=CC=C2)N=O,6652-04-06,Positive,in vitro
"1-NITROSO-5,6-DIHYDROTHYMINE",CC1CN(C(=O)NC1=O)N=O,62641-67-2,Negative,In vivo
"1-NITROSO-5,6-DIHYDROURACIL",C1CN(C(=O)NC1=O)N=O,16813-36-8,Positive,In vivo
"1-Nitroso-5,6-dihydrouracil",C1CN(C(=O)NC1=O)N=O,16813-36-8,Positive,in vitro
1-nitrosoazepane,C1CCCN(CC1)N=O,13613,Positive,In Vivo
1-nitrosoazetidine,C1CN(C1)N=O,27135,Positive,In Vivo
1-nitrosoazocane,C1CCCN(CCC1)N=O,30360,Positive,In Vivo
1-nitrosoazocane,C1CCCN(CCC1)N=O,30360,Negative,In Vivo
1-NITROSOHYDANTOIN,C1C(=O)NC(=O)N1N=O,42579-28-2,Positive,In vivo
1-Nitrosohydantoin,C1C(=O)NC(=O)N1N=O,42579-28-2,Positive,in vitro
1-nitrosoimidazolidin-2-one,C1CN(C(=O)N1)N=O,,Positive,in vitro
1-nitrosoimidazolidine-2-thione,C1CN(C(=S)N1)N=O,3715-92-2,Negative,in vivo
1-nitrosoimidazolidine-2-thione,C1CN(C(=S)N1)N=O,3715-92-2,Positive,in vitro
"1-nitrosoimidazolidine-2,4-dione",C1C(=O)NC(=O)N1N=O,42579-28-2,Positive,in vitro
1-nitrosopiperazine,C1CN(CCN1)N=O,21845,Positive,In Vivo
1-nitrosopiperazine,C1CN(CCN1)N=O,5632-47-3,Positive,in vitro
1-nitrosopiperidin-3-ol,C1CC(CN(C1)N=O)O,55556-85-9,Positive,in vitro
1-nitrosopiperidin-4-ol,C1CN(CCC1O)N=O,55556-93-9,Positive,in vitro
1-nitrosopiperidin-4-one,C1CN(CCC1=O)N=O,41469,Positive,In Vivo
1-nitrosopiperidin-4-one,C1CN(CCC1=O)N=O,55556-91-7,Positive,in vitro
1-nitrosopiperidine,C1CCN(CC1)N=O,7526,Positive,In Vivo
1-nitrosopiperidine,C1CCN(CC1)N=O,100-75-4,Positive,in vivo
1-nitrosopiperidine,C1CCN(CC1)N=O,100-75-4,Positive,in vitro
1-nitrosopyrene,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)N=O,86674-51-3,Positive,in vitro
1-nitrosopyrrolidin-2-one,C1CC(=O)N(C1)N=O,54634-49-0,Positive,in vitro
1-nitrosopyrrolidin-3-ol,C1CN(CC1O)N=O,56222-35-6,Positive,in vitro
1-nitrosopyrrolidine,C1CCN(C1)N=O,13591,Negative,In Vivo
1-nitrosopyrrolidine,C1CCN(C1)N=O,13591,Positive,In Vivo
1-nitrosopyrrolidine,C1CCN(C1)N=O,930-55-2,Positive,in vivo
1-nitrosopyrrolidine,C1CCN(C1)N=O,930-55-2,Positive,in vitro
1-oxidopyridin-1-ium,C1=CC=[N+](C=C1)[O-],694-59-7,Negative,in vitro
1-Phenyl-3-methyl-5-pyrazolone,CC1=NN(C(=O)C1)C2=CC=CC=C2,89-25-8,Negative,in vitro
"1-PHENYL-3,3-DIMETHYLTRIAZENE",CN(C)N=NC1=CC=CC=C1,7227-91-0,Positive,In vivo
"1-Phenyl-3,3-dimethyltriazene",CN(C)N=NC1=CC=CC=C1,7227-91-0,Positive,in vitro
1-PHENYLAZO-2-NAPHTHOL,C1=CC=C(C=C1)N=NC2=C(C=CC3=CC=CC=C32)O,842-07-9,Negative,In vivo
1-phenyldiazenylnaphthalen-2-ol,C1=CC=C(C=C1)N=NC2=C(C=CC3=CC=CC=C32)O,13297,Negative,In Vivo
1-phenyldiazenylnaphthalen-2-ol,C1=CC=C(C=C1)N=NC2=C(C=CC3=CC=CC=C32)O,13297,Positive,In Vivo
1-phenylethanol,CC(C1=CC=CC=C1)O,7409,Negative,In Vivo
1-phenylethanol,CC(C1=CC=CC=C1)O,7409,Positive,In Vivo
1-phenylethanone,CC(=O)C1=CC=CC=C1,98-86-2,Negative,in vitro
1-phenylethyl (E)-3-dimethoxyphosphoryloxybut-2-enoate,CC(C1=CC=CC=C1)OC(=O)/C=C(\C)/OP(=O)(OC)OC,7700-17-6,Negative,in vitro
1-phenylpropan-2-amine,CC(CC1=CC=CC=C1)N,300-62-9,Positive,in vitro
1-phenylpropan-2-amine;sulfuric acid,CC(CC1=CC=CC=C1)N.CC(CC1=CC=CC=C1)N.OS(=O)(=O)O,6055,Negative,In Vivo
1-sulfinylethanamine,CC(=S=O)N,2669-09-02,Positive,in vitro
"1-tert-butyl-3,5-dimethyl-2,4,6-trinitrobenzene",CC1=C(C(=C(C(=C1[N+](=O)[O-])C(C)(C)C)[N+](=O)[O-])C)[N+](=O)[O-],62329,Positive,In Vivo
1-tert-butylaziridine,CC(C)(C)N1CC1,4017-38-3,Positive,in vitro
"1,1-bis(prop-2-enyl)hydrazine",C=CCN(CC=C)N,21242,Positive,In Vivo
"1,1-bis(tert-butylperoxy)-3,3,5-trimethylcyclohexane",CC1CC(CC(C1)(OOC(C)(C)C)OOC(C)(C)C)(C)C,93038,Negative,In Vivo
"1,1-BIS(tert-BUTYLPEROXY)-3,3,5-TRIMETHYLCYCLOHEXANE",CC1CC(CC(C1)(OOC(C)(C)C)OOC(C)(C)C)(C)C,6731-36-8,Negative,In vivo
"1,1-DI-n-BUTYLHYDRAZINE",CCCCN(CCCC)N,7422-80-2,Negative,In vivo
"1,1-DI-n-BUTYLHYDRAZINE",CCCCN(CCCC)N,7422-80-2,Positive,In vivo
"1,1-DIALLYLHYDRAZINE",C=CCN(CC=C)N,5164-11-4,Negative,In vivo
"1,1-DIALLYLHYDRAZINE",C=CCN(CC=C)N,5164-11-4,Positive,In vivo
"1,1-dibromo-2-methylpropane",CC(C)C(Br)Br,,Positive,in vitro
"1,1-dibromoethane",CC(Br)Br,557-91-5,Negative,in vitro
"1,1-dichloro-1-fluoroethane",CC(F)(Cl)Cl,15586,Negative,In Vivo
"1,1-dichloro-1-fluoroethane",CC(F)(Cl)Cl,15586,Positive,In Vivo
"1,1-DICHLORO-1-FLUOROETHANE",CC(F)(Cl)Cl,1717-00-6,Positive,In vivo
"1,1-dichloroethane",CC(Cl)Cl,6365,Negative,In Vivo
"1,1-dichloroethene",C=C(Cl)Cl,6366,Negative,In Vivo
"1,1-dichloroethene",C=C(Cl)Cl,6366,Positive,In Vivo
"1,1-dichloroethene",C=C(Cl)Cl,75-35-4,Positive,in vivo
"1,1-dichloroethene",C=C(Cl)Cl,75-35-4,Negative,in vivo
"1,1-dichloroethene",C=C(Cl)Cl,75-35-4,Negative,in vitro
"1,1-diethyl-3-methyl-3-nitrosourea",CCN(CC)C(=O)N(C)N=O,39589,Positive,In Vivo
"1,1-difluoroethene",C=C(F)F,6369,Negative,In Vivo
"1,1-dimethyl-2-[4-(5-nitrofuran-2-yl)-1,3-thiazol-2-yl]hydrazine",CN(C)NC1=NC(=CS1)C2=CC=C(O2)[N+](=O)[O-],26049-69-4,Negative,in vitro
"1,1-dimethyl-3-[3-(trifluoromethyl)phenyl]urea",CN(C)C(=O)NC1=CC=CC(=C1)C(F)(F)F,16562,Negative,In Vivo
"1,1-dimethyl-3-[3-(trifluoromethyl)phenyl]urea",CN(C)C(=O)NC1=CC=CC(=C1)C(F)(F)F,16562,Positive,In Vivo
"1,1-dimethyl-3-[3-(trifluoromethyl)phenyl]urea",CN(C)C(=O)NC1=CC=CC(=C1)C(F)(F)F,2164-17-2,Negative,in vitro
"1,1-dimethyl-3-nitrosourea",CN(C)C(=O)NN=O,171407,Positive,In Vivo
"1,1-dimethylhydrazine",CN(C)N,5976,Negative,In Vivo
"1,1-DIMETHYLHYDRAZINE",CN(C)N,57-14-7,Positive,In vivo
"1,1-dimethylhydrazine",CN(C)N,57-14-7,Negative,in vivo
"1,1-dimethylhydrazine",CN(C)N,5976,Positive,In Vivo
"1,1-Dimethylhydrazine",CN(C)N,57-14-7,Positive,in vitro
"1,1-dimethylhydrazine;1,2-dimethylhydrazine",CNNC.CN(C)N,61870,Positive,In Vivo
"1,1-dimethylpiperidin-1-ium;chloride",C[N+]1(CCCCC1)C.[Cl-],62781,Negative,In Vivo
"1,1-dioxo-1,2-benzothiazol-3-one",C1=CC=C2C(=C1)C(=O)NS2(=O)=O,81-07-2,Positive,in vivo
"1,1-dioxo-1,2-benzothiazol-3-one",C1=CC=C2C(=C1)C(=O)NS2(=O)=O,81-07-2,Negative,in vitro
"1,1-diphenylbut-2-ynyl N-cyclohexylcarbamate",CC#CC(C1=CC=CC=C1)(C2=CC=CC=C2)OC(=O)NC3CCCCC3,20930-10-3,Positive,in vitro
"1,1-diphenylprop-2-ynyl N-cyclohexylcarbamate",C#CC(C1=CC=CC=C1)(C2=CC=CC=C2)OC(=O)NC3CCCCC3,10087-89-5,Positive,in vitro
"1,1,1-trichloroethane",CC(Cl)(Cl)Cl,6278,Negative,In Vivo
"1,1,1-trichloroethane",CC(Cl)(Cl)Cl,71-55-6,Negative,in vivo
"1,1,1-Trichloroethane",CC(Cl)(Cl)Cl,71-55-6,Positive,in vitro
"1,1,1-TRICHLOROETHANE, TECHNICAL GRADE",CC(Cl)(Cl)Cl,71-55-6,Negative,In vivo
"1,1,1,2-tetrachloroethane",C(C(Cl)(Cl)Cl)Cl,12418,Positive,In Vivo
"1,1,1,2-tetrachloroethane",C(C(Cl)(Cl)Cl)Cl,12418,Negative,In Vivo
"1,1,1,2-tetrachloroethane",C(C(Cl)(Cl)Cl)Cl,79-34-5,Positive,In vivo
"1,1,1,2-tetrachloroethane",C(C(Cl)(Cl)Cl)Cl,630-20-6,Positive,In vivo
"1,1,1,2-tetrafluoroethane",C(C(F)(F)F)F,13129,Negative,In Vivo
"1,1,1,2-TETRAFLUOROETHANE",C(C(F)(F)F)F,811-97-2,Negative,In vivo
"1,1,1,2-tetrafluoroethane",C(C(F)(F)F)F,13129,Positive,In Vivo
"1,1,1,2-TETRAFLUOROETHANE",C(C(F)(F)F)F,811-97-2,Positive,In vivo
"1,1,1,2,2-pentachloroethane",C(C(Cl)(Cl)Cl)(Cl)Cl,6419,Positive,In Vivo
"1,1,1,2,2-pentachloroethane",C(C(Cl)(Cl)Cl)(Cl)Cl,6419,Negative,In Vivo
"1,1,1,2,2,2-hexachloroethane",C(C(Cl)(Cl)Cl)(Cl)(Cl)Cl,6214,Positive,In Vivo
"1,1,1,2,2,2-hexachloroethane",C(C(Cl)(Cl)Cl)(Cl)(Cl)Cl,67-72-1,Positive,in vivo
"1,1,1,2,2,2-hexachloroethane",C(C(Cl)(Cl)Cl)(Cl)(Cl)Cl,6214,Negative,In Vivo
"1,1,1,2,2,2-hexachloroethane",C(C(Cl)(Cl)Cl)(Cl)(Cl)Cl,67-72-1,Negative,in vitro
"1,1,2-TRICHLORO-1,2,2-TRIFLUOROETHANE, TECHNICAL GRADE",C(C(F)(Cl)Cl)(F)(F)Cl,76-13-1,Negative,In vivo
"1,1,2-trichloroethane",C(C(Cl)Cl)Cl,6574,Positive,In Vivo
"1,1,2-trichloroethane",C(C(Cl)Cl)Cl,6574,Negative,In Vivo
"1,1,2-trichloroethene",C(=C(Cl)Cl)Cl,6575,Negative,In Vivo
"1,1,2-trichloroethene",C(=C(Cl)Cl)Cl,6575,Positive,In Vivo
"1,1,2-trichloroethene",C(=C(Cl)Cl)Cl,79-01-6,Positive,in vivo
"1,1,2-trichloroethene",C(=C(Cl)Cl)Cl,79-01-6,Negative,in vitro
"1,1,2,2-tetrabromoethane",C(C(Br)Br)(Br)Br,79-27-6,Positive,in vitro
"1,1,2,2-tetrachloroethane",C(C(Cl)Cl)(Cl)Cl,6591,Positive,In Vivo
"1,1,2,2-tetrachloroethane",C(C(Cl)Cl)(Cl)Cl,79-34-5,Positive,in vivo
"1,1,2,2-tetrachloroethane",C(C(Cl)Cl)(Cl)Cl,6591,Negative,In Vivo
"1,1,2,2-tetrachloroethane",C(C(Cl)Cl)(Cl)Cl,79-34-5,Positive,in vitro
"1,1,2,2-tetrachloroethene",C(=C(Cl)Cl)(Cl)Cl,31373,Positive,In Vivo
"1,1,2,2-tetrachloroethene",C(=C(Cl)Cl)(Cl)Cl,127-18-4,Positive,in vivo
"1,1,2,2-tetrachloroethene",C(=C(Cl)Cl)(Cl)Cl,127-18-4,Negative,in vitro
"1,1,2,2-tetrafluoroethene",C(=C(F)F)(F)F,8301,Positive,In Vivo
"1,1,2,3,4,4-hexachlorobuta-1,3-diene",C(=C(Cl)Cl)(C(=C(Cl)Cl)Cl)Cl,6901,Positive,In Vivo
"1,1,3-triethyl-3-nitrosourea",CCN(CC)C(=O)N(CC)N=O,39587,Positive,In Vivo
"1,1,3-trimethyl-3-nitrosourea",CN(C)C(=O)N(C)N=O,3475-63-6,Positive,in vitro
"1,1,3-trimethylthiourea",CNC(=S)N(C)C,2779938,Negative,In Vivo
"1,1,3-trimethylthiourea",CNC(=S)N(C)C,2779938,Positive,In Vivo
"1,1'-Azobisformamide",C(=O)(N)N=NC(=O)N,123-77-3,Positive,in vitro
"1,1'-biphenyl",C1=CC=C(C=C1)C2=CC=CC=C2,7095,Negative,In Vivo
"1,1'-biphenyl",C1=CC=C(C=C1)C2=CC=CC=C2,7095,Positive,In Vivo
"1,1'-biphenyl",C1=CC=C(C=C1)C2=CC=CC=C2,92-52-4,Negative,in vitro
"1,10-bis(aziridin-1-yl)decane-1,10-dione",C1CN1C(=O)CCCCCCCCC(=O)N2CC2,,Positive,in vitro
"1,10-Diazachrysene",C1=CC2=C(C3=C(C=C2)C4=C(C=C3)N=CC=C4)N=C1,218-21-3,Positive,in vitro
"1,11-dimethyl-3,4-dihydrochrysene",CC1=CCCC2=C1C=C(C3=C2C=CC4=CC=CC=C43)C,,Positive,in vitro
"1,11-dimethylchrysene",CC1=C2C=C(C3=C(C2=CC=C1)C=CC4=CC=CC=C43)C,52171-92-3,Positive,in vitro
"1,2-bis(chloromethoxy)ethane",C(COCCl)OCCl,61632,Positive,In Vivo
"1,2-DI-n-BUTYLHYDRAZINE.2HCl",CCCCNNCCCC.Cl.Cl,78776-28-0,Negative,In vivo
"1,2-DI-n-BUTYLHYDRAZINE.2HCl",CCCCNNCCCC.Cl.Cl,78776-28-0,Positive,In vivo
"1,2-DIALLYLHYDRAZINE.2HCl",C=CCNNCC=C.Cl.Cl,26072-78-6,Negative,In vivo
"1,2-DIALLYLHYDRAZINE.2HCl",C=CCNNCC=C.Cl.Cl,26072-78-6,Positive,In vivo
"1,2-dibromo-3-chloropropane",C(C(CBr)Br)Cl,96-12-8,Positive,in vivo
"1,2-dibromo-3-chloropropane",C(C(CBr)Br)Cl,7280,Positive,In Vivo
"1,2-Dibromo-3-chloropropane",C(C(CBr)Br)Cl,96-12-8,Positive,in vitro
"1,2-dibromoethane",C(CBr)Br,7839,Positive,In Vivo
"1,2-dibromoethane",C(CBr)Br,106-93-4,Positive,in vivo
"1,2-DIBROMOETHANE",C(CBr)Br,106-93-4,Negative,In vivo
"1,2-Dibromoethane",C(CBr)Br,106-93-4,Positive,in vitro
"1,2-dibromopropane",CC(CBr)Br,78-75-1,Positive,in vitro
"1,2-Dichloro-4-nitrobenzene",C1=CC(=C(C=C1[N+](=O)[O-])Cl)Cl,99-54-7,Positive,in vitro
"1,2-dichlorobenzene",C1=CC=C(C(=C1)Cl)Cl,7239,Negative,In Vivo
"1,2-Dichlorobenzene",C1=CC=C(C(=C1)Cl)Cl,95-50-1,Positive,in vitro
"1,2-dichloroethane",C(CCl)Cl,11,Negative,In Vivo
"1,2-DICHLOROETHANE",C(CCl)Cl,107-06-2,Negative,In vivo
"1,2-dichloroethane",C(CCl)Cl,11,Positive,In Vivo
"1,2-DICHLOROETHANE",C(CCl)Cl,107-06-2,Positive,In vivo
"1,2-dichloroethane",C(CCl)Cl,0107-06-02,Positive,in vivo
"1,2-Dichloroethane",C(CCl)Cl,0107-06-02,Positive,in vitro
"1,2-dichloroethyne",C(#CCl)Cl,24227,Positive,In Vivo
"1,2-dichloropropane",CC(CCl)Cl,6564,Positive,In Vivo
"1,2-dichloropropane",CC(CCl)Cl,6564,Negative,In Vivo
"1,2-Dichloropropane",CC(CCl)Cl,78-87-5,Positive,in vitro
"1,2-diethylhydrazine",CCNNCC,1615-80-1,Positive,in vivo
"1,2-diethylhydrazine",CCNNCC,15374,Positive,In Vivo
"1,2-DIFORMYLHYDRAZINE",C(=O)NNC=O,628-36-4,Negative,In vivo
"1,2-DIFORMYLHYDRAZINE",C(=O)NNC=O,628-36-4,Positive,In vivo
"1,2-DIHYDRO-2-(5-NITRO-2-THIENYL)QUINAZOLIN-4(3H)-ONE",C1=CC=C2C(=C1)C(=O)NC(N2)C3=CC=C(S3)[N+](=O)[O-],33389-33-2,Positive,In vivo
"1,2-Dihydro-2-(5-nitro-2-thienyl)quinazolin-4(3H)-one",C1=CC=C2C(=C1)C(=O)NC(N2)C3=CC=C(S3)[N+](=O)[O-],33389-33-2,Positive,in vitro
"1,2-dihydroaceanthrylene",C1CC2=C3C1=CC=CC3=CC4=CC=CC=C24,160539,Negative,In Vivo
"1,2-dihydroaceanthrylene",C1CC2=C3C1=CC=CC3=CC4=CC=CC=C24,160539,Positive,In Vivo
"1,2-dihydropyridazine-3,6-dione",C1=CC(=O)NNC1=O,21954,Negative,In Vivo
"1,2-dihydropyridazine-3,6-dione",C1=CC(=O)NNC1=O,21954,Positive,In Vivo
"1,2-dihydropyridazine-3,6-dione",C1=CC(=O)NNC1=O,123-33-1,Negative,in vivo
"1,2-dihydropyridazine-3,6-dione",C1=CC(=O)NNC1=O,123-33-1,Negative,in vitro
"1,2-dihydroxyanthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)O)O,72-48-0,Positive,in vitro
"1,2-dimethoxy-4-prop-2-enylbenzene",COC1=C(C=C(C=C1)CC=C)OC,7127,Positive,In Vivo
"1,2-DIMETHYL-5-NITROIMIDAZOLE",CC1=NC=C(N1C)[N+](=O)[O-],551-92-8,Positive,In vivo
"1,2-Dimethyl-5-nitroimidazole",CC1=NC=C(N1C)[N+](=O)[O-],551-92-8,Positive,in vitro
"1,2-dimethylhydrazine",CNNC,1322,Positive,In Vivo
"1,2-dimethylhydrazine",CNNC,1322,Negative,In Vivo
"1,2-dimethylhydrazine",CNNC,540-73-8,Positive,in vivo
"1,2-dimethylhydrazine",CNNC,540-73-8,Negative,in vitro
"1,2-Dimethylhydrazine 2HCl",CNNC.Cl.Cl,306-37-6,Positive,in vitro
"1,2-dimethylhydrazine;dihydrochloride",CNNC.Cl.Cl,306-37-6,Positive,in vivo
"1,2-dimethylhydrazine;dihydrochloride",CNNC.Cl.Cl,9380,Positive,In Vivo
"1,2-dimethylhydrazine;dihydrochloride",CNNC.Cl.Cl,306-37-6,Positive,in vitro
"1,2-DIMETHYLHYDRAZINE.2HCl",CNNC.Cl.Cl,306-37-6,Positive,In vivo
"1,2-diphenylhydrazine",C1=CC=C(C=C1)NNC2=CC=CC=C2,31222,Negative,In Vivo
"1,2-diphenylhydrazine",C1=CC=C(C=C1)NNC2=CC=CC=C2,31222,Positive,In Vivo
"1,2-diphenylhydrazine",C1=CC=C(C=C1)NNC2=CC=CC=C2,122-66-7,Positive,in vivo
"1,2-Epoxybutane",CCC1CO1,106-88-7,Positive,in vitro
"1,2-PROPYLENE OXIDE",CC1CO1,75-56-9,Positive,In vivo
"1,2-Propylene oxide",CC1CO1,75-56-9,Positive,in vitro
"1,2,3-Benzotriazole",C1=CC2=NNN=C2C=C1,95-14-7,Positive,in vitro
"1,2,3-tribromopropane",C(C(CBr)Br)Br,96-11-7,Positive,in vitro
"1,2,3-trichloro-4-(2,3-dichlorophenyl)benzene",C1=CC(=C(C(=C1)Cl)Cl)C2=C(C(=C(C=C2)Cl)Cl)Cl,52663-62-4,Negative,in vivo
"1,2,3-trichloro-4-(2,3-dichlorophenyl)benzene",C1=CC(=C(C(=C1)Cl)Cl)C2=C(C(=C(C=C2)Cl)Cl)Cl,40470,Positive,In Vivo
"1,2,3-trichloro-4-(2,3-dichlorophenyl)benzene",C1=CC(=C(C(=C1)Cl)Cl)C2=C(C(=C(C=C2)Cl)Cl)Cl,52663-62-4,Negative,in vitro
"1,2,3-trichloro-4-(2,3,4-trichlorophenyl)benzene",C1=CC(=C(C(=C1C2=C(C(=C(C=C2)Cl)Cl)Cl)Cl)Cl)Cl,38018,Negative,In Vivo
"1,2,3-trichloro-4-(2,3,4-trichlorophenyl)benzene",C1=CC(=C(C(=C1C2=C(C(=C(C=C2)Cl)Cl)Cl)Cl)Cl)Cl,38018,Positive,In Vivo
"1,2,3-trichloro-5-(3,4-dichlorophenyl)benzene",C1=CC(=C(C=C1C2=CC(=C(C(=C2)Cl)Cl)Cl)Cl)Cl,63090,Negative,In Vivo
"1,2,3-trichloro-5-(3,4-dichlorophenyl)benzene",C1=CC(=C(C=C1C2=CC(=C(C(=C2)Cl)Cl)Cl)Cl)Cl,63090,Positive,In Vivo
"1,2,3-trichlorobenzene",C1=CC(=C(C(=C1)Cl)Cl)Cl,87-61-6,Positive,in vitro
"1,2,3-trichloropropane",C(C(CCl)Cl)Cl,7285,Positive,In Vivo
"1,2,3-Trichloropropane",C(C(CCl)Cl)Cl,96-18-4,Positive,in vitro
"1,2,3,4-tetrabromobutane",C(C(C(CBr)Br)Br)Br,1529-68-6,Negative,in vivo
"1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalene",C1CCC2CCCCC2C1,7044,Negative,In Vivo
"1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalene",C1CCC2CCCCC2C1,7044,Positive,In Vivo
"1,2,3,4,5-pentabromo-6-(2,3,4,5,6-pentabromophenoxy)benzene",C1(=C(C(=C(C(=C1Br)Br)Br)Br)Br)OC2=C(C(=C(C(=C2Br)Br)Br)Br)Br,14410,Negative,In Vivo
"1,2,3,4,5-pentabromo-6-(2,3,4,5,6-pentabromophenoxy)benzene",C1(=C(C(=C(C(=C1Br)Br)Br)Br)Br)OC2=C(C(=C(C(=C2Br)Br)Br)Br)Br,14410,Positive,In Vivo
"1,2,3,4,5-pentachloro-6-methoxybenzene",COC1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl,15767,Negative,In Vivo
"1,2,3,4,5-pentachloro-6-methoxybenzene",COC1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl,15767,Positive,In Vivo
"1,2,3,4,5-pentachloro-6-nitrobenzene",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)[N+](=O)[O-],6720,Negative,In Vivo
"1,2,3,4,5-pentachloro-6-nitrobenzene",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)[N+](=O)[O-],6720,Positive,In Vivo
"1,2,3,4,5-pentachloro-6-nitrobenzene",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)[N+](=O)[O-],82-68-8,Negative,in vivo
"1,2,3,4,5-pentachloro-6-nitrobenzene",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)[N+](=O)[O-],82-68-8,Negative,in vitro
"1,2,3,4,5,5-hexachlorocyclopenta-1,3-diene",C1(=C(C(C(=C1Cl)Cl)(Cl)Cl)Cl)Cl,6478,Negative,In Vivo
"1,2,3,4,5,5,6,7,8,9,10,10-dodecachloropentacyclo[5.3.0.02,6.03,9.04,8]decane",C12(C3(C4(C5(C3(C(C1(C5(C2(C4(Cl)Cl)Cl)Cl)Cl)(Cl)Cl)Cl)Cl)Cl)Cl)Cl,16945,Positive,In Vivo
"1,2,3,4,5,5,6,7,8,9,10,10-dodecachloropentacyclo[5.3.0.02,6.03,9.04,8]decane",C12(C3(C4(C5(C3(C(C1(C5(C2(C4(Cl)Cl)Cl)Cl)Cl)(Cl)Cl)Cl)Cl)Cl)Cl)Cl,2385-85-5,Positive,in vivo
"1,2,3,4,5,5,6,7,8,9,10,10-dodecachloropentacyclo[5.3.0.02,6.03,9.04,8]decane",C12(C3(C4(C5(C3(C(C1(C5(C2(C4(Cl)Cl)Cl)Cl)Cl)(Cl)Cl)Cl)Cl)Cl)Cl)Cl,2385-85-5,Negative,in vivo
"1,2,3,4,5,6-hexachlorobenzene",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)Cl,8370,Positive,In Vivo
"1,2,3,4,5,6-hexachlorobenzene",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)Cl,118-74-1,Positive,in vivo
"1,2,3,4,5,6-hexachlorobenzene",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)Cl,8370,Negative,In Vivo
"1,2,3,4,5,6-hexachlorobenzene",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)Cl,118-74-1,Negative,in vivo
"1,2,3,4,5,6-hexachlorocyclohexane",C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,727,Negative,In Vivo
"1,2,3,4,5,6-hexachlorocyclohexane",C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,727,Positive,In Vivo
"1,2,3,4,5,6-hexachlorocyclohexane",C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,58-89-9,Positive,in vivo
"1,2,3,4,5,6-hexachlorocyclohexane",C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,58-89-9,Negative,in vitro
"1,2,3,4,5,6,8,9,10,11-decadeuterio-7,12-bis(trideuteriomethyl)benzo[a]anthracene",[2H]C1=C(C(=C2C(=C1[2H])C(=C(C3=C(C4=C(C(=C(C(=C4C(=C32)C([2H])([2H])[2H])[2H])[2H])[2H])[2H])C([2H])([2H])[2H])[2H])[2H])[2H])[2H],6913060,Positive,In Vivo
"1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin",C1=C2C(=C(C(=C1Cl)Cl)Cl)OC3=C(O2)C(=C(C(=C3Cl)Cl)Cl)Cl,37270,Positive,In Vivo
"1,2,3,4,6,7,8,9,10,10-decachloropentacyclo[5.3.0.02,6.03,9.04,8]decan-5-one",C1(=O)C2(C3(C4(C1(C5(C2(C3(C(C45Cl)(Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl,299,Positive,In Vivo
"1,2,3,4,6,7,8,9,10,10-decachloropentacyclo[5.3.0.02,6.03,9.04,8]decan-5-one",C1(=O)C2(C3(C4(C1(C5(C2(C3(C(C45Cl)(Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl,143-50-0,Positive,in vivo
"1,2,3,6,7,8-hexachlorodibenzo-p-dioxin",C1=C2C(=C(C(=C1Cl)Cl)Cl)OC3=CC(=C(C(=C3O2)Cl)Cl)Cl,42540,Negative,In Vivo
"1,2,3,6,7,8-hexachlorodibenzo-p-dioxin",C1=C2C(=C(C(=C1Cl)Cl)Cl)OC3=CC(=C(C(=C3O2)Cl)Cl)Cl,42540,Positive,In Vivo
"1,2,4-trichloro-5-(2,4,5-trichlorophenyl)benzene",C1=C(C(=CC(=C1Cl)Cl)Cl)C2=CC(=C(C=C2Cl)Cl)Cl,37034,Negative,In Vivo
"1,2,4-trichloro-5-(3-iodoprop-2-ynoxy)benzene",C1=C(C(=CC(=C1Cl)Cl)Cl)OCC#CI,0777-11-7,Negative,in vitro
"1,2,4-trichloro-5-(3,4-dichlorophenyl)benzene",C1=CC(=C(C=C1C2=CC(=C(C=C2Cl)Cl)Cl)Cl)Cl,35823,Positive,In Vivo
"1,2,4-trichloro-5-(4-chlorophenoxy)benzene",C1=CC(=CC=C1OC2=CC(=C(C=C2Cl)Cl)Cl)Cl,61328-45-8,Negative,in vitro
"1,2,4-trichloro-5-(4-chlorophenyl)sulfonylbenzene",C1=CC(=CC=C1S(=O)(=O)C2=CC(=C(C=C2Cl)Cl)Cl)Cl,116-29-0,Positive,in vitro
"1,2,4-trichlorobenzene",C1=CC(=C(C=C1Cl)Cl)Cl,120-82-1,Positive,in vitro
"1,2,4-trihydroxyanthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3O)O)O,6683,Positive,In Vivo
"1,2,4-Trihydroxybenzene - COLIPA A33",C1=CC(=C(C=C1O)O)O,533-73-3,Negative,in vitro
"1,2,4-trimethoxy-5-[(E)-prop-1-enyl]benzene",C/C=C/C1=CC(=C(C=C1OC)OC)OC,636822,Negative,In Vivo
"1,2,4-trimethoxy-5-[(E)-prop-1-enyl]benzene",C/C=C/C1=CC(=C(C=C1OC)OC)OC,636822,Positive,In Vivo
"1,2,4-TRIMETHYLBENZENE",CC1=CC(=C(C=C1)C)C,95-63-6,Positive,In vivo
"1,2,4-trimethylbenzene",CC1=CC(=C(C=C1)C)C,95-63-6,Negative,in vitro
"1,2,4,5-tetrachloro-3-methoxy-6-nitrobenzene",COC1=C(C(=C(C(=C1Cl)Cl)[N+](=O)[O-])Cl)Cl,17107,Negative,In Vivo
"1,2,4,5-tetrachloro-3-methoxy-6-nitrobenzene",COC1=C(C(=C(C(=C1Cl)Cl)[N+](=O)[O-])Cl)Cl,2438-88-2,Negative,in vivo
"1,2,6-trimethyl-4-nitrosopiperazine",CC1CN(CC(N1C)C)N=O,150692,Positive,In Vivo
"1,2,8-trihydroxy-3-methoxy-6-methylanthracene-9,10-dione",CC1=CC2=C(C(=C1)O)C(=O)C3=C(C(=C(C=C3C2=O)OC)O)O,7213-59-4,Positive,in vitro
"1,3-benzodioxol-5-ol",C1OC2=C(O1)C=C(C=C2)O,68289,Positive,In Vivo
"1,3-benzodioxol-5-ol",C1OC2=C(O1)C=C(C=C2)O,68289,Negative,In Vivo
"1,3-benzodioxol-5-yl(oxiran-2-yl)methanol",C1C(O1)C(C2=CC3=C(C=C2)OCO3)O,,Positive,in vitro
"1,3-benzodioxol-5-yl(oxiran-2-yl)methanone",C1C(O1)C(=O)C2=CC3=C(C=C2)OCO3,,Positive,in vitro
"1,3-bis(2-chloroethyl)-1-nitrosourea",C(CCl)NC(=O)N(CCCl)N=O,154-93-8,Positive,in vivo
"1,3-bis(2-chloroethyl)-1-nitrosourea",C(CCl)NC(=O)N(CCCl)N=O,154-93-8,Positive,in vitro
"1,3-BUTADIENE",C=CC=C,106-99-0,Positive,In vivo
"1,3-Butadiene",C=CC=C,106-99-0,Positive,in vitro
"1,3-diazinane-2,4,5,6-tetrone",C1(=O)C(=O)NC(=O)NC1=O,5781,Positive,In Vivo
"1,3-diazinane-2,4,5,6-tetrone",C1(=O)C(=O)NC(=O)NC1=O,50-71-5,Negative,in vitro
"1,3-dibutyl-1-(4-phenyl-1,3-thiazol-2-yl)urea",CCCCNC(=O)N(CCCC)C1=NC(=CS1)C2=CC=CC=C2,,Positive,in vitro
"1,3-DIBUTYL-1-NITROSOUREA",CCCCNC(=O)N(CCCC)N=O,56654-52-5,Positive,In vivo
"1,3-Dibutyl-1-nitrosourea",CCCCNC(=O)N(CCCC)N=O,56654-52-5,Positive,in vitro
"1,3-Dichloro-2-propanol",C(C(CCl)O)Cl,96-23-1,Positive,in vitro
"1,3-dichloro-5-(3-chlorophenyl)benzene",C1=CC(=CC(=C1)Cl)C2=CC(=CC(=C2)Cl)Cl,38037,Negative,In Vivo
"1,3-dichloro-5-(3-chlorophenyl)benzene",C1=CC(=CC(=C1)Cl)C2=CC(=CC(=C2)Cl)Cl,38037,Positive,In Vivo
"1,3-dichlorobenzene",C1=CC(=CC(=C1)Cl)Cl,541-73-1,Positive,in vitro
"1,3-dichloropropan-2-ol",C(C(CCl)O)Cl,96-23-1,Positive,in vitro
"1,3-dichloropropan-2-one",C(C(=O)CCl)Cl,0534-07-06,Positive,in vitro
"1,3-Dichloropropene (AKA Telone II)",C(C=CCl)Cl,542-75-6,Positive,in vitro
"1,3-dicyclohexylthiourea",C1CCC(CC1)NC(=S)NC2CCCCC2,727200,Negative,In Vivo
"1,3-dicyclohexylthiourea",C1CCC(CC1)NC(=S)NC2CCCCC2,1212-29-9,Positive,in vitro
"1,3-diethyl-1-nitrosourea",CCNC(=O)N(CC)N=O,96620,Positive,In Vivo
"1,3-diethyl-1-nitrosourea",CCNC(=O)N(CC)N=O,49540-32-1,Positive,in vitro
"1,3-diethylthiourea",CCNC(=S)NCC,2735009,Negative,In Vivo
"1,3-diethylthiourea",CCNC(=S)NCC,105-55-5,Positive,in vivo
"1,3-diethylthiourea",CCNC(=S)NCC,2735009,Positive,In Vivo
"1,3-diethylthiourea",CCNC(=S)NCC,105-55-5,Negative,in vitro
"1,3-dihydroxy-2-(hydroxymethyl)anthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)CO)O,478-08-0,Positive,in vitro
"1,3-dihydroxypropan-2-one",C(C(=O)CO)O,670,Negative,In Vivo
"1,3-dihydroxyurea",C(=O)(NO)NO,686-68-0,Negative,in vitro
"1,3-Diisopropylcarbodiimide",CC(C)N=C=NC(C)C,12734,Negative,In Vivo
"1,3-dimethyl-1-nitrosourea",CNC(=O)N(C)N=O,83273,Positive,In Vivo
"1,3-dimethyl-1-nitrosourea",CNC(=O)N(C)N=O,13256-32-1,Positive,in vitro
"1,3-dimethyl-7H-purine-2,6-dione",CN1C2=C(C(=O)N(C1=O)C)NC=N2,2153,Negative,In Vivo
"1,3-dimethyl-7H-purine-2,6-dione",CN1C2=C(C(=O)N(C1=O)C)NC=N2,58-55-9,Positive,in vitro
"1,3-dimethylnaphthalene",CC1=CC2=CC=CC=C2C(=C1)C,575-41-7,Negative,in vitro
"1,3-dinitrobenzene",C1=CC(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-],99-65-0,Positive,in vitro
"1,3-dinitropyrene",C1=CC2=C3C(=C1)C=CC4=C(C=C(C(=C43)C=C2)[N+](=O)[O-])[N+](=O)[O-],53230,Positive,In Vivo
"1,3-dinitropyrene",C1=CC2=C3C(=C1)C=CC4=C(C=C(C(=C43)C=C2)[N+](=O)[O-])[N+](=O)[O-],75321-20-9,Positive,in vitro
"1,3-dioxolan-2-one",C1COC(=O)O1,7303,Negative,In Vivo
"1,3-dioxolan-4-ylmethanol",C1C(OCO1)CO,5464-28-8,Negative,in vitro
"1,3-Propane sultone",C1COS(=O)(=O)C1,1120-71-4,Positive,in vitro
"1,3-thiazolidine",C1CSCN1,10444,Negative,In Vivo
"1,3,2-dioxathiane 2,2-dioxide",C1COS(=O)(=O)OC1,1073-05-08,Positive,in vitro
"1,3,2-dioxathiolane 2,2-dioxide",C1COS(=O)(=O)O1,1072-53-3,Positive,in vitro
"1,3,4-thiadiazol-2-amine",C1=NN=C(S1)N,4005-51-0,Positive,in vitro
"1,3,4,7,8,9,10,10-octachlorotricyclo[5.2.1.02,6]dec-8-ene",C1C2C(C(C1Cl)Cl)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl,5993,Negative,In Vivo
"1,3,4,7,8,9,10,10-octachlorotricyclo[5.2.1.02,6]dec-8-ene",C1C2C(C(C1Cl)Cl)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl,5993,Positive,In Vivo
"1,3,4,7,8,9,10,10-octachlorotricyclo[5.2.1.02,6]dec-8-ene",C1C2C(C(C1Cl)Cl)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl,12789-03-06,Positive,in vivo
"1,3,4,7,8,9,10,10-octachlorotricyclo[5.2.1.02,6]dec-8-ene",C1C2C(C(C1Cl)Cl)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl,12789-03-06,Positive,in vitro
"1,3,5-triazine-2,4,6-triamine",C1(=NC(=NC(=N1)N)N)N,7955,Negative,In Vivo
"1,3,5-triazine-2,4,6-triamine",C1(=NC(=NC(=N1)N)N)N,7955,Positive,In Vivo
"1,3,5-trichloro-2-(4-chlorophenoxy)benzene",C1=CC(=CC=C1OC2=C(C=C(C=C2Cl)Cl)Cl)Cl,,Negative,in vitro
"1,3,5-trichloro-2,4,6-trinitrobenzene",C1(=C(C(=C(C(=C1Cl)[N+](=O)[O-])Cl)[N+](=O)[O-])Cl)[N+](=O)[O-],2631-68-7,Negative,in vitro
"1,3,5-trichlorobenzene",C1=C(C=C(C=C1Cl)Cl)Cl,108-70-3,Negative,in vitro
"1,3,5-trinitrobenzene",C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],7434,Negative,In Vivo
"1,3,5-TRINITROBENZENE",C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],99-35-4,Negative,In vivo
"1,3,5-tris(oxyranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione",C1C(O1)CN2C(=O)N(C(=O)N(C2=O)CC3CO3)CC4CO4,2451-62-9,Positive,in vitro
"1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane",C1N2CN3CN1CN(C2)C3,100-97-0,Positive,in vitro
"1,3,6-trinitropyrene",C1=CC2=C3C(=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C=CC4=C(C=CC1=C43)[N+](=O)[O-],75321-19-6,Positive,in vitro
"1,3,7-triethylpurine-2,6-dione",CCN1C=NC2=C1C(=O)N(C(=O)N2CC)CC,,Negative,in vitro
"1,3,7-trimethyl-8-(methylamino)purine-2,6-dione",CNC1=NC2=C(N1C)C(=O)N(C(=O)N2C)C,5422-30-0,Positive,in vitro
"1,3,7-trimethyl-8-methylsulfanylpurine-2,6-dione",CN1C2=C(N=C1SC)N(C(=O)N(C2=O)C)C,6287-54-3,Positive,in vitro
"1,3,7-trimethyl-8-prop-2-enoxypurine-2,6-dione",CN1C2=C(N=C1OCC=C)N(C(=O)N(C2=O)C)C,6287-60-1,Positive,in vitro
"1,3,7-trimethyl-8-propoxypurine-2,6-dione",CCCOC1=NC2=C(N1C)C(=O)N(C(=O)N2C)C,1818-66-2,Positive,in vitro
"1,3,7-trimethyl-9-prop-2-enylpurine-2,6,8-trione",CN1C2=C(N(C(=O)N(C2=O)C)C)N(C1=O)CC=C,,Positive,in vitro
"1,3,7-trimethyl-9H-purine-2,6,8-trione",CN1C2=C(NC1=O)N(C(=O)N(C2=O)C)C,5415-44-1,Negative,in vitro
"1,3,7-trimethylpurine-2,6-dione",CN1C=NC2=C1C(=O)N(C(=O)N2C)C,58-08-2,Negative,in vivo
"1,3,7-trimethylpurine-2,6-dione",CN1C=NC2=C1C(=O)N(C(=O)N2C)C,58-08-2,Positive,in vivo
"1,3,7-trimethylpurine-2,6-dione",CN1C=NC2=C1C(=O)N(C(=O)N2C)C,2519,Negative,In Vivo
"1,3,7-trimethylpurine-2,6-dione",CN1C=NC2=C1C(=O)N(C(=O)N2C)C,58-08-2,Negative,in vitro
"1,3,7,11,15,19,23-heptachlorotetracosane",CC(CCCC(CCCC(CCCC(CCCC(CCCC(CCCl)Cl)Cl)Cl)Cl)Cl)Cl,22833490,Positive,In Vivo
"1,3,7,11,15,19,23-heptachlorotetracosane",CC(CCCC(CCCC(CCCC(CCCC(CCCC(CCCl)Cl)Cl)Cl)Cl)Cl)Cl,22833490,Negative,In Vivo
"1,3,7,9-tetramethylpurine-2,6,8-trione",CN1C2=C(N(C1=O)C)N(C(=O)N(C2=O)C)C,2309-49-1,Positive,in vitro
"1,3,8-triazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-4-amine",C1=CC2=NC3=C(N2C=C1)N=C(C=C3)N,49970,Positive,In Vivo
"1,3,8-triazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-4-amine",C1=CC2=NC3=C(N2C=C1)N=C(C=C3)N,67730-10-3,Positive,in vitro
"1,3,8-trihydroxy-6-methylanthracene-9,10-dione",CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)O,3220,Negative,In Vivo
"1,3,8-trihydroxy-6-methylanthracene-9,10-dione",CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)O,518-82-1,Negative,in vitro
"1,4-BENZOQUINONE",C1=CC(=O)C=CC1=O,106-51-4,Positive,In vivo
"1,4-bis(chloromethoxymethyl)benzene",C1=CC(=CC=C1COCCl)COCCl,62123,Positive,In Vivo
"1,4-bis(dimethylamino)-5,8-dihydroxyanthracene-9,10-dione",CN(C)C1=C2C(=C(C=C1)N(C)C)C(=O)C3=C(C=CC(=C3C2=O)O)O,,Positive,in vitro
"1,4-bis(hydroxymethyl)piperazine-2,5-dione",C1C(=O)N(CC(=O)N1CO)CO,7383-56-4,Negative,in vitro
"1,4-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCNCCO)NCCNCCO,64862-96-0,Positive,in vitro
"1,4-bis[2-(dimethylamino)ethylamino]-5,8-dihydroxyanthracene-9,10-dione",CN(C)CCNC1=C2C(=C(C=C1)NCCN(C)C)C(=O)C3=C(C=CC(=C3C2=O)O)O,70476-63-0,Positive,in vitro
"1,4-bis[bis(aziridin-1-yl)phosphoryl]piperazine",C1CN1P(=O)(N2CC2)N3CCN(CC3)P(=O)(N4CC4)N5CC5,738-99-8,Positive,in vitro
"1,4-diaminoanthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)N)N,128-95-0,Negative,in vitro
"1,4-dichloro-2-(2,5-dichlorophenyl)benzene",C1=CC(=C(C=C1Cl)C2=C(C=CC(=C2)Cl)Cl)Cl,37248,Negative,In Vivo
"1,4-Dichloro-2-nitrobenzene",C1=CC(=C(C=C1Cl)[N+](=O)[O-])Cl,89-61-2,Negative,in vitro
"1,4-dichloro-2,5-dimethoxybenzene",COC1=CC(=C(C=C1Cl)OC)Cl,2675-77-6,Positive,in vitro
"1,4-DICHLOROBENZENE",C1=CC(=CC=C1Cl)Cl,106-46-7,Negative,In vivo
"1,4-dichlorobenzene",C1=CC(=CC=C1Cl)Cl,4685,Positive,In Vivo
"1,4-DICHLOROBENZENE",C1=CC(=CC=C1Cl)Cl,106-46-7,Positive,In vivo
"1,4-dichlorobenzene",C1=CC(=CC=C1Cl)Cl,4685,Negative,In Vivo
"1,4-dichlorobenzene",C1=CC(=CC=C1Cl)Cl,106-46-7,Positive,in vitro
"1,4-DICHLOROBUTENE-2 (65% trans-, 35% cis-)",C(C=CCCl)Cl,764-41-0,Positive,In vivo
"1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione",C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,65271-80-9,Positive,in vitro
"1,4-dimethyl-5H-pyrido[4,3-b]indol-3-amine",CC1=C2C(=C(N=C1N)C)C3=CC=CC=C3N2,5284474,Positive,In Vivo
"1,4-dimethyl-5H-pyrido[4,3-b]indol-3-amine",CC1=C2C(=C(N=C1N)C)C3=CC=CC=C3N2,62450-06-0,Positive,in vivo
"1,4-dimethyl-5H-pyrido[4,3-b]indol-3-amine",CC1=C2C(=C(N=C1N)C)C3=CC=CC=C3N2,62450-06-0,Positive,in vitro
"1,4-Dimethylnaphthalene",Cc1ccc(C)c2ccccc12,571-58-4,Negative,in vivo
"1,4-Dimethylnaphthalene",Cc1ccc(C)c2ccccc12,571-58-4,Negative,in vitro
"1,4-dinitroso-1,4-diazepane",C1CN(CCN(C1)N=O)N=O,55557-00-1,Positive,in vitro
"1,4-DINITROSO-2,6-DIMETHYLPIPERAZINE",CC1CN(CC(N1N=O)C)N=O,55380-34-2,Positive,In vivo
"1,4-dinitrosopiperazine",C1CN(CCN1N=O)N=O,140-79-4,Positive,in vivo
"1,4-dinitrosopiperazine",C1CN(CCN1N=O)N=O,8819,Positive,In Vivo
"1,4-dinitrosopiperazine",C1CN(CCN1N=O)N=O,140-79-4,Negative,in vitro
"1,4-dioxane",C1COCCO1,31275,Positive,In Vivo
"1,4-DIOXANE",C1COCCO1,123-91-1,Positive,In vivo
"1,4-dioxane",C1COCCO1,123-91-1,Negative,in vitro
"1,4,5,6,7,7-hexachlorobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid",C1(C(C2(C(=C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)C(=O)O)C(=O)O,8266,Negative,In Vivo
"1,4,5,6,7,7-hexachlorobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid",C1(C(C2(C(=C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)C(=O)O)C(=O)O,8266,Positive,In Vivo
"1,4,5,7-tetrahydroxy-2-methylanthracene-9,10-dione",CC1=CC(=C2C(=C1O)C(=O)C3=C(C2=O)C(=CC(=C3)O)O)O,476-46-0,Positive,in vitro
"1,4,5,8-tetraaminoanthracene-9,10-dione",C1=CC(=C2C(=C1N)C(=O)C3=C(C=CC(=C3C2=O)N)N)N,17190,Negative,In Vivo
"1,4,5,8-tetraaminoanthracene-9,10-dione",C1=CC(=C2C(=C1N)C(=O)C3=C(C=CC(=C3C2=O)N)N)N,17190,Positive,In Vivo
"1,4,5,8-tetrahydroxy-2-methylanthracene-9,10-dione",CC1=CC(=C2C(=C1O)C(=O)C3=C(C=CC(=C3C2=O)O)O)O,476-43-7,Positive,in vitro
"1,5-dibromopentane",C(CCBr)CCBr,111-24-0,Positive,in vitro
"1,5-dichloro-4,8-dihydroxyanthracene-9,10-dione",C1=CC(=C2C(=C1O)C(=O)C3=C(C=CC(=C3C2=O)O)Cl)Cl,6837-97-4,Positive,in vitro
"1,5-dimethyl-2-phenylpyrazol-3-one",CC1=CC(=O)N(N1C)C2=CC=CC=C2,2206,Positive,In Vivo
"1,5-dimethyl-2-phenylpyrazol-3-one",CC1=CC(=O)N(N1C)C2=CC=CC=C2,60-80-0,Negative,in vitro
"1,5-Naphthalenediamine",C1=CC2=C(C=CC=C2N)C(=C1)N,2243-62-1,Positive,in vitro
"1,5,7,8,9,10,10-heptachlorotricyclo[5.2.1.02,6]deca-3,8-diene",C1=CC(C2C1C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl)Cl,3589,Positive,In Vivo
"1,5,7,8,9,10,10-heptachlorotricyclo[5.2.1.02,6]deca-3,8-diene",C1=CC(C2C1C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl)Cl,76-44-8,Positive,in vivo
"1,5,7,8,9,10,10-heptachlorotricyclo[5.2.1.02,6]deca-3,8-diene",C1=CC(C2C1C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl)Cl,3589,Negative,In Vivo
"1,5,7,8,9,10,10-heptachlorotricyclo[5.2.1.02,6]deca-3,8-diene",C1=CC(C2C1C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl)Cl,76-44-8,Positive,in vitro
"1,6-dihydroxy-3-methyl-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione",CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,23313-21-5,Positive,in vitro
"1,6-dinitrobenzo[a]pyrene",C1=CC=C2C(=C1)C3=C4C(=C2[N+](=O)[O-])C=CC5=C4C(=C(C=C5)[N+](=O)[O-])C=C3,86386,Negative,In Vivo
"1,6-dinitropyrene",C1=CC2=C(C=CC3=C2C4=C1C=CC(=C4C=C3)[N+](=O)[O-])[N+](=O)[O-],39184,Positive,In Vivo
"1,6-Dinitropyrene",C1=CC2=C(C=CC3=C2C4=C1C=CC(=C4C=C3)[N+](=O)[O-])[N+](=O)[O-],42397-64-8,Positive,in vitro
"1,7-dihydropurin-6-one",C1=NC2=C(N1)C(=O)NC=N2,1246820-04-1,Negative,in vitro
"1,7-dimethylpurin-6-one",CN1C=NC2=C1C(=O)N(C=N2)C,,Negative,in vitro
"1,7-Phenanthroline",C1=CC2=C(C3=C(C=C2)N=CC=C3)N=C1,230-46-6,Positive,in vitro
"1,7,12-trimethylbenzo[a]anthracene",CC1=C2C(=CC=C1)C=CC3=C(C4=CC=CC=C4C(=C32)C)C,,Negative,in vitro
"1,8-didiazooctane-2,7-dione",C(CCC(=O)C=[N+]=[N-])CC(=O)C=[N+]=[N-],1448-16-4,Negative,in vitro
"1,8-dihydroxy-10H-anthracen-9-one",C1C2=C(C(=CC=C2)O)C(=O)C3=C1C=CC=C3O,1143-38-0,Negative,in vitro
"1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione",CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)OC,521-61-9,Positive,in vitro
"1,8-dihydroxy-3-methyl-6-[(3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyanthracene-9,10-dione",C[C@H]1[C@@H]([C@H]([C@H](C(O1)OC2=CC3=C(C(=C2)O)C(=O)C4=C(C3=O)C=C(C=C4O)C)O)O)O,69686-05-01,Positive,in vitro
"1,8-dihydroxyanthracene-9,10-dione",C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=CC=C3O,2950,Positive,In Vivo
"1,8-dinitropyrene",C1=CC2=C3C(=C(C=C2)[N+](=O)[O-])C=CC4=C(C=CC1=C43)[N+](=O)[O-],39185,Positive,In Vivo
"1,8-Dinitropyrene",C1=CC2=C3C(=C(C=C2)[N+](=O)[O-])C=CC4=C(C=CC1=C43)[N+](=O)[O-],42397-65-9,Positive,in vitro
"1,9,10,11,12,12-hexachloro-4,6-dioxa-5lambda4-thiatricyclo[7.2.1.02,8]dodec-10-ene 5-oxide",C1C2C(COS(=O)O1)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl,3224,Negative,In Vivo
1'-ACETOXYSAFROLE,CC(=O)OC(C=C)C1=CC2=C(C=C1)OCO2,34627-78-6,Negative,In vivo
1'-ACETOXYSAFROLE,CC(=O)OC(C=C)C1=CC2=C(C=C1)OCO2,34627-78-6,Positive,In vivo
1'-Acetoxysafrole,CC(=O)OC(C=C)C1=CC2=C(C=C1)OCO2,34627-78-6,Positive,in vitro
1'-HYDROXYESTRAGOLE,COC1=CC=C(C=C1)C(C=C)O,51410-44-7,Positive,In vivo
1'-HYDROXYSAFROLE,C=CC(C1=CC2=C(C=C1)OCO2)O,5208-87-7,Positive,In vivo
1'-OXOSAFROLE,C=CC(=O)C1=CC2=C(C=C1)OCO2,30418-53-2,Negative,In vivo
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC,50-52-2,Positive,in vitro
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine;hydrochloride,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC.Cl,130-61-0,Positive,in vivo
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine;dihydrochloride,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl.Cl,440-17-5,Positive,in vitro
10-Azabenzo(a)pyrene,C1=CC2=C3C(=C1)C=CC4=C5C(=CC(=C43)C=C2)C=CC=N5,189-92-4,Positive,in vitro
"10-butanoyl-1,8-dihydroxy-10H-anthracen-9-one",CCCC(=O)C1C2=C(C(=CC=C2)O)C(=O)C3=C1C=CC=C3O,75464-11-8,Negative,in vitro
"10-methyl-1,3,8-triazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-4-amine",CC1=CC=CN2C1=NC3=C2N=C(C=C3)N,49971,Positive,In Vivo
"10-methyl-1,3,8-triazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-4-amine",CC1=CC=CN2C1=NC3=C2N=C(C=C3)N,67730-11-4,Positive,in vitro
10-methylacridin-10-ium-4-amine;chloride,C[N+]1=C2C(=CC3=CC=CC=C31)C=CC=C2N.[Cl-],,Positive,in vitro
10-methylbenzo[a]anthracene,CC1=CC2=CC3=C(C=CC4=CC=CC=C43)C=C2C=C1,2381-15-9,Positive,in vitro
10H-phenothiazine,C1=CC=C2C(=C1)NC3=CC=CC=C3S2,92-84-2,Positive,in vitro
11-aminoundecanoic acid,C(CCCCCN)CCCCC(=O)O,17083,Negative,In Vivo
11-aminoundecanoic acid,C(CCCCCN)CCCCC(=O)O,17083,Positive,In Vivo
11-aminoundecanoic acid,C(CCCCCN)CCCCC(=O)O,2432-99-7,Negative,in vitro
"11-ethyl-15,16-dihydrocyclopenta[a]phenanthren-17-one",CCC1=CC2=C(CCC2=O)C3=C1C4=CC=CC=C4C=C3,,Positive,in vitro
"11-fluoro-7,12-dimethylbenzo[a]anthracene",CC1=C2C=CC=C(C2=C(C3=C1C=CC4=CC=CC=C43)C)F,,Positive,in vitro
"11-hexoxy-15,16-dihydrocyclopenta[a]phenanthren-17-one",CCCCCCOC1=C2C(=C3CCC(=O)C3=C1)C=CC4=CC=CC=C42,154201,Negative,In Vivo
"11-methoxy-16,17-dihydro-15H-cyclopenta[a]phenanthrene",COC1=C2C(=C3CCCC3=C1)C=CC4=CC=CC=C42,154203,Positive,In Vivo
11-methoxy-17-methyl-15H-cyclopenta[a]phenanthrene,CC1=CCC2=C3C=CC4=CC=CC=C4C3=C(C=C12)OC,5831-12-9,Positive,in vitro
"11-methoxy-6,8,16,20-tetraoxapentacyclo[10.8.0.02,9.03,7.013,18]icosa-1,4,9,11,13(18)-pentaene-17,19-dione",COC1=C2C3=C(C(=O)OCC3)C(=O)OC2=C4C5C=COC5OC4=C1,1165-39-5,Positive,in vitro
"11-methoxy-7-methyl-15,16-dihydrocyclopenta[a]phenanthren-17-one",CC1=CC2=CC=CC=C2C3=C(C=C4C(=C13)CCC4=O)OC,,Positive,in vitro
"11-methyl-15,16-dihydrocyclopenta[a]phenanthren-17-one",CC1=CC2=C(CCC2=O)C3=C1C4=CC=CC=C4C=C3,3034752,Positive,In Vivo
"11-methyl-15,16-dihydrocyclopenta[a]phenanthren-17-one",CC1=CC2=C(CCC2=O)C3=C1C4=CC=CC=C4C=C3,892-17-1,Positive,in vivo
"11-methyl-15,16-dihydrocyclopenta[a]phenanthren-17-one",CC1=CC2=C(CCC2=O)C3=C1C4=CC=CC=C4C=C3,892-17-1,Positive,in vitro
"11-methyl-16,17-dihydrocyclopenta[a]phenanthren-15-one",CC1=CC2=C(C(=O)CC2)C3=C1C4=CC=CC=C4C=C3,,Positive,in vitro
"11-methyl-3,4-dihydro-2H-chrysen-1-one",CC1=CC2=C(CCCC2=O)C3=C1C4=CC=CC=C4C=C3,,Positive,in vitro
"11-methyl-9,13-dioxa-5-azatetracyclo[8.7.0.02,7.012,16]heptadeca-1(10),2(7),3,5,11,14,16-heptaen-8-one",CC1=C2C(=CC3=C1OC(=O)C4=C3C=CN=C4)C=CO2,85878-63-3,Positive,in vitro
11-methylbenzo[a]anthracene,CC1=C2C=C3C(=CC2=CC=C1)C=CC4=CC=CC=C43,6111-78-0,Negative,in vitro
"11,12-dihydrobenzo[a]pyrene-11,12-diol",C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2C(C(C5=CC=C4)O)O,28622-86-8,Negative,in vitro
"11,12-dimethyl-15,16-dihydrocyclopenta[a]phenanthren-17-one",CC1=C(C2=C(C=CC3=CC=CC=C32)C4=C1C(=O)CC4)C,,Positive,in vitro
"11,12,17-trimethyl-15H-cyclopenta[a]phenanthrene",CC1=CCC2=C1C(=C(C3=C2C=CC4=CC=CC=C43)C)C,5831-11-8,Positive,in vitro
"11,17-dimethyl-15H-cyclopenta[a]phenanthrene",CC1=CCC2=C1C=C(C3=C2C=CC4=CC=CC=C43)C,5831-10-7,Positive,in vitro
"11,17-dimethyl-16,17-dihydro-15H-cyclopenta[a]phenanthrene",CC1CCC2=C1C=C(C3=C2C=CC4=CC=CC=C43)C,,Positive,in vitro
"12-azapentacyclo[11.8.0.02,11.03,8.016,21]henicosa-1(13),2(11),3,5,7,9,14,16,18,20-decaene",C1=CC=C2C(=C1)C=CC3=C2C4=C(N3)C=CC5=CC=CC=C54,9134,Positive,In Vivo
"12-azapentacyclo[11.8.0.02,11.03,8.016,21]henicosa-1(13),2(11),3,5,7,9,14,16,18,20-decaene",C1=CC=C2C(=C1)C=CC3=C2C4=C(N3)C=CC5=CC=CC=C54,194-59-2,Positive,in vivo
12-methylbenzo[a]anthracene,CC1=C2C(=CC3=CC=CC=C13)C=CC4=CC=CC=C42,2422-79-9,Positive,in vitro
12-methylbenzo[a]anthracene-7-carbaldehyde,CC1=C2C(=C(C3=CC=CC=C13)C=O)C=CC4=CC=CC=C42,25894,Positive,In Vivo
"12,14-diethoxy-1,9-dimethyl-4-methylidene-6,13-dioxatricyclo[8.4.0.03,7]tetradecan-5-one",CCOC1CC2C(CC3C(CC2(C(O1)OCC)C)C(=C)C(=O)O3)C,,Positive,in vitro
"12,14-dihydroxy-1,4,9-trimethyl-6,13-dioxatricyclo[8.4.0.03,7]tetradecan-5-one",CC1CC2C(CC3(C1CC(OC3O)O)C)C(C(=O)O2)C,,Positive,in vitro
"12,17-dimethyl-15H-cyclopenta[a]phenanthrene",CC1=CCC2=C1C(=CC3=C2C=CC4=CC=CC=C43)C,5831-09-04,Positive,in vitro
"13-azapentacyclo[12.8.0.03,12.04,9.017,22]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene",C1=CC=C2C(=C1)C=CC3=NC4=C(C=C32)C5=CC=CC=C5C=C4,9177,Positive,In Vivo
"13-azapentacyclo[12.8.0.03,12.04,9.017,22]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene",C1=CC=C2C(=C1)C=CC3=NC4=C(C=C32)C5=CC=CC=C5C=C4,224-42-0,Positive,in vivo
"13-azapentacyclo[12.8.0.03,12.04,9.017,22]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene",C1=CC=C2C(=C1)C=CC3=NC4=C(C=C32)C5=CC=CC=C5C=C4,9177,Negative,In Vivo
"13-azapentacyclo[12.8.0.03,12.04,9.017,22]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene",C1=CC=C2C(=C1)C=CC3=NC4=C(C=C32)C5=CC=CC=C5C=C4,224-42-0,Positive,in vitro
"14-nitronaphtho[1,2-b]phenanthrene",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=CC=CC=C5C4=C3[N+](=O)[O-],148989,Positive,In Vivo
"15,16-dihydrocyclopenta[a]phenanthren-17-one",C1CC(=O)C2=C1C3=C(C=C2)C4=CC=CC=C4C=C3,786-66-3,Positive,in vitro
"16-hydroxy-11-methyl-15,16-dihydrocyclopenta[a]phenanthren-17-one",CC1=CC2=C(CC(C2=O)O)C3=C1C4=CC=CC=C4C=C3,,Positive,in vitro
"16,17-dihydro-15H-cyclopenta[a]phenanthren-11-ol",C1CC2=CC(=C3C(=C2C1)C=CC4=CC=CC=C43)O,154202,Positive,In Vivo
"16,17-dihydrocyclopenta[a]phenanthren-15-one",C1CC(=O)C2=C1C=CC3=C2C=CC4=CC=CC=C43,,Positive,in vitro
"16,19-dimethyl-4-oxapentacyclo[9.8.0.02,8.03,5.012,17]nonadeca-1(11),2(8),9,12,14,16,18-heptaene-6,7-diol",CC1=C2C=C(C3=C(C2=CC=C1)C=CC4=C3C5C(O5)C(C4O)O)C,132251,Positive,In Vivo
17-Beta-Estradiol,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,50-28-2,Positive,in vitro
"17-methyl-16,17-dihydro-15H-cyclopenta[a]phenanthrene",CC1CCC2=C1C=CC3=C2C=CC4=CC=CC=C43,,Positive,in vitro
17-methyl-17H-cyclopenta[a]phenanthrene,CC1C=CC2=C1C=CC3=C2C=CC4=CC=CC=C43,3353-08-0,Positive,in vitro
"17-methyl-4-oxahexacyclo[12.6.1.02,12.03,5.06,11.018,21]henicosa-1(21),2(12),6,8,10,13,15,17-octaene",CC1=C2CCC3=C2C(=CC4=C3C5C(O5)C6=CC=CC=C64)C=C1,3416-21-5,Positive,in vitro
17H-cyclopenta[a]phenanthrene,C1C=CC2=C1C=CC3=C2C=CC4=CC=CC=C43,0219-08-09,Positive,in vitro
"18-oxahexacyclo[10.7.2.03,8.09,20.016,21.017,19]henicosa-1,3,5,7,9(20),10,12(21),13,15-nonaene",C1=CC=C2C3=C4C(=CC2=C1)C5C(O5)C6=CC=CC(=C64)C=C3,37574-47-3,Positive,in vitro
"19-methyl-3-oxapentacyclo[9.8.0.02,4.05,10.013,18]nonadeca-1(19),5,7,9,11,13,15,17-octaene",CC1=C2C3C(O3)C4=CC=CC=C4C2=CC5=CC=CC=C15,1155-38-0,Positive,in vivo
"19-methyl-3-oxapentacyclo[9.8.0.02,4.05,10.013,18]nonadeca-1(19),5,7,9,11,13,15,17-octaene",CC1=C2C3C(O3)C4=CC=CC=C4C2=CC5=CC=CC=C15,1155-38-0,Positive,in vitro
"19-propyl-4-oxapentacyclo[9.8.0.02,8.03,5.012,17]nonadeca-1(11),2(8),9,12,14,16,18-heptaene-6,7-diol",CCCC1=CC2=CC=CC=C2C3=C1C4=C(C=C3)C(C(C5C4O5)O)O,147448,Negative,In Vivo
"1a,9b-dihydrophenanthro[9,10-b]oxirene",C1=CC=C2C(=C1)C3C(O3)C4=CC=CC=C42,585-08-0,Negative,in vitro
"1H-1,2,4-triazol-5-amine",C1=NNC(=N1)N,1639,Negative,In Vivo
"1H-1,2,4-triazol-5-amine",C1=NNC(=N1)N,61-82-5,Negative,in vivo
"1H-1,2,4-triazol-5-amine",C1=NNC(=N1)N,1639,Positive,In Vivo
"1H-1,2,4-triazol-5-amine",C1=NNC(=N1)N,61-82-5,Positive,in vivo
"1H-1,2,4-triazol-5-amine",C1=NNC(=N1)N,61-82-5,Negative,in vitro
1H-imidazol-2-ylsulfanylmethanol,C1=CN=C(N1)SCO,,Negative,in vitro
1H-indazol-5-amine;hydrochloride,C1=CC2=C(C=C1N)C=NN2.Cl,64309-76-8,Positive,in vivo
"1H-pyrimidine-2,4-dione",C1=CNC(=O)NC1=O,1174,Negative,In Vivo
"1H-pyrimidine-2,4-dione",C1=CNC(=O)NC1=O,1174,Positive,In Vivo
1H-quinolin-2-one,C1=CC=C2C(=C1)C=CC(=O)N2,59-31-4,Negative,in vitro
1H-quinolin-4-one,C1=CC=C2C(=C1)C(=O)C=CN2,611-36-9,Negative,in vitro
2- Biphenylamine (free base and HCl salt),C1=CC=C(C=C1)C2=CC=CC=C2N,90-41-5,Positive,in vitro
2-(1-Naphthyl)acetamide,NC(=O)Cc1cccc2ccccc12,86-86-2,Negative,in vivo
2-(1-Naphthyl)acetamide,NC(=O)Cc1cccc2ccccc12,86-86-2,Negative,in vitro
"2-(1,3-Dihydro-3-oxo-2H-indol-2-ylidene)-1,2 dihydro-3H-indol-3-one",C1=CC=C2C(=C1)C(=C(N2)C3=NC4=CC=CC=C4C3=O)O,482-89-3,Negative,in vitro
"2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid",CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,3308,Negative,In Vivo
2-(10-methylanthracen-9-yl)oxirane,CC1=C2C=CC=CC2=C(C3=CC=CC=C13)C4CO4,66842-42-0,Positive,in vitro
"2-(2-amino-4-nitroanilino)-2-(hydroxymethyl)propane-1,3-diol",C1=CC(=C(C=C1[N+](=O)[O-])N)NC(CO)(CO)CO,5484182,Negative,In Vivo
"2-(2-amino-4-nitroanilino)-2-(hydroxymethyl)propane-1,3-diol",C1=CC(=C(C=C1[N+](=O)[O-])N)NC(CO)(CO)CO,5484182,Positive,In Vivo
2-(2-aminoethyldisulfanyl)ethanamine;dihydrochloride,C(CSSCCN)N.Cl.Cl,56-17-7,Positive,in vitro
2-(2-dimethoxyphosphorylsulfanylethylsulfanyl)-N-methylpropanamide,CC(C(=O)NC)SCCSP(=O)(OC)OC,2275-23-2,Positive,in vitro
2-(2-ethylhexoxycarbonyl)benzoic acid,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)O,4376-20-9,Negative,in vitro
2-(2-hydroxyethoxy)ethanol,C(COCCO)O,8117,Negative,In Vivo
2-(2-hydroxyethylamino)ethanol,C(CO)NCCO,8113,Positive,In Vivo
2-(2-hydroxyethylamino)ethanol,C(CO)NCCO,8113,Negative,In Vivo
2-(2-methyl-5-nitroimidazol-1-yl)ethanol,CC1=NC=C(N1CCO)[N+](=O)[O-],4173,Positive,In Vivo
2-(2-methyl-5-nitroimidazol-1-yl)ethanol,CC1=NC=C(N1CCO)[N+](=O)[O-],443-48-1,Positive,in vivo
2-(2-methyl-5-nitroimidazol-1-yl)ethanol,CC1=NC=C(N1CCO)[N+](=O)[O-],443-48-1,Negative,in vitro
2-(2-nitrophenyl)acetic acid,C1=CC=C(C(=C1)CC(=O)O)[N+](=O)[O-],3740-52-1,Positive,in vitro
"2-(2,2-DIMETHYLHYDRAZINO)-4-(5-NITRO-2-FURYL)THIAZOLE",CN(C)NC1=NC(=CS1)C2=CC=C(O2)[N+](=O)[O-],26049-69-4,Positive,In vivo
"2-(2,2-Dimethylhydrazino)-4-(5-nitro-2-furyl)thiazole",CN(C)NC1=NC(=CS1)C2=CC=C(O2)[N+](=O)[O-],26049-69-4,Positive,in vitro
"2-(2,4-dichlorophenoxy)acetic acid",C1=CC(=C(C=C1Cl)Cl)OCC(=O)O,1486,Negative,In Vivo
"2-(2,4-dichlorophenoxy)acetic acid",C1=CC(=C(C=C1Cl)Cl)OCC(=O)O,94-75-7,Negative,in vitro
"2-(2,4-dichlorophenoxy)acetic acid;1,1,1,3,3,3-hexachloropropan-2-one;N-methylmethanamine",CNC.C1=CC(=C(C=C1Cl)Cl)OCC(=O)O.C(=O)(C(Cl)(Cl)Cl)C(Cl)(Cl)Cl,75492608,Positive,In Vivo
"2-(2,4-dichlorophenoxy)acetic acid;1,1,1,3,3,3-hexachloropropan-2-one;N-methylmethanamine",CNC.C1=CC(=C(C=C1Cl)Cl)OCC(=O)O.C(=O)(C(Cl)(Cl)Cl)C(Cl)(Cl)Cl,75492608,Negative,In Vivo
"2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol",C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,3365,Negative,In Vivo
"2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol",C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,3365,Positive,In Vivo
"2-(2,4,5-trichlorophenoxy)acetic acid",C1=C(C(=CC(=C1Cl)Cl)Cl)OCC(=O)O,93-76-5,Negative,in vitro
"2-(2,4,5-TRICHLOROPHENOXY)PROPIONIC ACID",CC(C(=O)O)OC1=CC(=C(C=C1Cl)Cl)Cl,93-72-1,Negative,In vivo
"2-(2,5-dihydroxy-4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-3,6-dihydroxy-5-methylcyclohexa-2,5-diene-1,4-dione",CC1=C(C(=O)C(=C(C1=O)O)C2=C(C(=O)C(=C(C2=O)O)C)O)O,475-54-7,Negative,in vitro
"2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione",C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,50-35-1,Negative,in vivo
"2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione",C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,50-35-1,Negative,in vitro
2-(3-chlorophenyl)oxirane,C1C(O1)C2=CC(=CC=C2)Cl,20697-04-05,Positive,in vitro
2-(3-hydroxy-1H-indol-2-yl)indol-3-one,C1=CC=C2C(=C1)C(=C(N2)C3=NC4=CC=CC=C4C3=O)O,482-89-3,Negative,in vitro
2-(3-methoxyphenyl)oxirane,COC1=CC=CC(=C1)C2CO2,32017-77-9,Negative,in vitro
"2-(3-methyl-1,2-dihydrobenzo[j]aceanthrylen-11-yl)phenol",CC1=C2CCC3=C2C(=CC4=C3C=C(C5=CC=CC=C54)C6=CC=CC=C6O)C=C1,,Negative,in vitro
2-(3-methylphenyl)oxirane,CC1=CC(=CC=C1)C2CO2,20697-03-04,Positive,in vitro
"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one",C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,117-39-5,Negative,in vivo
"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one",C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,5280343,Negative,In Vivo
"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one",C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,5280343,Positive,In Vivo
"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one",C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,117-39-5,Positive,in vitro
"2-(3,4-dihydroxyphenyl)-5-hydroxy-3,6,7,8-tetramethoxychromen-4-one",COC1=C(C(=C2C(=C1O)C(=O)C(=C(O2)C3=CC(=C(C=C3)O)O)OC)OC)OC,81943-52-4,Positive,in vitro
"2-(3,4-dimethylphenyl)oxirane",CC1=C(C=C(C=C1)C2CO2)C,1855-36-3,Positive,in vitro
"2-(3,5-dimethylphenyl)oxirane",CC1=CC(=CC(=C1)C2CO2)C,80648-26-6,Positive,in vitro
2-(4-acetamidophenyl)acetic acid,CC(=O)NC1=CC=C(C=C1)CC(=O)O,2018,Negative,In Vivo
2-(4-amino-2-nitroanilino)ethanol,C1=CC(=C(C=C1N)[N+](=O)[O-])NCCO,3465817,Negative,In Vivo
"2-(4-amino-3,5-dichloro-6-fluoropyridin-2-yl)oxyacetic acid",C(C(=O)O)OC1=NC(=C(C(=C1Cl)N)Cl)F,50465,Negative,In Vivo
2-(4-aminophenyl)sulfonylguanidine,C1=CC(=CC=C1N)S(=O)(=O)N=C(N)N,57-67-0,Negative,in vitro
2-(4-bromophenyl)oxirane,C1C(O1)C2=CC=C(C=C2)Br,32017-76-8,Positive,in vitro
2-(4-butoxyphenyl)-N-hydroxyacetamide,CCCCOC1=CC=C(C=C1)CC(=O)NO,2438-72-4,Positive,in vitro
2-(4-chloro-2-methylphenoxy)acetic acid,CC1=C(C=CC(=C1)Cl)OCC(=O)O,7204,Negative,In Vivo
2-(4-chloro-2-methylphenoxy)acetic acid,CC1=C(C=CC(=C1)Cl)OCC(=O)O,94-74-6,Negative,in vitro
2-(4-chloro-2-methylphenoxy)propanoic acid,CC1=C(C=CC(=C1)Cl)OC(C)C(=O)O,7153,Negative,In Vivo
2-(4-chloro-2-methylphenoxy)propanoic acid,CC1=C(C=CC(=C1)Cl)OC(C)C(=O)O,7153,Positive,In Vivo
2-(4-chloro-2-methylphenoxy)propanoic acid,CC1=C(C=CC(=C1)Cl)OC(C)C(=O)O,93-65-2,Positive,in vitro
2-(4-chlorophenyl)-2-oxoacetic acid,C1=CC(=CC=C1C(=O)C(=O)O)Cl,7099-88-9,Negative,in vitro
2-(4-chlorophenyl)-N-[2-(3-methoxy-4-prop-2-ynoxyphenyl)ethyl]-2-prop-2-ynoxyacetamide,COC1=C(C=CC(=C1)CCNC(=O)C(C2=CC=C(C=C2)Cl)OCC#C)OCC#C,11292824,Negative,In Vivo
2-(4-hydroxyanilino)acetic acid,C1=CC(=CC=C1NCC(=O)O)O,122-87-2,Positive,in vitro
2-(4-methylphenyl)oxirane,CC1=CC=C(C=C1)C2CO2,13107-39-6,Positive,in vitro
2-(4-methylpiperazin-1-yl)-N-[(E)-(5-nitrofuran-2-yl)methylideneamino]acetamide,CN1CCN(CC1)CC(=O)N/N=C/C2=CC=C(O2)[N+](=O)[O-],24632-47-1,Negative,in vivo
2-(4-methylpiperazin-1-yl)-N-[(E)-(5-nitrofuran-2-yl)methylideneamino]acetamide,CN1CCN(CC1)CC(=O)N/N=C/C2=CC=C(O2)[N+](=O)[O-],24632-47-1,Negative,in vitro
2-(4-methylpiperazin-1-yl)acetohydrazide,CN1CCN(CC1)CC(=O)NN,24632-44-8,Negative,in vitro
2-(4-nitrophenoxy)oxirane,C1C(O1)OC2=CC=C(C=C2)[N+](=O)[O-],124682,Positive,In Vivo
2-(4-nitrophenyl)oxirane,C1C(O1)C2=CC=C(C=C2)[N+](=O)[O-],6388-74-5,Positive,in vitro
2-(4-nonylphenoxy)ethanol,CCCCCCCCCC1=CC=C(C=C1)OCCO,7700,Negative,In Vivo
2-(4-phenylphenyl)oxirane,C1C(O1)C2=CC=C(C=C2)C3=CC=CC=C3,36099-26-0,Positive,in vitro
"2-(5-chloro-10-methyl-8-thia-14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-14-yl)ethyl-diethylazanium;methanesulfonate",CC[NH+](CC)CCN1C2=C3C(=C(C=C2)C)SC4=C(C3=N1)C=CC(=C4)Cl.CS(=O)(=O)[O-],43218-55-9,Negative,in vitro
"2-(5-nitrothiophen-2-yl)-2,3-dihydro-1H-quinazolin-4-one",C1=CC=C2C(=C1)C(=O)NC(N2)C3=CC=C(S3)[N+](=O)[O-],33389-33-2,Positive,in vitro
2-(6-oxabicyclo[3.1.0]hexan-2-yloxy)-6-oxabicyclo[3.1.0]hexane,C1CC(C2C1O2)OC3CCC4C3O4,2386-90-5,Negative,in vitro
"2-(7-fluoro-3-oxo-4-prop-2-ynyl-1,4-benzoxazin-6-yl)-4,5,6,7-tetrahydroisoindole-1,3-dione",C#CCN1C(=O)COC2=CC(=C(C=C21)N3C(=O)C4=C(C3=O)CCCC4)F,92425,Negative,In Vivo
2-(7-oxobenzo[a]phenalen-3-yl)sulfanylacetic acid,C1=CC=C2C(=C1)C3=C4C(=C(C=C3)SCC(=O)O)C=CC=C4C2=O,69658-13-5,Positive,in vitro
"2-(aziridin-1-yl)-4,6-dimethoxy-1,3,5-triazine",COC1=NC(=NC(=N1)N2CC2)OC,,Positive,in vitro
"2-(aziridin-1-yl)-5,6,7,8-tetrahydronaphthalene-1,4-dione",C1CCC2=C(C1)C(=O)C=C(C2=O)N3CC3,,Positive,in vitro
2-(bromomethyl)oxirane,C1C(O1)CBr,3132-64-7,Positive,in vitro
2-(butoxymethyl)oxirane,CCCCOCC1CO1,2426-08-06,Positive,in vitro
2-(carbamothioylamino)ethylthiourea,C(CNC(=S)N)NC(=S)N,,Positive,in vitro
2-(carboxymethyl)-2-hydroxybutanedioate;plutonium,C(C(=O)O)C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)O)C(CC(=O)[O-])(C(=O)[O-])O.[Pu],108004,Positive,In Vivo
2-(chloromethyl)oxirane,C1C(O1)CCl,106-89-8,Negative,in vivo
2-(chloromethyl)oxirane,C1C(O1)CCl,7835,Positive,In Vivo
2-(chloromethyl)oxirane,C1C(O1)CCl,106-89-8,Positive,in vivo
2-(chloromethyl)oxirane,C1C(O1)CCl,106-89-8,Positive,in vitro
2-(chloromethyl)oxirane;4-[2-(4-hydroxyphenyl)propan-2-yl]phenol,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O.C1C(O1)CCl,62790,Negative,In Vivo
2-(chloromethyl)oxirane;4-[2-(4-hydroxyphenyl)propan-2-yl]phenol,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O.C1C(O1)CCl,62790,Positive,In Vivo
2-(chloromethyl)oxirane;4-[2-(4-hydroxyphenyl)propan-2-yl]phenol,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O.C1C(O1)CCl,25068-38-6,Positive,in vitro
2-(Chloromethyl)pyridine HCl/ 2-(chloromethyl)pyridine,C1=CC=NC(=C1)CCl.Cl,6959-47-3,Positive,in vitro
2-(chloromethyl)pyridine;hydrochloride,C1=CC=NC(=C1)CCl.Cl,23392,Negative,In Vivo
2-(chloromethyl)pyridine;hydrochloride,C1=CC=NC(=C1)CCl.Cl,6959-47-3,Negative,in vivo
"2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one",C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,4891,Negative,In Vivo
"2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one",C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,55268-74-1,Negative,in vivo
"2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one",C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,55268-74-1,Negative,in vitro
2-(DIFLUOROMETHYL)-dl-ORNITHINE,C(CC(C(F)F)(C(=O)O)N)CN,70052-12-9,Negative,In vivo
"2-(ethoxymethyl)-1,3-dihydroxyanthracene-9,10-dione",CCOCC1=C(C=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)O,17526-17-9,Positive,in vitro
2-(methylamino)acetic acid,CNCC(=O)O,107-97-1,Negative,in vitro
"2-(N-benzylanilino)ethyl 5-(5,5-dimethyl-2-oxo-1,3,2lambda5-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate;hydrochloride",CC1=C(C(C(=C(N1)C)P2(=O)OCC(CO2)(C)C)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCN(CC4=CC=CC=C4)C5=CC=CC=C5.Cl,119170,Negative,In Vivo
2-(naphthalen-1-ylcarbamoyl)benzoic acid,C1=CC=C2C(=C1)C=CC=C2NC(=O)C3=CC=CC=C3C(=O)O,132-66-1,Positive,in vitro
2-(oxiran-2-yl)oxirane,C1C(O1)C2CO2,1464-53-5,Positive,in vivo
2-(oxiran-2-yl)oxirane,C1C(O1)C2CO2,11254,Positive,In Vivo
2-(oxiran-2-yl)oxirane,C1C(O1)C2CO2,1464-53-5,Positive,in vitro
2-(oxiran-2-ylmethoxymethyl)oxirane,C1C(O1)COCC2CO2,2238-07-05,Positive,in vitro
"2-(oxiran-2-ylmethyl)isoindole-1,3-dione",C1C(O1)CN2C(=O)C3=CC=CC=C3C2=O,5455-98-1,Positive,in vitro
2-(phenoxymethyl)oxirane,C1C(O1)COC2=CC=CC=C2,122-60-1,Positive,in vitro
2-(phosphonomethylamino)acetic acid,C(C(=O)O)NCP(=O)(O)O,3496,Negative,In Vivo
2-(phosphonomethylamino)acetic acid;propan-2-amine,CC(C)N.C(C(=O)O)NCP(=O)(O)O,38078,Negative,In Vivo
2-(phosphonomethylamino)acetic acid;propan-2-amine,CC(C)N.C(C(=O)O)NCP(=O)(O)O,38078,Positive,In Vivo
2-(phosphonomethylamino)acetic acid;propan-2-amine,CC(C)N.C(C(=O)O)NCP(=O)(O)O,38641-94-0,Positive,in vitro
2-(prop-2-enoxymethyl)oxirane,C=CCOCC1CO1,7838,Positive,In Vivo
2-(prop-2-enoxymethyl)oxirane,C=CCOCC1CO1,7838,Negative,In Vivo
2-(trichloromethyl)oxirane,C1C(O1)C(Cl)(Cl)Cl,3083-23-6,Positive,in vitro
"2-(trichloromethylsulfanyl)isoindole-1,3-dione",C1=CC=C2C(=C1)C(=O)N(C2=O)SC(Cl)(Cl)Cl,8607,Positive,In Vivo
"2-(trichloromethylsulfanyl)isoindole-1,3-dione",C1=CC=C2C(=C1)C(=O)N(C2=O)SC(Cl)(Cl)Cl,8607,Negative,In Vivo
"2-(trichloromethylsulfanyl)isoindole-1,3-dione",C1=CC=C2C(=C1)C(=O)N(C2=O)SC(Cl)(Cl)Cl,0133-07-03,Negative,in vitro
"2-[(1E,3E,5E,7E)-3,7-dimethylnona-1,3,5,7-tetraenyl]-1,3,3-trimethylcyclohexene",C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(CCCC1(C)C)C,6895-29-0,Positive,in vitro
"2-[(1E,3E,5E,7E)-9-methoxy-3,7-dimethylnona-1,3,5,7-tetraenyl]-1,3,3-trimethylcyclohexene",CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/COC)/C)/C,32450-56-9,Positive,in vitro
"2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine",C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O,57-92-1,Negative,in vitro
"2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine",C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(CO)O,128-46-1,Negative,in vitro
"2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol",CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O,13956-29-1,Negative,in vivo
"2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol",CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O,13956-29-1,Negative,in vitro
"2-[(1Z,3Z,5Z,7Z)-3,7-dimethyl-9-methylsulfanylnona-1,3,5,7-tetraenyl]-1,3,3-trimethylcyclohexene",CC1=C(C(CCC1)(C)C)/C=C\C(=C/C=C\C(=C/CSC)\C)\C,,Positive,in vitro
2-[(2-chlorophenyl)methylidene]propanedinitrile,C1=CC=C(C(=C1)C=C(C#N)C#N)Cl,17604,Negative,In Vivo
2-[(2-diazoacetyl)amino]acetamide,C(C(=O)N)NC(=O)C=[N+]=[N-],817-99-2,Positive,in vitro
"2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazine-3,5-dione",C1=NN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,54-25-1,Positive,in vivo
"2-[(2S,5S)-5-benzyl-3,6-dioxopiperazin-2-yl]acetic acid",C1=CC=C(C=C1)C[C@H]2C(=O)N[C@H](C(=O)N2)CC(=O)O,111054,Negative,In Vivo
"2-[(4-methoxyphenoxy)carbonyl-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]amino]acetic acid",CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CN(CC(=O)O)C(=O)OC4=CC=C(C=C4)OC,206044,Negative,In Vivo
"2-[(4-methoxyphenoxy)carbonyl-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]amino]acetic acid",CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CN(CC(=O)O)C(=O)OC4=CC=C(C=C4)OC,206044,Positive,In Vivo
"2-[(4,6-dimethoxypyrimidin-2-yl)carbamoylsulfamoyl]-4-formamido-N,N-dimethylbenzamide",CN(C)C(=O)C1=C(C=C(C=C1)NC=O)S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC,11419598,Negative,In Vivo
2-[(5-nitrofuran-2-yl)methylideneamino]ethanol,C1=C(OC(=C1)[N+](=O)[O-])C=NCCO,40855-12-7,Positive,in vitro
"2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile",C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC#N)O,65928-58-7,Positive,in vivo
2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine,CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC=N3,5282443,Negative,In Vivo
2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine;hydrate;hydrochloride,CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC=N3.O.Cl,5284472,Negative,In Vivo
2-[(E)-N-[(E)-3-chloroprop-2-enoxy]-C-ethylcarbonimidoyl]-5-(2-ethylsulfanylpropyl)-3-hydroxycyclohex-2-en-1-one,CC/C(=N\OC/C=C/Cl)/C1=C(CC(CC1=O)CC(C)SCC)O,135491728,Negative,In Vivo
2-[[(1R)-2-[bis(carboxymethyl)amino]cyclopropyl]-(carboxymethyl)amino]acetic acid,C1[C@H](C1N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,,Positive,in vitro
"2-[[(2S,3R)-2,3-dihydroxy-4-(2-methylsulfonyloxyethylamino)butyl]amino]ethyl methanesulfonate;methanesulfonic acid",CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)OCCNC[C@H]([C@H](CNCCOS(=O)(=O)C)O)O,2507-27-9,Positive,in vitro
"2-[[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-7-carbonyl]amino]-3-phenylpropanoic acid",C[C@@H]1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)NC(CC3=CC=CC=C3)C(=O)O)Cl,9344,Negative,In Vivo
"2-[[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-7-carbonyl]amino]-3-phenylpropanoic acid",C[C@@H]1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)NC(CC3=CC=CC=C3)C(=O)O)Cl,9344,Positive,In Vivo
"2-[[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-7-carbonyl]amino]-3-phenylpropanoic acid",C[C@@H]1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)NC(CC3=CC=CC=C3)C(=O)O)Cl,,Negative,in vivo
2-[[2-(5-nitrothiophen-2-yl)quinazolin-4-yl]amino]ethanol,C1=CC=C2C(=C1)C(=NC(=N2)C3=CC=C(S3)[N+](=O)[O-])NCCO,,Positive,in vitro
2-[[2-chloroethyl(nitroso)carbamoyl]amino]ethyl methanesulfonate,CS(=O)(=O)OCCNC(=O)N(CCCl)N=O,,Positive,in vitro
"2-[[3-(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-yl]amino]ethyl methanesulfonate",CS(=O)(=O)OCCNP1(=O)N(CCCO1)CCCl,37753-10-9,Positive,in vitro
2-[[3-(oxiran-2-ylmethoxy)phenoxy]methyl]oxirane,C1C(O1)COC2=CC(=CC=C2)OCC3CO3,7586,Positive,In Vivo
2-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid,CN(C)C1=CC=C(C=C1)N=NC2=CC=CC=C2C(=O)O,493-52-7,Positive,in vitro
2-[[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]methyl]oxirane,CC(C)(C1=CC=C(C=C1)OCC2CO2)C3=CC=C(C=C3)OCC4CO4,2286,Negative,In Vivo
2-[[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]methyl]oxirane,CC(C)(C1=CC=C(C=C1)OCC2CO2)C3=CC=C(C=C3)OCC4CO4,1675-54-3,Positive,in vitro
"2-[[4-[4-[(1-anilino-1,3-dioxobutan-2-yl)diazenyl]-3-chlorophenyl]-2-chlorophenyl]diazenyl]-3-oxo-N-phenylbutanamide",CC(=O)C(C(=O)NC1=CC=CC=C1)N=NC2=C(C=C(C=C2)C3=CC(=C(C=C3)N=NC(C(=O)C)C(=O)NC4=CC=CC=C4)Cl)Cl,186342,Negative,In Vivo
"2-[[4-[4-[(1-anilino-1,3-dioxobutan-2-yl)diazenyl]-3-chlorophenyl]-2-chlorophenyl]diazenyl]-3-oxo-N-phenylbutanamide",CC(=O)C(C(=O)NC1=CC=CC=C1)N=NC2=C(C=C(C=C2)C3=CC(=C(C=C3)N=NC(C(=O)C)C(=O)NC4=CC=CC=C4)Cl)Cl,6358-85-6,Negative,in vivo
2-[[4-[bis(2-chloroethyl)amino]-2-methylphenyl]diazenyl]benzoic acid,CC1=C(C=CC(=C1)N(CCCl)CCCl)N=NC2=CC=CC=C2C(=O)O,4213-40-5,Positive,in vitro
2-[[4-[bis(2-chloroethyl)amino]phenyl]diazenyl]benzoic acid,C1=CC=C(C(=C1)C(=O)O)N=NC2=CC=C(C=C2)N(CCCl)CCCl,40136-87-6,Positive,in vitro
"2-[[4-chloro-6-(cyclopropylamino)-1,3,5-triazin-2-yl]amino]-2-methylpropanenitrile",CC(C)(C#N)NC1=NC(=NC(=N1)NC2CC2)Cl,32889-48-8,Negative,in vitro
"2-[[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino]-2-methylpropanenitrile",CCNC1=NC(=NC(=N1)Cl)NC(C)(C)C#N,30773,Negative,In Vivo
"2-[[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino]-2-methylpropanenitrile",CCNC1=NC(=NC(=N1)Cl)NC(C)(C)C#N,21725-46-2,Negative,in vitro
"2-[[4-chloro-6-(propan-2-ylamino)-1,3,5-triazin-2-yl]amino]acetic acid",CC(C)NC1=NC(=NC(=N1)NCC(=O)O)Cl,14621415,Negative,In Vivo
"2-[[4-chloro-6-(propan-2-ylamino)-1,3,5-triazin-2-yl]amino]acetic acid",CC(C)NC1=NC(=NC(=N1)NCC(=O)O)Cl,14621415,Positive,In Vivo
2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,53-86-1,Positive,in vitro
2-[1-(aminomethyl)cyclohexyl]acetic acid,C1CCC(CC1)(CC(=O)O)CN,3446,Negative,In Vivo
2-[1-(aminomethyl)cyclohexyl]acetic acid,C1CCC(CC1)(CC(=O)O)CN,3446,Positive,In Vivo
"2-[1,5-bis(5-nitrofuran-2-yl)penta-1,4-dien-3-ylideneamino]guanidine;hydrochloride",C1=C(OC(=C1)[N+](=O)[O-])C=CC(=NN=C(N)N)C=CC2=CC=C(O2)[N+](=O)[O-].Cl,,Positive,in vitro
2-[2-(2-hydroxyethoxy)-4-nitroanilino]ethanol,C1=CC(=C(C=C1[N+](=O)[O-])OCCO)NCCO,62158,Negative,In Vivo
2-[2-(carboxylatomethylamino)ethylamino]acetate;iron(3+),C(CNCC(=O)[O-])NCC(=O)[O-].C(CNCC(=O)[O-])NCC(=O)[O-].C(CNCC(=O)[O-])NCC(=O)[O-].[Fe+3].[Fe+3],151996,Positive,In Vivo
2-[2-(oxiran-2-yl)ethyl]oxirane,C1C(O1)CCC2CO2,1888-89-7,Positive,in vivo
2-[2-(oxiran-2-yl)ethyl]oxirane,C1C(O1)CCC2CO2,1888-89-7,Positive,in vitro
"2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2S,3R,4R,5S)-4-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)-3-methyloxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-oxobutanoyl]amino]ethyl]-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazole-4-carboxamide",CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)O[C@H]3[C@@]([C@H]([C@@H]([C@@H](O3)CO)O)O)(C)O[C@H]4[C@@H]([C@]([C@H](C(O4)CO)O)(C(=O)N)O)O)C(=O)NC(C)C(C(C)C(=O)NC(C(=O)C)C(=O)NCCC5=NC(CS5)C6=NC(=CS6)C(=O)N)O,,Positive,in vitro
"2-[2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy]ethyl (E)-octadec-9-enoate",CCCCCCCC/C=C/CCCCCCCC(=O)OCCOCC(C1C(C(CO1)OCCO)OCCO)OCCO,5281955,Negative,In Vivo
2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,60-00-4,Negative,in vitro
2-[2-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid,CC(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,4408-81-5,Positive,in vitro
2-[3-[(6-chloro-2-methoxyacridin-9-yl)amino]propyl-ethylamino]ethanol;dihydrochloride,CCN(CCCNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC)CCO.Cl.Cl,,Negative,in vitro
2-[3-[(6-chloro-2-methoxyacridin-9-yl)amino]propylamino]ethanol;dihydrochloride,COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCO.Cl.Cl,,Negative,in vitro
"2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)OCCO)C5=CC(=C(C=C5)OCCO)OCCO)O)O)O)O)O)O,7085-55-4,Negative,in vitro
"2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid",CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,2763,Positive,In Vivo
"2-[4-(7-nitro-3-oxido-2,1,3-benzoxadiazol-3-ium-4-yl)piperazin-1-yl]ethanol",C1CN(CCN1CCO)C2=CC=C(C3=NO[N+](=C23)[O-])[N+](=O)[O-],,Positive,in vitro
2-[4-(oxiran-2-yl)butyl]oxirane,C1C(O1)CCCCC2CO2,2426-07-05,Positive,in vitro
"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine",CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,2733526,Negative,In Vivo
"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine",CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,2733526,Positive,In Vivo
"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid",CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,2733525,Negative,In Vivo
"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid",CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,2733525,Positive,In Vivo
"2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid",CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)\C2=CC=CC=C2)/C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,3005572,Negative,In Vivo
2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl.Cl,146-56-5,Positive,in vitro
2-[4-[bis(2-chloroethyl)amino]phenyl]acetic acid,C1=CC(=CC=C1CC(=O)O)N(CCCl)CCCl,10477-72-2,Positive,in vitro
2-[4-[bis(2-hydroxyethyl)amino]-2-nitroanilino]ethanol,C1=CC(=C(C=C1N(CCO)CCO)[N+](=O)[O-])NCCO,36383,Negative,In Vivo
2-[4-amino-N-(2-hydroxyethyl)anilino]ethanol;sulfuric acid,C1=CC(=CC=C1N)N(CCO)CCO.OS(=O)(=O)O,93296,Negative,In Vivo
"2-[4-chloro-6-(2,3-dimethylanilino)pyrimidin-2-yl]sulfanyl-N-(2-hydroxyethyl)acetamide",CC1=C(C(=CC=C1)NC2=CC(=NC(=N2)SCC(=O)NCCO)Cl)C,68851,Positive,In Vivo
"2-[4-chloro-6-(2,3-dimethylanilino)pyrimidin-2-yl]sulfanylacetic acid",CC1=C(C(=CC=C1)NC2=CC(=NC(=N2)SCC(=O)O)Cl)C,5694,Positive,In Vivo
"2-[4-chloro-6-(2,3-dimethylanilino)pyrimidin-2-yl]sulfanylacetic acid",CC1=C(C(=CC=C1)NC2=CC(=NC(=N2)SCC(=O)O)Cl)C,5694,Negative,In Vivo
"2-[4,6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol",CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,1403-66-3,Negative,in vitro
"2-[5-chloro-10-(hydroxymethyl)-8-thia-14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-14-yl]ethyl-diethylazanium;methanesulfonate",CC[NH+](CC)CCN1C2=C3C(=C(C=C2)CO)SC4=C(C3=N1)C=CC(=C4)Cl.CS(=O)(=O)[O-],,Negative,in vitro
"2-[bis(2-chloroethyl)amino]-2-oxo-1,3,2lambda5-oxazaphosphinan-4-one",C1COP(=O)(NC1=O)N(CCCl)CCCl,27046-19-1,Positive,in vitro
2-[bis(2-hydroxyethyl)amino]ethanol,C(CO)N(CCO)CCO,7618,Negative,In Vivo
2-[bis(2-hydroxyethyl)amino]ethanol,C(CO)N(CCO)CCO,7618,Positive,In Vivo
2-[bis(2-hydroxyethyl)amino]ethanol,C(CO)N(CCO)CCO,102-71-6,Positive,in vitro
2-[bis(carboxylatomethyl)amino]acetate;iron(3+),C(C(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Fe+3],27880,Positive,In Vivo
2-[bis(carboxymethyl)amino]acetic acid,C(C(=O)O)N(CC(=O)O)CC(=O)O,8758,Negative,In Vivo
2-[bis(carboxymethyl)amino]acetic acid,C(C(=O)O)N(CC(=O)O)CC(=O)O,8758,Positive,In Vivo
2-[bis(carboxymethyl)amino]acetic acid,C(C(=O)O)N(CC(=O)O)CC(=O)O,139-13-9,Positive,in vivo
2-[bis(carboxymethyl)amino]acetic acid,C(C(=O)O)N(CC(=O)O)CC(=O)O,139-13-9,Negative,in vitro
2-[ethoxycarbonyl(nitroso)amino]ethyl acetate,CCOC(=O)N(CCOC(=O)C)N=O,,Positive,in vitro
2-[ethyl(nitroso)amino]acetic acid,CCN(CC(=O)O)N=O,170434,Negative,In Vivo
2-[methyl(nitroso)amino]acetic acid,CN(CC(=O)O)N=O,25811,Positive,In Vivo
2-[methyl(nitroso)amino]acetic acid,CN(CC(=O)O)N=O,13256-22-9,Positive,in vivo
2-[methyl(nitroso)amino]acetic acid,CN(CC(=O)O)N=O,13256-22-9,Negative,in vitro
2-[N-(2-hydroxyethyl)-4-(methylamino)-3-nitroanilino]ethanol,CNC1=C(C=C(C=C1)N(CCO)CCO)[N+](=O)[O-],17734,Positive,In Vivo
2-[N-(2-hydroxyethyl)-4-(methylamino)-3-nitroanilino]ethanol,CNC1=C(C=C(C=C1)N(CCO)CCO)[N+](=O)[O-],2784-94-3,Positive,in vivo
2-[N-(2-hydroxyethyl)-4-(methylamino)-3-nitroanilino]ethanol,CNC1=C(C=C(C=C1)N(CCO)CCO)[N+](=O)[O-],2784-94-3,Positive,in vitro
"2-[nitroso-[4-[(3R,12S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid",CC(CCC(=O)N(CC(=O)O)N=O)C1CCC2C1([C@H](CC3C2C(CC4C3(CC[C@H](C4)O)C)O)O)C,25199586,Positive,In Vivo
2-ACETYLAMINOFLUORENE,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,53-96-3,Positive,In vivo
2-ACETYLAMINOFLUORENE,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,53-96-3,Negative,In vivo
2-Acetylaminofluorene,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,53-96-3,Positive,in vitro
2-acetyloxybenzoic acid,CC(=O)OC1=CC=CC=C1C(=O)O,50-78-2,Negative,in vivo
"2-acetyloxybenzoic acid;N-(4-ethoxyphenyl)acetamide;1,3,7-trimethylpurine-2,6-dione",CCOC1=CC=C(C=C1)NC(=O)C.CC(=O)OC1=CC=CC=C1C(=O)O.CN1C=NC2=C1C(=O)N(C(=O)N2C)C,24666,Negative,In Vivo
"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhiP - free base & HCl salt)",CN1C2=C(N=CC(=C2)C3=CC=CC=C3)N=C1N,105650-23-5,Positive,in vitro
2-amino-3-(1H-imidazol-5-yl)propanoic acid;hydrate;hydrochloride,C1=C(NC=N1)CC(C(=O)O)N.O.Cl,517335,Negative,In Vivo
2-amino-3-(1H-indol-3-yl)propanoic acid,C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N,54-12-6,Negative,in vivo
2-amino-3-(3-fluorophenyl)propanoic acid,C1=CC(=CC(=C1)F)CC(C(=O)O)N,456-88-2,Negative,in vitro
2-amino-3-(4-fluorophenyl)propanoic acid,C1=CC(=CC=C1CC(C(=O)O)N)F,51-65-0,Negative,in vitro
2-amino-3-[4-[4-[bis(2-chloroethyl)amino]phenoxy]phenyl]propanoic acid,C1=CC(=CC=C1CC(C(=O)O)N)OC2=CC=C(C=C2)N(CCCl)CCCl,857-95-4,Positive,in vitro
2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,531-76-0,Positive,in vivo
2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,4053,Positive,In Vivo
2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,531-76-0,Positive,in vitro
"2-amino-3-methyl-6H-imidazo[4,5-f]quinolin-7-one",CN1C2=C(C3=C(C=C2)NC(=O)C=C3)N=C1N,115222,Negative,In Vivo
"2-amino-3-methyl-6H-imidazo[4,5-f]quinolin-7-one",CN1C2=C(C3=C(C=C2)NC(=O)C=C3)N=C1N,115222,Positive,In Vivo
"2-Amino-3-methylimidazo[4,5-f]quinoline (IQ - free base & HCL salt)",CN1C2=C(C3=C(C=C2)N=CC=C3)N=C1N,76180-96-6,Positive,in vitro
"2-Amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ)",CC1=CC2=C(C=CC=N2)C3=C1N(C(=N3)N)C,77094-11-2,Positive,in vitro
"2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline (8-MeIQx)",CC1=CN=C2C=CC3=C(C2=N1)N=C(N3C)N,77500-04-0,Positive,in vitro
2-AMINO-4-(5-NITRO-2-FURYL)THIAZOLE,C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)N,38514-71-5,Positive,In vivo
2-Amino-4-(5-nitro-2-furyl)thiazole,C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)N,38514-71-5,Positive,in vitro
2-AMINO-4-(p-NITROPHENYL)THIAZOLE,C1=CC(=CC=C1C2=CSC(=N2)N)[N+](=O)[O-],2104-09-8,Positive,In vivo
2-amino-4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid,C1=CC(=CC=C1CCC(C(=O)O)N)N(CCCl)CCCl,3688-35-5,Positive,in vitro
2-amino-4-chlorophenol,C1=CC(=C(C=C1Cl)N)O,7265,Positive,In Vivo
2-Amino-4-chlorophenol,C1=CC(=C(C=C1Cl)N)O,95-85-2,Positive,in vitro
2-amino-4-ethenylsulfanylbutanoic acid,C=CSCCC(C(=O)O)N,55145,Positive,In Vivo
2-amino-4-ethylsulfanylbutanoic acid,CCSCCC(C(=O)O)N,67-21-0,Positive,in vivo
2-amino-4-ethylsulfanylbutanoic acid,CCSCCC(C(=O)O)N,6205,Positive,In Vivo
2-amino-4-ethylsulfanylbutanoic acid,CCSCCC(C(=O)O)N,67-21-0,Negative,in vitro
2-amino-4-nitrobenzoic acid,C1=CC(=C(C=C1[N+](=O)[O-])N)C(=O)O,12076,Negative,In Vivo
2-amino-4-nitrobenzoic acid,C1=CC(=C(C=C1[N+](=O)[O-])N)C(=O)O,619-17-0,Negative,in vivo
2-amino-4-nitrophenol,C1=CC(=C(C=C1[N+](=O)[O-])N)O,3613389,Negative,In Vivo
2-amino-4-nitrophenol,C1=CC(=C(C=C1[N+](=O)[O-])N)O,3613389,Positive,In Vivo
2-amino-4-nitrophenol,C1=CC(=C(C=C1[N+](=O)[O-])N)O,99-57-0,Negative,in vivo
2-Amino-4-nitrophenol,C1=CC(=C(C=C1[N+](=O)[O-])N)O,99-57-0,Positive,in vitro
"2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide",C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C,50-76-0,Positive,in vivo
"2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide",C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C,457193,Positive,In Vivo
"2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide",C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C,50-76-0,Negative,in vitro
"2-AMINO-5-(5-NITRO-2-FURYL)-1,3,4-OXADIAZOLE",C1=C(OC(=C1)[N+](=O)[O-])C2=NN=C(O2)N,3775-55-1,Positive,In vivo
"2-AMINO-5-(5-NITRO-2-FURYL)-1,3,4-THIADIAZOLE",C1=C(OC(=C1)[N+](=O)[O-])C2=NN=C(S2)N,712-68-5,Positive,In vivo
2-amino-5-nitrophenol,C1=CC(=C(C=C1[N+](=O)[O-])O)N,4984721,Negative,In Vivo
2-amino-5-nitrophenol,C1=CC(=C(C=C1[N+](=O)[O-])O)N,4984721,Positive,In Vivo
2-amino-5-nitrophenol,C1=CC(=C(C=C1[N+](=O)[O-])O)N,121-88-0,Negative,in vivo
2-Amino-5-nitrophenol,C1=CC(=C(C=C1[N+](=O)[O-])O)N,121-88-0,Positive,in vitro
2-AMINO-5-NITROTHIAZOLE,C1=C(SC(=N1)N)[N+](=O)[O-],121-66-4,Positive,In vivo
2-Amino-5-nitrothiazole,C1=C(SC(=N1)N)[N+](=O)[O-],121-66-4,Positive,in vitro
2-AMINO-5-PHENYL-2-OXAZOLIN-4-ONE + Mg(OH)2,C1=CC=C(C=C1)C2C(=O)N=C(O2)N.[OH-].[OH-].[Mg+2],18968-99-5,Negative,In vivo
2-amino-5-phenylphenol,C1=CC=C(C=C1)C2=CC(=C(C=C2)N)O,20376,Negative,In Vivo
2-amino-5-phenylphenol,C1=CC=C(C=C1)C2=CC(=C(C=C2)N)O,20376,Positive,In Vivo
"2-Amino-6-methyldipyridol[1,2-a:3',2'-d]imidazole (Glu-P-1)",CC1=CC=CN2C1=NC3=C2N=C(C=C3)N,67730-11-4,Positive,in vitro
2-amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one,C1=NC2=C(N1COCCO)N=C(NC2=O)N,135398513,Negative,In Vivo
"2-amino-9-[(1R,2R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one",C1[C@@H]([C@H]([C@@H]1N2C=NC3=C2N=C(NC3=O)N)CO)CO,135413519,Positive,In Vivo
"2-amino-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(NC3=O)N)CO)O,0961-07-09,Negative,in vitro
"2-amino-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-6-thione",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC(=NC3=S)N)CO)O,3000603,Positive,In Vivo
"2-Amino-9H-pyrido(2,3-b)indole (A-alpha-C)",C1=CC=C2C(=C1)C3=C(N2)N=C(C=C3)N,26148-68-5,Positive,in vitro
2-aminoacetic acid,C(C(=O)O)N,750,Negative,In Vivo
2-Aminoanthracene,C1=CC=C2C=C3C=C(C=CC3=CC2=C1)N,613-13-8,Positive,in vitro
"2-aminoanthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C=C(C=C3)N,8341,Positive,In Vivo
"2-aminoanthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C=C(C=C3)N,117-79-3,Positive,in vivo
2-Aminoanthraquinone,C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C=C(C=C3)N,117-79-3,Positive,in vitro
2-aminobenzoic acid,C1=CC=C(C(=C1)C(=O)O)N,227,Negative,In Vivo
2-AMINODIPHENYLENE OXIDE,C1=CC=C2C(=C1)C3=C(O2)C=CC(=C3)N,3693-22-9,Positive,In vivo
"2-Aminodipyrido[1,2-a:3',2'-d]imidazole (Glu-P-2)",C1=CC2=NC3=C(N2C=C1)N=C(C=C3)N,67730-10-3,Positive,in vitro
2-aminoethanethiol,C(CS)N,60-23-1,Negative,in vitro
2-aminoethanol;5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O.C(CO)N,14992,Negative,In Vivo
2-aminoethyl carbamimidothioate;dihydrobromide,C(CSC(=N)N)N.Br.Br,56-10-0,Positive,in vitro
2-Aminofluorene,C1C2=CC=CC=C2C3=C1C=C(C=C3)N,153-78-6,Positive,in vitro
2-aminophenol,C1=CC=C(C(=C1)N)O,95-55-6,Positive,in vitro
2-anthracen-9-yloxirane,C1C(O1)C2=C3C=CC=CC3=CC4=CC=CC=C42,,Positive,in vitro
"2-azapentacyclo[12.8.0.03,12.04,9.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=CC=CC=C5C4=N3,9183,Positive,In Vivo
"2-azapentacyclo[12.8.0.03,12.04,9.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=CC=CC=C5C4=N3,226-36-8,Positive,in vivo
"2-azapentacyclo[12.8.0.03,12.04,9.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene",C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC5=CC=CC=C5C4=N3,226-36-8,Positive,in vitro
"2-azapentacyclo[12.8.0.03,12.04,9.017,22]docosa-1,3(12),4,6,8,10,13,15,17,19,21-undecaene",C1=CC=C2C(=C1)C=CC3=C2N=C4C(=C3)C=CC5=CC=CC=C54,9178,Positive,In Vivo
2-azido-9H-fluorene,C1C2=CC=CC=C2C3=C1C=C(C=C3)N=[N+]=[N-],,Negative,in vitro
2-AZOXYPROPANE,CC(C)N=[N+](C(C)C)[O-],---,Positive,In vivo
"2-benzhydryloxy-N,N-dimethylethanamine",CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,3100,Negative,In Vivo
"2-benzhydryloxy-N,N-dimethylethanamine;hydrochloride",CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl,8980,Negative,In Vivo
2-Benzimidazolecarbamate (AKA Carbendazim),COC(=O)NC1=NC2=CC=CC=C2N1,10605-21-7,Positive,in vitro
2-Benzimidazolylurea,C1=CC=C2C(=C1)NC(=N2)NC(=O)N,24370-25-0,Positive,in vitro
2-benzo[a]anthracen-7-yloxirane,C1C(O1)C2=C3C=CC4=CC=CC=C4C3=CC5=CC=CC=C52,,Positive,in vitro
"2-benzofuran-1,3-dione",C1=CC=C2C(=C1)C(=O)OC2=O,6811,Negative,In Vivo
"2-benzofuran-1,3-dione",C1=CC=C2C(=C1)C(=O)OC2=O,85-44-9,Negative,in vivo
2-benzyl-4-chlorophenol,C1=CC=C(C=C1)CC2=C(C=CC(=C2)Cl)O,8425,Negative,In Vivo
2-benzyl-4-chlorophenol,C1=CC=C(C=C1)CC2=C(C=CC(=C2)Cl)O,8425,Positive,In Vivo
2-bromo-2-(bromomethyl)pentanedinitrile,C(CC(CBr)(C#N)Br)C#N,61948,Negative,In Vivo
"2-bromo-2-chloro-1,1,1-trifluoroethane",C(C(F)(F)F)(Cl)Br,151-67-7,Negative,in vivo
"2-bromo-2-chloro-1,1,1-trifluoroethane",C(C(F)(F)F)(Cl)Br,151-67-7,Negative,in vitro
2-bromo-2-chloroacetic acid,C(C(=O)O)(Cl)Br,542762,Positive,In Vivo
2-bromo-2-methylpropane,CC(C)(C)Br,10485,Positive,In Vivo
2-bromo-2-methylpropane,CC(C)(C)Br,507-19-7,Negative,in vitro
2-bromo-N-(2-bromoethyl)-N-(thiophen-2-ylmethyl)ethanamine,C1=CSC(=C1)CN(CCBr)CCBr,,Positive,in vitro
2-bromo-N-(2-bromoethyl)-N-[(5-methylthiophen-2-yl)methyl]ethanamine,CC1=CC=C(S1)CN(CCBr)CCBr,,Positive,in vitro
2-bromo-N-carbamoyl-2-ethylbutanamide,CCC(CC)(C(=O)NC(=O)N)Br,6488,Negative,In Vivo
2-bromo-N-carbamoyl-2-ethylbutanamide,CCC(CC)(C(=O)NC(=O)N)Br,77-65-6,Negative,in vivo
2-bromoacetaldehyde,C(C=O)Br,17157-48-1,Positive,in vitro
2-bromobutane,CCC(C)Br,6554,Positive,In Vivo
2-bromoethanol,C(CBr)O,540-51-2,Negative,in vivo
2-Bromoethanol,C(CBr)O,540-51-2,Positive,in vitro
2-bromoethyl acetate,CC(=O)OCCBr,927-68-4,Positive,in vitro
2-bromoethylazanium;bromide,C(CBr)[NH3+].[Br-],,Positive,in vitro
2-Bromopropane,CC(C)Br,75-26-3,Positive,in vitro
"2-butan-2-yl-4,6-dinitrophenol",CCC(C)C1=C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])O,88-85-7,Negative,in vitro
2-butoxyethanol,CCCCOCCO,8133,Positive,In Vivo
2-butoxyethanol,CCCCOCCO,8133,Negative,In Vivo
2-chloro-1-(2-chloro-1-hydroxyethoxy)ethanol;hydrate,C(C(O)OC(CCl)O)Cl.O,,Positive,in vitro
"2-chloro-1-(difluoromethoxy)-1,1,2-trifluoroethane",C(C(OC(F)F)(F)F)(F)Cl,13838-16-9,Negative,in vitro
2-chloro-1-phenylethanone,C1=CC=C(C=C1)C(=O)CCl,10757,Negative,In Vivo
2-chloro-1-phenylethanone,C1=CC=C(C=C1)C(=O)CCl,532-27-4,Negative,in vitro
"2-chloro-1,1,1-trifluoroethane",C(C(F)(F)F)Cl,6408,Positive,In Vivo
"2-CHLORO-1,1,1-TRIFLUOROETHANE",C(C(F)(F)F)Cl,75-88-7,Positive,In vivo
"2-chloro-1,1,1,2-tetrafluoroethane",C(C(F)(F)F)(F)Cl,17822,Negative,In Vivo
"2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane",C(C(F)(F)F)(OC(F)F)Cl,3763,Negative,In Vivo
"2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane",C(C(F)(F)F)(OC(F)F)Cl,26675-46-7,Negative,in vivo
"2-chloro-4-(5-nitrofuran-2-yl)-1,3-thiazole",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)Cl,,Positive,in vitro
"2-CHLORO-5-(3,5-DIMETHYLPIPERIDINOSULPHONYL)BENZOIC ACID",CC1CC(CN(C1)S(=O)(=O)C2=CC(=C(C=C2)Cl)C(=O)O)C,37087-94-8,Positive,In vivo
"2-chloro-5-[(3S,5R)-3,5-dimethylpiperidin-1-yl]sulfonylbenzoic acid",C[C@@H]1C[C@@H](CN(C1)S(=O)(=O)C2=CC(=C(C=C2)Cl)C(=O)O)C,32335,Positive,In Vivo
2-Chloro-6-ethylamino-4-nitrophenol - COLIPA B89,CCNC1=C(C(=CC(=C1)[N+](=O)[O-])Cl)O,131657-78-8,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-[(2-chlorophenyl)methyl]ethanamine,C1=CC=C(C(=C1)CN(CCCl)CCCl)Cl,,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-[(2-fluorophenyl)methyl]ethanamine,C1=CC=C(C(=C1)CN(CCCl)CCCl)F,1542-45-6,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-[(2-methylphenyl)methyl]ethanamine,CC1=CC=CC=C1CN(CCCl)CCCl,30377-48-1,Positive,in vitro
"2-chloro-N-(2-chloroethyl)-N-[(2,4,5-trimethylphenyl)methyl]ethanamine",CC1=CC(=C(C=C1C)CN(CCCl)CCCl)C,,Positive,in vitro
"2-chloro-N-(2-chloroethyl)-N-[(2,4,6-trimethylphenyl)methyl]ethanamine",CC1=CC(=C(C(=C1)C)CN(CCCl)CCCl)C,,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-[(3-chlorophenyl)methyl]ethanamine,C1=CC(=CC(=C1)Cl)CN(CCCl)CCCl,2361-63-9,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-[(3-fluorophenyl)methyl]ethanamine,C1=CC(=CC(=C1)F)CN(CCCl)CCCl,1542-44-5,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-[(3-iodophenyl)methyl]ethanamine,C1=CC(=CC(=C1)I)CN(CCCl)CCCl,40372-95-0,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-[(3-methylphenyl)methyl]ethanamine,CC1=CC(=CC=C1)CN(CCCl)CCCl,,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-[(4-chlorophenyl)methyl]ethanamine,C1=CC(=CC=C1CN(CCCl)CCCl)Cl,,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-[(4-ethylphenyl)methyl]ethanamine,CCC1=CC=C(C=C1)CN(CCCl)CCCl,,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-[(4-fluorophenyl)methyl]ethanamine,C1=CC(=CC=C1CN(CCCl)CCCl)F,1542-46-7,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-[(4-iodophenyl)methyl]ethanamine,C1=CC(=CC=C1CN(CCCl)CCCl)I,39644-00-3,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-[(4-methylphenyl)methyl]ethanamine,CC1=CC=C(C=C1)CN(CCCl)CCCl,30389-85-6,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-[(5-methylthiophen-2-yl)methyl]ethanamine,CC1=CC=C(S1)CN(CCCl)CCCl,,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-ethylethanamine;hydrochloride,CCN(CCCl)CCCl.Cl,3590-07-06,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-methylethanamine,CN(CCCl)CCCl,51-75-2,Positive,in vivo
2-chloro-N-(2-chloroethyl)-N-methylethanamine,CN(CCCl)CCCl,51-75-2,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-methylethanamine oxide,C[N+](CCCl)(CCCl)[O-],9335,Positive,In Vivo
2-chloro-N-(2-chloroethyl)-N-methylethanamine oxide,C[N+](CCCl)(CCCl)[O-],126-85-2,Positive,in vivo
2-chloro-N-(2-chloroethyl)-N-methylethanamine oxide,C[N+](CCCl)(CCCl)[O-],126-85-2,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-methylethanamine oxide;hydrochloride,C[N+](CCCl)(CCCl)[O-].Cl,302-70-5,Positive,in vivo
2-chloro-N-(2-chloroethyl)-N-methylethanamine oxide;hydrochloride,C[N+](CCCl)(CCCl)[O-].Cl,302-70-5,Positive,in vitro
2-chloro-N-(2-chloroethyl)-N-methylethanamine;hydrochloride,CN(CCCl)CCCl.Cl,5935,Positive,In Vivo
2-chloro-N-(2-chloroethyl)-N-methylethanamine;hydrochloride,CN(CCCl)CCCl.Cl,55-86-7,Positive,in vivo
2-chloro-N-(2-chloroethyl)-N-methylethanamine;hydrochloride,CN(CCCl)CCCl.Cl,55-86-7,Negative,in vitro
2-chloro-N-(2-chloroethyl)ethanamine,C(CCl)NCCCl,334-22-5,Positive,in vitro
2-chloro-N-(2-ethyl-6-methylphenyl)-N-(1-methoxypropan-2-yl)acetamide,CCC1=CC=CC(=C1N(C(C)COC)C(=O)CCl)C,51218-45-2,Negative,in vitro
"2-chloro-N-(2,6-diethylphenyl)-N-(methoxymethyl)acetamide",CCC1=C(C(=CC=C1)CC)N(COC)C(=O)CCl,15972-60-8,Positive,in vitro
2-chloro-N-(hydroxymethyl)acetamide,C(C(=O)NCO)Cl,2832-19-1,Positive,in vitro
2-chloro-N-phenyl-N-propan-2-ylacetamide,CC(C)N(C1=CC=CC=C1)C(=O)CCl,1918-16-7,Positive,in vitro
"2-chloro-N,N-bis(2-chloroethyl)ethanamine",C(CCl)N(CCCl)CCCl,555-77-1,Positive,in vitro
"2-chloro-N,N-bis(2-chloroethyl)ethanamine;hydrochloride",C(CCl)N(CCCl)CCCl.Cl,0817-09-04,Positive,in vitro
"2-chloro-N,N-diethylethanamine",CCN(CC)CCCl,100-35-6,Positive,in vitro
"2-chloro-N,N-diethylethanamine;hydrochloride",CCN(CC)CCCl.Cl,869-24-9,Negative,in vitro
"2-chloro-N,N-dimethylethanamine",CN(C)CCCl,107-99-3,Positive,in vitro
2-Chloro-p-phenylenediamine sulfate,C1=CC(=C(C=C1N)Cl)N.OS(=O)(=O)O,61702-44-1,Positive,in vitro
2-chloroacetaldehyde,C(C=O)Cl,33,Positive,In Vivo
2-chloroacetaldehyde,C(C=O)Cl,107-20-0,Negative,in vitro
2-chloroacetamide,C(C(=O)N)Cl,79-07-2,Positive,in vitro
2-chloroacetic acid,C(C(=O)O)Cl,300,Negative,In Vivo
2-chloroacetic acid,C(C(=O)O)Cl,79-11-8,Negative,in vitro
2-chloroaniline,C1=CC=C(C(=C1)N)Cl,95-51-2,Negative,in vivo
2-chloroaniline,C1=CC=C(C(=C1)N)Cl,95-51-2,Negative,in vitro
"2-chlorobenzene-1,4-diamine;sulfuric acid",C1=CC(=C(C=C1N)Cl)N.OS(=O)(=O)O,22584,Negative,In Vivo
"2-chlorobenzene-1,4-diamine;sulfuric acid",C1=CC(=C(C=C1N)Cl)N.OS(=O)(=O)O,61702-44-1,Negative,in vivo
"2-chlorobuta-1,3-diene",C=CC(=C)Cl,31369,Negative,In Vivo
"2-chlorobuta-1,3-diene",C=CC(=C)Cl,31369,Positive,In Vivo
"2-chlorobuta-1,3-diene",C=CC(=C)Cl,126-99-8,Positive,in vivo
"2-Chlorobuta-1,3-diene",C=CC(=C)Cl,126-99-8,Positive,in vitro
2-chloroethanol,C(CCl)O,34,Negative,In Vivo
2-chloroethanol,C(CCl)O,0107-07-03,Negative,in vivo
2-chloroethanol,C(CCl)O,0107-07-03,Negative,in vitro
2-chloroethyl carbonochloridate,C(CCl)OC(=O)Cl,0627-11-2,Negative,in vitro
2-chloroethyl methanesulfonate,CS(=O)(=O)OCCCl,3570-58-9,Positive,in vivo
2-chloroethyl methanesulfonate,CS(=O)(=O)OCCCl,3570-58-9,Positive,in vitro
2-chloroethyl-[2-[(6-chloro-2-methoxyacridin-9-yl)azaniumyl]ethyl]azanium;dichloride,COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)[NH2+]CC[NH2+]CCCl.[Cl-].[Cl-],,Positive,in vitro
2-chloroethyl-[3-[(6-chloro-2-methoxyacridin-9-yl)azaniumyl]propyl]azanium;dichloride,COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)[NH2+]CCC[NH2+]CCCl.[Cl-].[Cl-],,Negative,in vitro
"2-chloroethyl-[3-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-1-ium-10-yl)amino]propyl]-ethylazanium;dichloride",CC[NH+](CCCNC1=C2C(=NC3=C1C=CC(=C3)Cl)C=CC(=[NH+]2)OC)CCCl.[Cl-].[Cl-],38915-28-5,Positive,in vitro
2-chloroethyl(trimethyl)azanium;chloride,C[N+](C)(C)CCCl.[Cl-],13836,Negative,In Vivo
2-chloroethyl(trimethyl)azanium;chloride,C[N+](C)(C)CCCl.[Cl-],999-81-5,Negative,in vivo
2-chloroethyl(trimethyl)azanium;chloride,C[N+](C)(C)CCCl.[Cl-],999-81-5,Positive,in vitro
2-chloroethylphosphonic acid,C(CCl)P(=O)(O)O,27982,Negative,In Vivo
2-chloroethylphosphonic acid,C(CCl)P(=O)(O)O,16672-87-0,Positive,in vitro
2-Chloroethyltrimethylammonium chloride,C[N+](C)(C)CCCl.[Cl-],999-81-5,Negative,in vitro
2-chlorooxirane,C1C(O1)Cl,7763-77-1,Positive,in vivo
2-chlorooxirane,C1C(O1)Cl,7763-77-1,Positive,in vitro
"2-chloroprop-2-enyl N,N-diethylcarbamodithioate",CCN(CC)C(=S)SCC(=C)Cl,7216,Positive,In Vivo
"2-chloroprop-2-enyl N,N-diethylcarbamodithioate",CCN(CC)C(=S)SCC(=C)Cl,95-06-7,Positive,in vivo
"2-chloroprop-2-enyl N,N-diethylcarbamodithioate",CCN(CC)C(=S)SCC(=C)Cl,95-06-7,Positive,in vitro
2-CHLOROPROPANAL,CC(C=O)Cl,683-50-1,Positive,In vivo
2-chloropropane,CC(C)Cl,75-29-6,Negative,in vitro
2-chrysen-6-yloxirane,C1C(O1)C2=CC3=C(C=CC4=CC=CC=C43)C5=CC=CC=C52,66842-41-9,Positive,in vitro
"2-cyano-1-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]-1,3-dinitrosoguanidine",CC1=C(N=CN1)CSCCN(C(=NC#N)N(C)N=O)N=O,,Positive,in vitro
"2-cyano-N-[(E)-(1,4-dioxidoquinoxaline-1,4-diium-2-yl)methylideneamino]acetamide",C1=CC=C2C(=C1)[N+](=CC(=[N+]2[O-])/C=N/NC(=O)CC#N)[O-],65884-46-0,Positive,in vitro
2-cyanoguanidine,C(#N)N=C(N)N,10005,Negative,In Vivo
2-cyanoprop-2-enoic acid,C=C(C#N)C(=O)O,27488,Positive,In Vivo
2-diazo-N-(2-hydrazinyl-2-oxoethyl)acetamide,C(C(=O)NN)NC(=O)C=[N+]=[N-],820-75-7,Positive,in vitro
2-dimethoxyphosphinothioylsulfanyl-N-methylacetamide,CNC(=O)CSP(=S)(OC)OC,3082,Negative,In Vivo
2-dimethoxyphosphinothioylsulfanyl-N-methylacetamide,CNC(=O)CSP(=S)(OC)OC,60-51-5,Negative,in vivo
2-dimethoxyphosphinothioylsulfanyl-N-methylacetamide,CNC(=O)CSP(=S)(OC)OC,60-51-5,Negative,in vitro
2-DIMETHYLAMINOETHANOL,CN(C)CCO,108-01-0,Negative,In vivo
"2-ethenoxy-1,1,1-trifluoroethane",C=COCC(F)(F)F,406-90-6,Negative,in vitro
2-ethenyloxirane,C=CC1CO1,930-22-3,Positive,in vivo
2-ethenylpyridine,C=CC1=CC=CC=N1,7521,Negative,In Vivo
2-ethoxybenzamide,CCOC1=CC=CC=C1C(=O)N,938-73-8,Positive,in vitro
2-ethoxysulfonyloxyethyl ethyl sulfate,CCOS(=O)(=O)OCCOS(=O)(=O)OCC,,Positive,in vitro
"2-ethyl-1,3-hexanediol",CCCC(C(CC)CO)O,94-96-2,Negative,in vitro
2-ethylhexan-1-ol,CCCCC(CC)CO,7720,Negative,In Vivo
2-ETHYLHEXANOL,CCCCC(CC)CO,104-76-7,Negative,In vivo
2-ETHYLHEXANOL,CCCCC(CC)CO,104-76-7,Positive,In vivo
2-ethylhexyl prop-2-enoate,CCCCC(CC)COC(=O)C=C,7636,Negative,In Vivo
2-ethyloxirane,CCC1CO1,7834,Negative,In Vivo
2-ethyloxirane,CCC1CO1,7834,Positive,In Vivo
2-ethyloxirane,CCC1CO1,106-88-7,Negative,in vitro
2-ethylpyridine-4-carbothioamide,CCC1=NC=CC(=C1)C(=S)N,2761171,Negative,In Vivo
2-ethylpyridine-4-carbothioamide,CCC1=NC=CC(=C1)C(=S)N,2761171,Positive,In Vivo
2-ethylsulfanylethylsulfanyl-dimethoxy-sulfanylidene-lambda5-phosphane,CCSCCSP(=S)(OC)OC,640-15-3,Positive,in vitro
"2-fluoro-7,12-dimethylbenzo[a]anthracene",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C=C(C=C3)F,68141-56-0,Negative,in vitro
2-FLUOROETHYL-NITROSOUREA,C(CF)N(C(=O)N)N=O,69112-98-7,Positive,In vivo
2-FURALDEHYDE SEMICARBAZONE,C1=COC(=C1)C=NNC(=O)N,2411-74-7,Negative,In vivo
2-HYDRAZINO-4-(5-NITRO-2-FURYL)THIAZOLE,C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NN,26049-68-3,Positive,In vivo
2-HYDRAZINO-4-(p-AMINOPHENYL)THIAZOLE,C1=CC(=CC=C1C2=CSC(=N2)NN)N,26049-71-8,Positive,In vivo
2-HYDRAZINO-4-(p-NITROPHENYL)THIAZOLE,C1=CC(=CC=C1C2=CSC(=N2)NN)[N+](=O)[O-],26049-70-7,Positive,In vivo
2-HYDRAZINO-4-PHENYLTHIAZOLE,C1=CC=C(C=C1)C2=CSC(=N2)NN,34176-52-8,Negative,In vivo
2-hydrazinylethanol,C(CO)NN,109-84-2,Positive,in vitro
2-hydroperoxy-2-methylpropane,CC(C)(C)OO,75-91-2,Positive,in vitro
2-hydroperoxypropan-2-ylbenzene,CC(C)(C1=CC=CC=C1)OO,80-15-9,Negative,in vitro
"2-hydroxy-1,2-diphenylethanone",C1=CC=C(C=C1)C(C(=O)C2=CC=CC=C2)O,8400,Negative,In Vivo
"2-hydroxy-1,2-diphenylethanone",C1=CC=C(C=C1)C(C(=O)C2=CC=CC=C2)O,119-53-9,Negative,in vivo
2-hydroxy-3-methylcyclopent-2-en-1-one,CC1=C(C(=O)CC1)O,80-71-7,Positive,in vitro
2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,599-79-1,Positive,in vivo
2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,5339,Negative,In Vivo
2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,5339,Positive,In Vivo
2-hydroxyacetic acid,C(C(=O)O)O,757,Negative,In Vivo
2-hydroxybenzoic acid,C1=CC=C(C(=C1)C(=O)O)O,338,Negative,In Vivo
2-hydroxybenzoic acid,C1=CC=C(C(=C1)C(=O)O)O,69-72-7,Negative,in vitro
2-Hydroxyethyl acrylate,C=CC(=O)OCCO,818-61-1,Positive,in vitro
2-hydroxyethyl carbamate,C(COC(=O)N)O,21492,Positive,In Vivo
2-hydroxyethyl carbamate,C(COC(=O)N)O,5395-01-07,Positive,in vitro
2-hydroxyethyl methanesulfonate,CS(=O)(=O)OCCO,19690-37-0,Positive,in vitro
2-Hydroxyethyl picramic acid - COLIPA B72,C1=C(C=C(C(=C1NCCO)O)[N+](=O)[O-])[N+](=O)[O-],99610-72-7,Positive,in vitro
2-hydroxyethyl(trimethyl)azanium;chloride,C[N+](C)(C)CCO.[Cl-],67-48-1,Positive,in vitro
2-Hydroxyethylamino-5-nitroanisole - COLIPA B52,COC1=C(C=CC(=C1)[N+](=O)[O-])NCCO,66095-81-6,Positive,in vitro
2-HYDROXYETHYLHYDRAZINE,C(CO)NN,109-84-2,Negative,In vivo
2-HYDROXYETHYLHYDRAZINE,C(CO)NN,109-84-2,Positive,In vivo
2-Hydroxyethylhydrazine,C(CO)NN,109-84-2,Positive,in vitro
"2-hydroxypropane-1,2,3-tricarboxylate;iron(3+)",C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Fe+3],61300,Negative,In Vivo
2-iodo-2-methylpropane,CC(C)(C)I,558-17-8,Positive,in vitro
2-iodoacetamide,C(C(=O)N)I,144-48-9,Negative,in vitro
2-iodobutane,CCC(C)I,513-48-4,Positive,in vitro
2-iodoethanol,C(CI)O,624-76-0,Negative,in vivo
2-iodoethanol,C(CI)O,624-76-0,Positive,in vitro
2-isocyanatonaphthalene,C1=CC=C2C=C(C=CC2=C1)N=C=O,2243-54-1,Positive,in vitro
2-isothiocyanatoethylbenzene,C1=CC=C(C=C1)CCN=C=S,16741,Negative,In Vivo
2-isothiocyanatoethylbenzene,C1=CC=C(C=C1)CCN=C=S,16741,Positive,In Vivo
2-MERCAPTOBENZOTHIAZOLE,C1=CC=C2C(=C1)NC(=S)S2,149-30-4,Negative,In vivo
2-Mercaptobenzothiazole,C1=CC=C2C(=C1)NC(=S)S2,149-30-4,Positive,in vitro
"2-MERCAPTOBENZOTHIAZOLE, ZINC",C1=CC=C2C(=C1)N=C(S2)[S-].C1=CC=C2C(=C1)N=C(S2)[S-].[Zn+2],155-04-4,Negative,In vivo
2-methoxy-2-methylpropane,CC(C)(C)OC,15413,Negative,In Vivo
2-methoxy-2-methylpropane,CC(C)(C)OC,15413,Positive,In Vivo
2-METHOXY-3-AMINODIBENZOFURAN,COC1=C(C=C2C(=C1)C3=CC=CC=C3O2)N,5834-17-3,Positive,In vivo
2-methoxy-4-[(E)-prop-1-enyl]phenol,C/C=C/C1=CC(=C(C=C1)O)OC,853433,Negative,In Vivo
2-methoxy-4-[(E)-prop-1-enyl]phenol,C/C=C/C1=CC(=C(C=C1)O)OC,853433,Positive,In Vivo
2-methoxy-4-[(E)-prop-1-enyl]phenol,C/C=C/C1=CC(=C(C=C1)O)OC,97-54-1,Positive,in vitro
2-METHOXY-4-AMINOAZOBENZENE,COC1=C(C=CC(=C1)N)N=NC2=CC=CC=C2,80830-39-3,Negative,In vivo
2-methoxy-4-phenyldiazenylaniline,COC1=C(C=CC(=C1)N=NC2=CC=CC=C2)N,3544-23-8,Positive,in vivo
2-methoxy-4-phenyldiazenylaniline,COC1=C(C=CC(=C1)N=NC2=CC=CC=C2)N,3544-23-8,Positive,in vitro
2-methoxy-4-prop-2-enylphenol,COC1=C(C=CC(=C1)CC=C)O,3314,Negative,In Vivo
2-methoxy-4-prop-2-enylphenol,COC1=C(C=CC(=C1)CC=C)O,97-53-0,Positive,in vitro
2-methoxy-5-methylaniline,CC1=CC(=C(C=C1)OC)N,8445,Positive,In Vivo
2-methoxy-5-methylaniline,CC1=CC(=C(C=C1)OC)N,120-71-8,Positive,in vivo
2-methoxy-5-nitroaniline,COC1=C(C=C(C=C1)[N+](=O)[O-])N,7447,Negative,In Vivo
2-methoxy-5-nitroaniline,COC1=C(C=C(C=C1)[N+](=O)[O-])N,7447,Positive,In Vivo
2-methoxy-5-nitroaniline,COC1=C(C=C(C=C1)[N+](=O)[O-])N,99-59-2,Positive,in vivo
2-methoxy-5-nitroaniline,COC1=C(C=C(C=C1)[N+](=O)[O-])N,99-59-2,Positive,in vitro
2-methoxyaniline;hydrochloride,COC1=CC=CC=C1N.Cl,8638,Positive,In Vivo
2-methoxyaniline;hydrochloride,COC1=CC=CC=C1N.Cl,134-29-2,Positive,in vivo
"2-methoxybenzene-1,4-diamine",COC1=C(C=CC(=C1)N)N,5307-02-08,Negative,in vivo
"2-methoxybenzene-1,4-diamine;sulfuric acid",COC1=C(C=CC(=C1)N)N.OS(=O)(=O)O,66671-82-7,Negative,in vivo
"2-methoxybenzene-1,4-diamine;sulfuric acid",COC1=C(C=CC(=C1)N)N.OS(=O)(=O)O,66671-82-7,Negative,in vitro
2-methoxyethyl acetate,CC(=O)OCCOC,110-49-6,Negative,in vitro
2-methoxyethyl methanesulfonate,COCCOS(=O)(=O)C,16427-44-4,Positive,in vitro
2-methoxyphenol,COC1=CC=CC=C1O,460,Negative,In Vivo
2-methoxyphenol,COC1=CC=CC=C1O,90-05-1,Positive,in vitro
"2-methyl-1-nitroanthracene-9,10-dione",CC1=C(C2=C(C=C1)C(=O)C3=CC=CC=C3C2=O)[N+](=O)[O-],31426,Positive,In Vivo
2-Methyl-1-nitroanthraquinone,CC1=C(C2=C(C=C1)C(=O)C3=CC=CC=C3C2=O)[N+](=O)[O-],129-15-7,Positive,in vitro
2-methyl-1-nitrosopiperidine,CC1CCCCN1N=O,7247-89-4,Negative,in vitro
"2-methyl-1,2-thiazol-3-one;hydrochloride",CN1C(=O)C=CS1.Cl,26172-54-3,Negative,in vitro
"2-methyl-1,3,5-trinitrobenzene",CC1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],118-96-7,Negative,in vitro
"2-methyl-1,4-dinitrosopiperazine",CC1CN(CCN1N=O)N=O,,Positive,in vitro
"2-methyl-1,5-dinitroanthracene-9,10-dione",CC1=C(C2=C(C=C1)C(=O)C3=C(C2=O)C=CC=C3[N+](=O)[O-])[N+](=O)[O-],51461-16-6,Positive,in vitro
2-methyl-1H-imidazole,CC1=NC=CN1,12749,Positive,In Vivo
2-methyl-1H-imidazole,CC1=NC=CN1,12749,Negative,In Vivo
"2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid",CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CCCC3=CC=CC=C23,19592,Positive,In Vivo
"2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid",CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CCCC3=CC=CC=C23,3771-19-5,Positive,in vivo
"2-methyl-3-nitroso-1,3-oxazolidine",CC1N(CCO1)N=O,38357,Positive,In Vivo
2-methyl-4-(2-methylphenyl)-1-nitrosobenzene,CC1=CC=CC=C1C2=CC(=C(C=C2)N=O)C,51168,Positive,In Vivo
2-methyl-4-(2-methylphenyl)aniline,CC1=CC=CC=C1C2=CC(=C(C=C2)N)C,25948,Positive,In Vivo
2-methyl-4-(2-methylphenyl)aniline,CC1=CC=CC=C1C2=CC(=C(C=C2)N)C,13394-86-0,Negative,in vitro
"2-methyl-4-(5-nitrofuran-2-yl)-1,3-thiazole",CC1=NC(=CS1)C2=CC=C(O2)[N+](=O)[O-],53757-29-2,Positive,in vitro
2-methyl-4-[(2-methylphenyl)diazenyl]aniline,CC1=CC=CC=C1N=NC2=CC(=C(C=C2)N)C,7340,Positive,In Vivo
2-methyl-4-[(2-methylphenyl)diazenyl]aniline,CC1=CC=CC=C1N=NC2=CC(=C(C=C2)N)C,97-56-3,Positive,in vivo
2-methyl-4-[(2-methylphenyl)diazenyl]aniline,CC1=CC=CC=C1N=NC2=CC(=C(C=C2)N)C,97-56-3,Negative,in vitro
2-METHYL-4-CHLOROPHENOXYACETIC ACID,CC1=C(C=CC(=C1)Cl)OCC(=O)O,94-74-6,Negative,In vivo
2-methyl-4-nitrosomorpholine,CC1CN(CCO1)N=O,21116826,Positive,In Vivo
"2-methyl-4,6-dinitrophenol",CC1=CC(=CC(=C1O)[N+](=O)[O-])[N+](=O)[O-],534-52-1,Negative,in vivo
2-methyl-5-nitroaniline,CC1=C(C=C(C=C1)[N+](=O)[O-])N,7444,Positive,In Vivo
2-methyl-5-nitroaniline,CC1=C(C=C(C=C1)[N+](=O)[O-])N,7444,Negative,In Vivo
2-methyl-5-nitrofuran,CC1=CC=C(O1)[N+](=O)[O-],823-74-5,Positive,in vitro
"2-methyl-5-propan-2-ylbenzene-1,4-diol",CC1=CC(=C(C=C1O)C(C)C)O,2217-60-9,Negative,in vitro
2-methyl-6-nitro-1H-benzimidazole,CC1=NC2=C(N1)C=C(C=C2)[N+](=O)[O-],1792-40-1,Positive,in vitro
2-methyl-8-nitroquinoline,CC1=NC2=C(C=CC=C2[N+](=O)[O-])C=C1,0881-07-02,Positive,in vitro
2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,13311-84-7,Negative,in vivo
2-methylaniline,CC1=CC=CC=C1N,95-53-4,Negative,in vivo
2-methylaniline,CC1=CC=CC=C1N,95-53-4,Positive,in vivo
2-methylaniline,CC1=CC=CC=C1N,95-53-4,Negative,in vitro
2-methylaniline;hydrochloride,CC1=CC=CC=C1N.Cl,12484,Positive,In Vivo
2-methylaniline;hydrochloride,CC1=CC=CC=C1N.Cl,636-21-5,Positive,in vivo
2-methylaziridine,CC1CN1,75-55-8,Positive,in vivo
2-methylaziridine,CC1CN1,6377,Positive,In Vivo
2-methylaziridine,CC1CN1,75-55-8,Positive,in vitro
2-Methylaziridine (propyleneimine),CC1CN1,75-55-8,Positive,in vitro
"2-methylbenzene-1,3-diamine;dihydrochloride",CC1=C(C=CC=C1N)N.Cl.Cl,27324,Negative,In Vivo
"2-methylbenzene-1,3-diamine;dihydrochloride",CC1=C(C=CC=C1N)N.Cl.Cl,15481-70-6,Negative,in vivo
"2-methylbenzene-1,4-diamine",CC1=C(C=CC(=C1)N)N,95-70-5,Positive,in vivo
"2-methylbenzene-1,4-diamine",CC1=C(C=CC(=C1)N)N,95-70-5,Negative,in vivo
"2-methylbenzene-1,4-diamine;sulfuric acid",CC1=C(C=CC(=C1)N)N.OS(=O)(=O)O,22856,Negative,In Vivo
"2-methylbenzene-1,4-diamine;sulfuric acid",CC1=C(C=CC(=C1)N)N.OS(=O)(=O)O,615-50-9,Negative,in vivo
"2-methylbenzene-1,4-diamine;sulfuric acid",CC1=C(C=CC(=C1)N)N.OS(=O)(=O)O,615-50-9,Negative,in vitro
2-methylbenzenesulfonamide,CC1=CC=CC=C1S(=O)(=O)N,88-19-7,Negative,in vitro
2-methylbenzo[a]anthracene,CC1=CC2=C(C=C1)C=CC3=CC4=CC=CC=C4C=C32,2498-76-2,Positive,in vitro
"2-methylbuta-1,3-diene",CC(=C)C=C,6557,Positive,In Vivo
2-methylchrysene,CC1=CC2=C(C=C1)C3=C(C=C2)C4=CC=CC=C4C=C3,3351-32-4,Positive,in vitro
2-methylfluoranthene,CC1=CC2=C3C(=CC=C2)C4=CC=CC=C4C3=C1,35702,Positive,In Vivo
2-methylguanidine,CN=C(N)N,471-29-4,Negative,in vitro
2-methyloxirane,CC1CO1,6378,Positive,In Vivo
2-methyloxirane,CC1CO1,75-56-9,Positive,in vivo
2-methyloxirane,CC1CO1,6378,Negative,In Vivo
2-methyloxirane,CC1CO1,75-56-9,Negative,in vivo
2-methyloxirane,CC1CO1,75-56-9,Positive,in vitro
2-methylphenol,CC1=CC=CC=C1O,95-48-7,Positive,in vitro
2-methylprop-1-ene,CC(=C)C,8255,Negative,In Vivo
2-methylprop-2-enamide,CC(=C)C(=O)N,6595,Positive,In Vivo
2-methylprop-2-enenitrile,CC(=C)C#N,31368,Negative,In Vivo
2-methylpropan-2-ol,CC(C)(C)O,6386,Positive,In Vivo
2-methylpropan-2-ol,CC(C)(C)O,6386,Negative,In Vivo
2-methylpropan-2-ol,CC(C)(C)O,75-65-0,Negative,in vitro
2-methylpropanal,CC(C)C=O,6561,Negative,In Vivo
2-methylpropyl 2-cyanoprop-2-enoate,CC(C)COC(=O)C(=C)C#N,14046,Positive,In Vivo
2-methylpropyl 4-hydroxybenzoate,CC(C)COC(=O)C1=CC=C(C=C1)O,20240,Negative,In Vivo
2-methylpropyl nitrite,CC(C)CON=O,10958,Positive,In Vivo
2-methylquinoline,CC1=NC2=CC=CC=C2C=C1,91-63-4,Positive,in vitro
2-methylsulfinyl-1-pyridin-2-ylethanone,CS(=O)CC(=O)C1=CC=CC=N1,33770,Negative,In Vivo
2-methylsulfinyl-1-pyridin-2-ylethanone,CS(=O)CC(=O)C1=CC=CC=N1,33770,Positive,In Vivo
"2-N-[(1R,2S)-2,6-dimethyl-2,3-dihydro-1H-inden-1-yl]-6-(1-fluoroethyl)-1,3,5-triazine-2,4-diamine",C[C@H]1CC2=C([C@@H]1NC3=NC(=NC(=N3)N)C(C)F)C=C(C=C2)C,44146693,Negative,In Vivo
"2-N-tert-butyl-4-N-ethyl-6-methoxy-1,3,5-triazine-2,4-diamine",CCNC1=NC(=NC(=N1)OC)NC(C)(C)C,33693-04-08,Negative,in vitro
"2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine",CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,0645-05-06,Positive,in vitro
2-naphthalen-2-yloxirane,C1C(O1)C2=CC3=CC=CC=C3C=C2,20861-99-8,Positive,in vitro
2-NAPHTHYLAMINE,C1=CC=C2C=C(C=CC2=C1)N,91-59-8,Positive,In vivo
2-NAPHTHYLAMINE,C1=CC=C2C=C(C=CC2=C1)N,91-59-8,Negative,In vivo
2-Naphthylamine [CGX],C1=CC=C2C=C(C=CC2=C1)N,91-59-8,Positive,in vitro
"2-NAPHTHYLAMINO,1-SULFONIC ACID",C1=CC=C2C(=C1)C=CC(=C2S(=O)(=O)O)N,81-16-3,Negative,In vivo
2-nitro-1-(4-nitrophenoxy)-4-(trifluoromethyl)benzene,C1=CC(=CC=C1[N+](=O)[O-])OC2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],15457-05-03,Negative,in vitro
2-nitro-1-nitroso-1-pentylguanidine,CCCCCN(/C(=N/[N+](=O)[O-])/N)N=O,13010-10-1,Positive,in vitro
2-nitro-1-nitroso-1-propylguanidine,CCCN(/C(=N/[N+](=O)[O-])/N)N=O,,Positive,in vitro
2-Nitro-4-amino-diphenylamine-2’-carboxylic acid  - COLIPA B87,C1=CC=C(C(=C1)C(=O)O)NC2=C(C=C(C=C2)N)[N+](=O)[O-],117907-43-4,Positive,in vitro
2-nitro-9H-fluorene,C1C2=CC=CC=C2C3=C1C=C(C=C3)[N+](=O)[O-],607-57-8,Negative,in vivo
2-nitro-9H-fluorene,C1C2=CC=CC=C2C3=C1C=C(C=C3)[N+](=O)[O-],607-57-8,Positive,in vivo
2-nitro-9H-fluorene,C1C2=CC=CC=C2C3=C1C=C(C=C3)[N+](=O)[O-],11831,Positive,In Vivo
2-nitro-9H-fluorene,C1C2=CC=CC=C2C3=C1C=C(C=C3)[N+](=O)[O-],607-57-8,Negative,in vitro
2-Nitro-p-phenylenediamine,C1=CC(=C(C=C1N)[N+](=O)[O-])N,5307-14-2,Positive,in vitro
2-Nitroaniline,C1=CC=C(C(=C1)N)[N+](=O)[O-],88-74-4,Positive,in vitro
2-nitrobenzaldehyde,C1=CC=C(C(=C1)C=O)[N+](=O)[O-],552-89-6,Positive,in vitro
"2-nitrobenzene-1,4-diamine",C1=CC(=C(C=C1N)[N+](=O)[O-])N,4338370,Negative,In Vivo
"2-nitrobenzene-1,4-diamine",C1=CC(=C(C=C1N)[N+](=O)[O-])N,4338370,Positive,In Vivo
"2-nitrobenzene-1,4-diamine",C1=CC(=C(C=C1N)[N+](=O)[O-])N,5307-14-2,Positive,in vivo
"2-nitrobenzene-1,4-diamine",C1=CC(=C(C=C1N)[N+](=O)[O-])N,5307-14-2,Negative,in vivo
"2-nitrobenzene-1,4-diamine",C1=CC(=C(C=C1N)[N+](=O)[O-])N,5307-14-2,Positive,in vitro
2-nitrobenzidine,C1=CC(=CC=C1C2=C(C=C(C=C2)N)[N+](=O)[O-])N,2243-78-9,Positive,in vitro
2-nitrobenzo[a]pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=CC(=CC(=C54)C=C3)[N+](=O)[O-],154510,Positive,In Vivo
2-nitrobenzoic acid,C1=CC=C(C(=C1)C(=O)O)[N+](=O)[O-],552-16-9,Positive,in vitro
2-nitrobutane,CCC(C)[N+](=O)[O-],11749,Positive,In Vivo
2-NITROBUTANE,CCC(C)[N+](=O)[O-],600-24-8,Positive,In vivo
2-nitrochrysene,C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3C=CC(=C4)[N+](=O)[O-],62535,Negative,In Vivo
2-nitrofluoranthene,C1=CC=C2C(=C1)C3=CC=CC4=CC(=CC2=C43)[N+](=O)[O-],25760,Negative,In Vivo
2-NITROFLUORENE,C1C2=CC=CC=C2C3=C1C=C(C=C3)[N+](=O)[O-],607-57-8,Positive,In vivo
2-Nitrofluorene,C1C2=CC=CC=C2C3=C1C=C(C=C3)[N+](=O)[O-],607-57-8,Positive,in vitro
2-Nitronaphthalene,C1=CC=C2C=C(C=CC2=C1)[N+](=O)[O-],581-89-5,Positive,in vitro
2-nitrophenol,C1=CC=C(C(=C1)[N+](=O)[O-])O,88-75-5,Negative,in vitro
2-nitropropane,CC(C)[N+](=O)[O-],79-46-9,Positive,in vivo
2-NITROPROPANE,CC(C)[N+](=O)[O-],79-46-9,Negative,In vivo
2-nitropropane,CC(C)[N+](=O)[O-],398,Positive,In Vivo
2-Nitropropane,CC(C)[N+](=O)[O-],79-46-9,Positive,in vitro
2-nitropyrene,C1=CC2=C3C(=C1)C=CC4=C3C(=CC(=C4)[N+](=O)[O-])C=C2,13090,Negative,In Vivo
2-nitropyrene,C1=CC2=C3C(=C1)C=CC4=C3C(=CC(=C4)[N+](=O)[O-])C=C2,13090,Positive,In Vivo
2-nitroso-9H-fluorene,C1C2=CC=CC=C2C3=C1C=C(C=C3)N=O,2508-20-5,Positive,in vitro
2-NITROSOMETHYLAMINOPYRIDINE,CN(C1=CC=CC=N1)N=O,16219-98-0,Positive,In vivo
2-Nitrosomethylaminopyridine,CN(C1=CC=CC=N1)N=O,16219-98-0,Positive,in vitro
2-nitrosonaphthalene,C1=CC=C2C=C(C=CC2=C1)N=O,23098,Positive,In Vivo
2-nitrosonaphthalene,C1=CC=C2C=C(C=CC2=C1)N=O,6610-08-08,Positive,in vitro
"2-O-benzyl 1-O-butyl benzene-1,2-dicarboxylate",CCCCOC(=O)C1=CC=CC=C1C(=O)OCC2=CC=CC=C2,2347,Negative,In Vivo
"2-O-benzyl 1-O-butyl benzene-1,2-dicarboxylate",CCCCOC(=O)C1=CC=CC=C1C(=O)OCC2=CC=CC=C2,2347,Positive,In Vivo
2-oxopropanal,CC(=O)C=O,880,Negative,In Vivo
2-oxopropanal,CC(=O)C=O,78-98-8,Positive,in vitro
2-OXOPROPYLNITROSOUREA,CC(=O)CN(C(=O)N)N=O,89837-93-4,Positive,In vivo
2-phenanthren-9-yloxirane,C1C(O1)C2=CC3=CC=CC=C3C4=CC=CC=C42,,Positive,in vitro
"2-PHENYL-1,3-PROPANEDIOL DICARBAMATE",C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,25451-15-4,Positive,In vivo
"2-PHENYL-1,3-PROPANEDIOL DICARBAMATE",C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,25451-15-4,Negative,In vivo
2-phenylaniline,C1=CC=C(C=C1)C2=CC=CC=C2N,90-41-5,Negative,in vitro
2-phenylaniline;hydrochloride,C1=CC=C(C=C1)C2=CC=CC=C2N.Cl,5284347,Positive,In Vivo
2-phenylaniline;hydrochloride,C1=CC=C(C=C1)C2=CC=CC=C2N.Cl,5284347,Negative,In Vivo
"2-phenylbenzene-1,4-diol",C1=CC=C(C=C1)C2=C(C=CC(=C2)O)O,14116,Negative,In Vivo
2-phenylbenzo[h]chromen-4-one,C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3,604-59-1,Negative,in vitro
"2-phenylcyclohexa-2,5-diene-1,4-dione",C1=CC=C(C=C1)C2=CC(=O)C=CC2=O,9688,Negative,In Vivo
2-phenylethylhydrazine;sulfuric acid,C1=CC=C(C=C1)CCNN.OS(=O)(=O)O,61100,Positive,In Vivo
2-phenylethylhydrazine;sulfuric acid,C1=CC=C(C=C1)CCNN.OS(=O)(=O)O,156-51-4,Positive,in vivo
2-phenylethylhydrazine;sulfuric acid,C1=CC=C(C=C1)CCNN.OS(=O)(=O)O,61100,Negative,In Vivo
2-phenylethylhydrazine;sulfuric acid,C1=CC=C(C=C1)CCNN.OS(=O)(=O)O,156-51-4,Negative,In vivo
2-phenylethylhydrazine;sulfuric acid,C1=CC=C(C=C1)CCNN.OS(=O)(=O)O,156-51-4,Positive,In vivo
2-phenylethylhydrazine;sulfuric acid,C1=CC=C(C=C1)CCNN.OS(=O)(=O)O,156-51-4,Positive,in vitro
2-phenyloxirane,C1C(O1)C2=CC=CC=C2,7276,Positive,In Vivo
2-phenyloxirane,C1C(O1)C2=CC=CC=C2,96-09-3,Positive,in vivo
2-phenyloxirane,C1C(O1)C2=CC=CC=C2,7276,Negative,In Vivo
2-phenyloxirane,C1C(O1)C2=CC=CC=C2,96-09-3,Negative,in vivo
2-phenyloxirane,C1C(O1)C2=CC=CC=C2,96-09-3,Positive,in vitro
2-Phenylphenol,C1=CC=C(C=C1)C2=CC=CC=C2O,90-43-7,Negative,in vivo
2-Phenylphenol,C1=CC=C(C=C1)C2=CC=CC=C2O,90-43-7,Positive,in vivo
2-phenylphenol,C1=CC=C(C=C1)C2=CC=CC=C2O,7017,Negative,In Vivo
2-phenylphenol,C1=CC=C(C=C1)C2=CC=CC=C2O,7017,Positive,In Vivo
2-Phenylphenol,C1=CC=C(C=C1)C2=CC=CC=C2O,90-43-7,Negative,in vitro
2-phenylpropylhydrazine;hydrochloride,CC(CNN)C1=CC=CC=C1.Cl,6182,Negative,In Vivo
2-prop-1-enylphenol,CC=CC1=CC=CC=C1O,6380-21-8,Positive,in vitro
2-pyren-1-yloxirane,C1C(O1)C2=C3C=CC4=CC=CC5=C4C3=C(C=C5)C=C2,,Positive,in vitro
"2-quinolin-2-ylindene-1,3-dione",C1=CC=C2C(=C1)C=CC(=N2)C3C(=O)C4=CC=CC=C4C3=O,6731,Positive,In Vivo
"2-sec-BUTYL-4,6-DINITROPHENOL",CCC(C)C1=C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])O,88-85-7,Negative,In vivo
2-sulfanylethanol,C(CS)O,60-24-2,Positive,in vitro
2-sulfanylidene-1H-pyrimidin-4-one,C1=CNC(=S)NC1=O,1269845,Positive,In Vivo
2-tert-butyl-4-(5-tert-butyl-4-hydroxy-2-methylphenyl)sulfanyl-5-methylphenol,CC1=CC(=C(C=C1SC2=CC(=C(C=C2C)O)C(C)(C)C)C(C)(C)C)O,7308,Negative,In Vivo
2-tert-butyl-4-methoxyphenol,CC(C)(C)C1=C(C=CC(=C1)OC)O,8456,Positive,In Vivo
2-tert-butyl-6-[(3-tert-butyl-5-ethyl-2-hydroxyphenyl)methyl]-4-ethylphenol,CCC1=CC(=C(C(=C1)C(C)(C)C)O)CC2=C(C(=CC(=C2)CC)C(C)(C)C)O,6928,Negative,In Vivo
"2-tert-butylbenzene-1,4-diol",CC(C)(C)C1=C(C=CC(=C1)O)O,16043,Negative,In Vivo
"2,2-bis(4-chlorophenyl)acetic acid",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(=O)O)Cl,83-05-6,Negative,in vitro
"2,2-BIS(BROMOMETHYL)-1,3-PROPANEDIOL, TECHNICAL GRADE",C(C(CO)(CBr)CBr)O,3296-90-0,Negative,In vivo
"2,2-Bis(Bromomethyl)-1,3-propanediol, technical grade",C(C(CO)(CBr)CBr)O,3296-90-0,Positive,in vitro
"2,2-bis(bromomethyl)propane-1,3-diol",C(C(CO)(CBr)CBr)O,18692,Positive,In Vivo
"2,2-bis(bromomethyl)propane-1,3-diol",C(C(CO)(CBr)CBr)O,18692,Negative,In Vivo
"2,2-bis(methylsulfonyloxymethyl)butyl methanesulfonate",CCC(COS(=O)(=O)C)(COS(=O)(=O)C)COS(=O)(=O)C,,Positive,in vitro
"2,2-di(butan-2-yloxy)-1-phenylethanone",CCC(C)OC(C(=O)C1=CC=CC=C1)OC(C)CC,93376,Negative,In Vivo
"2,2-dibromoacetic acid",C(C(=O)O)(Br)Br,12433,Positive,In Vivo
"2,2-dibromoacetonitrile",C(#N)C(Br)Br,18617,Positive,In Vivo
"2,2-dichloro-1,1-difluoro-1-methoxyethane",COC(C(Cl)Cl)(F)F,76-38-0,Negative,in vivo
"2,2-dichloro-1,1,1-trifluoroethane",C(C(F)(F)F)(Cl)Cl,9385,Positive,In Vivo
"2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamide",CS(=O)(=O)C1=CC=C(C=C1)[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O,27200,Negative,In Vivo
"2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide",C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],56-75-7,Positive,in vivo
"2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide",C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],56-75-7,Negative,in vitro
"2,2-dichloro-N-[(1S,2S)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide",C1=CC(=CC=C1[C@@H]([C@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],134-90-7,Positive,in vitro
"2,2-dichloro-N-[[4-[[(2,2-dichloroacetyl)-ethylamino]methyl]phenyl]methyl]-N-ethylacetamide",CCN(CC1=CC=C(C=C1)CN(CC)C(=O)C(Cl)Cl)C(=O)C(Cl)Cl,1477-20-9,Positive,in vivo
"2,2-dichloro-N-[6-[(2,2-dichloroacetyl)-ethylamino]hexyl]-N-ethylacetamide",CCN(CCCCCCN(CC)C(=O)C(Cl)Cl)C(=O)C(Cl)Cl,3613-89-6,Positive,in vivo
"2,2-dichloro-N-[8-[(2,2-dichloroacetyl)amino]octyl]acetamide",C(CCCCNC(=O)C(Cl)Cl)CCCNC(=O)C(Cl)Cl,1477-57-2,Positive,in vivo
"2,2-dichloro-N,N-bis(prop-2-enyl)acetamide;S-ethyl N,N-dipropylcarbamothioate",CCCN(CCC)C(=O)SCC.C=CCN(CC=C)C(=O)C(Cl)Cl,51990-04-06,Negative,in vitro
"2,2-dichloroacetic acid",C(C(=O)O)(Cl)Cl,6597,Negative,In Vivo
"2,2-dichloroacetic acid",C(C(=O)O)(Cl)Cl,6597,Positive,In Vivo
"2,2-dichloroacetonitrile",C(#N)C(Cl)Cl,3018-12-0,Positive,in vitro
"2,2-dichloroethenyl dimethyl phosphate",COP(=O)(OC)OC=C(Cl)Cl,3039,Negative,In Vivo
"2,2-dichloroethenyl dimethyl phosphate",COP(=O)(OC)OC=C(Cl)Cl,3039,Positive,In Vivo
"2,2-dichloroethenyl dimethyl phosphate",COP(=O)(OC)OC=C(Cl)Cl,62-73-7,Negative,in vivo
"2,2-dichloroethenyl dimethyl phosphate",COP(=O)(OC)OC=C(Cl)Cl,62-73-7,Negative,in vitro
"2,2-dichloropropanoic acid",CC(C(=O)O)(Cl)Cl,75-99-0,Positive,in vitro
"2,2-diethoxy-1-phenylethanone",CCOC(C(=O)C1=CC=CC=C1)OCC,22555,Negative,In Vivo
"2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylic acid",CC(=CC1C(C1(C)C)C(=O)O)C,10453-89-1,Negative,in vitro
"2,2-dimethylaziridine",CC1(CN1)C,2658-24-4,Positive,in vitro
"2,2-dioxo-3-propan-2-yl-1H-2lambda6,1,3-benzothiadiazin-4-one",CC(C)N1C(=O)C2=CC=CC=C2NS1(=O)=O,2328,Negative,In Vivo
"2,2-dioxo-3-propan-2-yl-1H-2lambda6,1,3-benzothiadiazin-4-one",CC(C)N1C(=O)C2=CC=CC=C2NS1(=O)=O,2328,Positive,In Vivo
"2,2-dioxo-3-propan-2-yl-1H-2lambda6,1,3-benzothiadiazin-4-one",CC(C)N1C(=O)C2=CC=CC=C2NS1(=O)=O,25057-89-0,Negative,in vitro
"2,2,2-tribromoethanol",C(C(Br)(Br)Br)O,75-80-9,Negative,in vivo
"2,2,2-trichloro-1-dimethoxyphosphorylethanol",COP(=O)(C(C(Cl)(Cl)Cl)O)OC,52-68-6,Negative,in vitro
"2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)(C(Cl)(Cl)Cl)O)Cl,8268,Negative,In Vivo
"2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)(C(Cl)(Cl)Cl)O)Cl,8268,Positive,In Vivo
"2,2,2-trichloroacetic acid",C(=O)(C(Cl)(Cl)Cl)O,6421,Negative,In Vivo
"2,2,2-trichloroacetic acid",C(=O)(C(Cl)(Cl)Cl)O,6421,Positive,In Vivo
"2,2,2-trichloroacetic acid",C(=O)(C(Cl)(Cl)Cl)O,76-03-9,Positive,in vitro
"2,2,2-trichloroethane-1,1-diol",C(C(Cl)(Cl)Cl)(O)O,2707,Negative,In Vivo
"2,2,2-trichloroethane-1,1-diol",C(C(Cl)(Cl)Cl)(O)O,302-17-0,Negative,in vivo
"2,2,2-trichloroethane-1,1-diol",C(C(Cl)(Cl)Cl)(O)O,2707,Positive,In Vivo
"2,2,2-trichloroethane-1,1-diol",C(C(Cl)(Cl)Cl)(O)O,302-17-0,Negative,in vitro
"2,2,2-trichloroethanol",C(C(Cl)(Cl)Cl)O,8259,Negative,In Vivo
"2,2,2-Trifluoro-N-[4-(5-nitro-2-furyl)-2-thiazolyl acetamide",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NC(=O)C(F)(F)F,42011-48-3,Positive,in vitro
"2,2,2-TRIFLUORO-N-[4-(5-NITRO-2-FURYL)-2-THIAZOLYL]ACETAMIDE",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NC(=O)C(F)(F)F,42011-48-3,Positive,In vivo
"2,2,2-trifluoro-N-[4-(5-nitrofuran-2-yl)-1,3-thiazol-2-yl]acetamide",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NC(=O)C(F)(F)F,42011-48-3,Negative,in vitro
"2,2,4-trimethyl-1-nitrosoquinoline",CC1=CC(N(C2=CC=CC=C12)N=O)(C)C,88617,Positive,In Vivo
"2,2,4-trimethyl-1H-quinoline",CC1=CC(NC2=CC=CC=C12)(C)C,8981,Negative,In Vivo
"2,2,4-trimethyl-1H-quinoline",CC1=CC(NC2=CC=CC=C12)(C)C,8981,Positive,In Vivo
"2,2,4,4,6,6-hexakis(aziridin-1-yl)-1,3,5-triaza-2lambda5,4lambda5,6lambda5-triphosphacyclohexa-1,3,5-triene",C1CN1P2(=NP(=NP(=N2)(N3CC3)N4CC4)(N5CC5)N6CC6)N7CC7,52-46-0,Positive,in vivo
"2,2,4,4,6,6-hexakis(aziridin-1-yl)-1,3,5-triaza-2lambda5,4lambda5,6lambda5-triphosphacyclohexa-1,3,5-triene",C1CN1P2(=NP(=NP(=N2)(N3CC3)N4CC4)(N5CC5)N6CC6)N7CC7,52-46-0,Positive,in vitro
"2,2'-[(4-AMINOPHENYL)IMINO]BISETHANOL SULFATE",C1=CC(=CC=C1N)N(CCO)CCO.OS(=O)(=O)O,54381-16-7,Negative,In vivo
"2,2'-METHYLENEBIS(4-METHYL-6-TERT-BUTYLPHENOL)",CC1=CC(=C(C(=C1)C(C)(C)C)O)CC2=C(C(=CC(=C2)C)C(C)(C)C)O,119-47-1,Negative,In vivo
"2,3-bis(chloromethyl)oxirane",C(C1C(O1)CCl)Cl,3583-47-9,Positive,in vitro
"2,3-bis(sulfanyl)propan-1-ol",C(C(CS)S)O,59-52-9,Negative,in vitro
"2,3-Dibromo-1-propanol",C(C(CBr)Br)O,96-13-9,Positive,in vitro
"2,3-dibromopropan-1-ol",C(C(CBr)Br)O,7281,Positive,In Vivo
"2,3-dibromopropan-1-ol",C(C(CBr)Br)O,96-13-9,Positive,in vitro
"2,3-DICHLORO-1,4-NAPHTHOQUINONE",C1=CC=C2C(=C1)C(=O)C(=C(C2=O)Cl)Cl,117-80-6,Negative,In vivo
"2,3-dichloro-2-(chloromethyl)oxirane",C(C1(C(O1)Cl)Cl)Cl,67664-94-2,Positive,in vitro
"2,3-Dichlorobuta-1,3-diene",C=C(C(=C)Cl)Cl,1653-19-6,Negative,in vitro
"2,3-dichloroprop-1-ene",C=C(CCl)Cl,78-88-6,Positive,in vitro
"2,3-dimethoxy-6-[(E)-(pyridine-4-carbonylhydrazinylidene)methyl]benzoic acid",COC1=C(C(=C(C=C1)/C=N/NC(=O)C2=CC=NC=C2)C(=O)O)OC,2779-55-7,Negative,in vitro
"2,3-dimethyl-2,3-dinitrobutane",CC(C)(C(C)(C)[N+](=O)[O-])[N+](=O)[O-],77577,Negative,In Vivo
"2,3-dimethyl-4-nitro-1-oxidopyridin-1-ium",CC1=C(C=C[N+](=C1C)[O-])[N+](=O)[O-],37699-43-7,Positive,in vitro
"2,3-dimethyloxirane",CC1C(O1)C,3266-23-7,Positive,in vitro
"2,3-Epoxypropyl methacrylate",CC(=C)C(=O)OCC1CO1,106-91-2,Positive,in vitro
"2,3-epoxypropyl neodecanoate",CC(C)(C)CCCCCC(=O)OCC1CO1,26761-45-5,Positive,in vitro
"2,3,4-trichloro-6-(2,4-dichlorophenoxy)phenol",C1=CC(=C(C=C1Cl)Cl)OC2=CC(=C(C(=C2O)Cl)Cl)Cl,53555-01-04,Negative,in vitro
"2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal",C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC(C(C(C(C=O)O)O)O)O)O)O)O)O)O)O)O,4125253,Negative,In Vivo
"2,3,4,5-tetrahydroxybenzo[7]annulen-6-one",C1=CC(=O)C(=C2C(=C1)C=C(C(=C2O)O)O)O,,Negative,in vitro
"2,3,4,5,6-pentachlorophenol",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)O,992,Negative,In Vivo
"2,3,4,5,6-pentachlorophenol",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)O,87-86-5,Negative,in vivo
"2,3,4,5,6-pentachlorophenol",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)O,992,Positive,In Vivo
"2,3,4,5,6-pentachlorophenol",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)O,87-86-5,Negative,in vitro
"2,3,4,5,6-PENTACHLOROPHENOL (Dowicide EC-7)",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)O,87-86-5,Negative,In vivo
"2,3,4,5,6-PENTACHLOROPHENOL, TECHNICAL GRADE",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)O,87-86-5,Positive,In vivo
"2,3,4,6,7,8-hexachlorodecane",CCC(C(C(CC(C(C(C)Cl)Cl)Cl)Cl)Cl)Cl,22833489,Positive,In Vivo
"2,3,4,7,8-pentachlorodibenzofuran",C1=C2C3=CC(=C(C(=C3OC2=CC(=C1Cl)Cl)Cl)Cl)Cl,42128,Negative,In Vivo
"2,3,4,7,8-pentachlorodibenzofuran",C1=C2C3=CC(=C(C(=C3OC2=CC(=C1Cl)Cl)Cl)Cl)Cl,42128,Positive,In Vivo
"2,3,5-triiodobenzoic acid",C1=C(C=C(C(=C1C(=O)O)I)I)I,88-82-4,Positive,in vitro
"2,3,5-tris(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione",C1CN1C2=CC(=O)C(=C(C2=O)N3CC3)N4CC4,68-76-8,Positive,in vivo
"2,3,5-tris(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione",C1CN1C2=CC(=O)C(=C(C2=O)N3CC3)N4CC4,68-76-8,Positive,in vitro
"2,3,5,6-Tetrachloro-1,4-benzoquinone",C1(=C(C(=O)C(=C(C1=O)Cl)Cl)Cl)Cl,118-75-2,Positive,in vitro
"2,3,5,6-Tetrachloro-4-nitroanisole",COC1=C(C(=C(C(=C1Cl)Cl)[N+](=O)[O-])Cl)Cl,2438-88-2,Negative,in vitro
"2,3,5,6-tetrakis(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione",C1CN1C2=C(C(=O)C(=C(C2=O)N3CC3)N4CC4)N5CC5,4239-06-09,Positive,in vitro
"2,3,6-trimethyl-1H-indole",CC1=CC2=C(C=C1)C(=C(N2)C)C,22072-35-1,Positive,in vitro
"2,3,7,8-TETRACHLORODIBENZO-p-DIOXIN",C1=C2C(=CC(=C1Cl)Cl)OC3=CC(=C(C=C3O2)Cl)Cl,1746-01-6,Negative,In vivo
"2,3,7,8-tetrachlorodibenzo-p-dioxin",C1=C2C(=CC(=C1Cl)Cl)OC3=CC(=C(C=C3O2)Cl)Cl,15625,Positive,In Vivo
"2,3,7,8-TETRACHLORODIBENZO-p-DIOXIN",C1=C2C(=CC(=C1Cl)Cl)OC3=CC(=C(C=C3O2)Cl)Cl,1746-01-6,Positive,In vivo
"2,3,7,8-tetrachlorodibenzo-p-dioxin",C1=C2C(=CC(=C1Cl)Cl)OC3=CC(=C(C=C3O2)Cl)Cl,1746-01-06,Positive,in vivo
"2,3,7,8-tetrachlorodibenzo-p-dioxin",C1=C2C(=CC(=C1Cl)Cl)OC3=CC(=C(C=C3O2)Cl)Cl,15625,Negative,In Vivo
"2,3,7,8-tetrachlorodibenzo-p-dioxin",C1=C2C(=CC(=C1Cl)Cl)OC3=CC(=C(C=C3O2)Cl)Cl,1746-01-06,Negative,in vivo
"2,3,7,8-tetrachlorodibenzofuran",C1=C2C3=CC(=C(C=C3OC2=CC(=C1Cl)Cl)Cl)Cl,51207-31-9,Negative,in vitro
"2,4-bis(aziridin-1-yl)-6-chloropyrimidine",C1CN1C2=CC(=NC(=N2)N3CC3)Cl,2482-80-6,Positive,in vitro
"2,4-D",C1=CC(=C(C=C1Cl)Cl)OCC(=O)O,94-75-7,Negative,in vivo
"2,4-D",C1=CC(=C(C=C1Cl)Cl)OCC(=O)O,94-75-7,Positive,in vivo
"2,4-D",C1=CC(=C(C=C1Cl)Cl)OCC(=O)O,94-75-7,Negative,in vitro
"2,4-DB",C1=CC(=C(C=C1Cl)Cl)OCCCC(=O)O,94-82-6,Negative,in vivo
"2,4-DB",C1=CC(=C(C=C1Cl)Cl)OCCCC(=O)O,94-82-6,Negative,in vitro
"2,4-Diaminoanisole (free base and sulphate)",C1=CC(=C(C=C1OC)N)N,0615-05-04,Positive,in vitro
"2,4-DIAMINOANISOLE SULFATE",COC1=C(C=C(C=C1)N)N.OS(=O)(=O)O,39156-41-7,Positive,In vivo
"2,4-Diaminophenol 2HCl",C1=CC(=C(C=C1N)N)O,0137-09-07,Negative,in vitro
"2,4-diaminophenol;dihydrochloride",C1=CC(=C(C=C1N)N)O.Cl.Cl,8715,Negative,In Vivo
"2,4-diaminophenol;dihydrochloride",C1=CC(=C(C=C1N)N)O.Cl.Cl,0137-09-07,Negative,in vitro
"2,4-Diaminophenoxyethanol HCl - COLIPA A42",C1=CC(=C(C=C1N)N)OCCO.Cl.Cl,66422-95-5,Positive,in vitro
"2,4-Diaminotoluene (free base and 2HCl salt)",CC1=C(C=C(C=C1)N)N,95-80-7,Positive,in vitro
"2,4-DIAMINOTOLUENE.2HCl",CC1=C(C=C(C=C1)N)N.Cl.Cl,636-23-7,Negative,In vivo
"2,4-DIAMINOTOLUENE.2HCl",CC1=C(C=C(C=C1)N)N.Cl.Cl,636-23-7,Positive,In vivo
"2,4-dichloro-1-(4-nitrophenoxy)benzene",C1=CC(=CC=C1[N+](=O)[O-])OC2=C(C=C(C=C2)Cl)Cl,15787,Positive,In Vivo
"2,4-dichloro-1-(4-nitrophenoxy)benzene",C1=CC(=CC=C1[N+](=O)[O-])OC2=C(C=C(C=C2)Cl)Cl,1836-75-5,Positive,in vivo
"2,4-dichloro-1-(4-nitrophenoxy)benzene",C1=CC(=CC=C1[N+](=O)[O-])OC2=C(C=C(C=C2)Cl)Cl,15787,Negative,In Vivo
"2,4-Dichloro-1-nitrobenezene",C1=CC(=C(C=C1Cl)Cl)[N+](=O)[O-] ,0611-06-03,Negative,in vitro
"2,4-dichloroaniline",C1=CC(=C(C=C1Cl)Cl)N,554-00-7,Negative,in vivo
"2,4-dichlorophenol",C1=CC(=C(C=C1Cl)Cl)O,8449,Negative,In Vivo
"2,4-DICHLOROPHENOXYACETIC ACID",C1=CC(=C(C=C1Cl)Cl)OCC(=O)O,94-75-7,Negative,In vivo
"2,4-dichlorophenoxyacetic acid",C1=CC(=C(C=C1Cl)Cl)OCC(=O)O,94-75-7,Positive,in vitro
"2,4-DICHLOROPHENOXYACETIC ACID, ISOOCTYL ESTER",CC(C)CCCCCOC(=O)COC1=C(C=C(C=C1)Cl)Cl,25168-26-7,Negative,In vivo
"2,4-DICHLOROPHENOXYACETIC ACID, ISOPROPYL ESTER",CC(C)OC(=O)COC1=C(C=C(C=C1)Cl)Cl,94-11-1,Negative,In vivo
"2,4-DICHLOROPHENOXYACETIC ACID, n-BUTYL ESTER",CCCCOC(=O)COC1=C(C=C(C=C1)Cl)Cl,94-80-4,Negative,In vivo
"2,4-DICHLOROPHENYLBENZENE SULFONATE",C1=CC=C(C=C1)S(=O)(=O)OC2=C(C=C(C=C2)Cl)Cl,97-16-5,Negative,In vivo
"2,4-Dimethoxyaniline (free base and HCl salt)",COC1=C(C=C(C=C1)C(=O)NC2=CC=CC=C2)N,120-35-4,Positive,in vitro
"2,4-dimethylaniline;hydrochloride",CC1=CC(=C(C=C1)N)C.Cl,88898,Positive,In Vivo
"2,4-dinitrophenol",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])O,51-28-5,Negative,in vitro
"2,4-DINITROPHENOL, SODIUM",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])[O-].[Na+],1011-73-0,Negative,In vivo
"2,4-Dinitrotoluene",CC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],121-14-2,Negative,in vitro
"2,4-DINITROTOLUENE (CONTAINING 0.5% 2,6-DINITROTOLUENE)",CC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],121-14-2,Negative,In vivo
"2,4-DINITROTOLUENE (CONTAINING 1.0-1.5% 2,6-DINITROTOLUENE)",CC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],121-14-2,Positive,In vivo
"2,4-Hexadienal",CC=CC=CC=O,142-83-6,Positive,in vitro
"2,4-Toluene diisocyanate",CC1=C(C=C(C=C1)N=C=O)N=C=O,584-84-9,Negative,in vitro
"2,4-Xylidine HCl",CC1=CC(=C(C=C1)N)C.Cl,21436-96-4,Positive,in vitro
"2,4-XYLIDINE.HCl",CC1=CC(=C(C=C1)N)C.Cl,21436-96-4,Negative,In vivo
"2,4-XYLIDINE.HCl",CC1=CC(=C(C=C1)N)C.Cl,21436-96-4,Positive,In vivo
"2,4,5-TRICHLOROPHENOXYACETIC ACID",C1=C(C(=CC(=C1Cl)Cl)Cl)OCC(=O)O,93-76-5,Negative,In vivo
"2,4,5-Trichlorophenoxyacetic acid",C1=C(C(=CC(=C1Cl)Cl)Cl)OCC(=O)O,93-76-5,Positive,in vitro
"2,4,5-trimethylaniline",CC1=CC(=C(C=C1C)N)C,8717,Positive,In Vivo
"2,4,5-trimethylaniline",CC1=CC(=C(C=C1C)N)C,137-17-7,Positive,in vivo
"2,4,5-Trimethylaniline (free base and HCl salt)",CC1=CC(=C(C=C1C)N)C,137-17-7,Positive,in vitro
"2,4,5-TRIMETHYLANILINE.HCl",CC1=CC(=C(C=C1C)N)C.Cl,21436-97-5,Positive,In vivo
"2,4,5,4'-TETRACHLORODIPHENYL SULFONE",C1=CC(=CC=C1S(=O)(=O)C2=CC(=C(C=C2Cl)Cl)Cl)Cl,116-29-0,Negative,In vivo
"2,4,5,6-tetrachlorobenzene-1,3-dicarbonitrile",C(#N)C1=C(C(=C(C(=C1Cl)Cl)Cl)C#N)Cl,15910,Negative,In Vivo
"2,4,5,6-tetrachlorobenzene-1,3-dicarbonitrile",C(#N)C1=C(C(=C(C(=C1Cl)Cl)Cl)C#N)Cl,15910,Positive,In Vivo
"2,4,5,6-tetrachlorobenzene-1,3-dicarbonitrile",C(#N)C1=C(C(=C(C(=C1Cl)Cl)Cl)C#N)Cl,1897-45-6,Positive,in vivo
"2,4,5,6-tetrachlorobenzene-1,3-dicarbonitrile",C(#N)C1=C(C(=C(C(=C1Cl)Cl)Cl)C#N)Cl,1897-45-6,Negative,in vitro
"2,4,6-TRI-tert-BUTYLPHENOL",CC(C)(C)C1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C,732-26-3,Negative,In vivo
"2,4,6-trichloro-N-(methyldiazenyl)aniline",CN=NNC1=C(C=C(C=C1Cl)Cl)Cl,149027,Negative,In Vivo
"2,4,6-TRICHLOROANILINE",C1=C(C=C(C(=C1Cl)N)Cl)Cl,634-93-5,Negative,In vivo
"2,4,6-trichloroaniline",C1=C(C=C(C(=C1Cl)N)Cl)Cl,12471,Positive,In Vivo
"2,4,6-TRICHLOROANILINE",C1=C(C=C(C(=C1Cl)N)Cl)Cl,634-93-5,Positive,In vivo
"2,4,6-trichlorophenol",C1=C(C=C(C(=C1Cl)O)Cl)Cl,88-06-2,Negative,in vivo
"2,4,6-trichlorophenol",C1=C(C=C(C(=C1Cl)O)Cl)Cl,6914,Positive,In Vivo
"2,4,6-trichlorophenol",C1=C(C=C(C(=C1Cl)O)Cl)Cl,88-06-2,Positive,in vivo
"2,4,6-trichlorophenol",C1=C(C=C(C(=C1Cl)O)Cl)Cl,6914,Negative,In Vivo
"2,4,6-trichlorophenol",C1=C(C=C(C(=C1Cl)O)Cl)Cl,88-06-2,Negative,in vitro
"2,4,6-Trimethylaniline",CC1=CC(=C(C(=C1)C)N)C,88-05-1,Positive,in vitro
"2,4,6-TRIMETHYLANILINE.HCl",CC1=CC(=C(C(=C1)C)[NH3+])C.[Cl-],6334-11-8,Negative,In vivo
"2,4,6-TRIMETHYLANILINE.HCl",CC1=CC(=C(C(=C1)C)[NH3+])C.[Cl-],6334-11-8,Positive,In vivo
"2,4,6-trimethylpyrylium;perchlorate",CC1=CC(=[O+]C(=C1)C)C.[O-]Cl(=O)(=O)=O,940-93-2,Positive,in vitro
"2,4,6-TRINITRO-1,3-DIMETHYL-5-tert-BUTYLBENZENE",CC1=C(C(=C(C(=C1[N+](=O)[O-])C(C)(C)C)[N+](=O)[O-])C)[N+](=O)[O-],81-15-2,Positive,In vivo
"2,4,6-trinitrobenzene-1,3,5-triamine",C1(=C(C(=C(C(=C1[N+](=O)[O-])N)[N+](=O)[O-])N)[N+](=O)[O-])N,3058-38-6,Negative,in vitro
"2,4,6-trinitrophenol",C1=C(C=C(C(=C1[N+](=O)[O-])O)[N+](=O)[O-])[N+](=O)[O-],88-89-1,Negative,in vitro
"2,4,6-tris(aziridin-1-yl)-1,3,5-triazine",C1CN1C2=NC(=NC(=N2)N3CC3)N4CC4,51-18-3,Positive,in vivo
"2,4,6-tris(aziridin-1-yl)-1,3,5-triazine",C1CN1C2=NC(=NC(=N2)N3CC3)N4CC4,5799,Positive,In Vivo
"2,4,6-tris(aziridin-1-yl)-1,3,5-triazine",C1CN1C2=NC(=NC(=N2)N3CC3)N4CC4,51-18-3,Negative,in vitro
"2,4,6-tris(aziridin-1-yl)-5-chloropyrimidine",C1CN1C2=C(C(=NC(=N2)N3CC3)N4CC4)Cl,,Positive,in vitro
"2,4,6-tris(aziridin-1-yl)pyrimidine",C1CN1C2=CC(=NC(=N2)N3CC3)N4CC4,,Positive,in vitro
"2,4,6-tris(chloromethyl)-1,3,5-trioxane",C(C1OC(OC(O1)CCl)CCl)Cl,1129-52-8,Positive,in vitro
"2,4,6,8-Tetramethyl-1,3,5,7-tetraoxacyclooctane",CC1OC(C)OC(C)OC(C)O1,108-62-3,Negative,in vivo
"2,4,6,8-Tetramethyl-1,3,5,7-tetraoxacyclooctane",CC1OC(C)OC(C)OC(C)O1,108-62-3,Negative,in vitro
"2,4,7-trinitrofluoren-9-one",C1=CC2=C(C=C1[N+](=O)[O-])C(=O)C3=C2C(=CC(=C3)[N+](=O)[O-])[N+](=O)[O-],129-79-3,Positive,in vitro
"2,5-bis(aziridin-1-yl)-3,6-bis(2-methoxyethoxy)cyclohexa-2,5-diene-1,4-dione",COCCOC1=C(C(=O)C(=C(C1=O)N2CC2)OCCOC)N3CC3,61215,Positive,In Vivo
"2,5-bis(aziridin-1-yl)-3,6-bis(2-methoxyethoxy)cyclohexa-2,5-diene-1,4-dione",COCCOC1=C(C(=O)C(=C(C1=O)N2CC2)OCCOC)N3CC3,800-24-8,Positive,in vitro
"2,5-bis(aziridin-1-yl)-3,6-dipropoxycyclohexa-2,5-diene-1,4-dione",CCCOC1=C(C(=O)C(=C(C1=O)N2CC2)OCCC)N3CC3,436-40-8,Positive,in vitro
"2,5-bis(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione",C1CN1C2=CC(=O)C(=CC2=O)N3CC3,526-62-5,Positive,in vitro
"2,5-Diaminotoluene COLIPA A005 (free base and sulphate salts)",CC1=C(C=CC(=C1)N)N,95-70-5,Positive,in vitro
"2,5-dihydrothiophene 1,1-dioxide",C1C=CCS1(=O)=O,6498,Negative,In Vivo
"2,5-dihydrothiophene 1,1-dioxide",C1C=CCS1(=O)=O,77-79-2,Negative,in vivo
"2,5-DIMETHOXY-4'-AMINOSTILBENE",COC1=CC(=C(C=C1)OC)C=CC2=CC=C(C=C2)N,5803-51-0,Negative,In vivo
"2,5-DIMETHOXY-4'-AMINOSTILBENE",COC1=CC(=C(C=C1)OC)C=CC2=CC=C(C=C2)N,5803-51-0,Positive,In vivo
"2,5-dimethyl-1,4-dinitrosopiperazine",CC1CN(C(CN1N=O)C)N=O,55556-88-2,Positive,in vitro
"2,5-ditert-butyl-4-methoxyphenol",CC(C)(C)C1=CC(=C(C=C1OC)C(C)(C)C)O,74812,Negative,In Vivo
"2,5-ditert-butylbenzene-1,4-diol",CC(C)(C)C1=CC(=C(C=C1O)C(C)(C)C)O,2374,Positive,In Vivo
"2,5-Xylidine HCl",CC1=CC(=C(C=C1)C)N.Cl,51786-53-9,Positive,in vitro
"2,5-XYLIDINE.HCl",CC1=CC(=C(C=C1)C)N.Cl,51786-53-9,Negative,In vivo
"2,5-XYLIDINE.HCl",CC1=CC(=C(C=C1)C)N.Cl,51786-53-9,Positive,In vivo
"2,5,11-trimethyl-6H-pyrido[4,3-b]carbazol-2-ium-9-ol",CC1=C2C=C[N+](=CC2=C(C3=C1NC4=C3C=C(C=C4)O)C)C,58337-34-1,Positive,in vitro
"2,5,6-Triamino-4-Pyrimidinol sulfate - COLIPA A143",C1=C(N=C(N=C1N)N)N,1004-38-2,Positive,in vitro
"2,6-Diaminotoluene (free base and 2HCl salt)",CC1=C(C=CC=C1N)N,823-40-5,Positive,in vitro
"2,6-dibromo-4-[(E)-(2,4-dinitrophenoxy)iminomethyl]phenol",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])O/N=C/C2=CC(=C(C(=C2)Br)O)Br,,Negative,in vitro
"2,6-DICHLORO-4-NITROANILINE",C1=C(C=C(C(=C1Cl)N)Cl)[N+](=O)[O-],99-30-9,Negative,In vivo
"2,6-dichloro-4-nitroaniline",C1=C(C=C(C(=C1Cl)N)Cl)[N+](=O)[O-],99-30-9,Positive,in vitro
"2,6-Dichloro-p-phenylenediamine",C1=C(C=C(C(=C1Cl)N)Cl)N,609-20-1,Positive,in vitro
"2,6-dichlorobenzene-1,4-diamine",C1=C(C=C(C(=C1Cl)N)Cl)N,11860,Positive,In Vivo
"2,6-dichlorobenzene-1,4-diamine",C1=C(C=C(C(=C1Cl)N)Cl)N,11860,Negative,In Vivo
"2,6-dichlorobenzenecarbothioamide",C1=CC(=C(C(=C1)Cl)C(=S)N)Cl,1918-13-4,Negative,in vitro
"2,6-dichlorobenzonitrile",C1=CC(=C(C(=C1)Cl)C#N)Cl,3031,Positive,In Vivo
"2,6-dichlorobenzonitrile",C1=CC(=C(C(=C1)Cl)C#N)Cl,1194-65-6,Negative,in vitro
"2,6-dichlorophenol",C1=CC(=C(C(=C1)Cl)O)Cl,87-65-0,Negative,in vitro
"2,6-Dihydroxyethylaminotoluene -    COLIPA A138",CC1=C(C=CC=C1NCCO)NCCO,149330-25-6,Negative,in vitro
"2,6-dimethoxy-N-[3-(3-methylpentan-3-yl)-1,2-oxazol-5-yl]benzamide",CCC(C)(CC)C1=NOC(=C1)NC(=O)C2=C(C=CC=C2OC)OC,73672,Positive,In Vivo
"2,6-dimethoxy-N-[3-(3-methylpentan-3-yl)-1,2-oxazol-5-yl]benzamide",CCC(C)(CC)C1=NOC(=C1)NC(=O)C2=C(C=CC=C2OC)OC,73672,Negative,In Vivo
"2,6-dimethyl-1-nitrosopiperidine",CC1CCCC(N1N=O)C,17721-95-8,Negative,in vitro
"2,6-dimethyl-1,4-dinitrosopiperazine",CC1CN(CC(N1N=O)C)N=O,55380-34-2,Positive,in vitro
"2,6-dimethyl-4-nitrosomorpholine",CC1CN(CC(O1)C)N=O,15081,Positive,In Vivo
"2,6-dimethyl-4-nitrosomorpholine",CC1CN(CC(O1)C)N=O,1456-28-6,Positive,in vitro
"2,6-dimethylaniline",CC1=C(C(=CC=C1)C)N,6896,Positive,In Vivo
"2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)aniline",CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],5569,Negative,In Vivo
"2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)aniline",CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],5569,Positive,In Vivo
"2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)aniline",CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],1582-09-08,Positive,in vivo
"2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)aniline",CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],1582-09-08,Negative,in vitro
"2,6-DINITROTOLUENE",CC1=C(C=CC=C1[N+](=O)[O-])[N+](=O)[O-],606-20-2,Negative,In vivo
"2,6-DINITROTOLUENE",CC1=C(C=CC=C1[N+](=O)[O-])[N+](=O)[O-],606-20-2,Positive,In vivo
"2,6-Dinitrotoluene",CC1=C(C=CC=C1[N+](=O)[O-])[N+](=O)[O-],606-20-2,Positive,in vitro
"2,6-ditert-butyl-4-methoxyphenol",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)OC,10269,Negative,In Vivo
"2,6-ditert-butyl-4-methylphenol",CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C,31404,Negative,In Vivo
"2,6-ditert-butyl-4-methylphenol",CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C,128-37-0,Negative,in vivo
"2,6-ditert-butyl-4-methylphenol",CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C,128-37-0,Negative,in vitro
"2,6-Toluene diisocyanate",CC1=C(C=CC=C1N=C=O)N=C=O,91-08-7,Positive,in vitro
"2,6-Xylidine",CC1=C(C(=CC=C1)C)N,87-62-7,Positive,in vitro
"2,7-bis[2-(diethylamino)ethoxy]fluoren-9-one",CCN(CC)CCOC1=CC2=C(C=C1)C3=C(C2=O)C=C(C=C3)OCCN(CC)CC,27591-97-5,Negative,in vitro
"2,7-Diaminofluorene",C1C2=C(C=CC(=C2)N)C3=C1C=C(C=C3)N,525-64-4,Positive,in vitro
"2,7-dichlorodibenzo-p-dioxin",C1=CC2=C(C=C1Cl)OC3=C(O2)C=C(C=C3)Cl,36613,Negative,In Vivo
"2,7-dimethylacridine-3,6-diamine;hydrochloride",CC1=CC2=CC3=C(C=C(C(=C3)C)N)N=C2C=C1N.Cl,135-49-9,Positive,in vitro
"2,7-dinitro-9H-fluorene",C1C2=C(C=CC(=C2)[N+](=O)[O-])C3=C1C=C(C=C3)[N+](=O)[O-],21502,Negative,In Vivo
"2,7-dinitro-9H-fluorene",C1C2=C(C=CC(=C2)[N+](=O)[O-])C3=C1C=C(C=C3)[N+](=O)[O-],21502,Positive,In Vivo
"2,7,12-trimethylbenzo[a]anthracene",CC1=CC2=C(C=C1)C=CC3=C(C4=CC=CC=C4C(=C32)C)C,,Negative,in vitro
"2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-ol",CC1=C(C=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)O,14986,Positive,In Vivo
"2',3'-Dideoxyadenosine",C1CC(OC1CO)N2C=NC3=C(N=CN=C32)N,4097-22-7,Positive,in vitro
"2',3'-Dideoxycytidine",C1CC(OC1CO)N2C=CC(=NC2=O)N,7481-89-2,Positive,in vitro
"2',4',5',7'-tetrabromo-1,1-dioxospiro[2,1lambda6-benzoxathiole-3,9'-xanthene]-3',6'-diol",C1=CC=C2C(=C1)C3(C4=CC(=C(C(=C4OC5=C(C(=C(C=C53)Br)O)Br)Br)O)Br)OS2(=O)=O,,Positive,in vitro
"2',4',5',7'-tetrabromo-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one",C1=CC=C2C(=C1)C(=O)OC23C4=CC(=C(C(=C4OC5=C(C(=C(C=C35)Br)O)Br)Br)O)Br,27020,Negative,In Vivo
"2',4',5',7'-tetrabromo-4,5,6,7-tetrachloro-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one",C1=C2C(=C(C(=C1Br)O)Br)OC3=C(C(=C(C=C3C24C5=C(C(=C(C(=C5Cl)Cl)Cl)Cl)C(=O)O4)Br)O)Br,83511,Negative,In Vivo
"22-oxahexacyclo[12.9.0.03,12.04,9.015,20.021,23]tricosa-1(14),2,4,6,8,10,12,15,17,19-decaene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)C5C(O5)C6=CC=CC=C64,1421-85-8,Positive,in vivo
"22-oxahexacyclo[12.9.0.03,12.04,9.015,20.021,23]tricosa-1(14),2,4,6,8,10,12,15,17,19-decaene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)C5C(O5)C6=CC=CC=C64,1421-85-8,Positive,in vitro
"24R,25-DIHYDROXYVITAMIN D3",CC(CCC(C(C)(C)O)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,55721-11-4,Negative,In vivo
2H-benzotriazole,C1=CC2=NNN=C2C=C1,7220,Negative,In Vivo
2H-furan-5-one,C1C=CC(=O)O1,497-23-4,Negative,in vitro
2H-phthalazin-1-one,C1=CC=C2C(=C1)C=NNC2=O,119-39-1,Positive,in vitro
"2H-triazolo[4,5-d]pyrimidin-7-amine",C1=NC2=NNN=C2C(=N1)N,1123-54-2,Positive,in vitro
"3-(1-methyl-5-nitroimidazol-2-yl)-3a,4,5,6,7,7a-hexahydro-1,2-benzoxazole",CN1C(=CN=C1C2=NOC3C2CCCC3)[N+](=O)[O-],119263,Positive,In Vivo
"3-(1,3-benzothiazol-2-yl)-1-methyl-1-nitrosourea",CN(C(=O)NC1=NC2=CC=CC=C2S1)N=O,51542-33-7,Positive,in vitro
3-(2-chloroethyl)-1-(2-hydroxyethyl)-1-nitrosourea,C(CCl)NC(=O)N(CCO)N=O,124537,Positive,In Vivo
3-(2-chloroethyl)-1-(2-hydroxypropyl)-1-nitrosourea,CC(CN(C(=O)NCCCl)N=O)O,124538,Negative,In Vivo
3-(2-chloroethyl)-1-(2-hydroxypropyl)-1-nitrosourea,CC(CN(C(=O)NCCCl)N=O)O,124538,Positive,In Vivo
3-(2-chloroethyl)-1-nitroso-1-(2-oxopropyl)urea,CC(=O)CN(C(=O)NCCCl)N=O,135720,Negative,In Vivo
3-(2-chloroethyl)-1-nitroso-1-(2-oxopropyl)urea,CC(=O)CN(C(=O)NCCCl)N=O,135720,Positive,In Vivo
"3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine",CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,50-53-3,Negative,in vitro
"3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine;hydrochloride",CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl,69-09-0,Positive,in vitro
3-(2-hydroxyethylamino)-N-oxopropanamide,C(CNCCO)C(=O)N=O,151883,Positive,In Vivo
3-(3-methylsulfonyloxypropylamino)propyl methanesulfonate,CS(=O)(=O)OCCCNCCCOS(=O)(=O)C,13425-98-4,Positive,in vitro
"3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea",CN(C(=O)NC1=CC(=C(C=C1)Cl)Cl)OC,9502,Negative,In Vivo
"3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea",CN(C(=O)NC1=CC(=C(C=C1)Cl)Cl)OC,9502,Positive,In Vivo
"3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea",CN(C(=O)NC1=CC(=C(C=C1)Cl)Cl)OC,330-55-2,Positive,in vitro
"3-(3,4-dichlorophenyl)-1,1-dimethylurea",CN(C)C(=O)NC1=CC(=C(C=C1)Cl)Cl,3120,Negative,In Vivo
"3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYLUREA",CN(C)C(=O)NC1=CC(=C(C=C1)Cl)Cl,330-54-1,Negative,In vivo
"3-(3,4-dichlorophenyl)-1,1-dimethylurea",CN(C)C(=O)NC1=CC(=C(C=C1)Cl)Cl,3120,Positive,In Vivo
"3-(3,4-dichlorophenyl)-1,1-dimethylurea",CN(C)C(=O)NC1=CC(=C(C=C1)Cl)Cl,330-54-1,Negative,in vitro
"3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide",CC(C)NC(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,37517,Positive,In Vivo
"3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide",CC(C)NC(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,37517,Negative,In Vivo
"3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propyl-diethyl-methylazanium;diiodide",CC[N+](C)(CC)CCC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N)N.[I-].[I-],25535-16-4,Positive,in vitro
3-(4-bromophenyl)-1-methoxy-1-methylurea,CN(C(=O)NC1=CC=C(C=C1)Br)OC,3060-89-7,Negative,in vitro
3-(4-bromophenyl)-1-methyl-1-nitrosourea,CN(C(=O)NC1=CC=C(C=C1)Br)N=O,23139-02-08,Positive,in vitro
"3-(4-chlorophenyl)-1-[4-(4,5-dimethoxy-2-methylphenyl)-1,3-thiazol-2-yl]-1-methylurea",CC1=CC(=C(C=C1C2=CSC(=N2)N(C)C(=O)NC3=CC=C(C=C3)Cl)OC)OC,,Positive,in vitro
3-(4-chlorophenyl)-1-methyl-1-nitrosourea,CN(C(=O)NC1=CC=C(C=C1)Cl)N=O,,Positive,in vitro
"3-(4-chlorophenyl)-1,1-dimethylurea",CN(C)C(=O)NC1=CC=C(C=C1)Cl,8800,Negative,In Vivo
"3-(4-chlorophenyl)-1,1-dimethylurea",CN(C)C(=O)NC1=CC=C(C=C1)Cl,150-68-5,Positive,in vivo
"3-(4-chlorophenyl)-1,1-dimethylurea",CN(C)C(=O)NC1=CC=C(C=C1)Cl,8800,Positive,In Vivo
"3-(4-chlorophenyl)-1,1-dimethylurea",CN(C)C(=O)NC1=CC=C(C=C1)Cl,150-68-5,Negative,in vitro
3-(4-fluorophenyl)-1-methyl-1-nitrosourea,CN(C(=O)NC1=CC=C(C=C1)F)N=O,,Positive,in vitro
3-(4-methylanilino)benzo[b]phenalen-7-one,CC1=CC=C(C=C1)NC2=C3C=CC=C4C3=C(C=C2)C5=CC=CC=C5C4=O,,Positive,in vitro
"3-(5-NITRO-2-FURYL)-IMIDAZO(1,2-alpha)PYRIDINE",C1=CC2=NC=C(N2C=C1)C3=CC=C(O3)[N+](=O)[O-],75198-31-1,Negative,In vivo
"3-(5-NITRO-2-FURYL)-IMIDAZO(1,2-alpha)PYRIDINE",C1=CC2=NC=C(N2C=C1)C3=CC=C(O3)[N+](=O)[O-],75198-31-1,Positive,In vivo
3-(5-nitrofuran-2-yl)-2-phenylprop-2-enamide,C1=CC=C(C=C1)C(=CC2=CC=C(O2)[N+](=O)[O-])C(=O)N,,Positive,in vitro
"3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine",CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,50-49-7,Negative,in vivo
"3-(aziridin-1-yl)-2,4-diaza-3lambda5-phosphatricyclo[7.3.1.05,13]tridecane 3-oxide",C1CC2CCCC3C2C(C1)NP(=O)(N3)N4CC4,,Positive,in vitro
3-(aziridin-1-yl)propan-1-amine,C1CN1CCCN,1072-65-7,Positive,in vitro
3-(aziridin-1-yl)propanenitrile,C1CN1CCC#N,1072-66-8,Positive,in vitro
3-(Chloromethyl)pyridine HCl,C1=CC(=CN=C1)CCl.Cl,6959-48-4,Positive,in vitro
3-(chloromethyl)pyridine;hydrochloride,C1=CC(=CN=C1)CCl.Cl,23394,Positive,In Vivo
3-(chloromethyl)pyridine;hydrochloride,C1=CC(=CN=C1)CCl.Cl,6959-48-4,Positive,in vivo
3-(chloromethyl)pyridine;hydrochloride,C1=CC(=CN=C1)CCl.Cl,6959-48-4,Negative,in vitro
"3-(CYCLOPENTYLOXY)-N-(3,5-DICHLORO-4-PYRIDYL)-4-METHOXYBENZAMIDE",COC1=C(C=C(C=C1)C(=O)NC2=C(C=NC=C2Cl)Cl)OC3CCCC3,144035-83-6,Positive,In vivo
"3-(dimethoxyphosphinothioylsulfanylmethyl)-1,2,3-benzotriazin-4-one",COP(=S)(OC)SCN1C(=O)C2=CC=CC=C2N=N1,2268,Negative,In Vivo
"3-(dimethoxyphosphinothioylsulfanylmethyl)-1,2,3-benzotriazin-4-one",COP(=S)(OC)SCN1C(=O)C2=CC=CC=C2N=N1,86-50-0,Negative,in vitro
"3-(dimethoxyphosphinothioylsulfanylmethyl)-5-methoxy-1,3,4-thiadiazol-2-one",COC1=NN(C(=O)S1)CSP(=S)(OC)OC,13709,Negative,In Vivo
"3-(dimethoxyphosphinothioylsulfanylmethyl)-5-methoxy-1,3,4-thiadiazol-2-one",COC1=NN(C(=O)S1)CSP(=S)(OC)OC,950-37-8,Positive,in vitro
3-(dimethylaminodiazenyl)phenol,CN(C)N=NC1=CC(=CC=C1)O,,Positive,in vitro
"3-(HEXAHYDRO-4,7-METHANOINDAN-5-YL)-1,1-DIMETHYLUREA",CN(C)C(=O)NC1CC2CC1C3C2CCC3,2163-79-3,Negative,In vivo
3-(oxiran-2-yl)-7-oxabicyclo[4.1.0]heptane,C1CC2C(O2)CC1C3CO3,7833,Positive,In Vivo
3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride,CNC[C@@H](C1=CC(=CC=C1)O)O.Cl,5284443,Negative,In Vivo
"3-[(2S,3R,4R,5R)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one",C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@H](O4)[C@@H](CO)O)O)O)O)O,5484006,Negative,In Vivo
3-[(2S)-1-methylpyrrolidin-2-yl]pyridine,CN1CCC[C@H]1C2=CN=CC=C2,89594,Negative,In Vivo
3-[(2S)-1-methylpyrrolidin-2-yl]pyridine,CN1CCC[C@H]1C2=CN=CC=C2,54-11-5,Negative,in vitro
"3-[(2S)-1-nitroso-3,6-dihydro-2H-pyridin-2-yl]pyridine",C1C=CCN([C@@H]1C2=CN=CC=C2)N=O,51291,Negative,In Vivo
3-[(2S)-1-nitrosopiperidin-2-yl]pyridine,C1CCN([C@@H](C1)C2=CN=CC=C2)N=O,7069270,Positive,In Vivo
3-[(2S)-1-nitrosopyrrolidin-2-yl]pyridine,C1C[C@H](N(C1)N=O)C2=CN=CC=C2,12613538,Positive,In Vivo
3-[(2S)-1-nitrosopyrrolidin-2-yl]pyridine,C1C[C@H](N(C1)N=O)C2=CN=CC=C2,12613538,Negative,In Vivo
3-[(2S)-1-nitrosopyrrolidin-2-yl]pyridine,C1C[C@H](N(C1)N=O)C2=CN=CC=C2,16543-55-8,Positive,in vivo
3-[(2S)-1-nitrosopyrrolidin-2-yl]pyridine,C1C[C@H](N(C1)N=O)C2=CN=CC=C2,16543-55-8,Positive,in vitro
"3-[(2S)-1,2,3,6-tetrahydropyridin-2-yl]pyridine",C1C=CCN[C@@H]1C2=CN=CC=C2,581-49-7,Positive,in vitro
3-[(2S)-pyrrolidin-2-yl]pyridine,C1C[C@H](NC1)C2=CN=CC=C2,494-97-3,Positive,in vitro
"3-[(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one",C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],67-45-8,Negative,in vitro
"3-[(E)-(1-methyl-5-nitroimidazol-2-yl)methylideneamino]-5-(morpholin-4-ylmethyl)-1,3-oxazolidin-2-one",CN1C(=CN=C1/C=N/N2CC(OC2=O)CN3CCOCC3)[N+](=O)[O-],52279-59-1,Positive,in vivo
"3-[(E)-(1-methyl-5-nitroimidazol-2-yl)methylideneamino]-5-(morpholin-4-ylmethyl)-1,3-oxazolidin-2-one;hydrochloride",CN1C(=CN=C1/C=N/N2CC(OC2=O)CN3CCOCC3)[N+](=O)[O-].Cl,30185-92-3,Negative,in vitro
"3-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-1,2,4-oxadiazol-5-amine",C1=C(OC(=C1)[N+](=O)[O-])/C=C/C2=NOC(=N2)N,5284340,Positive,In Vivo
"3-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-1,2,4-oxadiazol-5-amine",C1=C(OC(=C1)[N+](=O)[O-])/C=C/C2=NOC(=N2)N,28754-68-9,Positive,in vitro
3-[(trimethylazaniumyl)amino]propanoate,C[N+](C)(C)NCCC(=O)[O-],123868,Negative,In Vivo
"3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[3-[4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium",CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,,Positive,in vivo
"3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[3-[4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium",CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,,Negative,in vitro
"3-[[2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium;hydrogen sulfate",CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.OS(=O)(=O)[O-],72466,Positive,In Vivo
"3-[[2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium;hydrogen sulfate",CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.OS(=O)(=O)[O-],,Positive,in vitro
3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid,CC1=C(NC(=C1CCC(=O)O)CC2=C(C(=C(N2)/C=C\3/C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)/C=C\4/C(=C(C(=O)N4)C=C)C,635-65-4,Negative,in vitro
"3-[3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea;hydrochloride",CCN(CC)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C)O)C(=O)C.Cl,42373,Negative,In Vivo
"3-[4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazin-1-yl]propyl decanoate",CCCCCCCCCC(=O)OCCCN1CCN(CC1)C2CC3=CC=CC=C3SC4=C2C=C(C=C4)SC,41931-86-6,Negative,in vivo
"3-[4-(4-chlorophenoxy)phenyl]-1,1-dimethylurea",CN(C)C(=O)NC1=CC=C(C=C1)OC2=CC=C(C=C2)Cl,1982-47-4,Negative,in vitro
3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,C1=CC(=CC=C1CCC(=O)O)N(CCCl)CCCl,6746-11-8,Positive,in vitro
3-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxypropanoic acid,C(COP(=O)(N)N(CCCl)CCCl)C(=O)O,22788-18-7,Positive,in vitro
3-[bis(2-chloroethyl)amino]-4-methylbenzoic acid,CC1=C(C=C(C=C1)C(=O)O)N(CCCl)CCCl,5977-35-5,Positive,in vitro
"3-[butan-2-ylsulfanyl(ethoxy)phosphoryl]-1,3-thiazolidin-2-one",CCC(C)SP(=O)(N1CCSC1=O)OCC,91758,Negative,In Vivo
3-[butyl(nitroso)amino]propanoic acid,CCCCN(CCC(=O)O)N=O,,Positive,in vitro
3-[methyl(nitroso)amino]propanoic acid,CN(CCC(=O)O)N=O,151519,Positive,In Vivo
"3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol;methanesulfonic acid",CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O,91430,Positive,In Vivo
3-3'-Dibromobenzidine,C1=CC(=C(C=C1C2=CC(=C(C=C2)N)Br)Br)N,34237-98-4,Positive,in vitro
3-3'-Dibromomethoxybenzidine,COC(=O)C1=C(C=CC(=C1)C2=CC(=C(C=C2)N)C(=O)OC)N,15403-45-9,Positive,in vitro
3-3'-Difluorobenzidine,C1=CC(=C(C=C1C2=CC(=C(C=C2)N)F)F)N,448-97-5,Positive,in vitro
"3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol",CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,13087-53-1,Positive,in vitro
"3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodo-N-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]benzamide",CC(=O)NC1=C(C(=C(C(=C1I)C(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O)I)N(C)C(=O)C)I,20056604,Positive,In Vivo
3-acetyl-4-ethenyl-5-methyloxolan-2-one,CC1C(C(C(=O)O1)C(=O)C)C=C,3251-21-6,Positive,in vitro
"3-ACETYL-6-METHYL-2,4-PYRANDIONE",CC1=CC(=O)C(C(=O)O1)C(=O)C,520-45-6,Negative,In vivo
"3-Amino-1-methyl-5h-pyrido(4,3-b)indole (Trp-P-2 - free base and acetate salt)",CC1=C2C(=C(N=C1N)C)C3=CC=CC=C3N2,62450-06-0,Positive,in vitro
"3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole acetate 
(Trp-P-1 acetate)",CC1=C2C(=C(N=C1N)C)C3=CC=CC=C3N2.CC(=O)O,68808-54-8,Positive,in vitro
"3-amino-2,5-dichlorobenzoic acid",C1=C(C=C(C(=C1C(=O)O)Cl)N)Cl,8630,Positive,In Vivo
"3-amino-2,5-dichlorobenzoic acid",C1=C(C=C(C(=C1C(=O)O)Cl)N)Cl,8630,Negative,In Vivo
"3-AMINO-4-[2-[(2-GUANIDINOTHIAZOL-4-YL)METHYLTHIO], ETHYLAMINO]-1,2,5-THIADIAZOLE",C1=C(N=C(S1)N=C(N)N)CSCCNC2=NSN=C2N,---,Positive,In vivo
3-Amino-4-ethoxyacetanilide,CCOC1=C(C=C(C=C1)NC(=O)C)N,17026-81-2,Negative,in vitro
3-Amino-9-ethyl carbazole (free base + HCl salt),CCN1C2=C(C=C(C=C2)N)C3=CC=CC=C31.Cl,6109-97-3,Negative,in vitro
3-aminobenzamide,C1=CC(=CC(=C1)N)C(=O)N,3544-24-9,Positive,in vitro
3-aminophenol,C1=CC(=CC(=C1)O)N,591-27-5,Negative,in vitro
3-Aminophenol/ m-aminophenol /Cl 76545 COLIPA A015,C1=CC(=CC(=C1)O)N,591-27-5,Positive,in vitro
3-aminopropanenitrile,C(CN)C#N,151-18-8,Positive,in vivo
3-AMINOTRIAZOLE,C1=NNC(=N1)N,61-82-5,Negative,In vivo
3-AMINOTRIAZOLE,C1=NNC(=N1)N,61-82-5,Positive,In vivo
"3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione",CC1(C(=O)N(C(=O)O1)NC2=CC=CC=C2)C3=CC=C(C=C3)OC4=CC=CC=C4,213032,Negative,In Vivo
3-BENZYLSYDNONE-4-ACETAMIDE,C1=CC=C(C=C1)C[N+]2=NOC(=C2CC(=O)N)[O-],14504-15-5,Positive,In vivo
3-BENZYLSYDNONE-4-ACETAMIDE,C1=CC=C(C=C1)C[N+]2=NOC(=C2CC(=O)N)[O-],14504-15-5,Negative,In vivo
3-carbamoyl-1-methyl-1-nitrosourea,CN(C(=O)NC(=O)N)N=O,13860-69-0,Positive,in vitro
3-chloro-1-nitrosopiperidine,C1CC(CN(C1)N=O)Cl,65445-60-5,Positive,in vitro
3-chloro-2-methylprop-1-ene,CC(=C)CCl,11241,Negative,In Vivo
3-chloro-2-methylprop-1-ene,CC(=C)CCl,11241,Positive,In Vivo
3-CHLORO-2-METHYLPROPENE,CC(=C)CCl,563-47-3,Positive,In vivo
3-Chloro-2-methylpropene,CC(=C)CCl,563-47-3,Positive,in vitro
3-CHLORO-4-(DICHLOROMETHYL)-5-HYDROXY-2(5H)-FURANONE,C1(C(=C(C(=O)O1)Cl)C(Cl)Cl)O,77439-76-0,Positive,In vivo
3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (AKA MX),C1(C(=C(C(=O)O1)Cl)C(Cl)Cl)O,77439-76-0,Positive,in vitro
3-chloro-4-methylaniline,CC1=C(C=C(C=C1)N)Cl,7255,Negative,In Vivo
3-chloro-4-methylaniline,CC1=C(C=C(C=C1)N)Cl,95-74-9,Negative,in vivo
3-chloro-7-diethoxyphosphinothioyloxy-4-methylchromen-2-one,CCOP(=S)(OCC)OC1=CC2=C(C=C1)C(=C(C(=O)O2)Cl)C,2871,Negative,In Vivo
3-chloro-7-diethoxyphosphinothioyloxy-4-methylchromen-2-one,CCOP(=S)(OCC)OC1=CC2=C(C=C1)C(=C(C(=O)O2)Cl)C,56-72-4,Negative,in vivo
3-chloroaniline,C1=CC(=CC(=C1)Cl)N,108-42-9,Negative,in vivo
3-chloroprop-1-ene,C=CCCl,7850,Negative,In Vivo
3-chloroprop-1-ene,C=CCCl,0107-05-01,Positive,in vitro
"3-chloropropane-1,2-diol",C(C(CCl)O)O,7290,Positive,In Vivo
"3-chloropropane-1,2-diol",C(C(CCl)O)O,96-24-2,Negative,in vivo
3-cyano-1-methyl-2-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]-1-nitrosoguanidine,CC1=C(N=CN1)CSCCN=C(NC#N)N(C)N=O,52445,Negative,In Vivo
3-cyano-1-methyl-2-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]-1-nitrosoguanidine,CC1=C(N=CN1)CSCCN=C(NC#N)N(C)N=O,73785-40-7,Positive,in vitro
"3-cyclohexyl-6-(dimethylamino)-1-methyl-1,3,5-triazine-2,4-dione",CN1C(=NC(=O)N(C1=O)C2CCCCC2)N(C)C,39965,Negative,In Vivo
"3-cyclopentyloxy-N-(3,5-dichloropyridin-4-yl)-4-methoxybenzamide",COC1=C(C=C(C=C1)C(=O)NC2=C(C=NC=C2Cl)Cl)OC3CCCC3,154575,Positive,In Vivo
3-DIAZOTYRAMINE.HCl,C1=CC(=C(C=C1CCN)[N+]#N)[O-].Cl,---,Positive,In vivo
3-DIBENZOFURANAMINE,C1=CC=C2C(=C1)C3=C(O2)C=C(C=C3)N,4106-66-5,Positive,In vivo
3-ethenylpyridine,C=CC1=CN=CC=C1,14272,Negative,In Vivo
3-ethyl-1-(2-hydroxyethyl)-1-nitrosourea,CCNC(=O)N(CCO)N=O,124536,Positive,In Vivo
3-ethyl-1-methyl-1-nitrosourea,CCNC(=O)N(C)N=O,149482,Positive,In Vivo
"3-ethyl-3-phenylpiperidine-2,6-dione",CCC1(CCC(=O)NC1=O)C2=CC=CC=C2,77-21-4,Negative,in vitro
"3-hydroxy-2-(5-nitrofuran-2-yl)-1,2-dihydroquinazolin-4-one",C1=CC=C2C(=C1)C(=O)N(C(N2)C3=CC=C(O3)[N+](=O)[O-])O,98754-77-9,Negative,in vitro
3-hydroxy-2-methylpyran-4-one,CC1=C(C(=O)C=CO1)O,118-71-8,Positive,in vitro
3-hydroxy-4-[(2-methoxy-5-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide,COC1=C(C=C(C=C1)[N+](=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC(=CC=C4)[N+](=O)[O-])O,22979,Negative,In Vivo
3-HYDROXY-4-ACETYLAMINOBIPHENYL,CC(=O)NC1=C(C=C(C=C1)C2=CC=CC=C2)O,4463-22-3,Negative,In vivo
3-HYDROXY-4-AMINOBIPHENYL,C1=CC=C(C=C1)C2=CC(=C(C=C2)N)O,4363-03-5,Negative,In vivo
"3-hydroxy-7H-purine-2,6-dione",C1=NC2=C(N1)C(=O)NC(=O)N2O,83520,Positive,In Vivo
3-HYDROXY-p-BUTYROPHENETIDIDE,CCOC1=CC=C(C=C1)NC(=O)CC(C)O,1083-57-4,Positive,In vivo
3-hydroxybenzo[b]phenalen-7-one,C1=CC=C2C(=C1)C3=C4C(=C(C=C3)O)C=CC=C4C2=O,,Positive,in vitro
"3-hydroxycyclobut-3-ene-1,2-dione",C1=C(C(=O)C1=O)O,31876-38-7,Negative,in vitro
3-iodoprop-2-ynyl N-butylcarbamate,CCCCNC(=O)OCC#CI,62097,Negative,In Vivo
3-isothiocyanatoprop-1-ene,C=CCN=C=S,5971,Negative,In Vivo
3-isothiocyanatoprop-1-ene,C=CCN=C=S,5971,Positive,In Vivo
3-isothiocyanatoprop-1-ene,C=CCN=C=S,57-06-7,Negative,in vitro
3-methoxy-17-methyl-15H-cyclopenta[a]phenanthrene,CC1=CCC2=C1C=CC3=C2C=CC4=C3C=CC(=C4)OC,5831-08-03,Positive,in vitro
3-METHOXY-4-AMINOAZOBENZENE,COC1=C(C=CC(=C1)N=NC2=CC=CC=C2)N,3544-23-8,Negative,In vivo
3-METHOXY-4-AMINOAZOBENZENE,COC1=C(C=CC(=C1)N=NC2=CC=CC=C2)N,3544-23-8,Positive,In vivo
3-Methoxy-4-aminoazobenzene,COC1=C(C=CC(=C1)N=NC2=CC=CC=C2)N,3544-23-8,Positive,in vitro
3-methoxybenzo[b]phenalen-7-one,COC1=C2C=CC=C3C2=C(C=C1)C4=CC=CC=C4C3=O,3688-79-7,Positive,in vitro
3-METHOXYCATECHOL,COC1=CC=CC(=C1O)O,934-00-9,Positive,In vivo
3-methyl-1-nitrosopiperidin-4-one,CC1CN(CCC1=O)N=O,123017,Positive,In Vivo
3-methyl-1-nitrosopiperidine,CC1CCCN(C1)N=O,13603-07-01,Positive,in vivo
3-methyl-1-nitrosopiperidine,CC1CCCN(C1)N=O,13603-07-01,Positive,in vitro
"3-methyl-1,2-dihydrobenzo[j]aceanthrylen-1-ol",CC1=C2CC(C3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1)O,,Positive,in vivo
"3-methyl-1,2-dihydrobenzo[j]aceanthrylen-1-ol",CC1=C2CC(C3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1)O,18759,Positive,In Vivo
"3-methyl-1,2-dihydrobenzo[j]aceanthrylen-1-ol",CC1=C2CC(C3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1)O,,Positive,in vitro
"3-methyl-1,2-dihydrobenzo[j]aceanthrylen-11-ol",CC1=C2CCC3=C2C(=CC4=C3C=C(C5=CC=CC=C54)O)C=C1,,Positive,in vitro
"3-methyl-1,2-dihydrobenzo[j]aceanthrylen-2-ol",CC1=C2C(CC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1)O,,Positive,in vivo
"3-methyl-1,2-dihydrobenzo[j]aceanthrylen-2-ol",CC1=C2C(CC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1)O,,Positive,in vitro
"3-methyl-1,2-dihydrobenzo[j]aceanthrylene",CC1=C2CCC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,1674,Negative,In Vivo
"3-methyl-1,2-dihydrobenzo[j]aceanthrylene",CC1=C2CCC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,1674,Positive,In Vivo
"3-methyl-1,2-dihydrobenzo[j]aceanthrylene",CC1=C2CCC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,56-49-5,Positive,in vivo
"3-methyl-1,2-dihydrobenzo[j]aceanthrylene",CC1=C2CCC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,56-49-5,Negative,in vitro
"3-methyl-1,2-dihydrobenzo[j]aceanthrylene-1,2-diol",CC1=C2C(C(C3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1)O)O,15544-91-9,Positive,in vitro
"3-methyl-1,2,4,5-tetrahydrobenzo[j]aceanthrylene-4,5-diol",CC1=C2CCC3=C4C=CC5=CC=CC=C5C4=CC(=C23)C(C1O)O,3343-04-02,Positive,in vivo
"3-methyl-1,2,4,5-tetrahydrobenzo[j]aceanthrylene-4,5-diol",CC1=C2CCC3=C4C=CC5=CC=CC=C5C4=CC(=C23)C(C1O)O,3343-04-02,Negative,in vitro
"3-methyl-1,2,9,10-tetrahydrobenzo[j]aceanthrylene-9,10-diol",CC1=C2CCC3=C2C(=CC4=C3C=CC5=C4C=CC(C5O)O)C=C1,67481-32-7,Positive,in vivo
"3-methyl-1,2,9,10-tetrahydrobenzo[j]aceanthrylene-9,10-diol",CC1=C2CCC3=C2C(=CC4=C3C=CC5=C4C=CC(C5O)O)C=C1,67481-32-7,Positive,in vitro
3-methyl-1H-benzo[j]aceanthrylen-2-one,CC1=C2C(=O)CC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,,Positive,in vivo
3-methyl-1H-benzo[j]aceanthrylen-2-one,CC1=C2C(=O)CC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,,Positive,in vitro
3-methyl-2H-benzo[j]aceanthrylen-1-one,CC1=C2CC(=O)C3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,,Positive,in vitro
3-methyl-4-nitrophenol,CC1=C(C=CC(=C1)O)[N+](=O)[O-],2581-34-2,Positive,in vitro
3-Methyl-4-nitroquinoline-N-oxide,CC1=C(C2=CC=CC=C2[N+](=C1)[O-])[N+](=O)[O-],14073-00-8,Positive,in vitro
3-methyl-4-nitroso-2-phenylmorpholine,CC1C(OCCN1N=O)C2=CC=CC=C2,34993-08-03,Negative,in vitro
3-methyl-4-nitrosomorpholine,CC1COCCN1N=O,92394,Positive,In Vivo
"3-methyl-9H-pyrido[2,3-b]indol-2-amine",CC1=CC2=C(NC3=CC=CC=C32)N=C1N,62244,Positive,In Vivo
3-methylbenzo[a]anthracene,CC1=CC2=C(C=C1)C3=CC4=CC=CC=C4C=C3C=C2,2498-75-1,Negative,in vitro
3-methylbenzo[a]pyrene,CC1=C2C=CC3=CC4=CC=CC=C4C5=C3C2=C(C=C1)C=C5,16757-81-6,Positive,in vitro
3-methylbenzo[j]aceanthrylene,CC1=C2C=CC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,18761,Positive,In Vivo
3-methylbutanal,CC(C)CC=O,590-86-3,Positive,in vitro
3-METHYLBUTANAL METHYLFORMYLHYDRAZONE,CC(C)CC=NN(C)C=O,57590-21-3,Positive,In vivo
3-METHYLCHOLANTHRENE,CC1=C2CCC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,56-49-5,Negative,In vivo
3-METHYLCHOLANTHRENE,CC1=C2CCC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,56-49-5,Positive,In vivo
3-Methylcholanthrene,CC1=C2CCC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,56-49-5,Positive,in vitro
3-methylchromen-2-one,CC1=CC2=CC=CC=C2OC1=O,2445-82-1,Positive,in vitro
3-methylchrysene,CC1=CC2=C(C=C1)C=CC3=C2C=CC4=CC=CC=C43,3351-31-3,Positive,in vitro
3-methylfluoranthene,CC1=C2C=CC=C3C2=C(C=C1)C4=CC=CC=C43,15565,Negative,In Vivo
3-methylfluoranthene,CC1=C2C=CC=C3C2=C(C=C1)C4=CC=CC=C43,15565,Positive,In Vivo
"3-methylimidazo[4,5-f]quinolin-2-amine",CN1C2=C(C3=C(C=C2)N=CC=C3)N=C1N,53462,Positive,In Vivo
"3-methylimidazo[4,5-f]quinolin-2-amine",CN1C2=C(C3=C(C=C2)N=CC=C3)N=C1N,53462,Negative,In Vivo
"3-methylimidazo[4,5-f]quinolin-2-amine",CN1C2=C(C3=C(C=C2)N=CC=C3)N=C1N,76180-96-6,Positive,in vivo
"3-methylimidazo[4,5-f]quinolin-2-amine",CN1C2=C(C3=C(C=C2)N=CC=C3)N=C1N,76180-96-6,Negative,in vitro
"3-methyloxathiolane 2,2-dioxide",CC1CCOS1(=O)=O,1121-03-05,Positive,in vitro
3-methylphenol,CC1=CC(=CC=C1)O,108-39-4,Positive,in vitro
3-methylquinoline,CC1=CC2=CC=CC=C2N=C1,612-58-8,Positive,in vitro
3-methylsulfonyloxypropyl methanesulfonate,CS(=O)(=O)OCCCOS(=O)(=O)C,15886-84-7,Positive,in vivo
3-methylsulfonyloxypropyl methanesulfonate,CS(=O)(=O)OCCCOS(=O)(=O)C,15886-84-7,Positive,in vitro
"3-N,3-N,6-N,6-N-tetramethylacridine-3,6-diamine;hydrochloride",CN(C)C1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)N(C)C.Cl,65-61-2,Positive,in vivo
"3-N,3-N,6-N,6-N-tetramethylacridine-3,6-diamine;hydrochloride",CN(C)C1=CC2=C(C=C1)C=C3C=CC(=CC3=N2)N(C)C.Cl,65-61-2,Positive,in vitro
3-nitro-1H-pyridin-2-one,C1=CNC(=O)C(=C1)[N+](=O)[O-],6332-56-5,Positive,in vitro
"3-nitro-2-oxatricyclo[7.3.1.05,13]trideca-1(12),3,5,7,9(13),10-hexaene",C1=CC2=C3C(=C1)C=C(OC3=CC=C2)[N+](=O)[O-],59909,Positive,In Vivo
3-NITRO-3-HEXENE,CCC=C(CC)[N+](=O)[O-],4812-22-0,Positive,In vivo
3-NITRO-4-HYDROXYPHENYLARSONIC ACID,C1=CC(=C(C=C1[As](=O)(O)O)[N+](=O)[O-])O,121-19-7,Negative,In vivo
3-Nitro-p-acetophenetide,CCOC1=C(C=C(C=C1)NC(=O)C)[N+](=O)[O-],1777-84-0,Negative,in vitro
3-Nitrobenzanthrone,C1=CC=C2C(=C1)C3=C4C(=C(C=C3)[N+](=O)[O-])C=CC=C4C2=O,17117-34-9,Positive,in vitro
3-nitrobenzidine,C1=CC(=CC=C1C2=CC(=C(C=C2)N)[N+](=O)[O-])N,61841-39-2,Positive,in vitro
3-nitrobenzo[a]pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C(C=CC(=C54)C=C3)[N+](=O)[O-],50961,Negative,In Vivo
3-nitrobenzo[a]pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C(C=CC(=C54)C=C3)[N+](=O)[O-],70021-98-6,Positive,in vitro
3-nitrobenzo[b]phenalen-7-one,C1=CC=C2C(=C1)C3=C4C(=C(C=C3)[N+](=O)[O-])C=CC=C4C2=O,2825690,Positive,In Vivo
3-nitrobenzo[e]pyrene,C1=CC=C2C(=C1)C3=C4C(=C(C=C3)[N+](=O)[O-])C=CC5=C4C2=CC=C5,149804,Negative,In Vivo
3-nitrobenzoic acid,C1=CC(=CC(=C1)[N+](=O)[O-])C(=O)O,121-92-6,Positive,in vitro
3-nitrochrysene,C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3C=C(C=C4)[N+](=O)[O-],151998,Negative,In Vivo
3-nitrofluoranthene,C1=CC=C2C(=C1)C3=C4C2=CC=CC4=C(C=C3)[N+](=O)[O-],13462,Negative,In Vivo
3-nitrofluoranthene,C1=CC=C2C(=C1)C3=C4C2=CC=CC4=C(C=C3)[N+](=O)[O-],13462,Positive,In Vivo
3-nitropentane,CCC(CC)[N+](=O)[O-],12333,Positive,In Vivo
3-NITROPENTANE,CCC(CC)[N+](=O)[O-],551-88-2,Positive,In vivo
3-nitroperylene,C1=CC2=C3C(=C1)C4=C5C(=CC=C4)C(=CC=C5C3=CC=C2)[N+](=O)[O-],20589-63-3,Positive,in vitro
3-nitrophenol,C1=CC(=CC(=C1)O)[N+](=O)[O-],554-84-7,Negative,in vitro
3-nitropropanoic acid,C(C[N+](=O)[O-])C(=O)O,1678,Negative,In Vivo
3-nitropropanoic acid,C(C[N+](=O)[O-])C(=O)O,504-88-1,Negative,in vivo
3-nitropropanoic acid,C(C[N+](=O)[O-])C(=O)O,504-88-1,Positive,in vitro
3-Nitroproprionic acid,C(C[N+](=O)[O-])C(=O)O,504-88-1,Positive,in vitro
3-nitropyren-1-ol,C1=CC2=C3C(=C1)C=CC4=C(C=C(C(=C43)C=C2)[N+](=O)[O-])O,104936,Negative,In Vivo
3-nitroquinoline,C1=CC=C2C(=C1)C=C(C=N2)[N+](=O)[O-],17576-53-3,Negative,in vitro
"3-nitroso-1,3-oxazinane",C1CN(COC1)N=O,93185,Positive,In Vivo
"3-nitroso-1,3-oxazolidin-2-one",C1COC(=O)N1N=O,148247,Positive,In Vivo
"3-nitroso-1,3-oxazolidine",C1COCN1N=O,114957,Positive,In Vivo
3-NITROSO-2-OXAZOLIDINONE,C1COC(=O)N1N=O,38347-74-9,Positive,In vivo
3-NITROSOMETHYLAMINOPYRIDINE,CN(C1=CN=CC=C1)N=O,69658-91-9,Negative,In vivo
"3-oxa-12-azapentacyclo[9.8.0.02,4.05,10.013,18]nonadeca-1(19),2(4),5,7,9,11,13,15,17-nonaene",C1=CC=C2C(=C1)C=C3C4=C(O4)C5=CC=CC=C5C3=N2,150767,Negative,In Vivo
"3-oxa-12-azapentacyclo[9.8.0.02,4.05,10.013,18]nonadeca-1(19),2(4),5,7,9,11,13,15,17-nonaene",C1=CC=C2C(=C1)C=C3C4=C(O4)C5=CC=CC=C5C3=N2,150767,Positive,In Vivo
"3-oxa-9-azatetracyclo[9.4.0.02,4.05,10]pentadeca-1(15),2(4),5(10),6,8,11,13-heptaene",C1=CC=C2C(=C1)C3=C(C=CC=N3)C4=C2O4,149858,Negative,In Vivo
"3-oxahexacyclo[13.8.0.02,4.05,14.06,11.018,23]tricosa-1,4,6(11),7,9,12,14,16,18,20,22-undecaene-7,8-diol",C1=CC=C2C(=C1)C=CC3=C4C=CC5=C(C4=C6C(=C32)O6)C(=C(C=C5)O)O,154430,Positive,In Vivo
"3-oxapentacyclo[9.8.0.02,4.05,10.013,18]nonadeca-1(19),5,7,9,11,13,15,17-octaen-19-ylmethanol",C1=CC=C2C(=C1)C=C3C4=CC=CC=C4C5C(C3=C2CO)O5,38554-81-3,Positive,in vitro
"3-oxapentacyclo[9.8.0.02,4.05,10.014,19]nonadeca-1(11),5,7,9,12,14,16,18-octaene",C1=CC=C2C(=C1)C=CC3=C2C4C(O4)C5=CC=CC=C35,15131-84-7,Negative,in vitro
"3-phenyldiazenylpyridine-2,6-diamine;hydrochloride",C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N.Cl,8691,Positive,In Vivo
"3-phenyldiazenylpyridine-2,6-diamine;hydrochloride",C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N.Cl,136-40-3,Positive,in vivo
"3,3-bis(4-hydroxy-3-methylphenyl)-2-benzofuran-1-one",CC1=C(C=CC(=C1)C2(C3=CC=CC=C3C(=O)O2)C4=CC(=C(C=C4)O)C)O,596-27-0,Positive,in vitro
"3,3-bis(4-hydroxyphenyl)-2-benzofuran-1-one",C1=CC=C2C(=C1)C(=O)OC2(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O,4764,Positive,In Vivo
"3,3-bis(4-hydroxyphenyl)-2-benzofuran-1-one",C1=CC=C2C(=C1)C(=O)OC2(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O,77-09-8,Negative,in vitro
"3,3-diethoxyprop-1-ene",CCOC(C=C)OCC,62477,Negative,In Vivo
"3,3-dimethyloxetan-2-one",CC1(COC1=O)C,16059,Negative,In Vivo
"3,3-dimethyloxetan-2-one",CC1(COC1=O)C,16059,Positive,In Vivo
"3,3,3-Trichloropropylene oxide",C1C(O1)C(Cl)(Cl)Cl,3083-23-6,Positive,in vitro
"3,3'-Diaminobenzidine",C1=CC(=C(C=C1C2=CC(=C(C=C2)N)N)N)N,91-95-2,Positive,in vitro
"3,3'-DICHLOROBENZIDINE",C1=CC(=C(C=C1C2=CC(=C(C=C2)N)Cl)Cl)N,91-94-1,Positive,In vivo
"3,3'-DICHLOROBENZIDINE",C1=CC(=C(C=C1C2=CC(=C(C=C2)N)Cl)Cl)N,91-94-1,Negative,In vivo
"3,3'-Dichlorobenzidine",C1=CC(=C(C=C1C2=CC(=C(C=C2)N)Cl)Cl)N,91-94-1,Positive,in vitro
"3,3'-DICHLOROBENZIDINE.2HCl",C1=CC(=C(C=C1C2=CC(=C(C=C2)N)Cl)Cl)N.Cl.Cl,612-83-9,Positive,In vivo
"3,3'-DIHYDROXYBENZIDINE.2HCl",C1=CC(=C(C=C1C2=CC(=C(C=C2)N)O)O)N.Cl.Cl,1592-36-5,Positive,In vivo
"3,3'-Dimethoxybenzidine (free base and 2HCl salt) / o-dianisidine",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)OC)N,119-90-4,Positive,in vitro
"3,3'-Dimethoxybenzidine-4,4'-diisocyante",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=C=O)OC)N=C=O,91-93-0,Positive,in vitro
"3,3'-DIMETHOXYBENZIDINE.2HCl",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)OC)N.Cl.Cl,20325-40-0,Negative,In vivo
"3,3'-DIMETHOXYBENZIDINE.2HCl",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)OC)N.Cl.Cl,20325-40-0,Positive,In vivo
"3,3'-Dimethylbenzidine (free base and 2HCl salt)",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)C)N,119-93-7,Positive,in vitro
"3,3'-DIMETHYLBENZIDINE.2HCl",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)C)N.Cl.Cl,612-82-8,Positive,In vivo
"3,3'-Dinitrobenzidine",C1=CC(=C(C=C1C2=CC(=C(C=C2)N)[N+](=O)[O-])[N+](=O)[O-])N,6271-79-0,Positive,in vitro
"3,3',4,4'-TETRAAMINOBIPHENYL.4HCl",C1=CC(=C(C=C1C2=CC(=C(C=C2)N)N)N)N.Cl.Cl.Cl.Cl,7411-49-6,Negative,In vivo
"3,3',4,4'-TETRAAMINOBIPHENYL.4HCl",C1=CC(=C(C=C1C2=CC(=C(C=C2)N)N)N)N.Cl.Cl.Cl.Cl,7411-49-6,Positive,In vivo
"3,3',5,5'-Tetramethylbenzidine",CC1=CC(=CC(=C1N)C)C2=CC(=C(C(=C2)C)N)C,54827-17-7,Negative,in vitro
"3,4-dibromo-1-nitrosopiperidine",C1CN(CC(C1Br)Br)N=O,57541-73-8,Positive,in vitro
"3,4-Dichloro-1-butene",C=CC(CCl)Cl,760-23-6,Positive,in vitro
"3,4-dichloro-1-nitrosopiperidine",C1CN(CC(C1Cl)Cl)N=O,57541-72-7,Positive,in vitro
"3,4-dichloroaniline",C1=CC(=C(C=C1N)Cl)Cl,95-76-1,Positive,in vitro
"3,4-dihydro-2H-chrysen-1-one",C1CC2=C(C=CC3=C2C=CC4=CC=CC=C43)C(=O)C1,,Positive,in vitro
"3,4-dihydrochromen-2-one",C1CC(=O)OC2=CC=CC=C21,660,Negative,In Vivo
"3,4-dihydrochromen-2-one",C1CC(=O)OC2=CC=CC=C21,660,Positive,In Vivo
"3,4-dimethylimidazo[4,5-f]quinolin-2-amine",CC1=CC2=C(C=CC=N2)C3=C1N(C(=N3)N)C,62274,Positive,In Vivo
"3,4,4'-TRIAMINODIPHENYL ETHER",C1=CC(=CC=C1N)OC2=CC(=C(C=C2)N)N,6264-66-0,Positive,In vivo
"3,4,5-trihydroxybenzoic acid",C1=C(C=C(C(=C1O)O)O)C(=O)O,149-91-7,Negative,in vitro
"3,4,5,6-tetrabromophthalic acid",C1(=C(C(=C(C(=C1Br)Br)Br)Br)C(=O)O)C(=O)O,13810-83-8,Negative,in vitro
"3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxyphenyl)methyl]phenol",C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl,3598,Negative,In Vivo
"3,4'-DICHLORO-2-METHYLACRYLANILIDE",CC(=C)C(=O)NC1=CC(=C(C=C1)Cl)Cl,2164-09-2,Negative,In vivo
"3,5-dibromo-4-hydroxybenzonitrile",C1=C(C=C(C(=C1Br)O)Br)C#N,15531,Positive,In Vivo
"3,5-dichloro-2-[4-(3,5-dichloropyridin-2-yl)oxyphenoxy]pyridine",C1=CC(=CC=C1OC2=C(C=C(C=N2)Cl)Cl)OC3=C(C=C(C=N3)Cl)Cl,5382,Positive,In Vivo
"3,5-dichloro-2-[4-(3,5-dichloropyridin-2-yl)oxyphenoxy]pyridine",C1=CC(=CC=C1OC2=C(C=C(C=N2)Cl)Cl)OC3=C(C=C(C=N3)Cl)Cl,5382,Negative,In Vivo
"3,5-dichloro-N-(2-methylbut-3-yn-2-yl)benzamide",CC(C)(C#C)NC(=O)C1=CC(=CC(=C1)Cl)Cl,32154,Positive,In Vivo
"3,5-DICHLORO(N-1,1-DIMETHYL-2-PROPYNYL)BENZAMIDE",CC(C)(C#C)NC(=O)C1=CC(=CC(=C1)Cl)Cl,23950-58-5,Positive,In vivo
"3,5-dimethyl-1-nitrosopiperazine",CC1CN(CC(N1)C)N=O,92376,Positive,In Vivo
"3,5-dimethyl-1-nitrosopiperidine",CC1CC(CN(C1)N=O)C,65445-59-2,Positive,in vitro
"3,5-dimethyl-1,3,5-thiadiazinane-2-thione",CN1CN(C(=S)SC1)C,10788,Negative,In Vivo
"3,5-dinitrobenzoyl chloride",C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])C(=O)Cl,99-33-2,Positive,in vitro
"3,5,5-trimethylcyclohex-2-en-1-one",CC1=CC(=O)CC(C1)(C)C,6544,Negative,In Vivo
"3,5,5-trimethylcyclohex-2-en-1-one",CC1=CC(=O)CC(C1)(C)C,6544,Positive,In Vivo
"3,5,6-trichloro-1H-pyridin-2-one",C1=C(C(=O)NC(=C1Cl)Cl)Cl,6515-38-4,Negative,in vivo
"3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-7-[(2S,3R,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracene-2-carboxylic acid",CC1=C2C(=CC(=C1C(=O)O)O)C(=O)C3=C(C2=O)C(=C(C(=C3O)O)[C@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)CO)O)O)O)O,25113282,Negative,In Vivo
"3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one",C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O,520-18-3,Positive,in vitro
"3,5,7-trihydroxy-2-phenylchromen-4-one",C1=CC=C(C=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O,548-83-4,Positive,in vitro
"3,6-dichloro-2-methoxybenzoic acid",COC1=C(C=CC(=C1C(=O)O)Cl)Cl,1918-00-9,Negative,in vitro
"3,6-DIHYDRO-2-NITROSO-2H-1,2-OXAZINE",C1C=CCON1N=O,3276-41-3,Negative,In vivo
"3,6-DIHYDRO-2-NITROSO-2H-1,2-OXAZINE",C1C=CCON1N=O,3276-41-3,Positive,In vivo
"3,6-dimethylbenzo[a]pyrene",CC1=C2C=CC3=C(C4=CC=CC=C4C5=C3C2=C(C=C1)C=C5)C,16757-91-8,Positive,in vitro
"3,6-dinitrobenzo[a]pyrene",C1=CC=C2C(=C1)C3=C4C(=C2[N+](=O)[O-])C=CC5=C(C=CC(=C54)C=C3)[N+](=O)[O-],86387,Positive,In Vivo
"3,6-Dinitrobenzopyrene",C1=CC=C2C(=C1)C3=C4C(=C2[N+](=O)[O-])C=CC5=C(C=CC(=C54)C=C3)[N+](=O)[O-],128714-76-1,Positive,in vitro
"3,6,7,8-tetramethoxy-2-(4-methoxyphenyl)chromen-4-one",COC1=CC=C(C=C1)C2=C(C(=O)C3=CC(=C(C(=C3O2)OC)OC)OC)OC,522-16-7,Positive,in vitro
"3,7-dihydropurine-6-thione",C1=NC2=C(N1)C(=S)N=CN2,50-44-2,Negative,in vivo
"3,7-dihydropurine-6-thione",C1=NC2=C(N1)C(=S)N=CN2,50-44-2,Positive,in vivo
"3,7-dihydropurine-6-thione",C1=NC2=C(N1)C(=S)N=CN2,50-44-2,Negative,in vitro
"3,7-dimethylpurine-2,6-dione",CN1C=NC2=C1C(=O)NC(=O)N2C,83-67-0,Positive,in vivo
"3,7-dimethylpurine-2,6-dione",CN1C=NC2=C1C(=O)NC(=O)N2C,83-67-0,Negative,in vitro
"3,7-dinitrofluoranthene",C1=CC2=C(C=CC3=C2C(=C1)C4=C3C=CC=C4[N+](=O)[O-])[N+](=O)[O-],60018,Positive,In Vivo
"3,7-dinitroso-1,3,5,7-tetrazabicyclo[3.3.1]nonane",C1N2CN(CN1CN(C2)N=O)N=O,101-25-7,Negative,in vitro
"3,7-dioxatricyclo[4.1.0.02,4]heptane",C1C2C(O2)C3C1O3,187-29-1,Positive,in vitro
"3,8-dimethylimidazo[4,5-f]quinoxalin-2-amine",CC1=CN=C2C=CC3=C(C2=N1)N=C(N3C)N,62275,Negative,In Vivo
"3,8-dimethylimidazo[4,5-f]quinoxalin-2-amine",CC1=CN=C2C=CC3=C(C2=N1)N=C(N3C)N,62275,Positive,In Vivo
"3,8-dioxatricyclo[5.1.0.02,4]octane",C1CC2C(O2)C3C1O3,,Negative,in vitro
"3,9-dihydroxybenzo[b]phenalen-7-one",C1=CC2=C(C=CC3=C2C(=C1)C(=O)C4=C3C=CC(=C4)O)O,,Positive,in vitro
"3,9-dinitrofluoranthene",C1=CC2=C(C=CC3=C2C(=C1)C4=C3C=C(C=C4)[N+](=O)[O-])[N+](=O)[O-],31186,Positive,In Vivo
"3'-Azido-3'-deoxythymidine (Zidovudine, AZT) and GSK33",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],30516-87-1,Positive,in vitro
3'-METHYL-4-DIMETHYLAMINOAZOBENZENE,CC1=CC(=CC=C1)N=NC2=CC=C(C=C2)N(C)C,55-80-1,Positive,In vivo
3'-Methyl-4-dimethylaminoazobenzene,CC1=CC(=CC=C1)N=NC2=CC=C(C=C2)N(C)C,55-80-1,Positive,in vitro
"3',6'-dihydroxy-4',5'-diiodospiro[2-benzofuran-3,9'-xanthene]-1-one",C1=CC=C2C(=C1)C(=O)OC23C4=C(C(=C(C=C4)O)I)OC5=C3C=CC(=C5I)O,92311,Negative,In Vivo
"3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one",C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O,16850,Negative,In Vivo
"3a,8b-dihydrofuro[2,3-b][1]benzofuran",C1=CC=C2C(=C1)C3C=COC3O2,,Positive,in vitro
"3H-1,3-benzothiazole-2-thione",C1=CC=C2C(=C1)NC(=S)S2,697993,Negative,In Vivo
"3H-1,3-benzothiazole-2-thione",C1=CC=C2C(=C1)NC(=S)S2,697993,Positive,In Vivo
3H-benzimidazol-5-amine,C1=CC2=C(C=C1N)NC=N2,934-22-5,Negative,in vitro
"4-(1H-benzimidazol-2-yl)-1,3-thiazole",C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,5430,Negative,In Vivo
"4-(1H-benzimidazol-2-yl)-1,3-thiazole",C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,148-79-8,Positive,in vitro
4-(2-amino-2-oxoethyl)-3-benzyloxadiazol-3-ium-5-olate,C1=CC=C(C=C1)C[N+]2=NOC(=C2CC(=O)N)[O-],84482,Negative,In Vivo
4-(2-amino-2-oxoethyl)-3-benzyloxadiazol-3-ium-5-olate,C1=CC=C(C=C1)C[N+]2=NOC(=C2CC(=O)N)[O-],84482,Positive,In Vivo
"4-(2-aminoethyl)-N,N-bis(2-chloroethyl)aniline",C1=CC(=CC=C1CCN)N(CCCl)CCCl,58880-18-5,Positive,in vitro
"4-(2-aminoethyl)benzene-1,2-diol",C1=CC(=C(C=C1CCN)O)O,51-61-6,Negative,in vitro
4-(2-HYDROXYETHYLAMINO)-2-(5-NITRO-2-THIENYL)QUINAZOLINE,C1=CC=C2C(=C1)C(=NC(=N2)C3=CC=C(S3)[N+](=O)[O-])NCCO,33389-36-5,Positive,In vivo
4-(2-Hydroxyethylamino)-2-(5-nitro-2-thienyl)quinazoline,C1=CC=C2C(=C1)C(=NC(=N2)C3=CC=C(S3)[N+](=O)[O-])NCCO,33389-36-5,Positive,in vitro
4-(2-Phenylethyl)aniline,C1=CC=C(C=C1)CCC2=CC=C(C=C2)N,13024-49-2,Positive,in vitro
"4-(2,2-dimethylhydrazinyl)-4-oxobutanoic acid",CN(C)NC(=O)CCC(=O)O,15331,Negative,In Vivo
"4-(2,2-dimethylhydrazinyl)-4-oxobutanoic acid",CN(C)NC(=O)CCC(=O)O,15331,Positive,In Vivo
"4-(2,2-dimethylhydrazinyl)-4-oxobutanoic acid",CN(C)NC(=O)CCC(=O)O,1596-84-5,Positive,in vitro
"4-(2,3,4,5-tetrachlorophenyl)phenol",C1=CC(=CC=C1C2=CC(=C(C(=C2Cl)Cl)Cl)Cl)O,105101,Positive,In Vivo
"4-(2,4-dichlorophenoxy)butanoic acid",C1=CC(=C(C=C1Cl)Cl)OCCCC(=O)O,1489,Negative,In Vivo
"4-(2,4-dichlorophenoxy)butanoic acid",C1=CC(=C(C=C1Cl)Cl)OCCCC(=O)O,94-82-6,Negative,in vitro
"4-(2,4,6-trichlorophenyl)phenol",C1=CC(=CC=C1C2=C(C=C(C=C2Cl)Cl)Cl)O,105036,Positive,In Vivo
4-(4-amino-2-chlorophenyl)-3-chloroaniline,C1=CC(=C(C=C1N)Cl)C2=C(C=C(C=C2)N)Cl,84-68-4,Positive,in vitro
4-(4-amino-3-chlorophenoxy)-2-chloroaniline,C1=CC(=C(C=C1OC2=CC(=C(C=C2)N)Cl)Cl)N,28434-86-8,Positive,in vivo
4-(4-amino-3-chlorophenoxy)-2-chloroaniline,C1=CC(=C(C=C1OC2=CC(=C(C=C2)N)Cl)Cl)N,34239,Positive,In Vivo
4-(4-amino-3-chlorophenyl)-2-chloroaniline,C1=CC(=C(C=C1C2=CC(=C(C=C2)N)Cl)Cl)N,7070,Positive,In Vivo
4-(4-amino-3-chlorophenyl)-2-chloroaniline,C1=CC(=C(C=C1C2=CC(=C(C=C2)N)Cl)Cl)N,91-94-1,Positive,in vivo
4-(4-amino-3-chlorophenyl)-2-chloroaniline,C1=CC(=C(C=C1C2=CC(=C(C=C2)N)Cl)Cl)N,91-94-1,Positive,in vitro
4-(4-amino-3-chlorophenyl)-2-chloroaniline;sulfuric acid,C1=CC(=C(C=C1C2=CC(=C(C=C2)N)Cl)Cl)N.OS(=O)(=O)O,,Positive,in vitro
4-(4-amino-3-methoxyphenyl)-2-methoxyaniline,COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)OC)N,8411,Positive,In Vivo
4-(4-amino-3-methoxyphenyl)-2-methoxyaniline,COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)OC)N,119-90-4,Positive,in vivo
4-(4-amino-3-methoxyphenyl)-2-methoxyaniline,COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)OC)N,119-90-4,Positive,in vitro
4-(4-amino-3-methoxyphenyl)-2-methoxyaniline;dihydrochloride,COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)OC)N.Cl.Cl,62311,Negative,In Vivo
4-(4-amino-3-methoxyphenyl)-2-methoxyaniline;dihydrochloride,COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)OC)N.Cl.Cl,62311,Positive,In Vivo
4-(4-amino-3-methylphenyl)-2-methylaniline,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)C)N,119-93-7,Positive,in vivo
4-(4-amino-3-methylphenyl)-2-methylaniline,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)C)N,8413,Positive,In Vivo
4-(4-amino-3-methylphenyl)-2-methylaniline,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)C)N,119-93-7,Positive,in vitro
"4-(4-amino-3,5-dichlorophenyl)-2,6-dichloroaniline",C1=C(C=C(C(=C1Cl)N)Cl)C2=CC(=C(C(=C2)Cl)N)Cl,,Positive,in vitro
"4-(4-amino-3,5-difluorophenyl)-2,6-difluoroaniline",C1=C(C=C(C(=C1F)N)F)C2=CC(=C(C(=C2)F)N)F,,Positive,in vitro
"4-(4-amino-3,5-dimethylphenyl)-2,6-dimethylaniline",CC1=CC(=CC(=C1N)C)C2=CC(=C(C(=C2)C)N)C,54827-17-7,Negative,in vivo
"4-(4-amino-3,5-dimethylphenyl)-2,6-dimethylaniline",CC1=CC(=CC(=C1N)C)C2=CC(=C(C(=C2)C)N)C,54827-17-7,Negative,in vitro
4-(4-aminophenoxy)aniline,C1=CC(=CC=C1N)OC2=CC=C(C=C2)N,7579,Positive,In Vivo
4-(4-aminophenoxy)aniline,C1=CC(=CC=C1N)OC2=CC=C(C=C2)N,101-80-4,Positive,in vivo
4-(4-aminophenyl)aniline,C1=CC(=CC=C1C2=CC=C(C=C2)N)N,7111,Positive,In Vivo
4-(4-aminophenyl)aniline,C1=CC(=CC=C1C2=CC=C(C=C2)N)N,92-87-5,Negative,in vivo
4-(4-aminophenyl)aniline,C1=CC(=CC=C1C2=CC=C(C=C2)N)N,92-87-5,Positive,in vivo
4-(4-aminophenyl)aniline,C1=CC(=CC=C1C2=CC=C(C=C2)N)N,92-87-5,Positive,in vitro
4-(4-aminophenyl)aniline;dihydrochloride,C1=CC(=CC=C1C2=CC=C(C=C2)N)N.Cl.Cl,531-85-1,Positive,in vivo
4-(4-aminophenyl)aniline;dihydrochloride,C1=CC(=CC=C1C2=CC=C(C=C2)N)N.Cl.Cl,10754,Positive,In Vivo
4-(4-aminophenyl)aniline;dihydrochloride,C1=CC(=CC=C1C2=CC=C(C=C2)N)N.Cl.Cl,531-85-1,Negative,in vitro
4-(4-aminophenyl)sulfanylaniline,C1=CC(=CC=C1N)SC2=CC=C(C=C2)N,8765,Positive,In Vivo
4-(4-aminophenyl)sulfanylaniline,C1=CC(=CC=C1N)SC2=CC=C(C=C2)N,139-65-1,Positive,in vivo
4-(4-aminophenyl)sulfonylaniline,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,2955,Negative,In Vivo
4-(4-aminophenyl)sulfonylaniline,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,2955,Positive,In Vivo
"4-(4-benzylpiperazin-1-yl)-7-nitro-3-oxido-2,1,3-benzoxadiazol-3-ium",C1CN(CCN1CC2=CC=CC=C2)C3=CC=C(C4=NO[N+](=C34)[O-])[N+](=O)[O-],61785-84-0,Positive,in vitro
4-(4-chloro-2-methylphenoxy)butanoic acid,CC1=C(C=CC(=C1)Cl)OCCCC(=O)O,94-81-5,Negative,in vitro
4-(4-fluorophenyl)aniline,C1=CC(=CC=C1C2=CC=C(C=C2)F)N,9462,Positive,In Vivo
4-(4-fluorophenyl)aniline,C1=CC(=CC=C1C2=CC=C(C=C2)F)N,324-93-6,Positive,in vitro
"4-(4-methylpiperazin-1-yl)-7-nitro-3-oxido-2,1,3-benzoxadiazol-3-ium",CN1CCN(CC1)C2=CC=C(C3=NO[N+](=C23)[O-])[N+](=O)[O-],58131-57-0,Positive,in vitro
4-(4-N-METHYL-N-NITROSAMINOSTYRYL)QUINOLINE,CN(C1=CC=C(C=C1)C=CC2=CC=NC3=CC=CC=C23)N=O,16699-10-8,Positive,In vivo
"4-(4-nitrothiophen-2-yl)-1,3-thiazol-2-amine",C1=C(SC=C1[N+](=O)[O-])C2=CSC(=N2)N,58139-51-8,Positive,in vitro
4-(5-NITRO-2-FURYL)THIAZOLE,C1=C(OC(=C1)[N+](=O)[O-])C2=CSC=N2,53757-28-1,Positive,In vivo
4-(5-Nitro-2-furyl)thiazole,C1=C(OC(=C1)[N+](=O)[O-])C2=CSC=N2,53757-28-1,Positive,in vitro
"4-(5-nitrofuran-2-yl)-1,3-thiazol-2-amine",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)N,38052,Positive,In Vivo
"4-(5-nitrofuran-2-yl)-1,3-thiazol-2-amine",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)N,38514-71-5,Negative,in vitro
"4-(5-nitrofuran-2-yl)-1,3-thiazole",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC=N2,53757-28-1,Positive,in vivo
"4-(5-nitrofuran-2-yl)-1,3-thiazole",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC=N2,107987,Positive,In Vivo
"4-(5-nitrofuran-2-yl)-1,3-thiazole",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC=N2,53757-28-1,Negative,in vitro
"4-(5-nitrofuran-2-yl)-N-phenyl-1,3-thiazol-2-amine",C1=CC=C(C=C1)NC2=NC(=CS2)C3=CC=C(O3)[N+](=O)[O-],51728-02-0,Negative,in vitro
"4-(5-nitrothiophen-2-yl)-1,3-thiazol-2-amine",C1=C(SC(=C1)[N+](=O)[O-])C2=CSC(=N2)N,34801-16-6,Positive,in vitro
"4-(aziridin-1-yl)-7-nitro-3-oxido-2,1,3-benzoxadiazol-3-ium",C1CN1C2=CC=C(C3=NO[N+](=C23)[O-])[N+](=O)[O-],,Positive,in vitro
"4-(aziridin-1-yl)naphthalene-1,2-dione",C1CN1C2=CC(=O)C(=O)C3=CC=CC=C32,439-55-4,Positive,in vitro
4-(butylamino)butan-1-ol,CCCCNCCCCO,4543-95-7,Negative,in vitro
"4-(dimethylamino)-1,5-dimethyl-2-phenylpyrazol-3-one",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C,6009,Negative,In Vivo
"4-(dimethylamino)-1,5-dimethyl-2-phenylpyrazol-3-one",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C,58-15-1,Negative,in vitro
4-(dipropylsulfamoyl)benzoic acid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,4911,Negative,In Vivo
4-(dipropylsulfamoyl)benzoic acid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,4911,Positive,In Vivo
4-(dipropylsulfamoyl)benzoic acid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,57-66-9,Negative,in vitro
4-(hydroxymethyl)-1-(2-piperidin-1-ylethylamino)thioxanthen-9-one,C1CCN(CC1)CCNC2=C3C(=C(C=C2)CO)SC4=CC=CC=C4C3=O,16140-27-5,Positive,in vitro
4-(hydroxymethyl)-1-[2-(2-methylpiperidin-1-yl)ethylamino]thioxanthen-9-one,CC1CCCCN1CCNC2=C3C(=C(C=C2)CO)SC4=CC=CC=C4C3=O,,Positive,in vitro
4-(methylamino)phenol;sulfuric acid,CNC1=CC=C(C=C1)O.CNC1=CC=C(C=C1)O.OS(=O)(=O)O,,Negative,in vitro
4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-(BUTANONE),CN(CCCC(=O)C1=CN=CC=C1)N=O,64091-91-4,Negative,In vivo
4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-(BUTANONE),CN(CCCC(=O)C1=CN=CC=C1)N=O,64091-91-4,Positive,In vivo
4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL,CN(CCCC(C1=CN=CC=C1)O)N=O,76014-81-8,Positive,In vivo
4-(nitrosomethylamino)butan-2-one,CC(=O)CCNCN=O,128952,Positive,In Vivo
"4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol",CNC[C@@H](C1=CC(=C(C=C1)O)O)O,51-43-4,Negative,in vivo
4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,671-16-9,Negative,in vivo
4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,671-16-9,Positive,in vivo
4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,671-16-9,Negative,in vitro
4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide;hydrochloride,CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl,9703,Positive,In Vivo
4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide;hydrochloride,CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl,366-70-1,Positive,in vitro
"4-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxobutanoic acid",C1=CC(=CC=C1[C@H]([C@@H](COC(=O)CCC(=O)O)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],3544-94-3,Negative,in vivo
"4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione",C[C@H]1C[C@@H](C(=O)[C@@H](C1)[C@@H](CC2CC(=O)NC(=O)C2)O)C,66-81-9,Positive,in vivo
"4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione",C[C@H]1C[C@@H](C(=O)[C@@H](C1)[C@@H](CC2CC(=O)NC(=O)C2)O)C,66-81-9,Negative,in vitro
"4-[(2Z,4Z)-4-(4-hydroxyphenyl)hexa-2,4-dien-3-yl]phenol",C/C=C(\C(=C/C)\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)O,35495-11-5,Positive,in vitro
"4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid;2-[(E)-2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethenyl]-N,N,1-trimethylquinolin-1-ium-6-amine",CC1=CC(=C(N1C2=CC=CC=C2)C)/C=C/C3=[N+](C4=C(C=C(C=C4)N(C)C)C=C3)C.CC1=CC(=C(N1C2=CC=CC=C2)C)/C=C/C3=[N+](C4=C(C=C(C=C4)N(C)C)C=C3)C.C1=CC=C2C(=C(C(=CC2=C1)C(=O)O)O)CC3=C(C(=CC4=CC=CC=C34)C(=O)O)O,,Positive,in vitro
4-[(4-amino-3-chlorophenyl)methyl]-2-chloroaniline,C1=CC(=C(C=C1CC2=CC(=C(C=C2)N)Cl)Cl)N,7543,Positive,In Vivo
4-[(4-amino-3-chlorophenyl)methyl]-2-chloroaniline,C1=CC(=C(C=C1CC2=CC(=C(C=C2)N)Cl)Cl)N,101-14-4,Positive,in vivo
4-[(4-amino-3-chlorophenyl)methyl]-2-chloroaniline,C1=CC(=C(C=C1CC2=CC(=C(C=C2)N)Cl)Cl)N,101-14-4,Positive,in vitro
4-[(4-amino-3-methylphenyl)methyl]-2-methylaniline,CC1=C(C=CC(=C1)CC2=CC(=C(C=C2)N)C)N,838-88-0,Positive,in vivo
4-[(4-amino-3-methylphenyl)methyl]-2-methylaniline,CC1=C(C=CC(=C1)CC2=CC(=C(C=C2)N)C)N,13283,Positive,In Vivo
"4-[(4-aminophenyl)-(4-imino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydrochloride",CC1=CC(=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N)C=CC1=N.Cl,12447,Positive,In Vivo
"4-[(4-aminophenyl)-(4-imino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydrochloride",CC1=CC(=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N)C=CC1=N.Cl,12447,Negative,In Vivo
"4-[(4-aminophenyl)-(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydrochloride",C1=CC(=N)C=CC1=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N.Cl,11292,Positive,In Vivo
"4-[(4-aminophenyl)-(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydrochloride",C1=CC(=N)C=CC1=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N.Cl,569-61-9,Positive,in vivo
"4-[(4-aminophenyl)-(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydrochloride",C1=CC(=N)C=CC1=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N.Cl,11292,Negative,In Vivo
"4-[(4-aminophenyl)-(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydrochloride",C1=CC(=N)C=CC1=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N.Cl,569-61-9,Negative,in vitro
4-[(4-aminophenyl)methyl]aniline,C1=CC(=CC=C1CC2=CC=C(C=C2)N)N,7577,Positive,In Vivo
4-[(4-aminophenyl)methyl]aniline,C1=CC(=CC=C1CC2=CC=C(C=C2)N)N,101-77-9,Positive,in vivo
4-[(4-aminophenyl)methyl]aniline;dihydrochloride,C1=CC(=CC=C1CC2=CC=C(C=C2)N)N.Cl.Cl,26108,Positive,In Vivo
4-[(4-aminophenyl)methyl]aniline;dihydrochloride,C1=CC(=CC=C1CC2=CC=C(C=C2)N)N.Cl.Cl,13552-44-8,Positive,in vivo
"4-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-1,3-thiazol-2-amine",C1=C(OC(=C1)[N+](=O)[O-])/C=C/C2=CSC(=N2)N,16239-84-2,Positive,in vitro
4-[(E)-2-(5-nitrofuran-2-yl)ethenyl]benzamide,C1=CC(=CC=C1/C=C/C2=CC=C(O2)[N+](=O)[O-])C(=O)N,1553-59-9,Positive,in vitro
4-[(E)-2-phenylethenyl]aniline,C1=CC=C(C=C1)/C=C/C2=CC=C(C=C2)N,1272788,Positive,In Vivo
4-[(E)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol,CC/C(=C(/CC)\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)O,448537,Positive,In Vivo
4-[(E)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol,CC/C(=C(/CC)\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)O,448537,Negative,In Vivo
4-[(E)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol,CC/C(=C(/CC)\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)O,56-53-1,Positive,in vivo
4-[(E)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol,CC/C(=C(/CC)\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)O,56-53-1,Negative,in vitro
4-[(E)-dimethylaminodiazenyl]-1H-imidazole-5-carboxamide,CN(C)/N=N/C1=C(NC=N1)C(=O)N,4342-03-04,Positive,in vivo
4-[(E)-dimethylaminodiazenyl]-1H-imidazole-5-carboxamide,CN(C)/N=N/C1=C(NC=N1)C(=O)N,135398738,Positive,In Vivo
4-[(E)-dimethylaminodiazenyl]-1H-imidazole-5-carboxamide,CN(C)/N=N/C1=C(NC=N1)C(=O)N,4342-03-04,Positive,in vitro
4-[(methyldiazenyl)methyl]-N-propan-2-ylbenzamide,CC(C)NC(=O)C1=CC=C(C=C1)CN=NC,75230,Positive,In Vivo
4-[(Z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol,CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,449459,Negative,In Vivo
"4-[[4-(dimethylamino)phenyl]-(4-methyliminocyclohexa-2,5-dien-1-ylidene)methyl]-N,N-dimethylaniline;hydrochloride",CN=C1C=CC(=C(C2=CC=C(C=C2)N(C)C)C3=CC=C(C=C3)N(C)C)C=C1.Cl,603-47-4,Positive,in vitro
"4-[[4-(dimethylamino)phenyl]-phenylmethyl]-N,N-dimethylaniline",CN(C)C1=CC=C(C=C1)C(C2=CC=CC=C2)C3=CC=C(C=C3)N(C)C,67215,Positive,In Vivo
"4-[[4-(dimethylamino)phenyl]methyl]-N,N-dimethylaniline",CN(C)C1=CC=C(C=C1)CC2=CC=C(C=C2)N(C)C,7567,Positive,In Vivo
"4-[[4-(dimethylamino)phenyl]methyl]-N,N-dimethylaniline",CN(C)C1=CC=C(C=C1)CC2=CC=C(C=C2)N(C)C,101-61-1,Positive,in vivo
"4-[[4-(dimethylamino)phenyl]methyl]-N,N-dimethylaniline",CN(C)C1=CC=C(C=C1)CC2=CC=C(C=C2)N(C)C,101-61-1,Negative,in vitro
"4-[2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione",CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,30623,Negative,In Vivo
"4-[2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione",CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,30623,Positive,In Vivo
"4-[2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione",CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,21416-67-1,Negative,in vitro
4-[2-(4-hydroxyphenyl)propan-2-yl]phenol,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,6623,Negative,In Vivo
4-[2-(4-hydroxyphenyl)propan-2-yl]phenol,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,6623,Positive,In Vivo
4-[2-(5-nitrothiophen-2-yl)quinazolin-4-yl]morpholine,C1COCCN1C2=NC(=NC3=CC=CC=C32)C4=CC=C(S4)[N+](=O)[O-],,Positive,in vitro
"4-[2,3-diethyl-3-(4-hydroxyphenyl)oxiran-2-yl]phenol",CCC1(C(O1)(CC)C2=CC=C(C=C2)O)C3=CC=C(C=C3)O,6052-82-0,Positive,in vitro
"4-[2,4,4,6,6-pentakis(aziridin-1-yl)-1,3,5-triaza-2lambda5,4lambda5,6lambda5-triphosphacyclohexa-1,3,5-trien-2-yl]morpholine",C1CN1P2(=NP(=NP(=N2)(N3CC3)N4CCOCC4)(N5CC5)N6CC6)N7CC7,37132-72-2,Positive,in vivo
"4-[2,4,4,6,6-pentakis(aziridin-1-yl)-1,3,5-triaza-2lambda5,4lambda5,6lambda5-triphosphacyclohexa-1,3,5-trien-2-yl]morpholine",C1CN1P2(=NP(=NP(=N2)(N3CC3)N4CCOCC4)(N5CC5)N6CC6)N7CC7,37132-72-2,Positive,in vitro
"4-[3-(4-hydroxy-2-methylphenyl)-1,1-dioxo-2,1lambda6-benzoxathiol-3-yl]-3-methylphenol",CC1=C(C=CC(=C1)O)C2(C3=CC=CC=C3S(=O)(=O)O2)C4=C(C=C(C=C4)O)C,2303-01-07,Positive,in vitro
4-[3-[2-(1-methyl-5-nitroimidazol-2-yl)benzimidazol-1-yl]propyl]morpholine,CN1C(=CN=C1C2=NC3=CC=CC=C3N2CCCN4CCOCC4)[N+](=O)[O-],,Negative,in vitro
"4-[4-(2-methoxyphenyl)piperazin-1-yl]-7-nitro-3-oxido-2,1,3-benzoxadiazol-3-ium",COC1=CC=CC=C1N2CCN(CC2)C3=CC=C(C4=NO[N+](=C34)[O-])[N+](=O)[O-],,Positive,in vitro
4-[4-(4-aminophenyl)phenyl]aniline,C1=CC(=CC=C1C2=CC=C(C=C2)N)C3=CC=C(C=C3)N,3365-85-3,Positive,in vitro
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,52-86-8,Positive,in vitro
"4-[4-(4-methoxyphenyl)piperazin-1-yl]-7-nitro-3-oxido-2,1,3-benzoxadiazol-3-ium",COC1=CC=C(C=C1)N2CCN(CC2)C3=CC=C(C4=NO[N+](=C34)[O-])[N+](=O)[O-],61785-71-5,Positive,in vitro
"4-[4-(dimethylamino)benzenecarboximidoyl]-N,N-dimethylaniline",CN(C)C1=CC=C(C=C1)C(=N)C2=CC=C(C=C2)N(C)C,10298,Positive,In Vivo
"4-[4-(dimethylamino)benzenecarboximidoyl]-N,N-dimethylaniline;hydrochloride",CN(C)C1=CC=C(C=C1)C(=N)C2=CC=C(C=C2)N(C)C.Cl,,Positive,in vivo
"4-[4-(dimethylamino)benzenecarboximidoyl]-N,N-dimethylaniline;hydrochloride",CN(C)C1=CC=C(C=C1)C(=N)C2=CC=C(C=C2)N(C)C.Cl,,Negative,in vitro
"4-[4-(dimethylamino)phenyl]-N,N-dimethylaniline",CN(C)C1=CC=C(C=C1)C2=CC=C(C=C2)N(C)C,366-29-0,Negative,in vitro
4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,2708,Positive,In Vivo
4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,0305-03-03,Positive,in vivo
4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,0305-03-03,Positive,in vitro
4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;hydrochloride,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl,77082,Positive,In Vivo
4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;hydrochloride,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl,3543-75-7,Positive,in vitro
4-[6-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-benzimidazol-2-yl]phenol;trihydrochloride,CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=CC5=C(C=C4)N=C(N5)C6=CC=C(C=C6)O.Cl.Cl.Cl,23491-45-4,Negative,in vivo
4-[6-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-benzimidazol-2-yl]phenol;trihydrochloride,CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=CC5=C(C=C4)N=C(N5)C6=CC=C(C=C6)O.Cl.Cl.Cl,23491-45-4,Positive,in vitro
4-[butyl(nitroso)amino]butanoic acid,CCCCN(CCCC(=O)O)N=O,37993,Positive,In Vivo
4-[ethyl(nitroso)amino]butanoic acid,CCN(CCCC(=O)O)N=O,54897-63-1,Positive,in vitro
4-[methyl(nitroso)amino]-4-pyridin-3-ylbutanoic acid,CN(C(CCC(=O)O)C1=CN=CC=C1)N=O,115108,Negative,In Vivo
4-[nitroso(propyl)amino]butanoic acid,CCCN(CCCC(=O)O)N=O,56316-37-1,Positive,in vitro
4-ACETYLAMINOBIPHENYL,CC(=O)NC1=CC=C(C=C1)C2=CC=CC=C2,4075-79-0,Positive,In vivo
4-Acetylaminofluorene,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,53-96-3,Negative,in vitro
4-ACETYLAMINOPHENYLACETIC ACID,CC(=O)NC1=CC=C(C=C1)CC(=O)O,18699-02-0,Negative,In vivo
"4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one",C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,9444,Negative,In Vivo
"4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one",C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,9444,Positive,In Vivo
"4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one",C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,320-67-2,Positive,in vivo
"4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one",C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,320-67-2,Positive,in vitro
"4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,6253,Negative,In Vivo
"4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,147-94-4,Negative,in vitro
"4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)CO)O,951-77-9,Negative,in vitro
"4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",C1C[C@@H](O[C@@H]1CO)N2C=CC(=NC2=O)N,24066,Negative,In Vivo
"4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",C1C[C@@H](O[C@@H]1CO)N2C=CC(=NC2=O)N,24066,Positive,In Vivo
"4-amino-1,5-dimethyl-2-phenylpyrazol-3-one",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N,83-07-8,Negative,in vitro
4-amino-2-nitrophenol,C1=CC(=C(C=C1N)[N+](=O)[O-])O,3417419,Negative,In Vivo
4-amino-2-nitrophenol,C1=CC(=C(C=C1N)[N+](=O)[O-])O,119-34-6,Positive,in vivo
4-amino-2-nitrophenol,C1=CC(=C(C=C1N)[N+](=O)[O-])O,3417419,Positive,In Vivo
4-amino-2-nitrophenol,C1=CC(=C(C=C1N)[N+](=O)[O-])O,119-34-6,Negative,in vivo
4-Amino-2-nitrophenol,C1=CC(=C(C=C1N)[N+](=O)[O-])O,119-34-6,Positive,in vitro
4-Amino-2'-methylbiphenyl,CC1=CC=CC=C1C2=CC=C(C=C2)N,1204-41-7,Positive,in vitro
4-Amino-3-nitrophenol (COLIPA B51),C1=CC(=C(C=C1O)[N+](=O)[O-])N,610-81-1,Positive,in vitro
"4-amino-3,5,6-trichloropyridine-2-carboxylic acid",C1(=C(C(=NC(=C1Cl)Cl)C(=O)O)Cl)N,15965,Negative,In Vivo
"4-amino-3,6-dichloropyridine-2-carboxylic acid",C1=C(C(=C(N=C1Cl)C(=O)O)Cl)N,213012,Negative,In Vivo
4-Amino-4'-chlorobiphenyl,C1=CC(=CC=C1C2=CC=C(C=C2)Cl)N,135-68-2,Positive,in vitro
4-Amino-4'-chlorostilbene,C1=CC(=CC=C1C=CC2=CC=C(C=C2)Cl)N,7570-36-7,Positive,in vitro
4-Amino-4'-nitrobiphenyl,C1=CC(=CC=C1C2=CC=C(C=C2)[N+](=O)[O-])N,1211-40-1,Positive,in vitro
4-Amino-4'-nitrostilbene,C1=CC(=CC=C1C=CC2=CC=C(C=C2)[N+](=O)[O-])N,7297-52-1,Positive,in vitro
"4-amino-5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=NC2=O)N)Br)CO)O,1022-79-3,Positive,in vitro
"4-amino-6-tert-butyl-3-methylsulfanyl-1,2,4-triazin-5-one",CC(C)(C)C1=NN=C(N(C1=O)N)SC,21087-64-9,Negative,in vitro
"4-amino-N-(1,3-thiazol-2-yl)benzenesulfonamide",C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2,72-14-0,Negative,in vitro
4-amino-N-(2-aminophenyl)benzamide,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)N,42725,Positive,In Vivo
"4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide",CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,5344,Negative,In Vivo
"4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide",CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C,5327,Positive,In Vivo
"4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide",CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,5329,Positive,In Vivo
4-Aminoazobenzene,C1=CC=C(C=C1)N=NC2=CC=C(C=C2)N,60-09-3,Positive,in vitro
4-aminobenzenesulfonamide,C1=CC(=CC=C1N)S(=O)(=O)N,63-74-1,Negative,in vitro
4-aminobenzenethiol,C1=CC(=CC=C1N)S,1193-02-08,Negative,in vivo
4-aminobenzonitrile,C1=CC(=CC=C1C#N)N,873-74-5,Negative,in vivo
4-Aminobiphenyl (free base + HCL salt),C1=CC=C(C=C1)C2=CC=C(C=C2)N,92-67-1,Positive,in vitro
4-AMINODIPHENYL,C1=CC=C(C=C1)C2=CC=C(C=C2)N,92-67-1,Negative,In vivo
4-AMINODIPHENYL,C1=CC=C(C=C1)C2=CC=C(C=C2)N,92-67-1,Positive,In vivo
4-AMINODIPHENYL.HCl,C1=CC=C(C=C1)C2=CC=C(C=C2)[NH3+].[Cl-],2113-61-3,Negative,In vivo
4-AMINODIPHENYL.HCl,C1=CC=C(C=C1)C2=CC=C(C=C2)[NH3+].[Cl-],2113-61-3,Positive,In vivo
4-aminophenol,C1=CC(=CC=C1N)O,123-30-8,Positive,in vivo
4-aminophenol,C1=CC(=CC=C1N)O,123-30-8,Negative,in vitro
4-Aminophenol / p-aminophenol/ 4-hydroxyaniline COLIPA A16,C1=CC(=CC=C1N)O,123-30-8,Positive,in vitro
4-Aminostilbene,C1=CC=C(C=C1)C=CC2=CC=C(C=C2)N,4309-66-4,Positive,in vitro
4-BIS(2-HYDROXYETHYL)AMINO-2-(5-NITRO-2-THIENYL)QUINAZOLINE,C1=CC=C2C(=C1)C(=NC(=N2)C3=CC=C(S3)[N+](=O)[O-])N(CCO)CCO,33372-39-3,Positive,In vivo
4-bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)pyrrole-3-carbonitrile,CCOCN1C(=C(C(=C1C(F)(F)F)Br)C#N)C2=CC=C(C=C2)Cl,91778,Negative,In Vivo
4-bromoaniline,C1=CC(=CC=C1N)Br,106-40-1,Negative,in vivo
"4-butyl-1,2-diphenylpyrazolidine-3,5-dione",CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,4781,Negative,In Vivo
"4-butyl-1,2-diphenylpyrazolidine-3,5-dione",CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,4781,Positive,In Vivo
"4-butyl-1,2-diphenylpyrazolidine-3,5-dione",CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,50-33-9,Negative,in vivo
"4-butyl-1,2-diphenylpyrazolidine-3,5-dione",CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,50-33-9,Positive,in vitro
4-chloro-1-nitrosopiperidine,C1CN(CCC1Cl)N=O,65445-61-6,Positive,in vitro
4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,3440,Negative,In Vivo
4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,3440,Positive,In Vivo
4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,54-31-9,Negative,in vitro
4-chloro-2-methylaniline,CC1=C(C=CC(=C1)Cl)N,95-69-2,Positive,in vivo
4-chloro-2-methylaniline;hydrochloride,CC1=C(C=CC(=C1)Cl)N.Cl,18487,Positive,In Vivo
4-chloro-2-methylaniline;hydrochloride,CC1=C(C=CC(=C1)Cl)N.Cl,18487,Negative,In Vivo
4-chloro-3-(dichloromethyl)-2-hydroxy-2H-furan-5-one,C1(C(=C(C(=O)O1)Cl)C(Cl)Cl)O,53665,Positive,In Vivo
4-chloro-3-(dichloromethyl)-2-hydroxy-2H-furan-5-one,C1(C(=C(C(=O)O1)Cl)C(Cl)Cl)O,77439-76-0,Negative,in vitro
4-CHLORO-4'-AMINODIPHENYLETHER,C1=CC(=CC=C1N)OC2=CC=C(C=C2)Cl,101-79-1,Negative,In vivo
4-CHLORO-4'-AMINODIPHENYLETHER,C1=CC(=CC=C1N)OC2=CC=C(C=C2)Cl,101-79-1,Positive,In vivo
"4-CHLORO-6-(2,3-XYLIDINO)-2-PYRIMIDINYLTHIO(N-beta-HYDROXYETHYL)ACETAMIDE",CC1=C(C(=CC=C1)NC2=CC(=NC(=N2)SCC(=O)NCCO)Cl)C,65089-17-0,Positive,In vivo
4-Chloro-m-phenylenediamine,C1=CC(=C(C=C1N)N)Cl,5131-60-2,Positive,in vitro
4-Chloro-o-phenylenediamine,C1=CC(=C(C=C1Cl)N)N,95-83-0,Positive,in vitro
4-CHLORO-o-TOLUIDINE.HCl,CC1=C(C=CC(=C1)Cl)N.Cl,3165-93-3,Negative,In vivo
4-CHLORO-o-TOLUIDINE.HCl,CC1=C(C=CC(=C1)Cl)N.Cl,3165-93-3,Positive,In vivo
4-chloroaniline,C1=CC(=CC=C1N)Cl,7812,Negative,In Vivo
4-chloroaniline,C1=CC(=CC=C1N)Cl,7812,Positive,In Vivo
4-chloroaniline,C1=CC(=CC=C1N)Cl,106-47-8,Negative,in vitro
4-chloroaniline;hydrochloride,C1=CC(=CC=C1N)Cl.Cl,5284363,Negative,In Vivo
4-chloroaniline;hydrochloride,C1=CC(=CC=C1N)Cl.Cl,5284363,Positive,In Vivo
"4-chlorobenzene-1,2-diamine",C1=CC(=C(C=C1Cl)N)N,7263,Positive,In Vivo
"4-chlorobenzene-1,2-diamine",C1=CC(=C(C=C1Cl)N)N,95-83-0,Positive,in vivo
"4-chlorobenzene-1,3-diamine",C1=CC(=C(C=C1N)N)Cl,21209,Negative,In Vivo
"4-chlorobenzene-1,3-diamine",C1=CC(=C(C=C1N)N)Cl,21209,Positive,In Vivo
"4-chlorobenzene-1,3-diamine",C1=CC(=C(C=C1N)N)Cl,5131-60-2,Positive,in vivo
"4-chlorobenzene-1,3-diol",C1=CC(=C(C=C1O)O)Cl,95-88-5,Negative,in vitro
4-chlorobut-2-ynyl N-(3-chlorophenyl)carbamate,C1=CC(=CC(=C1)Cl)NC(=O)OCC#CCCl,101-27-9,Positive,in vitro
4-dimethoxyphosphorylmorpholine,COP(=O)(N1CCOCC1)OC,11698,Negative,In Vivo
4-dimethoxyphosphorylmorpholine,COP(=O)(N1CCOCC1)OC,11698,Positive,In Vivo
"4-DIMETHYLAMINO-3,5-XYLENOL",CC1=CC(=CC(=C1N(C)C)C)O,6120-10-1,Negative,In vivo
4-DIMETHYLAMINOANTIPYRINE,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C,58-15-1,Negative,In vivo
4-Dimethylaminoazobenzeneazo-1-naphthalene,CN(C)C1=CC=C(C=C1)N=NC2=CC=CC3=CC=CC=C32,607-59-0,Positive,in vitro
4-Dimethylaminoazobenzeneazo-2-naphthalene,CN(C)C1=CC=C(C=C1)N=NC2=CC3=CC=CC=C3C=C2,613-65-0,Positive,in vitro
4-Dimethylaminobenzenediazosulfonic acid sodium salt (AKA fenaminosulf),CN(C)C1=CC=C(C=C1)N=NS(=O)(=O)[O-].[Na+],140-56-7,Positive,in vitro
4-Dimethylaminostilbene,CN(C)C1=CC=C(C=C1)C=CC2=CC=CC=C2,838-95-9,Positive,in vitro
4-ethenylcyclohexene,C=CC1CCC=CC1,7499,Positive,In Vivo
4-ethenylpyridine,C=CC1=CC=NC=C1,7502,Negative,In Vivo
4-ETHOXY-PHENYLUREA,CCOC1=CC=C(C=C1)NC(=O)N,150-69-6,Positive,In vivo
4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,3476,Negative,In Vivo
"4-ethylbenzene-1,2-diol",CCC1=CC(=C(C=C1)O)O,1124-39-6,Negative,in vitro
4-ethylsulfonylnaphthalene-1-sulfonamide,CCS(=O)(=O)C1=CC=C(C2=CC=CC=C21)S(=O)(=O)N,13296,Positive,In Vivo
4-ETHYLSULPHONYLNAPHTHALENE-1-SULFONAMIDE,CCS(=O)(=O)C1=CC=C(C2=CC=CC=C21)S(=O)(=O)N,842-00-2,Positive,In vivo
4-fluoro-10-methylbenzo[a]anthracene,CC1=CC2=CC3=C(C=CC4=C3C=CC=C4F)C=C2C=C1,,Positive,in vitro
4-fluoroaniline,C1=CC(=CC=C1N)F,371-40-4,Negative,in vivo
4-formylbenzoic acid,C1=CC(=CC=C1C=O)C(=O)O,619-66-9,Positive,in vitro
"4-hexylbenzene-1,3-diol",CCCCCCC1=C(C=C(C=C1)O)O,3610,Negative,In Vivo
4-hydrazinylbenzoic acid;hydrochloride,C1=CC(=CC=C1C(=O)O)NN.Cl,90547,Negative,In Vivo
4-hydroxy-1H-quinolin-2-one,C1=CC=C2C(=C1)C(=CC(=O)N2)O,86-95-3,Positive,in vitro
4-hydroxy-3-methoxybenzaldehyde,COC1=C(C=CC(=C1)C=O)O,121-33-5,Positive,in vitro
"4-hydroxy-4,6-dihydrofuro[3,2-c]pyran-2-one",C1C=C2C(=CC(=O)O2)C(O1)O,149-29-1,Negative,in vivo
"4-hydroxy-4,6-dihydrofuro[3,2-c]pyran-2-one",C1C=C2C(=CC(=O)O2)C(O1)O,149-29-1,Negative,in vitro
4-Hydroxyaminoquinoline-N-oxide,C1=CC=C2C(=C1)C(=NO)C=CN2O,4637-56-3,Positive,in vitro
4-hydroxybutyl methanesulfonate,CS(=O)(=O)OCCCCO,42729-95-3,Positive,in vitro
4-iodoaniline,C1=CC(=CC=C1N)I,540-37-4,Negative,in vivo
4-isothiocyanato-N-(4-nitrophenyl)aniline,C1=CC(=CC=C1NC2=CC=C(C=C2)[N+](=O)[O-])N=C=S,26328-53-0,Positive,in vitro
4-methoxy-2-methylaniline,CC1=C(C=CC(=C1)OC)N,7610,Negative,In Vivo
4-methoxy-2-methylaniline,CC1=C(C=CC(=C1)OC)N,7610,Positive,In Vivo
4-methoxyaniline;hydrochloride,COC1=CC=C(C=C1)N.Cl,2734956,Negative,In Vivo
"4-methoxybenzene-1,3-diamine",COC1=C(C=C(C=C1)N)N,0615-05-04,Negative,in vivo
"4-methoxybenzene-1,3-diamine",COC1=C(C=C(C=C1)N)N,0615-05-04,Positive,in vivo
"4-methoxybenzene-1,3-diamine",COC1=C(C=C(C=C1)N)N,0615-05-04,Positive,in vitro
"4-methoxybenzene-1,3-diamine;sulfuric acid",COC1=C(C=C(C=C1)N)N.OS(=O)(=O)O,38221,Positive,In Vivo
"4-methoxybenzene-1,3-diamine;sulfuric acid",COC1=C(C=C(C=C1)N)N.OS(=O)(=O)O,39156-41-7,Positive,in vivo
"4-methoxybenzene-1,3-diamine;sulfuric acid",COC1=C(C=C(C=C1)N)N.OS(=O)(=O)O,39156-41-7,Negative,in vivo
"4-methoxybenzene-1,3-diamine;sulfuric acid",COC1=C(C=C(C=C1)N)N.OS(=O)(=O)O,39156-41-7,Positive,in vitro
4-methoxyphenol,COC1=CC=C(C=C1)O,9015,Negative,In Vivo
4-METHOXYPHENOL,COC1=CC=C(C=C1)O,150-76-5,Negative,In vivo
4-methoxyphenol,COC1=CC=C(C=C1)O,9015,Positive,In Vivo
4-METHOXYPHENOL,COC1=CC=C(C=C1)O,150-76-5,Positive,In vivo
4-methoxyphenol,COC1=CC=C(C=C1)O,150-76-5,Positive,in vitro
4-methoxyphenol Hydroquinone monomethyl ether,COC1=CC=C(C=C1)O,150-76-5,Negative,in vitro
4-METHYL-1-[(5-NITROFURFURYLIDENE)AMINO]-2-IMIDAZOLIDINONE,CC1CN(C(=O)N1)N=CC2=CC=C(O2)[N+](=O)[O-],21638-36-8,Positive,In vivo
4-Methyl-1-[(5-nitrofurfurylidene)amino]-2-imidazoline,CC1CN(C(=O)N1)N=CC2=CC=C(O2)[N+](=O)[O-],21638-36-8,Positive,in vitro
4-methyl-1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidin-2-one,CC1CN(C(=O)N1)/N=C/C2=CC=C(O2)[N+](=O)[O-],15179-96-1,Positive,in vitro
4-methyl-1-nitrosopiperidine,CC1CCN(CC1)N=O,15104-03-07,Positive,in vitro
"4-methyl-1,3,2-dioxathiane 2,2-dioxide",CC1CCOS(=O)(=O)O1,4426-50-0,Positive,in vitro
"4-methyl-8,16,24,25-tetrazahexacyclo[15.7.1.02,7.09,25.010,15.018,23]pentacosa-1(24),2(7),3,5,8,10,12,14,16,18,20,22-dodecaene",CC1=CC2=C(C=C1)N=C3C4=CC=CC=C4N=C5N3C2=NC6=CC=CC=C65,198077,Positive,In Vivo
4-Methyl-o-phenylenediamine,CC1=CC(=C(C=C1)N)N,496-72-0,Positive,in vitro
4-methylaniline,CC1=CC=C(C=C1)N,7813,Positive,In Vivo
4-methylaniline,CC1=CC=C(C=C1)N,106-49-0,Negative,in vitro
4-methylaniline;hydrochloride,CC1=CC=C(C=C1)N.Cl,540-23-8,Positive,in vitro
"4-methylbenzene-1,2-diamine",CC1=CC(=C(C=C1)N)N,496-72-0,Positive,in vitro
"4-methylbenzene-1,2-diol",CC1=CC(=C(C=C1)O)O,9958,Positive,In Vivo
"4-methylbenzene-1,3-diamine",CC1=C(C=C(C=C1)N)N,7261,Negative,In Vivo
"4-methylbenzene-1,3-diamine",CC1=C(C=C(C=C1)N)N,95-80-7,Negative,in vivo
"4-methylbenzene-1,3-diamine",CC1=C(C=C(C=C1)N)N,7261,Positive,In Vivo
"4-methylbenzene-1,3-diamine",CC1=C(C=C(C=C1)N)N,95-80-7,Positive,in vivo
"4-methylbenzene-1,3-diamine",CC1=C(C=C(C=C1)N)N,95-80-7,Negative,in vitro
4-methylbenzenediazonium;sulfate,CC1=CC=C(C=C1)[N+]#N.[O-]S(=O)(=O)[O-],161732,Positive,In Vivo
4-METHYLCATECHOL,CC1=CC(=C(C=C1)O)O,452-86-8,Positive,In vivo
4-methylchromen-2-one,CC1=CC(=O)OC2=CC=CC=C12,607-71-6,Positive,in vitro
4-methylchrysene,CC1=C2C(=CC=C1)C=CC3=C2C=CC4=CC=CC=C43,3351-30-2,Positive,in vitro
4-methyloxetan-2-one,CC1CC(=O)O1,18303,Positive,In Vivo
4-methyloxetan-2-one,CC1CC(=O)O1,3068-88-0,Positive,in vivo
4-methylpentan-2-one,CC(C)CC(=O)C,7909,Positive,In Vivo
4-methylphenol,CC1=CC=C(C=C1)O,106-44-5,Negative,in vitro
4-methylquinoline,CC1=CC=NC2=CC=CC=C12,10285,Negative,In Vivo
4-methylquinoline,CC1=CC=NC2=CC=CC=C12,10285,Positive,In Vivo
4-methylquinoline,CC1=CC=NC2=CC=CC=C12,491-35-0,Positive,in vitro
4-methylsulfonyloxybut-2-ynyl methanesulfonate,CS(=O)(=O)OCC#CCOS(=O)(=O)C,,Positive,in vitro
4-methylsulfonyloxybutyl methanesulfonate,CS(=O)(=O)OCCCCOS(=O)(=O)C,2478,Positive,In Vivo
4-methylsulfonyloxybutyl methanesulfonate,CS(=O)(=O)OCCCCOS(=O)(=O)C,55-98-1,Positive,in vivo
4-methylsulfonyloxybutyl methanesulfonate,CS(=O)(=O)OCCCCOS(=O)(=O)C,55-98-1,Positive,in vitro
4-Monochlorobiphenyl,C1=CC=C(C=C1)C2=CC=C(C=C2)Cl,2051-62-9,Negative,in vitro
4-MORPHOLINO-2-(5-NITRO-2-THIENYL)QUINAZOLINE,C1COCCN1C2=NC(=NC3=CC=CC=C32)C4=CC=C(S4)[N+](=O)[O-],58139-48-3,Positive,In vivo
4-Morpholino-2-(5-nitro-2-thienyl)quinazoline,C1COCCN1C2=NC(=NC3=CC=CC=C32)C4=CC=C(S4)[N+](=O)[O-],58139-48-3,Positive,in vitro
"4-N-(6-chloro-2-methoxyacridin-9-yl)-1-N,1-N-diethylpentane-1,4-diamine",CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,83-89-6,Positive,in vitro
"4-N-(6-chloro-2-methoxyacridin-9-yl)-1-N,1-N-diethylpentane-1,4-diamine;dihydrate;dihydrochloride",CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC.O.O.Cl.Cl,2725002,Negative,In Vivo
"4-N-(6-chloro-2-methoxyacridin-9-yl)-1-N,1-N-diethylpentane-1,4-diamine;dihydrochloride",CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC.Cl.Cl,69-05-6,Negative,in vivo
"4-N-(6-chloro-2-methoxyacridin-9-yl)-1-N,1-N-diethylpentane-1,4-diamine;dihydrochloride",CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC.Cl.Cl,69-05-6,Positive,in vitro
"4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine",CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,54-05-7,Positive,in vitro
"4-N-ethyl-6-methylsulfanyl-2-N-propan-2-yl-1,3,5-triazine-2,4-diamine",CCNC1=NC(=NC(=N1)SC)NC(C)C,0834-12-8,Negative,in vitro
"4-N-methylbenzene-1,4-diamine;dihydrochloride",CNC1=CC=C(C=C1)N.Cl.Cl,79373,Negative,In Vivo
"4-N-phenylbenzene-1,4-diamine",C1=CC=C(C=C1)NC2=CC=C(C=C2)N,7564,Negative,In Vivo
"4-N-phenylbenzene-1,4-diamine",C1=CC=C(C=C1)NC2=CC=C(C=C2)N,101-54-2,Negative,in vivo
"4-N-phenylbenzene-1,4-diamine;hydrochloride",C1=CC=C(C=C1)NC2=CC=C(C=C2)N.Cl,2198-59-6,Negative,in vitro
"4-N,4-N-bis(2-chloroethyl)benzene-1,4-diamine",C1=CC(=CC=C1N)N(CCCl)CCCl,2067-58-5,Positive,in vitro
"4-nitro-1-oxido-2,1,3-benzoxadiazol-1-ium",C1=CC2=[N+](ON=C2C(=C1)[N+](=O)[O-])[O-],18771-85-2,Positive,in vitro
4-Nitro-o-phenylenediamine (free base and HCL salt),C1=CC(=C(C=C1[N+](=O)[O-])N)N,99-56-9,Positive,in vitro
4-nitroaniline,C1=CC(=CC=C1N)[N+](=O)[O-],7475,Negative,In Vivo
4-nitroaniline,C1=CC(=CC=C1N)[N+](=O)[O-],0100-01-06,Negative,in vivo
4-Nitroanthranilic acid,C1=CC(=C(C=C1[N+](=O)[O-])N)C(=O)O,619-17-0,Positive,in vitro
4-nitrobenzaldehyde,C1=CC(=CC=C1C=O)[N+](=O)[O-],555-16-8,Positive,in vitro
"4-nitrobenzene-1,2-diamine",C1=CC(=C(C=C1[N+](=O)[O-])N)N,5111791,Negative,In Vivo
"4-nitrobenzene-1,2-diamine",C1=CC(=C(C=C1[N+](=O)[O-])N)N,99-56-9,Negative,in vivo
"4-nitrobenzene-1,2-diamine",C1=CC(=C(C=C1[N+](=O)[O-])N)N,99-56-9,Negative,in vitro
4-nitrobenzoic acid,C1=CC(=CC=C1C(=O)O)[N+](=O)[O-],6108,Negative,In Vivo
4-nitrobenzoic acid,C1=CC(=CC=C1C(=O)O)[N+](=O)[O-],6108,Positive,In Vivo
4-nitrobenzoic acid,C1=CC(=CC=C1C(=O)O)[N+](=O)[O-],62-23-7,Negative,in vitro
4-nitrobiphenyl,C1=CC=C(C=C1)C2=CC=C(C=C2)[N+](=O)[O-],92-93-3,Positive,in vitro
4-nitrophenol,C1=CC(=CC=C1[N+](=O)[O-])O,980,Negative,In Vivo
4-nitrophenol,C1=CC(=CC=C1[N+](=O)[O-])O,0100-02-07,Negative,in vitro
4-Nitrophenyl aminothyourea -  COLIPA B70,C1=CC(=CC=C1NCCNC(=O)N)[N+](=O)[O-],27080-42-8,Negative,in vitro
4-Nitrophenyl glycidyl ether,C1C(O1)COC2=CC=C(C=C2)[N+](=O)[O-],5255-75-4,Positive,in vitro
4-nitropyrene,C1=CC2=C3C(=C1)C=C(C4=CC=CC(=C43)C=C2)[N+](=O)[O-],62134,Positive,In Vivo
4-nitroquinoline,C1=CC=C2C(=C1)C(=CC=N2)[N+](=O)[O-],3741-15-9,Negative,in vitro
4-Nitroquinoline-N-oxide,C1=CC=C2C(=C1)C(=CC=[N+]2[O-])[N+](=O)[O-],56-57-5,Positive,in vitro
4-nitroso-N-phenylaniline,C1=CC=C(C=C1)NC2=CC=C(C=C2)N=O,9074,Negative,In Vivo
4-nitroso-N-phenylaniline,C1=CC=C(C=C1)NC2=CC=C(C=C2)N=O,9074,Positive,In Vivo
4-nitroso-N-phenylaniline,C1=CC=C(C=C1)NC2=CC=C(C=C2)N=O,0156-10-5,Positive,in vivo
4-NITROSOMETHYLAMINOPYRIDINE,CN(C1=CC=NC=C1)N=O,16219-99-1,Negative,In vivo
4-nitrosomorpholin-2-ol,C1COC(CN1N=O)O,107887,Positive,In Vivo
4-nitrosomorpholin-2-ol,C1COC(CN1N=O)O,107887,Negative,In Vivo
4-nitrosomorpholine,C1COCCN1N=O,6046,Positive,In Vivo
4-nitrosomorpholine,C1COCCN1N=O,59-89-2,Negative,in vivo
4-nitrosomorpholine,C1COCCN1N=O,59-89-2,Positive,in vivo
4-nitrosomorpholine,C1COCCN1N=O,6046,Negative,In Vivo
4-nitrosomorpholine,C1COCCN1N=O,59-89-2,Positive,in vitro
4-Nitrostilbene,C1=CC=C(C=C1)C=CC2=CC=C(C=C2)[N+](=O)[O-],4003-94-5,Positive,in vitro
"4-oxa-19-azapentacyclo[9.8.0.02,8.03,5.013,18]nonadeca-1(19),2(8),9,11,13,15,17-heptaene-6,7-diol",C1=CC=C2C(=C1)C=C3C=CC4=C(C3=N2)C5C(O5)C(C4O)O,163488,Positive,In Vivo
"4-oxapentacyclo[9.8.0.02,8.03,5.013,18]nonadeca-1(19),2(8),9,11,13,15,17-heptaene",C1CC2=C(C3C1O3)C4=CC5=CC=CC=C5C=C4C=C2,,Positive,in vitro
"4-phenyl-1,3-thiazol-2-amine",C1=CC=C(C=C1)C2=CSC(=N2)N,2010-06-02,Negative,in vitro
4-phenylaniline,C1=CC=C(C=C1)C2=CC=C(C=C2)N,7102,Positive,In Vivo
4-phenylaniline,C1=CC=C(C=C1)C2=CC=C(C=C2)N,92-67-1,Positive,in vivo
4-phenylaniline,C1=CC=C(C=C1)C2=CC=C(C=C2)N,92-67-1,Negative,in vitro
4-phenyldiazenylaniline,C1=CC=C(C=C1)N=NC2=CC=C(C=C2)N,6051,Negative,In Vivo
4-phenyldiazenylaniline,C1=CC=C(C=C1)N=NC2=CC=C(C=C2)N,6051,Positive,In Vivo
4-phenyldiazenylaniline,C1=CC=C(C=C1)N=NC2=CC=C(C=C2)N,60-09-3,Positive,in vivo
4-phenyldiazenylaniline,C1=CC=C(C=C1)N=NC2=CC=C(C=C2)N,60-09-3,Negative,in vitro
"4-phenyldiazenylbenzene-1,3-diamine;hydrochloride",C1=CC=C(C=C1)N=NC2=C(C=C(C=C2)N)N.Cl,10771,Positive,In Vivo
"4-phenyldiazenylbenzene-1,3-diamine;hydrochloride",C1=CC=C(C=C1)N=NC2=C(C=C(C=C2)N)N.Cl,532-82-1,Positive,in vitro
4-phenyldiazenylphenol,C1=CC=C(C=C1)N=NC2=CC=C(C=C2)O,1689-82-3,Negative,in vitro
"4-pyrido[3,4-b]indol-9-ylaniline",C1=CC=C2C(=C1)C3=C(N2C4=CC=C(C=C4)N)C=NC=C3,154224,Positive,In Vivo
4-vinylcyclohexene,C=CC1CCC=CC1,100-40-3,Negative,in vitro
"4,10-Diazachrysene",C1=CC2=C(C3=C(C=C2)C4=C(C=CC=N4)C=C3)N=C1,218-34-8,Positive,in vitro
"4,11,17,24-tetramethoxyhexacyclo[12.12.0.02,7.08,13.015,20.021,26]hexacosa-1,3,5,7,9,11,13,15(20),16,18,21(26),22,24-tridecaene",COC1=CC2=C3C4=C(C=CC(=C4)OC)C5=C(C3=C6C=C(C=CC6=C2C=C1)OC)C=C(C=C5)OC,60223-52-1,Positive,in vitro
"4,4-Thiobis6-tert-butyl-m-cresol  Santonox-R",CC1=CC(=C(C=C1SC2=CC(=C(C=C2C)O)C(C)(C)C)C(C)(C)C)O,96-69-5,Negative,in vitro
"4,4'-DIAMINOAZOBENZENE",C1=CC(=CC=C1N)N=NC2=CC=C(C=C2)N,538-41-0,Negative,In vivo
"4,4'-DIAMINOBENZANILIDE",C1=CC(=CC=C1C(=O)NC2=CC=C(C=C2)N)N,785-30-8,Negative,In vivo
"4,4'-Diaminostilbene",C1=CC(=CC=C1C=CC2=CC=C(C=C2)N)N,621-96-5,Positive,in vitro
"4,4'-isopropylidenediphenol",CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,80-05-7,Negative,in vitro
"4,4'-METHYLENE-BIS(2-CHLOROANILINE)",C1=CC(=C(C=C1CC2=CC(=C(C=C2)N)Cl)Cl)N,101-14-4,Negative,In vivo
"4,4'-METHYLENE-BIS(2-CHLOROANILINE)",C1=CC(=C(C=C1CC2=CC(=C(C=C2)N)Cl)Cl)N,101-14-4,Positive,In vivo
"4,4'-METHYLENE-BIS(2-CHLOROANILINE).2HCl",C1=CC(=C(C=C1CC2=CC(=C(C=C2)N)Cl)Cl)[NH3+].[Cl-],64049-29-2,Negative,In vivo
"4,4'-METHYLENE-BIS(2-CHLOROANILINE).2HCl",C1=CC(=C(C=C1CC2=CC(=C(C=C2)N)Cl)Cl)[NH3+].[Cl-],64049-29-2,Positive,In vivo
"4,4'-METHYLENE-BIS(2-METHYLANILINE)",CC1=C(C=CC(=C1)CC2=CC(=C(C=C2)N)C)N,838-88-0,Positive,In vivo
"4,4'-Methylene-bis(2-methylaniline)",CC1=C(C=CC(=C1)CC2=CC(=C(C=C2)N)C)N,838-88-0,Positive,in vitro
"4,4'-Methylenebis(2-chloroaniline) (free base and 2HCl salt)",C1=CC(=C(C=C1CC2=CC(=C(C=C2)N)Cl)Cl)N,101-14-4,Positive,in vitro
"4,4'-Methylenebis(N,N-dimethylaniline)",CN(C)C1=CC=C(C=C1)CC2=CC=C(C=C2)N(C)C,101-61-1,Positive,in vitro
"4,4'-Methylenediamine (free base and 2HCl salt)",C1=CC(=CC=C1CC2=CC=C(C=C2)N)N,101-77-9,Positive,in vitro
"4,4'-Oxybis(Benzenesulfonylhydrazide)",C1=CC(=CC=C1OC2=CC=C(C=C2)S(=O)(=O)NN)S(=O)(=O)NN,80-51-3,Positive,in vitro
"4,4'-Oxydianiline",C1=CC(=CC=C1N)OC2=CC=C(C=C2)N,101-80-4,Positive,in vitro
"4,4'-SULFONYLBISACETANILIDE",CC(=O)NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)NC(=O)C,77-46-3,Positive,In vivo
"4,4'-THIODIANILINE",C1=CC(=CC=C1N)SC2=CC=C(C=C2)N,139-65-1,Positive,In vivo
"4,4'-Thiodianiline",C1=CC(=CC=C1N)SC2=CC=C(C=C2)N,139-65-1,Positive,in vitro
"4,4''-Diaminoterphenyl ",C1=CC(=CC=C1C2=CC=C(C=C2)N)C3=CC=C(C=C3)N,3365-85-3,Positive,in vitro
"4,5-dihydrobenzo[a]pyrene-4,5-diol",C1=CC=C2C3=C4C(=CC2=C1)C(C(C5=CC=CC(=C54)C=C3)O)O,28622-84-6,Negative,in vitro
"4,5-dimethoxy-1,3,7,9-tetramethylpurine-2,6,8-trione",CN1C(=O)C2(C(N(C1=O)C)(N(C(=O)N2C)C)OC)OC,21802-56-2,Negative,in vitro
"4,5,12-trimethoxy-9-azatetracyclo[7.5.2.01,10.02,7]hexadeca-2,4,6-trien-3-ol",COC1CCC23CCN(C2C1)CC4=CC(=C(C(=C34)O)OC)OC,66276-51-5,Positive,in vitro
"4,5,6,7-tetrabromo-2-benzofuran-1,3-dione",C12=C(C(=C(C(=C1Br)Br)Br)Br)C(=O)OC2=O,632-79-1,Negative,in vitro
"4,6-DIAMINO-2-(5-NITRO-2-FURYL)-s-TRIAZINE",C1=C(OC(=C1)[N+](=O)[O-])C2=NC(=NC(=N2)N)N,720-69-4,Positive,In vivo
"4,6-Diamino-2-(5-nitro-2-furyl)-s-triazine",C1=C(OC(=C1)[N+](=O)[O-])C2=NC(=NC(=N2)N)N,720-69-4,Positive,in vitro
"4,6-dichloro-N-(2-chlorophenyl)-1,3,5-triazin-2-amine",C1=CC=C(C(=C1)NC2=NC(=NC(=N2)Cl)Cl)Cl,7541,Negative,In Vivo
"4,6-dichloro-N-(2-chlorophenyl)-1,3,5-triazin-2-amine",C1=CC=C(C(=C1)NC2=NC(=NC(=N2)Cl)Cl)Cl,0101-05-03,Negative,in vivo
"4,6-dichloro-N-(2-chlorophenyl)-1,3,5-triazin-2-amine",C1=CC=C(C(=C1)NC2=NC(=NC(=N2)Cl)Cl)Cl,0101-05-03,Positive,in vitro
"4,6-DIMETHYL-2-(5-NITRO-2-FURYL)PYRIMIDINE",CC1=CC(=NC(=N1)C2=CC=C(O2)[N+](=O)[O-])C,59-35-8,Positive,In vivo
"4,6,9-trimethylfuro[2,3-h]chromen-2-one",CC1=CC2=C(C3=C1OC=C3C)OC(=O)C=C2C,107731,Negative,In Vivo
4'-(Chloroacetyl)acetanilide,CC(=O)NC1=CC=C(C=C1)C(=O)CCl,140-49-8,Positive,in vitro
4'-FLUORO-4-AMINODIPHENYL,C1=CC(=CC=C1C2=CC=C(C=C2)F)N,324-93-6,Positive,In vivo
"4',5'-dibromo-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one",C1=CC=C2C(=C1)C(=O)OC23C4=C(C(=C(C=C4)O)Br)OC5=C3C=CC(=C5Br)O,11689,Negative,In Vivo
"5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol",C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO,5677,Negative,In Vivo
5-(2-Chloroethyl)2-deoxyuridine,C1C(C(OC1N2C=C(C(=O)NC2=O)CCCl)CO)O,90301-59-0,Negative,in vitro
"5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,1622-61-3,Negative,in vitro
"5-(2-octylsulfinylpropyl)-1,3-benzodioxole",CCCCCCCCS(=O)C(C)CC1=CC2=C(C=C1)OCO2,8442,Negative,In Vivo
"5-(2-octylsulfinylpropyl)-1,3-benzodioxole",CCCCCCCCS(=O)C(C)CC1=CC2=C(C=C1)OCO2,8442,Positive,In Vivo
"5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid",CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,3463,Positive,In Vivo
"5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine",CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,4993,Negative,In Vivo
"5-(4-Nitrophenyl)-2,4-pentadien-1-al (AKA Spy dust)",C1=CC(=CC=C1C=CC=CC=O)[N+](=O)[O-],2608-48-2,Negative,in vitro
"5-(5-NITRO-2-FURYL)-1,3,4-OXADIAZOLE-2-OL",C1=C(OC(=C1)[N+](=O)[O-])C2=NNC(=O)O2,2122-86-3,Positive,In vivo
"5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-amine",C1=C(OC(=C1)[N+](=O)[O-])C2=NN=C(S2)N,712-68-5,Positive,in vivo
"5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-amine",C1=C(OC(=C1)[N+](=O)[O-])C2=NN=C(S2)N,61205,Positive,In Vivo
"5-(5-nitrofuran-2-yl)-1H-1,2,4-triazole",C1=C(OC(=C1)[N+](=O)[O-])C2=NC=NN2,,Negative,in vitro
5-(chloromethyl)furan-2-carbaldehyde,C1=C(OC(=C1)C=O)CCl,74191,Positive,In Vivo
5-(hydroxymethyl)furan-2-carbaldehyde,C1=C(OC(=C1)C=O)CO,237332,Negative,In Vivo
5-(methoxymethyl)-2-(4-methyl-5-oxo-4-propan-2-yl-1H-imidazol-2-yl)pyridine-3-carboxylic acid,CC(C)C1(C(=O)NC(=N1)C2=C(C=C(C=N2)COC)C(=O)O)C,86137,Negative,In Vivo
"5-(morpholin-4-ylmethyl)-3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one",C1COCCN1CC2CN(C(=O)O2)/N=C/C3=CC=C(O3)[N+](=O)[O-],139-91-3,Positive,in vivo
"5-(morpholin-4-ylmethyl)-3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one",C1COCCN1CC2CN(C(=O)O2)/N=C/C3=CC=C(O3)[N+](=O)[O-],139-91-3,Positive,in vitro
"5-(morpholin-4-ylmethyl)-3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one;hydrochloride",C1COCCN1CC2CN(C(=O)O2)/N=C/C3=CC=C(O3)[N+](=O)[O-].Cl,3759-92-0,Positive,in vitro
"5-(oxiran-2-ylmethyl)-1,3-benzodioxole",C1C(O1)CC2=CC3=C(C=C2)OCO3,7470-44-2,Positive,in vitro
5-(p-Dimethylaminophenylazo)benzothiazole,CN(C)C1=CC=C(C=C1)N=NC2=CC3=C(C=C2)SC=N3,18463-90-6,Positive,in vitro
"5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one",CC(C)(C)NC[C@@H](COC1=CC=CC2=C1CCCC2=O)O,39468,Negative,In Vivo
"5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one",CC(C)(C)NC[C@@H](COC1=CC=CC2=C1CCCC2=O)O,39468,Positive,In Vivo
"5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine",COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,738-70-5,Positive,in vitro
5-[(4-carboxyphenyl)diazenyl]-2-hydroxybenzoic acid,C1=CC(=CC=C1C(=O)O)N=NC2=CC(=C(C=C2)O)C(=O)O,127824,Negative,In Vivo
"5-[(E)-1-(furan-2-yl)-2-(5-nitrofuran-2-yl)ethenyl]-1,3,4-oxadiazol-2-amine",C1=COC(=C1)/C(=C\C2=CC=C(O2)[N+](=O)[O-])/C3=NN=C(O3)N,17505-25-8,Positive,in vitro
"5-[(E)-2-bromoethenyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)/C=C/Br)CO)O,69304-47-8,Positive,in vitro
"5-[(E)-2-chloroethenyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)/C=C/Cl)CO)O,74131-08-01,Positive,in vitro
"5-[(E)-prop-1-enyl]-1,3-benzodioxole",C/C=C/C1=CC2=C(C=C1)OCO2,637796,Positive,In Vivo
"5-[(E)-prop-1-enyl]-1,3-benzodioxole",C/C=C/C1=CC2=C(C=C1)OCO2,120-58-1,Positive,in vivo
"5-[2-(2-butoxyethoxy)ethoxymethyl]-6-propyl-1,3-benzodioxole",CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2,5794,Negative,In Vivo
"5-[2-(2-butoxyethoxy)ethoxymethyl]-6-propyl-1,3-benzodioxole",CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2,5794,Positive,In Vivo
"5-[2-(2-butoxyethoxy)ethoxymethyl]-6-propyl-1,3-benzodioxole",CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2,51-03-6,Negative,in vivo
5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid,C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)[N+](=O)[O-])C(=O)O,44073,Positive,In Vivo
5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid,C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)[N+](=O)[O-])C(=O)O,44073,Negative,In Vivo
"5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one;hydrochloride",CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O.Cl,51781-21-6,Negative,in vitro
5-[4-[bis(2-chloroethyl)amino]phenyl]pentanoic acid,C1=CC(=CC=C1CCCCC(=O)O)N(CCCl)CCCl,,Positive,in vitro
"5-[bis(2-chloroethyl)amino]-1H-pyrimidine-2,4-dione",C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,6194,Positive,In Vivo
"5-[bis(2-chloroethyl)amino]-1H-pyrimidine-2,4-dione",C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,66-75-1,Positive,in vivo
"5-[bis(2-chloroethyl)amino]-1H-pyrimidine-2,4-dione",C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,66-75-1,Negative,in vitro
"5-[bis(2-chloroethyl)aminomethyl]-1H-pyrimidine-2,4-dione;hydrochloride",C1=C(C(=O)NC(=O)N1)CN(CCCl)CCCl.Cl,6860-12-4,Positive,in vitro
"5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)pyrazole-3-carbonitrile",C1=C(C=C(C(=C1Cl)N2C(=C(C(=N2)C#N)S(=O)C(F)(F)F)N)Cl)C(F)(F)F,3352,Negative,In Vivo
"5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)pyrazole-3-carbonitrile",C1=C(C=C(C(=C1Cl)N2C(=C(C(=N2)C#N)S(=O)C(F)(F)F)N)Cl)C(F)(F)F,3352,Positive,In Vivo
"5-amino-1,4-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione",C1=CC2=C(C(=C1)N)C(=O)C3=C(C=CC(=C3C2=O)NCCNCCO)NCCNCCO,,Positive,in vitro
"5-amino-1H-pyrimidine-2,4-dione",C1=C(C(=O)NC(=O)N1)N,932-52-5,Positive,in vitro
"5-amino-2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazin-3-one",C1=NN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,65114,Negative,In Vivo
"5-amino-2,6-dihydrotriazolo[4,5-d]pyrimidin-7-one",C12=NNN=C1N=C(NC2=O)N,134-58-7,Negative,in vitro
5-amino-4-chloro-2-phenylpyridazin-3-one,C1=CC=C(C=C1)N2C(=O)C(=C(C=N2)N)Cl,1698-60-8,Negative,in vitro
5-Amino-4-chloro-o-cresol-HCl -COLIPA A117,CC1=CC(=C(C=C1O)N)Cl.Cl,110102-85-7,Positive,in vitro
5-amino-4-oxopentanoic acid;hydrochloride,C(CC(=O)O)C(=O)CN.Cl,5451-09-02,Negative,in vivo
"5-amino-6-(7-amino-6-methoxy-5,8-dioxoquinolin-2-yl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpyridine-2-carboxylic acid",CC1=C(C(=C(N=C1C(=O)O)C2=NC3=C(C=C2)C(=O)C(=C(C3=O)N)OC)N)C4=C(C(=C(C=C4)OC)OC)O,3930-19-6,Positive,in vivo
"5-amino-6-(7-amino-6-methoxy-5,8-dioxoquinolin-2-yl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpyridine-2-carboxylic acid",CC1=C(C(=C(N=C1C(=O)O)C2=NC3=C(C=C2)C(=O)C(=C(C3=O)N)OC)N)C4=C(C(=C(C=C4)OC)OC)O,3930-19-6,Negative,in vitro
5-AZACYTIDINE,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,320-67-2,Positive,In vivo
5-Azacytidine,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,320-67-2,Positive,in vitro
"5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)Br)CO)O,59-14-3,Positive,in vivo
"5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)Br)CO)O,6035,Positive,In Vivo
"5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)Br)CO)O,59-14-3,Negative,in vitro
"5-bromo-1H-pyrimidine-2,4-dione",C1=C(C(=O)NC(=O)N1)Br,51-20-7,Negative,in vitro
"5-bromo-3-butan-2-yl-6-methyl-1H-pyrimidine-2,4-dione",CCC(C)N1C(=O)C(=C(NC1=O)C)Br,9411,Negative,In Vivo
"5-bromo-3-butan-2-yl-6-methyl-1H-pyrimidine-2,4-dione",CCC(C)N1C(=O)C(=C(NC1=O)C)Br,9411,Positive,In Vivo
"5-bromo-3-butan-2-yl-6-methyl-1H-pyrimidine-2,4-dione",CCC(C)N1C(=O)C(=C(NC1=O)C)Br,314-40-9,Negative,in vitro
5-butylpyridine-2-carboxylic acid,CCCCC1=CN=C(C=C1)C(=O)O,536-69-6,Negative,in vitro
5-carbamoyl-1H-imidazole-4-diazonium,C1=NC(=C(N1)C(=O)N)[N+]#N,24316-91-4,Positive,in vitro
"5-chloro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)Cl)CO)O,50-90-8,Positive,in vitro
"5-chloro-2-(2,4-dichlorophenoxy)phenol",C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl,5564,Negative,In Vivo
"5-chloro-2-(2,4-dichlorophenoxy)phenol",C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl,3380-34-5,Negative,in vivo
"5-chloro-2-(2,4-dichlorophenoxy)phenol",C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl,3380-34-5,Negative,in vitro
"5-chloro-2-methyl-1,2-thiazol-3-one",CN1C(=O)C=C(S1)Cl,26172-55-4,Negative,in vitro
5-chloro-2-methylaniline,CC1=C(C=C(C=C1)Cl)N,95-79-4,Negative,in vivo
5-chloro-2-methylaniline,CC1=C(C=C(C=C1)Cl)N,7260,Positive,In Vivo
5-chloro-2-methylaniline,CC1=C(C=C(C=C1)Cl)N,95-79-4,Positive,in vivo
5-chloro-2-methylaniline,CC1=C(C=C(C=C1)Cl)N,7260,Negative,In Vivo
5-chloro-7-iodoquinolin-8-ol,C1=CC2=C(C(=C(C=C2Cl)I)O)N=C1,130-26-7,Negative,in vitro
5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,50-65-7,Positive,in vitro
"5-ethenyl-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",C=CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,55520-67-7,Positive,in vitro
5-ethyl-2-methylpyridine,CCC1=CN=C(C=C1)C,104-90-5,Negative,in vitro
"5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione",CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,50-06-6,Negative,in vivo
"5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione",CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,4763,Positive,In Vivo
"5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione",CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,50-06-6,Negative,in vitro
"5-ethyl-5-phenyl-1,3-diazinane-4,6-dione",CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,4909,Positive,In Vivo
"5-ethyl-5-phenyl-1,3-diazinane-4,6-dione",CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,4909,Negative,In Vivo
"5-ethyl-5-phenyl-1,3-diazinane-4,6-dione",CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,125-33-7,Positive,in vitro
"5-ethyl-6-phenylphenanthridin-5-ium-3,8-diamine;bromide",CC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N)N.[Br-],1239-45-8,Negative,in vivo
"5-ethyl-6-phenylphenanthridin-5-ium-3,8-diamine;bromide",CC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N)N.[Br-],1239-45-8,Negative,in vitro
"5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid",CCN1C=C(C(=O)C2=CC3=C(C=C21)OCO3)C(=O)O,4628,Negative,In Vivo
"5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid",CCN1C=C(C(=O)C2=CC3=C(C=C21)OCO3)C(=O)O,4628,Positive,In Vivo
"5-ethynyl-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",C#CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,61135-33-9,Positive,in vitro
"5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione",C1CC(OC1)N2C=C(C(=O)NC2=O)F,5386,Negative,In Vivo
"5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)CO)O,50-91-9,Negative,in vitro
"5-fluoro-1H-pyrimidine-2,4-dione",C1=C(C(=O)NC(=O)N1)F,3385,Negative,In Vivo
"5-fluoro-1H-pyrimidine-2,4-dione",C1=C(C(=O)NC(=O)N1)F,51-21-8,Negative,in vivo
"5-fluoro-1H-pyrimidine-2,4-dione",C1=C(C(=O)NC(=O)N1)F,3385,Positive,In Vivo
"5-fluoro-1H-pyrimidine-2,4-dione",C1=C(C(=O)NC(=O)N1)F,51-21-8,Negative,in vitro
"5-fluoro-7,12-dimethylbenzo[a]anthracene",CC1=C2C=C(C3=CC=CC=C3C2=C(C4=CC=CC=C14)C)F,,Negative,in vitro
5-fluoroquinoline,C1=CC2=C(C=CC=N2)C(=C1)F,115243,Negative,In Vivo
5-fluoroquinoline,C1=CC2=C(C=CC=N2)C(=C1)F,115243,Positive,In Vivo
5-Fluoroquinoline,C1=CC2=C(C=CC=N2)C(=C1)F,394-69-4,Positive,in vitro
5-FLUOROURACIL,C1=C(C(=O)NC(=O)N1)F,51-21-8,Negative,In vivo
5-FLUOROURACIL,C1=C(C(=O)NC(=O)N1)F,51-21-8,Positive,In vivo
5-fluorouracil,C1=C(C(=O)NC(=O)N1)F,51-21-8,Positive,in vitro
"5-hydroxy-1,4-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione",C1=CC2=C(C(=C1)O)C(=O)C3=C(C=CC(=C3C2=O)NCCNCCO)NCCNCCO,80189-44-2,Positive,in vitro
5-hydroxy-2-(hydroxymethyl)pyran-4-one,C1=C(OC=C(C1=O)O)CO,3840,Positive,In Vivo
5-hydroxy-2-(hydroxymethyl)pyran-4-one,C1=C(OC=C(C1=O)O)CO,3840,Negative,In Vivo
5-hydroxy-2-(hydroxymethyl)pyran-4-one,C1=C(OC=C(C1=O)O)CO,501-30-4,Positive,in vitro
"5-hydroxy-2-[5-hydroxy-4-methoxy-2-[(1R,12S)-3-methyl-7-oxo-5,10-diazatetracyclo[7.4.0.01,12.02,6]trideca-2(6),3,8-triene-10-carbonyl]-7,8-dihydro-3H-pyrrolo[3,2-e]indole-6-carbonyl]-4-methoxy-7,8-dihydro-3H-pyrrolo[3,2-e]indole-6-carboxamide",CC1=CNC2=C1[C@@]34C[C@@H]3CN(C4=CC2=O)C(=O)C5=CC6=C7CCN(C7=C(C(=C6N5)OC)O)C(=O)C8=CC9=C1CCN(C1=C(C(=C9N8)OC)O)C(=O)N,9939943,Positive,In Vivo
"5-hydroxy-2-[5-hydroxy-4-methoxy-2-[(1R,12S)-3-methyl-7-oxo-5,10-diazatetracyclo[7.4.0.01,12.02,6]trideca-2(6),3,8-triene-10-carbonyl]-7,8-dihydro-3H-pyrrolo[3,2-e]indole-6-carbonyl]-4-methoxy-7,8-dihydro-3H-pyrrolo[3,2-e]indole-6-carboxamide",CC1=CNC2=C1[C@@]34C[C@@H]3CN(C4=CC2=O)C(=O)C5=CC6=C7CCN(C7=C(C(=C6N5)OC)O)C(=O)C8=CC9=C1CCN(C1=C(C(=C9N8)OC)O)C(=O)N,69866-21-3,Positive,in vitro
"5-iodo-1H-pyrimidine-2,4-dione",C1=C(C(=O)NC(=O)N1)I,0696-07-01,Positive,in vitro
5-Methoxypsoralen,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3,484-20-8,Positive,in vitro
"5-methyl-1-nitroso-1,3-diazinane-2,4-dione",CC1CN(C(=O)NC1=O)N=O,124937,Negative,In Vivo
"5-methyl-1-nitroso-1,3-diazinane-2,4-dione",CC1CN(C(=O)NC1=O)N=O,62641-67-2,Positive,in vitro
5-methyl-12-nitrochrysene,CC1=CC2=CC=CC=C2C3=C1C4=CC=CC=C4C(=C3)[N+](=O)[O-],147799,Positive,In Vivo
5-methyl-1H-imidazole,CC1=CN=CN1,13195,Positive,In Vivo
5-methyl-1H-imidazole,CC1=CN=CN1,13195,Negative,In Vivo
"5-methyl-1H-pyrimidine-2,4-dione",CC1=CNC(=O)NC1=O,1135,Positive,In Vivo
5-methyl-2-(4-methyl-5-oxo-4-propan-2-yl-1H-imidazol-2-yl)pyridine-3-carboxylic acid,CC1=CC(=C(N=C1)C2=NC(C(=O)N2)(C)C(C)C)C(=O)O,91770,Negative,In Vivo
5-methyl-2-nitrophenol,CC1=CC(=C(C=C1)[N+](=O)[O-])O,700-38-9,Positive,in vitro
5-methyl-2-phenyl-4H-pyrazol-3-one,CC1=NN(C(=O)C1)C2=CC=CC=C2,4021,Negative,In Vivo
5-methyl-2-phenyl-4H-pyrazol-3-one,CC1=NN(C(=O)C1)C2=CC=CC=C2,89-25-8,Negative,in vivo
5-methyl-2-propan-2-ylphenol,CC1=CC(=C(C=C1)C(C)C)O,89-83-8,Negative,in vitro
"5-methyl-3-nitroso-1,3-oxazolidin-2-one",CC1CN(C(=O)O1)N=O,133239,Positive,In Vivo
"5-methyl-3-nitroso-1,3-oxazolidine",CC1CN(CO1)N=O,147617,Positive,In Vivo
5-methyl-4-nitro-2-(4-nitrophenyl)-4H-pyrazol-3-one,CC1=NN(C(=O)C1[N+](=O)[O-])C2=CC=C(C=C2)[N+](=O)[O-],550-74-3,Positive,in vitro
5-methyl-6-nitrochrysene,CC1=C(C2=CC=CC=C2C3=C1C4=CC=CC=C4C=C3)[N+](=O)[O-],60025,Negative,In Vivo
5-methyl-6-nitrochrysene,CC1=C(C2=CC=CC=C2C3=C1C4=CC=CC=C4C=C3)[N+](=O)[O-],60025,Positive,In Vivo
"5-methylbenzene-1,3-diol",CC1=CC(=CC(=C1)O)O,504-15-4,Negative,in vitro
5-methylbenzo[a]anthracene,CC1=CC2=CC3=CC=CC=C3C=C2C4=CC=CC=C14,2319-96-2,Positive,in vitro
5-methylchrysene,CC1=CC2=CC=CC=C2C3=C1C4=CC=CC=C4C=C3,19427,Positive,In Vivo
5-methylchrysene,CC1=CC2=CC=CC=C2C3=C1C4=CC=CC=C4C=C3,3697-24-3,Positive,in vivo
5-methylchrysene,CC1=CC2=CC=CC=C2C3=C1C4=CC=CC=C4C=C3,3697-24-3,Positive,in vitro
5-methylquinoline,CC1=C2C=CC=NC2=CC=C1,7661-55-4,Positive,in vitro
5-methylsulfonyloxyhexan-2-yl methanesulfonate,CC(CCC(C)OS(=O)(=O)C)OS(=O)(=O)C,55-93-6,Positive,in vitro
"5-nitro-1,2-dihydroacenaphthylene",C1CC2=CC=C(C3=CC=CC1=C23)[N+](=O)[O-],11769,Negative,In Vivo
"5-nitro-1,2-dihydroacenaphthylene",C1CC2=CC=C(C3=CC=CC1=C23)[N+](=O)[O-],11769,Positive,In Vivo
"5-nitro-1,2-dihydroacenaphthylene",C1CC2=CC=C(C3=CC=CC1=C23)[N+](=O)[O-],602-87-9,Positive,in vivo
"5-nitro-1,2-dihydroacenaphthylene",C1CC2=CC=C(C3=CC=CC1=C23)[N+](=O)[O-],602-87-9,Positive,in vitro
"5-nitro-1,3-thiazol-2-amine",C1=C(SC(=N1)N)[N+](=O)[O-],8486,Negative,In Vivo
5-nitro-1H-indazole,C1=CC2=C(C=C1[N+](=O)[O-])C=NN2,5401-94-5,Positive,in vitro
5-nitro-1H-indole,C1=CC2=C(C=CN2)C=C1[N+](=O)[O-],6146-52-7,Positive,in vitro
"5-nitro-1H-indole-2,3-dione",C1=CC2=C(C=C1[N+](=O)[O-])C(=O)C(=O)N2,0611-09-06,Positive,in vitro
5-NITRO-2-FURALDEHYDE SEMICARBAZONE,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,59-87-0,Positive,In vivo
5-Nitro-2-furaldehyde semicarbazone (AKA Nitrofurazone),C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,59-87-0,Positive,in vitro
5-NITRO-2-FURAMIDOXIME,C1=C(OC(=C1)[N+](=O)[O-])C(=NO)N,772-43-0,Negative,In vivo
5-NITRO-2-FURANMETHANEDIOL DIACETATE,CC(=O)OC(C1=CC=C(O1)[N+](=O)[O-])OC(=O)C,92-55-7,Negative,In vivo
5-Nitro-o-anisidine,COC1=C(C=C(C=C1)[N+](=O)[O-])N,99-59-2,Negative,in vitro
5-Nitro-o-toluidine,CC1=C(C=C(C=C1)[N+](=O)[O-])N,99-55-8,Positive,in vitro
5-Nitroacenaphthene,C1CC2=CC=C(C3=CC=CC1=C23)[N+](=O)[O-],602-87-9,Positive,in vitro
5-nitrofuran-2-carbaldehyde,C1=C(OC(=C1)[N+](=O)[O-])C=O,698-63-5,Negative,in vitro
5-nitrofuran-2-carboxylic acid,C1=C(OC(=C1)[N+](=O)[O-])C(=O)O,0645-12-5,Negative,in vitro
5-nitronaphthalene-1-carbonitrile,C1=CC(=C2C=CC=C(C2=C1)[N+](=O)[O-])C#N,23245-64-9,Negative,in vitro
5-nitroquinoline,C1=CC2=C(C=CC=N2)C(=C1)[N+](=O)[O-],607-34-1,Positive,in vitro
5-nitroquinoline-2-carboxylic acid,C1=CC2=C(C=CC(=N2)C(=O)O)C(=C1)[N+](=O)[O-],525-47-3,Positive,in vitro
"5-O-[2-[4-(4-benzhydrylpiperazin-1-yl)phenyl]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate",CC1=C(C(C(=C(N1)C)C(=O)OCCC2=CC=C(C=C2)N3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5)C6=CC(=CC=C6)[N+](=O)[O-])C(=O)OC,122073,Negative,In Vivo
"5-O-[3-[benzyl(methyl)amino]-2,2-dimethylpropyl] 3-O-methyl 4-(2-fluoro-5-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride",CC1=C(C(C(=C(N1)C)C(=O)OCC(C)(C)CN(C)CC2=CC=CC=C2)C3=C(C=CC(=C3)[N+](=O)[O-])F)C(=O)OC.Cl,119153,Negative,In Vivo
"5-oxa-10-azapentacyclo[9.8.0.03,9.04,6.012,17]nonadeca-1,3(9),10,12,14,16,18-heptaene-7,8-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C(C(C5C4O5)O)O)N=C32,163486,Negative,In Vivo
"5-oxa-2-azapentacyclo[9.8.0.03,9.04,6.014,19]nonadeca-1,3(9),10,12,14,16,18-heptaene-7,8-diol",C1=CC=C2C(=C1)C=CC3=CC4=C(C5C(O5)C(C4O)O)N=C32,163485,Negative,In Vivo
"5-oxapentacyclo[9.8.0.03,9.04,6.012,17]nonadeca-1,3(9),7,10,12,14,16,18-octaene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=CC5C4O5)C=C32,34501-55-8,Positive,in vitro
5-p-Dimethylaminophenylazoindazole,CN(C)C1=CC=C(C=C1)N=NC2=CC3=C(C=C2)NN=C3,17309-86-3,Positive,in vitro
"5-pentylbenzene-1,3-diol",CCCCCC1=CC(=CC(=C1)O)O,500-66-3,Positive,in vitro
"5-prop-2-enyl-1,3-benzodioxole",C=CCC1=CC2=C(C=C1)OCO2,5144,Positive,In Vivo
"5-prop-2-enyl-1,3-benzodioxole",C=CCC1=CC2=C(C=C1)OCO2,94-59-7,Positive,in vivo
"5-prop-2-enyl-1,3-benzodioxole",C=CCC1=CC2=C(C=C1)OCO2,94-59-7,Negative,in vitro
"5-propyl-1,3-benzodioxole",CCCC1=CC2=C(C=C1)OCO2,7197,Positive,In Vivo
"5-propyl-1,3-benzodioxole",CCCC1=CC2=C(C=C1)OCO2,94-58-6,Positive,in vivo
"5-tert-butyl-3-(2,4-dichloro-5-propan-2-yloxyphenyl)-1,3,4-oxadiazol-2-one",CC(C)OC1=C(C=C(C(=C1)N2C(=O)OC(=N2)C(C)(C)C)Cl)Cl,19666-30-9,Negative,in vitro
"5,11-dimethyl-6H-pyrido[4,3-b]carbazol-9-amine",CC1=C2C=CN=CC2=C(C3=C1NC4=C3C=C(C=C4)N)C,54779-53-2,Positive,in vitro
"5,11-dimethyl-6H-pyrido[4,3-b]carbazole",CC1=C2C=CN=CC2=C(C3=C1NC4=CC=CC=C43)C,519-23-3,Positive,in vitro
"5,12-dihydrophthalazino[3,2-b]phthalazine-7,14-dione",C1C2=CC=CC=C2C(=O)N3N1C(=O)C4=CC=CC=C4C3,30717,Positive,In Vivo
"5,5-diethyl-1,3-diazinane-2,4,6-trione",CCC1(C(=O)NC(=O)NC1=O)CC,57-44-3,Negative,in vitro
"5,5-DIPHENYLHYDANTOIN",C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,57-41-0,Negative,In vivo
"5,5-diphenylimidazolidine-2,4-dione",C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,1775,Negative,In Vivo
"5,5-diphenylimidazolidine-2,4-dione",C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,1775,Positive,In Vivo
"5,5-diphenylimidazolidine-2,4-dione",C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,57-41-0,Positive,in vivo
"5,5'-(1,1'-BIPHENYL)-2,5-DIYLBIS(OXY)(2,2-DIMETHYLPENTANOIC ACID",CC(C)(CCCOC1=CC(=C(C=C1)OCCCC(C)(C)C(=O)O)C2=CC=CC=C2)C(=O)O,79520-77-7,Positive,In vivo
"5,6-dihydrobenzo[c]anthracene-5,6-diol",C1=CC=C2C=C3C4=CC=CC=C4C(C(C3=CC2=C1)O)O,1421-78-9,Negative,in vitro
"5,6-dihydroimidazo[2,1-c][1,2,4]dithiazole-3-thione",C1CN2C(=N1)SSC2=S,33813-20-6,Positive,in vitro
"5,6-dihydroxy-4,5,6-trimethyl-13-oxido-2,8-dioxa-13-azoniatricyclo[8.5.1.013,16]hexadec-10-ene-3,7-dione",CC1C(=O)OC2CC[N+]3(C2C(=CC3)COC(=O)C(C1(C)O)(C)O)[O-],35337-98-5,Positive,in vitro
"5,6-DIMETHOXYSTERIGMATOCYSTIN",COC1=C(C2=C(C(=C1)O)C(=O)C3=C(C=C4C(=C3O2)C5C=COC5O4)OC)OC,65176-75-2,Positive,In vivo
"5,6,8,9,10,11-hexahydronaphtho[1,2-b]phenanthrene",C1CCC2=C(C1)C=CC3=CC4=C(CCC5=CC=CC=C54)C=C23,9056,Positive,In Vivo
"5,7-dibromoquinoline",C1=CC2=C(C=C(C=C2Br)Br)N=C1,154903,Negative,In Vivo
"5,7-DIBROMOQUINOLINE",C1=CC2=C(C=C(C=C2Br)Br)N=C1,34522-69-5,Negative,In vivo
"5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one",C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,5280961,Negative,In Vivo
"5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one",C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,5280961,Positive,In Vivo
"5,7-DIMETHOXYCYCLOPENTENE[c]COUMARIN",COC1=CC2=C(C3=C(CCC3)C(=O)O2)C(=C1)OC,1146-71-0,Negative,In vivo
"5,7-DIMETHOXYCYCLOPENTENONE[3,2-c]COUMARIN",COC1=CC2=C(C3=C(C(=O)CC3)C(=O)O2)C(=C1)OC,1150-42-1,Negative,In vivo
"5,7,12-trimethylbenzo[a]anthracene",CC1=CC2=C(C3=CC=CC=C3C(=C2C4=CC=CC=C14)C)C,,Negative,in vitro
"5,8,10,14,20,23,25,28-octahydroxy-6,21-dimethyloctacyclo[14.11.1.02,11.02,15.04,9.013,17.017,26.019,24]octacosa-4,6,8,10,19,21,23,25-octaene-3,12,18,27-tetrone",CC1=CC(=C2C(=C1O)C(=O)C34C5C6C(C3C(=O)C7=C(C8=C(C=C(C(=C8C(=O)C67C(C5O)C(=O)C4=C2O)O)C)O)O)O)O,30840,Positive,In Vivo
"5,8,10,14,20,23,25,28-octahydroxy-6,21-dimethyloctacyclo[14.11.1.02,11.02,15.04,9.013,17.017,26.019,24]octacosa-4,6,8,10,19,21,23,25-octaene-3,12,18,27-tetrone",CC1=CC(=C2C(=C1O)C(=O)C34C5C6C(C3C(=O)C7=C(C8=C(C=C(C(=C8C(=O)C67C(C5O)C(=O)C4=C2O)O)C)O)O)O)O,21884-44-6,Positive,in vivo
"5,8,10,14,20,23,25,28-octahydroxy-6,21-dimethyloctacyclo[14.11.1.02,11.02,15.04,9.013,17.017,26.019,24]octacosa-4,6,8,10,19,21,23,25-octaene-3,12,18,27-tetrone",CC1=CC(=C2C(=C1O)C(=O)C34C5C6C(C3C(=O)C7=C(C8=C(C=C(C(=C8C(=O)C67C(C5O)C(=O)C4=C2O)O)C)O)O)O)O,21884-44-6,Positive,in vitro
"5,9-Dimethyldibenzo[c,g]carbazole",C1=CC=C2C(=C1)C=CC3=C2C4=C(N3)C=CC5=CC=CC=C54,194-59-2,Negative,in vitro
5H-phenanthridin-6-one,C1=CC=C2C(=C1)C3=CC=CC=C3NC2=O,1853,Negative,In Vivo
6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],2265,Negative,In Vivo
6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],2265,Positive,In Vivo
6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],446-86-6,Positive,in vivo
6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],446-86-6,Negative,in vivo
6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],446-86-6,Positive,in vitro
"6-(4-aminophenyl)-5-methylphenanthridin-5-ium-3,8-diamine;chloride",C[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=C(C=C4)N)N)N.[Cl-],,Positive,in vitro
"6-(5-nitrofuran-2-yl)-1,3,5-triazine-2,4-diamine",C1=C(OC(=C1)[N+](=O)[O-])C2=NC(=NC(=N2)N)N,720-69-4,Positive,in vitro
"6-(dimethoxyphosphinothioylsulfanylmethyl)-1,3,5-triazine-2,4-diamine",COP(=S)(OC)SCC1=NC(=NC(=N1)N)N,78-57-9,Negative,in vitro
"6-(dimethylamino)-4,4-diphenylheptan-3-one",CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,76-99-3,Negative,in vivo
"6-(dimethylamino)-4,4-diphenylheptan-3-one",CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,76-99-3,Negative,in vitro
"6-(dimethylamino)-4,4-diphenylheptan-3-one;hydrochloride",CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2.Cl,14184,Negative,In Vivo
6-(p-Dimethylaminophenylazo)benzthiazole,CN(C)C1=CC=C(C=C1)N=NC2=CC3=C(C=C2)N=CS3,18463-85-9,Positive,in vitro
"6-[(1E,3E,5E,7E)-8-[(2S,3R,4R,5R)-3,4-dihydroxy-2,4,5-trimethyloxolan-2-yl]-7-methylocta-1,3,5,7-tetraenyl]-4-methoxy-5-methylpyran-2-one",C[C@@H]1[C@]([C@H]([C@](O1)(C)/C=C(\C)/C=C/C=C/C=C/C2=C(C(=CC(=O)O2)OC)C)O)(C)O,25425-12-1,Negative,in vitro
"6-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-1,2,4-triazin-3-amine",C1=C(OC(=C1)[N+](=O)[O-])/C=C/C2=CN=C(N=N2)N,0556-12-7,Negative,in vitro
6-[(E)-2-(5-nitrofuran-2-yl)ethenyl]pyridazin-3-amine;hydrochloride,C1=CC(=NN=C1/C=C/C2=CC=C(O2)[N+](=O)[O-])N.Cl,,Negative,in vitro
6-[bis(3-oxa-6-azabicyclo[3.1.0]hexan-6-yl)phosphoryl]-3-oxa-6-azabicyclo[3.1.0]hexane,C1C2C(N2P(=O)(N3C4C3COC4)N5C6C5COC6)CO1,,Positive,in vitro
"6-[p-(N-β-Cyanoethyl-N-methylamino)phenyl-
azo]benzthiazol",CN(CCC#N)C1=CC=C(C=C1)N=NC2=CC3=C(C=C2)N=CS3,92887-88-2,Positive,in vitro
"6-amino-3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,4-dihydro-1,3,5-triazin-2-one",C1N=C(NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,99681,Negative,In Vivo
"6-amino-5H-pyrimidine-2,4-dione",C1C(=NC(=O)NC1=O)N,,Positive,in vitro
6-Amino-m-cresol  COLIPA A75   (2-amino-5-methylphenol),CC1=CC(=C(C=C1)N)O,2835-98-5,Positive,in vitro
6-AZACYTIDINE,C1=NN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,3131-60-0,Negative,In vivo
6-Benzyladenine,C1=CC=C(C=C1)CNC2=NC=NC3=C2NC=N3,1214-39-7,Negative,in vivo
6-Benzyladenine,C1=CC=C(C=C1)CNC2=NC=NC3=C2NC=N3,1214-39-7,Negative,in vitro
6-chloro-1-[2-(ethylamino)ethylamino]-4-(hydroxymethyl)thioxanthen-9-one,CCNCCNC1=C2C(=C(C=C1)CO)SC3=C(C2=O)C=CC(=C3)Cl,57292-30-5,Positive,in vitro
6-chloro-1-[2-[ethyl(2-hydroxyethyl)amino]ethylamino]-4-(hydroxymethyl)thioxanthen-9-one,CCN(CCNC1=C2C(=C(C=C1)CO)SC3=C(C2=O)C=CC(=C3)Cl)CCO,17319-11-8,Positive,in vitro
"6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide",C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,3639,Negative,In Vivo
"6-chloro-2-N,4-N-diethyl-1,3,5-triazine-2,4-diamine",CCNC1=NC(=NC(=N1)Cl)NCC,122-34-9,Negative,in vitro
"6-chloro-2-N,4-N-diethyl-1,3,5-triazine-2,4-diamine;1H-1,2,4-triazol-5-amine",CCNC1=NC(=NC(=N1)Cl)NCC.C1=NNC(=N1)N,,Negative,in vitro
6-chloro-3-[1-[3-(2-oxo-3H-benzimidazol-1-yl)propyl]piperidin-4-yl]-1H-benzimidazol-2-one,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,57808-66-9,Positive,in vitro
"6-chloro-4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-ylthieno[2,3-e]thiazine-3-carboxamide",CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,54690031,Negative,In Vivo
"6-chloro-4-N-ethyl-2-N-propan-2-yl-1,3,5-triazine-2,4-diamine",CCNC1=NC(=NC(=N1)Cl)NC(C)C,2256,Negative,In Vivo
"6-chloro-4-N-ethyl-2-N-propan-2-yl-1,3,5-triazine-2,4-diamine",CCNC1=NC(=NC(=N1)Cl)NC(C)C,2256,Positive,In Vivo
"6-chloro-4-N-ethyl-2-N-propan-2-yl-1,3,5-triazine-2,4-diamine",CCNC1=NC(=NC(=N1)Cl)NC(C)C,1912-24-9,Negative,in vitro
6-chloro-N-[2-(diethylamino)ethyl]-4-methyl-9-oxothioxanthen-1-amine oxide,CCN(CC)CC[NH+](C1=C2C(=C(C=C1)C)SC3=C(C2=O)C=CC(=C3)Cl)[O-],,Positive,in vitro
"6-DIMETHYLAMINO-4,4-DIPHENYL-3-HEPTANOL ACETATE.HCl",CCC(C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C.Cl,43033-72-3,Positive,In vivo
"6-DIMETHYLAMINO-4,4-DIPHENYL-3-HEPTANONE.HCl",CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2.Cl,1095-90-5,Negative,In vivo
"6-ethoxy-2,2,4-trimethyl-1H-quinoline",CCOC1=CC2=C(C=C1)NC(C=C2C)(C)C,91-53-2,Negative,in vitro
6-fluoro-12-methylbenzo[a]anthracene,CC1=C2C3=CC=CC=C3C=C(C2=CC4=CC=CC=C14)F,,Positive,in vitro
6-Hydroxyindole - COLIPA A128,C1=CC(=CC2=C1C=CN2)O,2380-86-1,Positive,in vitro
6-MERCAPTOPURINE,C1=NC2=C(N1)C(=S)N=CN2,50-44-2,Negative,In vivo
6-Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,50-44-2,Positive,in vitro
"6-methoxy-11-methyl-15,16-dihydrocyclopenta[a]phenanthren-17-one",CC1=CC2=C(CCC2=O)C3=C1C4=CC=CC=C4C(=C3)OC,,Positive,in vitro
6-Methoxy-2-methylamino-3-aminopyridine dihydrochloride,CNC1=C(C=CC(=N1)OC)N.Cl.Cl,83732-72-3,Positive,in vitro
"6-methoxy-3,3,12-trimethylpyrano[2,3-c]acridin-7-one",CC1(C=CC2=C3C(=C(C=C2O1)OC)C(=O)C4=CC=CC=C4N3C)C,345512,Positive,In Vivo
6-methoxy-8-nitroquinoline,COC1=CC(=C2C(=C1)C=CC=N2)[N+](=O)[O-],85-81-4,Positive,in vitro
"6-methyl-[1,3]dithiolo[4,5-b]quinoxalin-2-one",CC1=CC2=C(C=C1)N=C3C(=N2)SC(=O)S3,2439-01-02,Negative,in vitro
6-methyl-2-sulfanylidene-1H-pyrimidin-4-one,CC1=CC(=O)NC(=S)N1,667493,Positive,In Vivo
6-methyl-2-sulfanylidene-1H-pyrimidin-4-one,CC1=CC(=O)NC(=S)N1,56-04-2,Positive,in vivo
"6-methyl-N-phenyl-2,3-dihydro-1,4-oxathiine-5-carboxamide",CC1=C(SCCO1)C(=O)NC2=CC=CC=C2,21307,Negative,In Vivo
"6-methyl-N-phenyl-2,3-dihydro-1,4-oxathiine-5-carboxamide",CC1=C(SCCO1)C(=O)NC2=CC=CC=C2,21307,Positive,In Vivo
6-methylbenzo[a]anthracene,CC1=CC2=CC=CC=C2C3=CC4=CC=CC=C4C=C13,316-14-3,Negative,in vitro
6-methylbenzo[a]pyrene,CC1=C2C=CC3=C4C2=C(C=CC4=CC=C3)C5=CC=CC=C15,2381-39-7,Positive,in vivo
6-methylbenzo[a]pyrene,CC1=C2C=CC3=C4C2=C(C=CC4=CC=C3)C5=CC=CC=C15,2381-39-7,Positive,in vitro
6-methylchromen-2-one,CC1=CC2=C(C=C1)OC(=O)C=C2,92-48-8,Positive,in vitro
6-methylchrysene,CC1=CC2=C(C=CC3=CC=CC=C32)C4=CC=CC=C14,1705-85-7,Positive,in vitro
6-methylheptyl prop-2-enoate,CC(C)CCCCCOC(=O)C=C,165746,Negative,In Vivo
6-methylheptyl propanoate,CCC(=O)OCCCCCC(C)C,111811,Negative,In Vivo
6-methylquinoline,CC1=CC2=C(C=C1)N=CC=C2,7059,Negative,In Vivo
6-METHYLQUINOLINE,CC1=CC2=C(C=C1)N=CC=C2,91-62-3,Negative,In vivo
6-methylquinoline,CC1=CC2=C(C=C1)N=CC=C2,91-62-3,Positive,in vitro
6-Monomethylaminophenylazobenzthiazole,CNC1=CC=C(C=C1)N=NC2=CC3=C(C=C2)N=CS3,92911-19-8,Positive,in vitro
6-nitro-1-oxidoquinolin-1-ium,C1=CC2=C(C=CC(=C2)[N+](=O)[O-])[N+](=C1)[O-],13675-92-8,Negative,in vitro
6-nitro-1H-benzimidazole,C1=CC2=C(C=C1[N+](=O)[O-])NC=N2,7195,Positive,In Vivo
6-nitro-1H-benzimidazole,C1=CC2=C(C=C1[N+](=O)[O-])NC=N2,7195,Negative,In Vivo
"6-nitro-3-oxapentacyclo[7.6.2.02,4.05,17.012,16]heptadeca-1(15),5,7,9(17),10,12(16),13-heptaene",C1=CC2=C3C(=C1)C4C(O4)C5=C(C=CC(=C53)C=C2)[N+](=O)[O-],107809,Negative,In Vivo
6-Nitro-o-toloudine COLIPA B56,CC1=C(C(=CC=C1)[N+](=O)[O-])N,570-24-1,Positive,in vitro
6-nitrobenzimidazole,C1=CC2=C(C=C1[N+](=O)[O-])NC=N2,94-52-0,Positive,in vitro
6-nitrobenzo[a]pyrene,C1=CC=C2C(=C1)C3=C4C(=C2[N+](=O)[O-])C=CC5=CC=CC(=C54)C=C3,44374,Negative,In Vivo
6-nitrobenzo[a]pyrene,C1=CC=C2C(=C1)C3=C4C(=C2[N+](=O)[O-])C=CC5=CC=CC(=C54)C=C3,63041-90-7,Positive,in vitro
6-nitrochrysene,C1=CC=C2C(=C1)C=CC3=C2C=C(C4=CC=CC=C34)[N+](=O)[O-],24121,Positive,In Vivo
6-Nitrochrysene,C1=CC=C2C(=C1)C=CC3=C2C=C(C4=CC=CC=C34)[N+](=O)[O-],7496-02-8,Positive,in vitro
6-nitropyren-1-ol,C1=CC2=C(C=CC3=C2C4=C1C=CC(=C4C=C3)O)[N+](=O)[O-],104988,Negative,In Vivo
6-nitroquinoline,C1=CC2=C(C=CC(=C2)[N+](=O)[O-])N=C1,11945,Negative,In Vivo
6-NITROQUINOLINE,C1=CC2=C(C=CC(=C2)[N+](=O)[O-])N=C1,613-50-3,Negative,In vivo
6-nitroquinoline,C1=CC2=C(C=CC(=C2)[N+](=O)[O-])N=C1,613-50-3,Positive,in vitro
6-nitrosochrysene,C1=CC=C2C(=C1)C=CC3=C2C=C(C4=CC=CC=C34)N=O,3028003,Positive,In Vivo
"6-oxahexacyclo[11.6.2.02,8.05,7.010,20.017,21]henicosa-1(20),2(8),3,9,11,13(21),14,16,18-nonaene",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=CC6C5O6)C=C2,36504-65-1,Positive,in vivo
"6-oxahexacyclo[11.6.2.02,8.05,7.010,20.017,21]henicosa-1(20),2(8),3,9,11,13(21),14,16,18-nonaene",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=CC6C5O6)C=C2,36504-65-1,Negative,in vitro
"6-oxahexacyclo[11.6.2.02,8.05,7.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene",C1CC2=C(C=C3C=CC4=C5C3=C2C=CC5=CC=C4)C6C1O6,,Negative,in vitro
"6-oxahexacyclo[11.6.2.02,8.05,7.010,20.017,21]henicosa-1(20),7,9,11,13(21),14,16,18-octaene-3,4-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C6C(O6)C(C(C45)O)O)C=C2,,Positive,in vitro
6-PHENYLHEXYL ISOTHIOCYANATE,C1=CC=C(C=C1)CCCCCCN=C=S,133920-06-6,Negative,In vivo
"6-phenylpteridine-2,4,7-triamine",C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,5546,Positive,In Vivo
"6-phenylpteridine-2,4,7-triamine",C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,5546,Negative,In Vivo
6-propyl-2-sulfanylidene-1H-pyrimidin-4-one,CCCC1=CC(=O)NC(=S)N1,657298,Positive,In Vivo
6-propyl-2-sulfanylidene-1H-pyrimidin-4-one,CCCC1=CC(=O)NC(=S)N1,51-52-5,Positive,in vivo
"6,11-Dimethylbenzo(b)naphthol(2,3-d)thiophene",CC1=C2C3=CC=CC=C3SC2=C(C4=CC=CC=C14)C,32362-68-8,Positive,in vitro
"6,6,9-trimethyl-3-pentylbenzo[c]chromen-1-ol",CCCCCC1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)C)(C)C)O,521-35-7,Positive,in vivo
"6,6,9-trimethyl-3-pentylbenzo[c]chromen-1-ol",CCCCCC1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)C)(C)C)O,521-35-7,Negative,in vitro
"7-(8-formyl-1,6,7-trihydroxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)-2,3,8-trihydroxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde",CC1=CC2=C(C(=C(C(=C2C(C)C)O)O)C=O)C(=C1C3=C(C4=C(C=C3C)C(=C(C(=C4C=O)O)O)C(C)C)O)O,303-45-7,Positive,in vivo
"7-(8-formyl-1,6,7-trihydroxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)-2,3,8-trihydroxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde",CC1=CC2=C(C(=C(C(=C2C(C)C)O)O)C=O)C(=C1C3=C(C4=C(C=C3C)C(=C(C(=C4C=O)O)O)C(C)C)O)O,303-45-7,Positive,in vitro
7-(bromomethyl)-12-methylbenzo[a]anthracene,CC1=C2C(=C(C3=CC=CC=C13)CBr)C=CC4=CC=CC=C42,16238-56-5,Positive,in vivo
7-(bromomethyl)-12-methylbenzo[a]anthracene,CC1=C2C(=C(C3=CC=CC=C13)CBr)C=CC4=CC=CC=C42,16238-56-5,Negative,in vitro
7-(bromomethyl)benzo[a]anthracene,C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C=C32)CBr,24961-39-5,Positive,in vivo
7-(bromomethyl)benzo[a]anthracene,C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C=C32)CBr,24961-39-5,Negative,in vitro
7-(chloromethyl)-12-methylbenzo[a]anthracene,CC1=C2C(=C(C3=CC=CC=C13)CCl)C=CC4=CC=CC=C42,13345-62-5,Positive,in vitro
7-(chloromethyl)benzo[a]anthracene,C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C=C32)CCl,6325-54-8,Positive,in vitro
"7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid",COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,152946,Negative,In Vivo
7-bromobenzo[a]anthracene,C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C=C32)Br,72849,Positive,In Vivo
7-Bromomethyl-12-methylbenz[a]anthracene,CC1=C2C(=C(C3=CC=CC=C13)CBr)C=CC4=CC=CC=C42,16238-56-5,Positive,in vitro
"7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one",CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,439-14-5,Positive,in vitro
"7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one",CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,5391,Negative,In Vivo
"7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one",C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,4616,Positive,In Vivo
"7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one",C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,4616,Negative,In Vivo
"7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine",CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O,58-25-3,Negative,in vitro
"7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine;hydrochloride",CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O.Cl,438-41-5,Positive,in vitro
"7-chloro-5-(2-fluorophenyl)-3-hydroxy-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one",C1=CC=C(C(=C1)C2=NC(C(=O)N(C3=C2C=C(C=C3)Cl)CCO)O)F,38668,Negative,In Vivo
"7-chloro-N-[3-(2-chloroethylsulfanyl)propyl]-2-methoxybenzo[b][1,5]naphthyridin-1-ium-10-amine;chloride",COC1=[NH+]C2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCSCCCl.[Cl-],,Positive,in vitro
7-chlorobenzo[a]anthracene,C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C=C32)Cl,88446,Positive,In Vivo
7-hydroxy-4-methylchromen-2-one,CC1=CC(=O)OC2=C1C=CC(=C2)O,90-33-5,Positive,in vitro
7-hydroxy-6-methoxychromen-2-one,COC1=C(C=C2C(=C1)C=CC(=O)O2)O,92-61-5,Positive,in vitro
"7-methoxy-1-methyl-9H-pyrido[3,4-b]indole;hydrochloride",CC1=NC=CC2=C1NC3=C2C=CC(=C3)OC.Cl,343-27-1,Positive,in vitro
"7-Methoxy-2-nitronaphthol(2,1-b)furan",COC1=CC2=C(C=C1)C3=C(C=C2)OC(=C3)[N+](=O)[O-],75965-74-1,Positive,in vitro
7-methoxychromen-2-one,COC1=CC2=C(C=C1)C=CC(=O)O2,531-59-9,Positive,in vitro
"7-methyl-1,2-dihydrobenzo[a]anthracene-1,2-diol",CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)C(C(C=C3)O)O,62641-69-4,Positive,in vitro
"7-methyl-15,16-dihydrocyclopenta[a]phenanthren-17-one",CC1=CC2=CC=CC=C2C3=C1C4=C(C=C3)C(=O)CC4,,Positive,in vitro
"7-methyl-3-methylideneocta-1,6-diene",CC(=CCCC(=C)C=C)C,31253,Negative,In Vivo
"7-methyl-3-methylideneocta-1,6-diene",CC(=CCCC(=C)C=C)C,31253,Positive,In Vivo
"7-methyl-3,4-dihydrobenzo[a]anthracene-3,4-diol",CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)C=CC(C3O)O,,Positive,in vitro
"7-methyl-5,6-dihydrobenzo[a]anthracene-5,6-diol",CC1=C2C(C(C3=CC=CC=C3C2=CC4=CC=CC=C14)O)O,966-39-2,Negative,in vitro
"7-methyl-8,9-dihydrobenzo[a]anthracene-8,9-diol",CC1=C2C(C(C=CC2=CC3=C1C=CC4=CC=CC=C43)O)O,,Positive,in vitro
7-methylbenzo[a]anthracene,CC1=C2C=CC3=CC=CC=C3C2=CC4=CC=CC=C14,17347,Positive,In Vivo
7-methylbenzo[a]anthracene,CC1=C2C=CC3=CC=CC=C3C2=CC4=CC=CC=C14,2541-69-7,Positive,in vivo
7-methylbenzo[a]anthracene,CC1=C2C=CC3=CC=CC=C3C2=CC4=CC=CC=C14,2541-69-7,Positive,in vitro
7-methylbenzo[c]acridine,CC1=C2C=CC3=CC=CC=C3C2=NC4=CC=CC=C14,3340-94-1,Positive,in vitro
7-METHYLGUANINE,CN1C=NC2=C1C(=O)NC(=N2)N,578-76-7,Negative,In vivo
7-methylquinoline,CC1=CC2=C(C=CC=N2)C=C1,612-60-2,Positive,in vitro
7-nitro-1H-indazole,C1=CC2=C(C(=C1)[N+](=O)[O-])NN=C2,2942-42-9,Positive,in vitro
7-nitro-1H-indole,C1=CC2=C(C(=C1)[N+](=O)[O-])NC=C2,6960-42-5,Positive,in vitro
"7-nitro-3-oxido-4-(4-phenylpiperazin-1-yl)-2,1,3-benzoxadiazol-3-ium",C1CN(CCN1C2=CC=CC=C2)C3=CC=C(C4=NO[N+](=C34)[O-])[N+](=O)[O-],,Positive,in vitro
"7-nitro-3-oxido-4-(4-propylpiperazin-1-yl)-2,1,3-benzoxadiazol-3-ium",CCCN1CCN(CC1)C2=CC=C(C3=NO[N+](=C23)[O-])[N+](=O)[O-],,Positive,in vitro
"7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one",C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,146-22-5,Positive,in vitro
"7-oxabicyclo[4.1.0]hepta-2,4-diene",C1=CC2C(O2)C=C1,104944,Negative,In Vivo
"7-oxahexacyclo[15.2.1.03,9.06,8.010,19.013,18]icosa-1,3(9),10(19),11,13(18),14,16-heptaene-4,5-diol",C1C2=CC=CC3=C2C4=C(C=C3)C5=C(C=C41)C(C(C6C5O6)O)O,44148075,Positive,In Vivo
"7-oxido-3H-purin-3-ium-2,6-dione",C1=NC2=C(N1[O-])C(=O)NC(=O)[NH2+]2,146310,Positive,In Vivo
"7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoic acid",CC1=C(C(=O)C(=C(C1=O)C)C(CCCCCC(=O)O)C2=CC=CC=C2)C,2449,Negative,In Vivo
"7,10-diazoniatricyclo[8.4.0.02,7]tetradeca-1(14),2,4,6,10,12-hexaene",C1C[N+]2=CC=CC=C2C3=CC=CC=[N+]31,2764-72-9,Negative,in vivo
"7,10-diazoniatricyclo[8.4.0.02,7]tetradeca-1(14),2,4,6,10,12-hexaene",C1C[N+]2=CC=CC=C2C3=CC=CC=[N+]31,2764-72-9,Positive,in vitro
"7,10-dimethylbenzo[c]acridine",CC1=CC2=NC3=C(C=CC4=CC=CC=C43)C(=C2C=C1)C,2381-40-0,Positive,in vitro
"7,12-dimethyl-5,6-dihydrobenzo[a]anthracene-5,6-diol",CC1=C2C(C(C3=CC=CC=C3C2=C(C4=CC=CC=C14)C)O)O,16644-15-8,Negative,in vitro
"7,12-dimethyl-8,9,10,11-tetrahydrobenzo[a]anthracene",CC1=C2C=CC3=CC=CC=C3C2=C(C4=C1CCCC4)C,33012,Positive,In Vivo
"7,12-DIMETHYLBENZ(a)ANTHRACENE",CC1=C2C=CC3=CC=CC=C3C2=C(C4=CC=CC=C14)C,57-97-6,Positive,In vivo
"7,12-Dimethylbenz[a]anthracene",CC1=C2C=CC3=CC=CC=C3C2=C(C4=CC=CC=C14)C,57-97-6,Positive,in vitro
"7,12-dimethylbenzo[a]anthracen-2-ol",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C=C(C=C3)O,,Negative,in vitro
"7,12-dimethylbenzo[a]anthracen-3-ol",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C=CC(=C3)O,57266-83-8,Negative,in vitro
"7,12-dimethylbenzo[a]anthracen-4-ol",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C=CC=C3O,,Negative,in vitro
"7,12-dimethylbenzo[a]anthracen-5-ol",CC1=C2C=C(C3=CC=CC=C3C2=C(C4=CC=CC=C14)C)O,,Negative,in vitro
"7,12-dimethylbenzo[a]anthracene",CC1=C2C=CC3=CC=CC=C3C2=C(C4=CC=CC=C14)C,6001,Positive,In Vivo
"7,12-dimethylbenzo[a]anthracene",CC1=C2C=CC3=CC=CC=C3C2=C(C4=CC=CC=C14)C,6001,Negative,In Vivo
"7,12-dimethylbenzo[a]anthracene",CC1=C2C=CC3=CC=CC=C3C2=C(C4=CC=CC=C14)C,57-97-6,Positive,in vivo
"7,12-dimethylbenzo[a]anthracene",CC1=C2C=CC3=CC=CC=C3C2=C(C4=CC=CC=C14)C,57-97-6,Negative,in vitro
"7,12-dimethylbenzo[a]anthracene-5,6-diol",CC1=C2C3=CC=CC=C3C(=C(C2=C(C4=CC=CC=C14)C)O)O,16033-60-6,Negative,in vitro
"7,14-dihydronaphtho[1,2-b]phenanthrene",C1C2=C(CC3=C1C4=CC=CC=C4C=C3)C5=CC=CC=C5C=C2,57816-08-07,Positive,in vitro
"7,8-dihydrobenzo[a]pyrene",C1CC2=C(C=C1)C3=C4C(=C2)C=CC5=C4C(=CC=C5)C=C3,17573-23-8,Positive,in vitro
"7,8-dihydrobenzo[a]pyrene-7,8-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=CC(C5O)O)C=C2,13345-25-0,Positive,in vitro
"7,8,12-trimethylbenzo[a]anthracene",CC1=C2C(=C3C=CC4=CC=CC=C4C3=C(C2=CC=C1)C)C,83363,Positive,In Vivo
"7,9-dimethylbenzo[c]acridine",CC1=CC2=C(C=C1)N=C3C(=C2C)C=CC4=CC=CC=C43,963-89-3,Positive,in vivo
"7,9-dimethylbenzo[c]acridine",CC1=CC2=C(C=C1)N=C3C(=C2C)C=CC4=CC=CC=C43,963-89-3,Negative,in vitro
"7H-Dibenzo[c,g]carbazole",C1=CC=C2C(=C1)C=CC3=C2C4=C(N3)C=CC5=CC=CC=C54,194-59-2,Negative,in vitro
7H-purin-2-amine,C1=C2C(=NC(=N1)N)N=CN2,0452-06-02,Positive,in vivo
7H-purin-2-amine,C1=C2C(=NC(=N1)N)N=CN2,0452-06-02,Positive,in vitro
7H-purin-6-amine,C1=NC2=NC=NC(=C2N1)N,73-24-5,Positive,in vitro
7H-purine,C1=C2C(=NC=N1)N=CN2,120-73-0,Negative,in vitro
"7H-purine-2,6-diamine",C1=NC2=NC(=NC(=C2N1)N)N,1904-98-9,Positive,in vitro
"8-(2-ethoxyethyl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-5-amine",CCOCCC1=C(N=C(N2C1=NC=N2)N)C3=CC=CC=C3,55784,Positive,In Vivo
"8-[(2-amino-1,6-dimethylpyrimidin-4-ylidene)amino]-6-(4-aminophenyl)-5-methylphenanthridin-5-ium-3-amine;bromide;hydrobromide",CC1=CC(=NC2=CC3=C([N+](=C4C=C(C=CC4=C3C=C2)N)C)C5=CC=C(C=C5)N)N=C(N1C)N.Br.[Br-],14222-46-9,Positive,in vitro
8-[[4-(dimethylamino)phenyl]diazenyl]-10-phenylphenazin-10-ium-2-amine;chloride,CN(C)C1=CC=C(C=C1)N=NC2=CC3=[N+](C4=C(C=CC(=C4)N)N=C3C=C2)C5=CC=CC=C5.[Cl-],4618-88-6,Negative,in vitro
8-azido-3-diazonioimino-5-ethyl-6-phenylphenanthridine,CCN1C2=CC(=N[N+]#N)C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N=[N+]=[N-],,Negative,in vitro
"8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine",C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,3261,Negative,In Vivo
"8-ethoxy-1,3,7-trimethylpurine-2,6-dione",CCOC1=NC2=C(N1C)C(=O)N(C(=O)N2C)C,577-66-2,Negative,in vitro
"8-ethylsulfanyl-1,3,7-trimethylpurine-2,6-dione",CCSC1=NC2=C(N1C)C(=O)N(C(=O)N2C)C,6287-57-6,Positive,in vitro
"8-hydroxy-5,7-dinitronaphthalene-2-sulfonic acid",C1=CC2=C(C=C1S(=O)(=O)O)C(=C(C=C2[N+](=O)[O-])[N+](=O)[O-])O,483-84-1,Positive,in vitro
8-Hydroxyquinoline,C1=CC2=C(C(=C1)O)N=CC=C2,148-24-3,Negative,in vivo
8-Hydroxyquinoline,C1=CC2=C(C(=C1)O)N=CC=C2,148-24-3,Positive,in vivo
8-Hydroxyquinoline,C1=CC2=C(C(=C1)O)N=CC=C2,148-24-3,Positive,in vitro
8-hydroxyquinoline-5-sulfonic acid,C1=CC2=C(C=CC(=C2N=C1)O)S(=O)(=O)O,84-88-8,Positive,in vitro
"8-methoxy-1,3,7-trimethylpurine-2,6-dione",CN1C2=C(N=C1OC)N(C(=O)N(C2=O)C)C,569-34-6,Positive,in vitro
"8-methoxy-3-nitro-2-oxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,8,10-hexaene",COC1=C2C=CC=C3C2=C(C=C1)C=C(O3)[N+](=O)[O-],59910,Positive,In Vivo
"8-methoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid",COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O,2236,Positive,In Vivo
"8-methoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid",COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O,313-67-7,Positive,in vitro
"8-methoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid;6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid",COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O.COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O.C1OC2=C(O1)C3=C(C(=C2)C(=O)O)C(=CC4=CC=CC=C43)[N+](=O)[O-],56841539,Positive,In Vivo
8-METHOXYPSORALEN,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,298-81-7,Negative,In vivo
8-Methoxypsoralen,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,298-81-7,Positive,in vitro
8-methylbenzo[a]anthracene,CC1=C2C=C3C=CC4=CC=CC=C4C3=CC2=CC=C1,2381-31-9,Positive,in vivo
8-methylbenzo[a]anthracene,CC1=C2C=C3C=CC4=CC=CC=C4C3=CC2=CC=C1,2381-31-9,Negative,in vitro
8-methylquinoline,CC1=C2C(=CC=C1)C=CC=N2,11910,Negative,In Vivo
8-METHYLQUINOLINE,CC1=C2C(=CC=C1)C=CC=N2,611-32-5,Negative,In vivo
8-methylquinoline,CC1=C2C(=CC=C1)C=CC=N2,611-32-5,Positive,in vitro
"8-N,8-N,3-trimethylphenazine-2,8-diamine;hydrochloride",CC1=CC2=NC3=C(C=C(C=C3)N(C)C)N=C2C=C1N.Cl,,Negative,in vitro
8-nitrobenzo[e]pyrene,C1=CC=C2C(=C1)C3=CC=CC4=C3C5=C(C=C4)C=CC(=C25)[N+](=O)[O-],114893,Negative,In Vivo
8-NITROQUINOLINE,C1=CC2=C(C(=C1)[N+](=O)[O-])N=CC=C2,607-35-2,Negative,In vivo
8-nitroquinoline,C1=CC2=C(C(=C1)[N+](=O)[O-])N=CC=C2,11830,Positive,In Vivo
8-NITROQUINOLINE,C1=CC2=C(C(=C1)[N+](=O)[O-])N=CC=C2,607-35-2,Positive,In vivo
8-Nitroquinoline,C1=CC2=C(C(=C1)[N+](=O)[O-])N=CC=C2,607-35-2,Positive,in vitro
"8,10,14,23,25,28-hexahydroxy-6,21-dimethyloctacyclo[14.11.1.02,11.02,15.04,9.013,17.017,26.019,24]octacosa-4(9),5,7,10,19(24),20,22,25-octaene-3,12,18,27-tetrone",CC1=CC2=C(C(=C1)O)C(=C3C(=O)C4C(C5C3(C2=O)C6C(C5C47C(=C(C8=C(C7=O)C=C(C=C8O)C)O)C6=O)O)O)O,23537-16-8,Positive,in vitro
"8,9,10,11-tetrahydronaphtho[1,2-b]phenanthrene",C1CCC2=C(C1)C=CC3=CC4=C(C=CC5=CC=CC=C54)C=C23,9058,Positive,In Vivo
"9-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one",CC(=CCOC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2)C,482-44-0,Positive,in vitro
9-(bromomethyl)anthracene,C1=CC=C2C(=C1)C=C3C=CC=CC3=C2CBr,2417-77-8,Positive,in vitro
"9-[[(2R)-3,3-dimethyloxiran-2-yl]methoxy]furo[3,2-g]chromen-7-one",CC1([C@H](O1)COC2=C3C(=CC4=C2OC=C4)C=CC(=O)O3)C,2880-49-1,Positive,in vitro
9-[3-(propan-2-ylamino)propyl]fluorene-9-carboxamide,CC(C)NCCCC1(C2=CC=CC=C2C3=CC=CC=C31)C(=O)N,52195,Negative,In Vivo
9-chloro-10-(chloromethyl)anthracene,C1=CC=C2C(=C1)C(=C3C=CC=CC3=C2Cl)CCl,19996-03-03,Positive,in vitro
"9-ethyl-1,3,7-trimethylpurine-2,6,8-trione",CCN1C2=C(C(=O)N(C(=O)N2C)C)N(C1=O)C,,Positive,in vitro
9-ethylcarbazol-3-amine,CCN1C2=C(C=C(C=C2)N)C3=CC=CC=C31,132-32-1,Positive,in vivo
9-ethylcarbazole,CCN1C2=CC=CC=C2C3=CC=CC=C31,6836,Negative,In Vivo
9-hydroxyfluorene-9-carboxylic acid,C1=CC=C2C(=C1)C3=CC=CC=C3C2(C(=O)O)O,467-69-6,Negative,in vitro
"9-methoxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazole",CC1=C2C=CN=CC2=C(C3=C1NC4=C3C=C(C=C4)OC)C,10371-86-5,Positive,in vitro
"9-methoxyfuro[3,2-g]chromen-7-one",COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,4114,Negative,In Vivo
"9-methoxyfuro[3,2-g]chromen-7-one",COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,4114,Positive,In Vivo
"9-methoxyfuro[3,2-g]chromen-7-one",COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,298-81-7,Negative,in vitro
9-methylbenzo[a]anthracene,CC1=CC2=C(C=C1)C=C3C(=C2)C=CC4=CC=CC=C43,2381-16-0,Positive,in vitro
9-methylcarbazole,CN1C2=CC=CC=C2C3=CC=CC=C31,15142,Negative,In Vivo
9-nitro-9H-fluorene,C1=CC=C2C(=C1)C(C3=CC=CC=C32)[N+](=O)[O-],14544-96-8,Positive,in vitro
9-nitrobenzo[b]triphenylene,C1=CC=C2C(=C1)C=C3C4=CC=CC=C4C5=CC=CC=C5C3=C2[N+](=O)[O-],150723,Negative,In Vivo
9-nitrosocarbazole,C1=CC=C2C(=C1)C3=CC=CC=C3N2N=O,2788-23-0,Negative,in vitro
"9,10-ANTHRAQUINONE",C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O,84-65-1,Negative,In vivo
"9,10-Anthraquinone",C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O,84-65-1,Positive,in vitro
"9,10-bis(chloromethyl)anthracene",C1=CC=C2C(=C1)C(=C3C=CC=CC3=C2CCl)CCl,10387-13-0,Positive,in vitro
"9,10-dihydrobenzo[a]pyrene",C1CC2=C(C=C1)C=C3C=CC4=C5C3=C2C=CC5=CC=C4,17573-15-8,Negative,in vitro
"9,10-dihydrobenzo[a]pyrene-9,10-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C(C(C=C5)O)O)C=C2,,Positive,in vitro
"9,10-dimethylanthracene",CC1=C2C=CC=CC2=C(C3=CC=CC=C13)C,781-43-1,Negative,in vivo
"9,10-dimethylanthracene",CC1=C2C=CC=CC2=C(C3=CC=CC=C13)C,781-43-1,Positive,in vitro
"9,14-dihydrobenzo[b]triphenylene",C1C2=CC=CC=C2CC3=C1C4=CC=CC=C4C5=CC=CC=C35,35281-25-5,Positive,in vitro
"9,15-dimethyl-12-azapentacyclo[11.8.0.02,11.03,8.016,21]henicosa-1(13),2(11),3,5,7,9,14,16,18,20-decaene",CC1=CC2=C(C3=CC=CC=C13)C4=C(N2)C=C(C5=CC=CC=C54)C,55786,Positive,In Vivo
9H-acridin-10-yl-(4-methoxyphenyl)methanone,COC1=CC=C(C=C1)C(=O)N2C3=CC=CC=C3CC4=CC=CC=C42,,Positive,in vivo
9H-carbazole,C1=CC=C2C(=C1)C3=CC=CC=C3N2,6854,Negative,In Vivo
9H-carbazole,C1=CC=C2C(=C1)C3=CC=CC=C3N2,6854,Positive,In Vivo
9H-fluoren-2-amine,C1C2=CC=CC=C2C3=C1C=C(C=C3)N,1539,Positive,In Vivo
9H-fluoren-2-amine,C1C2=CC=CC=C2C3=C1C=C(C=C3)N,153-78-6,Positive,in vivo
9H-fluoren-2-amine,C1C2=CC=CC=C2C3=C1C=C(C=C3)N,1539,Negative,In Vivo
9H-fluoren-2-amine,C1C2=CC=CC=C2C3=C1C=C(C=C3)N,153-78-6,Negative,in vitro
9H-fluoren-3-amine,C1C2=C(C=C(C=C2)N)C3=CC=CC=C31,6344-66-7,Negative,in vitro
9H-fluoren-4-amine,C1C2=C(C3=CC=CC=C31)C(=CC=C2)N,7083-63-8,Negative,in vitro
9H-fluorene,C1C2=CC=CC=C2C3=CC=CC=C31,86-73-7,Negative,in vitro
"9H-fluorene-2,7-diamine",C1C2=C(C=CC(=C2)N)C3=C1C=C(C=C3)N,525-64-4,Positive,in vitro
"9H-pyrido[2,3-b]indol-2-amine",C1=CC=C2C(=C1)C3=C(N2)N=C(C=C3)N,62805,Positive,In Vivo
"9H-pyrido[2,3-b]indol-2-amine",C1=CC=C2C(=C1)C3=C(N2)N=C(C=C3)N,62805,Negative,In Vivo
"9H-pyrido[2,3-b]indol-2-amine",C1=CC=C2C(=C1)C3=C(N2)N=C(C=C3)N,26148-68-5,Positive,in vitro
"9H-pyrido[3,4-b]indol-1-amine",C1=CC=C2C(=C1)C3=C(N2)C(=NC=C3)N,30684-41-4,Positive,in vitro
"9H-pyrido[3,4-b]indol-3-amine",C1=CC=C2C(=C1)C3=CC(=NC=C3N2)N,73834-77-2,Positive,in vitro
"9H-pyrido[3,4-b]indole",C1=CC=C2C(=C1)C3=C(N2)C=NC=C3,244-63-3,Positive,in vitro
A-alpha-C,C1=CC=C2C(=C1)C3=C(N2)N=C(C=C3)N,26148-68-5,Positive,In vivo
Abamectin,CCC(C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C.C[C@H]1/C=C/C=C/2\CO[C@H]3[C@@]2([C@@H](C=C([C@H]3O)C)C(=O)O[C@H]4C[C@@H](C/C=C(/[C@H]1O[C@H]5C[C@@H]([C@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)OC)\C)O[C@]7(C4)C=C[C@@H]([C@H](O7)C(C)C)C)O,71751-41-2,Negative,in vivo
Abamectin,CCC(C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C.C[C@H]1/C=C/C=C/2\CO[C@H]3[C@@]2([C@@H](C=C([C@H]3O)C)C(=O)O[C@H]4C[C@@H](C/C=C(/[C@H]1O[C@H]5C[C@@H]([C@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)OC)\C)O[C@]7(C4)C=C[C@@H]([C@H](O7)C(C)C)C)O,71751-41-2,Negative,in vitro
aceanthrylene,C1=CC=C2C3=C4C(=CC=CC4=CC2=C1)C=C3,107781,Positive,In Vivo
Acenaphthene,C1CC2=CC=CC3=C2C1=CC=C3,83-32-9,Negative,In vivo
Acenaphthylene,C1=CC2=C3C(=C1)C=CC3=CC=C2,208-96-8,Negative,In vivo
Acephate,CC(=O)NP(=O)(OC)SC,30560-19-1,Positive,In vivo
Acephate,CC(=O)NP(=O)(OC)SC,30560-19-1,Positive,in vitro
acephenanthrylene,C1=CC=C2C(=C1)C=C3C=CC4=C3C2=CC=C4,9143,Negative,In Vivo
acephenanthrylene,C1=CC=C2C(=C1)C=C3C=CC4=C3C2=CC=C4,9143,Positive,In Vivo
Acequinocyl,CCCCCCCCCCCCC1=C(C(=O)C2=CC=CC=C2C1=O)OC(=O)C,57960-19-7,Negative,in vivo
Acequinocyl,CCCCCCCCCCCCC1=C(C(=O)C2=CC=CC=C2C1=O)OC(=O)C,57960-19-7,Negative,in vitro
ACESULFAME-K,CC1=CC(=O)[N-]S(=O)(=O)O1.[K+],55589-62-3,Negative,In vivo
Acesulfame-K,CC1=CC(=O)[N-]S(=O)(=O)O1.[K+],55589-62-3,Negative,in vitro
ACETALDEHYDE,CC=O,75-07-0,Positive,In vivo
acetaldehyde,CC=O,177,Positive,In Vivo
Acetaldehyde,CC=O,75-07-0,Positive,in vitro
ACETALDEHYDE METHYLFORMYLHYDRAZONE,CC=NN(C)C=O,16568-02-8,Negative,In vivo
ACETALDEHYDE METHYLFORMYLHYDRAZONE,CC=NN(C)C=O,16568-02-8,Positive,In vivo
acetamide,CC(=O)N,60-35-5,Negative,in vivo
ACETAMIDE,CC(=O)N,60-35-5,Positive,In vivo
acetamide,CC(=O)N,178,Positive,In Vivo
Acetamide,CC(=O)N,60-35-5,Positive,in vitro
ACETAMINOPHEN,CC(=O)NC1=CC=C(C=C1)O,103-90-2,Negative,In vivo
ACETAMINOPHEN,CC(=O)NC1=CC=C(C=C1)O,103-90-2,Positive,In vivo
Acetaminophen,CC(=O)NC1=CC=C(C=C1)O,103-90-2,Positive,in vitro
Acetic acid,CC(=O)O,64-19-7,Negative,in vitro
"acetic acid;1-methyl-5H-pyrido[4,3-b]indol-3-amine",CC1=C2C3=CC=CC=C3NC2=CC(=N1)N.CC(=O)O,5284475,Positive,In Vivo
"acetic acid;1-methyl-5H-pyrido[4,3-b]indol-3-amine",CC1=C2C3=CC=CC=C3NC2=CC(=N1)N.CC(=O)O,72254-58-1,Positive,in vivo
"acetic acid;1,4-dimethyl-5H-pyrido[4,3-b]indol-3-amine",CC1=C2C(=C(N=C1N)C)C3=CC=CC=C3N2.CC(=O)O,5284473,Positive,In Vivo
acetic acid;2-dodecylguanidine,CCCCCCCCCCCCN=C(N)N.CC(=O)O,17110,Negative,In Vivo
acetic acid;2-dodecylguanidine,CCCCCCCCCCCCN=C(N)N.CC(=O)O,17110,Positive,In Vivo
acetic acid;2-dodecylguanidine,CCCCCCCCCCCCN=C(N)N.CC(=O)O,2439-10-3,Negative,in vitro
"acetic acid;7-(8-acetyl-1,6-dihydroxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)-2,3,8-trihydroxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde",CC1=CC2=C(C(=CC(=C2C(C)C)O)C(=O)C)C(=C1C3=C(C4=C(C=C3C)C(=C(C(=C4C=O)O)O)C(C)C)O)O.CC(=O)O,,Positive,in vivo
Acetochlor,CCC1=CC=CC(=C1N(COCC)C(=O)CCl)C,34256-82-1,Negative,In vivo
Acetochlor,CCC1=CC=CC(=C1N(COCC)C(=O)CCl)C,34256-82-1,Positive,in vitro
Acetohexamide,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2,968-81-0,Negative,in vitro
acetohydrazide,CC(=O)NN,1068-57-1,Positive,in vitro
Acetone,CC(=O)C,67-64-1,Negative,In vivo
ACETONE[4-(5-NITRO-2-FURYL)-2-THIAZOLYL]HYDRAZONE,CC(=NNC1=NC(=CS1)C2=CC=C(O2)[N+](=O)[O-])C,18523-69-8,Positive,In vivo
acetonitrile,CC#N,6342,Negative,In Vivo
Acetonitrile,CC#N,75-05-8,Negative,In vivo
Acetonitrile Ethyl nitrile,CC#N,75-05-8,Negative,in vitro
Acetophenone,CC(=O)C1=CC=CC=C1,98-86-2,Negative,In vivo
ACETOXIME,CC(=NO)C,127-06-0,Negative,In vivo
ACETOXIME,CC(=NO)C,127-06-0,Positive,In vivo
Acetoxime,CC(=NO)C,127-06-0,Negative,in vitro
Acetyl chloride,CC(=O)Cl,75-36-5,Negative,In vivo
acetyloxy(methyl)mercury,CC(=O)O[Hg]C,16682934,Negative,In Vivo
acetyloxy(methyl)mercury,CC(=O)O[Hg]C,0108-07-06,Negative,in vivo
acetyloxy(phenyl)mercury,CC(=O)O[Hg]C1=CC=CC=C1,62-38-4,Positive,in vitro
Acibenzolar-S-methyl,CSC(=O)C1=C2C(=CC=C1)N=NS2,135158-54-2,Negative,in vivo
Acibenzolar-S-methyl,CSC(=O)C1=C2C(=CC=C1)N=NS2,135158-54-2,Negative,in vitro
Acid blue 9,CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=CC=CC=C5S(=O)(=O)[O-].[Na+].[Na+],2650-18-2,Positive,in vitro
ACIFLUORFEN,C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)[N+](=O)[O-])C(=O)O,50594-66-6,Positive,In vivo
"Acifluorfen, sodium",C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)[N+](=O)[O-])C(=O)[O-].[Na+],62476-59-9,Negative,In vivo
Aclonifen,Clc2c(N)c(ccc2Oc1ccccc1)[N+]([O-])=O,74070-46-5,Negative,in vivo
Aclonifen,Clc2c(N)c(ccc2Oc1ccccc1)[N+]([O-])=O,74070-46-5,Negative,in vitro
Acranyl dihydrochloride,CCN(CC)CC(CNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC)O.Cl.Cl,1684-42-0,Positive,in vitro
"acridin-10-ium-3,6-diamine;chloride",C1=CC(=CC2=[NH+]C3=C(C=CC(=C3)N)C=C21)N.[Cl-],44581885,Negative,In Vivo
acridin-3-amine,C1=CC=C2C(=C1)C=C3C=CC(=CC3=N2)N,581-29-3,Negative,in vitro
acridin-9-amine,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)N,90-45-9,Negative,in vitro
acridine,C1=CC=C2C(=C1)C=C3C=CC=CC3=N2,9215,Negative,In Vivo
"acridine-3,6-diamine",C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N,92-62-6,Negative,in vivo
"acridine-3,6-diamine",C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N,92-62-6,Positive,in vitro
"acridine-3,6-diamine;10-methylacridin-10-ium-3,6-diamine;chloride",C[N+]1=C2C=C(C=CC2=CC3=C1C=C(C=C3)N)N.C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N.[Cl-],8048-52-0,Positive,in vivo
"acridine-3,6-diamine;10-methylacridin-10-ium-3,6-diamine;chloride",C[N+]1=C2C=C(C=CC2=CC3=C1C=C(C=C3)N)N.C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N.[Cl-],8048-52-0,Negative,in vitro
"acridine-3,6-diamine;sulfuric acid",C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N.OS(=O)(=O)O,553-30-0,Positive,in vitro
Acrinathrin,CC1([C@H]([C@H]1C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)/C=C\C(=O)OC(C(F)(F)F)C(F)(F)F)C,101007-06-1,Negative,in vivo
Acrinathrin,CC1([C@H]([C@H]1C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)/C=C\C(=O)OC(C(F)(F)F)C(F)(F)F)C,101007-06-1,Negative,in vitro
ACROLEIN,C=CC=O,107-02-8,Negative,In vivo
Acrolein,C=CC=O,0107-02-08,Negative,In vivo
Acrolein,C=CC=O,0107-02-08,Negative,in vitro
Acrylamide,C=CC(=O)N,79-06-1,Positive,In vivo
Acrylamide,C=CC(=O)N,79-06-1,Positive,in vitro
Acrylic acid,C=CC(=O)O,79-10-7,Negative,In vivo
Acrylonitrile,C=CC#N,107-13-1,Positive,In vivo
ACRYLONITRILE,C=CC#N,107-13-1,Negative,In vivo
Acrylonitrile,C=CC#N,107-13-1,Positive,in vitro
ACTINOMYCIN D,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,50-76-0,Positive,In vivo
adamantan-1-amine,C1C2CC3CC1CC(C2)(C3)N,768-94-5,Negative,in vitro
ADIPAMIDE,C(CCC(=O)N)CC(=O)N,628-94-4,Negative,In vivo
Adiponitrile,C(CCC#N)CC#N,111-69-3,Negative,In vivo
Adriamycin [ AKA doxorubicin],CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,23214-92-8,Positive,in vitro
AF-2,C1=COC(=C1)C(=CC2=CC=C(O2)[N+](=O)[O-])C(=O)N,3688-53-7,Positive,In vivo
AF-2,C1=COC(=C1)C(=CC2=CC=C(O2)[N+](=O)[O-])C(=O)N,3688-53-7,Negative,In vivo
AFLATOXICOL,COC1=C2C3=C([C@H](CC3)O)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,29611-03-8,Positive,In vivo
Aflatoxicol,COC1=C2C3=C([C@H](CC3)O)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,29611-03-8 ,Positive,in vitro
AFLATOXIN B1,COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C5C=COC5OC4=C1,1162-65-8,Positive,In vivo
AFLATOXIN B1,COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C5C=COC5OC4=C1,1162-65-8,Negative,In vivo
Aflatoxin B1,COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4C5C=COC5OC4=C1,1162-65-8,Positive,in vitro
"AFLATOXIN, CRUDE",COC1=C2C3=C(C(=O)OCC3)C(=O)OC2=C4C5C=COC5OC4=C1,1402-68-2,Positive,In vivo
Agaritine,C1=CC(=CC=C1CO)NNC(=O)CCC(C(=O)O)N,2757-90-6,Negative,in vitro
Alachlor,CCC1=C(C(=CC=C1)CC)N(COC)C(=O)CCl,15972-60-8,Negative,In vivo
Alar,CN(C)NC(=O)CCC(=O)O,1596-84-5,Negative,In vivo
ALCLOFENAC,C=CCOC1=C(C=C(C=C1)CC(=O)O)Cl,22131-79-9,Negative,In vivo
Aldicarb,CC(C)(C=NOC(=O)NC)SC,0116-06-03,Negative,In vivo
Aldicarb,CC(C)(C=NOC(=O)NC)SC,116-06-3,Positive,in vitro
Aldicarb sulfone,CC(C)(C=NOC(=O)NC)S(=O)(=O)C,1646-88-4,Negative,In vivo
ALDRIN,C1C2C=CC1C3C2C4(C(=C(C3(C4(Cl)Cl)Cl)Cl)Cl)Cl,309-00-2,Positive,In vivo
ALDRIN,C1C2C=CC1C3C2C4(C(=C(C3(C4(Cl)Cl)Cl)Cl)Cl)Cl,309-00-2,Negative,In vivo
Aldrin,C1C2C=CC1C3C2C4(C(=C(C3(C4(Cl)Cl)Cl)Cl)Cl)Cl,309-00-2,Positive,in vitro
alfa-Hydroxytamoxifen,CC(/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3)O ,97151-02-5,Positive,in vitro
"ALKYLBENZENESULFONATE, LINEAR",CCCCCCCCCCC(C)C1=CC=C(C=C1)S(=O)(=O)[O-].[Na+],42615-29-2,Negative,In vivo
ALLANTOIN,C1(C(=O)NC(=O)N1)NC(=O)N,97-59-6,Negative,In vivo
Allura Red AC Food Red 40,CC1=CC(=C(C=C1S(=O)(=O)[O-])OC)N=NC2=C(C=CC3=C2C=CC(=C3)S(=O)(=O)[O-])O.[Na+].[Na+],25956-17-6,Negative,in vitro
Ally,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC,74223-64-6,Negative,In vivo
Allyl alcohol,C=CCO,107-18-6,Negative,In vivo
Allyl chloride,C=CCCl,0107-05-01,Negative,In vivo
Allyl chloride (Chloropropene),ClC=CC,0107-05-01,Positive,in vitro
Allyl glycidyl ether,C=CCOCC1CO1,106-92-3,Positive,in vitro
ALLYLHYDRAZINE.HCl,C=CCNN.Cl,52207-83-7,Negative,In vivo
ALLYLHYDRAZINE.HCl,C=CCNN.Cl,52207-83-7,Positive,In vivo
Alosteron ,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C,122852-42-0,Negative,in vitro
"alpha-(2,4-DICHLOROPHENOXY)PROPIONIC ACID",CC(C(=O)O)OC1=C(C=C(C=C1)Cl)Cl,120-36-5,Negative,In vivo
"alpha-(2,5-DICHLOROPHENOXY)PROPIONIC ACID",CC(C(=O)O)OC1=C(C=CC(=C1)Cl)Cl,6965-71-5,Negative,In vivo
"alpha-1,2,3,4,5,6-HEXACHLOROCYCLOHEXANE",C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,319-84-6,Positive,In vivo
"alpha-1,2,3,4,5,6-HEXACHLOROCYCLOHEXANE",C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,319-84-6,Negative,In vivo
alpha-ECDYSONE,CC(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)C(CCC(C)(C)O)O,3604-87-3,Positive,In vivo
"alpha,beta-DICHLORO-beta-FORMYLACRYLIC ACID",C(=O)C(=C(C(=O)O)Cl)Cl,87-56-9,Negative,In vivo
Aluminium ammonium sulphate dodecahydrate,[NH4+].O.O.O.O.O.O.O.O.O.O.O.O.[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Al+3],7784-26-1,Positive,in vivo
Aluminium ammonium sulphate dodecahydrate,[NH4+].O.O.O.O.O.O.O.O.O.O.O.O.[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Al+3],7784-26-1,Negative,in vitro
Aluminium phosphide,[Al]#P,20859-73-8,Negative,in vivo
Aluminium phosphide,[Al]#P,20859-73-8,Positive,in vivo
Aluminium phosphide,[Al]#P,20859-73-8,Negative,in vitro
Aluminium sulphate,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Al+3].[Al+3],10043-01-3,Positive,in vivo
Aluminium sulphate,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Al+3].[Al+3],10043-01-03,Negative,in vitro
Aluminum phosphide,[Al]#P,20859-73-8,Negative,In vivo
ALUMINUM POTASSIUM SULFATE,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Al+3].[K+],10043-67-1,Negative,In vivo
aluminum;potassium;disulfate,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Al+3].[K+],24856,Negative,In Vivo
aluminum;silicate,[O-][Si]([O-])([O-])[O-].[Al+3],44144451,Positive,In Vivo
Amdro,CC1(CNC(=NC1)NN=C(C=CC2=CC=C(C=C2)C(F)(F)F)C=CC3=CC=C(C=C3)C(F)(F)F)C,67485-29-4,Negative,In vivo
Ametryn,CCNC1=NC(=NC(=N1)SC)NC(C)C,0834-12-8,Negative,In vivo
Amidosulfuron,O=C(Nc1nc(cc(OC)n1)OC)NS(=O)(=O)N(C)S(C)(=O)=O,120923-37-7,Negative,in vivo
Amidosulfuron,O=C(Nc1nc(cc(OC)n1)OC)NS(=O)(=O)N(C)S(C)(=O)=O,120923-37-7,Negative,in vitro
amino hydrogen sulfate,NOS(=O)(=O)O,2950-43-8,Positive,in vitro
amino-[bis(2-chloroethyl)amino]phosphinic acid,C(CCl)N(CCCl)P(=O)(N)O,10159-53-2,Positive,in vitro
Aminophenylnorharman,C1=CC=C2C(=C1)C3=C(N2C4=CC=C(C=C4)N)C=NC=C3,219959-86-1,Positive,in vitro
Aminopyralid,Clc1c(nc(Cl)cc1N)C(=O)O,150114-71-9,Negative,in vivo
Aminopyralid,Clc1c(nc(Cl)cc1N)C(=O)O,150114-71-9,Negative,in vitro
Aminopyridine,C1=CN=CC=C1N,504-24-5,Negative,In vivo
aminothiourea,C(=S)(N)NN,2723789,Negative,In Vivo
aminourea;hydrochloride,C(=O)(N)NN.Cl,11236,Positive,In Vivo
aminourea;hydrochloride,C(=O)(N)NN.Cl,11236,Negative,In Vivo
Amisulbrom,CC1=C(C2=C(N1S(=O)(=O)C3=NN(C=N3)S(=O)(=O)N(C)C)C=C(C=C2)F)Br,348635-87-0,Negative,in vivo
Amisulbrom,CC1=C(C2=C(N1S(=O)(=O)C3=NN(C=N3)S(=O)(=O)N(C)C)C=C(C=C2)F)Br,348635-87-0,Negative,in vitro
Amitraz,CC1=CC(=C(C=C1)N=CN(C)C=NC2=C(C=C(C=C2)C)C)C,33089-61-1,Negative,In vivo
Amitrole,C1=NNC(=N1)N,61-82-5,Negative,in vivo
Amitrole,C1=NNC(=N1)N,61-82-5,Positive,in vivo
Amitrole,C1=NNC(=N1)N,61-82-5,Negative,in vitro
"Amitrole 3-amino-1,2,4-triazole",C1=NNC(=N1)N,61-82-5,Negative,in vitro
Ammonia,N,7664-41-7,Negative,In vivo
Ammonium acetate,CC(=O)[O-].[NH4+],631-61-8,Negative,In vivo
AMMONIUM CITRATE,C(C(=O)O)C(CC(=O)O)(C(=O)O)O.N,3012-65-5,Negative,In vivo
AMMONIUM HYDROXIDE,[NH4+].[OH-],1336-21-6,Negative,In vivo
Ammonium methacrylate,CC(=C)C(=O)[O-].[NH4+],16325-47-6,Negative,In vivo
Ammonium sulfamate,[NH4+].NS(=O)(=O)[O-],7773-06-0,Negative,In vivo
Amodiaquine,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,86-42-0,Positive,in vitro
AMP397,C1=C(C=C2C(=C1CNCP(=O)(O)O)NC(=O)C(=O)N2)[N+](=O)[O-],188696-80-2,Positive,in vitro
Ampicillin trihydrate,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C.O.O.O,7177-48-2,Negative,in vitro
Amscarine,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,51264-14-3,Positive,in vitro
ANETHOLE,CC=CC1=CC=C(C=C1)OC,104-46-1,Negative,In vivo
ANHYDROGLUCOCHLORAL,C(C(C1C(C2C(O1)OC(O2)C(Cl)(Cl)Cl)O)O)O,15879-93-3,Negative,In vivo
Anilazine,C1=CC=C(C(=C1)NC2=NC(=NC(=N2)Cl)Cl)Cl,101-05-3,Positive,in vitro
aniline,C1=CC=C(C=C1)N,6115,Negative,In Vivo
Aniline,C1=CC=C(C=C1)N,62-53-3,Positive,In vivo
ANILINE,C1=CC=C(C=C1)N,62-53-3,Negative,In vivo
aniline,C1=CC=C(C=C1)N,62-53-3,Negative,in vitro
aniline;hydrochloride,C1=CC=C(C=C1)N.Cl,8870,Negative,In Vivo
aniline;hydrochloride,C1=CC=C(C=C1)N.Cl,0142-04-01,Negative,in vivo
aniline;hydrochloride,C1=CC=C(C=C1)N.Cl,0142-04-01,Positive,in vivo
aniline;hydrochloride,C1=CC=C(C=C1)N.Cl,8870,Positive,In Vivo
aniline;hydrochloride,C1=CC=C(C=C1)N.Cl,0142-04-01,Positive,in vitro
Aniline/Aniline hydrochloride,C1=CC=C(C=C1)N,62-53-3,Positive,in vitro
Anisidine,COC1=CC=CC=C1N,90-04-0,Negative,In vivo
anthracen-1-amine,C1=CC=C2C=C3C(=CC2=C1)C=CC=C3N,610-49-1,Negative,in vitro
anthracen-2-amine,C1=CC=C2C=C3C=C(C=CC3=CC2=C1)N,11937,Positive,In Vivo
anthracen-2-amine,C1=CC=C2C=C3C=C(C=CC3=CC2=C1)N,613-13-8,Positive,in vivo
anthracen-2-amine,C1=CC=C2C=C3C=C(C=CC3=CC2=C1)N,613-13-8,Negative,in vitro
anthracene,C1=CC=C2C=C3C=CC=CC3=CC2=C1,0120-12-7,Negative,in vivo
anthracene,C1=CC=C2C=C3C=CC=CC3=CC2=C1,0120-12-7,Negative,in vitro
"anthracene-1,8,9-triol",C1=CC2=CC3=C(C(=CC=C3)O)C(=C2C(=C1)O)O,480-22-8,Negative,in vitro
"anthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O,6780,Positive,In Vivo
Antimony,[Sb],7440-36-0,Negative,In vivo
ANTIMONY POTASSIUM TARTRATE,C(C(C(=O)[O-])[O-])(C(=O)[O-])[O-].C(C(C(=O)[O-])[O-])(C(=O)[O-])[O-].[K+].[K+].[Sb+3].[Sb+3],28300-74-5,Negative,In vivo
Antimony trioxide,[O-2].[O-2].[O-2].[Sb+3].[Sb+3],1309-64-4,Negative,In vivo
antimony(3+);oxygen(2-),[O-2].[O-2].[O-2].[Sb+3].[Sb+3],14794,Negative,In Vivo
antimony(3+);oxygen(2-),[O-2].[O-2].[O-2].[Sb+3].[Sb+3],14794,Positive,In Vivo
antimony(3+);oxygen(2-),[O-2].[O-2].[O-2].[Sb+3].[Sb+3],1327-33-9,Positive,in vitro
antimony(3+);triacetate,CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Sb+3],6923-52-0,Positive,in vitro
Apicidin,CC[C@H](C)[C@H]1C(=O)N2CCCC[C@@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC3=CN(C4=CC=CC=C43)OC)CCCCCC(=O)CC ,183506-66-3 ,Positive,in vitro
Apollo,C1=CC=C(C(=C1)C2=NN=C(N=N2)C3=CC=CC=C3Cl)Cl,74115-24-5,Negative,In vivo
ARAMITE,CC(COC1=CC=C(C=C1)C(C)(C)C)OS(=O)OCCCl,140-57-8,Positive,In vivo
ARAMITE,CC(COC1=CC=C(C=C1)C(C)(C)C)OS(=O)OCCCl,140-57-8,Negative,In vivo
ARECOLINE.HCl,CN1CCC=C(C1)C(=O)OC.Cl,61-94-9,Negative,In vivo
ARECOLINE.HCl,CN1CCC=C(C1)C(=O)OC.Cl,61-94-9,Positive,In vivo
Aristolochic acid,COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O,313-67-7,Positive,in vitro
"ARISTOLOCHIC ACID, SODIUM SALT (77% AA I, 21% AA II)",COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)[O-].[Na+],10190-99-5,Positive,In vivo
Aroclor 1016,C1=CC(=CC(=C1)Cl)C2=CC(=CC(=C2)Cl)Cl,12674-11-2,Negative,In vivo
AROCLOR 1016,C1=CC(=CC(=C1)Cl)C2=CC(=CC(=C2)Cl)Cl,12674-11-2,Positive,In vivo
Aroclor 1248,C1=C(C=C(C=C1Cl)Cl)C2=CC(=CC(=C2)Cl)Cl,12672-29-6,Negative,In vivo
AROCLOR 1254,C1=CC(=C(C(=C1)Cl)Cl)C2=C(C(=C(C=C2)Cl)Cl)Cl,11097-69-1,Positive,In vivo
Aroclor 1254,C1=CC(=C(C(=C1)Cl)Cl)C2=C(C(=C(C=C2)Cl)Cl)Cl,11097-69-1,Negative,In vivo
Aroclor 1254,C1=CC(=C(C(=C1)Cl)Cl)C2=C(C(=C(C=C2)Cl)Cl)Cl,11097-69-1,Negative,in vitro
AROCLOR 1260,C1=CC(=C(C(=C1C2=C(C(=C(C=C2)Cl)Cl)Cl)Cl)Cl)Cl,11096-82-5,Positive,In vivo
arsanylidynenickel,[Ni]#[As],62391,Negative,In Vivo
arsanylidynenickel,[Ni]#[As],62391,Positive,In Vivo
"ARSENATE, SODIUM",O[As](=O)(O)[O-].[Na+],7631-89-2,Negative,In vivo
arsenic,[As],5359596,Positive,In Vivo
Arsenic pentoxide,O=[As](=O)O[As](=O)=O,1303-28-2,Positive,in vitro
"Arsenic, Inorganic",[As],7440-38-2,Positive,In vivo
arsenic(3+);oxygen(2-),[O-2].[O-2].[O-2].[As+3].[As+3],14888,Positive,In Vivo
arsenic(3+);oxygen(2-),[O-2].[O-2].[O-2].[As+3].[As+3],,Positive,in vitro
"ARSENITE, SODIUM",[O-][As]=O.[Na+],7784-46-5,Negative,In vivo
Arsine,[AsH3],7784-42-1,Negative,In vivo
ASPARTAME,COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)N,22839-47-0,Negative,In vivo
ASPIRIN,CC(=O)OC1=CC=CC=C1C(=O)O,50-78-2,Negative,In vivo
"Aspirin, phenacetin,  caffeine",CCOC1=CC=C(C=C1)NC(=O)C.CC(=O)OC1=CC=CC=C1C(=O)O.CN1C=NC2=C1C(=O)N(C(=O)N2C)C,8003-03-0,Negative,in vitro
"ASPIRIN, PHENACETIN, AND CAFFEINE",CCOC1=CC=C(C=C1)NC(=O)C.CC(=O)OC1=CC=CC=C1C(=O)O.CN1C=NC2=C1C(=O)N(C(=O)N2C)C,8003-03-0,Negative,In vivo
Assure,CCOC(=O)C(C)OC1=CC=C(C=C1)OC2=CN=C3C=C(C=CC3=N2)Cl,76578-14-8,Negative,In vivo
ASTEMIZOLE,COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F,68844-77-9,Negative,In vivo
Asulam,COC(=O)NS(=O)(=O)C1=CC=C(C=C1)N,3337-71-1,Negative,In vivo
ATRAZINE,CCNC1=NC(=NC(=N1)Cl)NC(C)C,1912-24-9,Negative,In vivo
ATRAZINE,CCNC1=NC(=NC(=N1)Cl)NC(C)C,1912-24-9,Positive,In vivo
Atrazine,CCNC1=NC(=NC(=N1)Cl)NC(C)C,1912-24-9,Negative,in vitro
ATROPINE,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,51-55-8,Negative,In vivo
Auramine O,CN(C)C1=CC=C(C=C1)C(=N)C2=CC=C(C=C2)N(C)C.Cl,2465-27-2,Positive,in vitro
AURAMINE-O,CN(C)C1=CC=C(C=C1)C(=N)C2=CC=C(C=C2)N(C)C.Cl,2465-27-2,Positive,In vivo
AURANOFIN,CCP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+],34031-32-8,Negative,In vivo
Avermectin B1,CCC(C)C1C(C=CC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C,65195-55-3,Negative,In vivo
Azadirachtin A,C24(C(C3C1(C=COC1OC2C3)O)(C)O4)C6(C8C5(C(CC(C7(C5C(C6O)OC7)OC(=O)C)OC(=O)C)OC(/C(=C/C)C)=O)COC8(C(=O)OC)O)C,11141-17-6,Negative,in vivo
Azadirachtin A,C24(C(C3C1(C=COC1OC2C3)O)(C)O4)C6(C8C5(C(CC(C7(C5C(C6O)OC7)OC(=O)C)OC(=O)C)OC(/C(=C/C)C)=O)COC8(C(=O)OC)O)C,11141-17-6,Negative,in vitro
azane;platinum(4+);tetrachloride,N.N.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+4],16949-90-9,Positive,in vitro
azanide;platinum(2+);dichloride,[NH2-].[NH2-].[NH2-].[Cl-].[Cl-].[Pt+2],13815-16-2,Positive,in vitro
azanium;(Z)-oxido-oxidoimino-phenylazanium,C1=CC=C(C=C1)/[N+](=N/[O-])/[O-].[NH4+],135465076,Positive,In Vivo
azanium;(Z)-oxido-oxidoimino-phenylazanium,C1=CC=C(C=C1)/[N+](=N/[O-])/[O-].[NH4+],,Positive,in vivo
azanium;(Z)-oxido-oxidoimino-phenylazanium,C1=CC=C(C=C1)/[N+](=N/[O-])/[O-].[NH4+],,Positive,in vitro
"azanium;2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctanoate",C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)[O-].[NH4+],2776282,Positive,In Vivo
azanium;antimony(3+);oxygen(2-);tungsten,[NH4+].[O-2].[O-2].[O-2].[O-2].[O-2].[Sb+3].[W],59372-48-4,Positive,in vitro
azanium;oxido(dioxo)vanadium,[NH4+].[O-][V](=O)=O,7803-55-6,Positive,in vitro
azanium;thiocyanate,C(#N)[S-].[NH4+],1762-95-4,Negative,in vitro
AZASERINE,C([C@@H](C(=O)O)N)OC(=O)C=[N+]=[N-],115-02-6,Negative,In vivo
AZASERINE,C([C@@H](C(=O)O)N)OC(=O)C=[N+]=[N-],115-02-6,Positive,In vivo
Azaserine,C([C@@H](C(=O)O)N)OC(=O)C=[N+]=[N-],0115-02-06,Positive,in vitro
AZATHIOPRINE,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],446-86-6,Positive,In vivo
AZATHIOPRINE,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],446-86-6,Negative,In vivo
Azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],446-86-6,Positive,in vitro
AZELNIDIPINE,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C,123524-52-7,Negative,In vivo
azepan-2-one,C1CCC(=O)NCC1,7768,Negative,In Vivo
azepan-2-one,C1CCC(=O)NCC1,105-60-2,Negative,in vivo
azepan-2-one,C1CCC(=O)NCC1,105-60-2,Negative,in vitro
"AZIDE, SODIUM",[N-]=[N+]=[N-].[Na+],26628-22-8,Negative,In vivo
Azimsulfuron,CN1C(=C(C=N1)C2=NN(N=N2)C)S(=O)(=O)NC(=O)NC3=NC(=CC(=N3)OC)OC,120162-55-2,Negative,in vivo
Azimsulfuron,CN1C(=C(C=N1)C2=NN(N=N2)C)S(=O)(=O)NC(=O)NC3=NC(=CC(=N3)OC)OC,120162-55-2,Negative,in vitro
Azinphosmethyl [AKA gusathion],COP(=S)(OC)SCN1C(=O)C2=CC=CC=C2N=N1,86-50-0,Positive,in vitro
aziridine,C1CN1,151-56-4,Positive,in vivo
aziridine,C1CN1,9033,Positive,In Vivo
aziridine,C1CN1,151-56-4,Positive,in vitro
Azobenzene,C1=CC=C(C=C1)N=NC2=CC=CC=C2,103-33-3,Negative,In vivo
Azobenzene,C1=CC=C(C=C1)N=NC2=CC=CC=C2,103-33-3,Positive,in vitro
Azoxybenzene,C1=CC=C(C=C1)N=[N+](C2=CC=CC=C2)[O-],495-48-7,Positive,in vitro
AZOXYMETHANE,CN=[N+](C)[O-],25843-45-2,Negative,In vivo
AZOXYMETHANE,CN=[N+](C)[O-],25843-45-2,Positive,In vivo
Azoxymethane,CN=[N+](C)[O-],25843-45-2,Positive,in vitro
Azoxystrobin,N#CC1=CC=CC=C1OC2=NC=NC(OC3=CC=CC=C3/C(C(OC)=O)=C\OC)=C2,131860-33-8,Negative,in vivo
Azoxystrobin,N#CC1=CC=CC=C1OC2=NC=NC(OC3=CC=CC=C3/C(C(OC)=O)=C\OC)=C2,131860-33-8,Negative,in vitro
AZT,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],30516-87-1,Negative,In vivo
AZT,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],30516-87-1,Positive,In vivo
"BARBITAL, SODIUM",CCC1(C(=O)NC(=NC1=O)[O-])CC.[Na+],144-02-5,Negative,In vivo
"BARBITAL, SODIUM",CCC1(C(=O)NC(=NC1=O)[O-])CC.[Na+],144-02-5,Positive,In vivo
BARIUM ACETATE,CC(=O)[O-].CC(=O)[O-].[Ba+2],543-80-6,Negative,In vivo
Barium and Compounds,[Ba],7440-39-3,Negative,In vivo
Barium cyanide,[C-]#N.[C-]#N.[Ba+2],542-62-1,Negative,In vivo
barium(2+);5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate,CC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.CC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.[Ba+2],21238,Negative,In Vivo
barium(2+);5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate,CC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.CC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.[Ba+2],21238,Positive,In Vivo
barium(2+);diacetate,CC(=O)[O-].CC(=O)[O-].[Ba+2],10980,Negative,In Vivo
barium(2+);dichloride,[Cl-].[Cl-].[Ba+2],10361-37-2,Negative,in vitro
barium(2+);dichloride;dihydrate,O.O.[Cl-].[Cl-].[Ba+2],25157,Negative,In Vivo
barium(2+);dioxido(dioxo)chromium,[O-][Cr](=O)(=O)[O-].[Ba+2],10294-40-3,Positive,in vitro
Basic brown 16/CI 12250   COLIPA C9,C[N+](C)(C)C1=CC2=C(C=C1)C=CC(=C2N=NC3=CC=C(C=C3)N)O.[Cl-],26381-41-9,Positive,in vitro
Basic orange 31,CN1C=C[N+](=C1N=NC2=CC=C(C=C2)N)C.[Cl-],97404-02-9,Negative,in vitro
Basic orange 69               ,C[N+](C)(C)C1=CC=CC(=C1)N=NC2=C(C=C(C(=C2)OC)N)OC.[Cl-],226940-14-3,Negative,in vitro
Basic red 51 COLIPA B116                    ,CN1C=C[N+](=C1N=NC2=CC=C(C=C2)N(C)C)C.[Cl-],77061-58-6,Negative,in vitro
Baygon,CC(C)OC1=CC=CC=C1OC(=O)NC,114-26-1,Negative,In vivo
Bayleton,CC(C)(C)C(=O)C(N1C=NC=N1)OC2=CC=C(C=C2)Cl,43121-43-3,Negative,In vivo
Baythroid,CC1(C(C1C(=O)OC(C#N)C2=CC(=C(C=C2)F)OC3=CC=CC=C3)C=C(Cl)Cl)C,68359-37-5,Negative,In vivo
BEMITRADINE,CCOCCC1=C(N=C(N2C1=NC=N2)N)C3=CC=CC=C3,88133-11-3,Positive,In vivo
Benalaxyl,CC1=C(C(=CC=C1)C)N(C(C)C(=O)OC)C(=O)CC2=CC=CC=C2,71626-11-4,Negative,in vivo
Benalaxyl,CC1=C(C(=CC=C1)C)N(C(C)C(=O)OC)C(=O)CC2=CC=CC=C2,71626-11-4,Negative,in vitro
Benalaxyl-M,CC1=C(C(=CC=C1)C)N([C@H](C)C(=O)OC)C(=O)CC2=CC=CC=C2,98243-83-5,Negative,in vivo
Benalaxyl-M,CC1=C(C(=CC=C1)C)N([C@H](C)C(=O)OC)C(=O)CC2=CC=CC=C2,98243-83-5,Negative,in vitro
Benefin,CCCCN(CC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],1861-40-1,Negative,In vivo
Benfluralin,CCCCN(CC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],1861-40-1,Negative,in vivo
Benfluralin,CCCCN(CC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],1861-40-1,Negative,in vitro
Benfuracarb,CCOC(=O)CCN(C(C)C)SN(C)C(=O)OC1=CC=CC2=C1OC(C2)(C)C,82560-54-1,Negative,in vivo
Benfuracarb,CCOC(=O)CCN(C(C)C)SN(C)C(=O)OC1=CC=CC2=C1OC(C2)(C)C,82560-54-1,Negative,in vitro
Benomyl,CCCCNC(=O)N1C2=CC=CC=C2N=C1NC(=O)OC,17804-35-2,Negative,In vivo
Bensulfuron-methyl,COC1=CC(=NC(=N1)NC(=O)NS(=O)(=O)CC2=CC=CC=C2C(=O)OC)OC,83055-99-6,Negative,in vivo
Bensulfuron-methyl,COC1=CC(=NC(=N1)NC(=O)NS(=O)(=O)CC2=CC=CC=C2C(=O)OC)OC,83055-99-6,Negative,in vitro
Bentazon (Basagran),CC(C)N1C(=O)C2=CC=CC=C2NS1(=O)=O,25057-89-0,Negative,In vivo
Bentazone,CC(C)N1C(=O)C2=CC=CC=C2NS1(=O)=O,25057-89-0,Negative,in vivo
Bentazone,CC(C)N1C(=O)C2=CC=CC=C2NS1(=O)=O,25057-89-0,Negative,in vitro
Benthiavalicarb-isopropyl,C[C@H](C1=NC2=C(S1)C=C(C=C2)F)NC(=O)[C@@H](C(C)C)NC(=O)OC(C)C,177406-68-7,Negative,in vivo
Benthiavalicarb-isopropyl,C[C@H](C1=NC2=C(S1)C=C(C=C2)F)NC(=O)[C@@H](C(C)C)NC(=O)OC(C)C,177406-68-7,Negative,in vitro
Benz[a]anthracene,C1=CC=C2C(=C1)C=CC3=CC4=CC=CC=C4C=C32,56-55-3,Negative,In vivo
Benz[a]anthracene  ,C1=CC=C2C(=C1)C=CC3=CC4=CC=CC=C4C=C32,56-55-3,Positive,in vitro
BENZALAZINE,C1=CC=C(C=C1)C=NN=CC2=CC=CC=C2,64896-26-0,Negative,In vivo
benzaldehyde,C1=CC=C(C=C1)C=O,240,Positive,In Vivo
Benzaldehyde,C1=CC=C(C=C1)C=O,100-52-7,Negative,In vivo
benzaldehyde,C1=CC=C(C=C1)C=O,240,Negative,In Vivo
Benzaldehyde,C1=CC=C(C=C1)C=O,100-52-7,Negative,in vitro
benzamide,C1=CC=C(C=C1)C(=O)N,55-21-0,Positive,in vitro
benzene,C1=CC=CC=C1,241,Positive,In Vivo
benzene,C1=CC=CC=C1,241,Negative,In Vivo
BENZENE,C1=CC=CC=C1,71-43-2,Negative,In vivo
benzene,C1=CC=CC=C1,71-43-2,Positive,in vivo
Benzene,C1=CC=CC=C1,71-43-2,Positive,in vitro
"benzene-1,2-diamine",C1=CC=C(C(=C1)N)N,7243,Positive,In Vivo
"benzene-1,2-diamine",C1=CC=C(C(=C1)N)N,95-54-5,Negative,in vivo
"benzene-1,2-diamine",C1=CC=C(C(=C1)N)N,95-54-5,Negative,in vitro
"benzene-1,2-dicarboxamide",C1=CC=C(C(=C1)C(=O)N)C(=O)N,6956,Negative,In Vivo
"benzene-1,2-dicarboxamide",C1=CC=C(C(=C1)C(=O)N)C(=O)N,88-96-0,Negative,in vivo
"benzene-1,2-diol",C1=CC=C(C(=C1)O)O,289,Negative,In Vivo
"benzene-1,2-diol",C1=CC=C(C(=C1)O)O,289,Positive,In Vivo
"benzene-1,2-diol",C1=CC=C(C(=C1)O)O,120-80-9,Positive,in vitro
"benzene-1,2,3-triol",C1=CC(=C(C(=C1)O)O)O,87-66-1,Positive,in vitro
"benzene-1,2,4-triamine",C1=CC(=C(C=C1N)N)N,615-71-4,Negative,in vivo
"benzene-1,2,4-triol",C1=CC(=C(C=C1O)O)O,533-73-3,Positive,in vitro
"benzene-1,3-diamine",C1=CC(=CC(=C1)N)N,7935,Negative,In Vivo
"benzene-1,3-diamine",C1=CC(=CC(=C1)N)N,108-45-2,Positive,in vitro
"benzene-1,3-diol",C1=CC(=CC(=C1)O)O,5054,Negative,In Vivo
"benzene-1,3-diol",C1=CC(=CC(=C1)O)O,108-46-3,Negative,in vivo
"benzene-1,3-diol",C1=CC(=CC(=C1)O)O,108-46-3,Negative,in vitro
"benzene-1,3,5-triol",C1=C(C=C(C=C1O)O)O,108-73-6,Positive,in vitro
"benzene-1,4-diamine",C1=CC(=CC=C1N)N,106-50-3,Negative,in vivo
"benzene-1,4-diamine",C1=CC(=CC=C1N)N,106-50-3,Negative,in vitro
"benzene-1,4-diamine;dihydrochloride",C1=CC(=CC=C1N)N.Cl.Cl,12205,Negative,In Vivo
"benzene-1,4-diamine;dihydrochloride",C1=CC(=CC=C1N)N.Cl.Cl,624-18-0,Negative,in vivo
"benzene-1,4-diol",C1=CC(=CC=C1O)O,123-31-9,Positive,in vitro
benzenecarbothioamide,C1=CC=C(C=C1)C(=S)N,2227-79-4,Positive,in vitro
BENZENEDIAZONIUM SULFATE,C1=CC=C(C=C1)[N+]#N.OS(=O)(=O)[O-],6415-38-9,Positive,In vivo
BENZENEDIAZONIUM TETRAFLUOROBORATE,[B-](F)(F)(F)F.C1=CC=C(C=C1)[N+]#N,369-57-3,Negative,In vivo
benzenediazonium;hydrogen sulfate,C1=CC=C(C=C1)[N+]#N.OS(=O)(=O)[O-],12496962,Negative,In Vivo
benzenediazonium;hydrogen sulfate,C1=CC=C(C=C1)[N+]#N.OS(=O)(=O)[O-],12496962,Positive,In Vivo
BENZIDINE,C1=CC(=CC=C1C2=CC=C(C=C2)N)N,92-87-5,Positive,In vivo
Benzidine (free base and 2HCl salt),C1=CC(=CC=C1C2=CC=C(C=C2)N)N,92-87-5,Positive,in vitro
BENZIDINE.2HCl,C1=CC(=CC=C1C2=CC=C(C=C2)N)N.Cl.Cl,531-85-1,Positive,In vivo
benzimidazol-1-ylmethanol,C1=CC=C2C(=C1)N=CN2CO,19541-99-2,Negative,in vitro
Benznidazole,C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-],22994-85-0,Positive,in vitro
BENZO(a)PYRENE,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC=C5)C=C3,50-32-8,Negative,In vivo
BENZO(a)PYRENE,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC=C5)C=C3,50-32-8,Positive,In vivo
Benzo(f)quinoline,C1=CC=C2C(=C1)C=CC3=C2C=CC=N3,85-02-9,Positive,in vitro
Benzo(h)quinoline,C1=CC=C2C(=C1)C=CC3=C2N=CC=C3,230-27-3,Positive,in vitro
benzo[a]acridine,C1=CC=C2C(=C1)C=CC3=NC4=CC=CC=C4C=C32,9180,Negative,In Vivo
benzo[a]anthracen-5-ol,C1=CC=C2C=C3C4=CC=CC=C4C(=CC3=CC2=C1)O,,Negative,in vitro
benzo[a]anthracen-7-ylmethanol,C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C=C32)CO,85290,Positive,In Vivo
benzo[a]anthracen-7-ylmethanol,C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C=C32)CO,16110-13-7,Positive,in vitro
benzo[a]anthracen-7-ylmethyl hydrogen sulfate,C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C=C32)COS(=O)(=O)O,137372,Positive,In Vivo
benzo[a]anthracene,C1=CC=C2C(=C1)C=CC3=CC4=CC=CC=C4C=C32,5954,Positive,In Vivo
benzo[a]anthracene,C1=CC=C2C(=C1)C=CC3=CC4=CC=CC=C4C=C32,56-55-3,Positive,in vivo
benzo[a]anthracene,C1=CC=C2C(=C1)C=CC3=CC4=CC=CC=C4C=C32,56-55-3,Negative,in vitro
benzo[a]pyren-1-ol,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=C(C=C5)O)C=C3,13345-23-8,Positive,in vitro
benzo[a]pyren-11-ol,C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2C(=CC5=CC=C4)O,56892-32-1,Positive,in vivo
benzo[a]pyren-11-ol,C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2C(=CC5=CC=C4)O,56892-32-1,Negative,in vitro
benzo[a]pyren-12-ol,C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2C=C(C5=CC=C4)O,56892-33-2,Negative,in vitro
benzo[a]pyren-2-ol,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=CC(=CC(=C54)C=C3)O,56892-30-9,Positive,in vivo
benzo[a]pyren-2-ol,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=CC(=CC(=C54)C=C3)O,56892-30-9,Negative,in vitro
benzo[a]pyren-3-ol,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C(C=CC(=C54)C=C3)O,13345-21-6,Negative,in vitro
benzo[a]pyren-4-ol,C1=CC=C2C3=C4C(=CC2=C1)C=C(C5=CC=CC(=C54)C=C3)O,37574-48-4,Negative,in vitro
benzo[a]pyren-5-ol,C1=CC=C2C3=C4C(=CC2=C1)C(=CC5=CC=CC(=C54)C=C3)O,24027-84-7,Negative,in vitro
benzo[a]pyren-7-ol,C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=CC=C5O)C=C2,37994-82-4,Negative,in vitro
benzo[a]pyren-8-ol,C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=CC(=C5)O)C=C2,13345-26-1,Negative,in vitro
benzo[a]pyren-9-ol,C1=CC2=C3C(=C1)C=CC4=C5C=C(C=CC5=CC(=C43)C=C2)O,17573-21-6,Positive,in vitro
benzo[a]pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC=C5)C=C3,2336,Negative,In Vivo
benzo[a]pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC=C5)C=C3,2336,Positive,In Vivo
benzo[a]pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC=C5)C=C3,50-32-8,Negative,in vivo
benzo[a]pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC=C5)C=C3,50-32-8,Positive,in vivo
Benzo[a]pyrene,C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC=C5)C=C3,50-32-8,Positive,in vitro
Benzo[a]pyrene (BaP),C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC=C5)C=C3,50-32-8,Positive,In vivo
"benzo[a]pyrene-11,12-dione",C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2C(=O)C(=O)C5=CC=C4,60657-26-3,Negative,in vitro
"benzo[a]pyrene-3,6-dione",C1=CC=C2C(=C1)C3=C4C(=CC=C5C4=C(C=C3)C=CC5=O)C2=O,3067-14-9,Positive,in vitro
"benzo[a]pyrene-4,5-dione",C1=CC=C2C3=C4C(=CC2=C1)C(=O)C(=O)C5=CC=CC(=C54)C=C3,42286-46-4,Negative,in vitro
"benzo[a]pyrene-7,8-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=CC(=C5O)O)C=C2,57303-99-8,Positive,in vitro
"Benzo[a]pyrene-7,8-diol-9,10-epoxide",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C6C(O6)C(C5O)O)C=C2,58917-67-2,Positive,in vitro
Benzo[b]fluoranthene,C1=CC=C2C3=C4C(=CC=C3)C5=CC=CC=C5C4=CC2=C1,205-99-2,Negative,In vivo
benzo[b]pyren-6-ol,C1=CC=C2C(=C1)C3=C4C(=C2O)C=CC5=CC=CC(=C54)C=C3,33953-73-0,Positive,in vitro
benzo[b]pyren-6-yl acetate,CC(=O)OC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C5=CC=CC=C51,,Positive,in vitro
benzo[b]pyren-6-ylmethanol,C1=CC=C2C(=C1)C3=C4C(=C2CO)C=CC5=CC=CC(=C54)C=C3,30544,Positive,In Vivo
benzo[b]pyren-6-ylmethanol,C1=CC=C2C(=C1)C3=C4C(=C2CO)C=CC5=CC=CC(=C54)C=C3,21247-98-3,Positive,in vivo
benzo[b]pyren-6-ylmethanol,C1=CC=C2C(=C1)C3=C4C(=C2CO)C=CC5=CC=CC(=C54)C=C3,21247-98-3,Positive,in vitro
benzo[b]pyren-6-ylmethyl acetate,CC(=O)OCC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C5=CC=CC=C51,39363,Positive,In Vivo
benzo[b]pyren-6-ylmethyl hydrogen sulfate,C1=CC=C2C(=C1)C3=C4C(=C2COS(=O)(=O)O)C=CC5=CC=CC(=C54)C=C3,50026,Positive,In Vivo
"benzo[b]pyrene-1,6-dione",C1=CC=C2C(=C1)C3=CC=C4C(=O)C=CC5=C4C3=C(C2=O)C=C5,3067-13-8,Negative,in vitro
"benzo[b]pyrene-6,12-dione",C1=CC=C2C(=C1)C3=CC(=O)C4=CC=CC5=C4C3=C(C2=O)C=C5,3067-12-7,Negative,in vitro
benzo[b]triphenylene,C1=CC=C2C=C3C4=CC=CC=C4C5=CC=CC=C5C3=CC2=C1,9164,Negative,In Vivo
benzo[b]triphenylene,C1=CC=C2C=C3C4=CC=CC=C4C5=CC=CC=C5C3=CC2=C1,215-58-7,Positive,in vivo
benzo[b]triphenylene,C1=CC=C2C=C3C4=CC=CC=C4C5=CC=CC=C5C3=CC2=C1,215-58-7,Negative,in vitro
benzo[c]acridine,C1=CC=C2C(=C1)C=CC3=CC4=CC=CC=C4N=C32,9181,Positive,In Vivo
benzo[c]acridine,C1=CC=C2C(=C1)C=CC3=CC4=CC=CC=C4N=C32,9181,Negative,In Vivo
benzo[c]acridine,C1=CC=C2C(=C1)C=CC3=CC4=CC=CC=C4N=C32,225-51-4,Positive,in vitro
benzo[e]pyrene,C1=CC=C2C(=C1)C3=CC=CC4=C3C5=C(C=CC=C25)C=C4,192-97-2,Positive,in vivo
benzo[e]pyrene,C1=CC=C2C(=C1)C3=CC=CC4=C3C5=C(C=CC=C25)C=C4,9128,Negative,In Vivo
benzo[e]pyrene,C1=CC=C2C(=C1)C3=CC=CC4=C3C5=C(C=CC=C25)C=C4,192-97-2,Negative,in vitro
benzo[f]quinolin-3-amine,C1=CC=C2C(=C1)C=CC3=C2C=CC(=N3)N,,Positive,in vitro
benzo[f]quinoline,C1=CC=C2C(=C1)C=CC3=C2C=CC=N3,6796,Negative,In Vivo
benzo[f]quinoline,C1=CC=C2C(=C1)C=CC3=C2C=CC=N3,85-02-9,Positive,in vitro
"Benzo[g,h,i]perylene",C1=CC2=C3C(=C1)C4=CC=CC5=C4C6=C(C=C5)C=CC(=C36)C=C2,191-24-2,Negative,In vivo
benzo[h]quinolin-2-amine,C1=CC=C2C(=C1)C=CC3=C2N=C(C=C3)N,67410-22-4,Positive,in vitro
benzo[h]quinoline,C1=CC=C2C(=C1)C=CC3=C2N=CC=C3,9191,Negative,In Vivo
benzo[k]fluoranthene,C1=CC=C2C=C3C4=CC=CC5=C4C(=CC=C5)C3=CC2=C1,9158,Positive,In Vivo
Benzo[k]fluoranthene,C1=CC=C2C=C3C4=CC=CC5=C4C(=CC=C5)C3=CC2=C1,0207-08-09,Negative,In vivo
benzo[k]fluoranthene,C1=CC=C2C=C3C4=CC=CC5=C4C(=CC=C5)C3=CC2=C1,0207-08-09,Positive,in vivo
Benzoate sodium,C1=CC=C(C=C1)C(=O)[O-].[Na+],532-32-1,Positive,in vitro
"BENZOATE, SODIUM",C1=CC=C(C=C1)C(=O)[O-].[Na+],532-32-1,Negative,In vivo
BENZOGUANAMINE,C1=CC=C(C=C1)C2=NC(=NC(=N2)N)N,91-76-9,Negative,In vivo
benzohydrazide,C1=CC=C(C=C1)C(=O)NN,11955,Positive,In Vivo
Benzoic acid,C1=CC=C(C=C1)C(=O)O,65-85-0,Negative,In vivo
Benzoic acid,C1=CC=C(C=C1)C(=O)O,65-85-0,Negative,in vitro
Benzoin,C1=CC=C(C=C1)C(C(=O)C2=CC=CC=C2)O,119-53-9,Negative,in vitro
BENZOTHIAZYL DISULFIDE,C1=CC=C2C(=C1)N=C(S2)SSC3=NC4=CC=CC=C4S3,120-78-5,Negative,In vivo
BENZOTRICHLORIDE,C1=CC=C(C=C1)C(Cl)(Cl)Cl,98-07-7,Positive,In vivo
Benzotrichloride,C1=CC=C(C=C1)C(Cl)(Cl)Cl,98-07-7,Positive,in vitro
benzoyl benzenecarboperoxoate,C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2,7187,Positive,In Vivo
BENZOYL HYDRAZINE,C1=CC=C(C=C1)C(=O)NN,613-94-5,Negative,In vivo
BENZOYL HYDRAZINE,C1=CC=C(C=C1)C(=O)NN,613-94-5,Positive,In vivo
benzyl acetate,CC(=O)OCC1=CC=CC=C1,8785,Negative,In Vivo
benzyl acetate,CC(=O)OCC1=CC=CC=C1,8785,Positive,In Vivo
Benzyl alcohol,C1=CC=C(C=C1)CO,100-51-6,Negative,in vitro
BENZYL CHLORIDE,C1=CC=C(C=C1)CCl,100-44-7,Positive,In vivo
Benzyl chloride,C1=CC=C(C=C1)CCl,100-44-7,Positive,in vitro
Benzyl glycidyl ether -R- and S-isomers,C1C(O1)COCC2=CC=CC=C2,89616-40-0,Positive,in vitro
Benzyl Violet 4B,CCN(CC1=CC(=CC=C1)S(=O)(=O)O)C2=CC=C(C=C2)C(=C3C=CC(=[N+](C)C)C=C3)C4=CC=C(C=C4)N(CC)CC5=CC(=CC=C5)S(=O)(=O)O.[Na] ,1694-09-03,Positive,in vitro
benzyl-(2-chloroethyl)-(1-phenoxypropan-2-yl)azanium;chloride,CC(COC1=CC=CC=C1)[NH+](CCCl)CC2=CC=CC=C2.[Cl-],6141,Positive,In Vivo
benzyl-(2-chloroethyl)-(1-phenoxypropan-2-yl)azanium;chloride,CC(COC1=CC=CC=C1)[NH+](CCCl)CC2=CC=CC=C2.[Cl-],,Positive,in vivo
"benzyl-dimethyl-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium;chloride",CC(C)(C)CC(C)(C)C1=CC=C(C=C1)OCCOCC[N+](C)(C)CC2=CC=CC=C2.[Cl-],8478,Negative,In Vivo
BENZYLHYDRAZINE.2HCl,C1=CC=C(C=C1)CNN.Cl.Cl,20570-96-1,Negative,In vivo
BENZYLHYDRAZINE.2HCl,C1=CC=C(C=C1)CNN.Cl.Cl,20570-96-1,Positive,In vivo
beryllium,[Be],7440-41-7,Positive,in vivo
beryllium,[Be],5460467,Positive,In Vivo
Beryllium and compounds,[Be],7440-41-7,Positive,In vivo
BERYLLIUM SULFATE,[Be+2].[O-]S(=O)(=O)[O-],13510-49-1,Negative,In vivo
beryllium;carbonate,[Be+2].C(=O)([O-])[O-],61577,Positive,In Vivo
beryllium;dichloride,[Be+2].[Cl-].[Cl-],7787-47-5,Negative,in vitro
beryllium;dihydroxide,[Be+2].[OH-].[OH-],518753,Positive,In Vivo
beryllium;sulfate,[Be+2].[O-]S(=O)(=O)[O-],26077,Positive,In Vivo
beryllium;sulfate,[Be+2].[O-]S(=O)(=O)[O-],26077,Negative,In Vivo
beryllium;sulfate,[Be+2].[O-]S(=O)(=O)[O-],13510-49-1,Positive,in vivo
beryllium;sulfate,[Be+2].[O-]S(=O)(=O)[O-],13510-49-1,Negative,in vitro
beryllium;sulfate;tetrahydrate,[Be+2].O.O.O.O.[O-]S(=O)(=O)[O-],62672,Positive,In Vivo
beryllium;sulfate;tetrahydrate,[Be+2].O.O.O.O.[O-]S(=O)(=O)[O-],7787-56-6,Positive,in vitro
beryllium;zinc;silicate,[Be+2].[O-][Si]([O-])([O-])[O-].[Zn+2],,Positive,in vivo
beryllium;zinc;silicate,[Be+2].[O-][Si]([O-])([O-])[O-].[Zn+2],22748686,Positive,In Vivo
"beta-1,2,3,4,5,6-HEXACHLOROCYCLOHEXANE",C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,319-85-7,Negative,In vivo
"beta-1,2,3,4,5,6-HEXACHLOROCYCLOHEXANE",C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,319-85-7,Positive,In vivo
beta-BUTYROLACTONE,CC1CC(=O)O1,3068-88-0,Positive,In vivo
Beta-butyrolactone,CC1CC(=O)O1,3068-88-0,Positive,in vitro
beta-CAROTENE,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C)C)C,7235-40-7,Negative,In vivo
beta-CYCLODEXTRIN,C(C1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(O2)C(C8O)O)CO)CO)CO)CO)CO)CO)O)O)O,7585-39-9,Negative,In vivo
Beta-Cypermethrin,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,65731-84-2,Negative,in vivo
Beta-Cypermethrin,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,65731-84-2,Negative,in vitro
beta-N-[gamma-L(+)-GLUTAMYL]-4-HYDROXYMETHYLPHENYLHYDRAZINE,C1=CC(=CC=C1CO)NNC(=O)CCC(C(=O)O)N,2757-90-6,Negative,In vivo
beta-PHENYLISOPROPYLHYDRAZINE.HCl,CC(CC1=CC=CC=C1)NN.Cl,66-05-7,Negative,In vivo
beta-PROPIOLACTONE,C1COC1=O,57-57-8,Positive,In vivo
beta-Propiolactone,C1COC1=O,57-57-8,Positive,in vitro
Bidrin,CC(=CC(=O)N(C)C)OP(=O)(OC)OC,141-66-2,Negative,In vivo
Bifenox,[O-][N+](C(C=C2)=C(C=C2OC1=CC=C(Cl)C=C1Cl)C(OC)=O)=O,42576-02-3,Negative,in vivo
Bifenox,[O-][N+](C(C=C2)=C(C=C2OC1=CC=C(Cl)C=C1Cl)C(OC)=O)=O,42576-02-03,Negative,in vitro
Bifenthrin,O=C(OCC2=CC=CC(C3=CC=CC=C3)=C2C)C1C(C)(C)C1/C=C(Cl)/C(F)(F)F,82657-04-3,Negative,in vivo
Bifenthrin,O=C(OCC2=CC=CC(C3=CC=CC=C3)=C2C)C1C(C)(C)C1/C=C(Cl)/C(F)(F)F,82657-04-03,Negative,in vitro
Biphenthrin,CC1=C(C=CC=C1C2=CC=CC=C2)COC(=O)C3C(C3(C)C)C=C(C(F)(F)F)Cl,82657-04-03,Negative,In vivo
BIPHENYL,C1=CC=C(C=C1)C2=CC=CC=C2,92-52-4,Negative,In vivo
Biphenyl,C1=CC=C(C=C1)C2=CC=CC=C2,92-52-4,Positive,In vivo
BIS-(CHLOROMETHYL)ETHER,C(OCCl)Cl,542-88-1,Negative,In vivo
BIS-(CHLOROMETHYL)ETHER,C(OCCl)Cl,542-88-1,Positive,In vivo
"BIS-1,2-(CHLOROMETHOXY)ETHANE",C(COCCl)OCCl,13483-18-6,Positive,In vivo
"BIS-1,4-(CHLOROMETHOXY)-p-XYLENE",C1=CC(=CC=C1COCCl)COCCl,56894-91-8,Positive,In vivo
"BIS-1,4-(CHLOROMETHOXY)BUTANE",C(CCOCCl)COCCl,13483-19-7,Negative,In vivo
"BIS-1,6-(CHLOROMETHOXY)HEXANE",C(CCCOCCl)CCOCCl,56894-92-9,Negative,In vivo
BIS-2-CHLOROETHYLETHER,C(CCl)OCCCl,111-44-4,Positive,In vivo
Bis-2-chloroethylether,C(CCl)OCCCl,111-44-4,Positive,in vitro
"BIS-2-HYDROXYETHYLDITHIOCARBAMIC ACID, POTASSIUM",C(CO)N(CCO)C(=S)[S-].[K+],23746-34-1,Positive,In vivo
Bis-chloro-methylether,C(OCCl)Cl,542-88-1,Positive,in vitro
Bis(2-chloro-1-methylethyl) ether,CC(CCl)OC(C)CCl,108-60-1,Negative,In vivo
"Bis(2-chloro-1-methylethyl)ether, technical grade",CC(CCl)OC(C)CCl,108-60-1,Positive,in vitro
Bis(2-chloroethoxy)methane,C(CCl)OCOCCCl,111-91-1,Negative,In vivo
Bis(2-chloroethoxy)methane,C(CCl)OCOCCCl,111-91-1,Positive,in vitro
bis(2-chloroethyl)azanium;chloride,C(CCl)[NH2+]CCCl.[Cl-],102092-04-6,Positive,in vitro
"bis(2-ethylhexyl) benzene-1,2-dicarboxylate",CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC,8343,Positive,In Vivo
"bis(2-ethylhexyl) benzene-1,2-dicarboxylate",CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC,117-81-7,Positive,in vivo
"bis(2-ethylhexyl) benzene-1,4-dicarboxylate",CCCCC(CC)COC(=O)C1=CC=C(C=C1)C(=O)OCC(CC)CCCC,22932,Negative,In Vivo
bis(2-ethylhexyl) hexanedioate,CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC,7641,Positive,In Vivo
bis(2-ethylhexyl) hexanedioate,CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC,7641,Negative,In Vivo
bis(2-ethylhexyl) hexanedioate,CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC,103-23-1,Positive,in vivo
BIS(2-HYDROXYPROPYL)AMINE,CC(CNCC(C)O)O,110-97-4,Negative,In vivo
"Bis(2,3-dibromopropyl)phosphate, magnesium salt",C(C(CBr)Br)OP(=O)(O)OCC(CBr)Br.[Mg],44144565,Positive,In Vivo
"BIS(2,3-DIBROMOPROPYL)PHOSPHATE, MAGNESIUM SALT",C(C(CBr)Br)OP(=O)(O)OCC(CBr)Br.[Mg],36711-31-6,Positive,In vivo
"Bis(2,3-dibromopropyl)phosphate, magnesium salt",C(C(CBr)Br)OP(=O)(O)OCC(CBr)Br.[Mg],36711-31-6,Positive,in vitro
"bis(3,4-dichlorophenyl)diazene",C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)Cl)Cl)Cl)Cl,14047-09-07,Positive,in vitro
"bis(7-methyloctyl) benzene-1,2-dicarboxylate",CC(C)CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC(C)C,590836,Negative,In Vivo
bis(aziridin-1-yl)-morpholin-4-yl-sulfanylidene-lambda5-phosphane,C1CN1P(=S)(N2CC2)N3CCOCC3,62432,Positive,In Vivo
Bis(chloroethyl)ether (BCEE),C(CCl)OCCCl,111-44-4,Positive,In vivo
Bis(chloromethyl)ether (BCME),C(OCCl)Cl,542-88-1,Positive,In vivo
Bis(dimethylamino)benzophenone (Michler's ketone),CN(C)C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)N(C)C,90-94-8,Positive,in vitro
"bis(prop-2-enyl) benzene-1,2-dicarboxylate",C=CCOC(=O)C1=CC=CC=C1C(=O)OCC=C,8560,Negative,In Vivo
bis(sulfanylidene)molybdenum,S=[Mo]=S,1317-33-5,Positive,in vitro
"bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate",C/C(=C\C=C\C=C(\C=C\C=C(\C(=O)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CO)/C)/C)/C=C/C=C(/C(=O)O[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)CO[C@@H]4O[C@@H]([C@H]([C@@H]([C@H]4O)O)O)CO)\C,5281233,Negative,In Vivo
bis[4-(dimethylamino)phenyl]methanone,CN(C)C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)N(C)C,7031,Positive,In Vivo
bis[4-(dimethylamino)phenyl]methanone,CN(C)C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)N(C)C,90-94-8,Positive,in vivo
bis[4-(dimethylamino)phenyl]methanone,CN(C)C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)N(C)C,90-94-8,Positive,in vitro
BISMUTH DIMETHYLDITHIOCARBAMATE,CN(C)C(=S)S[Bi](SC(=S)N(C)C)SC(=S)N(C)C,21260-46-8,Negative,In vivo
BISMUTH OXYCHLORIDE,O=[Bi].Cl,7787-59-9,Negative,In vivo
Bisphenol A,CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,80-05-7,Negative,In vivo
Bispyribac-sodium,COC1=CC(=NC(=N1)OC2=C(C(=CC=C2)OC3=NC(=CC(=N3)OC)OC)C(=O)[O-])OC.[Na+],125401-92-5,Negative,in vivo
Bispyribac-sodium,COC1=CC(=NC(=N1)OC2=C(C(=CC=C2)OC3=NC(=CC(=N3)OC)OC)C(=O)[O-])OC.[Na+],125401-92-5,Negative,in vitro
Bitertanol,CC(C)(C)C(C(N1C=NC=N1)OC2=CC=C(C=C2)C3=CC=CC=C3)O,55179-31-2,Negative,in vivo
Bitertanol,CC(C)(C)C(C(N1C=NC=N1)OC2=CC=C(C=C2)C3=CC=CC=C3)O,55179-31-2,Negative,in vitro
Bixafen,FC(F)c3nn(C)cc3C(=O)Nc2ccc(F)cc2c1ccc(Cl)c(Cl)c1,581809-46-3,Negative,in vivo
Bixafen,FC(F)c3nn(C)cc3C(=O)Nc2ccc(F)cc2c1ccc(Cl)c(Cl)c1,581809-46-3,Negative,in vitro
BLACK PN,CC(=O)NC1=C2C(=C(C=C1)S(=O)(=O)[O-])C=C(C(=C2O)N=NC3=C4C=C(C=CC4=C(C=C3)N=NC5=CC=C(C=C5)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],2519-30-4,Negative,In vivo
Bleomycin,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,11056-06-7,Positive,in vitro
Blue VRS,CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=C(C=C(C=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+],129-17-9,Positive,in vitro
boric acid,B(O)(O)O,7628,Negative,In Vivo
Boron and Compounds,[B],7440-42-8,Negative,In vivo
Bromadiolone,C1=CC=C(C=C1)C(CC(C2=CC=C(C=C2)C3=CC=C(C=C3)Br)O)C4=C(C5=CC=CC=C5OC4=O)O,28772-56-7,Negative,in vivo
Bromadiolone,C1=CC=C(C=C1)C(CC(C2=CC=C(C=C2)C3=CC=C(C=C3)Br)O)C4=C(C5=CC=CC=C5OC4=O)O,28772-56-7,Negative,in vitro
Bromate,[O-]Br(=O)=O,15541-45-4,Positive,In vivo
"BROMATE, POTASSIUM",[O-]Br(=O)=O.[K+],7758-01-2,Positive,In vivo
"BROMATE, POTASSIUM",[O-]Br(=O)=O.[K+],7758-01-2,Negative,In vivo
"Bromate, potassium",[O-]Br(=O)=O.[K+],7758-01-2,Positive,in vitro
bromo-chloro-difluoromethane,C(F)(F)(Cl)Br,353-59-3,Negative,in vitro
bromo(dichloro)methane,C(Cl)(Cl)Br,6359,Negative,In Vivo
bromo(dichloro)methane,C(Cl)(Cl)Br,6359,Positive,In Vivo
bromo(dichloro)methane,C(Cl)(Cl)Br,75-27-4,Positive,in vivo
bromo(dichloro)methane,C(Cl)(Cl)Br,75-27-4,Negative,in vitro
bromo(hexyl)mercury,CCCCCC[Hg]Br,18431-36-2,Positive,in vitro
BROMOACETALDEHYDE,C(C=O)Br,17157-48-1,Negative,In vivo
Bromobenzene,C1=CC=C(C=C1)Br,108-86-1,Negative,In vivo
bromobenzene,C1=CC=C(C=C1)Br,108-86-1,Negative,in vitro
Bromochloroacetic acid,C(C(=O)O)(Cl)Br,5589-96-8,Positive,in vitro
Bromochloromethane,C(Cl)Br,74-97-5,Negative,In vivo
BROMOCRIPTINE MESYLATE,CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O.CS(=O)(=O)O,22260-51-1,Negative,In vivo
BROMOCRIPTINE MESYLATE,CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O.CS(=O)(=O)O,22260-51-1,Positive,In vivo
Bromodichloromethane,C(Cl)(Cl)Br,75-27-4,Positive,In vivo
Bromodiphenyl ether,C1=CC=C(C=C1)OC2=CC=C(C=C2)Br,101-55-3,Negative,In vivo
bromoethane,CCBr,6332,Positive,In Vivo
Bromoethane (ethyl bromide),CCBr,74-96-4,Negative,in vitro
BROMOETHANOL,C(CBr)O,540-51-2,Positive,In vivo
bromoethene,C=CBr,11641,Positive,In Vivo
bromoethene,C=CBr,593-60-2,Positive,in vitro
bromoform,C(Br)(Br)Br,5558,Negative,In Vivo
bromoform,C(Br)(Br)Br,5558,Positive,In Vivo
Bromoform,C(Br)(Br)Br,75-25-2,Positive,In vivo
bromoform,C(Br)(Br)Br,75-25-2,Positive,in vitro
bromomethane,CBr,6323,Negative,In Vivo
Bromomethane,CBr,74-83-9,Negative,In vivo
bromomethane,CBr,6323,Positive,In Vivo
Bromotrichloromethane,C(Cl)(Cl)(Cl)Br,75-62-7,Negative,In vivo
Bromoxynil,C1=C(C=C(C(=C1Br)O)Br)C#N,1689-84-5,Negative,In vivo
Bromoxynil octanoate,CCCCCCCC(=O)OC1=C(C=C(C=C1Br)C#N)Br,1689-99-2,Negative,In vivo
Bromuconazole,BrC1CC(CN2N=CN=C2)(C3=C(Cl)C=C(Cl)C=C3)OC1,116255-48-2,Negative,in vivo
Bromuconazole,BrC1CC(CN2N=CN=C2)(C3=C(Cl)C=C(Cl)C=C3)OC1,116255-48-2,Negative,in vitro
BUDESONIDE,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,51333-22-3,Positive,In vivo
Bupirimate,CCCCC1=C(N=C(N=C1OS(=O)(=O)N(C)C)NCC)C,41483-43-6,Negative,in vivo
Bupirimate,CCCCC1=C(N=C(N=C1OS(=O)(=O)N(C)C)NCC)C,41483-43-6,Negative,in vitro
Buprofezin,CC(C)N1C(=NC(C)(C)C)SCN(C1=O)C2=CC=CC=C2,69327-76-0,Negative,in vivo
Buprofezin,CC(C)N1C(=NC(C)(C)C)SCN(C1=O)C2=CC=CC=C2,69327-76-0,Negative,in vitro
Bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,34911-55-2,Positive,in vitro
Busulfan -compound GSK 34,CS(=O)(=O)OCCCCOS(=O)(=O)C,55-98-1,Positive,in vitro
but-2-ynediamide,C(#CC(=O)N)C(=O)N,543-21-5,Negative,in vitro
"but-3-yn-2-yl N-(3-chlorophenyl)carbamate;3-cyclooctyl-1,1-dimethylurea",CC(C#C)OC(=O)NC1=CC(=CC=C1)Cl.CN(C)C(=O)NC1CCCCCCC1,8015-55-2,Negative,in vitro
"buta-1,3-diene",C=CC=C,7845,Negative,In Vivo
"buta-1,3-diene",C=CC=C,7845,Positive,In Vivo
"buta-1,3-diene",C=CC=C,106-99-0,Positive,in vitro
Butadiene,C=CC=C,106-99-0,Positive,In vivo
Butadiene monoxide,C=CC1CO1,930-22-3,Negative,in vitro
butan-1-ol,CCCCO,71-36-3,Negative,in vitro
butan-2-one,CCC(=O)C,78-93-3,Negative,in vitro
butan-2-yl 2-(2-hydroxyethyl)piperidine-1-carboxylate,CCC(C)OC(=O)N1CCCCC1CCO,125098,Negative,In Vivo
butanal,CCCC=O,123-72-8,Positive,in vitro
"butanedioic acid;2-[4-(3-chloro-5,6-dihydrobenzo[b][1]benzothiepin-6-yl)piperazin-1-yl]ethanol",C1CN(CCN1CCO)C2CC3=C(C=CC(=C3)Cl)SC4=CC=CC=C24.C(CC(=O)O)C(=O)O,,Negative,in vivo
"butanedioic acid;N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine",CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O,11224,Positive,In Vivo
"butanedioic acid;N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine",CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O,11224,Negative,In Vivo
butyl (2R)-2-[4-(4-cyano-2-fluorophenoxy)phenoxy]propanoate,CCCCOC(=O)[C@@H](C)OC1=CC=C(C=C1)OC2=C(C=C(C=C2)C#N)F,180089,Negative,In Vivo
butyl (2R)-2-[4-[5-(trifluoromethyl)pyridin-2-yl]oxyphenoxy]propanoate,CCCCOC(=O)[C@@H](C)OC1=CC=C(C=C1)OC2=NC=C(C=C2)C(F)(F)F,3033674,Negative,In Vivo
butyl 2-diazoacetate,CCCCOC(=O)C=[N+]=[N-],,Positive,in vitro
butyl 4-hydroxybenzoate,CCCCOC(=O)C1=CC=C(C=C1)O,7184,Negative,In Vivo
Butyl benzyl phthalate (BBP),CCCCOC(=O)C1=CC=CC=C1C(=O)OCC2=CC=CC=C2,85-68-7,Negative,In vivo
butyl methanesulfonate,CCCCOS(=O)(=O)C,1912-32-9,Positive,in vitro
BUTYL p-HYDROXYBENZOATE,CCCCOC(=O)C1=CC=C(C=C1)O,94-26-8,Negative,In vivo
butyl prop-2-enoate,CCCCOC(=O)C=C,8846,Negative,In Vivo
Butylate,CCSC(=O)N(CC(C)C)CC(C)C,2008-41-5,Negative,In vivo
BUTYLATED HYDROXYANISOLE,CC(C)(C)C1=C(C=CC(=C1)OC)O,25013-16-5,Negative,In vivo
BUTYLATED HYDROXYANISOLE,CC(C)(C)C1=C(C=CC(=C1)OC)O,25013-16-5,Positive,In vivo
Butylated hydroxyanisole,CC(C)(C)C1=C(C=CC(=C1)OC)O,25013-16-5,Positive,in vitro
BUTYLATED HYDROXYTOLUENE,CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C,128-37-0,Negative,In vivo
BUTYLATED HYDROXYTOLUENE,CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C,128-37-0,Positive,In vivo
Butylated hydroxytoluene,CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C,128-37-0,Positive,in vitro
Butylchloride,CC(C)(C)Cl,507-20-0,Negative,In vivo
butylhydrazine;hydrochloride,CCCCNN.Cl,93308,Positive,In Vivo
Butylphthalyl butylglycolate (BPBG),CCCCOC(=O)COC(=O)C1=CC=CC=C1C(=O)OCCCC,85-70-1,Negative,In vivo
butylurea,CCCCNC(=O)N,592-31-4,Negative,in vitro
C.I. Acid orange 3,C1=CC=C(C=C1)NC2=C(C=C(C=C2)NC3=C(C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-])S(=O)(=O)[O-].[Na+],6373-74-6,Positive,in vitro
C.I. Acid red 114,CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)N=NC3=C(C=C(C=C3)C4=CC(=C(C=C4)N=NC5=C(C=CC6=CC(=CC(=C65)S(=O)(=O)[O-])S(=O)(=O)[O-])O)C)C.[Na+].[Na+],6459-94-5,Negative,in vitro
C.I. Basic red 9 (pararosaniline HCl),C1=CC(=N)C=CC1=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N.Cl,569-61-9,Negative,in vitro
C.I. DIRECT BLACK 38,C1=CC=C(C=C1)N=NC2=C(C3=C(C(=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC4=CC=C(C=C4)C5=CC=C(C=C5)N=NC6=C(C=C(C=C6)N)N)N)O.[Na+].[Na+],1937-37-7,Positive,In vivo
C.I. Direct black 38,C1=CC=C(C=C1)N=NC2=C(C3=C(C(=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC4=CC=C(C=C4)C5=CC=C(C=C5)N=NC6=C(C=C(C=C6)N)N)N)O.[Na+].[Na+],1937-37-7,Negative,in vitro
C.I. Direct blue 14 (Trypan blue),CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])N)O)C)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])N)O.[Na+].[Na+].[Na+].[Na+],72-57-1,Negative,in vitro
C.I. Direct blue 15,COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])N)O)OC)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])N)O.[Na+].[Na+].[Na+].[Na+],2429-74-5,Positive,in vitro
C.I. Direct blue 53,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C3)C(=CC(=C4N)S(=O)(=O)[O-])S(=O)(=O)[O-])O)C)N=NC5=C(C6=C(C=C5)C(=CC(=C6N)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+].[Na+].[Na+],314-13-6,Positive,in vitro
C.I. Direct blue 6,C1=CC(=CC=C1C2=CC=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])N)O)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])N)O.[Na+].[Na+].[Na+].[Na+],2602-46-2,Negative,in vitro
C.I. Direct brown 95,C1=CC(=CC=C1C2=CC=C(C=C2)N=NC3=C(C=CC(=C3[O-])N=NC4=C(C=CC(=C4)S(=O)(=O)[O-])[O-])O)N=NC5=CC(=C(C=C5)O)C(=O)[O-].[Na+].[Na+].[Cu+2],16071-86-6,Negative,in vitro
C.I. Direct red 28 ( Congo Red),C1=CC=C2C(=C1)C(=CC(=C2N)N=NC3=CC=C(C=C3)C4=CC=C(C=C4)N=NC5=C(C6=CC=CC=C6C(=C5)S(=O)(=O)[O-])N)S(=O)(=O)[O-].[Na+].[Na+],573-58-0,Positive,in vitro
C.I. Disperse blue 1,C1=CC(=C2C(=C1N)C(=O)C3=C(C=CC(=C3C2=O)N)N)N,2475-45-8,Positive,in vitro
C.I. Disperse orange 2 (1-amino-2-methyl-anthrquinone),CC1=C(C2=C(C=C1)C(=O)C3=CC=CC=C3C2=O)N,82-28-0,Positive,in vitro
C.I. Disperse yellow 3,CC1=CC(=C(C=C1)O)N=NC2=CC=C(C=C2)NC(=O)C,2832-40-8,Negative,in vitro
C.I. FOOD RED 3,C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C(C4=CC=CC=C4C(=C3)S(=O)(=O)[O-])O.[Na+].[Na+],3567-69-9,Negative,In vivo
C.I. food red 3 [AKA Acid red 14],C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C(C4=CC=CC=C4C(=C3)S(=O)(=O)[O-])O.[Na+].[Na+],3567-69-9,Negative,in vitro
C.I. Pigment red 23,COC1=C(C=C(C=C1)[N+](=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC(=CC=C4)[N+](=O)[O-])O,6471-49-4,Negative,in vitro
C.I. Pigment red 3,CC1=CC(=C(C=C1)N=NC2=C(C=CC3=CC=CC=C32)O)[N+](=O)[O-],2425-85-6,Negative,in vitro
C.I. PIGMENT YELLOW 12,CC(=O)C(C(=O)NC1=CC=CC=C1)N=NC2=C(C=C(C=C2)C3=CC(=C(C=C3)N=NC(C(=O)C)C(=O)NC4=CC=CC=C4)Cl)Cl,6358-85-6,Negative,In vivo
C.I. pigment yellow 12 Diarylanilide yellow,CC(=O)C(C(=O)NC1=CC=CC=C1)N=NC2=C(C=C(C=C2)C3=CC(=C(C=C3)N=NC(C(=O)C)C(=O)NC4=CC=CC=C4)Cl)Cl,6358-85-6,Negative,in vitro
C.I. PIGMENT YELLOW 83,CC(=O)C(C(=O)NC1=CC(=C(C=C1OC)Cl)OC)N=NC2=C(C=C(C=C2)C3=CC(=C(C=C3)N=NC(C(=O)C)C(=O)NC4=CC(=C(C=C4OC)Cl)OC)Cl)Cl,5567-15-7,Negative,In vivo
C.I. Solvent yellow 14,C1=CC=C(C=C1)N=NC2=C(C=CC3=CC=CC=C32)O ,0842-07-09,Negative,in vitro
C.I. Solvent yellow 3 (o-aminoazotoluene),CC1=CC=CC=C1N=NC2=CC(=C(C=C2)N)C,97-56-3,Positive,in vitro
Cacodylic acid,C[As](=O)(C)O,75-60-5,Negative,In vivo
cadmium,[Cd],23973,Positive,In Vivo
Cadmium,[Cd],7440-43-9,Positive,In vivo
CADMIUM ACETATE,CC(=O)[O-].CC(=O)[O-].[Cd+2],543-90-8,Negative,In vivo
CADMIUM CHLORIDE,Cl[Cd]Cl,10108-64-2,Negative,In vivo
CADMIUM CHLORIDE,Cl[Cd]Cl,10108-64-2,Positive,In vivo
CADMIUM CHLORIDE MONOHYDRATE,O.Cl[Cd]Cl,35658-65-2,Negative,In vivo
CADMIUM DIETHYLDITHIOCARBAMATE,CCN(CC)C(=S)[S-].CCN(CC)C(=S)[S-].[Cd+2],14239-68-0,Negative,In vivo
CADMIUM SULPHATE (1:1),[O-]S(=O)(=O)[O-].[Cd+2],10124-36-4,Negative,In vivo
CADMIUM SULPHATE (1:1),[O-]S(=O)(=O)[O-].[Cd+2],10124-36-4,Positive,In vivo
cadmium(2+);carbonate,C(=O)([O-])[O-].[Cd+2],513-78-0,Positive,in vitro
cadmium(2+);diacetate,CC(=O)[O-].CC(=O)[O-].[Cd+2],543-90-8,Negative,in vitro
cadmium(2+);dinitrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Cd+2],10325-94-7,Positive,in vitro
cadmium(2+);nitric acid,[N+](=O)(O)[O-].[N+](=O)(O)[O-].[Cd+2],,Negative,in vitro
cadmium(2+);sulfate,[O-]S(=O)(=O)[O-].[Cd+2],24962,Negative,In Vivo
cadmium(2+);sulfate,[O-]S(=O)(=O)[O-].[Cd+2],10124-36-4,Positive,in vivo
cadmium(2+);sulfate,[O-]S(=O)(=O)[O-].[Cd+2],24962,Positive,In Vivo
cadmium(2+);sulfate,[O-]S(=O)(=O)[O-].[Cd+2],10124-36-4,Positive,in vitro
cadmium(2+);tetrachloride;pentahydrate,O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Cl-].[Cd+2].[Cd+2],24978551,Negative,In Vivo
cadmium(2+);tetrachloride;pentahydrate,O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Cl-].[Cd+2].[Cd+2],24978551,Positive,In Vivo
cadmium(2+);tetrachloride;pentahydrate,O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Cl-].[Cd+2].[Cd+2],,Positive,in vitro
Cadusafos,CCC(C)SP(=O)(OCC)SC(C)CC,95465-99-9,Negative,in vivo
Cadusafos,CCC(C)SP(=O)(OCC)SC(C)CC,95465-99-9,Negative,in vitro
CAFFEIC ACID,C1=CC(=C(C=C1C=CC(=O)O)O)O,331-39-5,Positive,In vivo
CAFFEINE,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,58-08-2,Negative,In vivo
Caffeine,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,58-08-2,Positive,in vitro
Calcium 3-hydroxy-4-[4-methyl-2-sulphonatophenylazol]-2-napthoate,CC1=CC(=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)[O-])S(=O)(=O)[O-].[Ca+2],5281-04-9,Negative,in vitro
Calcium chromate,[O-][Cr](=O)(=O)[O-].[Ca+2],13765-19-0,Positive,in vitro
Calcium cyanamide,C(#N)N.[Ca+2],156-62-7,Positive,in vitro
Calcium cyanide,[C-]#N.[C-]#N.[Ca+2],0592-01-08,Negative,In vivo
Calcium phosphide,[P-3].[P-3].[Ca+2].[Ca+2].[Ca+2],1305-99-3,Negative,in vivo
Calcium phosphide,[P-3].[P-3].[Ca+2].[Ca+2].[Ca+2],1305-99-3,Positive,in vivo
Calcium phosphide,[P-3].[P-3].[Ca+2].[Ca+2].[Ca+2],1305-99-3,Negative,in vitro
Calcium sodium metaphosphate,[O-]P(=O)=O.[O-]P(=O)=O.[O-]P(=O)=O.[Na+].[Ca+2],16166309,Negative,In Vivo
CALCIUM VALPROATE,CCCC(CCC)C(=O)[O-].CCCC(CCC)C(=O)[O-].[Ca+2],33433-82-8,Positive,In vivo
calcium;2-[(3-carboxy-2-oxidonaphthalen-1-yl)diazenyl]-5-methylbenzenesulfonate,CC1=CC(=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)[O-])S(=O)(=O)[O-].[Ca+2],135423095,Negative,In Vivo
calcium;2-[(3-carboxy-2-oxidonaphthalen-1-yl)diazenyl]naphthalene-1-sulfonate,C1=CC=C2C(=C1)C=CC(=C2S(=O)(=O)[O-])N=NC3=C(C(=CC4=CC=CC=C43)C(=O)O)[O-].[Ca+2],135487685,Negative,In Vivo
calcium;2-hydroxypropanoate,CC(C(=O)[O-])O.CC(C(=O)[O-])O.[Ca+2],13144,Negative,In Vivo
calcium;2-propylpentanoate,CCCC(CCC)C(=O)[O-].CCCC(CCC)C(=O)[O-].[Ca+2],86480,Negative,In Vivo
calcium;2-propylpentanoate,CCCC(CCC)C(=O)[O-].CCCC(CCC)C(=O)[O-].[Ca+2],86480,Positive,In Vivo
"calcium;2,2-dichloropropanoate",CC(C(=O)[O-])(Cl)Cl.CC(C(=O)[O-])(Cl)Cl.[Ca+2],,Positive,in vitro
calcium;3-carboxy-1-phenyldiazenylnaphthalen-2-olate,C1=CC=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)[O-].C1=CC=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)[O-].[Ca+2],135565537,Negative,In Vivo
calcium;dichloride,[Cl-].[Cl-].[Ca+2],14639-81-7,Negative,in vitro
calcium;dioxido(dioxo)chromium,[O-][Cr](=O)(=O)[O-].[Ca+2],26264,Positive,In Vivo
calcium;dioxido(dioxo)chromium,[O-][Cr](=O)(=O)[O-].[Ca+2],13765-19-0,Positive,in vivo
calcium;dioxido(dioxo)chromium,[O-][Cr](=O)(=O)[O-].[Ca+2],13765-19-0,Positive,in vitro
calcium;N-cyclohexylsulfamate,C1CCC(CC1)NS(=O)(=O)[O-].C1CCC(CC1)NS(=O)(=O)[O-].[Ca+2],139-06-0,Negative,in vivo
calcium;N-cyclohexylsulfamate,C1CCC(CC1)NS(=O)(=O)[O-].C1CCC(CC1)NS(=O)(=O)[O-].[Ca+2],8752,Positive,In Vivo
calcium;sodium;2-[bis(carboxylatomethyl)amino]acetate,C(C(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Ca+2],,Negative,in vivo
CANDESARTAN CILEXETIL,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC(C)OC(=O)OC6CCCCC6,145040-37-5,Negative,In vivo
Caprolactam,C1CCC(=O)NCC1,105-60-2,Negative,In vivo
Caprolactam,C1CCC(=O)NCC1,105-60-2,Negative,in vitro
CAPSAICIN,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,404-86-4,Negative,In vivo
CAPSAICIN,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,404-86-4,Positive,In vivo
Capsaicin,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,404-86-4,Positive,in vitro
CAPTAFOL,C1C=CCC2C1C(=O)N(C2=O)SC(C(Cl)Cl)(Cl)Cl,2425-06-1,Positive,In vivo
Captafol,C1C=CCC2C1C(=O)N(C2=O)SC(C(Cl)Cl)(Cl)Cl,2425-06-01,Negative,In vivo
Captafol,C1C=CCC2C1C(=O)N(C2=O)SC(C(Cl)Cl)(Cl)Cl,2425-06-1,Positive,in vitro
Captan,C1C=CCC2C1C(=O)N(C2=O)SC(Cl)(Cl)Cl,133-06-2,Negative,in vivo
Captan,C1C=CCC2C1C(=O)N(C2=O)SC(Cl)(Cl)Cl,133-06-2,Positive,in vivo
Captan,C1C=CCC2C1C(=O)N(C2=O)SC(Cl)(Cl)Cl,0133-06-02,Negative,In vivo
Captan,C1C=CCC2C1C(=O)N(C2=O)SC(Cl)(Cl)Cl,133-06-2,Positive,in vitro
Carbadox,COC(=O)NN=CC1=[N+](C2=CC=CC=C2[N+](=C1)[O-])[O-],6804-07-5,Positive,in vitro
CARBAMYL HYDRAZINE.HCl,C(=O)(N)NN.Cl,563-41-7,Negative,In vivo
CARBAMYL HYDRAZINE.HCl,C(=O)(N)NN.Cl,563-41-7,Positive,In vivo
CARBARSONE,C1=CC(=CC=C1NC(=O)N)[As](=O)(O)O,121-59-5,Negative,In vivo
Carbaryl,CNC(=O)OC1=CC=CC2=CC=CC=C21,63-25-2,Negative,in vivo
Carbaryl,CNC(=O)OC1=CC=CC2=CC=CC=C21,63-25-2,Positive,In vivo
Carbaryl,CNC(=O)OC1=CC=CC2=CC=CC=C21,63-25-2,Negative,in vitro
Carbaryl,CNC(=O)OC1=CC=CC2=CC=CC=C21,63-25-2,Positive,in vitro
CARBAZOLE,C1=CC=C2C(=C1)C3=CC=CC=C3N2,86-74-8,Positive,In vivo
Carbendazim,COC(=O)NC1=NC2=CC=CC=C2N1,10605-21-7,Negative,in vivo
Carbendazim,COC(=O)NC1=NC2=CC=CC=C2N1,10605-21-7,Positive,in vivo
Carbendazim,COC(=O)NC1=NC2=CC=CC=C2N1,10605-21-7,Negative,in vitro
Carbetamide,CCNC(=O)[C@@H](C)OC(=O)NC1=CC=CC=C1,16118-49-3,Negative,in vivo
Carbetamide,CCNC(=O)[C@@H](C)OC(=O)NC1=CC=CC=C1,16118-49-3,Negative,in vitro
Carbofuran,CC1(CC2=C(O1)C(=CC=C2)OC(=O)NC)C,1563-66-2,Negative,in vivo
Carbofuran,CC1(CC2=C(O1)C(=CC=C2)OC(=O)NC)C,1563-66-2,Positive,in vivo
Carbofuran,CC1(CC2=C(O1)C(=CC=C2)OC(=O)NC)C,1563-66-2,Negative,in vitro
Carbon Disulfide,C(=S)=S,75-15-0,Positive,in vivo
Carbon disulfide,C(=S)=S,75-15-0,Negative,In vivo
CARBON TETRACHLORIDE,C(Cl)(Cl)(Cl)Cl,56-23-5,Positive,In vivo
Carbonyl sulfide,C(=O)=S,463-58-1,Negative,In vivo
Carbosulfan,CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C2)(C)C,55285-14-8,Negative,in vivo
Carbosulfan,CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C2)(C)C,55285-14-8,Positive,in vivo
Carbosulfan,CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C2)(C)C,55285-14-8,Negative,in vitro
Carboxin,CC1=C(SCCO1)C(=O)NC2=CC=CC=C2,5234-68-4,Negative,In vivo
Carboxin,CC1=C(SCCO1)C(=O)NC2=CC=CC=C2,5234-68-4,Negative,in vitro
CARBOXYMETHYLNITROSOUREA,C(C(=O)O)N(C(=O)N)N=O,60391-92-6,Positive,In vivo
Carfentrazone-ethyl,CCOC(=O)C(CC1=CC(=C(C=C1Cl)F)N2C(=O)N(C(=N2)C)C(F)F)Cl,128639-02-1,Negative,in vivo
Carfentrazone-ethyl,CCOC(=O)C(CC1=CC(=C(C=C1Cl)F)N2C(=O)N(C(=N2)C)C(F)F)Cl,128639-02-1,Negative,in vitro
"Carmustine [1,3-bis(2-chloroethyl)nitrosurea]",C(CCl)NC(=O)N(CCCl)N=O,154-93-8,Positive,in vitro
"CARRAGEENAN, NATIVE",CCC(=O)C1=C(C(=C(C=C1)F)C2CC2NC(=O)NC3=NC=C(C=C3)C#N)O.CC(=O)[O-].CC(=O)[O-].[Zn+2],9000-07-1,Negative,In vivo
CATECHOL,C1=CC=C(C(=C1)O)O,120-80-9,Positive,In vivo
CATECHOL,C1=CC=C(C(=C1)O)O,120-80-9,Negative,In vivo
CELECOXIB,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,169590-42-5,Negative,In vivo
CELIPROLOL,CCN(CC)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C)O)C(=O)C,56980-93-9,Negative,In vivo
Cerium Oxide and Cerium Compounds,O=[Ce]=O,1306-38-3,Negative,In vivo
cesium;chloride,[Cl-].[Cs+],7647-17-8,Positive,in vitro
cesium;nitrate,[N+](=O)([O-])[O-].[Cs+],7789-18-6,Positive,in vitro
CEVIMELINE.HCl,CC1OC2(CN3CCC2CC3)CS1.CC1OC2(CN3CCC2CC3)CS1.O.Cl.Cl,153504-70-2,Negative,In vivo
CHENODEOXYCHOLIC ACID,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,474-25-9,Negative,In vivo
CHLORAL HYDRATE,C(C(Cl)(Cl)Cl)(O)O,302-17-0,Positive,In vivo
Chloral hydrate,C(C(Cl)(Cl)Cl)(O)O,302-17-0,Negative,In vivo
Chloral hydrate,C(C(Cl)(Cl)Cl)(O)O,302-17-0,Positive,in vitro
Chloramben,C1=C(C=C(C(=C1C(=O)O)Cl)N)Cl,133-90-4,Negative,In vivo
Chloramben,C1=C(C=C(C(=C1C(=O)O)Cl)N)Cl,133-90-4,Positive,in vitro
CHLORAMBUCIL,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,305-03-3,Positive,In vivo
Chlorambucil,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,0305-03-03,Positive,in vitro
Chloramine,NCl,25423,Negative,In Vivo
CHLORAMPHENICOL,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],56-75-7,Negative,In vivo
chlorane,Cl,7647-01-0,Negative,in vitro
Chlorantraniliprole,CC1=C(C(=CC(=C1)Cl)C(=O)NC)NC(=O)C2=CC(=NN2C3=C(C=CC=N3)Cl)Br,500008-45-7,Negative,in vivo
Chlorantraniliprole,CC1=C(C(=CC(=C1)Cl)C(=O)NC)NC(=O)C2=CC(=NN2C3=C(C=CC=N3)Cl)Br,500008-45-7,Negative,in vitro
Chlordane (technical grade),C1C2C(C(C1Cl)Cl)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl,57-74-9,Positive,in vitro
Chlordane (Technical),C1C2C(C(C1Cl)Cl)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl,12789-03-06,Positive,In vivo
"Chlordane, analytical grade",C1C2C(C(C1Cl)Cl)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl,57-74-9,Positive,in vitro
"CHLORDANE, TECHNICAL GRADE",C1C2C(C(C1Cl)Cl)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl,57-74-9,Positive,In vivo
Chlordecone (Kepone),C1(=O)C2(C3(C4(C1(C5(C2(C3(C(C45Cl)(Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl,143-50-0,Positive,In vivo
Chloridazon,C1=CC=C(C=C1)N2C(=O)C(=C(C=N2)N)Cl,1698-60-8,Negative,in vivo
Chloridazon,C1=CC=C(C=C1)N2C(=O)C(=C(C=N2)N)Cl,1698-60-8,Negative,in vitro
Chlorimuron-ethyl,CCOC(=O)C1=CC=CC=C1S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)Cl)OC,90982-32-4,Negative,In vivo
CHLORINE,ClCl,7782-50-5,Negative,In vivo
Chlorine cyanide,C(#N)Cl,506-77-4,Negative,In vivo
Chlorine dioxide,O=Cl[O],10049-04-04,Negative,In vivo
Chlorine dioxide,O=Cl[O],10049-04-4,Positive,in vitro
Chlorite (sodium salt),[O-]Cl=O.[Na+],7758-19-2,Negative,In vivo
Chlormequat chloride,C[N+](C)(C)CCCl.[Cl-],999-81-5,Negative,in vivo
Chlormequat chloride,C[N+](C)(C)CCCl.[Cl-],999-81-5,Negative,in vitro
Chlornaphazine,C1=CC=C2C=C(C=CC2=C1)N(CCCl)CCCl ,0494-03-01,Positive,in vitro
"Chloro-1,1-difluoroethane",CC(F)(F)Cl,75-68-3,Negative,In vivo
chloro(2-methoxyethyl)mercury,COCC[Hg]Cl,123-88-6,Negative,in vitro
chloro(chloromethoxy)methane,C(OCCl)Cl,10967,Positive,In Vivo
chloro(chloromethoxy)methane,C(OCCl)Cl,542-88-1,Positive,in vivo
chloro(difluoro)methane,C(F)(F)Cl,6372,Negative,In Vivo
chloro(difluoro)methane,C(F)(F)Cl,75-45-6,Positive,in vitro
chloro(fluoro)methane,C(F)Cl,11643,Positive,In Vivo
chloro(methoxy)methane,COCCl,7864,Positive,In Vivo
chloro(methoxy)methane,COCCl,107-30-2,Positive,in vivo
chloro(methoxy)methane,COCCl,107-30-2,Positive,in vitro
chloro(methyl)mercury,C[Hg]Cl,409301,Negative,In Vivo
chloro(methyl)mercury,C[Hg]Cl,409301,Positive,In Vivo
chloro(methyl)mercury,C[Hg]Cl,0115-09-03,Negative,in vivo
chloro(methyl)mercury,C[Hg]Cl,0115-09-03,Positive,in vitro
chloro(triethyl)plumbane,CC[Pb](CC)(CC)Cl,1067-14-7,Negative,in vitro
CHLOROACETALDEHYDE,C(C=O)Cl,107-20-0,Negative,In vivo
CHLOROACETALDEHYDE,C(C=O)Cl,107-20-0,Positive,In vivo
Chloroacetaldehyde,C(C=O)Cl,107-20-0,Positive,in vitro
Chloroacetophenone,C1=CC=C(C=C1)C(=O)CCl,532-27-4,Negative,In vivo
Chloroaniline,C1=CC(=CC=C1N)Cl,106-47-8,Negative,In vivo
chlorobenzene,C1=CC=C(C=C1)Cl,7964,Negative,In Vivo
Chlorobenzene,C1=CC=C(C=C1)Cl,108-90-7,Negative,In vivo
chlorobenzene,C1=CC=C(C=C1)Cl,108-90-7,Positive,in vitro
CHLOROBENZILATE,CCOC(=O)C(C1=CC=C(C=C1)Cl)(C2=CC=C(C=C2)Cl)O,510-15-6,Positive,In vivo
Chlorobenzilate,CCOC(=O)C(C1=CC=C(C=C1)Cl)(C2=CC=C(C=C2)Cl)O,510-15-6,Negative,In vivo
Chlorobenzilate,CCOC(=O)C(C1=CC=C(C=C1)Cl)(C2=CC=C(C=C2)Cl)O,510-15-6,Negative,in vitro
Chlorobutane,CCCCCl,78-86-4,Negative,In vivo
Chlorobutane,CCCCCl,109-69-3,Negative,In vivo
chlorocopper,Cl[Cu],7758-89-6,Negative,in vitro
Chlorocyclopentadiene,C1=CC(C=C1)Cl,41851-50-7,Negative,In vivo
Chlorodibromomethane,C(Cl)(Br)Br,124-48-1,Positive,in vitro
CHLORODIFLUOROMETHANE,C(F)(F)Cl,75-45-6,Negative,In vivo
Chlorodifluoromethane (GAS) [AKA fluorocarbon 22],C(F)(F)Cl,75-45-6,Negative,in vitro
chloroethane,CCCl,6337,Negative,In Vivo
chloroethane,CCCl,6337,Positive,In Vivo
Chloroethane,CCCl,75-00-3,Positive,in vitro
chloroethene,C=CCl,75-01-4,Negative,in vivo
chloroethene,C=CCl,6338,Positive,In Vivo
chloroethene,C=CCl,75-01-4,Positive,in vivo
chloroethene,C=CCl,6338,Negative,In Vivo
chloroethene,C=CCl,75-01-4,Negative,in vitro
CHLOROFLUOROMETHANE,C(F)Cl,593-70-4,Positive,In vivo
CHLOROFORM,C(Cl)(Cl)Cl,67-66-3,Negative,In vivo
chloroform,C(Cl)(Cl)Cl,6212,Negative,In Vivo
chloroform,C(Cl)(Cl)Cl,6212,Positive,In Vivo
CHLOROFORM,C(Cl)(Cl)Cl,67-66-3,Positive,In vivo
chloroform,C(Cl)(Cl)Cl,67-66-3,Negative,in vitro
chloromercury,Cl[Hg],7546-30-7,Positive,in vitro
chloromethane,CCl,74-87-3,Positive,in vitro
CHLOROMETHYL METHYL ETHER,COCCl,107-30-2,Positive,In vivo
Chloromethyl methyl ether (CMME),COCCl,107-30-2,Negative,In vivo
chloromethylbenzene,C1=CC=C(C=C1)CCl,7503,Positive,In Vivo
chloromethylbenzene,C1=CC=C(C=C1)CCl,100-44-7,Positive,in vivo
chloromethylbenzene,C1=CC=C(C=C1)CCl,7503,Negative,In Vivo
chloromethylbenzene,C1=CC=C(C=C1)CCl,100-44-7,Negative,in vitro
Chloronaphthalene,C1=CC=C2C=C(C=CC2=C1)Cl,91-58-7,Negative,In vivo
Chlorophenol,C1=CC=C(C(=C1)O)Cl,95-57-8,Negative,In vivo
Chlorophenyl methyl sulfide,CSC1=CC=C(C=C1)Cl,0123-09-01,Negative,In vivo
Chlorophenyl methyl sulfone,CS(=O)(=O)C1=CC=C(C=C1)Cl,98-57-7,Negative,In vivo
Chlorophenyl methyl sulfoxide,CS(=O)C1=CC=C(C=C1)Cl,934-73-6,Negative,In vivo
Chloroprene,C=CC(=C)Cl,126-99-8,Positive,In vivo
CHLOROPRENE (99.6% CHLOROPRENE),C=CC(=C)Cl,126-99-8,Negative,In vivo
Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,54-05-7,Positive,in vitro
chlorosilver,Cl[Ag],7783-90-6,Negative,in vitro
CHLOROTETRAFLUOROETHANE,C(C(F)(F)F)(F)Cl,2837-89-0,Negative,In vivo
chlorothallium,Cl[Tl],7791-12-0,Positive,in vitro
Chlorothalonil,C(#N)C1=C(C(=C(C(=C1Cl)Cl)Cl)C#N)Cl,1897-45-6,Negative,In vivo
Chlorotoluene,CC1=CC=CC=C1Cl,95-49-8,Negative,In vivo
CHLOROZOTOCIN,C(CCl)N(C(=O)NC(C=O)C(C(C(CO)O)O)O)N=O,54749-90-5,Positive,In vivo
Chlorozotocin,C(CCl)N(C(=O)NC(C=O)C(C(C(CO)O)O)O)N=O,54749-90-5,Positive,in vitro
CHLORPHENIRAMINE MALEATE,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,113-92-8,Negative,In vivo
"Chlorpheniramine maleate 
[AKA pyridine,2-p-chloro-alpha-2-
dimethylaminoethylbenzyl-, maleate 1:1,]",CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,113-92-8,Positive,in vitro
Chlorpropham,CC(C)OC(=O)NC1=CC(=CC=C1)Cl,101-21-3,Negative,In vivo
Chlorpyrifos,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl,2921-88-2,Negative,in vivo
Chlorpyrifos,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl,2921-88-2,Negative,in vitro
Chlorsulfuron,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=CC=CC=C2Cl,64902-72-3,Negative,in vivo
Chlorsulfuron,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=CC=CC=C2Cl,64902-72-3,Negative,in vitro
Chlorthal-dimethyl,COC(=O)C1=C(C(=C(C(=C1Cl)Cl)C(=O)OC)Cl)Cl,1861-32-1,Negative,in vivo
Chlorthal-dimethyl,COC(=O)C1=C(C(=C(C(=C1Cl)Cl)C(=O)OC)Cl)Cl,1861-32-1,Positive,in vivo
Chlorthal-dimethyl,COC(=O)C1=C(C(=C(C(=C1Cl)Cl)C(=O)OC)Cl)Cl,1861-32-1,Negative,in vitro
CHOCOLATE BROWN HT,C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])NN=C3C=C(C(=O)C(=NNC4=CC=C(C5=CC=CC=C54)S(=O)(=O)[O-])C3=O)CO.[Na+].[Na+],4553-89-3,Negative,In vivo
CHOLINE CHLORIDE,C[N+](C)(C)CCO.[Cl-],67-48-1,Negative,In vivo
Chromafenozide,CC1=CC(=CC(=C1)C(=O)N(C(C)(C)C)NC(=O)C2=C(C3=C(C=C2)OCCC3)C)C,143807-66-3,Negative,in vivo
Chromafenozide,CC1=CC(=CC(=C1)C(=O)N(C(C)(C)C)NC(=O)C2=C(C3=C(C=C2)OCCC3)C)C,143807-66-3,Negative,in vitro
chromen-2-one,C1=CC=C2C(=C1)C=CC(=O)O2,323,Negative,In Vivo
chromen-2-one,C1=CC=C2C(=C1)C=CC(=O)O2,323,Positive,In Vivo
chromen-2-one,C1=CC=C2C(=C1)C=CC(=O)O2,91-64-5,Positive,in vitro
CHROMIC OXIDE PIGMENT,O=[Cr]O[Cr]=O,1308-38-9,Negative,In vivo
chromium,[Cr],23976,Positive,In Vivo
CHROMIUM (III) ACETATE,CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Cr+3],1066-30-4,Negative,In vivo
chromium(3+);dioxido(dioxo)chromium,[O-][Cr](=O)(=O)[O-].[O-][Cr](=O)(=O)[O-].[O-][Cr](=O)(=O)[O-].[Cr+3].[Cr+3],32520,Positive,In Vivo
chromium(3+);pyridine-2-carboxylate;hydrate,C1=CC=NC(=C1)C(=O)[O-].C1=CC=NC(=C1)C(=O)[O-].C1=CC=NC(=C1)C(=O)[O-].O.[Cr+3],22833491,Negative,In Vivo
chromium(3+);trinitrate;nonahydrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].O.O.O.O.O.O.O.O.O.[Cr+3],7789-02-08,Positive,in vitro
"Chromium(III), insoluble salts",[Cr+3],16065-83-1,Negative,In vivo
Chromium(VI),[Cr+6],18540-29-9,Positive,In vivo
CHRYSAZIN,C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=CC=C3O,117-10-2,Positive,In vivo
Chrysazin,C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=CC=C3O,81-55-0,Positive,in vitro
chrysen-6-amine,C1=CC=C2C(=C1)C=CC3=C2C=C(C4=CC=CC=C34)N,17534,Negative,In Vivo
chrysen-6-amine,C1=CC=C2C(=C1)C=CC3=C2C=C(C4=CC=CC=C34)N,2642-98-0,Positive,in vitro
chrysene,C1=CC=C2C(=C1)C=CC3=C2C=CC4=CC=CC=C43,9171,Negative,In Vivo
chrysene,C1=CC=C2C(=C1)C=CC3=C2C=CC4=CC=CC=C43,9171,Positive,In Vivo
Chrysene,C1=CC=C2C(=C1)C=CC3=C2C=CC4=CC=CC=C43,0218-01-09,Negative,In vivo
chrysene,C1=CC=C2C(=C1)C=CC3=C2C=CC4=CC=CC=C43,0218-01-09,Positive,in vivo
Chrysene,C1=CC=C2C(=C1)C=CC3=C2C=CC4=CC=CC=C43,0218-01-09,Positive,in vitro
CIMETIDINE,CC1=C(N=CN1)CSCCNC(=NC)NC#N,51481-61-9,Negative,In vivo
CIPROFIBRATE,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,52214-84-3,Positive,In vivo
CIPROFIBRATE,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,52214-84-3,Negative,In vivo
Ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,85721-33-1,Positive,in vitro
Cisplatin,N.N.Cl[Pt]Cl,15663-27-1,Positive,in vitro
CITRININ,CC1C(OC=C2C1=C(C(=C(C2=O)C(=O)O)O)C)C,518-75-2,Positive,In vivo
Citrinin,CC1C(OC=C2C1=C(C(=C(C2=O)C(=O)O)O)C)C,518-75-2,Positive,in vitro
Clethodim,CC/C(=N\OC/C=C/Cl)/C1=C(CC(CC1=O)CC(C)SCC)O,99129-21-2,Negative,in vivo
Clethodim,CC/C(=N\OC/C=C/Cl)/C1=C(CC(CC1=O)CC(C)SCC)O,99129-21-2,Negative,in vitro
CLIVORINE,CC1C=C(C(=O)OC2CC[N+]3(C2(C(=CC3)COC(=O)C1(C)OC(=O)C)[O-])C)C=C,33979-15-6,Positive,In vivo
CLOBUZARIT,CC(C)(C(=O)O)OCC1=CC=C(C=C1)C2=CC=C(C=C2)Cl,22494-47-9,Negative,In vivo
CLOBUZARIT,CC(C)(C(=O)O)OCC1=CC=C(C=C1)C2=CC=C(C=C2)Cl,22494-47-9,Positive,In vivo
Clodinafop-propargyl,O=C(OCC#C)[C@H](OC1=CC=C(OC2=NC=C(Cl)C=C2F)C=C1)C,105512-06-9,Negative,in vivo
Clodinafop-propargyl,O=C(OCC#C)[C@H](OC1=CC=C(OC2=NC=C(Cl)C=C2F)C=C1)C,105512-06-9,Negative,in vitro
Clofentezine,Clc3ccccc3c1nnc(nn1)c2ccccc2Cl,74115-24-5,Negative,in vivo
Clofentezine,Clc3ccccc3c1nnc(nn1)c2ccccc2Cl,74115-24-5,Negative,in vitro
CLOFIBRATE,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,637-07-0,Negative,In vivo
CLOFIBRATE,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,637-07-0,Positive,In vivo
Clofibrate,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,637-07-0,Negative,in vitro
Clomazone,O=C1N(CC(C=CC=C2)=C2Cl)OCC(C)1C,81777-89-1,Negative,in vivo
Clomazone,O=C1N(CC(C=CC=C2)=C2Cl)OCC(C)1C,81777-89-1,Negative,in vitro
CLOMIPHENE CITRATE,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,43054-45-1,Negative,In vivo
CLOPHEN A 30,C1=CC(=CC(=C1)Cl)C2=CC(=CC=C2)Cl,55600-34-5,Positive,In vivo
Clopyralid,C1=CC(=NC(=C1Cl)C(=O)O)Cl,1702-17-6,Negative,in vivo
Clopyralid,C1=CC(=NC(=C1Cl)C(=O)O)Cl,1702-17-6,Negative,in vitro
Coal tar,CC(C)(C)C1=CC(=C(C(=C1)C2=CC=CC=N2)O)C=NC3CCCCC3N=CC4=C(C(=CC(=C4)C(C)(C)C)C5=CC=CC=N5)O.[Cu],8007-45-2,Positive,in vitro
Cobalt (II) acetate tetrahydrate,CC(=O)[O-].CC(=O)[O-].O.O.O.O.[Co+2],6147-53-1,Positive,in vitro
Cobalt and Cobalt Compounds,O=[Co],1307-96-6,Negative,In vivo
Cobalt dichloride hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Co+2],7791-13-1,Positive,in vitro
Cobalt Sulfate heptahydrate,O.O.O.O.O.O.O.[O-]S(=O)(=O)[O-].[Co+2],10026-24-1,Positive,in vitro
cobalt;trihydrate,O.O.O.[Co],1307-86-4,Positive,in vitro
cobalt(2+);diacetate,CC(=O)[O-].CC(=O)[O-].[Co+2],71-48-7,Positive,in vitro
cobalt(2+);dichloride,[Cl-].[Cl-].[Co+2],1332-82-7,Negative,in vitro
cobalt(2+);dioxido(dioxo)molybdenum,[O-][Mo](=O)(=O)[O-].[Co+2],13762-14-6,Positive,in vitro
cobalt(2+);sulfate,[O-]S(=O)(=O)[O-].[Co+2],10124-43-3,Positive,in vitro
cobalt(2+);sulfuric acid;heptahydrate,O.O.O.O.O.O.O.OS(=O)(=O)O.[Co+2],76960584,Positive,In Vivo
COLCEMID,CNC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,477-30-5,Negative,In vivo
Colchicine,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,64-86-8,Positive,in vitro
COMPOUND 50-892,CC1=CC2=C(C=C1)C(=NC(=O)N2C(C)C)C3=CC(=CC=C3)O,65765-07-3,Negative,In vivo
COMPOUND LY171883,CCCC1=C(C=CC(=C1O)C(=O)C)OCCCCC2=NNN=N2,88107-10-2,Positive,In vivo
Copper,[Cu],7440-50-8,Negative,in vivo
Copper,[Cu],7440-50-8,Positive,in vivo
Copper,[Cu],7440-50-8,Negative,in vitro
Copper cyanide,[C-]#N.[Cu+],544-92-3,Negative,In vivo
COPPER DIMETHYLDITHIOCARBAMATE,CN(C)C(=S)[S-].CN(C)C(=S)[S-].[Cu+2],137-29-1,Negative,In vivo
COPPER-8-HYDROXYQUINOLINE,C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.[Cu+2],10380-28-6,Negative,In vivo
copper;2-[bis(carboxylatomethyl)amino]acetate,C(C(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Cu+2],61819,Positive,In Vivo
copper;copper(1+);sulfanide,[SH-].[Cu].[Cu+],21112-20-9,Positive,in vitro
"copper;disodium;2-oxido-5-[[4-[4-[(2Z)-2-[(5E)-5-[(2-oxido-5-sulfonatophenyl)hydrazinylidene]-2,6-dioxocyclohex-3-en-1-ylidene]hydrazinyl]phenyl]phenyl]diazenyl]benzoate",C1=CC(=CC=C1C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)[O-])C(=O)[O-])N/N=C\4/C(=O)C=C/C(=N\NC5=C(C=CC(=C5)S(=O)(=O)[O-])[O-])/C4=O.[Na+].[Na+].[Cu+2],9570322,Positive,In Vivo
copper;sulfate,[O-]S(=O)(=O)[O-].[Cu+2],7758-98-7,Negative,in vitro
Coumaphos,CCOP(=S)(OCC)OC1=CC2=C(C=C1)C(=C(C(=O)O2)Cl)C,56-72-4,Negative,in vitro
COUMARIN,C1=CC=C2C(=C1)C=CC(=O)O2,91-64-5,Negative,In vivo
COUMARIN,C1=CC=C2C(=C1)C=CC(=O)O2,91-64-5,Positive,In vivo
Coumarin,C1=CC=C2C(=C1)C=CC(=O)O2,91-64-5,Positive,in vitro
Crotonaldehyde,CC=CC=O,123-73-9,Negative,In vivo
Crotonaldehyde,CC=CC=O,123-73-9,Positive,in vitro
cumene,CC(C)C1=CC=CC=C1,7406,Positive,In Vivo
Cumene,CC(C)C1=CC=CC=C1,98-82-8,Negative,In vivo
cumene,CC(C)C1=CC=CC=C1,7406,Negative,In Vivo
cumene,CC(C)C1=CC=CC=C1,98-82-8,Negative,in vitro
Cupferron,C1=CC=C(C=C1)[N+](=N[O-])[O-].[NH4+],135-20-6,Positive,in vitro
Curcumin,COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O,458-37-7,Positive,in vitro
Cyanazine,CCNC1=NC(=NC(=N1)Cl)NC(C)(C)C#N,21725-46-2,Negative,In vivo
CYANAZINE,CCNC1=NC(=NC(=N1)Cl)NC(C)(C)C#N,21725-46-2,Positive,In vivo
"Cyanide, free",[C-]#N,57-12-5,Negative,In vivo
Cyanogen,C(#N)C#N,460-19-5,Negative,In vivo
Cyanogen bromide,C(#N)Br,506-68-3,Negative,In vivo
CYANOGUANIDINE,C(#N)N=C(N)N,157480-33-6,Negative,In vivo
Cyantraniliprole,CC1=CC(=CC(=C1NC(=O)C2=CC(=NN2C3=C(C=CC=N3)Cl)Br)C(=O)NC)C#N,736994-63-1,Negative,in vivo
Cyantraniliprole,CC1=CC(=CC(=C1NC(=O)C2=CC(=NN2C3=C(C=CC=N3)Cl)Br)C(=O)NC)C#N,736994-63-1,Negative,in vitro
CYCASIN AND METHYLAZOXYMETHANOL ACETATE,C[N+](=NCOC1C(C(C(C(O1)CO)O)O)O)[O-],mixture,Positive,In vivo
"CYCLAMATE, SODIUM",C1CCC(CC1)NS(=O)(=O)[O-].[Na+],139-05-9,Negative,In vivo
"CYCLAMATE, SODIUM",C1CCC(CC1)NS(=O)(=O)[O-].[Na+],139-05-9,Positive,In vivo
CYCLOCHLOROTINE,CCC1C(=O)NC(C(=O)NC(CC(=O)NC(C(=O)N2CC(C(C2C(=O)N1)Cl)Cl)CO)C3=CC=CC=C3)CO,12663-46-6,Positive,In vivo
CYCLOCYTIDINE,C1=CN2C3C(C(C(O3)CO)O)OC2=NC1=N,31698-14-3,Negative,In vivo
"cyclohexa-2,5-diene-1,4-dione",C1=CC(=O)C=CC1=O,106-51-4,Positive,in vitro
cyclohexanamine,C1CCC(CC1)N,108-91-8,Negative,in vivo
cyclohexanamine,C1CCC(CC1)N,108-91-8,Negative,in vitro
cyclohexanamine;sulfuric acid,C1CCC(CC1)N.OS(=O)(=O)O,,Negative,in vivo
Cyclohexane,C1CCCCC1,110-82-7,Negative,In vivo
cyclohexane,C1CCCCC1,110-82-7,Negative,in vitro
cyclohexanol,C1CCC(CC1)O,108-93-0,Negative,in vitro
Cyclohexanone,C1CCC(=O)CC1,108-94-1,Negative,In vivo
Cyclohexanone,C1CCC(=O)CC1,108-94-1,Positive,in vitro
Cyclohexylamine,C1CCC(CC1)N,108-91-8,Negative,In vivo
CYCLOHEXYLAMINE SULFATE,C1CCC(CC1)N.OS(=O)(=O)O,19834-02-7,Negative,In vivo
CYCLOHEXYLAMINE.HCl,C1CCC(CC1)N,4998-76-9,Negative,In vivo
cyclohexylazanium;chloride,C1CCC(CC1)[NH3+].[Cl-],,Positive,in vivo
"cyclopenta-1,3-diene;iron(2+)",[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Fe+2],102-54-5,Positive,in vitro
"cyclopenta-1,3-diene;nickel(2+)",[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Ni+2],62390,Positive,In Vivo
"Cyclopenta[c,d]pyrene",C1=CC2=C3C(=C1)C=C4C=CC5=C4C3=C(C=C2)C=C5,27208-37-3,Positive,in vitro
CYCLOPENTANONE OXIME,C1CCC(=NO)C1,1192-28-5,Positive,In vivo
CYCLOPHOSPHAMIDE,C1CNP(=O)(OC1)N(CCCl)CCCl,50-18-0,Positive,In vivo
Cyclophosphamide (free base and monohydrate),C1CNP(=O)(OC1)N(CCCl)CCCl,50-18-0,Positive,in vitro
CYCLOSPORIN A,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,59865-13-3,Negative,In vivo
Cycloxydim,CCC/C(=N\OCC)C=1C(=O)CC(CC=1O)C2CCCSC2,101205-02-1,Negative,in vivo
Cycloxydim,CCC/C(=N\OCC)C=1C(=O)CC(CC=1O)C2CCCSC2,101205-02-1,Negative,in vitro
Cyflufenamid,C1CC1CONC(=NC(=O)CC2=CC=CC=C2)C3=C(C=CC(=C3F)F)C(F)(F)F,180409-60-3,Negative,in vivo
Cyflufenamid,C1CC1CONC(=NC(=O)CC2=CC=CC=C2)C3=C(C=CC(=C3F)F)C(F)(F)F,180409-60-3,Negative,in vitro
Cyflumetofen,CC(C)(C)C1=CC=C(C=C1)C(C#N)(C(=O)C2=CC=CC=C2C(F)(F)F)C(=O)OCCOC,400882-07-7,Negative,in vivo
Cyflumetofen,CC(C)(C)C1=CC=C(C=C1)C(C#N)(C(=O)C2=CC=CC=C2C(F)(F)F)C(=O)OCCOC,400882-07-7,Negative,in vitro
Cyhalofop-butyl,CCCCOC(=O)C(C)OC1=CC=C(C=C1)OC2=C(C=C(C=C2)C#N)F,122008-85-9,Negative,in vivo
Cyhalofop-butyl,CCCCOC(=O)C(C)OC1=CC=C(C=C1)OC2=C(C=C(C=C2)C#N)F,122008-85-9,Negative,in vitro
Cyhalothrin/Karate,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(C(F)(F)F)Cl)C,68085-85-8,Negative,In vivo
Cyhexatin,C1CCC(CC1)[Sn](C2CCCCC2)C3CCCCC3.O,6327054,Negative,In Vivo
Cymoxanil,CCNC(=O)NC(=O)/C(=N/OC)/C#N,57966-95-7,Negative,in vivo
Cymoxanil,CCNC(=O)NC(=O)/C(=N/OC)/C#N,57966-95-7,Negative,in vitro
Cypermethrin,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,52315-07-8,Positive,in vivo
Cypermethrin,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,52315-07-8,Negative,in vivo
Cypermethrin,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,52315-07-08,Negative,In vivo
Cypermethrin,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,52315-07-08,Negative,in vitro
Cypermethrin Supercypermethrin,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,52315-07-8,Positive,in vitro
Cyproconazole,CC(C1CC1)C(CN2C=NC=N2)(C3=CC=C(C=C3)Cl)O,94361-06-5,Negative,in vivo
Cyproconazole,CC(C1CC1)C(CN2C=NC=N2)(C3=CC=C(C=C3)Cl)O,94361-06-05,Negative,in vitro
Cyprodinil,CC1=CC(=NC(=N1)NC2=CC=CC=C2)C3CC3,121552-61-2,Negative,in vivo
Cyprodinil,CC1=CC(=NC(=N1)NC2=CC=CC=C2)C3CC3,121552-61-2,Negative,in vitro
CYPROTERONE ACETATE,CC(=O)C1(CCC2C1(CCC3C2C=C(C4=CC(=O)C5CC5C34C)Cl)C)OC(=O)C,427-51-0,Positive,In vivo
Cyromazine,C1CC1NC2=NC(=NC(=N2)N)N,66215-27-8,Negative,in vivo
Cyromazine,C1CC1NC2=NC(=NC(=N2)N)N,66215-27-8,Negative,in vitro
Cytembena,COC1=CC=C(C=C1)C(=O)C(=CC(=O)[O-])Br.[Na+],21739-91-3,Positive,in vitro
D & C RED NO. 10,C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C4=CC=CC=C4C=C3)S(=O)(=O)[O-])O.[Na+],1248-18-6,Negative,In vivo
D & C RED NO. 5,CC1=CC(=C(C=C1)N=NC2=C3C=CC(=CC3=CC(=C2O)S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+],3761-53-3,Positive,In vivo
D & C RED NO. 9,CC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.CC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.[Ba+2],5160-02-1,Negative,In vivo
d-l menthol/ also racemic form,CC1CCC(C(C1)O)C(C)C,2216-51-5,Negative,in vitro
D-limonene,CC1=CCC(CC1)C(=C)C,5989-27-5,Negative,in vitro
d-Mannitol,C(C(C(C(C(CO)O)O)O)O)O,69-65-8,Negative,in vitro
D&C Red 9,CC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.CC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.[Ba+2] ,5160-02-1,Negative,in vitro
D&C Yellow 11 (AKA C.I. Solvent Yellow 33),C1=CC=C2C(=C1)C=CC(=N2)C3C(=O)C4=CC=CC=C4C3=O,8003-22-3,Positive,in vitro
DACARBAZINE,CN(C)/N=N/C1=C(NC=N1)C(=O)N,4342-03-4,Positive,In vivo
Dacarbazine,CN(C)/N=N/C1=C(NC=N1)C(=O)N,4342-03-4,Positive,in vitro
Dacthal,COC(=O)C1=C(C(=C(C(=C1Cl)Cl)C(=O)OC)Cl)Cl,1861-32-1,Negative,In vivo
"Daidzein 4',7-Dihydroxyisoflavone",C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O)O,486-66-8,Negative,in vitro
"Dalapon, sodium salt",CC(C(=O)O)(Cl)Cl,75-99-0,Negative,In vivo
DAMINOZIDE,CN(C)NC(=O)CCC(=O)O,1596-84-5,Negative,In vivo
DAMINOZIDE,CN(C)NC(=O)CCC(=O)O,1596-84-5,Positive,In vivo
Daminozide,CN(C)NC(=O)CCC(=O)O,1596-84-5,Negative,in vitro
Danitol,CC1(C(C1(C)C)C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C,39515-41-8,Negative,In vivo
Danthron,C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O,0117-10-2,Positive,in vitro
Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,80-08-0,Positive,in vitro
Daunomycin/ Daunorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,20830-81-3,Positive,in vitro
Dazomet,CN1CN(C(=S)SC1)C,533-74-4,Negative,in vivo
Dazomet,CN1CN(C(=S)SC1)C,533-74-4,Positive,in vivo
Dazomet,CN1CN(C(=S)SC1)C,533-74-4,Negative,in vitro
DDT,C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,50-29-3,Negative,In vivo
DDT,C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,50-29-3,Positive,In vivo
Decabromodiphenyl ether (BDE-209),C1(=C(C(=C(C(=C1Br)Br)Br)Br)Br)OC2=C(C(=C(C(=C2Br)Br)Br)Br)Br,1163-19-5,Positive,In vivo
Decabromodiphenyl oxide,C1(=C(C(=C(C(=C1Br)Br)Br)Br)Br)OC2=C(C(=C(C(=C2Br)Br)Br)Br)Br,1163-19-5,Negative,in vitro
"DECABROMODIPHENYL OXIDE, TECHNICAL GRADE (77.4% DBDPO, 21.8% NONABROMODIPHENYL OXIDE, 0.8% OCTABROMODIPHENYL OXIDE)",C1(=C(C(=C(C(=C1Br)Br)Br)Br)Br)OC2=C(C(=C(C(=C2Br)Br)Br)Br)Br,1163-19-5,Negative,In vivo
Decalin,C1CCC2CCCCC2C1,91-17-8,Negative,in vitro
DEFLAZACORT,CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C,14484-47-0,Positive,In vivo
DEHYDROEPIANDROSTERONE,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,53-43-0,Positive,In vivo
DEHYDROEPIANDROSTERONE ACETATE,CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CCC4=O)C)C,853-23-6,Negative,In vivo
DEHYDROEPIANDROSTERONE ACETATE,CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CCC4=O)C)C,853-23-6,Positive,In vivo
DEHYDROEPIANDROSTERONE SULFATE,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)OS(=O)(=O)O)C,651-48-9,Negative,In vivo
DELTAMETHRIN,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Br)Br)C,52918-63-5,Negative,In vivo
Demeton,CCOP(=O)(OCC)SCCSCC.CCOP(=S)(OCC)OCCSCC,8065-48-3,Negative,In vivo
DEOXYNIVALENOL,CC1=CC2C(C(C1=O)O)(C3(CC(C(C34CO4)O2)O)C)CO,51481-10-8,Negative,In vivo
DESERPIDINE,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,131-01-1,Negative,In vivo
DEXTRAN,C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC(C(C(C(C=O)O)O)O)O)O)O)O)O)O)O)O,9004-54-0,Negative,In vivo
DEXTRAN SULFATE SODIUM (DS-M-1),CCOC(=O)C1=CC=C(C=C1)N,9011-18-1,Positive,In vivo
DEXTRAN SULFATE SODIUM (DST-H),CCOC(=O)C1=CC=C(C=C1)N,9011-18-1,Negative,In vivo
DEXTRAN SULFATE SODIUM (KMDS-H),CCOC(=O)C1=CC=C(C=C1)N,9011-18-1,Negative,In vivo
Di (2-ethylhexyl)phthalate (DEHP),CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC,117-81-7,Positive,In vivo
DI-tert-BUTYL-4-HYDROXYMETHYL PHENOL,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CO,88-26-6,Negative,In vivo
Di(2-ethylhexyl)adipate,CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC,103-23-1,Positive,In vivo
DI(2-ETHYLHEXYL)PHTHALATE,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC,117-81-7,Positive,In vivo
DI(N-NITROSO)-PERHYDROPYRIMIDINE,C1CN(CN(C1)N=O)N=O,15973-99-6,Positive,In vivo
Di2-ethylhexylphthalate,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC,117-81-7,Negative,in vitro
DIACETYL HYDRAZINE,CC(=O)NNC(=O)C,3148-73-0,Negative,In vivo
DIALLATE,CC(C)N(C(C)C)C(=O)SCC(=CCl)Cl,2303-16-4,Positive,In vivo
Diallate,CC(C)N(C(C)C)C(=O)SCC(=CCl)Cl,2303-16-4,Positive,in vitro
Diallyl phthalate,C=CCOC(=O)C1=CC=CC=C1C(=O)OCC=C,131-17-9,Positive,in vitro
DIALLYLNITROSAMINE,C=CCN(CC=C)N=O,16338-97-9,Positive,In vivo
Diallylnitrosamine,C=CCN(CC=C)N=O,16338-97-9,Positive,in vitro
dialuminum;oxygen(2-),[O-2].[O-2].[O-2].[Al+3].[Al+3],9989226,Positive,In Vivo
dialuminum;triberyllium;dioxido(oxo)silane,[Be+2].[Be+2].[Be+2].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[Al+3].[Al+3],14767,Positive,In Vivo
dialuminum;trisulfate,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Al+3].[Al+3],10043-01-03,Negative,in vitro
Diaminotoluene,CC1=C(C=C(C=C1)N)N,95-80-7,Negative,In vivo
"diazanium;2-[[4-[ethyl-[(3-sulfonatophenyl)methyl]amino]phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]benzenesulfonate",CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=CC=CC=C5S(=O)(=O)[O-].[NH4+].[NH4+],2650-18-2,Negative,in vitro
diazanium;sulfate,[NH4+].[NH4+].[O-]S(=O)(=O)[O-],7783-20-2,Negative,in vitro
DIAZEPAM,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,439-14-5,Negative,In vivo
Diazinon,CCOP(=S)(OCC)OC1=NC(=NC(=C1)C)C(C)C,333-41-5,Negative,in vivo
Diazinon,CCOP(=S)(OCC)OC1=NC(=NC(=C1)C)C(C)C,333-41-5,Negative,in vitro
diazomethane,C=[N+]=[N-],9550,Positive,In Vivo
Diazomethane,C=[N+]=[N-],334-88-3,Negative,In vivo
diazomethane,C=[N+]=[N-],334-88-3,Positive,in vivo
diazomethane,C=[N+]=[N-],334-88-3,Positive,in vitro
"DIBENZ(a,h)ANTHRACENE",C1=CC=C2C(=C1)C=CC3=CC4=C(C=CC5=CC=CC=C54)C=C32,53-70-3,Positive,In vivo
"Dibenz[a,h]anthracene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=CC5=CC=CC=C54)C=C32,53-70-3,Negative,In vivo
"Dibenz[a,h]anthracene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=CC5=CC=CC=C54)C=C32,53-70-3,Positive,in vitro
dibenzo-p-dioxin,C1=CC=C2C(=C1)OC3=CC=CC=C3O2,9216,Negative,In Vivo
dibenzo-p-dioxin,C1=CC=C2C(=C1)OC3=CC=CC=C3O2,0262-12-4,Negative,in vivo
Dibenzofuran,C1=CC=C2C(=C1)C3=CC=CC=C3O2,132-64-9,Negative,In vivo
Dibromo-3-chloropropane (DBCP),C(C(CBr)Br)Cl,96-12-8,Negative,In vivo
dibromo(chloro)methane,C(Cl)(Br)Br,31296,Positive,In Vivo
dibromo(chloro)methane,C(Cl)(Br)Br,124-48-1,Positive,in vivo
dibromo(chloro)methane,C(Cl)(Br)Br,31296,Negative,In Vivo
dibromo(chloro)methane,C(Cl)(Br)Br,124-48-1,Positive,in vitro
Dibromoacetic acid,C(C(=O)O)(Br)Br,631-64-1,Positive,in vitro
Dibromoacetonitrile,C(#N)C(Br)Br,3252-43-5,Positive,in vitro
Dibromobenzene,C1=CC(=CC=C1Br)Br,106-37-6,Negative,In vivo
Dibromochloromethane,C(Cl)(Br)Br,124-48-1,Positive,In vivo
Dibromodichloromethane,C(Cl)(Cl)(Br)Br,594-18-3,Negative,In vivo
Dibromodiphenyl ether,C1=CC(=CC=C1OC2=CC=C(C=C2)Br)Br,2050-47-7,Negative,In vivo
DIBROMODULCITOL,C(C(C(C(C(CBr)O)O)O)O)Br,10318-26-0,Positive,In vivo
Dibromodulcitol,C(C(C(C(C(CBr)O)O)O)O)Br,10318-26-0,Positive,in vitro
Dibromoethane,C(CBr)Br,106-93-4,Positive,In vivo
DIBROMOMANNITOL,C(C(C(C(C(CBr)O)O)O)O)Br,488-41-5,Positive,In vivo
Dibromomannitol,C(C(C(C(C(CBr)O)O)O)O)Br,488-41-5,Positive,in vitro
Dibuthyltin dichloride,CCCC[Sn](CCCC)(Cl)Cl,683-18-1,Positive,in vitro
"dibutyl benzene-1,2-dicarboxylate",CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC,84-74-2,Negative,in vitro
Dibutyl phthalate (DBP),CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC,84-74-2,Negative,In vivo
dicalcium;dioxido(oxo)silane;hydron;iron(2+),[H+].[H+].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[Ca+2].[Ca+2].[Fe+2].[Fe+2].[Fe+2].[Fe+2].[Fe+2],73456703,Positive,In Vivo
Dicamba,COC1=C(C=CC(=C1C(=O)O)Cl)Cl,1918-00-9,Negative,in vivo
Dicamba,COC1=C(C=CC(=C1C(=O)O)Cl)Cl,1918-00-9,Positive,in vivo
Dicamba,COC1=C(C=CC(=C1C(=O)O)Cl)Cl,1918-00-9,Negative,in vitro
dicesium;carbonate,C(=O)([O-])[O-].[Cs+].[Cs+],534-17-8,Positive,in vitro
dicesium;sulfate,[O-]S(=O)(=O)[O-].[Cs+].[Cs+],10294-54-9,Positive,in vitro
dichloro(difluoro)methane,C(F)(F)(Cl)Cl,6391,Negative,In Vivo
dichloro(difluoro)methane,C(F)(F)(Cl)Cl,75-71-8,Negative,in vitro
DICHLOROACETIC ACID,C(C(=O)O)(Cl)Cl,79-43-6,Positive,In vivo
Dichloroacetic acid,C(C(=O)O)(Cl)Cl,79-43-6,Positive,in vitro
DICHLOROACETYLENE,C(#CCl)Cl,7572-29-4,Positive,In vivo
Dichlorobenzene,C1=CC=C(C(=C1)Cl)Cl,95-50-1,Negative,In vivo
Dichlorobenzene,C1=CC=C(C(=C1)Cl)Cl,541-73-1,Negative,In vivo
Dichlorobenzene,C1=CC=C(C(=C1)Cl)Cl,106-46-7,Negative,In vivo
Dichlorobenzidine,C1=CC(=C(C=C1C2=CC(=C(C=C2)N)Cl)Cl)N,91-94-1,Positive,In vivo
dichlorocadmium,Cl[Cd]Cl,24947,Negative,In Vivo
dichlorocadmium,Cl[Cd]Cl,24947,Positive,In Vivo
dichlorocadmium,Cl[Cd]Cl,10108-64-2,Positive,in vivo
dichlorocadmium,Cl[Cd]Cl,10108-64-2,Negative,in vivo
dichlorocadmium,Cl[Cd]Cl,10108-64-2,Negative,in vitro
dichlorocopper,Cl[Cu]Cl,,Negative,in vitro
DICHLORODIFLUOROMETHANE,C(F)(F)(Cl)Cl,75-71-8,Negative,In vivo
Dichlorodifluoromethane,C(F)(F)(Cl)Cl,75-71-8,Negative,in vitro
Dichlorodiphenyl dichloroethane (DDD),C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,72-54-8,Positive,In vivo
Dichlorodiphenyldichloroethylene (DDE),C1=CC(=CC=C1C(=C(Cl)Cl)C2=CC=C(C=C2)Cl)Cl,72-55-9,Positive,In vivo
Dichlorodiphenyltrichloroethane (DDT),C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,50-29-3,Positive,In vivo
Dichloroethane,CC(Cl)Cl,75-34-3,Negative,In vivo
Dichloroethane,CC(Cl)Cl,0107-06-02,Negative,In vivo
Dichloroethylene,C(=CCl)Cl,156-60-5,Negative,In vivo
Dichloroethylene,C(=CCl)Cl,156-59-2,Negative,In vivo
"Dichloroethylene (1,1-DCE)",C=C(Cl)Cl,75-35-4,Negative,In vivo
dichloroiron,Cl[Fe]Cl,,Negative,in vitro
dichlorolead,Cl[Pb]Cl,7758-95-4,Negative,in vitro
dichloromanganese,Cl[Mn]Cl,,Positive,in vitro
dichloromanganese;tetrahydrate,O.O.O.O.Cl[Mn]Cl,,Positive,in vitro
dichloromercury,Cl[Hg]Cl,24085,Negative,In Vivo
dichloromercury,Cl[Hg]Cl,24085,Positive,In Vivo
dichloromercury,Cl[Hg]Cl,7487-94-7,Negative,in vitro
dichloromethane,C(Cl)Cl,6344,Negative,In Vivo
dichloromethane,C(Cl)Cl,6344,Positive,In Vivo
Dichloromethane,C(Cl)Cl,75-09-2,Positive,In vivo
Dichloromethane,C(Cl)Cl,75-09-2,Positive,in vitro
dichloromethylbenzene,C1=CC=C(C=C1)C(Cl)Cl,7411,Negative,In Vivo
dichloromethylbenzene,C1=CC=C(C=C1)C(Cl)Cl,98-87-3,Positive,in vitro
dichloronickel,Cl[Ni]Cl,7718-54-9,Negative,in vitro
dichloropalladium,Cl[Pd]Cl,7647-10-1,Negative,in vitro
Dichlorophenol,C1=CC(=C(C=C1Cl)Cl)O,120-83-2,Negative,In vivo
"Dichlorophenoxy)butyric acid (2,4-DB)",C1=CC(=C(C=C1Cl)Cl)OCCCC(=O)O,94-82-6,Negative,In vivo
"Dichlorophenoxyacetic acid (2,4-D)",C1=CC(=C(C=C1Cl)Cl)OCC(=O)O,94-75-7,Negative,In vivo
Dichloropropane,CC(CCl)Cl,78-87-5,Negative,In vivo
Dichloropropanol,C(C(CCl)Cl)O,616-23-9,Negative,In vivo
Dichloropropene,C(C=CCl)Cl,542-75-6,Positive,In vivo
dichlororuthenium;methylsulfinylmethane,CS(=O)C.CS(=O)C.CS(=O)C.CS(=O)C.Cl[Ru]Cl,11070-19-2,Positive,in vitro
dichlorotin,Cl[Sn]Cl,24479,Negative,In Vivo
dichlorotin,Cl[Sn]Cl,7772-99-8,Negative,in vivo
dichlorotin,Cl[Sn]Cl,7772-99-8,Negative,in vitro
dichlorotin;dihydrate,O.O.Cl[Sn]Cl,,Negative,in vitro
dichlorozinc,Cl[Zn]Cl,7646-85-7,Negative,in vivo
dichlorozinc,Cl[Zn]Cl,7646-85-7,Negative,in vitro
Dichlorprop-P,Clc1cc(Cl)ccc1O[C@H](C)C(=O)O,15165-67-0,Negative,in vivo
Dichlorprop-P,Clc1cc(Cl)ccc1O[C@H](C)C(=O)O,15165-67-0,Negative,in vitro
Dichlorvos,COP(=O)(OC)OC=C(Cl)Cl,62-73-7,Negative,in vivo
Dichlorvos,COP(=O)(OC)OC=C(Cl)Cl,62-73-7,Positive,in vivo
Dichlorvos,COP(=O)(OC)OC=C(Cl)Cl,62-73-7,Positive,in vitro
"DICHROMATE, SODIUM",[O-][Cr](=O)(=O)O[Cr](=O)(=O)[O-].[Na+].[Na+],10588-01-9,Positive,In vivo
Diclofop-methyl,CC(C(=O)OC)OC1=CC=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl,51338-27-3,Negative,in vivo
Diclofop-methyl,CC(C(=O)OC)OC1=CC=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl,51338-27-3,Negative,in vitro
Dicloran,Nc1c(Cl)cc(cc1Cl)[N+](=O)[O-],99-30-9,Negative,in vivo
Dicloran,Nc1c(Cl)cc(cc1Cl)[N+](=O)[O-],99-30-9,Negative,in vitro
Dicofol,C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)(C(Cl)(Cl)Cl)O)Cl,115-32-2,Negative,In vivo
Dicyclanil,C1CC1NC2=NC(=C(C(=N2)N)C#N)N,112636-83-6,Negative,in vitro
DICYCLOPENTADIENE DIOXIDE,C1C2C3CC4C(C3C1C5C2O5)O4,81-21-0,Negative,In vivo
Didecyldimethylammonium chloride,[Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC,7173-51-5,Negative,in vivo
Didecyldimethylammonium chloride,[Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC,7173-51-5,Negative,in vitro
DIELDRIN,C1C2C3C(C1C4C2O4)C5(C(=C(C3(C5(Cl)Cl)Cl)Cl)Cl)Cl,60-57-1,Negative,In vivo
DIELDRIN,C1C2C3C(C1C4C2O4)C5(C(=C(C3(C5(Cl)Cl)Cl)Cl)Cl)Cl,60-57-1,Positive,In vivo
Dieldrin,C1C2C3C(C1C4C2O4)C5(C(=C(C3(C5(Cl)Cl)Cl)Cl)Cl)Cl,60-57-1,Negative,in vitro
"Diepoxybutane/1,2,3,4-diepoxybutane/ 1,2,3,4-DL-diepoxybutane",C1C(O1)C2CO2,1464-53-5,Positive,in vitro
Diethanolamine,C(CO)NCCO,111-42-2,Negative,in vitro
Diethofencarb,O=C(OC(C)C)NC1=CC=C(OCC)C(OCC)=C1,87130-20-9,Negative,in vivo
Diethofencarb,O=C(OC(C)C)NC1=CC=C(OCC)C(OCC)=C1,87130-20-9,Negative,in vitro
diethoxy-(2-ethylsulfanylethoxy)-sulfanylidene-lambda5-phosphane;1-diethoxyphosphorylsulfanyl-2-ethylsulfanylethane,CCOP(=O)(OCC)SCCSCC.CCOP(=S)(OCC)OCCSCC,8065-48-3,Negative,in vitro
diethoxy-(2-ethylsulfanylethylsulfanyl)-sulfanylidene-lambda5-phosphane,CCOP(=S)(OCC)SCCSCC,3118,Negative,In Vivo
diethoxy-(2-ethylsulfanylethylsulfanyl)-sulfanylidene-lambda5-phosphane,CCOP(=S)(OCC)SCCSCC,0298-04-04,Negative,in vitro
diethoxy-(4-methylsulfinylphenoxy)-sulfanylidene-lambda5-phosphane,CCOP(=S)(OCC)OC1=CC=C(C=C1)S(=O)C,115-90-2,Negative,in vitro
diethoxy-(4-nitrophenoxy)-sulfanylidene-lambda5-phosphane,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-],991,Negative,In Vivo
diethoxy-(4-nitrophenoxy)-sulfanylidene-lambda5-phosphane,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-],56-38-2,Negative,in vitro
diethoxy-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxy-sulfanylidene-lambda5-phosphane,CCOP(=S)(OCC)OC1=NC(=NC(=C1)C)C(C)C,3017,Negative,In Vivo
diethoxy-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxy-sulfanylidene-lambda5-phosphane,CCOP(=S)(OCC)OC1=NC(=NC(=C1)C)C(C)C,333-41-5,Negative,in vivo
diethoxy-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxy-sulfanylidene-lambda5-phosphane,CCOP(=S)(OCC)OC1=NC(=NC(=C1)C)C(C)C,333-41-5,Negative,in vitro
diethoxy-(ethylsulfanylmethylsulfanyl)-sulfanylidene-lambda5-phosphane,CCOP(=S)(OCC)SCSCC,0298-02-02,Negative,in vitro
"diethoxy-sulfanylidene-(3,5,6-trichloropyridin-2-yl)oxy-lambda5-phosphane",CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl,2730,Negative,In Vivo
"diethoxy-sulfanylidene-(3,5,6-trichloropyridin-2-yl)oxy-lambda5-phosphane",CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl,2921-88-2,Negative,in vivo
"diethoxy-sulfanylidene-(3,5,6-trichloropyridin-2-yl)oxy-lambda5-phosphane",CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl,2921-88-2,Negative,in vitro
diethoxyphosphinothioylsulfanylmethylsulfanyl-diethoxy-sulfanylidene-lambda5-phosphane,CCOP(=S)(OCC)SCSP(=S)(OCC)OCC,0563-12-2,Negative,in vitro
"diethyl (3,5,6-trichloropyridin-2-yl) phosphate",CCOP(=O)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl,5598-15-2,Negative,in vivo
diethyl (4-nitrophenyl) phosphate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-],311-45-5,Positive,in vitro
diethyl (6-methyl-2-propan-2-ylpyrimidin-4-yl) phosphate,CCOP(=O)(OCC)OC1=NC(=NC(=C1)C)C(C)C,962-58-3,Positive,in vitro
diethyl 2-dimethoxyphosphinothioylsulfanylbutanedioate,CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC,4004,Negative,In Vivo
diethyl 2-dimethoxyphosphinothioylsulfanylbutanedioate,CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC,121-75-5,Negative,in vivo
diethyl 2-dimethoxyphosphinothioylsulfanylbutanedioate,CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC,121-75-5,Negative,in vitro
diethyl 2-dimethoxyphosphinothioylsulfanylbutanedioate;dimethoxy-(3-methyl-4-nitrophenoxy)-sulfanylidene-lambda5-phosphane,CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC.CC1=C(C=CC(=C1)OP(=S)(OC)OC)[N+](=O)[O-],,Positive,in vitro
diethyl 2-dimethoxyphosphorylsulfanylbutanedioate,CCOC(=O)CC(C(=O)OCC)SP(=O)(OC)OC,15415,Negative,In Vivo
diethyl 2-dimethoxyphosphorylsulfanylbutanedioate,CCOC(=O)CC(C(=O)OCC)SP(=O)(OC)OC,1634-78-2,Negative,in vivo
diethyl 2-dimethoxyphosphorylsulfanylbutanedioate,CCOC(=O)CC(C(=O)OCC)SP(=O)(OC)OC,1634-78-2,Positive,in vitro
"diethyl benzene-1,2-dicarboxylate",CCOC(=O)C1=CC=CC=C1C(=O)OCC,6781,Negative,In Vivo
diethyl hexanedioate,CCOC(=O)CCCCC(=O)OCC,141-28-6,Positive,in vivo
Diethyl phthalate (DEP),CCOC(=O)C1=CC=CC=C1C(=O)OCC,84-66-2,Negative,In vivo
"diethyl propane-1,3-disulfonate",CCOS(=O)(=O)CCCS(=O)(=O)OCC,,Positive,in vitro
diethyl sulfate,CCOS(=O)(=O)OCC,64-67-5,Positive,in vivo
Diethyl sulfate,CCOS(=O)(=O)OCC,64-67-5,Negative,In vivo
diethyl sulfate,CCOS(=O)(=O)OCC,6163,Positive,In Vivo
Diethyl sulfate,CCOS(=O)(=O)OCC,64-67-5,Positive,in vitro
"diethyl-[2-(10-methyl-8-thia-14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9,11,13(16)-heptaen-14-yl)ethyl]azanium;methanesulfonate",CC[NH+](CC)CCN1C2=C3C(=C(C=C2)C)SC4=CC=CC=C4C3=N1.CS(=O)(=O)[O-],,Positive,in vitro
diethyl-[2-[[4-(hydroxymethyl)-9-oxothioxanthen-1-yl]amino]ethyl]azanium;methanesulfonate,CC[NH+](CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O.CS(=O)(=O)[O-],,Negative,in vivo
diethyl-[2-[[4-(hydroxymethyl)-9-oxothioxanthen-1-yl]amino]ethyl]azanium;methanesulfonate,CC[NH+](CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O.CS(=O)(=O)[O-],31764,Positive,In Vivo
diethyl-[2-[[4-(hydroxymethyl)-9-oxothioxanthen-1-yl]amino]ethyl]azanium;methanesulfonate,CC[NH+](CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O.CS(=O)(=O)[O-],,Positive,in vivo
diethyl-[2-[[4-(hydroxymethyl)-9-oxothioxanthen-1-yl]amino]ethyl]azanium;methanesulfonate,CC[NH+](CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O.CS(=O)(=O)[O-],,Negative,in vitro
diethyl-[3-[[2-[(2E)-2-[(5-nitrofuran-2-yl)methylidene]hydrazinyl]-2-oxoacetyl]amino]propyl]azanium;chloride,CC[NH+](CC)CCCNC(=O)C(=O)N/N=C/C1=CC=C(O1)[N+](=O)[O-].[Cl-],51415-04-04,Positive,in vitro
Diethyl-p-nitrophenylphosphate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-],311-45-5,Negative,In vivo
DIETHYLACETAMIDE,CCN(CC)C(=O)C,685-91-6,Positive,In vivo
diethylazanium;chloride,CC[NH2+]CC.[Cl-],,Negative,in vitro
diethylcarbamodithioic acid,CCN(CC)C(=S)S,147-84-2,Positive,in vitro
"diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate",CCN(CC)C(=S)SSC(=S)N(CC)CC,3117,Negative,In Vivo
"diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate",CCN(CC)C(=S)SSC(=S)N(CC)CC,97-77-8,Negative,in vivo
DIETHYLENE GLYCOL,C(COCCO)O,111-46-6,Negative,In vivo
DIETHYLENE GLYCOL,C(COCCO)O,111-46-6,Positive,In vivo
Diethylene glycol,C(COCCO)O,111-46-6,Negative,in vitro
Diethylene glycol dinitrate (DEGDN),C(CO[N+](=O)[O-])OCCO[N+](=O)[O-],693-21-0,Negative,In vivo
DIETHYLMALEATE,CCOC(=O)C=CC(=O)OCC,141-05-9,Negative,In vivo
DIETHYLSTILBESTROL,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,56-53-1,Positive,In vivo
DIETHYLSTILBESTROL,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,56-53-1,Negative,In vivo
Diethylstilbestrol ,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,56-53-1,Positive,in vitro
Difenoconazole,CC1COC(O1)(CN2C=NC=N2)C3=C(C=C(C=C3)OC4=CC=C(C=C4)Cl)Cl,119446-68-3,Negative,in vivo
Difenoconazole,CC1COC(O1)(CN2C=NC=N2)C3=C(C=C(C=C3)OC4=CC=C(C=C4)Cl)Cl,119446-68-3,Negative,in vitro
Difenzoquat,CN1C(=CC(=[N+]1C)C2=CC=CC=C2)C3=CC=CC=C3.COS(=O)(=O)[O-],43222-48-6,Negative,In vivo
Diflubenzuron,C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)Cl)F,35367-38-5,Negative,in vivo
Diflubenzuron,C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)Cl)F,35367-38-5,Negative,in vitro
Diflufenican,C1=CC(=CC(=C1)OC2=C(C=CC=N2)C(=O)NC3=C(C=C(C=C3)F)F)C(F)(F)F,83164-33-4,Negative,in vivo
Diflufenican,C1=CC(=CC(=C1)OC2=C(C=CC=N2)C(=O)NC3=C(C=C(C=C3)F)F)C(F)(F)F,83164-33-4,Negative,in vitro
Difluoroethane,CC(F)F,75-37-6,Negative,In vivo
difluorotin,F[Sn]F,7783-47-3,Negative,in vitro
DIFTALONE,C1C2=CC=CC=C2C(=O)N3N1C(=O)C4=CC=CC=C4C3,21626-89-1,Negative,In vivo
DIFTALONE,C1C2=CC=CC=C2C(=O)N3N1C(=O)C4=CC=CC=C4C3,21626-89-1,Positive,In vivo
digallium;oxygen(2-),[O-2].[O-2].[O-2].[Ga+3].[Ga+3],158605,Negative,In Vivo
"Diglycidyl resorcinol ether, technical grade",C1C(O1)COC2=CC(=CC=C2)OCC3CO3,101-90-6,Positive,in vitro
Dihydralazine,C1=CC=C2C(=C1)C(=NN=C2NN)NN,484-23-1,Positive,in vitro
DIHYDROSAFROLE,CCCC1=CC2=C(C=C1)OCO2,94-58-6,Positive,In vivo
dihydroxy(dioxo)chromium,O[Cr](=O)(=O)O,7738-94-5,Positive,in vitro
Dihydroxyindoline HBr          COLIPA A147,C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(NC2=O)N,118-00-3,Negative,in vitro
diiodomercury,I[Hg]I,7774-29-0,Negative,in vitro
Diisobutyl phthalate (DIBP),CC(C)COC(=O)C1=CC=CC=C1C(=O)OCC(C)C,84-69-5,Negative,In vivo
DIISONONYL PHTHALATE,CC(C)CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC(C)C,68515-48-0,Positive,In vivo
Diisononyl phthalate (DINP),CC(C)CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC(C)C,28553-12-0,Negative,In vivo
Diisopropyl methylphosphonate (DIMP),CC(C)OP(=O)(C)OC(C)C,1445-75-6,Negative,In vivo
Diisopropylcarbodiimide,CC(C)N=C=NC(C)C,693-13-0,Negative,in vitro
Dimethachlor,ClCC(=O)N(CCOC)c1c(C)cccc1C,50563-36-5,Negative,in vivo
Dimethachlor,ClCC(=O)N(CCOC)c1c(C)cccc1C,50563-36-5,Negative,in vitro
Dimethipin,CC1=C(S(=O)(=O)CCS1(=O)=O)C,55290-64-7,Negative,In vivo
Dimethoate,CNC(=O)CSP(=S)(OC)OC,60-51-5,Negative,in vivo
Dimethoate,CNC(=O)CSP(=S)(OC)OC,60-51-5,Positive,in vivo
Dimethoate,CNC(=O)CSP(=S)(OC)OC,60-51-5,Negative,in vitro
"Dimethoate [AKA phosphorodithioic acid,o,o-dimethyl ester,S-ester with 2-mercapto-N-methylacetamide]",CNC(=O)CSP(=S)(OC)OC,60-51-5,Positive,in vitro
Dimethomorph,COC1=C(C=C(C=C1)/C(=C/C(=O)N2CCOCC2)/C3=CC=C(C=C3)Cl)OC,110488-70-5,Negative,in vivo
Dimethomorph,COC1=C(C=C(C=C1)/C(=C/C(=O)N2CCOCC2)/C3=CC=C(C=C3)Cl)OC,110488-70-5,Negative,in vitro
DIMETHOXANE,CC1CC(OC(O1)C)OC(=O)C,828-00-2,Positive,In vivo
"Dimethoxane, commercial grade [AKA acetic acid ester with 2,6-dimethyl-m-dioxan-4-ol]",CC1CC(OC(O1)C)OC(=O)C,828-00-2,Positive,in vitro
dimethoxy-(3-methyl-4-methylsulfanylphenoxy)-sulfanylidene-lambda5-phosphane,CC1=C(C=CC(=C1)OP(=S)(OC)OC)SC,3346,Negative,In Vivo
dimethoxy-(3-methyl-4-methylsulfanylphenoxy)-sulfanylidene-lambda5-phosphane,CC1=C(C=CC(=C1)OP(=S)(OC)OC)SC,55-38-9,Negative,in vitro
dimethoxy-(3-methyl-4-nitrophenoxy)-sulfanylidene-lambda5-phosphane,CC1=C(C=CC(=C1)OP(=S)(OC)OC)[N+](=O)[O-],122-14-5,Negative,in vivo
dimethoxy-(3-methyl-4-nitrophenoxy)-sulfanylidene-lambda5-phosphane,CC1=C(C=CC(=C1)OP(=S)(OC)OC)[N+](=O)[O-],122-14-5,Negative,in vitro
dimethoxy-(4-nitrophenoxy)-sulfanylidene-lambda5-phosphane,COP(=S)(OC)OC1=CC=C(C=C1)[N+](=O)[O-],4130,Negative,In Vivo
dimethoxy-(4-nitrophenoxy)-sulfanylidene-lambda5-phosphane,COP(=S)(OC)OC1=CC=C(C=C1)[N+](=O)[O-],298-00-0,Negative,in vivo
dimethoxy-(4-nitrophenoxy)-sulfanylidene-lambda5-phosphane,COP(=S)(OC)OC1=CC=C(C=C1)[N+](=O)[O-],298-00-0,Negative,in vitro
"dimethoxy-sulfanylidene-(2,4,5-trichlorophenoxy)-lambda5-phosphane",COP(=S)(OC)OC1=CC(=C(C=C1Cl)Cl)Cl,299-84-3,Positive,in vitro
dimethoxy(oxo)phosphanium,CO[P+](=O)OC,6327114,Negative,In Vivo
dimethoxy(oxo)phosphanium,CO[P+](=O)OC,6327114,Positive,In Vivo
dimethyl [(E)-4-(methylamino)-4-oxobut-2-en-2-yl] phosphate,C/C(=C\C(=O)NC)/OP(=O)(OC)OC,6923-22-4,Negative,in vitro
"dimethyl 2,3,5,6-tetrachlorobenzene-1,4-dicarboxylate",COC(=O)C1=C(C(=C(C(=C1Cl)Cl)C(=O)OC)Cl)Cl,2943,Negative,In Vivo
"dimethyl 2,3,5,6-tetrachlorobenzene-1,4-dicarboxylate",COC(=O)C1=C(C(=C(C(=C1Cl)Cl)C(=O)OC)Cl)Cl,2943,Positive,In Vivo
"dimethyl benzene-1,4-dicarboxylate",COC(=O)C1=CC=C(C=C1)C(=O)OC,8441,Negative,In Vivo
"dimethyl benzene-1,4-dicarboxylate",COC(=O)C1=CC=C(C=C1)C(=O)OC,120-61-6,Negative,in vivo
"dimethyl benzene-1,4-dicarboxylate",COC(=O)C1=CC=C(C=C1)C(=O)OC,120-61-6,Negative,in vitro
Dimethyl hydrogen phosphite,CO[P+](=O)OC,868-85-9,Positive,in vitro
Dimethyl phthalate,COC(=O)C1=CC=CC=C1C(=O)OC,0131-11-3,Negative,In vivo
dimethyl sulfate,COS(=O)(=O)OC,77-78-1,Positive,in vivo
Dimethyl sulfate,COS(=O)(=O)OC,77-78-1,Negative,In vivo
dimethyl sulfate,COS(=O)(=O)OC,6497,Positive,In Vivo
dimethyl sulfate,COS(=O)(=O)OC,77-78-1,Negative,in vitro
Dimethyl terephthalate,COC(=O)C1=CC=C(C=C1)C(=O)OC,120-61-6,Negative,in vitro
Dimethyl terephthalate (DMT),COC(=O)C1=CC=C(C=C1)C(=O)OC,120-61-6,Negative,In vivo
"dimethyl-[2-[[(6E)-6-[(1-methyl-5-nitro-1H-imidazol-1-ium-2-yl)methylidene]-5-oxo-7,8-dihydronaphthalen-2-yl]oxy]ethyl]azanium;sulfate",C[NH+]1C(=CN=C1/C=C/2\CCC3=C(C2=O)C=CC(=C3)OCC[NH+](C)C)[N+](=O)[O-].[O-]S(=O)(=O)[O-],,Positive,in vitro
"dimethyl-[2-[[(6E)-6-[(1-methyl-5-nitroimidazol-2-yl)methylidene]-5-oxo-7,8-dihydronaphthalen-2-yl]oxy]ethyl]azanium;hydrogen sulfate",CN1C(=CN=C1/C=C/2\CCC3=C(C2=O)C=CC(=C3)OCC[NH+](C)C)[N+](=O)[O-].OS(=O)(=O)[O-],,Positive,in vitro
dimethyl-[2-[pyridin-2-yl(thiophen-3-ylmethyl)amino]ethyl]azanium;chloride,C[NH+](C)CCN(CC1=CSC=C1)C2=CC=CC=N2.[Cl-],13734,Negative,In Vivo
DIMETHYLACETAMIDE,CC(=O)N(C)C,127-19-5,Negative,In vivo
Dimethylamine,CNC,124-40-3,Negative,In vivo
"DIMETHYLAMINOETHYLNITROSOETHYLUREA, NITRITE SALT",CC[NH2+]C(=O)N(CCN(C)C)C=O.N(=O)[O-],142713-78-8,Positive,In vivo
Dimethylaniline,CN(C)C1=CC=CC=C1,121-69-7,Negative,In vivo
dimethylarsinic acid,C[As](=O)(C)O,2513,Negative,In Vivo
DIMETHYLARSINIC ACID,C[As](=O)(C)O,75-60-5,Negative,In vivo
dimethylarsinic acid,C[As](=O)(C)O,2513,Positive,In Vivo
DIMETHYLARSINIC ACID,C[As](=O)(C)O,75-60-5,Positive,In vivo
dimethylarsinic acid,C[As](=O)(C)O,75-60-5,Negative,in vitro
dimethylarsorylmethane,C[As](=O)(C)C,104930,Positive,In Vivo
Dimethylbenzidine,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)C)N,119-93-7,Negative,In vivo
"dimethylcarbamothioyl N,N-dimethylcarbamodithioate",CN(C)C(=S)SC(=S)N(C)C,97-74-5,Positive,in vitro
"dimethylcarbamothioylsulfanyl N,N-dimethylcarbamodithioate",CN(C)C(=S)SSC(=S)N(C)C,5455,Negative,In Vivo
"dimethylcarbamothioylsulfanyl N,N-dimethylcarbamodithioate",CN(C)C(=S)SSC(=S)N(C)C,137-26-8,Positive,in vitro
Dimethylcarbamoyl chloride,CN(C)C(=O)Cl,79-44-7,Positive,in vitro
DIMETHYLCARBAMYL CHLORIDE,CN(C)C(=O)Cl,79-44-7,Positive,In vivo
"DIMETHYLDITHIOCARBAMIC ACID, DIMETHYLAMINE",CNC.CN(C)C(=S)S,598-64-1,Negative,In vivo
DIMETHYLFORMAMIDE,CN(C)C=O,68-12-2,Negative,In vivo
Dimethylformamide,CN(C)C=O,68-12-2,Negative,in vitro
DIMETHYLNITRAMINE,CN(C)[N+](=O)[O-],4164-28-7,Positive,In vivo
Dimethylnitramine,CN(C)[N+](=O)[O-],4164-28-7,Positive,in vitro
Dimethylphenol,CC1=C(C(=CC=C1)O)C,95-65-8,Negative,In vivo
Dimethylphenol,CC1=C(C(=CC=C1)O)C,576-26-1,Negative,In vivo
Dimethylphenol,CC1=C(C(=CC=C1)O)C,105-67-9,Negative,In vivo
Dimethylsulfate,COS(=O)(=O)OC,77-78-1,Positive,in vitro
DIMETHYLTHIOUREA,CNC(=S)NC,61805-96-7,Negative,In vivo
Dimethylvinyl chloride,CC(=CCl)C,513-37-1,Negative,in vitro
Dimoxystrobin,CC1=CC(=C(C=C1)C)OCC2=CC=CC=C2C(=NOC)C(=O)NC,149961-52-4,Negative,in vivo
Dimoxystrobin,CC1=CC(=C(C=C1)C)OCC2=CC=CC=C2C(=NOC)C(=O)NC,149961-52-4,Negative,in vitro
Dinitro-o-cyclohexyl phenol,C1CCC(CC1)C2=C(C(=CC(=C2)[N+](=O)[O-])[N+](=O)[O-])O,131-89-5,Negative,In vivo
"DINITRO(1-METHYLHEPTYL)PHENYL CROTONATE, COMMERCIAL GRADE (78%)",CCCCCCC(C)C1=C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])OC(=O)C=CC,6119-92-2,Negative,In vivo
Dinitrobenzene,C1=CC(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-],99-65-0,Negative,In vivo
Dinitrobenzene,C1=CC(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-],528-29-0,Negative,In vivo
Dinitrophenol,C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])O,51-28-5,Negative,In vivo
DINITROSOCAFFEIDINE,CN1C=NC(=C1C(=O)N(C)N=O)N(C)N=O,145438-97-7,Positive,In vivo
DINITROSOHOMOPIPERAZINE,C1CN(CCN(C1)N=O)N=O,55557-00-1,Positive,In vivo
Dinitrosohomopiperazine,C1CN(CCN(C1)N=O)N=O,55557-00-1,Positive,in vitro
DINITROSOPIPERAZINE,C1CN(CCN1N=O)N=O,140-79-4,Positive,In vivo
Dinitrosopiperazine,C1CN(CCN1N=O)N=O,140-79-4,Positive,in vitro
Dinitrotoluene,CC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],121-14-2,Negative,In vivo
Dinitrotoluene mixture,CC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],121-14-2,Positive,In vivo
"Dinitrotoluene, technical grade",CC1=C(C(=CC=C1)[N+](=O)[O-])[N+](=O)[O-],25321-14-6,Positive,in vitro
"DINITROTOLUENE, TECHNICAL GRADE (2,4 (77%)- and 2,6 (19%)-)",CC1=C(C(=CC=C1)[N+](=O)[O-])[N+](=O)[O-],25321-14-6,Positive,In vivo
Dinocap,CCCCCCC(C)C1=C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])OC(=O)/C=C/C ,39300-45-3,Negative,in vitro
Dinoseb,CCC(C)C1=C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])O,88-85-7,Negative,In vivo
Dioxane,C1COCCO1,123-91-1,Positive,In vivo
"Dioxathion [AKA phosphorodithioic acid, S,S'-p-dioxane-2,3-diyl-O,O,O',O'-tetraethyl ester]",CCOP(=S)(OCC)SC1C(OCCO1)SP(=S)(OCC)OCC,78-34-2,Negative,in vitro
dioxido(dioxo)chromium;lead(2+),[O-][Cr](=O)(=O)[O-].[Pb+2],7758-97-6,Positive,in vivo
dioxido(dioxo)chromium;lead(2+),[O-][Cr](=O)(=O)[O-].[Pb+2],24460,Positive,In Vivo
dioxido(dioxo)chromium;lead(2+),[O-][Cr](=O)(=O)[O-].[Pb+2],7758-97-6,Positive,in vitro
dioxido(dioxo)chromium;nickel(2+),[O-][Cr](=O)(=O)[O-].[Ni+2],61767,Negative,In Vivo
dioxosilane,O=[Si]=O,24261,Negative,In Vivo
dioxosilane,O=[Si]=O,24261,Positive,In Vivo
dioxosilane;oxo(oxoalumanyloxy)alumane,O=[Al]O[Al]=O.O=[Si]=O,9942228,Positive,In Vivo
dioxotitanium,O=[Ti]=O,26042,Negative,In Vivo
dioxotitanium,O=[Ti]=O,13463-67-7,Negative,in vivo
dioxotitanium,O=[Ti]=O,26042,Positive,In Vivo
dioxotitanium,O=[Ti]=O,13463-67-7,Negative,in vitro
dioxovanadiooxy(dioxo)vanadium,O=[V](=O)O[V](=O)=O,14814,Positive,In Vivo
dioxovanadiooxy(dioxo)vanadium,O=[V](=O)O[V](=O)=O,14814,Negative,In Vivo
dioxovanadiooxy(dioxo)vanadium,O=[V](=O)O[V](=O)=O,1314-62-1,Positive,in vitro
dioxovanadiooxy(dioxo)vanadium,O=[V](=O)O[V](=O)=O,1314-62-1,Negative,In vivo
dioxovanadiooxy(dioxo)vanadium,O=[V](=O)O[V](=O)=O,1314-62-1,Negative,in vitro
dioxozirconium,O=[Zr]=O,62395,Positive,In Vivo
DIPENTAMETHYLENETHIURAM HEXASULFIDE,C1CCN(CC1)C(=S)SSSSSSC(=S)N2CCCCC2,971-15-3,Negative,In vivo
DIPENTYLNITROSAMINE,CCCCCN(CCCCC)N=O,13256-06-9,Positive,In vivo
Diphenamid,CN(C)C(=O)C(C1=CC=CC=C1)C2=CC=CC=C2,957-51-7,Negative,In vivo
DIPHENHYDRAMINE.HCl,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl,147-24-0,Negative,In vivo
Diphenyl diselenide,C1=CC=C(C=C1)[Se][Se]C2=CC=CC=C2,1666-13-3,Positive,in vitro
DIPHENYL-p-PHENYLENEDIAMINE,C1=CC=C(C=C1)NC2=CC=C(C=C2)NC3=CC=CC=C3,74-31-7,Negative,In vivo
Diphenyl-p-phenylenediamine,C1=CC=C(C=C1)NC2=CC=C(C=C2)NC3=CC=CC=C3,74-31-7,Positive,in vitro
DIPHENYLACETONITRILE,C1=CC=C(C=C1)C(C#N)C2=CC=CC=C2,86-29-3,Negative,In vivo
Diphenylamine,C1=CC=C(C=C1)NC2=CC=CC=C2,122-39-4,Negative,in vivo
Diphenylamine,C1=CC=C(C=C1)NC2=CC=CC=C2,122-39-4,Negative,in vitro
DIPHENYLCARBONATE,C1=CC=C(C=C1)OC(=O)OC2=CC=CC=C2,102-09-0,Negative,In vivo
diphenyldiazene,C1=CC=C(C=C1)N=NC2=CC=CC=C2,2272,Negative,In Vivo
diphenyldiazene,C1=CC=C(C=C1)N=NC2=CC=CC=C2,103-33-3,Positive,in vivo
diphenyldiazene,C1=CC=C(C=C1)N=NC2=CC=CC=C2,2272,Positive,In Vivo
diphenyldiazene,C1=CC=C(C=C1)N=NC2=CC=CC=C2,103-33-3,Positive,in vitro
Diphenylhydrazine,C1=CC=C(C=C1)NNC2=CC=CC=C2,122-66-7,Positive,In vivo
diphenylmethanone,C1=CC=C(C=C1)C(=O)C2=CC=CC=C2,3102,Positive,In Vivo
diphenylmethanone,C1=CC=C(C=C1)C(=O)C2=CC=CC=C2,119-61-9,Negative,in vitro
"dipotassium;2,3,4,5-tetrachloro-6-(2,4,5,7-tetraiodo-3-oxido-6-oxoxanthen-9-yl)benzoate",C1=C2C(=C3C=C(C(=O)C(=C3OC2=C(C(=C1I)[O-])I)I)I)C4=C(C(=C(C(=C4Cl)Cl)Cl)Cl)C(=O)[O-].[K+].[K+],11121-48-5,Negative,in vitro
"dipotassium;2',4',5',7'-tetrabromo-4,7-dichloro-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate",C1=CC(=C2C(=C1Cl)C(=O)OC23C4=CC(=C(C(=C4OC5=C(C(=C(C=C35)Br)[O-])Br)Br)[O-])Br)Cl.[K+].[K+],6441-77-6,Negative,in vitro
dipotassium;dioxido(dioxo)chromium,[O-][Cr](=O)(=O)[O-].[K+].[K+],7789-00-6,Positive,in vitro
dipotassium;dioxido(dioxo)molybdenum;pentahydrate,O.O.O.O.O.[O-][Mo](=O)(=O)[O-].[K+].[K+],7790-55-8,Positive,in vitro
dipotassium;oxalate;oxotitanium(2+),C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].O=[Ti+2].[K+].[K+],56841016,Negative,In Vivo
dipotassium;oxido-(oxido(dioxo)chromio)oxy-dioxochromium,[O-][Cr](=O)(=O)O[Cr](=O)(=O)[O-].[K+].[K+],7778-50-9,Positive,in vitro
dipotassium;selenate,[O-][Se](=O)(=O)[O-].[K+].[K+],7790-59-2,Negative,in vitro
dipotassium;selenite,[O-][Se](=O)[O-].[K+].[K+],10431-47-7,Negative,in vitro
dipotassium;tellurate,[O-][Te](=O)(=O)[O-].[K+].[K+],15571-91-2,Negative,in vitro
dipropoxyphosphinothioyloxy-dipropoxy-sulfanylidene-lambda5-phosphane,CCCOP(=S)(OCCC)OP(=S)(OCCC)OCCC,3244-90-4,Negative,in vitro
DIPYRONE,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+],68-89-3,Positive,In vivo
DIPYRONE,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+],68-89-3,Negative,In vivo
Diquat,C1C[N+]2=CC=CC=C2C3=CC=CC=[N+]31,85-00-7,Negative,in vivo
Diquat,C1C[N+]2=CC=CC=C2C3=CC=CC=[N+]31,2764-72-9,Negative,In vivo
Diquat,C1C[N+]2=CC=CC=C2C3=CC=CC=[N+]31,85-00-7,Negative,in vitro
DISODIUM 5'-RIBONUCLEOTIDE,C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)([O-])[O-])O)O.C1=NC2=C(N1C3C(C(C(O3)COP(=O)([O-])[O-])O)O)N=C(NC2=O)N.[Na+].[Na+].[Na+].[Na+],80702-47-2,Negative,In vivo
Disodium phosphonate,[O-]P(=O)=O.[Na+].[Na+],13708-85-5,Negative,in vivo
Disodium phosphonate,[O-]P(=O)=O.[Na+].[Na+],13708-85-5,Negative,in vitro
"disodium;(1R,2S,3R,4S)-7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylate",C1C[C@H]2[C@@H]([C@@H]([C@@H]1O2)C(=O)[O-])C(=O)[O-].[Na+].[Na+],44318676,Positive,In Vivo
"disodium;(1R,2S,3R,4S)-7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylate",C1C[C@H]2[C@@H]([C@@H]([C@@H]1O2)C(=O)[O-])C(=O)[O-].[Na+].[Na+],44318676,Negative,In Vivo
"disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate",C1=CC=C2C(=C1)C(=O)OC23C4=CC(=C(C=C4OC5=C(C(=C(C=C35)Br)[O-])[Hg])[O-])Br.O.[Na+].[Na+],,Positive,in vitro
"disodium;(2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate",C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)[O-])O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)[O-])O)O)O)C)(C)C(=O)[O-].[Na+].[Na+],118984432,Negative,In Vivo
"disodium;(6Z)-4-amino-3-[[4-[4-[(2,4-diaminophenyl)diazenyl]phenyl]phenyl]diazenyl]-5-oxo-6-(phenylhydrazinylidene)naphthalene-2,7-disulfonate",C1=CC=C(C=C1)N/N=C/2\C(=CC3=CC(=C(C(=C3C2=O)N)N=NC4=CC=C(C=C4)C5=CC=C(C=C5)N=NC6=C(C=C(C=C6)N)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],5359662,Positive,In Vivo
"disodium;(6Z)-4-amino-3-[[4-[4-[(2,4-diaminophenyl)diazenyl]phenyl]phenyl]diazenyl]-5-oxo-6-(phenylhydrazinylidene)naphthalene-2,7-disulfonate",C1=CC=C(C=C1)N/N=C/2\C(=CC3=CC(=C(C(=C3C2=O)N)N=NC4=CC=C(C=C4)C5=CC=C(C=C5)N=NC6=C(C=C(C=C6)N)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,Positive,in vivo
"disodium;(6Z)-4-amino-3-[[4-[4-[(2,4-diaminophenyl)diazenyl]phenyl]phenyl]diazenyl]-5-oxo-6-(phenylhydrazinylidene)naphthalene-2,7-disulfonate",C1=CC=C(C=C1)N/N=C/2\C(=CC3=CC(=C(C(=C3C2=O)N)N=NC4=CC=C(C=C4)C5=CC=C(C=C5)N=NC6=C(C=C(C=C6)N)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,Negative,in vitro
"disodium;[2-(3,4-dihydroxyphenyl)-4-oxo-5-sulfonatooxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-7-yl] sulfate",C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=C(C3=O)C(=CC(=C4)OS(=O)(=O)[O-])OS(=O)(=O)[O-])C5=CC(=C(C=C5)O)O)O)O)O)O)O)O.[Na+].[Na+],76958463,Negative,In Vivo
"disodium;2-(2,4,5,7-tetrabromo-3-oxido-6-oxoxanthen-9-yl)benzoate",C1=CC=C(C(=C1)C2=C3C=C(C(=O)C(=C3OC4=C(C(=C(C=C24)Br)[O-])Br)Br)Br)C(=O)[O-].[Na+].[Na+],548-26-5,Negative,in vitro
disodium;2-(3-hydroxy-5-sulfonato-1H-indol-2-yl)-3-oxoindole-5-sulfonate,C1=CC2=C(C=C1S(=O)(=O)[O-])C(=C(N2)C3=NC4=C(C3=O)C=C(C=C4)S(=O)(=O)[O-])O.[Na+].[Na+],2723854,Negative,In Vivo
disodium;2-(3-hydroxy-5-sulfonato-1H-indol-2-yl)-3-oxoindole-5-sulfonate,C1=CC2=C(C=C1S(=O)(=O)[O-])C(=C(N2)C3=NC4=C(C3=O)C=C(C=C4)S(=O)(=O)[O-])O.[Na+].[Na+],2723854,Positive,In Vivo
disodium;2-(3-hydroxy-5-sulfonato-1H-indol-2-yl)-3-oxoindole-5-sulfonate,C1=CC2=C(C=C1S(=O)(=O)[O-])C(=C(N2)C3=NC4=C(C3=O)C=C(C=C4)S(=O)(=O)[O-])O.[Na+].[Na+],860-22-0,Negative,in vitro
disodium;2-[(Z)-2-[4-[4-[(Z)-2-(2-sulfonatophenyl)ethenyl]phenyl]phenyl]ethenyl]benzenesulfonate,C1=CC=C(C(=C1)/C=C\C2=CC=C(C=C2)C3=CC=C(C=C3)/C=C\C4=CC=CC=C4S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],60317-04-06,Negative,in vivo
"disodium;2-[[4-[ethyl-[(3-sulfonatophenyl)methyl]amino]phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]-5-hydroxybenzenesulfonate",CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=C(C=C(C=C5)O)S(=O)(=O)[O-].[Na+].[Na+],16887,Negative,In Vivo
"disodium;2-[[4-[ethyl-[(3-sulfonatophenyl)methyl]amino]phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]-5-hydroxybenzenesulfonate",CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=C(C=C(C=C5)O)S(=O)(=O)[O-].[Na+].[Na+],16887,Positive,In Vivo
"disodium;2-[[4-[ethyl-[(3-sulfonatophenyl)methyl]amino]phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]-5-hydroxybenzenesulfonate",CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=C(C=C(C=C5)O)S(=O)(=O)[O-].[Na+].[Na+],2353-45-9,Negative,in vitro
"disodium;2-[[4-[ethyl-[(3-sulfonatophenyl)methyl]amino]phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]benzenesulfonate",CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=CC=CC=C5S(=O)(=O)[O-].[Na+].[Na+],19700,Negative,In Vivo
"disodium;2-[[4-[ethyl-[(3-sulfonatophenyl)methyl]amino]phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]benzenesulfonate",CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=CC=CC=C5S(=O)(=O)[O-].[Na+].[Na+],19700,Positive,In Vivo
disodium;2-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate,C(CN(CC(=O)O)CC(=O)[O-])N(CC(=O)O)CC(=O)[O-].[Na+].[Na+],139-33-3,Negative,in vitro
disodium;2-amino-5-[(E)-2-(4-amino-2-sulfonatophenyl)ethenyl]benzenesulfonate,C1=CC(=C(C=C1/C=C/C2=C(C=C(C=C2)N)S(=O)(=O)[O-])S(=O)(=O)[O-])N.[Na+].[Na+],6433499,Negative,In Vivo
"disodium;2',4',5',7'-tetrabromo-4,5,6,7-tetrachloro-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate",C1=C2C(=C(C(=C1Br)[O-])Br)OC3=C(C(=C(C=C3C24C5=C(C(=C(C(=C5Cl)Cl)Cl)Cl)C(=O)O4)Br)[O-])Br.[Na+].[Na+],6433718,Negative,In Vivo
"disodium;2',4',5',7'-tetraiodo-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate",C1=CC=C2C(=C1)C(=O)OC23C4=CC(=C(C(=C4OC5=C(C(=C(C=C35)I)[O-])I)I)[O-])I.[Na+].[Na+],12961638,Negative,In Vivo
"disodium;2',4',5',7'-tetraiodo-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate",C1=CC=C2C(=C1)C(=O)OC23C4=CC(=C(C(=C4OC5=C(C(=C(C=C35)I)[O-])I)I)[O-])I.[Na+].[Na+],12961638,Positive,In Vivo
"disodium;2',4',5',7'-tetraiodo-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate",C1=CC=C2C(=C1)C(=O)OC23C4=CC(=C(C(=C4OC5=C(C(=C(C=C35)I)[O-])I)I)[O-])I.[Na+].[Na+],16423-68-0,Negative,in vitro
"disodium;3-[(2,4-dimethyl-5-sulfonatophenyl)diazenyl]-4-hydroxynaphthalene-1-sulfonate",CC1=CC(=C(C=C1N=NC2=C(C3=CC=CC=C3C(=C2)S(=O)(=O)[O-])O)S(=O)(=O)[O-])C.[Na+].[Na+],62542,Negative,In Vivo
"disodium;3-[(2,4-dimethyl-5-sulfonatophenyl)diazenyl]-4-hydroxynaphthalene-1-sulfonate",CC1=CC(=C(C=C1N=NC2=C(C3=CC=CC=C3C(=C2)S(=O)(=O)[O-])O)S(=O)(=O)[O-])C.[Na+].[Na+],4548-53-2,Negative,in vitro
"disodium;3-[[N-ethyl-4-[[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]-(4-sulfonatophenyl)methyl]anilino]methyl]benzenesulfonate",CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=CC=C(C=C5)S(=O)(=O)[O-].[Na+].[Na+],5141-20-8,Negative,in vitro
"disodium;3-hydroxy-4-[(2,4,5-trimethylphenyl)diazenyl]naphthalene-2,7-disulfonate",CC1=CC(=C(C=C1C)N=NC2=C3C=CC(=CC3=CC(=C2O)S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+],3564-09-08,Positive,in vivo
"disodium;3-hydroxy-4-[(2,4,5-trimethylphenyl)diazenyl]naphthalene-2,7-disulfonate",CC1=CC(=C(C=C1C)N=NC2=C3C=CC(=CC3=CC(=C2O)S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+],19095,Positive,In Vivo
"disodium;3-hydroxy-4-[(2,4,5-trimethylphenyl)diazenyl]naphthalene-2,7-disulfonate",CC1=CC(=C(C=C1C)N=NC2=C3C=CC(=CC3=CC(=C2O)S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+],3564-09-08,Negative,in vitro
"disodium;3-hydroxy-4-nitrosonaphthalene-2,7-disulfonate",C1=CC2=C(C(=C(C=C2C=C1S(=O)(=O)[O-])S(=O)(=O)[O-])O)N=O.[Na+].[Na+],0525-05-03,Negative,in vitro
"disodium;4-[(2,4-dimethylphenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonate",CC1=CC(=C(C=C1)N=NC2=C3C=CC(=CC3=CC(=C2O)S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+],2724065,Positive,In Vivo
"disodium;4-[(2,4-dimethylphenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonate",CC1=CC(=C(C=C1)N=NC2=C3C=CC(=CC3=CC(=C2O)S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+],3761-53-3,Positive,in vivo
"disodium;4-[(2,4-dimethylphenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonate",CC1=CC(=C(C=C1)N=NC2=C3C=CC(=CC3=CC(=C2O)S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+],3761-53-3,Negative,in vitro
"disodium;4-[3-(diethylamino)-6-diethylazaniumylidenexanthen-9-yl]benzene-1,3-dicarboxylate;chloride",CCN(CC)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](CC)CC)C=C3O2)C4=C(C=C(C=C4)C(=O)[O-])C(=O)[O-].[Na+].[Na+].[Cl-],37299-86-8,Negative,in vitro
"disodium;4-amino-3-hydroxynaphthalene-2,7-disulfonate",C1=CC2=C(C(=C(C=C2C=C1S(=O)(=O)[O-])S(=O)(=O)[O-])O)N.[Na+].[Na+],,Negative,in vivo
disodium;4-hydroxy-3-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-1-sulfonate,C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C(C4=CC=CC=C4C(=C3)S(=O)(=O)[O-])O.[Na+].[Na+],19118,Negative,In Vivo
disodium;4-hydroxy-3-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-1-sulfonate,C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C(C4=CC=CC=C4C(=C3)S(=O)(=O)[O-])O.[Na+].[Na+],3567-69-9,Negative,in vivo
disodium;4-hydroxy-3-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-1-sulfonate,C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C(C4=CC=CC=C4C(=C3)S(=O)(=O)[O-])O.[Na+].[Na+],3567-69-9,Negative,in vitro
"disodium;5-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-[(E)-2-[4-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-sulfonatophenyl]ethenyl]benzenesulfonate",C1COCCN1C2=NC(=NC(=N2)NC3=CC(=C(C=C3)/C=C/C4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6)N7CCOCC7)S(=O)(=O)[O-])S(=O)(=O)[O-])NC8=CC=CC=C8.[Na+].[Na+],,Negative,in vivo
"disodium;5-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-[(E)-2-[4-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-sulfonatophenyl]ethenyl]benzenesulfonate",C1COCCN1C2=NC(=NC(=N2)NC3=CC(=C(C=C3)/C=C/C4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6)N7CCOCC7)S(=O)(=O)[O-])S(=O)(=O)[O-])NC8=CC=CC=C8.[Na+].[Na+],,Negative,in vitro
"disodium;5-[[4-anilino-6-[2-hydroxyethyl(methyl)amino]-1,3,5-triazin-2-yl]amino]-2-[(E)-2-[4-[[4-anilino-6-[2-hydroxyethyl(methyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfonatophenyl]ethenyl]benzenesulfonate",CN(CCO)C1=NC(=NC(=N1)NC2=CC(=C(C=C2)/C=C/C3=C(C=C(C=C3)NC4=NC(=NC(=N4)NC5=CC=CC=C5)N(C)CCO)S(=O)(=O)[O-])S(=O)(=O)[O-])NC6=CC=CC=C6.[Na+].[Na+],13863-31-5,Negative,in vivo
"disodium;5,7-dinitro-8-oxidonaphthalene-2-sulfonate",C1=CC2=C(C=C1S(=O)(=O)[O-])C(=C(C=C2[N+](=O)[O-])[N+](=O)[O-])[O-].[Na+].[Na+],2724063,Negative,In Vivo
disodium;6-hydroxy-5-[(2-methoxy-5-methyl-4-sulfonatophenyl)diazenyl]naphthalene-2-sulfonate,CC1=CC(=C(C=C1S(=O)(=O)[O-])OC)N=NC2=C(C=CC3=C2C=CC(=C3)S(=O)(=O)[O-])O.[Na+].[Na+],33258,Negative,In Vivo
disodium;6-hydroxy-5-[(2-methoxy-5-methyl-4-sulfonatophenyl)diazenyl]naphthalene-2-sulfonate,CC1=CC(=C(C=C1S(=O)(=O)[O-])OC)N=NC2=C(C=CC3=C2C=CC(=C3)S(=O)(=O)[O-])O.[Na+].[Na+],25956-17-6,Negative,in vitro
disodium;6-hydroxy-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate,C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C(C=CC4=C3C=CC(=C4)S(=O)(=O)[O-])O.[Na+].[Na+],2302-96-7,Negative,in vitro
disodium;6-hydroxy-5-[(4-sulfonatophenyl)diazenyl]naphthalene-2-sulfonate,C1=CC(=CC=C1N=NC2=C(C=CC3=C2C=CC(=C3)S(=O)(=O)[O-])O)S(=O)(=O)[O-].[Na+].[Na+],17730,Negative,In Vivo
disodium;6-hydroxy-5-[(4-sulfonatophenyl)diazenyl]naphthalene-2-sulfonate,C1=CC(=CC=C1N=NC2=C(C=CC3=C2C=CC(=C3)S(=O)(=O)[O-])O)S(=O)(=O)[O-].[Na+].[Na+],2783-94-0,Negative,in vivo
disodium;6-hydroxy-5-[(4-sulfonatophenyl)diazenyl]naphthalene-2-sulfonate,C1=CC(=CC=C1N=NC2=C(C=CC3=C2C=CC(=C3)S(=O)(=O)[O-])O)S(=O)(=O)[O-].[Na+].[Na+],2783-94-0,Negative,in vitro
"disodium;7-hydroxy-8-[[2-methyl-4-[3-methyl-4-[[4-(4-methylphenyl)sulfonyloxyphenyl]diazenyl]phenyl]phenyl]diazenyl]naphthalene-1,3-disulfonate",CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)N=NC3=C(C=C(C=C3)C4=CC(=C(C=C4)N=NC5=C(C=CC6=CC(=CC(=C65)S(=O)(=O)[O-])S(=O)(=O)[O-])O)C)C.[Na+].[Na+],22960,Positive,In Vivo
"disodium;7-hydroxy-8-phenyldiazenylnaphthalene-1,3-disulfonate",C1=CC=C(C=C1)N=NC2=C(C=CC3=CC(=CC(=C32)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+],16015,Negative,In Vivo
disodium;butanedioate,C(CC(=O)[O-])C(=O)[O-].[Na+].[Na+],9020,Negative,In Vivo
disodium;decanedioate,C(CCCCC(=O)[O-])CCCC(=O)[O-].[Na+].[Na+],134734,Negative,In Vivo
disodium;dioxido-oxo-sulfanylidene-lambda6-sulfane,[O-]S(=O)(=S)[O-].[Na+].[Na+],7772-98-7,Negative,in vitro
disodium;dioxido(dioxo)chromium,[O-][Cr](=O)(=O)[O-].[Na+].[Na+],7775-11-3,Positive,in vitro
disodium;dioxido(oxo)tin,[O-][Sn](=O)[O-].[Na+].[Na+],12058-66-1,Negative,in vitro
disodium;hydrogen arsorate,O[As](=O)([O-])[O-].[Na+].[Na+],24500,Negative,In Vivo
disodium;hydrogen arsorate,O[As](=O)([O-])[O-].[Na+].[Na+],7778-43-0,Positive,in vitro
disodium;hydrogen arsorate;heptahydrate,O.O.O.O.O.O.O.O[As](=O)([O-])[O-].[Na+].[Na+],10048-95-0,Positive,in vitro
disodium;methyl-dioxido-oxo-lambda5-arsane,C[As](=O)([O-])[O-].[Na+].[Na+],144-21-8,Negative,in vitro
disodium;N-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate,C(CNC(=S)[S-])NC(=S)[S-].[Na+].[Na+],142-59-6,Positive,in vitro
disodium;oxido-(oxido(dioxo)chromio)oxy-dioxochromium,[O-][Cr](=O)(=O)O[Cr](=O)(=O)[O-].[Na+].[Na+],10588-01-09,Positive,in vitro
disodium;oxido-(oxido(dioxo)chromio)oxy-dioxochromium;dihydrate,O.O.[O-][Cr](=O)(=O)O[Cr](=O)(=O)[O-].[Na+].[Na+],108005,Positive,In Vivo
disodium;oxido-(oxido(dioxo)chromio)oxy-dioxochromium;dihydrate,O.O.[O-][Cr](=O)(=O)O[Cr](=O)(=O)[O-].[Na+].[Na+],7789-12-0,Positive,in vitro
disodium;selenate,[O-][Se](=O)(=O)[O-].[Na+].[Na+],13410-01-0,Positive,in vitro
disodium;selenite,[O-][Se](=O)[O-].[Na+].[Na+],10102-18-8,Positive,in vivo
disodium;selenite,[O-][Se](=O)[O-].[Na+].[Na+],10102-18-8,Positive,in vitro
disodium;selenium(2-),[Na+].[Na+].[Se-2],1313-85-5,Positive,in vitro
disodium;sulfate,[O-]S(=O)(=O)[O-].[Na+].[Na+],7757-82-6,Negative,in vitro
disodium;sulfinato sulfite,[O-]S(=O)OS(=O)[O-].[Na+].[Na+],,Negative,in vitro
disodium;sulfite,[O-]S(=O)[O-].[Na+].[Na+],,Positive,in vitro
disodium;tellurate;pentahydrate,O.O.O.O.O.[O-][Te](=O)(=O)[O-].[Na+].[Na+],,Positive,in vitro
Disperse black 9                 COLIPA C106,C1=CC(=CC=C1N)N=NC2=CC=C(C=C2)N(CCO)CCO,20721-50-0/ 12222-69-4,Positive,in vitro
Disperse red 17/ Cl 11210    COLIPA B5,CC1=C(C=CC(=C1)N(CCO)CCO)N=NC2=CC=C(C=C2)[N+](=O)[O-],3179-89-3,Positive,in vitro
Disperse violet 1/ Cl 61100   COLIPA C64,C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)N)N,128-95-0,Positive,in vitro
Disulfiram Tetraethylthiuram disulfide,CCN(CC)C(=S)SSC(=S)N(CC)CC,97-77-8,Positive,in vitro
Disulfoton,CCOP(=S)(OCC)SCCSCC,0298-04-04,Negative,In vivo
Dithiane,C1CSCCS1,505-29-3,Negative,In vivo
Dithianon,O=C1C2=C(SC(=C(S2)C#N)C#N)C(=O)c3ccccc13,3347-22-6,Negative,in vivo
Dithianon,O=C1C2=C(SC(=C(S2)C#N)C#N)C(=O)c3ccccc13,3347-22-6,Positive,in vivo
Dithianon,O=C1C2=C(SC(=C(S2)C#N)C#N)C(=O)c3ccccc13,3347-22-6,Negative,in vitro
Diuron,CN(C)C(=O)NC1=CC(=C(C=C1)Cl)Cl,330-54-1,Negative,in vivo
Diuron,CN(C)C(=O)NC1=CC(=C(C=C1)Cl)Cl,330-54-1,Positive,in vivo
Diuron,CN(C)C(=O)NC1=CC(=C(C=C1)Cl)Cl,330-54-1,Negative,in vitro
Divinylbenzene-55,C=CC1=CC=CC=C1C=C,1321-74-0,Negative,in vitro
dl-alpha-TOCOPHEROL,CC1=C(C2=C(CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C)C(=C1O)C)C,10191-41-0,Negative,In vivo
dl-alpha-TOCOPHEROL ACETATE,CC1=C(C(=C(C2=C1OC(CC2)(C)CCCC(C)CCCC(C)CCCC(C)C)C)OC(=O)C)C,7695-91-2,Negative,In vivo
dl-ATENOLOL.HCl,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O.Cl,51706-40-2,Negative,In vivo
dl-DIEPOXYBUTANE,C1C(O1)C2CO2,298-18-0,Negative,In vivo
dl-ETHIONINE,CCSCCC(C(=O)O)N,67-21-0,Positive,In vivo
dl-METHIONINE,CSCCC(C(=O)O)N,59-51-8,Negative,In vivo
dl-MONOSODIUM GLUTAMATE,C(CC(=O)[O-])C(C(=O)O)N.[Na+],32221-81-1,Negative,In vivo
"dl-TOCOPHEROL MIXTURE, NATURAL (alpha, beta, gamma and delta)",CC1=C(C=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)O,1406-66-2,Positive,In vivo
dl-TRYPTOPHAN,C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N,54-12-6,Negative,In vivo
dodecylbenzene,CCCCCCCCCCCCC1=CC=CC=C1,31237,Positive,In Vivo
Dodemorph acetate,CC1CN(CC(O1)C)C2CCCCCCCCCCC2.CC(=O)O,31717-87-0,Negative,in vivo
Dodemorph acetate,CC1CN(CC(O1)C)C2CCCCCCCCCCC2.CC(=O)O,31717-87-0,Negative,in vitro
Dodine,CCCCCCCCCCCCN=C(N)N.CC(=O)O,2439-10-3,Negative,in vivo
Dodine,CCCCCCCCCCCCN=C(N)N.CC(=O)O,2439-10-3,Negative,in vitro
DOXEFAZEPAM,C1=CC=C(C(=C1)C2=NC(C(=O)N(C3=C2C=C(C=C3)Cl)CCO)O)F,40762-15-0,Negative,In vivo
Dursban Chlorpyrifos,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl,2921-88-2,Negative,in vitro
EDIFAS B,CC(=O)O.C(C(C(C(C(C=O)O)O)O)O)O.[Na],9004-32-4,Negative,In vivo
EDTA trisodium salt trihydrate,C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)O)CC(=O)[O-].[Na+].[Na+].[Na+],150-38-9,Negative,in vitro
EFONIDIPINE.HCl ETHANOLATE,CCO.CC1=C(C(C(=C(N1)C)P2(=O)OCC(CO2)(C)C)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCN(CC4=CC=CC=C4)C5=CC=CC=C5.Cl,111011-76-8,Negative,In vivo
Ekatin,CCSCCSP(=S)(OC)OC,640-15-3,Positive,in vitro
Emamectin,CCC(C)C1C(C=CC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)[NH2+]C)OC)OC)C)C.C1=CC=C(C=C1)C(=O)[O-],119791-41-2,Negative,in vivo
Emamectin,CCC(C)C1C(C=CC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)[NH2+]C)OC)OC)C)C.C1=CC=C(C=C1)C(=O)[O-],119791-41-2,Negative,in vitro
Emodin,CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)O,518-82-1,Positive,in vitro
ENDOSULFAN,C1C2C(COS(=O)O1)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl,115-29-7,Negative,In vivo
Endothall,C1CC2C(C(C1O2)C(=O)O)C(=O)O,145-73-3,Negative,In vivo
Endrin,C1C2C3C(C1C4C2O4)C5(C(=C(C3(C5(Cl)Cl)Cl)Cl)Cl)Cl,72-20-8,Negative,In vivo
Endrin,C1C2C3C(C1C4C2O4)C5(C(=C(C3(C5(Cl)Cl)Cl)Cl)Cl)Cl,72-20-8,Negative,in vitro
ENFLURANE,C(C(OC(F)F)(F)F)(F)Cl,13838-16-9,Negative,In vivo
ENOVID,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3CCC(=O)C4.CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,8015-30-3,Negative,In vivo
ENOVID,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3CCC(=O)C4.CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,8015-30-3,Positive,In vivo
ENOVID-E,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3CCC(=O)C4.CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,8015-30-3,Negative,In vivo
Ephedrine sulphate/Ephedrine hydrochloride,CC(C(C1=CC=CC=C1)O)NC.Cl,50-98-6,Negative,in vitro
Epichlorhydrin,C1C(O1)CCl,106-89-8,Positive,in vitro
Epichlorohydrin,C1C(O1)CCl,106-89-8,Positive,In vivo
EPICHLOROHYDRIN,C1C(O1)CCl,106-89-8,Negative,In vivo
Epoxiconazole,ClC3=C(C=CC=C3)C1OC(C4=CC=C(F)C=C4)1CN2N=CN=C2,106325-08-0,Negative,in vivo
Epoxiconazole,ClC3=C(C=CC=C3)C1OC(C4=CC=C(F)C=C4)1CN2N=CN=C2,106325-08-0,Negative,in vitro
Epoxybutane (EBU),CCC1CO1,106-88-7,Negative,In vivo
"ERYTHORBATE, SODIUM",C(C(C1C(=C(C(=O)O1)O)[O-])O)O.[Na+],6381-77-7,Negative,In vivo
Erythromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,0114-07-08,Negative,in vitro
Esfenvalerate,CC(C)C(C1=CC=C(C=C1)Cl)C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3,66230-04-4,Negative,in vivo
Esfenvalerate,CC(C)C(C1=CC=C(C=C1)Cl)C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3,66230-04-04,Negative,in vitro
ESTAZOLAM,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,29975-16-4,Negative,In vivo
ESTRAGOLE,COC1=CC=C(C=C1)CC=C,140-67-0,Positive,In vivo
Estragole,COC1=CC=C(C=C1)CC=C,140-67-0,Negative,in vitro
Ethametsulfuron methyl,CCOC1=NC(=NC(=N1)NC(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC)NC,97780-06-8,Negative,in vivo
Ethametsulfuron methyl,CCOC1=NC(=NC(=N1)NC(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC)NC,97780-06-8,Positive,in vivo
Ethametsulfuron methyl,CCOC1=NC(=NC(=N1)NC(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC)NC,97780-06-08,Negative,in vitro
"ethane-1,2-diamine",C(CN)N,3301,Negative,In Vivo
"ethane-1,2-diamine",C(CN)N,107-15-3,Negative,in vitro
"ethane-1,2-diamine;dihydrochloride",C(CN)N.Cl.Cl,9521,Negative,In Vivo
"ethane-1,2-diol",C(CO)O,174,Negative,In Vivo
"ethane-1,2-diol",C(CO)O,107-21-1,Negative,in vitro
ethanethioamide,CC(=S)N,62-55-5,Negative,in vivo
ethanethioamide,CC(=S)N,2723949,Positive,In Vivo
ethanethioamide,CC(=S)N,62-55-5,Positive,in vivo
ethanethioamide,CC(=S)N,62-55-5,Negative,in vitro
ethanol,CCO,702,Negative,In Vivo
ethanol,CCO,64-17-5,Negative,in vivo
ethanol,CCO,702,Positive,In Vivo
ethanol,CCO,64-17-5,Positive,in vivo
ethanol,CCO,64-17-5,Negative,in vitro
ethenoxyethane,CCOC=C,109-92-2,Positive,in vitro
ethenoxyethene,C=COC=C,109-93-3,Positive,in vitro
ethenyl acetate,CC(=O)OC=C,7904,Negative,In Vivo
ethenyl acetate,CC(=O)OC=C,7904,Positive,In Vivo
ethenyl acetate,CC(=O)OC=C,0108-05-04,Positive,in vivo
ethenyl acetate,CC(=O)OC=C,0108-05-04,Negative,in vitro
ethenyl carbamate,C=COC(=O)N,27492,Positive,In Vivo
ethenyl carbamate,C=COC(=O)N,15805-73-9,Positive,in vivo
ethenyl carbamate,C=COC(=O)N,27492,Negative,In Vivo
ethenyl carbamate,C=COC(=O)N,15805-73-9,Positive,in vitro
Ethephon,C(CCl)P(=O)(O)O,16672-87-0,Negative,In vivo
Ethephon,C(CCl)P(=O)(O)O,16672-87-0,Negative,in vitro
ETHINYL ESTRADIOL,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,57-63-6,Positive,In vivo
Ethinyl estradiol,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,57-63-6,Negative,in vitro
Ethion,CCOP(=S)(OCC)SCSP(=S)(OCC)OCC,0563-12-2,Negative,In vivo
ETHIONAMIDE,CCC1=NC=CC(=C1)C(=S)N,536-33-4,Negative,In vivo
ETHIONAMIDE,CCC1=NC=CC(=C1)C(=S)N,536-33-4,Positive,In vivo
Ethionamide,CCC1=NC=CC(=C1)C(=S)N,536-33-4,Positive,in vitro
ETHIONINE,CCSCCC(C(=O)O)N,13073-35-3,Positive,In vivo
Ethofumesate,CCOC1C(C2=C(O1)C=CC(=C2)OS(=O)(=O)C)(C)C,26225-79-6,Negative,in vivo
Ethofumesate,CCOC1C(C2=C(O1)C=CC(=C2)OS(=O)(=O)C)(C)C,26225-79-6,Positive,in vivo
Ethofumesate,CCOC1C(C2=C(O1)C=CC(=C2)OS(=O)(=O)C)(C)C,26225-79-6,Negative,in vitro
Ethoprophos,O=P(SCCC)(OCC)SCCC,13194-48-4,Negative,in vivo
Ethoprophos,O=P(SCCC)(OCC)SCCC,13194-48-4,Positive,in vivo
Ethoprophos,O=P(SCCC)(OCC)SCCC,13194-48-4,Negative,in vitro
ethoxy-ethyl-phenylsulfanyl-sulfanylidene-lambda5-phosphane,CCOP(=S)(CC)SC1=CC=CC=C1,13676,Negative,In Vivo
ethoxy-ethyl-phenylsulfanyl-sulfanylidene-lambda5-phosphane,CCOP(=S)(CC)SC1=CC=CC=C1,944-22-9,Negative,in vitro
Ethoxydiglycol   ,CCOCCOCCO,111-90-0,Positive,in vitro
ethoxyethane,CCOCC,60-29-7,Negative,in vivo
ethoxyethane,CCOCC,60-29-7,Negative,in vitro
Ethoxyethanol,CCOCCO,110-80-5,Negative,In vivo
ETHOXYQUIN,CCOC1=CC2=C(C=C1)NC(C=C2C)(C)C,91-53-2,Negative,In vivo
"ethyl (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate",CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C,54350-48-0,Positive,in vitro
ethyl 2-(4-chlorophenoxy)-2-methylpropanoate,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,2796,Negative,In Vivo
ethyl 2-(4-chlorophenoxy)-2-methylpropanoate,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,2796,Positive,In Vivo
ethyl 2-(7-oxobenzo[a]phenalen-3-yl)sulfanylacetate,CCOC(=O)CSC1=C2C=CC=C3C2=C(C=C1)C4=CC=CC=C4C3=O,,Positive,in vitro
ethyl 2-[(2-diazoacetyl)amino]acetate,CCOC(=O)CNC(=O)C=[N+]=[N-],,Positive,in vitro
"ethyl 2-[4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy]propanoate",CCOC(=O)C(C)OC1=CC=C(C=C1)OC2=NC3=C(O2)C=C(C=C3)Cl,47938,Negative,In Vivo
ethyl 2-diazoacetate,CCOC(=O)C=[N+]=[N-],12192,Negative,In Vivo
ethyl 2-diazoacetate,CCOC(=O)C=[N+]=[N-],12192,Positive,In Vivo
"ethyl 2,2-bis(4-chlorophenyl)-2-hydroxyacetate",CCOC(=O)C(C1=CC=C(C=C1)Cl)(C2=CC=C(C=C2)Cl)O,10522,Positive,In Vivo
"ethyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate",CCOC(=O)C1C(C1(C)C)C=C(C)C,97-41-6,Negative,in vitro
ethyl 4-(dimethylaminodiazenyl)benzoate,CCOC(=O)C1=CC=C(C=C1)N=NN(C)C,21600-51-1,Positive,in vitro
ethyl 4-[butyl(nitroso)amino]-4-oxobutanoate,CCCCN(C(=O)CCC(=O)OCC)N=O,150695,Positive,In Vivo
ethyl 4-methylbenzenesulfonate,CCOS(=O)(=O)C1=CC=C(C=C1)C,80-40-0,Negative,in vitro
"ethyl 7-oxofuro[3,2-g]chromene-6-carboxylate",CCOC(=O)C1=CC2=C(C=C3C(=C2)C=CO3)OC1=O,20073-24-9,Positive,in vitro
Ethyl acetate,CCOC(=O)C,141-78-6,Negative,In vivo
ethyl acetate,CCOC(=O)C,141-78-6,Negative,in vitro
ETHYL ACRYLATE,CCOC(=O)C=C,140-88-5,Negative,In vivo
ETHYL ACRYLATE,CCOC(=O)C=C,140-88-5,Positive,In vivo
Ethyl acrylate,CCOC(=O)C=C,140-88-5,Positive,in vitro
ETHYL ALCOHOL,CCO,64-17-5,Negative,In vivo
ETHYL ALCOHOL,CCO,64-17-5,Positive,In vivo
ethyl aziridine-1-carboxylate,CCOC(=O)N1CC1,671-51-2,Positive,in vitro
ethyl carbamate,CCOC(=O)N,51-79-6,Positive,in vivo
ethyl carbamate,CCOC(=O)N,5641,Positive,In Vivo
ethyl carbamate,CCOC(=O)N,5641,Negative,In Vivo
ethyl carbamate,CCOC(=O)N,51-79-6,Negative,in vivo
ethyl carbamate,CCOC(=O)N,51-79-6,Negative,in vitro
Ethyl chloride,CCCl,75-00-3,Negative,In vivo
ethyl chloromethanesulfonate,CCOS(=O)(=O)CCl,,Positive,in vitro
Ethyl dipropylthiocarbamate (EPTC),CCCN(CCC)C(=O)SCC,759-94-4,Negative,In vivo
ethyl ethanesulfonate,CCOS(=O)(=O)CC,1912-30-7,Negative,in vitro
Ethyl ether,CCOCC,60-29-7,Negative,In vivo
ethyl methanesulfonate,CCOS(=O)(=O)C,62-50-0,Positive,in vivo
ethyl methanesulfonate,CCOS(=O)(=O)C,6113,Positive,In Vivo
ethyl methanesulfonate,CCOS(=O)(=O)C,62-50-0,Negative,in vitro
Ethyl methanesulphonate,CCOS(=O)(=O)C,62-50-0,Positive,in vitro
ETHYL METHYLPHENYLGLYCIDATE,CCOC(=O)C1C(O1)(C)C2=CC=CC=C2,77-83-8,Negative,In vivo
ethyl N-(2-hydroxyethyl)-N-nitrosocarbamate,CCOC(=O)N(CCO)N=O,62641-68-3,Positive,in vitro
ethyl N-[[2-(ethoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate,CCOC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OCC,23564-06-09,Positive,in vitro
ethyl N-[2-(4-phenoxyphenoxy)ethyl]carbamate,CCOC(=O)NCCOC1=CC=C(C=C1)OC2=CC=CC=C2,51605,Negative,In Vivo
ethyl N-[2-(4-phenoxyphenoxy)ethyl]carbamate,CCOC(=O)NCCOC1=CC=C(C=C1)OC2=CC=CC=C2,51605,Positive,In Vivo
ethyl N-[4-(2-amino-5-methylphenanthridin-5-ium-6-yl)phenyl]carbamate;sulfate,CCOC(=O)NC1=CC=C(C=C1)C2=[N+](C3=C(C=C(C=C3)N)C4=CC=CC=C42)C.CCOC(=O)NC1=CC=C(C=C1)C2=[N+](C3=C(C=C(C=C3)N)C4=CC=CC=C42)C.[O-]S(=O)(=O)[O-],,Positive,in vitro
ethyl N-butyl-N-nitrosocarbamate,CCCCN(C(=O)OCC)N=O,6558-78-7,Positive,in vivo
ethyl N-butyl-N-nitrosocarbamate,CCCCN(C(=O)OCC)N=O,6558-78-7,Positive,in vitro
ethyl N-butylcarbamate,CCCCNC(=O)OCC,591-62-8,Negative,in vitro
ethyl N-ethyl-N-nitrosocarbamate,CCN(C(=O)OCC)N=O,11977,Positive,In Vivo
ethyl N-ethyl-N-nitrosocarbamate,CCN(C(=O)OCC)N=O,614-95-9,Positive,in vitro
ethyl N-hydroxycarbamate,CCOC(=O)NO,11510,Positive,In Vivo
ethyl N-hydroxycarbamate,CCOC(=O)NO,589-41-3,Positive,in vivo
ethyl N-hydroxycarbamate,CCOC(=O)NO,589-41-3,Positive,in vitro
ethyl N-methyl-N-nitrosocarbamate,CCOC(=O)N(C)N=O,12001,Positive,In Vivo
ethyl N-methyl-N-nitrosocarbamate,CCOC(=O)N(C)N=O,615-53-2,Positive,in vivo
ethyl N-methyl-N-nitrosocarbamate,CCOC(=O)N(C)N=O,615-53-2,Positive,in vitro
ethyl N-nitroso-N-pentylcarbamate,CCCCCN(C(=O)OCC)N=O,46335,Positive,In Vivo
Ethyl p-nitrophenyl phenylphosphorothioate (EPN),CCOP(=S)(C1=CC=CC=C1)OC2=CC=C(C=C2)[N+](=O)[O-],2104-64-5,Negative,In vivo
ethyl prop-2-enoate,CCOC(=O)C=C,8821,Negative,In Vivo
ethyl prop-2-enoate,CCOC(=O)C=C,8821,Positive,In Vivo
ethyl prop-2-enoate,CCOC(=O)C=C,140-88-5,Positive,in vitro
Ethyl Tertiary Butyl Ether (ETBE),CCOC(C)(C)C,637-92-3,Positive,In vivo
ethyl-(N-(4-methylphenyl)sulfonylanilino)mercury,CC[Hg]N(C1=CC=CC=C1)S(=O)(=O)C2=CC=C(C=C2)C,517-16-8,Positive,in vitro
ethyl-ethylimino-oxidoazanium,CCN=[N+](CC)[O-],519246,Positive,In Vivo
ethyl-methylimino-oxidoazanium,CC[N+](=NC)[O-],152160,Positive,In Vivo
ethyl(nitroso)cyanamide,CCN(C#N)N=O,38434-77-4,Positive,in vitro
ethylbenzene,CCC1=CC=CC=C1,7500,Positive,In Vivo
Ethylbenzene,CCC1=CC=CC=C1,100-41-4,Negative,In vivo
ethylbenzene,CCC1=CC=CC=C1,7500,Negative,In Vivo
ETHYLBENZENE,CCC1=CC=CC=C1,100-41-4,Positive,In vivo
ethylbenzene,CCC1=CC=CC=C1,100-41-4,Negative,in vitro
Ethylene chlorohydrin/ 2-chloroethanol,ClCCO,0107-07-03,Positive,in vitro
Ethylene diamine,C(CN)N,107-15-3,Negative,In vivo
Ethylene glycol,C(CO)O,107-21-1,Negative,In vivo
Ethylene glycol anhydrous,C(CO)O,107-21-1,Negative,in vitro
Ethylene glycol monobutyl ether (EGBE) (2-Butoxyethanol),CCCCOCCO,111-76-2,Negative,In vivo
ETHYLENE IMINE,C1CN1,151-56-4,Positive,In vivo
Ethylene imine (AKA Aziridine),C1CN1,151-56-4,Positive,in vitro
Ethylene oxide,C1CO1,75-21-8,Positive,In vivo
ETHYLENE OXIDE,C1CO1,75-21-8,Negative,In vivo
Ethylene oxide,C1CO1,75-21-8,Positive,in vitro
ETHYLENE THIOUREA,C1CNC(=S)N1,96-45-7,Positive,In vivo
Ethylene thiourea (ETU),C1CNC(=S)N1,96-45-7,Negative,In vivo
ETHYLENE UREA,C1CNC(=O)N1,120-93-4,Negative,In vivo
Ethylene-glycol-monomethyl ether,COCCO,109-86-4,Negative,in vitro
"ETHYLENEBISDITHIOCARBAMATE, DISODIUM",C(CNC(=S)[S-])NC(=S)[S-].[Na+].[Na+],142-59-6,Negative,In vivo
Ethyleneimine,C1CN1,151-56-4,Negative,In vivo
ethylhydrazine;hydrochloride,CCNN.Cl,29061,Positive,In Vivo
ETHYLHYDRAZINE.HCl,CCNN.Cl,18413-14-4,Positive,In vivo
ethylimino-methyl-oxidoazanium,CCN=[N+](C)[O-],152014,Positive,In Vivo
ETHYLNITROSOCYANAMIDE,CCN(C#N)N=O,38434-77-4,Positive,In vivo
Ethylnitrosocyanamide,CCN(C#N)N=O,38434-77-4,Positive,in vitro
Ethylphthalyl ethylglycolate (EPEG),CCOC(=O)COC(=O)C1=CC=CC=C1C(=O)OCC,84-72-0,Negative,In vivo
ethylurea,CCNC(=O)N,625-52-5,Positive,in vitro
ETHYNODIOL DIACETATE,CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C,297-76-7,Negative,In vivo
ETODOLAC,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,41340-25-4,Negative,In vivo
Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,41340-25-4,Negative,in vitro
Etofenprox,CCOC1=CC=C(C=C1)C(C)(C)COCC2=CC(=CC=C2)OC3=CC=CC=C3,80844-07-1,Negative,in vivo
Etofenprox,CCOC1=CC=C(C=C1)C(C)(C)COCC2=CC(=CC=C2)OC3=CC=CC=C3,80844-07-01,Negative,in vitro
Etoposide,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,33419-42-0,Positive,in vitro
Etridiazole,CCOC1=NC(=NS1)C(Cl)(Cl)Cl,2593-15-9,Negative,in vivo
Etridiazole,CCOC1=NC(=NS1)C(Cl)(Cl)Cl,2593-15-9,Positive,in vivo
Etridiazole,CCOC1=NC(=NS1)C(Cl)(Cl)Cl,2593-15-9,Negative,in vitro
Eugenol,COC1=C(C=CC(=C1)CC=C)O,97-53-0,Negative,in vivo
Eugenol,COC1=C(C=CC(=C1)CC=C)O,97-53-0,Positive,in vivo
Eugenol,COC1=C(C=CC(=C1)CC=C)O,97-53-0,Positive,in vitro
Express,CC1=NC(=NC(=N1)OC)N(C)C(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC,101200-48-0,Negative,In vivo
FADROZOLE.HCl,C1CC(N2C=NC=C2C1)C3=CC=C(C=C3)C#N.Cl,102676-31-3,Negative,In vivo
Famoxadone,CC1(C(=O)N(C(=O)O1)NC2=CC=CC=C2)C3=CC=C(C=C3)OC4=CC=CC=C4,131807-57-3,Negative,in vivo
Famoxadone,CC1(C(=O)N(C(=O)O1)NC2=CC=CC=C2)C3=CC=C(C=C3)OC4=CC=CC=C4,131807-57-3,Negative,in vitro
"FD  C red no. 3 fluorescein, 2', 4', 5', 7'-tetraiodo, disodium salt",C1=CC=C2C(=C1)C(=O)OC23C4=CC(=C(C(=C4OC5=C(C(=C(C=C35)I)[O-])I)I)[O-])I.[Na+].[Na+],16423-68-0,Positive,in vitro
FD & C BLUE NO. 1,CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=CC=CC=C5S(=O)(=O)[O-].[Na+].[Na+],3844-45-9,Negative,In vivo
FD & C BLUE NO. 2,C1=CC2=C(C=C1S(=O)(=O)[O-])C(=C(N2)C3=NC4=C(C3=O)C=C(C=C4)S(=O)(=O)[O-])O.[Na+].[Na+],860-22-0,Negative,In vivo
FD & C GREEN NO. 1,CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=CC=CC=C5.[Na+],4680-78-8,Negative,In vivo
FD & C GREEN NO. 1,CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=CC=CC=C5.[Na+],4680-78-8,Positive,In vivo
FD & C GREEN NO. 2,CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=CC=C(C=C5)S(=O)(=O)[O-].[Na+].[Na+],5141-20-8,Negative,In vivo
FD & C GREEN NO. 2,CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=CC=C(C=C5)S(=O)(=O)[O-].[Na+].[Na+],5141-20-8,Positive,In vivo
FD & C GREEN NO. 3,CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3)C5=C(C=C(C=C5)O)S(=O)(=O)[O-].[Na+].[Na+],2353-45-9,Negative,In vivo
FD & C RED NO. 1,CC1=CC(=C(C=C1C)N=NC2=C3C=CC(=CC3=CC(=C2O)S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+],3564-09-8,Positive,In vivo
FD & C RED NO. 2,C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C4C=CC(=CC4=CC(=C3O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],915-67-3,Negative,In vivo
FD & C RED NO. 2,C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C4C=CC(=CC4=CC(=C3O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],915-67-3,Positive,In vivo
FD & C RED NO. 3,C1=CC=C2C(=C1)C(=O)OC23C4=CC(=C(C(=C4OC5=C(C(=C(C=C35)I)[O-])I)I)[O-])I.[Na+].[Na+],16423-68-0,Negative,In vivo
FD & C RED NO. 4,CC1=CC(=C(C=C1N=NC2=C(C3=CC=CC=C3C(=C2)S(=O)(=O)[O-])O)S(=O)(=O)[O-])C.[Na+].[Na+],4548-53-2,Negative,In vivo
FD & C RED NO. 4,CC1=CC(=C(C=C1N=NC2=C(C3=CC=CC=C3C(=C2)S(=O)(=O)[O-])O)S(=O)(=O)[O-])C.[Na+].[Na+],4548-53-2,Positive,In vivo
FD & C VIOLET NO. 1,CCN(CC1=CC(=CC=C1)S(=O)(=O)O)C2=CC=C(C=C2)C(=C3C=CC(=[N+](C)C)C=C3)C4=CC=C(C=C4)N(CC)CC5=CC(=CC=C5)S(=O)(=O)[O-].[Na+],1694-09-3,Negative,In vivo
FD & C VIOLET NO. 1,CCN(CC1=CC(=CC=C1)S(=O)(=O)O)C2=CC=C(C=C2)C(=C3C=CC(=[N+](C)C)C=C3)C4=CC=C(C=C4)N(CC)CC5=CC(=CC=C5)S(=O)(=O)[O-].[Na+],1694-09-3,Positive,In vivo
FD & C YELLOW NO. 5,C1=CC(=CC=C1N=NC2C(=NN(C2=O)C3=CC=C(C=C3)S(=O)(=O)[O-])C(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],1934-21-0,Negative,In vivo
FD & C YELLOW NO. 6,C1=CC(=CC=C1N=NC2=C(C=CC3=C2C=CC(=C3)S(=O)(=O)[O-])O)S(=O)(=O)[O-].[Na+].[Na+],2783-94-0,Negative,In vivo
Fenamidone,C[C@@]1(C(=O)N(C(=N1)SC)NC2=CC=CC=C2)C3=CC=CC=C3,161326-34-7,Negative,in vivo
Fenamidone,C[C@@]1(C(=O)N(C(=N1)SC)NC2=CC=CC=C2)C3=CC=CC=C3,161326-34-7,Negative,in vitro
Fenamiphos,CCOP(=O)(NC(C)C)OC1=CC(=C(C=C1)SC)C,22224-92-6,Negative,In vivo
Fenamiphos,CCOP(=O)(NC(C)C)OC1=CC(=C(C=C1)SC)C,22224-92-6,Negative,in vitro
Fenazaquin,CC(C)(C)C3=CC=C(C=C3)CCOC1=NC=NC2=C1C=CC=C2,120928-09-8,Negative,in vivo
Fenazaquin,CC(C)(C)C3=CC=C(C=C3)CCOC1=NC=NC2=C1C=CC=C2,120928-09-8,Negative,in vitro
Fenbuconazole,C1=CC=C(C=C1)C(CCC2=CC=C(C=C2)Cl)(CN3C=NC=N3)C#N,114369-43-6,Negative,in vivo
Fenbuconazole,C1=CC=C(C=C1)C(CCC2=CC=C(C=C2)Cl)(CN3C=NC=N3)C#N,114369-43-6,Negative,in vitro
Fenbutatin oxide,CC(C)(C[Sn](CC(C)(C)c1ccccc1)(CC(C)(C)c2ccccc2)O[Sn](CC(C)(C)c3ccccc3)(CC(C)(C)c4ccccc4)CC(C)(C)c5ccccc5)c6ccccc6,13356-08-6,Negative,in vivo
Fenbutatin oxide,CC(C)(C[Sn](CC(C)(C)c1ccccc1)(CC(C)(C)c2ccccc2)O[Sn](CC(C)(C)c3ccccc3)(CC(C)(C)c4ccccc4)CC(C)(C)c5ccccc5)c6ccccc6,13356-08-06,Negative,in vitro
Fenhexamid,CC1(CCCCC1)C(=O)NC2=C(C(=C(C=C2)O)Cl)Cl,126833-17-8,Negative,in vivo
Fenhexamid,CC1(CCCCC1)C(=O)NC2=C(C(=C(C=C2)O)Cl)Cl,126833-17-8,Negative,in vitro
Fenitrothion,CC1=C(C=CC(=C1)OP(=S)(OC)OC)[N+](=O)[O-],122-14-5,Negative,in vivo
Fenitrothion,CC1=C(C=CC(=C1)OP(=S)(OC)OC)[N+](=O)[O-],122-14-5,Negative,in vitro
Fenoxaprop-P-ethyl,CCOC(=O)[C@@H](C)OC1=CC=C(C=C1)OC2=NC3=C(O2)C=C(C=C3)Cl,71283-80-2,Negative,in vivo
Fenoxaprop-P-ethyl,CCOC(=O)[C@@H](C)OC1=CC=C(C=C1)OC2=NC3=C(O2)C=C(C=C3)Cl,71283-80-2,Negative,in vitro
Fenoxycarb,O=C(NCCOC1=CC=C(OC2=CC=CC=C2)C=C1)OCC,72490-01-8,Negative,in vivo
Fenoxycarb,O=C(NCCOC1=CC=C(OC2=CC=CC=C2)C=C1)OCC,72490-01-08,Negative,in vitro
Fenpropidin,CC(CC1=CC=C(C=C1)C(C)(C)C)CN2CCCCC2,67306-00-7,Negative,in vivo
Fenpropidin,CC(CC1=CC=C(C=C1)C(C)(C)C)CN2CCCCC2,67306-00-7,Negative,in vitro
Fenpropimorph,CC(C)(C)C(C=C2)=CC=C2CC(C)CN1C[C@@H](C)O[C@@H](C)C1,67564-91-4,Negative,in vivo
Fenpropimorph,CC(C)(C)C(C=C2)=CC=C2CC(C)CN1C[C@@H](C)O[C@@H](C)C1,67564-91-4,Negative,in vitro
Fenpyrazamine,n1(c(c(c(=O)n1C(C)C)c1ccccc1C)N)C(=O)SCC=C,473798-59-3,Negative,in vivo
Fenpyrazamine,n1(c(c(c(=O)n1C(C)C)c1ccccc1C)N)C(=O)SCC=C,473798-59-3,Negative,in vitro
Fenpyroximate,CC1=NN(C(=C1/C=N/OCC2=CC=C(C=C2)C(=O)OC(C)(C)C)OC3=CC=CC=C3)C,134098-61-6,Negative,in vivo
Fenpyroximate,CC1=NN(C(=C1/C=N/OCC2=CC=C(C=C2)C(=O)OC(C)(C)C)OC3=CC=CC=C3)C,134098-61-6,Negative,in vitro
FENVALERATE,CC(C)C(C1=CC=C(C=C1)Cl)C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3,51630-58-1,Negative,In vivo
Fenvalerate cyano-3-phenoxyphenylmethyl-4-chloro-alpha-1-methylethylbenzene acetate,CC(C)C(C1=CC=C(C=C1)Cl)C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3,51630-58-1,Negative,in vitro
FERRIC CHLORIDE,Cl[Fe](Cl)Cl,7705-08-0,Negative,In vivo
FERRIC CITRATE TETRAHYDRATE,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.O.O.O.O.[Fe+3],2338-05-8,Negative,In vivo
FERRIC DIMETHYLDITHIOCARBAMATE,CN(C)C(=S)[S-].CN(C)C(=S)[S-].CN(C)C(=S)[S-].[Fe+3],14484-64-1,Negative,In vivo
Ferric phosphate,[O-]P(=O)([O-])[O-].[Fe+3],10045-86-0,Negative,in vivo
Ferric phosphate,[O-]P(=O)([O-])[O-].[Fe+3],10045-86-0,Negative,in vitro
Ferrous sulfate,[O-]S(=O)(=O)[O-].[Fe+2],7720-78-7,Positive,in vitro
FINASTERIDE,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,98319-26-7,Positive,In vivo
Fipronil,C1=C(C=C(C(=C1Cl)N2C(=C(C(=N2)C#N)S(=O)C(F)(F)F)N)Cl)C(F)(F)F,120068-37-3,Negative,in vivo
Fipronil,C1=C(C=C(C(=C1Cl)N2C(=C(C(=N2)C#N)S(=O)C(F)(F)F)N)Cl)C(F)(F)F,120068-37-3,Negative,in vitro
FLECAINIDE ACETATE,CC(=O)O.C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,54143-56-5,Negative,In vivo
Flonicamid,O=C(NCC#N)c1cnccc1C(F)(F)F,158062-67-0,Negative,in vivo
Flonicamid,O=C(NCC#N)c1cnccc1C(F)(F)F,158062-67-0,Negative,in vitro
Florasulam,COC1=NC=C(C2=NC(=NN21)S(=O)(=O)NC3=C(C=CC=C3F)F)F,145701-23-1,Negative,in vivo
Florasulam,COC1=NC=C(C2=NC(=NN21)S(=O)(=O)NC3=C(C=CC=C3F)F)F,145701-23-1,Negative,in vitro
Fluazifop-P-butyl,CCCCOC(=O)[C@@H](C)OC1=CC=C(C=C1)OC2=NC=C(C=C2)C(F)(F)F,79241-46-6,Negative,in vivo
Fluazifop-P-butyl,CCCCOC(=O)[C@@H](C)OC1=CC=C(C=C1)OC2=NC=C(C=C2)C(F)(F)F,79241-46-6,Negative,in vitro
Fluazinam,C1=C(C=NC(=C1Cl)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-])C(F)(F)F,79622-59-6,Negative,in vivo
Fluazinam,C1=C(C=NC(=C1Cl)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-])C(F)(F)F,79622-59-6,Negative,in vitro
Flubendiamide,CC1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)F)NC(=O)C2=C(C(=CC=C2)I)C(=O)NC(C)(C)CS(=O)(=O)C,272451-65-7,Negative,in vivo
Flubendiamide,CC1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)F)NC(=O)C2=C(C(=CC=C2)I)C(=O)NC(C)(C)CS(=O)(=O)C,272451-65-7,Negative,in vitro
FLUCONAZOLE,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,86386-73-4,Negative,In vivo
FLUCONAZOLE,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,86386-73-4,Positive,In vivo
Fludioxonil,C1=CC(=C2C(=C1)OC(O2)(F)F)C3=CNC=C3C#N,131341-86-1,Negative,in vivo
Fludioxonil,C1=CC(=C2C(=C1)OC(O2)(F)F)C3=CNC=C3C#N,131341-86-1,Negative,in vitro
Flufenoxuron,C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=C(C=C(C=C2)OC3=C(C=C(C=C3)C(F)(F)F)Cl)F)F,101463-69-8,Negative,in vivo
Flufenoxuron,C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=C(C=C(C=C2)OC3=C(C=C(C=C3)C(F)(F)F)Cl)F)F,101463-69-8,Negative,in vitro
Flumioxazin,C#CCN1C(=O)COC2=CC(=C(C=C21)N3C(=O)C4=C(C3=O)CCCC4)F,103361-09-7,Negative,in vivo
Flumioxazin,C#CCN1C(=O)COC2=CC(=C(C=C21)N3C(=O)C4=C(C3=O)CCCC4)F,103361-09-7,Negative,in vitro
Fluometuron,CN(C)C(=O)NC1=CC=CC(=C1)C(F)(F)F,2164-17-2,Negative,in vivo
Fluometuron,CN(C)C(=O)NC1=CC=CC(=C1)C(F)(F)F,2164-17-2,Negative,in vitro
Fluopicolide,C1=CC(=C(C(=C1)Cl)C(=O)NCC2=C(C=C(C=N2)C(F)(F)F)Cl)Cl,239110-15-7,Negative,in vivo
Fluopicolide,C1=CC(=C(C(=C1)Cl)C(=O)NCC2=C(C=C(C=N2)C(F)(F)F)Cl)Cl,239110-15-7,Negative,in vitro
Fluopyram,C1=CC=C(C(=C1)C(=O)NCCC2=C(C=C(C=N2)C(F)(F)F)Cl)C(F)(F)F,658066-35-4,Negative,in vivo
Fluopyram,C1=CC=C(C(=C1)C(=O)NCCC2=C(C=C(C=N2)C(F)(F)F)Cl)C(F)(F)F,658066-35-4,Negative,in vitro
fluorane,F,7664-39-3,Positive,in vitro
fluoranthene,C1=CC=C2C(=C1)C3=CC=CC4=C3C2=CC=C4,9154,Negative,In Vivo
fluoranthene,C1=CC=C2C(=C1)C3=CC=CC4=C3C2=CC=C4,9154,Positive,In Vivo
Fluoranthene,C1=CC=C2C(=C1)C3=CC=CC4=C3C2=CC=C4,206-44-0,Negative,In vivo
fluoranthene,C1=CC=C2C(=C1)C3=CC=CC4=C3C2=CC=C4,206-44-0,Positive,in vitro
Fluorene,C1C2=CC=CC=C2C3=CC=CC=C31,86-73-7,Negative,In vivo
"FLUORIDE, SODIUM",[F-].[Na+],7681-49-4,Negative,In vivo
Fluorine (soluble fluoride),FF,7782-41-4,Negative,In vivo
fluoroethene,C=CF,6339,Positive,In Vivo
fluorosulfonyloxymethane,COS(=O)(=O)F,421-20-5,Positive,in vitro
Fluoxastrobin,CO/N=C(\C1=CC=CC=C1OC2=C(C(=NC=N2)OC3=CC=CC=C3Cl)F)/C4=NOCCO4,361377-29-9,Negative,in vivo
Fluoxastrobin,CO/N=C(\C1=CC=CC=C1OC2=C(C(=NC=N2)OC3=CC=CC=C3Cl)F)/C4=NOCCO4,361377-29-9,Negative,in vitro
FLUOXETINE.HCl,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl,59333-67-4,Negative,In vivo
Fluoxymesterone,CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C)O)C)O)F,76-43-7,Positive,in vitro
Fluphenazine decanoate,CCCCCCCCCC(=O)OCCN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F,5002-47-1,Negative,in vitro
Fluphenazine/Fluphenazine hydrochloride,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,69-23-8,Positive,in vitro
Flupyrsulfuron-methyl-sodium,COC1=CC(=NC(=N1)[N-]C(=O)NS(=O)(=O)C2=C(C=CC(=N2)C(F)(F)F)C(=O)OC)OC.[Na+],144740-54-5,Negative,in vivo
Flupyrsulfuron-methyl-sodium,COC1=CC(=NC(=N1)[N-]C(=O)NS(=O)(=O)C2=C(C=CC(=N2)C(F)(F)F)C(=O)OC)OC.[Na+],144740-54-5,Negative,in vitro
Fluquinconazole,C1=CC2=C(C=C1F)C(=O)N(C(=N2)N3C=NC=N3)C4=C(C=C(C=C4)Cl)Cl,136426-54-5,Negative,in vivo
Fluquinconazole,C1=CC2=C(C=C1F)C(=O)N(C(=N2)N3C=NC=N3)C4=C(C=C(C=C4)Cl)Cl,136426-54-5,Negative,in vitro
Fluridone,CN1C=C(C(=O)C(=C1)C2=CC(=CC=C2)C(F)(F)F)C3=CC=CC=C3,59756-60-4,Negative,In vivo
Flurochloridone,C1C(C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)Cl)CCl,61213-25-0,Negative,in vivo
Flurochloridone,C1C(C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)Cl)CCl,61213-25-0,Negative,in vitro
Fluroxypyr-meptyl,CCCCCCC(C)OC(=O)COC1=NC(=C(C(=C1Cl)N)Cl)F,81406-37-3,Negative,in vivo
Fluroxypyr-meptyl,CCCCCCC(C)OC(=O)COC1=NC(=C(C(=C1Cl)N)Cl)F,81406-37-3,Negative,in vitro
Flurprimidol,CC(C)C(C1=CC=C(C=C1)OC(F)(F)F)(C2=CN=CN=C2)O,56425-91-3,Negative,In vivo
Flurtamone,CNC1=C(C(=O)C(O1)C2=CC=CC=C2)C3=CC(=CC=C3)C(F)(F)F,96525-23-4,Negative,in vivo
Flurtamone,CNC1=C(C(=O)C(O1)C2=CC=CC=C2)C3=CC(=CC=C3)C(F)(F)F,96525-23-4,Negative,in vitro
Flutolanil,CC(C)OC1=CC=CC(=C1)NC(=O)C2=CC=CC=C2C(F)(F)F,66332-96-5,Negative,in vivo
Flutolanil,CC(C)OC1=CC=CC(=C1)NC(=O)C2=CC=CC=C2C(F)(F)F,66332-96-5,Negative,in vitro
Flutriafol,OC(CN1N=CN=C1)(C(C=C2)=CC=C2F)C(C=CC=C3)=C3F,76674-21-0,Negative,in vivo
Flutriafol,OC(CN1N=CN=C1)(C(C=C2)=CC=C2F)C(C=CC=C3)=C3F,76674-21-0,Negative,in vitro
Fluvalinate,CC(C)C(C(=O)OC(C#N)C1=CC(=CC=C1)OC2=CC=CC=C2)NC3=C(C=C(C=C3)C(F)(F)F)Cl,69409-94-5,Negative,In vivo
FLUVASTATIN,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,93957-54-1,Positive,In vivo
Fluvastatin/Fluvastatin sodium salt,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,93957-54-1,Negative,in vitro
Fluxapyroxad,CN1C=C(C(=N1)C(F)F)C(=O)NC2=CC=CC=C2C3=CC(=C(C(=C3)F)F)F,907204-31-3,Negative,in vivo
Fluxapyroxad,CN1C=C(C(=N1)C(F)F)C(=O)NC2=CC=CC=C2C3=CC(=C(C(=C3)F)F)F,907204-31-3,Negative,in vitro
Folpet,C1=CC=C2C(=C1)C(=O)N(C2=O)SC(Cl)(Cl)Cl,133-07-3,Negative,in vivo
Folpet,C1=CC=C2C(=C1)C(=O)N(C2=O)SC(Cl)(Cl)Cl,0133-07-03,Positive,In vivo
Folpet,C1=CC=C2C(=C1)C(=O)N(C2=O)SC(Cl)(Cl)Cl,0133-07-03,Positive,in vitro
Fomesafen,CS(=O)(=O)NC(=O)C1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],72178-02-0,Positive,In vivo
Fonofos,CCOP(=S)(CC)SC1=CC=CC=C1,944-22-9,Negative,In vivo
FOOD RED NO. 106,CCN(CC)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](CC)CC)C=C3O2)C4=C(C=C(C=C4)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+],3520-42-1,Negative,In vivo
Foramsulfuron,CN(C)C(=O)C1=C(C=C(C=C1)NC=O)S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC,173159-57-4,Negative,in vivo
Foramsulfuron,CN(C)C(=O)C1=C(C=C(C=C1)NC=O)S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC,173159-57-4,Negative,in vitro
formaldehyde,C=O,50-00-0,Positive,in vivo
formaldehyde,C=O,712,Negative,In Vivo
FORMALDEHYDE,C=O,50-00-0,Negative,In vivo
formaldehyde,C=O,712,Positive,In Vivo
Formaldehyde,C=O,50-00-0,Positive,in vitro
formamide,C(=O)N,713,Positive,In Vivo
formamide,C(=O)N,713,Negative,In Vivo
formamide,C(=O)N,75-12-7,Negative,in vitro
Formetanate hydrochloride,CNC(=O)OC1=CC=CC(=C1)N=CN(C)C.Cl,23422-53-9,Negative,in vivo
Formetanate hydrochloride,CNC(=O)OC1=CC=CC(=C1)N=CN(C)C.Cl,23422-53-9,Negative,in vitro
Formic acid,C(=O)O,64-18-6,Negative,In vivo
FORMIC ACID 2-(4-METHYL-2-THIAZOLYL)HYDRAZIDE,CC1=CSC(=N1)NNC=O,32852-21-4,Positive,In vivo
FORMIC ACID 2-[4-(2-FURYL)-2-THIAZOLYL]HYDRAZIDE,C1=COC(=C1)C2=CSC(=N2)NNC=O,31873-81-1,Negative,In vivo
FORMIC ACID 2-[4-(5-NITRO-2-FURYL)-2-THIAZOLYL]HYDRAZIDE,C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NNC=O,3570-75-0,Positive,In vivo
FORMIC ACID 2-[4-(5-NITRO-2-FURYL)-2-THIAZOLYL]HYDRAZIDE,C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NNC=O,3570-75-0,Negative,In vivo
Formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazide,C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NNC=O,3570-75-0,Positive,in vitro
FORMYLHYDRAZINE,C(=O)NN,624-84-0,Positive,In vivo
Fosetyl AI,CCOP(=O)=O.CCOP(=O)=O.CCOP(=O)=O.[Al+3] ,39148-24-8,Negative,in vitro
FOSETYL Al,CCOP(=O)=O.CCOP(=O)=O.CCOP(=O)=O.[Al+3],39148-24-8,Positive,In vivo
Fosetyl-al,CCOP(=O)=O.CCOP(=O)=O.CCOP(=O)=O.[Al+3],6328269,Negative,In Vivo
Fosetyl-al,CCOP(=O)=O.CCOP(=O)=O.CCOP(=O)=O.[Al+3],39148-24-8,Negative,In vivo
Fosetyl-al,CCOP(=O)=O.CCOP(=O)=O.CCOP(=O)=O.[Al+3],6328269,Positive,In Vivo
Fosetyl-aluminium,CCO[P+](=O)[O-].CCO[P+](=O)[O-].CCO[P+](=O)[O-].[Al+3],39148-24-8,Negative,in vivo
Fosetyl-aluminium,CCO[P+](=O)[O-].CCO[P+](=O)[O-].CCO[P+](=O)[O-].[Al+3],39148-24-8,Negative,in vitro
Fotemustine,CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC,92118-27-9,Positive,in vitro
Fuberidazole,o1cccc1c2nc3ccccc3[nH]2,3878-19-1,Negative,in vivo
Fuberidazole,o1cccc1c2nc3ccccc3[nH]2,3878-19-1,Negative,in vitro
FUMONISIN B1,CCCCC(C)C(C(CC(C)CC(CCCCC(CC(C(C)N)O)O)O)OC(=O)CC(CC(=O)O)C(=O)O)OC(=O)CC(CC(=O)O)C(=O)O,116355-83-0,Positive,In vivo
Fumonisin B1,CCCCC(C)C(C(CC(C)CC(CCCCC(CC(C(C)N)O)O)O)OC(=O)CC(CC(=O)O)C(=O)O)OC(=O)CC(CC(=O)O)C(=O)O,116355-83-0,Positive,in vitro
furan,C1=COC=C1,8029,Negative,In Vivo
furan,C1=COC=C1,8029,Positive,In Vivo
Furan,C1=COC=C1,110-00-9,Negative,In vivo
furan-2-carbaldehyde,C1=COC(=C1)C=O,7362,Negative,In Vivo
furan-2-carbaldehyde,C1=COC(=C1)C=O,7362,Positive,In Vivo
furan-2-carbaldehyde,C1=COC(=C1)C=O,98-01-1,Positive,in vitro
furan-2-ylmethanol,C1=COC(=C1)CO,7361,Negative,In Vivo
furan-2-ylmethanol,C1=COC(=C1)CO,7361,Positive,In Vivo
FURFURAL,C1=COC(=C1)C=O,98-01-1,Negative,In vivo
Furfuryl Alcohol,C1=COC(=C1)CO,98-00-0,Negative,in vitro
Furmecyclox,CC1=CC(=C(O1)C)C(=O)N(C2CCCCC2)OC,60568-05-0,Positive,In vivo
"furo[2,3-h]chromen-2-one",C1=CC2=C(C=CO2)C3=C1C=CC(=O)O3,10658,Negative,In Vivo
"furo[2,3-h]chromen-2-one",C1=CC2=C(C=CO2)C3=C1C=CC(=O)O3,523-50-2,Positive,in vitro
"furo[3,2-g]chromen-7-one",C1=CC(=O)OC2=CC3=C(C=CO3)C=C21,66-97-7,Positive,in vitro
Furylfuramide (AF-2),C1=COC(=C1)C(=CC2=CC=C(O2)[N+](=O)[O-])C(=O)N,3688-53-7,Positive,in vitro
Galangin,C1=CC=C(C=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O,548-83-4,Positive,in vitro
gallanylidynearsane,[Ga]#[As],14770,Negative,In Vivo
gallanylidynearsane,[Ga]#[As],14770,Positive,In Vivo
gallanylidynephosphane,P#[Ga],82901,Negative,In Vivo
GALLIC ACID,C1=C(C=C(C(=C1O)O)O)C(=O)O,149-91-7,Negative,In vivo
Gallium arsenide,[Ga]#[As],1303-00-0,Negative,in vitro
"gamma-1,2,3,4,5,6-HEXACHLOROCYCLOHEXANE",C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,58-89-9,Negative,In vivo
"gamma-1,2,3,4,5,6-HEXACHLOROCYCLOHEXANE",C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,58-89-9,Positive,In vivo
gamma-Butyrolactone,C1CC(=O)OC1,96-48-0,Positive,in vitro
gamma-ORYZANOL,CC(CCC=C(C)C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)OC(=O)C=CC6=CC(=C(C=C6)O)OC)C)C,11042-64-1,Negative,In vivo
gamma-Oryzanol,CC(CCC=C(C)C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)OC(=O)C=CC6=CC(=C(C=C6)O)OC)C)C,11042-64-1,Negative,in vitro
GARDENIA YELLOW,CC(=CC=CC=C(C)C=CC=C(C)C(=O)OC1C(C(C(C(O1)COC2C(C(C(C(O2)CO)O)O)O)O)O)O)C=CC=C(C)C(=O)OC3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)O,94238-00-3,Negative,In vivo
GEMFIBROZIL,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,25812-30-0,Negative,In vivo
GEMFIBROZIL,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,25812-30-0,Positive,In vivo
GENTIAN VIOLET,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-],548-62-9,Negative,In vivo
GENTIAN VIOLET,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-],548-62-9,Positive,In vivo
Geraniol,CC(=CCC/C(=C/CO)/C)C,106-24-1,Negative,in vivo
Geraniol,CC(=CCC/C(=C/CO)/C)C,106-24-1,Negative,in vitro
"GERMANATE, SODIUM",O.[Na].[Ge],12025-19-3,Negative,In vivo
GIBBERELLIC ACID,CC12C(C=CC3(C1C(C45C3CCC(C4)(C(=C)C5)O)C(=O)O)OC2=O)O,77-06-5,Negative,In vivo
Gibberellins,CC12C(C=CC3(C1C(C45C3CCC(C4)(C(=C)C5)O)C(=O)O)OC2=O)O,77-06-5,Negative,in vivo
Gibberellins,CC12C(C=CC3(C1C(C45C3CCC(C4)(C(=C)C5)O)C(=O)O)OC2=O)O,77-06-5,Negative,in vitro
Glu-P-1,CC1=CC=CN2C1=NC3=C2N=C(C=C3)N,67730-11-4,Positive,In vivo
Glu-P-2,C1=CC2=NC3=C(N2C=C1)N=C(C=C3)N,67730-10-3,Positive,In vivo
Glufosinate-ammonium,CP(=O)(CCC(C(=O)[O-])N)O.[NH4+],77182-82-2,Negative,in vivo
Glufosinate-ammonium,CP(=O)(CCC(C(=O)[O-])N)O.[NH4+],77182-82-2,Negative,in vitro
"Glutaral; Glutaric dialdehyde solution, Pentane-1,5-dial ; protectol GDA; glutaraldehyde
",C(CC=O)CC=O,111-30-8,Positive,in vitro
GLUTARALDEHYDE,C(CC=O)CC=O,111-30-8,Negative,In vivo
"GLYCERIN, NATURAL",C(C(CO)O)O,56-81-5,Negative,In vivo
"GLYCERIN, SYNTHETIC",C(C(CO)O)O,56-81-5,Negative,In vivo
GLYCEROL alpha-MONOCHLOROHYDRIN,C(C(CCl)O)O,96-24-2,Negative,In vivo
Glycidaldehyde,C1C(O1)C=O,765-34-4,Negative,In vivo
Glycidaldehyde,C1C(O1)C=O,765-34-4,Positive,in vitro
Glycidamide,C1C(O1)C(=O)N,5694-00-8,Positive,in vitro
GLYCIDOL,C1C(O1)CO,556-52-5,Positive,In vivo
Glycidol,C1C(O1)CO,556-52-5,Positive,in vitro
Glycidyl 4-nitrobenzoate R- and S-isomers,CCCCCCCCCCCCCCCCCC(=O)OCC(CO)(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC,28188-24-1,Positive,in vitro
GLYCINE,C(C(=O)O)N,56-40-6,Positive,In vivo
"GLYCYRRHIZINATE, DISODIUM",CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)[O-])O)O)OC5C(C(C(C(O5)C(=O)[O-])O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C.[Na+].[Na+],71277-79-7,Negative,In vivo
Glyoxal (40% in water),C(=O)C=O,107-22-2,Positive,in vitro
Glyphosate,C(C(=O)O)NCP(=O)(O)O,1071-83-6,Positive,in vivo
Glyphosate,C(C(=O)O)NCP(=O)(O)O,1071-83-6,Negative,in vivo
Glyphosate,C(C(=O)O)NCP(=O)(O)O,1071-83-6,Negative,in vitro
GRISEOFULVIN,CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC,126-07-8,Negative,In vivo
GRISEOFULVIN,CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC,126-07-8,Positive,In vivo
Gum arabic,CC.CC.CC.CC.CC.CC,9000-01-5,Positive,in vitro
Halosulfuron-methyl,CN1C(=C(C(=N1)Cl)C(=O)OC)S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC,100784-20-1,Negative,in vivo
Halosulfuron-methyl,CN1C(=C(C(=N1)Cl)C(=O)OC)S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC,100784-20-1,Negative,in vitro
Haloxyfop-methyl,CC(C(=O)OC)OC1=CC=C(C=C1)OC2=C(C=C(C=N2)C(F)(F)F)Cl,69806-40-2,Negative,In vivo
Haloxyfop-P,C[C@H](C(=O)O)OC1=CC=C(C=C1)OC2=C(C=C(C=N2)C(F)(F)F)Cl,95977-29-0,Negative,in vivo
Haloxyfop-P,C[C@H](C(=O)O)OC1=CC=C(C=C1)OC2=C(C=C(C=N2)C(F)(F)F)Cl,95977-29-0,Negative,in vitro
Harmony,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=C(SC=C2)C(=O)OC,79277-27-3,Negative,In vivo
HC Blue 12 - COLIPA B073,C=C1CCC2C(C3C1CC(=O)C34CCC5(CCC6C(C7C5=C4C(=O)C7=C)OC(=O)C6=C)O)OC(=O)C2=C,87606-12-0,Positive,in vitro
HC Blue 14 -  COLIPA C172,C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCC(CO)O)NCC(CO)O,99788-75-7,Negative,in vitro
HC Blue 2 -   COLIPA B037,C1=CC(=C(C=C1N(CCO)CCO)[N+](=O)[O-])NCCO,33229-34-4,Positive,in vitro
HC BLUE NO. 1,CNC1=C(C=C(C=C1)N(CCO)CCO)[N+](=O)[O-],2784-94-3,Positive,In vivo
HC BLUE NO. 1 (PURIFIED),CNC1=C(C=C(C=C1)N(CCO)CCO)[N+](=O)[O-],2784-94-3,Positive,In vivo
HC Green 1 - COLIPA C129,C1=CC(=CC=C1NC2=CC(=O)C(=CC2=O)NCCO)N(CCO)CCO,52136-25-1,Positive,in vitro
HC Orange 3 - COLIPA B68,C1=CC(=C(C=C1OCC(CO)O)[N+](=O)[O-])NCCO,81612-54-6,Negative,in vitro
HC Red 3 -  COLIPA B050,C1=CC(=C(C=C1N)[N+](=O)[O-])NCCO,2871-01-4,Positive,in vitro
HC Red 7 - COLIPA B036,C1=CC(=C(C=C1NCCO)[N+](=O)[O-])N,24905-87-1,Positive,in vitro
HC violet 1 - COLIPA B066,CC1=CC(=C(C=C1NCCO)[N+](=O)[O-])N,82576-75-8,Negative,in vitro
HC Yellow 11 - COLIPA B063,C1=CC(=C(C=C1[N+](=O)[O-])O)NCCO,73388-54-2,Positive,in vitro
HC Yellow 4 - COLIPA B038,C1=CC(=C(C=C1[N+](=O)[O-])OCCO)NCCO,59820-43-8,Negative,in vitro
HC Yellow No. 2 submission II COLIPA B041,C1=CC=C(C(=C1)NCCO)[N+](=O)[O-],4926-55-0,Positive,in vitro
Heliothrine,CC(C)C(C(C)OC)(C(=O)OCC1=CCN2C1C(CC2)O)O,303-33-3,Positive,in vitro
HEMATOXYLIN,C1C2=CC(=C(C=C2C3C1(COC4=C3C=CC(=C4O)O)O)O)O,517-28-2,Positive,In vivo
Heptachlor,C1=CC(C2C1C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl)Cl,76-44-8,Positive,In vivo
HEPTACHLOR,C1=CC(C2C1C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl)Cl,76-44-8,Negative,In vivo
Heptachlor epoxide,C12C(C(C3C1O3)Cl)C4(C(=C(C2(C4(Cl)Cl)Cl)Cl)Cl)Cl,1024-57-3,Positive,In vivo
Heptane,CCCCCCC,142-82-5,Negative,In vivo
HEPTYLAMINE,CCCCCCCN,111-68-2,Negative,In vivo
Hexabromobenzene,C1(=C(C(=C(C(=C1Br)Br)Br)Br)Br)Br,87-82-1,Negative,In vivo
Hexabromocyclododecane (HBCD),C1CC(C(CCC(C(CCC(C1Br)Br)Br)Br)Br)Br,3194-55-6,Negative,In vivo
Hexabromodiphenyl ether,C1=C(C(=CC(=C1Br)Br)Br)OC2=CC(=C(C=C2Br)Br)Br,68631-49-2,Negative,In vivo
Hexabromodiphenyl ether (BDE-153),C1=C(C(=CC(=C1Br)Br)Br)OC2=CC(=C(C=C2Br)Br)Br,68631-49-2,Negative,In vivo
HEXACHLOROBENZENE,C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)Cl,118-74-1,Positive,In vivo
HEXACHLOROBENZENE,C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)Cl,118-74-1,Negative,In vivo
Hexachlorobutadiene,C(=C(Cl)Cl)(C(=C(Cl)Cl)Cl)Cl,87-68-3,Positive,In vivo
HEXACHLOROBUTADIENE,C(=C(Cl)Cl)(C(=C(Cl)Cl)Cl)Cl,87-68-3,Negative,In vivo
Hexachlorocyclohexane (alpha-HCH),C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,319-84-6,Positive,In vivo
Hexachlorocyclohexane (beta-HCH),C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,319-85-7,Positive,In vivo
Hexachlorocyclohexane (delta-HCH),C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,319-86-8,Negative,In vivo
Hexachlorocyclohexane (epsilon-HC),C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,6108-10-7,Negative,In vivo
Hexachlorocyclohexane (gamma-HCH),C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,58-89-9,Negative,In vivo
Hexachlorocyclohexane (t-HCH),C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,608-73-1,Positive,In vivo
"HEXACHLOROCYCLOHEXANE, TECHNICAL GRADE",C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl,608-73-1,Positive,In vivo
Hexachlorocyclopentadiene,C1(=C(C(C(=C1Cl)Cl)(Cl)Cl)Cl)Cl,77-47-4,Negative,in vitro
Hexachlorocyclopentadiene (HCCPD),C1(=C(C(C(=C1Cl)Cl)(Cl)Cl)Cl)Cl,77-47-4,Negative,In vivo
"Hexachlorodibenzo-p-dioxin (HxCDD), mixture of 1,2,3,6,7,8-HxCDD and 1,2,3,7,8,9-HxCDD",C1=C2C(=C(C(=C1Cl)Cl)Cl)OC3=CC(=C(C(=C3O2)Cl)Cl)Cl,57653-85-7,Positive,In vivo
Hexachloroethane,C(C(Cl)(Cl)Cl)(Cl)(Cl)Cl,67-72-1,Positive,In vivo
Hexachloroethane,C(C(Cl)(Cl)Cl)(Cl)(Cl)Cl,67-72-1,Negative,in vitro
hexachloroiridium(2-);hydron,[H+].[H+].Cl[Ir-2](Cl)(Cl)(Cl)(Cl)Cl,,Positive,in vitro
HEXACHLOROPHENE,C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl,70-30-4,Negative,In vivo
hexachloroplatinum(2-);hydron,[H+].[H+].Cl[Pt-2](Cl)(Cl)(Cl)(Cl)Cl,,Positive,in vitro
hexachlorotungsten,Cl[W](Cl)(Cl)(Cl)(Cl)Cl,13283-01-07,Negative,in vitro
"hexacyclo[10.10.2.02,7.08,24.015,23.016,21]tetracosa-1(22),2,4,6,8,10,12(24),13,15(23),16,18,20-dodecaene",C1=CC=C2C3=C4C(=CC2=C1)C5=CC=CC=C5C6=CC=CC(=C64)C=C3,9126,Positive,In Vivo
"hexacyclo[10.10.2.02,7.08,24.015,23.016,21]tetracosa-1(22),2,4,6,8,10,12(24),13,15(23),16,18,20-dodecaene",C1=CC=C2C3=C4C(=CC2=C1)C5=CC=CC=C5C6=CC=CC(=C64)C=C3,192-65-4,Positive,in vivo
"hexacyclo[10.10.2.02,7.08,24.015,23.017,22]tetracosa-1(23),2,4,6,8,10,12(24),13,15,17,19,21-dodecaene",C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2C6=CC=CC=C6C5=CC=C4,9119,Positive,In Vivo
"hexacyclo[10.10.2.02,7.08,24.015,23.017,22]tetracosa-1(23),2,4,6,8,10,12(24),13,15,17,19,21-dodecaene",C1=CC=C2C(=C1)C=C3C=CC4=C5C3=C2C6=CC=CC=C6C5=CC=C4,191-30-0,Positive,in vivo
"hexacyclo[10.10.2.02,7.08,24.015,23.017,22]tetracosa-1(23),2,4,6,8,10,12(24),13,15,17(22),20-undecaene-18,19-diol",C1=CC=C2C(=C1)C3=CC=CC4=C3C5=C2C6=C(C=C5C=C4)C(C(C=C6)O)O,114983,Positive,In Vivo
"hexacyclo[10.10.2.02,7.08,24.015,23.017,22]tetracosa-1(23),2,4,6,8(24),9,11,15,17,19,21-undecaene-13,14-diol",C1=CC=C2C(=C1)C=C3C(C(C4=CC=CC5=C4C3=C2C6=CC=CC=C56)O)O,125404,Negative,In Vivo
"hexacyclo[10.10.2.02,7.09,23.013,18.020,24]tetracosa-1(23),2,4,6,8,10,12(24),13,15,17,19,21-dodecaene",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC6=CC=CC=C56)C=C3,9108,Positive,In Vivo
"hexacyclo[10.10.2.02,7.09,23.013,18.020,24]tetracosa-1(23),2,4,6,8,10,12(24),13,15,17,19,21-dodecaene",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC6=CC=CC=C56)C=C3,189-64-0,Positive,in vivo
"hexacyclo[10.10.2.02,7.09,23.013,18.020,24]tetracosa-1(23),2,4,6,9,11,13,15,17,20(24),21-undecaene-8,19-dione",C1=CC=C2C(=C1)C3=C4C(=CC=C5C4=C(C=C3)C(=O)C6=CC=CC=C65)C2=O,31412,Negative,In Vivo
"hexacyclo[10.10.2.02,7.09,23.013,18.020,24]tetracosa-1(23),2,4,6,9,11,13,15,17,20(24),21-undecaene-8,19-dione",C1=CC=C2C(=C1)C3=C4C(=CC=C5C4=C(C=C3)C(=O)C6=CC=CC=C65)C2=O,31412,Positive,In Vivo
"hexacyclo[10.10.2.02,7.09,23.014,19.020,24]tetracosa-1(23),2,4,6,8,10,12,14,16,18,20(24),21-dodecaene",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=CC6=CC=CC=C6C(=C54)C=C3,9106,Positive,In Vivo
"hexacyclo[10.10.2.02,7.09,23.014,19.020,24]tetracosa-1(23),2,4,6,8,10,12,14,16,18,20(24),21-dodecaene",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=CC6=CC=CC=C6C(=C54)C=C3,189-55-9,Positive,in vivo
"hexacyclo[10.10.2.02,7.09,23.014,19.020,24]tetracosa-1(23),2,4,6,8,10,12,14,16,18,20(24),21-dodecaene",C1=CC=C2C3=C4C(=CC2=C1)C=CC5=CC6=CC=CC=C6C(=C54)C=C3,189-55-9,Positive,in vitro
"hexacyclo[11.7.1.14,20.02,11.03,8.017,21]docosa-1,3(8),4,6,9,11,13,15,17(21),18,20(22)-undecaene",C1=CC2=C3C(=C1)C=C4C=CC5=C6C4=C3C(=CC6=CC=C5)C=C2,9118,Positive,In Vivo
"hexacyclo[11.7.1.14,20.02,11.03,8.017,21]docosa-1,3(8),4,6,9,11,13,15,17(21),18,20(22)-undecaene",C1=CC2=C3C(=C1)C=C4C=CC5=C6C4=C3C(=CC6=CC=C5)C=C2,191-26-4,Positive,in vitro
"hexacyclo[11.7.1.14,20.02,11.03,8.017,21]docosa-1(20),2(11),3(8),4(22),9,12,17(21),18-octaene",C1CC2=C3C(=CC4=C5C3=C(C=C2)C=C6C5=C(CCC6)C=C4)C1,,Positive,in vitro
"hexacyclo[11.7.1.14,20.02,11.03,8.017,21]docosa-1(21),2(11),3(8),4,6,9,12,14,16,20(22)-decaene",C1CC2=CC3=CC=CC4=C3C5=C(C=C4)C=C6C=CC=C1C6=C25,,Positive,in vitro
"hexacyclo[12.8.0.02,11.03,8.04,21.017,22]docosa-1(14),2(11),3(8),4,6,9,12,15,17(22),18,20-undecaene",C1=CC2=C3C(=C1)C4=CC=CC5=C4C6=C(C=C5)C=CC(=C36)C=C2,9117,Negative,In Vivo
"hexacyclo[16.3.1.02,7.08,21.011,20.014,19]docosa-1(22),2,4,6,8(21),9,11(20),12,14(19),15,17-undecaene",C1=CC=C2C(=C1)C3=C4C2=CC5=CC=CC6=C5C4=C(C=C6)C=C3,9131,Positive,In Vivo
"hexacyclo[16.3.1.02,7.08,21.011,20.014,19]docosa-1(22),2,4,6,8(21),9,11(20),12,14(19),15,17-undecaene",C1=CC=C2C(=C1)C3=C4C2=CC5=CC=CC6=C5C4=C(C=C6)C=C3,193-39-5,Positive,in vivo
"Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)",C1N(CN(CN1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],121-82-4,Positive,In vivo
Hexamethylene diisocyanate,C(CCCN=C=O)CCN=C=O,822-06-0,Negative,In vivo
HEXAMETHYLENETETRAMINE,C1N2CN3CN1CN(C2)C3,100-97-0,Negative,In vivo
Hexamethylenetetramine,C1N2CN3CN1CN(C2)C3,100-97-0,Positive,in vitro
HEXAMETHYLMELAMINE,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,531-18-0,Positive,In vivo
HEXAMETHYLPHOSPHORAMIDE,CN(C)P(=O)(N(C)C)N(C)C,680-31-9,Positive,In vivo
HEXANAL METHYLFORMYLHYDRAZONE,CCCCCC=NN(C)C=O,57590-22-4,Positive,In vivo
HEXANAMIDE,CCCCCC(=O)N,628-02-4,Negative,In vivo
HEXANAMIDE,CCCCCC(=O)N,628-02-4,Positive,In vivo
Hexane,CCCCCC,110-54-3,Negative,In vivo
"HEXANE, COMMERCIAL GRADE (52% n-HEXANE, 16% 3-METHYLCYCLOPENTANE, 16% METHYLCYCLOPENTANE)",CCCCCC,110-54-3,Negative,In vivo
"HEXANE, COMMERCIAL GRADE (52% n-HEXANE, 16% 3-METHYLCYCLOPENTANE, 16% METHYLCYCLOPENTANE)",CCCCCC,110-54-3,Positive,In vivo
hexanedioic acid,C(CCC(=O)O)CC(=O)O,0124-04-09,Negative,in vitro
Hexanone,CCCCC(=O)C,591-78-6,Negative,In vivo
Hexazinone,CN1C(=NC(=O)N(C1=O)C2CCCCC2)N(C)C,51235-04-02,Negative,In vivo
Hexythiazox,C[C@H]2[C@@H](SC(=O)N2C(=O)NC1CCCCC1)c3ccc(Cl)cc3,78587-05-0,Negative,in vivo
Hexythiazox,C[C@H]2[C@@H](SC(=O)N2C(=O)NC1CCCCC1)c3ccc(Cl)cc3,78587-05-0,Negative,in vitro
"Hinosan o-ethyl-S,S-diphenyldithiophosphate",CCOP(=O)(SC1=CC=CC=C1)SC2=CC=CC=C2,17109-49-8,Negative,in vitro
Hycanthone,CCN(CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O,3105-97-3,Positive,in vitro
Hycanthone methanesulfonate,CCN(CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O.CS(=O)(=O)O,23255-93-8,Positive,in vitro
HYDRAZINE,NN,302-01-2,Positive,In vivo
hydrazine,NN,9321,Negative,In Vivo
HYDRAZINE,NN,302-01-2,Negative,In vivo
hydrazine,NN,9321,Positive,In Vivo
hydrazine,NN,0302-01-02,Positive,in vivo
HYDRAZINE SULFATE,NN.OS(=O)(=O)O,10034-93-2,Negative,In vivo
HYDRAZINE SULFATE,NN.OS(=O)(=O)O,10034-93-2,Positive,In vivo
hydrazine;dihydrochloride,NN.Cl.Cl,5341-61-7,Positive,in vitro
hydrazine;hydrate,NN.O,7803-57-8,Positive,in vitro
hydrazine;hydrochloride,NN.Cl,2644-70-4,Positive,in vitro
hydrazine;sulfuric acid,NN.OS(=O)(=O)O,24842,Positive,In Vivo
hydrazine;sulfuric acid,NN.OS(=O)(=O)O,,Negative,in vivo
hydrazine;sulfuric acid,NN.OS(=O)(=O)O,,Positive,in vivo
hydrazine;sulfuric acid,NN.OS(=O)(=O)O,,Negative,in vitro
Hydrazine/Hydrazine sulfate,NN,0302-01-02,Positive,In vivo
Hydrazobenzene,C1=CC=C(C=C1)NNC2=CC=CC=C2,122-66-7,Positive,in vitro
Hydrazoic acid,N=[N+]=[N-],7782-79-8,Positive,in vitro
HYDROCHLORIC ACID,Cl,7647-01-0,Negative,In vivo
HYDROCHLOROFLUOROCARBON 123,C(C(F)(F)F)(Cl)Cl,306-83-2,Positive,In vivo
HYDROCORTISONE,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,50-23-7,Negative,In vivo
Hydrogen chloride,Cl,7647-01-0,Negative,In vivo
Hydrogen Cyanide and Cyanide Salts,C#N,27072-02-02,Negative,In vivo
hydrogen peroxide,OO,784,Positive,In Vivo
HYDROGEN PEROXIDE,OO,7722-84-1,Positive,In vivo
Hydrogen Peroxide,OO,7722-84-1,Positive,in vitro
hydrogen peroxide;iron(2+);sulfuric acid,OO.OS(=O)(=O)O.[Fe+2],36047-38-8,Positive,in vitro
hydrogen sulfate;4-hydroxybenzenediazonium,C1=CC(=CC=C1[N+]#N)O.OS(=O)(=O)[O-],24849108,Negative,In Vivo
hydrogen sulfate;4-hydroxybenzenediazonium,C1=CC(=CC=C1[N+]#N)O.OS(=O)(=O)[O-],24849108,Positive,In Vivo
hydrogen sulfate;methylaminoazanium,CN[NH3+].OS(=O)(=O)[O-],9323,Positive,In Vivo
Hydrogen sulfide,S,7783-06-04,Negative,In vivo
hydrogen sulfite;4-(hydroxymethyl)benzenediazonium,C1=CC(=CC=C1CO)[N+]#N.OS(=O)[O-],91827143,Positive,In Vivo
Hydroquinone,C1=CC(=CC=C1O)O,123-31-9,Negative,In vivo
HYDROQUINONE MONOBENZYL ETHER,C1=CC=C(C=C1)COC2=CC=C(C=C2)O,103-16-2,Negative,In vivo
hydroxy(oxo)iron;iron,O[Fe]=O.O[Fe]=O.[Fe],14789,Negative,In Vivo
hydroxy(oxo)iron;iron,O[Fe]=O.O[Fe]=O.[Fe],,Negative,in vitro
hydroxyazanium;chloride,[NH3+]O.[Cl-],,Negative,in vitro
Hydroxybenzomorpholine - COLIPA A25,C1COC2=C(N1)C=C(C=C2)O,26021-57-8,Negative,in vitro
hydroxylamine,NO,7803-49-8,Negative,in vitro
hydroxymethylperoxymethanol,C(O)OOCO,17088-73-2,Positive,in vitro
Hydroxypropyl acrylate,CC(COC(=O)C=C)O,25584-83-2,Positive,in vitro
hydroxyurea,C(=O)(N)NO,0127-07-01,Positive,in vivo
Hydroxyurea,C(=O)(N)NO,0127-07-01,Positive,in vitro
Hydroxyurethane,CCOC(=O)NO,589-41-3,Positive,in vitro
Hymexazol,O=C1C=C(C)ON1,10004-44-1,Negative,in vivo
Hymexazol,O=C1C=C(C)ON1,10004-44-1,Positive,in vivo
Hymexazol,O=C1C=C(C)ON1,10004-44-1,Negative,in vitro
ICR 170,CCN(CCCNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC)CCCl.Cl.Cl,146-59-8,Positive,in vitro
Imazalil,C=CCOC(CN1C=CN=C1)C2=C(C=C(C=C2)Cl)Cl,35554-44-0,Negative,in vivo
Imazalil,C=CCOC(CN1C=CN=C1)C2=C(C=C(C=C2)Cl)Cl,35554-44-0,Negative,in vitro
Imazaquin,CC(C)C1(C(=O)NC(=N1)C2=NC3=CC=CC=C3C=C2C(=O)O)C,81335-37-7,Negative,in vivo
Imazaquin,CC(C)C1(C(=O)NC(=N1)C2=NC3=CC=CC=C3C=C2C(=O)O)C,81335-37-7,Negative,in vitro
Imidacloprid,C1CN(/C(=N/[N+](=O)[O-])/N1)CC2=CN=C(C=C2)Cl,138261-41-3,Negative,in vivo
Imidacloprid,C1CN(/C(=N/[N+](=O)[O-])/N1)CC2=CN=C(C=C2)Cl,138261-41-3,Negative,in vitro
imidazolidine-2-thione,C1CNC(=S)N1,96-45-7,Negative,in vivo
imidazolidine-2-thione,C1CNC(=S)N1,2723650,Positive,In Vivo
imidazolidine-2-thione,C1CNC(=S)N1,96-45-7,Positive,in vivo
imidazolidine-2-thione,C1CNC(=S)N1,96-45-7,Negative,in vitro
"IMINODIACETIC ACID, MONOSODIUM",C(C(=O)O)NCC(=O)[O-].[Na+],32607-00-4,Negative,In vivo
"Indeno[1,2,3-cd]pyrene",C1=CC=C2C(=C1)C3=C4C2=CC5=CC=CC6=C5C4=C(C=C6)C=C3,193-39-5,Negative,In vivo
indiganylidynephosphane,P#[In],31170,Positive,In Vivo
INDOLE,C1=CC=C2C(=C1)C=CN2,120-72-9,Negative,In vivo
INDOLE-3-ACETIC ACID,C1=CC=C2C(=C1)C(=CN2)CC(=O)O,87-51-4,Negative,In vivo
INDOLIDAN,CC1(C2=C(C=CC(=C2)C3=NNC(=O)CC3)NC1=O)C,100643-96-7,Positive,In vivo
Indolylbutyric acid,OC(=O)CCCc1c[nH]c2ccccc12,133-32-4,Negative,in vivo
Indolylbutyric acid,OC(=O)CCCc1c[nH]c2ccccc12,133-32-4,Negative,in vitro
INDOMETHACIN,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,53-86-1,Positive,In vivo
Iodinated glycerol,CC(C1OCC(O1)CO)I,5634-39-9,Positive,in vitro
IODOACETAMIDE,C(C(=O)N)I,144-48-9,Negative,In vivo
iodoform,C(I)(I)I,6374,Negative,In Vivo
Iodoform,C(I)(I)I,75-47-8,Negative,in vitro
iodomethane,CI,6328,Positive,In Vivo
iodomethane,CI,74-88-4,Positive,in vivo
iodomethane,CI,74-88-4,Positive,in vitro
Iodotrifluoromethane,C(F)(F)(F)I,2314-97-8,Positive,in vitro
IPAZILIDE FUMARATE,CCN(CC)CCCNC(=O)CN1C(=C(C=N1)C2=CC=CC=C2)C3=CC=CC=C3.C(=CC(=O)O)C(=O)O,115436-74-3,Negative,In vivo
Ipconazole,OC1(CN3N=CN=C3)C(CC2=CC=C(Cl)C=C2)CCC1C(C)C,125225-28-7,Negative,in vivo
Ipconazole,OC1(CN3N=CN=C3)C(CC2=CC=C(Cl)C=C2)CCC1C(C)C,125225-28-7,Negative,in vitro
Iprodione,CC(C)NC(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,36734-19-7,Negative,In vivo
Iprovalicarb,CC1=CC=C(C=C1)C(C)NC(=O)C(C(C)C)NC(=O)OC(C)C,,Negative,in vivo
Iprovalicarb,CC1=CC=C(C=C1)C(C)NC(=O)C(C(C)C)NC(=O)OC(C)C,,Negative,in vitro
IQ,CN1C2=C(C3=C(C=C2)N=CC=C3)N=C1N,76180-96-6,Positive,In vivo
Iron sulfate anhydrous,[O-]S(=O)(=O)[O-].[Fe+2],7720-78-7,Negative,in vivo
Iron sulfate anhydrous,[O-]S(=O)(=O)[O-].[Fe+2],7720-78-7,Negative,in vitro
iron;nickel,[Fe].[Ni],10080372,Negative,In Vivo
iron(2+);sulfate,[O-]S(=O)(=O)[O-].[Fe+2],7720-78-7,Negative,in vitro
iron(2+);sulfate;heptahydrate,O.O.O.O.O.O.O.[O-]S(=O)(=O)[O-].[Fe+2],7782-63-0,Negative,in vitro
"iron(3+);(2R,3S,4S,5S)-2,3,4,5,6-pentahydroxy-6-oxohexanoate",[C@H]([C@@H]([C@H](C(=O)[O-])O)O)([C@@H](C(=O)O)O)O.[C@H]([C@@H]([C@H](C(=O)[O-])O)O)([C@@H](C(=O)O)O)O.[C@H]([C@@H]([C@H](C(=O)[O-])O)O)([C@@H](C(=O)O)O)O.[Fe+3],24849109,Positive,In Vivo
iron(3+);nickel(2+);tetrasulfide,[S-2].[S-2].[S-2].[S-2].[Fe+3].[Ni+2].[Ni+2].[Ni+2].[Ni+2],197200,Positive,In Vivo
iron(3+);oxygen(2-),[O-2].[O-2].[O-2].[Fe+3].[Fe+3],14833,Negative,In Vivo
iron(3+);trichloride;hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Fe+3],,Negative,in vitro
IRSOGLADINE MALEATE,C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl.C(=CC(=O)O)C(=O)O,84504-69-8,Negative,In vivo
ISATIDINE,CC=C1CC(C(C(=O)OCC2=CC[N+]3(C2C(CC3)OC1=O)[O-])(CO)O)C,15503-86-3,Positive,In vivo
Isobutene,CC(=C)C,115-11-7,Negative,in vitro
Isobutyl alcohol,CC(C)CO,78-83-1,Negative,In vivo
Isobutyl nitrite,CC(C)CON=O,542-56-3,Positive,in vitro
ISOBUTYL p-HYDROXYBENZOATE,CC(C)COC(=O)C1=CC=C(C=C1)O,4247-02-3,Negative,In vivo
Isobutyraldehyde,CC(C)C=O,78-84-2,Positive,in vitro
Isoeugenol,CC=CC1=CC(=C(C=C1)O)OC,97-54-1,Negative,in vitro
ISOFLURANE,C(C(F)(F)F)(OC(F)F)Cl,26675-46-7,Negative,In vivo
ISOMALT,C(C1C(C(C(C(O1)OCC(C(C(C(CO)O)O)O)O)O)O)O)O,64519-82-0,Negative,In vivo
ISOMAZOLE,COC1=C(C=CC(=C1)S(=O)C)C2=NC3=C(N2)C=NC=C3,86315-52-8,Positive,In vivo
ISONIAZID,C1=CN=CC=C1C(=O)NN,54-85-3,Negative,In vivo
ISONIAZID,C1=CN=CC=C1C(=O)NN,54-85-3,Positive,In vivo
Isoniazid,C1=CN=CC=C1C(=O)NN,54-85-3,Positive,in vitro
ISONICOTINAMIDE,C1=CN=CC=C1C(=O)N,1453-82-3,Negative,In vivo
ISONICOTINIC ACID,C1=CN=CC=C1C(=O)O,55-22-1,Negative,In vivo
ISONICOTINIC ACID VANILLYLIDENEHYDRAZIDE,COC1=C(C=CC(=C1)C=NNC(=O)C2=CC=NC=C2)O,149-17-7,Positive,In vivo
Isophorone,CC1=CC(=O)CC(C1)(C)C,78-59-1,Positive,In vivo
Isophosphamide,C1CN(P(=O)(OC1)NCCCl)CCCl,3778-73-2,Positive,in vitro
ISOPRENE,CC(=C)C=C,78-79-5,Positive,In vivo
Isoprene,CC(=C)C=C,78-79-5,Negative,in vitro
Isopropalin,CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])C(C)C)[N+](=O)[O-],33820-53-0,Negative,In vivo
ISOPROPANOL,CC(C)O,67-63-0,Negative,In vivo
Isopropyl methanesulfonate,CN(C)CC#N,926-64-7,Positive,in vitro
Isopropyl methyl phosphonic acid (IMPA),CC(C)OP(=O)(C)O,1832-54-8,Negative,In vivo
ISOPROPYL-N-(3-CHLOROPHENYL)CARBAMATE,CC(C)OC(=O)NC1=CC(=CC=C1)Cl,101-21-3,Negative,In vivo
ISOPROPYL-N-PHENYL CARBAMATE,CC(C)OC(=O)NC1=CC=CC=C1,122-42-9,Negative,In vivo
Isoproturon,CC(C)C1=CC=C(C=C1)NC(=O)N(C)C,34123-59-6,Negative,in vivo
Isoproturon,CC(C)C1=CC=C(C=C1)NC(=O)N(C)C,34123-59-6,Positive,in vivo
Isoproturon,CC(C)C1=CC=C(C=C1)NC(=O)N(C)C,34123-59-6,Negative,in vitro
Isopyrazam,CC(C)C1C2CCC1C3=C2C=CC=C3NC(=O)C4=CN(N=C4C(F)F)C,881685-58-1,Negative,in vivo
Isopyrazam,CC(C)C1C2CCC1C3=C2C=CC=C3NC(=O)C4=CN(N=C4C(F)F)C,881685-58-1,Negative,in vitro
Isoxaben,CCC(C)(CC)C1=NOC(=C1)NC(=O)C2=C(C=CC=C2OC)OC,82558-50-7,Negative,in vivo
Isoxaben,CCC(C)(CC)C1=NOC(=C1)NC(=O)C2=C(C=CC=C2OC)OC,82558-50-7,Positive,in vivo
Isoxaben,CCC(C)(CC)C1=NOC(=C1)NC(=O)C2=C(C=CC=C2OC)OC,82558-50-7,Negative,in vitro
Isoxaflutole,CS(=O)(=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C2=C(ON=C2)C3CC3,141112-29-0,Negative,in vivo
Isoxaflutole,CS(=O)(=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C2=C(ON=C2)C3CC3,141112-29-0,Negative,in vitro
IVERMECTIN,CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C,70288-86-7,Negative,In vivo
JOSAMYCIN,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)OC(=O)C)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O,16846-24-5,Negative,In vivo
Kaemferol ,C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O,520-18-3,Positive,in vitro
KAEMPFEROL,C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O,520-18-3,Negative,In vivo
KANECHLOR 400,C1=C(C=C(C=C1Cl)Cl)C2=CC(=CC(=C2)Cl)Cl,12737-87-0,Negative,In vivo
Kepone Chlordecone,C1(=O)C2(C3(C4(C1(C5(C2(C3(C(C45Cl)(Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl,143-50-0,Negative,in vitro
Ketene,C=C=O,463-51-4,Positive,in vitro
Kilakar [Proclonol],C1CC1C(C2=CC=C(C=C2)Cl)(C3=CC=C(C=C3)Cl)O,14088-71-2,Positive,in vitro
KOJIC ACID,C1=C(OC=C(C1=O)O)CO,501-30-4,Positive,In vivo
Kojic Acid ,C1=C(OC=C(C1=O)O)CO,501-30-4,Positive,in vitro
Kresoxim-methyl,CC1=CC=CC=C1OCC2=CC=CC=C2/C(=N\OC)/C(=O)OC,143390-89-0,Negative,in vivo
Kresoxim-methyl,CC1=CC=CC=C1OCC2=CC=CC=C2/C(=N\OC)/C(=O)OC,143390-89-0,Negative,in vitro
l-5-MORPHOLINOMETHYL-3-[(5-NITROFURFURYLIDENE)AMINO]-2-OXAZOLIDINONE.HCl,C1COCCN1CC2CN(C(=O)O2)N=CC3=CC=C(O3)[N+](=O)[O-].Cl,3031-51-4,Positive,In vivo
"l-ASCORBATE, SODIUM",C(C(C1C(=C(C(=O)O1)O)[O-])O)O.[Na+],134-03-2,Negative,In vivo
L-ascorbic acid,C(C(C1C(=C(C(=O)O1)O)O)O)O,50-81-7,Negative,in vivo
L-ascorbic acid,C(C(C1C(=C(C(=O)O1)O)O)O)O,50-81-7,Negative,in vitro
l-CYSTEINE.HCl,C(C(C(=O)O)N)S.Cl,52-89-1,Negative,In vivo
l-GLUTAMIC ACID,C(CC(=O)O)C(C(=O)O)N,56-86-0,Negative,In vivo
l-HISTIDINE.HCl,C1=C(NC=N1)CC(C(=O)O)N.Cl,645-35-2,Negative,In vivo
l-MONOSODIUM GLUTAMATE,C(CC(=O)O)C(C(=O)[O-])N.[Na+],142-47-2,Negative,In vivo
l-TRYPTOPHAN,C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N,73-22-3,Negative,In vivo
Lactofen,CCOC(=O)C(C)OC(=O)C1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],77501-63-4,Negative,In vivo
Lambda-cyhalothrin,CC1([C@@H]([C@@H]1C(=O)O[C@@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)/C=C(/C(F)(F)F)\Cl)C,91465-08-6,Negative,in vivo
Lambda-cyhalothrin,CC1([C@@H]([C@@H]1C(=O)O[C@@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)/C=C(/C(F)(F)F)\Cl)C,91465-08-06,Negative,in vitro
LASIOCARPINE,CC=C(C)C(=O)OC1CCN2C1C(=CC2)COC(=O)C(C(C)OC)(C(C)(C)O)O,303-34-4,Positive,In vivo
Lasiocarpine,CC=C(C)C(=O)OC1CCN2C1C(=CC2)COC(=O)C(C(C)OC)(C(C)(C)O)O,303-34-4,Positive,in vitro
lead,[Pb],7439-92-1,Positive,in vivo
lead,[Pb],7439-92-1,Negative,in vitro
LEAD ACETATE,CC(=O)[O-].CC(=O)[O-].[Pb+2],301-04-2,Negative,In vivo
LEAD ACETATE,CC(=O)[O-].CC(=O)[O-].[Pb+2],301-04-2,Positive,In vivo
Lead Acetate,CC(=O)[O-].CC(=O)[O-].[Pb+2],301-04-2,Positive,in vitro
"LEAD ACETATE, BASIC",CC(=O)[O-].CC(=O)[O-].[OH-].[OH-].[OH-].[OH-].[Pb+2].[Pb+2].[Pb+2],1335-32-6,Positive,In vivo
"LEAD ACETATE, BASIC",CC(=O)[O-].CC(=O)[O-].[OH-].[OH-].[OH-].[OH-].[Pb+2].[Pb+2].[Pb+2],1335-32-6,Negative,In vivo
Lead and compounds (inorganic),[Pb],7439-92-1,Negative,In vivo
Lead dimethyldithiocarbamate,CN(C)C(=S)S[Pb]SC(=S)N(C)C,19010-66-3,Positive,in vitro
lead(2+);diacetate,CC(=O)[O-].CC(=O)[O-].[Pb+2],0301-04-02,Positive,in vivo
lead(2+);diacetate,CC(=O)[O-].CC(=O)[O-].[Pb+2],9317,Negative,In Vivo
lead(2+);diacetate,CC(=O)[O-].CC(=O)[O-].[Pb+2],9317,Positive,In Vivo
lead(2+);diacetate,CC(=O)[O-].CC(=O)[O-].[Pb+2],0301-04-02,Negative,in vitro
lead(2+);diacetate;tetrahydroxide,CC(=O)[O-].CC(=O)[O-].[OH-].[OH-].[OH-].[OH-].[Pb+2].[Pb+2].[Pb+2],5284406,Positive,In Vivo
lead(2+);diacetate;tetrahydroxide,CC(=O)[O-].CC(=O)[O-].[OH-].[OH-].[OH-].[OH-].[Pb+2].[Pb+2].[Pb+2],1335-32-6,Positive,in vivo
lead(2+);diacetate;trihydrate,CC(=O)[O-].CC(=O)[O-].O.O.O.[Pb+2],,Positive,in vitro
lead(2+);diphosphate,[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Pb+2].[Pb+2].[Pb+2],,Positive,in vivo
lead(2+);diphosphate,[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Pb+2].[Pb+2].[Pb+2],24009,Positive,In Vivo
lead(2+);sulfate,[O-]S(=O)(=O)[O-].[Pb+2],7446-14-2,Positive,in vitro
lead(2+);tetraacetate,CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Pb+2],546-67-8,Positive,in vivo
Lenacil,O=C1NC2=C(CCC2)C(=O)N1C3CCCCC3,2164-08-1,Negative,in vivo
Lenacil,O=C1NC2=C(CCC2)C(=O)N1C3CCCCC3,2164-08-01,Negative,in vitro
Leucomalachite green,CN(C)C1=CC=C(C=C1)C(C2=CC=CC=C2)C3=CC=C(C=C3)N(C)C,129-73-7,Negative,in vitro
LEUPEPTIN,CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C=O)NC(=O)C,24365-47-7,Negative,In vivo
LEUPEPTIN,CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C=O)NC(=O)C,24365-47-7,Positive,In vivo
Limonene,CC1=CCC(CC1)C(=C)C,5989-27-5,Negative,In vivo
Linuron,CN(C(=O)NC1=CC(=C(C=C1)Cl)Cl)OC,330-55-2,Negative,In vivo
lithium;chloride,[Li+].[Cl-],7447-41-8,Negative,in vitro
Lithocholic acid,CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,434-13-9,Negative,in vitro
LOFEXIDINE.HCl,CC(C1=NCCN1)OC2=C(C=CC=C2Cl)Cl.Cl,21498-08-8,Negative,In vivo
Lomefloxacin,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O,98079-51-7,Positive,in vitro
Londax,COC1=CC(=NC(=N1)NC(=O)NS(=O)(=O)CC2=CC=CC=C2C(=O)OC)OC,83055-99-6,Negative,In vivo
LORNOXICAM,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,70374-39-9,Negative,In vivo
LOVASTATIN,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,75330-75-5,Positive,In vivo
LOVASTATIN,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,75330-75-5,Negative,In vivo
LOXTIDINE,CN1C(=NC(=N1)CO)NCCCOC2=CC=CC(=C2)CN3CCCCC3,76956-02-0,Positive,In vivo
Lufenuron,O=C(NC(NC2=C(Cl)C=C(OC(F)(F)C(F)C(F)(F)F)C(Cl)=C2)=O)C1=C(F)C=CC=C1F,103055-07-8,Negative,in vivo
Lufenuron,O=C(NC(NC2=C(Cl)C=C(OC(F)(F)C(F)C(F)(F)F)C(Cl)=C2)=O)C1=C(F)C=CC=C1F,103055-07-8,Negative,in vitro
LUPITIDINE.3HCl,CC1=NC=C(C=C1)CC2=CN=C(NC2=O)NCCSCC3=CC=C(O3)CN(C)C.Cl.Cl.Cl,72716-75-7,Negative,In vivo
LUPITIDINE.3HCl,CC1=NC=C(C=C1)CC2=CN=C(NC2=O)NCCSCC3=CC=C(O3)CN(C)C.Cl.Cl.Cl,72716-75-7,Positive,In vivo
LUTEOSKYRIN,CC1=CC(=C2C(=C1O)C(=O)C34C5C6C(C3C(=O)C7=C(C8=C(C=C(C(=C8C(=O)C67C(C5O)C(=O)C4=C2O)O)C)O)O)O)O,21884-44-6,Positive,In vivo
LYNESTRENOL,CC12CCC3C(C1CCC2(C#C)O)CCC4=CCCCC34,52-76-6,Positive,In vivo
m-Anisidine (3-methoxybenzeneamine),COC1=CC=CC(=C1)N,536-90-3,Positive,in vitro
m-Cresidine,CC1=C(C=CC(=C1)OC)N,102-50-1,Positive,in vitro
m-Nitroaniline,C1=CC(=CC(=C1)[N+](=O)[O-])N,99-09-2,Positive,in vitro
m-PHENYLENEDIAMINE,C1=CC(=CC(=C1)N)N,108-45-2,Negative,In vivo
m-Phenylenediamine,C1=CC(=CC(=C1)N)N,108-45-2,Positive,in vitro
m-PHENYLENEDIAMINE.2HCl,C1=CC(=CC(=C1)N)N.Cl.Cl,541-69-5,Negative,In vivo
m-TOLUIDINE.HCl,CC1=CC(=CC=C1)N.Cl,638-03-9,Negative,In vivo
m-TOLUIDINE.HCl,CC1=CC(=CC=C1)N.Cl,638-03-9,Positive,In vivo
m-Toluidine/m-Toloudine hydrochloride,CC1=CC(=CC=C1)N,108-44-1,Negative,in vitro
MAGNESIUM CHLORIDE HEXAHYDRATE,O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-],7791-18-6,Negative,In vivo
Magnesium phosphide,[Mg+2].[Mg+2].[Mg+2].[P-3].[P-3],12057-74-8,Negative,in vivo
Magnesium phosphide,[Mg+2].[Mg+2].[Mg+2].[P-3].[P-3],12057-74-8,Positive,in vivo
Magnesium phosphide,[Mg+2].[Mg+2].[Mg+2].[P-3].[P-3],12057-74-8,Negative,in vitro
magnesium;diacetate,CC(=O)[O-].CC(=O)[O-].[Mg+2],142-72-3,Negative,in vitro
magnesium;dichloride,[Mg+2].[Cl-].[Cl-],,Negative,in vitro
magnesium;dichloride;hexahydrate,O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-],24644,Negative,In Vivo
magnesium;dihydroxide,[OH-].[OH-].[Mg+2],14791,Positive,In Vivo
Malathion,CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC,121-75-5,Negative,in vivo
Malathion,CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC,121-75-5,Positive,in vivo
Malathion,CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC,121-75-5,Positive,in vitro
Maleic anhydride,C1=CC(=O)OC1=O,108-31-6,Negative,In vivo
MALEIC HYDRAZIDE,C1=CC(=O)NNC1=O,123-33-1,Negative,In vivo
Malonaldehyde / Na salt,C(=C/[O-])\C=O.[Na+] ,24382-04-5,Negative,in vitro
"MALONALDEHYDE, SODIUM SALT",[CH-](C=O)C=O.[Na+],24382-04-5,Negative,In vivo
"MALONALDEHYDE, SODIUM SALT",[CH-](C=O)C=O.[Na+],24382-04-5,Positive,In vivo
Maltol,CC1=C(C(=O)C=CO1)O,118-71-8,Positive,in vitro
Mandipropamid,Clc1ccc(cc1)C(OCC#C)C(=O)NCCc2ccc(OCC#C)c(OC)c2,374726-62-2,Negative,in vivo
Mandipropamid,Clc1ccc(cc1)C(OCC#C)C(=O)NCCc2ccc(OCC#C)c(OC)c2,374726-62-2,Negative,in vitro
Maneb,C(CNC(=S)[S-])NC(=S)[S-].[Mn+2],12427-38-2,Negative,In vivo
Manganese,[Mn],7439-96-5,Negative,In vivo
Manganese (II) sulfate monohydrate,O.[O-]S(=O)(=O)[O-].[Mn+2],10034-96-5,Positive,in vitro
MANGANESE ETHYLENEBISTHIOCARBAMATE,C(CNC(=S)[S-])NC(=S)[S-].[Mn+2],12427-38-2,Negative,In vivo
MANGANESE ETHYLENEBISTHIOCARBAMATE,C(CNC(=S)[S-])NC(=S)[S-].[Mn+2],12427-38-2,Positive,In vivo
manganese(2+);diacetate,CC(=O)[O-].CC(=O)[O-].[Mn+2],638-38-0,Positive,in vitro
manganese(2+);dinitrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Mn+2],10377-66-9,Positive,in vitro
manganese(2+);sulfate,[O-]S(=O)(=O)[O-].[Mn+2],7785-87-7,Negative,in vitro
manganese(2+);sulfate;hydrate,O.[O-]S(=O)(=O)[O-].[Mn+2],177577,Negative,In Vivo
MANIDIPINE.2HCl,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC.Cl.Cl,89226-75-5,Negative,In vivo
Mea-alpha-C (free base and acetate salt),C1=CC(=CC=C1C(C2=CC=C(C=C2)O)(C(F)(F)F)C(F)(F)F)O,1478-61-1,Positive,in vitro
MeA-alpha-C ACETATE,CC1=CC2=C(NC3=CC=CC=C32)N=C1N.CC(=O)O,117831-29-5,Positive,In vivo
Megazol (CL 64855),CN1C(=CN=C1C2=NN=C(S2)N)[N+](=O)[O-],19622-55-0,Positive,in vitro
MeIQ,CC1=CC2=C(C=CC=N2)C3=C1N(C(=N3)N)C,77094-11-2,Negative,In vivo
MeIQ,CC1=CC2=C(C=CC=N2)C3=C1N(C(=N3)N)C,77094-11-2,Positive,In vivo
MeIQx,CC1=CN=C2C=CC3=C(C2=N1)N=C(N3C)N,77500-04-0,Positive,In vivo
Melamine,C1(=NC(=NC(=N1)N)N)N,108-78-1,Negative,in vitro
MELOXICAM,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,71125-38-7,Negative,In vivo
MELPHALAN,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,148-82-3,Positive,In vivo
Melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,148-82-3,Positive,in vitro
Menogarol,CC1(CC(C2=C(C3=C(C=C2C1)C(=O)C4=C5C(=CC(=C4C3=O)O)C6(C(C(C(C(O5)O6)O)N(C)C)O)C)O)OC)O,71628-96-1,Positive,in vitro
Mepiquat chloride,C[N+]1(CCCCC1)C.[Cl-],24307-26-4,Negative,in vivo
Mepiquat chloride,C[N+]1(CCCCC1)C.[Cl-],24307-26-4,Negative,in vitro
Meptyldinocap,CCCCCCC(C)C1=CC(=CC(=C1OC(=O)C=CC)[N+](=O)[O-])[N+](=O)[O-],131-72-6,Negative,in vivo
Meptyldinocap,CCCCCCC(C)C1=CC(=CC(=C1OC(=O)C=CC)[N+](=O)[O-])[N+](=O)[O-],131-72-6,Negative,in vitro
MER-25,CCN(CC)CCOC1=CC=C(C=C1)C(CC2=CC=C(C=C2)OC)(C3=CC=CC=C3)O,67-98-1,Negative,In vivo
MERCURIC CHLORIDE,Cl[Hg]Cl,7487-94-7,Negative,In vivo
Mercuric chloride,Cl[Hg]Cl,7487-94-7,Positive,in vitro
Mercuric chloride (HgCl2),Cl[Hg]Cl,7487-94-7,Negative,In vivo
MERCUROUS CHLORIDE,Cl[Hg],7546-30-7,Negative,In vivo
"Mercury, elemental",[Hg],7439-97-6,Negative,In vivo
mercury(2+);diacetate,CC(=O)[O-].CC(=O)[O-].[Hg+2],592-63-2,Negative,in vitro
MERCURYMETHYL CHLORIDE,C[Hg]Cl,115-09-3,Negative,In vivo
MERCURYMETHYL CHLORIDE,C[Hg]Cl,115-09-3,Positive,In vivo
Merphos,CCCCSP(SCCCC)SCCCC,150-50-5,Negative,In vivo
Merphos oxide,CCCCSP(=O)(SCCCC)SCCCC,78-48-8,Negative,In vivo
Mesotrione,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)C2C(=O)CCCC2=O)[N+](=O)[O-],104206-82-8,Negative,in vivo
Mesotrione,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)C2C(=O)CCCC2=O)[N+](=O)[O-],104206-82-8,Negative,in vitro
MESTRANOL,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,72-33-3,Negative,In vivo
Metaflumizone,C1=CC(=CC(=C1)C(F)(F)F)/C(=N\NC(=O)NC2=CC=C(C=C2)OC(F)(F)F)/CC3=CC=C(C=C3)C#N,139968-49-3,Negative,in vivo
Metaflumizone,C1=CC(=CC(=C1)C(F)(F)F)/C(=N\NC(=O)NC2=CC=C(C=C2)OC(F)(F)F)/CC3=CC=C(C=C3)C#N,139968-49-3,Negative,in vitro
Metalaxyl,CC1=C(C(=CC=C1)C)N(C(C)C(=O)OC)C(=O)COC,57837-19-1,Negative,In vivo
Metalaxyl-M,CC1=C(C(=CC=C1)C)N([C@H](C)C(=O)OC)C(=O)COC,70630-17-0,Negative,in vivo
Metalaxyl-M,CC1=C(C(=CC=C1)C)N([C@H](C)C(=O)OC)C(=O)COC,70630-17-0,Positive,in vivo
Metalaxyl-M,CC1=C(C(=CC=C1)C)N([C@H](C)C(=O)OC)C(=O)COC,70630-17-0,Negative,in vitro
Metam-sodium,CNC(=S)[S-].[Na+],137-42-8,Negative,in vivo
Metam-sodium,CNC(=S)[S-].[Na+],137-42-8,Positive,in vivo
Metam-sodium,CNC(=S)[S-].[Na+],137-42-8,Negative,in vitro
Metamitron,O=C1C(C2=CC=CC=C2)=NN=C(C)N1N,41394-05-2,Negative,in vivo
Metamitron,O=C1C(C2=CC=CC=C2)=NN=C(C)N1N,41394-05-02,Negative,in vitro
Metazachlor,CC1=C(C(=CC=C1)C)N(CN2C=CC=N2)C(=O)CCl,67129-08-2,Negative,in vivo
Metazachlor,CC1=C(C(=CC=C1)C)N(CN2C=CC=N2)C(=O)CCl,67129-08-02,Negative,in vitro
Metconazole,CC1(CCC(C1(CN2C=NC=N2)O)CC3=CC=C(C=C3)Cl)C,125116-23-6,Negative,in vivo
Metconazole,CC1(CCC(C1(CN2C=NC=N2)O)CC3=CC=C(C=C3)Cl)C,125116-23-6,Negative,in vitro
METEPA,CC1CN1P(=O)(N2CC2C)N3CC3C,57-39-6,Positive,In vivo
Methacrylonitrile,CC(=C)C#N,126-98-7,Negative,In vivo
METHAFURYLENE,CN(C)CCN(CC1=CC=CO1)C2=CC=CC=N2,531-06-6,Negative,In vivo
Methamidophos,COP(=O)(N)SC,10265-92-6,Negative,In vivo
methane,C,297,Negative,In Vivo
methane,C,297,Positive,In Vivo
methane,C,14493-06-02,Positive,in vitro
methanidylidynesilanylium,[C-]#[Si+],9863,Positive,In Vivo
Methanol,CO,67-56-1,Negative,In vivo
methanol,CO,67-56-1,Negative,in vitro
METHAPHENILENE,CN(C)CCN(CC1=CC=CS1)C2=CC=CC=C2,493-78-7,Negative,In vivo
Methapyrilene hydrochloride,CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2.Cl,135-23-9,Positive,in vitro
METHAPYRILENE.HCl,CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2.Cl,135-23-9,Positive,In vivo
METHIDATHION,COC1=NN(C(=O)S1)CSP(=S)(OC)OC,950-37-8,Negative,In vivo
METHIDATHION,COC1=NN(C(=O)S1)CSP(=S)(OC)OC,950-37-8,Positive,In vivo
Methidathion,COC1=NN(C(=O)S1)CSP(=S)(OC)OC,950-37-8,Negative,in vitro
METHIMAZOLE,CN1C=CNC1=S,60-56-0,Positive,In vivo
Methiocarb,CNC(=O)Oc1cc(C)c(SC)c(C)c1,2032-65-7,Negative,in vivo
Methiocarb,CNC(=O)Oc1cc(C)c(SC)c(C)c1,2032-65-7,Negative,in vitro
Methomyl,CC(=NOC(=O)NC)SC,16752-77-5,Negative,in vivo
Methomyl,CC(=NOC(=O)NC)SC,16752-77-5,Negative,in vitro
METHOTREXATE,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,59-05-2,Negative,In vivo
Methoxychlor,COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)C(Cl)(Cl)Cl,72-43-5,Negative,In vivo
Methoxychlor,COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)C(Cl)(Cl)Cl,72-43-5,Negative,in vitro
Methoxyethanol,COCCO,109-86-4,Negative,In vivo
METHOXYPHENYLACETIC ACID,COC(C1=CC=CC=C1)C(=O)O,1701-77-5,Negative,In vivo
methyl (1E)-N-(methylcarbamoyloxy)ethanimidothioate,C/C(=N\OC(=O)NC)/SC,19928-35-9,Negative,in vitro
methyl (1E)-N-[methyl(nitroso)carbamoyl]oxyethanimidothioate,C/C(=N\OC(=O)N(C)N=O)/SC,,Positive,in vitro
"methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate",CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,5770,Positive,In Vivo
"methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate",CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,50-55-5,Positive,in vivo
"methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate",CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,5770,Negative,In Vivo
"methyl (1R,2R,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate",CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N)O,,Positive,in vitro
"methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate",CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,865-21-4,Positive,in vivo
"methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate",CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,865-21-4,Positive,in vitro
"methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate;sulfuric acid",CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O,143-67-9,Negative,in vitro
"methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate",CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,57-22-7,Negative,in vitro
"methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate;sulfuric acid",CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O,,Positive,in vitro
methyl (2E)-2-methoxyimino-2-[2-[(2-methylphenoxy)methyl]phenyl]acetate,CC1=CC=CC=C1OCC2=CC=CC=C2/C(=N\OC)/C(=O)OC,6112114,Negative,In Vivo
methyl (2E)-2-methoxyimino-2-[2-[(2-methylphenoxy)methyl]phenyl]acetate,CC1=CC=CC=C1OCC2=CC=CC=C2/C(=N\OC)/C(=O)OC,6112114,Positive,In Vivo
methyl (2R)-2-amino-3-(1H-imidazol-5-yl)propanoate;hydrochloride,COC(=O)[C@@H](CC1=CN=CN1)N.Cl,92742-29-5,Negative,in vitro
"methyl (4aS)-7-chloro-2-[methoxycarbonyl-[4-(trifluoromethoxy)phenyl]carbamoyl]-3,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a-carboxylate",COC(=O)[C@]12CC3=C(C1=NN(CO2)C(=O)N(C4=CC=C(C=C4)OC(F)(F)F)C(=O)OC)C=CC(=C3)Cl,107720,Negative,In Vivo
methyl (E)-3-dimethoxyphosphoryloxybut-2-enoate,C/C(=C\C(=O)OC)/OP(=O)(OC)OC,7786-34-7,Positive,in vitro
"methyl 1-methyl-3,6-dihydro-2H-pyridine-5-carboxylate",CN1CCC=C(C1)C(=O)OC,63-75-2,Positive,in vivo
"methyl 1-methyl-3,6-dihydro-2H-pyridine-5-carboxylate;hydrochloride",CN1CCC=C(C1)C(=O)OC.Cl,6107,Negative,In Vivo
"methyl 1-methyl-3,6-dihydro-2H-pyridine-5-carboxylate;hydrochloride",CN1CCC=C(C1)C(=O)OC.Cl,6107,Positive,In Vivo
"methyl 1-methyl-3,6-dihydro-2H-pyridine-5-carboxylate;hydrochloride",CN1CCC=C(C1)C(=O)OC.Cl,61-94-9,Positive,in vitro
"methyl 1-nitroso-3,6-dihydro-2H-pyridine-5-carboxylate",COC(=O)C1=CCCN(C1)N=O,62103,Positive,In Vivo
"methyl 1-nitroso-3,6-dihydro-2H-pyridine-5-carboxylate",COC(=O)C1=CCCN(C1)N=O,55557-02-03,Positive,in vitro
METHYL 12-OXO-trans-10-OCTADECENOATE,CCCCCCC(=O)CC=CCCCCCCCC(=O)OC,21308-79-2,Negative,In vivo
methyl 2-(4-chloro-2-methylphenoxy)acetate,CC1=C(C=CC(=C1)Cl)OCC(=O)OC,2436-73-9,Positive,in vitro
methyl 2-(dimethylamino)-N-(methylcarbamoyloxy)-2-oxoethanimidothioate,CNC(=O)ON=C(C(=O)N(C)C)SC,31657,Negative,In Vivo
"methyl 2-(N-(2-methoxyacetyl)-2,6-dimethylanilino)propanoate",CC1=C(C(=CC=C1)C)N(C(C)C(=O)OC)C(=O)COC,42586,Negative,In Vivo
"methyl 2-(N-(2-methoxyacetyl)-2,6-dimethylanilino)propanoate",CC1=C(C(=CC=C1)C)N(C(C)C(=O)OC)C(=O)COC,42586,Positive,In Vivo
"methyl 2-[(3S)-6-[(3S)-9,10-dihydroxy-7-methoxy-3-(2-methoxy-2-oxoethyl)-1-oxo-3,4-dihydrobenzo[g]isochromen-6-yl]-9,10-dihydroxy-7-methoxy-1-oxo-3,4-dihydrobenzo[g]isochromen-3-yl]acetate",COC1=C(C2=C(C(=C1)O)C(=C3C(=C2)C[C@H](OC3=O)CC(=O)OC)O)C4=C(C=C(C5=C4C=C6C[C@H](OC(=O)C6=C5O)CC(=O)OC)O)OC,1381782-08-6,Negative,in vitro
"methyl 2-[(4,6-dimethoxypyrimidin-2-yl)carbamoylsulfamoyl]-4-(methanesulfonamidomethyl)benzoate",COC1=CC(=NC(=N1)NC(=O)NS(=O)(=O)C2=C(C=CC(=C2)CNS(=O)(=O)C)C(=O)OC)OC,11409499,Negative,In Vivo
methyl 2-[4-(4-chlorophenyl)phenoxy]-2-methylpropanoate,CC(C)(C(=O)OC)OC1=CC=C(C=C1)C2=CC=C(C=C2)Cl,30602,Positive,In Vivo
"methyl 2-[4-bromo-2-(chloromethyl)phenoxy]acetate;1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane",COC(=O)COC1=C(C=C(C=C1)Br)CCl.C1N2CN3CN1CN(C2)C3,,Positive,in vitro
methyl 2-methylprop-2-enoate,CC(=C)C(=O)OC,6658,Negative,In Vivo
methyl 2-phenyl-2-piperidin-2-ylacetate;hydrochloride,COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl,9280,Positive,In Vivo
methyl 2-phenyl-2-piperidin-2-ylacetate;hydrochloride,COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl,9280,Negative,In Vivo
methyl 3-(aziridin-1-yl)propanoate,COC(=O)CCN1CC1,1073-77-4,Positive,in vitro
methyl 4-[[4-[acetyloxy(methyl)amino]phenyl]diazenyl]benzoate,CC(=O)ON(C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)C(=O)OC,,Positive,in vitro
methyl 4-[1-acetyloxybutyl(nitroso)amino]butanoate,CCCC(N(CCCC(=O)OC)N=O)OC(=O)C,150131,Positive,In Vivo
"methyl 4-[4-amino-5-[4-hydroxy-6-methyl-5-(6-methyl-5-oxooxan-2-yl)oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate",CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O)N)O,,Positive,in vitro
methyl 4-methyl-2-(4-methyl-5-oxo-4-propan-2-yl-1H-imidazol-2-yl)benzoate;methyl 5-methyl-2-(4-methyl-5-oxo-4-propan-2-yl-1H-imidazol-2-yl)benzoate,CC1=CC(=C(C=C1)C(=O)OC)C2=NC(C(=O)N2)(C)C(C)C.CC1=CC(=C(C=C1)C2=NC(C(=O)N2)(C)C(C)C)C(=O)OC,21873022,Negative,In Vivo
"methyl 5-(2,4-dichlorophenoxy)-2-nitrobenzoate",COC(=O)C1=C(C=CC(=C1)OC2=C(C=C(C=C2)Cl)Cl)[N+](=O)[O-],39230,Negative,In Vivo
"methyl 5-(2,4-dichlorophenoxy)-2-nitrobenzoate",COC(=O)C1=C(C=CC(=C1)OC2=C(C=C(C=C2)Cl)Cl)[N+](=O)[O-],39230,Positive,In Vivo
Methyl acetoacetate,CC(=O)CC(=O)OC,105-45-3,Positive,in vitro
Methyl acrylate,COC(=O)C=C,96-33-3,Negative,In vivo
Methyl acrylate,COC(=O)C=C,96-33-3,Positive,in vitro
METHYL BROMIDE,CBr,74-83-9,Negative,In vivo
Methyl bromide,CBr,74-83-9,Positive,in vitro
methyl butane-1-sulfonate,CCCCS(=O)(=O)OC,2374-69-8,Positive,in vitro
methyl carbamate,COC(=O)N,11722,Negative,In Vivo
methyl carbamate,COC(=O)N,11722,Positive,In Vivo
Methyl carbamate,COC(=O)N,598-55-0,Negative,in vitro
METHYL CARBAZATE,COC(=O)NN,6294-89-9,Negative,In vivo
Methyl chloride,CCl,74-87-3,Negative,In vivo
Methyl chloride,CCl,74-87-3,Positive,in vitro
Methyl chlorocarbonate,COC(=O)Cl,79-22-1,Negative,In vivo
METHYL CLOFENAPATE,CC(C)(C(=O)OC)OC1=CC=C(C=C1)C2=CC=C(C=C2)Cl,21340-68-1,Positive,In vivo
methyl ethanesulfonate,CCS(=O)(=O)OC,1912-28-3,Positive,in vitro
Methyl ethyl ketone (MEK),CCC(=O)C,78-93-3,Negative,In vivo
METHYL HESPERIDIN,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC(=C(C=C5)OC)OC)O)O)O)O)O)O)O,11013-97-1,Negative,In vivo
Methyl iodide,CI,74-88-4,Negative,In vivo
Methyl iodide,CI,74-88-4,Positive,in vitro
Methyl isobutyl ketone (MIBK),CC(C)CC(=O)C,0108-10-1,Negative,In vivo
Methyl isocyanate,CN=C=O,624-83-9,Negative,In vivo
Methyl isocyanate,CN=C=O,624-83-9,Positive,in vitro
METHYL LINOLEATE HYDROPEROXIDE,CCCCCC(C=CC=CCCCCCCCC(=O)OC)OO,27323-65-5,Negative,In vivo
"METHYL LINOLEATE, NATIVE",CCCCCC=CCC=CCCCCCCCC(=O)OC,112-63-0,Negative,In vivo
METHYL METHACRYLATE,CC(=C)C(=O)OC,80-62-6,Negative,In vivo
methyl methanesulfonate,COS(=O)(=O)C,66-27-3,Positive,in vivo
METHYL METHANESULFONATE,COS(=O)(=O)C,66-27-3,Negative,In vivo
methyl methanesulfonate,COS(=O)(=O)C,4156,Positive,In Vivo
methyl methanesulfonate,COS(=O)(=O)C,66-27-3,Negative,in vitro
Methyl methanesulphonate,COS(=O)(=O)C,66-27-3,Positive,in vitro
methyl N-(1H-benzimidazol-2-yl)carbamate,COC(=O)NC1=NC2=CC=CC=C2N1,25429,Negative,In Vivo
methyl N-(1H-benzimidazol-2-yl)carbamate,COC(=O)NC1=NC2=CC=CC=C2N1,25429,Positive,In Vivo
methyl N-(1H-benzimidazol-2-yl)carbamate,COC(=O)NC1=NC2=CC=CC=C2N1,10605-21-7,Positive,in vivo
methyl N-(1H-benzimidazol-2-yl)carbamate,COC(=O)NC1=NC2=CC=CC=C2N1,10605-21-7,Positive,in vitro
methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,31431-39-7,Positive,in vitro
methyl N-[(2-aminophenyl)carbamothioyl]carbamate,COC(=O)NC(=S)NC1=CC=CC=C1N,27079-29-4,Negative,in vitro
"methyl N-[(E)-(1,4-dioxidoquinoxaline-1,4-diium-2-yl)methylideneamino]carbamate",COC(=O)N/N=C/C1=[N+](C2=CC=CC=C2[N+](=C1)[O-])[O-],135511839,Positive,In Vivo
"methyl N-[(E)-(1,4-dioxidoquinoxaline-1,4-diium-2-yl)methylideneamino]carbamate",COC(=O)N/N=C/C1=[N+](C2=CC=CC=C2[N+](=C1)[O-])[O-],6804-07-05,Positive,in vitro
methyl N-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate,COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC,23564-05-08,Positive,in vitro
methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate,CCCCNC(=O)N1C2=CC=CC=C2N=C1NC(=O)OC,28780,Positive,In Vivo
methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate,CCCCNC(=O)N1C2=CC=CC=C2N=C1NC(=O)OC,17804-35-2,Negative,in vitro
methyl N-[5-(4-methoxyphenyl)-1H-imidazol-2-yl]carbamate,COC1=CC=C(C=C1)C2=CN=C(N2)NC(=O)OC,,Positive,in vitro
Methyl parathion,COP(=S)(OC)OC1=CC=C(C=C1)[N+](=O)[O-],298-00-0,Negative,In vivo
methyl prop-2-enoate,COC(=O)C=C,7294,Negative,In Vivo
methyl prop-2-enoate,COC(=O)C=C,96-33-3,Positive,in vitro
METHYL tert-BUTYL ETHER,CC(C)(C)OC,1634-04-4,Positive,In vivo
Methyl tert-butyl ether,CC(C)(C)OC,1634-04-4,Negative,in vitro
Methyl tert-butyl ether (MTBE),CC(C)(C)OC,1634-04-04,Negative,In vivo
Methyl thiophanate,COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC ,23564-05-8,Positive,in vitro
Methyl trans-styryl ketone,CC(=O)C=CC1=CC=CC=C1,1896-62-4,Positive,in vitro
Methyl-4-chlorophenoxy) butyric acid (MCPB),CC1=C(C=CC(=C1)Cl)OCCCC(=O)O,94-81-5,Negative,In vivo
Methyl-4-chlorophenoxy)propionic acid (MCPP),CC1=C(C=CC(=C1)Cl)OC(C)C(=O)O,93-65-2,Negative,In vivo
Methyl-4-chlorophenoxyacetic acid (MCPA),CC1=C(C=CC(=C1)Cl)OCC(=O)O,94-74-6,Negative,In vivo
methyl-methylimino-oxidoazanium,CN=[N+](C)[O-],33184,Positive,In Vivo
methyl-methylimino-oxidoazanium,CN=[N+](C)[O-],25843-45-2,Positive,in vivo
methyl-methylimino-oxidoazanium,CN=[N+](C)[O-],25843-45-2,Negative,in vitro
methyl(nitroso)cyanamide,CN(C#N)N=O,36618,Positive,In Vivo
methyl(nitroso)cyanamide,CN(C#N)N=O,33868-17-6,Positive,in vitro
Methylazoxymethanol acetate,CC(=O)OCN=[N+](C)[O-],592-62-1,Positive,in vitro
"Methylene bis(N,N'-dimethyl)aniline",CN(C)C1=CC=C(C=C1)CC2=CC=C(C=C2)N(C)C,101-61-1,Positive,In vivo
Methylene blue (free base and trihydrate),CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-],61-73-4,Positive,in vitro
METHYLENE CHLORIDE,C(Cl)Cl,75-09-2,Negative,In vivo
METHYLENE CHLORIDE,C(Cl)Cl,75-09-2,Positive,In vivo
Methylene Diphenyl Diisocyanate (monomeric MDI) and polymeric MDI (PMDI),C1=CC(=CC=C1CC2=CC=C(C=C2)N=C=O)N=C=O,101-68-8,Negative,In vivo
Methylenedianiline/HCl,C1=CC(=CC=C1CC2=CC=C(C=C2)N)N,101-77-9,Positive,in vitro
METHYLETHYLKETOXIME,CCC(=NO)C,96-29-7,Positive,In vivo
Methyleugenol,COC1=C(C=C(C=C1)CC=C)OC,93-15-2,Negative,in vitro
methylhydrazine,CNN,6061,Negative,In Vivo
METHYLHYDRAZINE,CNN,60-34-4,Negative,In vivo
methylhydrazine,CNN,6061,Positive,In Vivo
METHYLHYDRAZINE,CNN,60-34-4,Positive,In vivo
Methylhydrazine,CNN,60-34-4,Positive,in vitro
METHYLHYDRAZINE SULFATE,CNN.OS(=O)(=O)O,302-15-8,Negative,In vivo
METHYLHYDRAZINE SULFATE,CNN.OS(=O)(=O)O,302-15-8,Positive,In vivo
methylimino-oxido-[[4-(propan-2-ylcarbamoyl)phenyl]methyl]azanium,CC(C)NC(=O)C1=CC=C(C=C1)C[N+](=NC)[O-],13344-51-9,Positive,in vitro
methylimino(oxo)methane,CN=C=O,624-83-9,Positive,in vitro
Methylmercury (MeHg),C[Hg+],22967-92-6,Negative,In vivo
methylmercury(1+);hydroxide,C[Hg+].[OH-],1184-57-2,Positive,in vitro
Methylnaphthalene,CC1=CC2=CC=CC=C2C=C1,91-57-6,Negative,In vivo
METHYLNITRAMINE,CN[N+](=O)[O-],598-57-2,Positive,In vivo
"METHYLNITROSAMINO-N,N-DIMETHYLETHYLAMINE",CN(C)CCN(C)N=O,23834-30-2,Positive,In vivo
METHYLNITROSOCYANAMIDE,CN(C#N)N=O,33868-17-6,Positive,In vivo
Methylnitrosocyanamide,CN(C#N)N=O,33868-17-6,Positive,in vitro
Methylphenidate HCl,COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl,298-59-9,Negative,in vitro
Methylphenol,CC1=CC=C(C=C1)O,95-48-7,Negative,In vivo
Methylphenol,CC1=CC=C(C=C1)O,108-39-4,Negative,In vivo
Methylphenol,CC1=CC=C(C=C1)O,106-44-5,Negative,In vivo
methylsulfinylmethane,CS(=O)C,67-68-5,Positive,in vivo
methylsulfinylmethane,CS(=O)C,67-68-5,Negative,in vitro
METHYLTHIOURACIL,CC1=CC(=O)NC(=S)N1,56-04-2,Positive,In vivo
methylurea,CNC(=O)N,598-50-5,Positive,in vitro
METIAPINE,CC1=CC2=C(C=C1)SC3=CC=CC=C3N=C2N4CCN(CC4)C,5800-19-1,Negative,In vivo
"METIRAM, TECHNICAL GRADE (WITH 2% ADDED ETHYLENETHIOUREA)",C(CNC(=S)[S-])NC(=S)[S-].[Zn+2],9006-42-2,Negative,In vivo
Metobromuron,CN(C(=O)NC1=CC=C(C=C1)Br)OC,3060-89-7,Negative,in vivo
Metobromuron,CN(C(=O)NC1=CC=C(C=C1)Br)OC,3060-89-7,Negative,in vitro
Metolachlor,CCC1=CC=CC(=C1N(C(C)COC)C(=O)CCl)C,51218-45-2,Negative,In vivo
Metosulam,Clc3c(C)ccc(Cl)c3NS(=O)(=O)c1nc2nc(cc(OC)n2n1)OC,139528-85-1,Negative,in vivo
Metosulam,Clc3c(C)ccc(Cl)c3NS(=O)(=O)c1nc2nc(cc(OC)n2n1)OC,139528-85-1,Negative,in vitro
Metrafenone,CC1=CC(=C(C(=C1C(=O)C2=C(C=CC(=C2C)Br)OC)OC)OC)OC,220899-03-6,Negative,in vivo
Metrafenone,CC1=CC(=C(C(=C1C(=O)C2=C(C=CC(=C2C)Br)OC)OC)OC)OC,220899-03-6,Negative,in vitro
Metribuzin,CC(C)(C)C1=NN=C(N(C1=O)N)SC,21087-64-9,Negative,in vivo
Metribuzin,CC(C)(C)C1=NN=C(N(C1=O)N)SC,21087-64-9,Negative,in vitro
METRONIDAZOLE,CC1=NC=C(N1CCO)[N+](=O)[O-],443-48-1,Negative,In vivo
METRONIDAZOLE,CC1=NC=C(N1CCO)[N+](=O)[O-],443-48-1,Positive,In vivo
Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],443-48-1,Positive,in vitro
Metsulfuron-methyl,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC,74223-64-6,Negative,in vivo
Metsulfuron-methyl,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC,74223-64-6,Negative,in vitro
Miral,CCOP(=S)(OCC)OC1=NN(C(=N1)Cl)C(C)C,42509-80-8,Positive,in vitro
MIREX,C12(C3(C4(C5(C3(C(C1(C5(C2(C4(Cl)Cl)Cl)Cl)Cl)(Cl)Cl)Cl)Cl)Cl)Cl)Cl,2385-85-5,Positive,In vivo
Mirex,C12(C3(C4(C5(C3(C(C1(C5(C2(C4(Cl)Cl)Cl)Cl)Cl)(Cl)Cl)Cl)Cl)Cl)Cl)Cl,2385-85-5,Negative,In vivo
Mirex,C12(C3(C4(C5(C3(C(C1(C5(C2(C4(Cl)Cl)Cl)Cl)Cl)(Cl)Cl)Cl)Cl)Cl)Cl)Cl,2385-85-5,Negative,in vitro
"MIREX, PHOTO-",C12C3(C4(C5(C3(C(C1(C5(C2(C4(Cl)Cl)Cl)Cl)Cl)(Cl)Cl)Cl)Cl)Cl)Cl,39801-14-4,Positive,In vivo
Misonidazole,COCC(CN1C=CN=C1[N+](=O)[O-])O,13551-87-6,Positive,in vitro
MISOPROSTOL,CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O,59122-46-2,Negative,In vivo
Mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,50-07-7,Positive,in vitro
MITOMYCIN-C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,50-07-7,Positive,In vivo
molecular bromine,BrBr,7726-95-6,Positive,in vitro
molecular chlorine,ClCl,24526,Negative,In Vivo
molecular oxygen,O=O,7782-44-7,Positive,in vitro
Molinate,CCSC(=O)N1CCCCCC1,2212-67-1,Negative,In vivo
Molybdenum,[Mo],7439-98-7,Negative,In vivo
molybdenum;hexachloride,[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Mo],11119-46-3,Positive,in vitro
MONOACETYL HYDRAZINE,CC(=O)NN,1068-57-1,Positive,In vivo
Monochloramine,NCl,10599-90-3,Negative,In vivo
MONOCHLOROACETIC ACID,C(C(=O)O)Cl,79-11-8,Negative,In vivo
Monochloroacetic acid,C(C(=O)O)Cl,79-11-8,Negative,in vitro
MONOCROTALINE,CC1C(=O)OC2CCN3C2C(=CC3)COC(=O)C(C1(C)O)(C)O,315-22-0,Positive,In vivo
Monocrotophos,CC(=CC(=O)NC)OP(=O)(OC)OC,6923-22-4,Positive,in vitro
MONOMETHYLARSONIC ACID,C[As](=O)(O)O,124-58-3,Negative,In vivo
MONONITROSOCAFFEIDINE,CNC(=O)C1=C(N=CN1C)N(C)N=O,145438-96-6,Positive,In vivo
MONOSODIUM ASPARTATE,C(C(C(=O)[O-])N)C(=O)O.[Na+],3792-50-5,Negative,In vivo
MONOSODIUM SUCCINATE,C(CC(=O)[O-])C(=O)O.[Na+],2922-54-5,Negative,In vivo
morpholine,C1COCCN1,8083,Negative,In Vivo
morpholine,C1COCCN1,110-91-8,Positive,in vitro
morpholine;(Z)-octadec-9-enoic acid,CCCCCCCC/C=C\CCCCCCCC(=O)O.C1COCCN1,20838052,Negative,In Vivo
Myclobutanil,CCCCC(CN1C=NC=N1)(C#N)C2=CC=C(C=C2)Cl,88671-89-0,Negative,in vivo
Myclobutanil,CCCCC(CN1C=NC=N1)(C#N)C2=CC=C(C=C2)Cl,88671-89-0,Negative,in vitro
N-(1-hydroxy-9H-fluoren-2-yl)acetamide,CC(=O)NC1=C(C2=C(C=C1)C3=CC=CC=C3C2)O,2784-86-3,Negative,in vitro
"N-(1-methyl-5H-pyrido[4,3-b]indol-3-yl)hydroxylamine",CC1=C2C3=CC=CC=C3NC2=CC(=N1)NO,74317-45-6,Positive,in vitro
"N-(1-methyl-6-phenylimidazo[4,5-b]pyridin-2-yl)hydroxylamine",CN1C2=C(N=CC(=C2)C3=CC=CC=C3)N=C1NO,104954,Negative,In Vivo
N-(1-Naphthyl)ethylenediamine 2HCl / N-(1-Naphthyl)ethylenediamine,C1=CC=C2C(=C1)C=CC=C2NCCN.Cl.Cl,1465-25-4,Positive,in vitro
"N-(1-nitroacridin-9-yl)-N'-propan-2-ylpropane-1,3-diamine;dihydrochloride",CC(C)NCCCNC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-].Cl.Cl,63710-43-0,Positive,in vitro
N-(2-amino-7H-purin-6-yl)hydroxylamine,C1=NC2=C(N1)C(=NC(=N2)N)NO,7269-57-0,Positive,in vitro
"N-(2-butoxy-7-chlorobenzo[b][1,5]naphthyridin-10-yl)-N'-(2-chloroethyl)-N'-ethylpropane-1,3-diamine;hydrate;dihydrochloride",CCCCOC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCN(CC)CCCl.O.Cl.Cl,,Positive,in vitro
"N-(2-chloroethyl)-N'-(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)propane-1,3-diamine;dihydrochloride",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCCl.Cl.Cl,36167-69-8,Positive,in vitro
N-(2-cyanoethyl)-N-methylnitrous amide,CN(CCC#N)N=O,62163,Positive,In Vivo
"N-(2-FLUORENYL)-2,2,2-TRIFLUOROACETAMIDE",C1C2=CC=CC=C2C3=C1C=C(C=C3)NC(=O)C(F)(F)F,363-17-7,Positive,In vivo
N-(2-hydroxypropyl)-N-(2-oxopropyl)nitrous amide,CC(CN(CC(=O)C)N=O)O,43677,Positive,In Vivo
N-(2-hydroxypropyl)-N-methylnitrous amide,CC(CN(C)N=O)O,107719,Positive,In Vivo
N-(2-oxopropyl)-N-propylnitrous amide,CCCN(CC(=O)C)N=O,91630,Positive,In Vivo
"N-(2,2,2-trichloro-1-morpholin-4-ylethyl)formamide",C1COCCN1C(C(Cl)(Cl)Cl)NC=O,43172,Negative,In Vivo
"N-(2,3-dihydroxypropyl)-N-methylnitrous amide",CN(CC(CO)O)N=O,128823,Positive,In Vivo
"N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide",CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O,71157,Negative,In Vivo
"N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine;hydrochloride",CC1=C(C(=CC=C1)C)NC2=NCCCS2.Cl,68554,Positive,In Vivo
N-(3-amino-4-ethoxyphenyl)acetamide,CCOC1=C(C=C(C=C1)NC(=O)C)N,28207,Negative,In Vivo
N-(3-amino-4-ethoxyphenyl)acetamide,CCOC1=C(C=C(C=C1)NC(=O)C)N,28207,Positive,In Vivo
N-(3-hydroxy-9H-fluoren-2-yl)acetamide,CC(=O)NC1=C(C=C2C(=C1)CC3=CC=CC=C32)O,1838-56-8,Negative,in vitro
"N-(3,4-dichlorophenyl)propanamide",CCC(=O)NC1=CC(=C(C=C1)Cl)Cl,709-98-8,Negative,in vitro
"N-(3,8-dimethylimidazo[4,5-f]quinoxalin-2-yl)hydroxylamine",CC1=CN=C2C=CC3=C(C2=N1)N=C(N3C)NO,115104,Positive,In Vivo
"N-(4-acetamido-9,10-dioxoanthracen-1-yl)acetamide",CC(=O)NC1=C2C(=C(C=C1)NC(=O)C)C(=O)C3=CC=CC=C3C2=O,6534-28-7,Positive,in vitro
N-(4-aminophenyl)sulfonylacetamide,CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N,144-80-9,Positive,in vitro
"N-(4-bromophenyl)sulfonyl-N'-[2-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]methanimidamide",C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br,65869,Negative,In Vivo
"N-(4-chlorophenyl)-2,2-dimethylpentanamide",CCCC(C)(C)C(=O)NC1=CC=C(C=C1)Cl,7287-36-7,Negative,in vitro
N-(4-ethoxy-3-nitrophenyl)acetamide,CCOC1=C(C=C(C=C1)NC(=O)C)[N+](=O)[O-],15685,Negative,In Vivo
N-(4-ethoxy-3-nitrophenyl)acetamide,CCOC1=C(C=C(C=C1)NC(=O)C)[N+](=O)[O-],15685,Positive,In Vivo
N-(4-ethoxyphenyl)-3-hydroxybutanamide,CCOC1=CC=C(C=C1)NC(=O)CC(C)O,14130,Negative,In Vivo
N-(4-ethoxyphenyl)-3-hydroxybutanamide,CCOC1=CC=C(C=C1)NC(=O)CC(C)O,14130,Positive,In Vivo
N-(4-ethoxyphenyl)-N-hydroxyacetamide,CCOC1=CC=C(C=C1)N(C(=O)C)O,29539,Positive,In Vivo
N-(4-ethoxyphenyl)acetamide,CCOC1=CC=C(C=C1)NC(=O)C,4754,Positive,In Vivo
N-(4-ethoxyphenyl)acetamide,CCOC1=CC=C(C=C1)NC(=O)C,62-44-2,Positive,in vivo
N-(4-ethoxyphenyl)acetamide,CCOC1=CC=C(C=C1)NC(=O)C,62-44-2,Positive,in vitro
N-(4-hydroxy-1-pyridin-3-ylbutyl)-N-methylnitrous amide,CN(C(CCCO)C1=CN=CC=C1)N=O,105067,Negative,In Vivo
N-(4-hydroxy-4-pyridin-3-ylbutyl)-N-methylnitrous amide,CN(CCCC(C1=CN=CC=C1)O)N=O,104856,Positive,In Vivo
N-(4-hydroxybutyl)-N-(2-hydroxyethyl)nitrous amide,C(CCO)CN(CCO)N=O,62018-89-7,Positive,in vitro
N-(4-hydroxybutyl)-N-pentylnitrous amide,CCCCCN(CCCCO)N=O,,Positive,in vitro
N-(4-hydroxybutyl)-N-propylnitrous amide,CCCN(CCCCO)N=O,51938-12-6,Positive,in vitro
N-(4-hydroxyphenyl)acetamide,CC(=O)NC1=CC=C(C=C1)O,1983,Negative,In Vivo
N-(4-hydroxyphenyl)acetamide,CC(=O)NC1=CC=C(C=C1)O,1983,Positive,In Vivo
N-(4-hydroxyphenyl)acetamide,CC(=O)NC1=CC=C(C=C1)O,103-90-2,Negative,in vitro
N-(4-nitrosophenyl)hydroxylamine,C1=CC(=CC=C1NO)N=O,7737,Negative,In Vivo
N-(4-nitrosophenyl)hydroxylamine,C1=CC(=CC=C1NO)N=O,7737,Positive,In Vivo
N-(4-phenylphenyl)acetamide,CC(=O)NC1=CC=C(C=C1)C2=CC=CC=C2,4075-79-0,Negative,in vitro
N-(4-phenylphenyl)hydroxylamine,C1=CC=C(C=C1)C2=CC=C(C=C2)NO,6810-26-0,Positive,in vitro
N-(5-hydroxy-9H-fluoren-2-yl)acetamide,CC(=O)NC1=CC2=C(C=C1)C3=C(C2)C=CC=C3O,1147-55-3,Negative,in vitro
N-(7-acetamido-9H-fluoren-2-yl)acetamide,CC(=O)NC1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)NC(=O)C,304-28-9,Positive,in vitro
"N-(7-chloro-4-oxido-5-phenyl-3H-1,4-benzodiazepin-4-ium-2-yl)-N-methylnitrous amide",CN(C1=NC2=C(C=C(C=C2)Cl)C(=[N+](C1)[O-])C3=CC=CC=C3)N=O,51715-17-4,Positive,in vitro
N-(7-hydroxy-9H-fluoren-2-yl)acetamide,CC(=O)NC1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)O,363-49-5,Negative,in vitro
N-(7H-purin-6-yl)hydroxylamine,C1=NC2=C(N1)C(=NC=N2)NO,5667-20-9,Positive,in vitro
N-(9-OXO-2-FLUORENYL)ACETAMIDE,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2=O,3096-50-2,Positive,In vivo
N-(9H-fluoren-2-yl)-N-hydroxyacetamide,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)O,5896,Positive,In Vivo
N-(9H-fluoren-2-yl)-N-hydroxyacetamide,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)O,53-95-2,Positive,in vivo
N-(9H-fluoren-2-yl)-N-hydroxyacetamide,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)O,53-95-2,Negative,in vitro
N-(9H-fluoren-2-yl)-N-hydroxytetradecanamide,CCCCCCCCCCCCCC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)O,32766-75-9,Negative,in vitro
N-(9H-fluoren-2-yl)acetamide,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,5897,Positive,In Vivo
N-(9H-fluoren-2-yl)acetamide,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,5897,Negative,In Vivo
N-(9H-fluoren-2-yl)acetamide,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,53-96-3,Negative,in vivo
N-(9H-fluoren-2-yl)acetamide,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,53-96-3,Positive,in vivo
N-(9H-fluoren-2-yl)acetamide,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,53-96-3,Negative,in vitro
N-(9H-fluoren-2-yl)hydroxylamine,C1C2=CC=CC=C2C3=C1C=C(C=C3)NO,53-94-1,Positive,in vitro
N-(9H-fluoren-4-yl)acetamide,CC(=O)NC1=CC=CC2=C1C3=CC=CC=C3C2,28322-02-03,Negative,in vitro
N-(Aminoethyl)ethanolamine,C(CNCCO)N,111-41-1,Positive,in vitro
N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide,C1=CN=CC(=C1C(F)(F)F)C(=O)NCC#N,9834513,Positive,In Vivo
N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide,C1=CN=CC(=C1C(F)(F)F)C(=O)NCC#N,9834513,Negative,In Vivo
N-(hydroxymethyl)prop-2-enamide,C=CC(=O)NCO,13543,Positive,In Vivo
N-(hydroxymethyl)prop-2-enamide,C=CC(=O)NCO,13543,Negative,In Vivo
N-(methyldiazenyl)aniline,CN=NNC1=CC=CC=C1,16033-21-9,Positive,in vitro
N-(N-METHYL-N-NITROSOCARBAMOYL)-l-ORNITHINE,CN(C(=O)NCCCC(C(=O)O)N)N=O,63642-17-1,Positive,In vivo
"N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide",C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,3356,Negative,In Vivo
N-(TRICHLOROMETHYLTHIO)PHTHALIMIDE,C1=CC=C2C(=C1)C(=O)N(C2=O)SC(Cl)(Cl)Cl,133-07-3,Negative,In vivo
N-(TRICHLOROMETHYLTHIO)PHTHALIMIDE,C1=CC=C2C(=C1)C(=O)N(C2=O)SC(Cl)(Cl)Cl,133-07-3,Positive,In vivo
N-[(2-bromophenyl)methyl]-2-chloro-N-(2-chloroethyl)ethanamine,C1=CC=C(C(=C1)CN(CCCl)CCCl)Br,2361-57-1,Positive,in vitro
"N-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]acetamide",CC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O,1738118,Negative,In Vivo
"N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(6R,9S,12R,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-5-methylheptanamide",CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)C(NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)[C@@H](C)O,1066-17-7,Negative,in vitro
N-[(3-bromophenyl)methyl]-2-chloro-N-(2-chloroethyl)ethanamine,C1=CC(=CC(=C1)Br)CN(CCCl)CCCl,2361-59-3,Positive,in vitro
N-[(4-bromophenyl)diazenyl]-N-methylmethanamine,CN(C)N=NC1=CC=C(C=C1)Br,81652,Negative,In Vivo
N-[(4-bromophenyl)diazenyl]-N-methylmethanamine,CN(C)N=NC1=CC=C(C=C1)Br,7239-21-6,Positive,in vitro
N-[(4-bromophenyl)methyl]-2-chloro-N-(2-chloroethyl)ethanamine,C1=CC(=CC=C1CN(CCCl)CCCl)Br,2743-05-07,Positive,in vitro
"N-[(4-chlorophenyl)carbamoyl]-2,6-difluorobenzamide",C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)Cl)F,35367-38-5,Negative,in vitro
N-[(4-chlorophenyl)diazenyl]-N-methylmethanamine,CN(C)N=NC1=CC=C(C=C1)Cl,23605,Negative,In Vivo
N-[(4-chlorophenyl)diazenyl]-N-methylmethanamine,CN(C)N=NC1=CC=C(C=C1)Cl,7203-90-9,Positive,in vitro
N-[(4-methoxyphenyl)diazenyl]-N-methylmethanamine,CN(C)N=NC1=CC=C(C=C1)OC,,Positive,in vitro
"N-[(4-methyl-1,3-thiazol-2-yl)amino]formamide",CC1=CSC(=N1)NNC=O,32852-21-4,Negative,in vitro
N-[(6-chloropyridin-3-yl)methyl]-N'-cyano-N-methylethanimidamide,CC(=NC#N)N(C)CC1=CN=C(C=C1)Cl,213021,Negative,In Vivo
"N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,64-86-8,Positive,in vivo
"N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,64-86-8,Negative,in vivo
"N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,64-86-8,Negative,in vitro
N-[(E)-ethylideneamino]-N-methylformamide,C/C=N/N(C)C=O,16568-02-08,Positive,in vivo
N-[(E)-ethylideneamino]-N-methylformamide,C/C=N/N(C)C=O,16568-02-08,Negative,in vitro
N-[(E)-hexylideneamino]-N-methylformamide,CCCCC/C=N/N(C)C=O,9556443,Positive,In Vivo
"N-[[(1E,4E)-1,5-bis[4-(trifluoromethyl)phenyl]penta-1,4-dien-3-ylidene]amino]-5,5-dimethyl-4,6-dihydro-1H-pyrimidin-2-amine",CC1(CN=C(NC1)NN=C(/C=C/C2=CC=C(C=C2)C(F)(F)F)/C=C/C3=CC=C(C=C3)C(F)(F)F)C,5281875,Negative,In Vivo
"N-[[3-(5-nitrofuran-2-yl)-1,2,4-oxadiazol-5-yl]methyl]acetamide",CC(=O)NCC1=NC(=NO1)C2=CC=C(O2)[N+](=O)[O-],36133-88-7,Positive,in vitro
"N-[[4-(5-nitrofuran-2-yl)-1,3-thiazol-2-yl]amino]formamide",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NNC=O,3607071,Positive,In Vivo
"N-[[4-(5-nitrofuran-2-yl)-1,3-thiazol-2-yl]amino]formamide",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NNC=O,3570-75-0,Positive,in vivo
"N-[[4-(5-nitrofuran-2-yl)-1,3-thiazol-2-yl]amino]formamide",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NNC=O,3570-75-0,Positive,in vitro
"N-[[4-(furan-2-yl)-1,3-thiazol-2-yl]amino]formamide",C1=COC(=C1)C2=CSC(=N2)NNC=O,,Negative,in vitro
"N-[1-[(6-chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl]nitramide",C1CN(C(=N1)N[N+](=O)[O-])CC2=CN=C(C=C2)Cl,86418,Negative,In Vivo
"N-[1-[(6-chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl]nitramide",C1CN(C(=N1)N[N+](=O)[O-])CC2=CN=C(C=C2)Cl,86418,Positive,In Vivo
N-[1-amino-5-[cyano(nitroso)amino]-1-oxopentan-2-yl]benzamide,C1=CC=C(C=C1)C(=O)NC(CCCN(C#N)N=O)C(=O)N,,Positive,in vitro
N-[2-(dimethylamino)ethyl]-N-methylnitrous amide,CN(C)CCN(C)N=O,146842,Positive,In Vivo
N-[2-(hydroxyamino)-2-oxoethyl]benzamide,C1=CC=C(C=C1)C(=O)NCC(=O)NO,1499-54-3,Positive,in vitro
N-[2-di(propan-2-yloxy)phosphinothioylsulfanylethyl]benzenesulfonamide,CC(C)OP(=S)(OC(C)C)SCCNS(=O)(=O)C1=CC=CC=C1,12932,Negative,In Vivo
N-[2-methyl-4-(2-methylphenyl)phenyl]hydroxylamine,CC1=CC=CC=C1C2=CC(=C(C=C2)NO)C,108211,Positive,In Vivo
"N-[2,4-dimethyl-5-(trifluoromethylsulfonylamino)phenyl]acetamide;2-(2-hydroxyethylamino)ethanol",CC1=CC(=C(C=C1NC(=O)C)NS(=O)(=O)C(F)(F)F)C.C(CO)NCCO,62067,Negative,In Vivo
"N-[3-(5-nitrofuran-2-yl)-6H-1,2,4-oxadiazin-5-yl]acetamide",CC(=O)NC1=NC(=NOC1)C2=CC=C(O2)[N+](=O)[O-],,Positive,in vitro
N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide;hydrochloride,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C.Cl,34381-68-5,Positive,in vitro
N-[4-(2-chloroacetyl)phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)C(=O)CCl,8805,Negative,In Vivo
N-[4-(2-chloroacetyl)phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)C(=O)CCl,140-49-8,Negative,in vivo
N-[4-(4-acetamidophenyl)phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)C,613-35-4,Positive,in vivo
N-[4-(4-acetamidophenyl)phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)C,11942,Positive,In Vivo
"N-[4-(4-nitrothiophen-2-yl)-1,3-thiazol-2-yl]acetamide",CC(=O)NC1=NC(=CS1)C2=CC(=CS2)[N+](=O)[O-],58139-53-0,Positive,in vitro
"N-[4-(4-nitrothiophen-2-yl)-1,3-thiazol-2-yl]formamide",C1=C(SC=C1[N+](=O)[O-])C2=CSC(=N2)NC=O,,Positive,in vitro
N-[4-(5-NITRO-2-FURYL)-2-THIAZOLYL]ACETAMIDE,CC(=O)NC1=NC(=CS1)C2=CC=C(O2)[N+](=O)[O-],531-82-8,Positive,In vivo
N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide (Furazolidone),CC(=O)NC1=NC(=CS1)C2=CC=C(O2)[N+](=O)[O-],531-82-8,Positive,in vitro
N-[4-(5-NITRO-2-FURYL)-2-THIAZOLYL]FORMAMIDE,C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NC=O,24554-26-5,Positive,In vivo
N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide,C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NC=O,24554-26-5,Positive,in vitro
"N-[4-(5-nitrofuran-2-yl)-1,3-thiazol-2-yl]acetamide",CC(=O)NC1=NC(=CS1)C2=CC=C(O2)[N+](=O)[O-],10753,Positive,In Vivo
"N-[4-(5-nitrofuran-2-yl)-1,3-thiazol-2-yl]acetamide",CC(=O)NC1=NC(=CS1)C2=CC=C(O2)[N+](=O)[O-],531-82-8,Positive,in vivo
"N-[4-(5-nitrofuran-2-yl)-1,3-thiazol-2-yl]acetamide",CC(=O)NC1=NC(=CS1)C2=CC=C(O2)[N+](=O)[O-],531-82-8,Negative,in vitro
"N-[4-(5-nitrofuran-2-yl)-1,3-thiazol-2-yl]formamide",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NC=O,32486,Positive,In Vivo
"N-[4-(5-nitrofuran-2-yl)-1,3-thiazol-2-yl]formamide",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NC=O,24554-26-5,Positive,in vivo
"N-[4-(5-nitrofuran-2-yl)-1,3-thiazol-2-yl]formamide",C1=C(OC(=C1)[N+](=O)[O-])C2=CSC(=N2)NC=O,24554-26-5,Positive,in vitro
"N-[4-(5-nitrothiophen-2-yl)-1,3-thiazol-2-yl]formamide",C1=C(SC(=C1)[N+](=O)[O-])C2=CSC(=N2)NC=O,,Positive,in vitro
N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,51264-14-3,Positive,in vivo
N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,2179,Negative,In Vivo
N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,2179,Positive,In Vivo
N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,51264-14-3,Positive,in vitro
N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide;hydrochloride,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl,54301-15-4,Positive,in vitro
N-[4-(dimethylaminodiazenyl)phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)N=NN(C)C,1933-50-2,Positive,in vitro
N-[4-[(2-hydroxy-5-methylphenyl)diazenyl]phenyl]acetamide,CC1=CC(=C(C=C1)O)N=NC2=CC=C(C=C2)NC(=O)C,17811,Negative,In Vivo
N-[4-[(2-hydroxy-5-methylphenyl)diazenyl]phenyl]acetamide,CC1=CC(=C(C=C1)O)N=NC2=CC=C(C=C2)NC(=O)C,17811,Positive,In Vivo
N-[4-[(2-hydroxy-5-methylphenyl)diazenyl]phenyl]acetamide,CC1=CC(=C(C=C1)O)N=NC2=CC=C(C=C2)NC(=O)C,2832-40-8,Positive,in vivo
"N-[4-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-1,3-thiazol-2-yl]acetamide",CC(=O)NC1=NC(=CS1)/C=C/C2=CC=C(O2)[N+](=O)[O-],,Positive,in vitro
"N-[4-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-1,3-thiazol-2-yl]formamide",C1=C(OC(=C1)[N+](=O)[O-])/C=C/C2=CSC(=N2)NC=O,,Positive,in vitro
N-[4-[(E)-2-phenylethenyl]phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)/C=C/C2=CC=CC=C2,786655,Positive,In Vivo
N-[4-[(E)-2-phenylethenyl]phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)/C=C/C2=CC=CC=C2,841-18-9,Negative,in vitro
N-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide,CC(C)NCC(COC1=CC=C(C=C1)NC(=O)C)O,6673-35-4,Negative,in vivo
N-[4-[4-(hydroxyamino)phenyl]phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)C2=CC=C(C=C2)NO,,Positive,in vitro
N-[4-[4-[acetyl(hydroxy)amino]phenyl]phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)C2=CC=C(C=C2)N(C(=O)C)O,51366,Positive,In Vivo
"N-[4-acetamido-6-(5-nitrofuran-2-yl)-1,3,5-triazin-2-yl]acetamide",CC(=O)NC1=NC(=NC(=N1)C2=CC=C(O2)[N+](=O)[O-])NC(=O)C,,Positive,in vitro
"N-[5-(5-Nitro-2-furyl)-1,3,4-thiadazol-2-yl]acetamide",CC(=O)NC1=NN=C(S1)C2=CC=C(O2)[N+](=O)[O-],2578-75-8,Positive,in vitro
"N-[5-(5-NITRO-2-FURYL)-1,3,4-THIADIAZOL-2-YL]ACETAMIDE",CC(=O)NC1=NN=C(S1)C2=CC=C(O2)[N+](=O)[O-],2578-75-8,Positive,In vivo
"N-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]acetamide",CC(=O)NC1=NN=C(S1)C2=CC=C(O2)[N+](=O)[O-],2578-75-8,Positive,in vitro
N-[aziridin-1-yl(dimethylamino)phosphoryl]-N-methylmethanamine,CN(C)P(=O)(N1CC1)N(C)C,1195-67-1,Positive,in vitro
N-[bis(aziridin-1-yl)phosphoryl]-N-methylmethanamine,CN(C)P(=O)(N1CC1)N2CC2,,Positive,in vitro
N-[bis(aziridin-1-yl)phosphoryl]butan-1-amine,CCCCNP(=O)(N1CC1)N2CC2,,Positive,in vitro
N-[bis(aziridin-1-yl)phosphoryl]ethanamine,CCNP(=O)(N1CC1)N2CC2,,Positive,in vitro
N-[bis(aziridin-1-yl)phosphoryl]methanamine,CNP(=O)(N1CC1)N2CC2,,Positive,in vitro
N-[bis(aziridin-1-yl)phosphoryl]propan-1-amine,CCCNP(=O)(N1CC1)N2CC2,,Positive,in vitro
N-[bis(aziridin-1-yl)phosphoryl]propan-2-amine,CC(C)NP(=O)(N1CC1)N2CC2,,Positive,in vitro
N-[bis(aziridin-1-yl)phosphoryl]pyrimidin-2-amine,C1CN1P(=O)(NC2=NC=CC=N2)N3CC3,882-58-6,Positive,in vitro
N-[bis(dimethylamino)phosphoryl]-N-methylmethanamine,CN(C)P(=O)(N(C)C)N(C)C,680-31-9,Positive,in vivo
N-[bis(dimethylamino)phosphoryl]-N-methylmethanamine,CN(C)P(=O)(N(C)C)N(C)C,12679,Positive,In Vivo
N-[bis(dimethylamino)phosphoryl]-N-methylmethanamine,CN(C)P(=O)(N(C)C)N(C)C,680-31-9,Positive,in vitro
N-[dichloro(fluoro)methyl]sulfanyl-N-(dimethylsulfamoyl)aniline,CN(C)S(=O)(=O)N(C1=CC=CC=C1)SC(F)(Cl)Cl,1085-98-9,Negative,in vitro
N-[dimethylamino-(2-methylaziridin-1-yl)phosphoryl]-N-methylmethanamine,CC1CN1P(=O)(N(C)C)N(C)C,,Positive,in vitro
N-[ethoxy-(3-methyl-4-methylsulfanylphenoxy)phosphoryl]propan-2-amine,CCOP(=O)(NC(C)C)OC1=CC(=C(C=C1)SC)C,31070,Negative,In Vivo
N-[ethoxy-(3-methyl-4-methylsulfanylphenoxy)phosphoryl]propan-2-amine,CCOP(=O)(NC(C)C)OC1=CC(=C(C=C1)SC)C,22224-92-6,Negative,in vitro
N-[ethoxy-(5-methyl-2-nitrophenoxy)phosphinothioyl]butan-2-amine,CCC(C)NP(=S)(OCC)OC1=C(C=CC(=C1)C)[N+](=O)[O-],36335-67-8,Negative,in vitro
N-[methoxy(methylsulfanyl)phosphoryl]acetamide,CC(=O)NP(=O)(OC)SC,1982,Negative,In Vivo
N-[methoxy(methylsulfanyl)phosphoryl]acetamide,CC(=O)NP(=O)(OC)SC,30560-19-1,Negative,in vitro
"N-{[3-(5-Nitro-2-furyl)-1,2,4-oxadiazole-
5-yl]-methyl}acetamide",CC(=O)NCC1=NC(=NO1)C2=CC=C(O2)[N+](=O)[O-],36133-88-7,Positive,in vitro
"N-{[3-(5-NITRO-2-FURYL)-1,2,4-OXADIAZOLE-5-YL]-METHYL}ACETAMIDE",CC(=O)NCC1=NC(=NO1)C2=CC=C(O2)[N+](=O)[O-],36133-88-7,Positive,In vivo
N-1-DIACETAMIDOFLUORENE,CC(=O)N(C1=CC=CC2=C1CC3=CC=CC=C32)C(=O)C,63019-65-8,Positive,In vivo
N-4-(4'-FLUOROBIPHENYL)ACETAMIDE,CC(=O)NC1=CC=C(C=C1)C2=CC=C(C=C2)F,398-32-3,Positive,In vivo
N-Acetoxy-2-acetylaminofluorene,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)OC(=O)C,6098-44-8,Positive,in vitro
N-ACETYLCYSTEINE,CC(=O)NC(CS)C(=O)O,616-91-1,Negative,In vivo
"N-acridin-9-yl-N'-(2-chloroethyl)-N'-ethylpropane-1,3-diamine;dihydrochloride",CCN(CCCNC1=C2C=CC=CC2=NC3=CC=CC=C31)CCCl.Cl.Cl,,Positive,in vitro
N-amino-N-methylformamide,CN(C=O)N,12962,Positive,In Vivo
"N-benzo[b][1,10]phenanthrolin-7-yl-N'-(2-chloroethyl)-N'-ethylpropane-1,3-diamine;dihydrochloride",CCN(CCCNC1=C2C=CC3=C(C2=NC4=CC=CC=C41)N=CC=C3)CCCl.Cl.Cl,,Positive,in vitro
"N-benzo[c]acridin-7-yl-N'-(2-chloroethyl)-N'-ethylpropane-1,3-diamine;dihydrochloride",CCN(CCCNC1=C2C=CC3=CC=CC=C3C2=NC4=CC=CC=C41)CCCl.Cl.Cl,,Positive,in vitro
N-benzyl-2-(2-nitroimidazol-1-yl)acetamide,C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-],31593,Positive,In Vivo
N-benzyl-2-(2-nitroimidazol-1-yl)acetamide,C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-],22994-85-0,Positive,in vitro
N-benzyl-2-bromo-N-(2-bromoethyl)ethanamine,C1=CC=C(C=C1)CN(CCBr)CCBr,24468-88-0,Positive,in vitro
N-benzyl-2-chloro-N-(2-chloroethyl)ethanamine,C1=CC=C(C=C1)CN(CCCl)CCCl,55-51-6,Positive,in vitro
N-benzyl-3-[2-(pyridine-4-carbonyl)hydrazinyl]propanamide,C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2,51-12-7,Positive,in vivo
N-benzyl-3-[2-(pyridine-4-carbonyl)hydrazinyl]propanamide,C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2,51-12-7,Positive,in vitro
N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,4768,Positive,In Vivo
N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,59-96-1,Positive,in vivo
N-benzyl-N-methylnitrous amide,CN(CC1=CC=CC=C1)N=O,13643,Positive,In Vivo
N-benzyl-N-methylnitrous amide,CN(CC1=CC=CC=C1)N=O,937-40-6,Positive,in vitro
N-but-3-yn-2-yl-2-chloro-N-phenylacetamide,CC(C#C)N(C1=CC=CC=C1)C(=O)CCl,21267-72-1,Negative,in vitro
n-Butanol,CCCCO,71-36-3,Negative,In vivo
n-Butyl chloride,CCCCCl,109-69-3,Negative,in vitro
N-butyl-N-(1-hydroperoxybutyl)nitrous amide,CCCCN(C(CCC)OO)N=O,149520,Positive,In Vivo
N-butyl-N-(2-hydroxybutyl)nitrous amide,CCCCN(CC(CC)O)N=O,55621-29-9,Positive,in vitro
N-butyl-N-(2-hydroxyethyl)nitrous amide,CCCCN(CCO)N=O,51938-14-8,Positive,in vitro
N-butyl-N-(2-oxobutyl)nitrous amide,CCCCN(CC(=O)CC)N=O,,Positive,in vitro
N-butyl-N-(2-oxopropyl)nitrous amide,CCCCN(CC(=O)C)N=O,51938-15-9,Positive,in vitro
"N-butyl-N-(2,4-dihydroxybutyl)nitrous amide",CCCCN(CC(CCO)O)N=O,62018-91-1,Positive,in vitro
N-butyl-N-(3-hydroxybutyl)nitrous amide,CCCCN(CCC(C)O)N=O,40911-07-07,Positive,in vitro
N-butyl-N-(3-hydroxypropyl)nitrous amide,CCCCN(CCCO)N=O,,Positive,in vitro
N-butyl-N-(3-oxobutyl)nitrous amide,CCCCN(CCC(=O)C)N=O,61734-89-2,Positive,in vitro
N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE,CCCCN(CCCCO)N=O,3817-11-6,Positive,In vivo
N-Butyl-N-(4-hydroxybutyl)nitrosamine,CCCCN(CCCCO)N=O,3817-11-6,Positive,in vitro
N-butyl-N-(4-hydroxybutyl)nitrous amide,CCCCN(CCCCO)N=O,19665,Positive,In Vivo
N-butyl-N-(4-hydroxybutyl)nitrous amide,CCCCN(CCCCO)N=O,3817-11-6,Positive,in vivo
N-butyl-N-(4-hydroxybutyl)nitrous amide,CCCCN(CCCCO)N=O,3817-11-6,Negative,in vitro
N-butyl-N-(5-oxooxolan-2-yl)nitrous amide,CCCCN(C1CCC(=O)O1)N=O,51804,Positive,In Vivo
"N-butyl-N-ethyl-2,6-dinitro-4-(trifluoromethyl)aniline",CCCCN(CC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],2319,Negative,In Vivo
"N-butyl-N-ethyl-2,6-dinitro-4-(trifluoromethyl)aniline",CCCCN(CC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],2319,Positive,In Vivo
N-butyl-N-ethylnitrous amide,CCCCN(CC)N=O,20680,Positive,In Vivo
N-butyl-N-methylnitrous amide,CCCCN(C)N=O,23471,Positive,In Vivo
N-butyl-N-methylnitrous amide,CCCCN(C)N=O,7068-83-9,Positive,in vitro
N-butyl-N-nitrosobutanamide,CCCCN(C(=O)CCC)N=O,149617,Positive,In Vivo
N-butyl-N-pentylnitrous amide,CCCCCN(CCCC)N=O,16339-05-02,Positive,in vitro
N-butyl-N-propylnitrous amide,CCCCN(CCC)N=O,25413-64-3,Positive,in vitro
N-BUTYL-N'-NITRO-N-NITROSOGUANIDINE,CCCCN(C(=N)N[N+](=O)[O-])N=O,13010-08-7,Negative,In vivo
N-butylbutan-1-amine,CCCCNCCCC,111-92-2,Positive,in vitro
n-Butylglycidyl ether,CCCCOCC1CO1,2426-08-6,Positive,in vitro
n-BUTYLHYDRAZINE.HCl,CCCCNN.Cl,56795-65-4,Positive,In vivo
N-BUTYLUREA,CCCCNC(=O)N,592-31-4,Negative,In vivo
N-CYCLOHEXYL-2-BENZOTHIAZOLE SULFENAMIDE,C1CCC(CC1)NSC2=NC3=CC=CC=C3S2,95-33-0,Negative,In vivo
N-cyclohexyl-3-(5-nitrofuran-2-yl)prop-2-ynamide,C1CCC(CC1)NC(=O)C#CC2=CC=C(O2)[N+](=O)[O-],,Negative,in vitro
N-cyclohexyl-3-(5-nitrofuran-2-yl)propanamide,C1CCC(CC1)NC(=O)CCC2=CC=C(O2)[N+](=O)[O-],39965-29-2,Negative,in vitro
N-cyclohexyl-N-methylnitrous amide,CN(C1CCCCC1)N=O,21567,Negative,In Vivo
N-cyclohexyl-N-methylnitrous amide,CN(C1CCCCC1)N=O,21567,Positive,In Vivo
N-cyclohexylhydroxylamine,C1CCC(CC1)NO,2211-64-5,Negative,in vitro
N-cyclopentylidenehydroxylamine,C1CCC(=NO)C1,14500,Negative,In Vivo
N-decyl-N-methylnitrous amide,CCCCCCCCCCN(C)N=O,53394,Positive,In Vivo
"N-diethoxyphosphoryl-4-methyl-1,3-dithiolan-2-imine",CCOP(=O)(N=C1SCC(S1)C)OCC,0950-10-7,Positive,in vitro
N-dodecyl-N-methylnitrous amide,CCCCCCCCCCCCN(C)N=O,41320,Positive,In Vivo
N-dodecyl-N-methylnitrous amide,CCCCCCCCCCCCN(C)N=O,55090-44-3,Positive,in vitro
n-DODECYLGUANIDINE ACETATE,CCCCCCCCCCCCN=C(N)N.CC(=O)O,2439-10-3,Negative,In vivo
N-ethenyl-N-ethylnitrous amide,CCN(C=C)N=O,25807,Positive,In Vivo
N-ethenyl-N-ethylnitrous amide,CCN(C=C)N=O,13256-13-8,Positive,in vitro
N-ethenyl-N-methylnitrous amide,CN(C=C)N=O,4549-40-0,Positive,in vivo
N-ethenyl-N-methylnitrous amide,CN(C=C)N=O,20678,Positive,In Vivo
N-ethenyl-N-methylnitrous amide,CN(C=C)N=O,4549-40-0,Positive,in vitro
N-ethyl-1-phenylcyclohexan-1-amine,CCNC1(CCCCC1)C2=CC=CC=C2,2201-15-2,Positive,in vitro
N-ethyl-N-(2-hydroxyethyl)nitrous amide,CCN(CCO)N=O,25742,Negative,In Vivo
N-ethyl-N-(2-hydroxyethyl)nitrous amide,CCN(CCO)N=O,25742,Positive,In Vivo
N-ethyl-N-(2-hydroxyethyl)nitrous amide,CCN(CCO)N=O,13147-25-6,Positive,in vitro
"N-ethyl-N-(2-methylprop-2-enyl)-2,6-dinitro-4-(trifluoromethyl)aniline",CCN(CC(=C)C)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],41381,Negative,In Vivo
"N-ethyl-N-(2-methylprop-2-enyl)-2,6-dinitro-4-(trifluoromethyl)aniline",CCN(CC(=C)C)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],41381,Positive,In Vivo
"N-ethyl-N-(2,2,2-trifluoroethyl)nitrous amide",CCN(CC(F)(F)F)N=O,54806,Positive,In Vivo
N-ethyl-N-(3-hydroxypropyl)nitrous amide,CCN(CCCO)N=O,61734-88-1,Positive,in vitro
N-ETHYL-N-FORMYLHYDRAZINE,CCN(C=O)N,74920-78-8,Positive,In vivo
N-ethyl-N-methylnitrous amide,CCN(C)N=O,25418,Positive,In Vivo
N-ethyl-N-methylnitrous amide,CCN(C)N=O,10595-95-6,Positive,in vivo
N-ethyl-N-nitrosoacetamide,CCN(C(=O)C)N=O,24849110,Positive,In Vivo
N-ethyl-N-nitrosoacetamide,CCN(C(=O)C)N=O,24849110,Negative,In Vivo
N-ethyl-N-phenyldiazenylethanamine,CCN(CC)N=NC1=CC=CC=C1,13056-98-9,Positive,in vivo
N-ethyl-N-phenyldiazenylethanamine,CCN(CC)N=NC1=CC=CC=C1,13056-98-9,Positive,in vitro
N-ethyl-N-phenylnitrous amide,CCN(C1=CC=CC=C1)N=O,612-64-6,Negative,in vitro
N-Ethyl-N'-nitro-N-nitroguanidine - [1-Ethyl-2-nitro-1-nitroso-guanidine],CCN=C(N)N(N=O)[N+](=O)[O-],63885-23-4,Positive,in vitro
N-ETHYL-N'-NITRO-N-NITROSOGUANIDINE,CCN(C(=N)N[N+](=O)[O-])N=O,63885-23-4,Positive,In vivo
N-ethylbutan-1-amine,CCCCNCC,13360-63-9,Negative,in vitro
N-formamidoformamide,C(=O)NNC=O,12342,Positive,In Vivo
N-heptyl-N-methylnitrous amide,CCCCCCCN(C)N=O,27822,Positive,In Vivo
N-hexyl-N-methylnitrous amide,CCCCCCN(C)N=O,34273,Positive,In Vivo
N-HEXYLNITROSOUREA,CCCCCCN(C(=O)N)N=O,18774-85-1,Positive,In vivo
N-Hexylnitrosourea,CCCCCCN(C(=O)N)N=O,18774-85-1,Positive,in vitro
N-hydroxy-1H-indole-2-carboxamide,C1=CC=C2C(=C1)C=C(N2)C(=O)NO,63408-86-6,Positive,in vitro
N-HYDROXY-2-ACETYLAMINOFLUORENE,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)O,53-95-2,Positive,In vivo
N-HYDROXY-2-ACETYLAMINOFLUORENE,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)O,53-95-2,Negative,In vivo
N-Hydroxy-2-acetylaminofluorene,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)O,53-95-2,Positive,in vitro
N-hydroxy-N-(4-phenylphenyl)acetamide,CC(=O)N(C1=CC=C(C=C1)C2=CC=CC=C2)O,20527,Negative,In Vivo
N-hydroxy-N-(4-phenylphenyl)acetamide,CC(=O)N(C1=CC=C(C=C1)C2=CC=CC=C2)O,4463-22-3,Positive,in vitro
N-hydroxy-N-(4-phenylphenyl)propanamide,CCC(=O)N(C1=CC=C(C=C1)C2=CC=CC=C2)O,149799,Negative,In Vivo
N-hydroxy-N-[4-[(E)-2-phenylethenyl]phenyl]acetamide,CC(=O)N(C1=CC=C(C=C1)/C=C/C2=CC=CC=C2)O,6054491,Positive,In Vivo
N-hydroxy-N-[4-[(E)-2-phenylethenyl]phenyl]formamide,C1=CC=C(C=C1)/C=C/C2=CC=C(C=C2)N(C=O)O,6439953,Positive,In Vivo
N-hydroxy-N-[4-[(E)-2-phenylethenyl]phenyl]propanamide,CCC(=O)N(C1=CC=C(C=C1)/C=C/C2=CC=CC=C2)O,6366991,Positive,In Vivo
N-hydroxy-N-[4-[(Z)-2-phenylethenyl]phenyl]acetamide,CC(=O)N(C1=CC=C(C=C1)/C=C\C2=CC=CC=C2)O,18559-95-0,Positive,in vivo
N-hydroxy-N-[4-[(Z)-2-phenylethenyl]phenyl]acetamide,CC(=O)N(C1=CC=C(C=C1)/C=C\C2=CC=CC=C2)O,18559-95-0,Positive,in vitro
N-hydroxy-N-methylnaphthalene-2-carboxamide,CN(C(=O)C1=CC2=CC=CC=C2C=C1)O,76790-15-3,Positive,in vitro
N-hydroxy-N-phenanthren-2-ylacetamide,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C=C2)O,,Positive,in vivo
N-hydroxy-N-phenanthren-2-ylacetamide,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C=C2)O,,Positive,in vitro
N-hydroxy-N-pyren-1-ylacetamide,CC(=O)N(C1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1)O,56886,Negative,In Vivo
N-hydroxyacetamide,CC(=O)NO,546-88-3,Negative,in vitro
N-hydroxybenzamide,C1=CC=C(C=C1)C(=O)NO,495-18-1,Positive,in vitro
N-hydroxynaphthalene-2-carboxamide,C1=CC=C2C=C(C=CC2=C1)C(=O)NO,10335-79-2,Positive,in vitro
N-ISOBUTYL-N'-NITRO-N-NITROSOGUANIDINE,CC(C)CN(C(=N)N[N+](=O)[O-])N=O,5461-85-8,Negative,In vivo
N-METHYL-2-PYRROLIDONE,CN1CCCC1=O,872-50-4,Positive,In vivo
N-METHYL-2-PYRROLIDONE,CN1CCCC1=O,872-50-4,Negative,In vivo
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl,62857,Negative,In Vivo
N-methyl-4-phenyldiazenylaniline,CNC1=CC=C(C=C1)N=NC2=CC=CC=C2,12137,Negative,In Vivo
N-methyl-4-phenyldiazenylaniline,CNC1=CC=C(C=C1)N=NC2=CC=CC=C2,12137,Positive,In Vivo
N-methyl-4-phenyldiazenylaniline,CNC1=CC=C(C=C1)N=NC2=CC=CC=C2,621-90-9,Positive,in vitro
N-methyl-N-(2-oxopentyl)nitrous amide,CCCC(=O)CN(C)N=O,154830,Positive,In Vivo
N-methyl-N-(2-oxopropyl)nitrous amide,CC(=O)CN(C)N=O,104910,Positive,In Vivo
N-methyl-N-(3-oxopropyl)nitrous amide,CN(CCC=O)N=O,98533,Positive,In Vivo
N-methyl-N-(4-oxo-4-pyridin-3-ylbutyl)nitrous amide,CN(CCCC(=O)C1=CN=CC=C1)N=O,47289,Positive,In Vivo
N-methyl-N-(4-oxo-4-pyridin-3-ylbutyl)nitrous amide,CN(CCCC(=O)C1=CN=CC=C1)N=O,47289,Negative,In Vivo
N-methyl-N-(4-oxo-4-pyridin-3-ylbutyl)nitrous amide,CN(CCCC(=O)C1=CN=CC=C1)N=O,64091-91-4,Positive,in vitro
N-methyl-N-(pyridin-3-yldiazenyl)methanamine,CN(C)N=NC1=CN=CC=C1,19992-69-9,Positive,in vitro
"N-methyl-N-[(2,4,6-tribromophenyl)diazenyl]methanamine",CN(C)N=NC1=C(C=C(C=C1Br)Br)Br,99637,Negative,In Vivo
"N-methyl-N-[(2,4,6-tribromophenyl)diazenyl]methanamine",CN(C)N=NC1=C(C=C(C=C1Br)Br)Br,,Positive,in vitro
"N-methyl-N-[(2,4,6-trichlorophenyl)diazenyl]methanamine",CN(C)N=NC1=C(C=C(C=C1Cl)Cl)Cl,,Positive,in vitro
"N-methyl-N-[(2,4,6-trifluorophenyl)diazenyl]methanamine",CN(C)N=NC1=C(C=C(C=C1F)F)F,82136-27-4,Positive,in vitro
N-methyl-N-[(E)-3-methylbutylideneamino]formamide,CC(C)C/C=N/N(C)C=O,9556442,Positive,In Vivo
N-METHYL-N-FORMYLHYDRAZINE,CN(C=O)N,758-17-8,Positive,In vivo
N-METHYL-N-FORMYLHYDRAZINE,CN(C=O)N,758-17-8,Negative,In vivo
N-methyl-N-nitrosoacetamide,CC(=O)N(C)N=O,7417-67-6,Positive,in vitro
N-METHYL-N-NITROSOBENZAMIDE,CN(C(=O)C1=CC=CC=C1)N=O,63412-06-6,Negative,In vivo
N-METHYL-N-NITROSOBENZAMIDE,CN(C(=O)C1=CC=CC=C1)N=O,63412-06-6,Positive,In vivo
N-Methyl-N-nitrosobenzamide,CN(C(=O)C1=CC=CC=C1)N=O,614-00-6,Positive,in vitro
N-methyl-N-nitrosododecanamide,CCCCCCCCCCCC(=O)N(C)N=O,16395-85-0,Positive,in vitro
N-methyl-N-nitrosoformamide,CN(C=O)N=O,96148,Negative,In Vivo
N-methyl-N-nitrosoformamide,CN(C=O)N=O,96148,Positive,In Vivo
N-methyl-N-nitrosoheptanamide,CCCCCCC(=O)N(C)N=O,16395-83-8,Positive,in vitro
N-methyl-N-nitrosohexanamide,CCCCCC(=O)N(C)N=O,16395-82-7,Positive,in vitro
N-methyl-N-nitrosooctanamide,CCCCCCCC(=O)N(C)N=O,15567-46-1,Positive,in vitro
N-methyl-N-nitrosopentanamide,CCCCC(=O)N(C)N=O,16451-26-6,Positive,in vitro
N-methyl-N-nitrosopropanamide,CCC(=O)N(C)N=O,16395-80-5,Positive,in vitro
N-methyl-N-nitrosotetradecanamide,CCCCCCCCCCCCCC(=O)N(C)N=O,,Positive,in vitro
N-methyl-N-nonylnitrous amide,CCCCCCCCCN(C)N=O,53393,Positive,In Vivo
N-methyl-N-octylnitrous amide,CCCCCCCCN(C)N=O,36828,Positive,In Vivo
N-methyl-N-pentylnitrous amide,CCCCCN(C)N=O,25805,Negative,In Vivo
N-methyl-N-pentylnitrous amide,CCCCCN(C)N=O,25805,Positive,In Vivo
N-methyl-N-pentylnitrous amide,CCCCCN(C)N=O,13256-07-0,Positive,in vitro
N-methyl-N-phenyldiazenylmethanamine,CN(C)N=NC1=CC=CC=C1,7227-91-0,Positive,in vivo
N-methyl-N-phenyldiazenylmethanamine,CN(C)N=NC1=CC=CC=C1,23654,Negative,In Vivo
N-methyl-N-phenyldiazenylmethanamine,CN(C)N=NC1=CC=CC=C1,23654,Positive,In Vivo
N-methyl-N-phenyldiazenylmethanamine,CN(C)N=NC1=CC=CC=C1,7227-91-0,Positive,in vitro
N-methyl-N-phenylnitrous amide,CN(C1=CC=CC=C1)N=O,11957,Positive,In Vivo
N-methyl-N-phenylnitrous amide,CN(C1=CC=CC=C1)N=O,614-00-6,Negative,in vitro
N-methyl-N-propylnitrous amide,CCCN(C)N=O,13545,Positive,In Vivo
N-methyl-N-propylnitrous amide,CCCN(C)N=O,924-46-9,Positive,in vitro
N-methyl-N-tetradecylnitrous amide,CCCCCCCCCCCCCCN(C)N=O,115083,Positive,In Vivo
"N-METHYL-N,4-DINITROSOANILINE",CN(C1=CC=C(C=C1)N=O)N=O,99-80-9,Negative,In vivo
"N-METHYL-N,4-DINITROSOANILINE",CN(C1=CC=C(C=C1)N=O)N=O,99-80-9,Positive,In vivo
N-METHYL-N'-NITRO-N-NITROSOGUANIDINE,CN(C(=N)N[N+](=O)[O-])N=O,70-25-7,Positive,In vivo
N-METHYL-N'-NITRO-N-NITROSOGUANIDINE,CN(C(=N)N[N+](=O)[O-])N=O,70-25-7,Negative,In vivo
N-Methyl-N'-nitro-N-nitrosoguanidine,CN(C(=N)N[N+](=O)[O-])N=O,70-25-7,Positive,in vitro
"N-METHYLDOPAMINE,O,O'-DIISOBUTYROYL ESTER.HCl",CC(C)C(=O)OC1=C(C=C(C=C1)CCNC)OC(=O)C(C)C.Cl,75011-65-3,Negative,In vivo
N-methylformamide,CNC=O,123-39-7,Negative,in vitro
N-methylhydroxylamine,CNO,593-77-1,Positive,in vitro
N-methylmethanamine,CNC,124-40-3,Negative,in vitro
N-methylmethanamine;hydrochloride,CNC.Cl,506-59-2,Negative,in vitro
N-methylolacrylamide,C=CC(=O)NCO,924-42-5,Positive,in vitro
N-methylphthalazin-1-amine;hydrochloride,CNC1=NN=CC2=CC=CC=C21.Cl,131709167,Positive,In Vivo
N-methylphthalazin-1-amine;hydrochloride,CNC1=NN=CC2=CC=CC=C21.Cl,,Positive,in vivo
N-methylphthalazin-1-amine;hydrochloride,CNC1=NN=CC2=CC=CC=C21.Cl,131709167,Negative,In Vivo
N-methylphthalazin-1-amine;hydrochloride,CNC1=NN=CC2=CC=CC=C21.Cl,,Positive,in vitro
N-n-BUTYL-N-FORMYLHYDRAZINE,CCCCN(C=O)N,16120-70-0,Negative,In vivo
N-n-BUTYL-N-FORMYLHYDRAZINE,CCCCN(C=O)N,16120-70-0,Positive,In vivo
N-n-BUTYL-N-NITROSOUREA,CCCCN(C(=O)N)N=O,869-01-2,Negative,In vivo
N-n-BUTYL-N-NITROSOUREA,CCCCN(C(=O)N)N=O,869-01-2,Positive,In vivo
N-n-Butyl-N-nitrosourea,CCCCN(C(=O)N)N=O,759-73-9,Positive,in vitro
N-N'-PROPYL-N-FORMYLHYDRAZINE,CCCN(C=O)N,77337-54-3,Positive,In vivo
N-naphthalen-1-ylhydroxylamine,C1=CC=C2C(=C1)C=CC=C2NO,607-30-7,Positive,in vivo
N-naphthalen-1-ylhydroxylamine,C1=CC=C2C(=C1)C=CC=C2NO,607-30-7,Negative,in vitro
N-naphthalen-2-ylhydroxylamine,C1=CC=C2C=C(C=CC2=C1)NO,69176,Positive,In Vivo
N-naphthalen-2-ylhydroxylamine,C1=CC=C2C=C(C=CC2=C1)NO,613-47-8,Positive,in vivo
N-naphthalen-2-ylhydroxylamine,C1=CC=C2C=C(C=CC2=C1)NO,613-47-8,Positive,in vitro
N-NITROSO-(2-HYDROXYPROPYL)-(2-HYDROXYETHYL)AMINE,CC(CN(CCO)N=O)O,75896-33-2,Positive,In vivo
"N-NITROSO-1,3-OXAZOLIDINE",C1COCN1N=O,39884-52-1,Positive,In vivo
N-NITROSO-2-HYDROXYMORPHOLINE,C1COC(CN1N=O)O,67587-52-4,Negative,In vivo
N-NITROSO-2-PHENYLETHYLUREA,C1=CC=C(C=C1)CCN(C(=O)N)N=O,---,Positive,In vivo
"N-NITROSO-2,2,4-TRIMETHYL-1,2-DIHYDROQUINOLINE POLYMER",CC1=CC(N(C2=CC=CC=C12)N=O)(C)C,29929-77-9,Positive,In vivo
"N-Nitroso-2,3-dihydroxypropyl-2-hydroxypropyl-amine",CC(CN(CC(CO)O)N=O)O,89911-79-5,Positive,in vitro
"N-NITROSO-2,3-DIHYDROXYPROPYL-2-HYDROXYPROPYLAMINE",CC(CN(CC(CO)O)N=O)O,89911-79-5,Positive,In vivo
"N-NITROSO-2,3-DIHYDROXYPROPYLETHANOLAMINE",C(CO)N(CC(CO)O)N=O,89911-78-4,Positive,In vivo
N-NITROSO-3-HYDROXYPYRROLIDINE,C1CN(CC1O)N=O,56222-35-6,Positive,In vivo
N-Nitroso-3-hydroxypyrrolidine,C1CN(CC1O)N=O,56222-35-6,Positive,in vitro
"N-NITROSO-BIS-(4,4,4-TRIFLUORO-N-BUTYL)AMINE",C(CC(F)(F)F)CN(CCCC(F)(F)F)N=O,83335-32-4,Positive,In vivo
N-NITROSO-N-ISOBUTYLUREA,CC(C)CN(C(=O)N)N=O,760-60-1,Positive,In vivo
N-NITROSO-N-METHYL-4-FLUOROANILINE,CN(C1=CC=C(C=C1)F)N=O,937-25-7,Positive,In vivo
N-NITROSO-N-METHYL-4-NITROANILINE,CN(C1=CC=C(C=C1)[N+](=O)[O-])N=O,943-41-9,Negative,In vivo
N-NITROSO-N-METHYL-N-DODECYLAMINE,CCCCCCCCCCCCN(C)N=O,55090-44-3,Positive,In vivo
N-NITROSO-N-METHYL-N-TETRADECYLAMINE,CCCCCCCCCCCCCCN(C)N=O,75881-20-8,Positive,In vivo
N-NITROSO-N-METHYLDECYLAMINE,CCCCCCCCCCN(C)N=O,75881-22-0,Positive,In vivo
N-NITROSO-N-METHYLUREA,CN(C(=O)N)N=O,684-93-5,Positive,In vivo
N-Nitroso-N-methylurea,CN(C(=O)N)N=O,684-93-5,Positive,in vitro
N-NITROSO-N-METHYLURETHAN,CCOC(=O)N(C)N=O,615-53-2,Positive,In vivo
"N-NITROSO(2,2,2-TRIFLUOROETHYL)ETHYLAMINE",CCN(CC(F)(F)F)N=O,82018-90-4,Positive,In vivo
N-NITROSOALLYL-2-HYDROXYPROPYLAMINE,CC(CN(CC=C)N=O)O,91308-70-2,Positive,In vivo
N-NITROSOALLYL-2-OXOPROPYLAMINE,CC(=O)CN(CC=C)N=O,91308-71-3,Positive,In vivo
"N-NITROSOALLYL-2,3-DIHYDROXYPROPYLAMINE",C=CCN(CC(CO)O)N=O,88208-16-6,Negative,In vivo
"N-NITROSOALLYL-2,3-DIHYDROXYPROPYLAMINE",C=CCN(CC(CO)O)N=O,88208-16-6,Positive,In vivo
N-NITROSOALLYLETHANOLAMINE,C=CCN(CCO)N=O,91308-69-9,Positive,In vivo
N-NITROSOAZETIDINE,C1CN(C1)N=O,15216-10-1,Positive,In vivo
N-NITROSOBENZTHIAZURON,CN(C(=O)NC1=NC2=CC=CC=C2S1)N=O,51542-33-7,Positive,In vivo
N-NITROSOBIS(2-HYDROXYPROPYL)AMINE,CC(CN(CC(C)O)N=O)O,53609-64-6,Positive,In vivo
N-NITROSOBIS(2-OXOPROPYL)AMINE,CC(=O)CN(CC(=O)C)N=O,60599-38-4,Positive,In vivo
"N-NITROSOBIS(2,2,2-TRIFLUOROETHYL)AMINE",C(C(F)(F)F)N(CC(F)(F)F)N=O,625-89-8,Negative,In vivo
N-NITROSOCIMETIDINE,CC1=C(N=CN1)CSCCN=C(NC#N)N(C)N=O,73785-40-7,Negative,In vivo
N-Nitrosodibenzylamine,C1=CC=C(C=C1)CN(CC2=CC=CC=C2)N=O,5336-53-8,Positive,in vitro
N-NITROSODIETHANOLAMINE,C(CO)N(CCO)N=O,1116-54-7,Negative,In vivo
N-NITROSODIETHANOLAMINE,C(CO)N(CCO)N=O,1116-54-7,Positive,In vivo
N-Nitrosodiethanolamine,C(CO)N(CCO)N=O,1116-54-7,Positive,in vitro
N-NITROSODIETHYLAMINE,CCN(CC)N=O,55-18-5,Positive,In vivo
N-NITROSODIETHYLAMINE,CCN(CC)N=O,55-18-5,Negative,In vivo
N-Nitrosodiethylamine (diethylnitrosamine),CCN(CC)N=O,55-18-5,Positive,in vitro
N-NITROSODIMETHYLAMINE,CN(C)N=O,62-75-9,Positive,In vivo
N-NITROSODIMETHYLAMINE,CN(C)N=O,62-75-9,Negative,In vivo
N-Nitrosodimethylamine (dimethylnitrosamine),CN(C)N=O,62-75-9,Positive,in vitro
N-NITROSODIPHENYLAMINE,C1=CC=C(C=C1)N(C2=CC=CC=C2)N=O,86-30-6,Negative,In vivo
N-NITROSODIPROPYLAMINE,CCCN(CCC)N=O,621-64-7,Positive,In vivo
N-Nitrosodipropylamine [dipropylnitrosamine],CCCN(CCC)N=O,621-64-7,Positive,in vitro
N-NITROSODITHIAZINE,C1N(CSCS1)N=O,114282-83-6,Negative,In vivo
N-NITROSOEPHEDRINE,CC(C(C1=CC=CC=C1)O)N(C)N=O,17608-59-2,Positive,In vivo
N-NITROSOHEXAMETHYLENEIMINE,C1CCCN(CC1)N=O,932-83-2,Positive,In vivo
N-Nitrosohexamethyleneimine,C1CCCN(CC1)N=O,932-83-2,Positive,in vitro
N-NITROSOMETHYL-(2-HYDROXYETHYL)AMINE,CN(CCO)N=O,26921-68-6,Positive,In vivo
N-NITROSOMETHYL-(2-TOSYLOXYETHYL)AMINE,CC1=CC=C(C=C1)S(=O)(=O)OCCN(C)N=O,---,Positive,In vivo
N-NITROSOMETHYL-(3-HYDROXYPROPYL)AMINE,CN(CCCO)N=O,70415-59-7,Positive,In vivo
N-NITROSOMETHYL-2-HYDROXYPROPYLAMINE,CC(CN(C)N=O)O,75411-83-5,Negative,In vivo
N-NITROSOMETHYL-2-HYDROXYPROPYLAMINE,CC(CN(C)N=O)O,75411-83-5,Positive,In vivo
"N-NITROSOMETHYL-2,3-DIHYDROXYPROPYLAMINE",CN(CC(CO)O)N=O,86451-37-8,Negative,In vivo
"N-NITROSOMETHYL-2,3-DIHYDROXYPROPYLAMINE",CN(CC(CO)O)N=O,86451-37-8,Positive,In vivo
N-NITROSOMETHYL(2-OXOPROPYL)AMINE,CC(=O)CN(C)N=O,55984-51-5,Positive,In vivo
N-Nitrosomethylbenzylamine,CN(CC1=CC=CC=C1)N=O,937-40-6,Positive,in vitro
N-NITROSOMORPHOLINE,C1COCCN1N=O,59-89-2,Positive,In vivo
N-Nitrosomorpholine,C1COCCN1N=O,59-89-2,Positive,in vitro
N-Nitrosonornicotine,C1CC(N(C1)N=O)C2=CN=CC=C2,16543-55-8,Positive,in vitro
N-NITROSOPIPERAZINE,C1CN(CCN1)N=O,5632-47-3,Positive,In vivo
N-Nitrosopiperazine,C1CN(CCN1)N=O,5632-47-3,Positive,in vitro
N-NITROSOPIPERIDINE,C1CCN(CC1)N=O,100-75-4,Positive,In vivo
N-Nitrosopiperidine,C1CCN(CC1)N=O,100-75-4,Positive,in vitro
N-NITROSOPYRROLIDINE,C1CCN(C1)N=O,930-55-2,Positive,In vivo
N-Nitrosopyrrolidine / mesH: 35844-45-8,C1CCN(C1)N=O,930-55-2,Positive,in vitro
N-NITROSOTHIALDINE,CC1N(C(SC(S1)C)C)N=O,81795-07-5,Positive,In vivo
N-NITROSOTHIOMORPHOLINE,C1CSCCN1N=O,26541-51-5,Positive,In vivo
N-Nitrosothiomorpholine,C1CSCCN1N=O,26541-51-5,Positive,in vitro
N-OXYDIETHYLENE THIOCARBAMYL-N-OXYDIETHYLENE SULFENAMIDE,C1COCCN1C(=S)SN2CCOCC2,13752-51-7,Positive,In vivo
N-OXYDIETHYLENEBENZOTHIAZOLE-2-SULFENAMIDE,C1COCCN1SC2=NC3=CC=CC=C3S2,102-77-2,Negative,In vivo
N-PENTYL-N'-NITRO-N-NITROSOGUANIDINE,CCCCCN(C(=N)N[N+](=O)[O-])N=O,13010-10-1,Negative,In vivo
n-PENTYLHYDRAZINE.HCl,CCCCCN[NH3+].[Cl-],1119-68-2,Positive,In vivo
N-phenanthren-2-ylacetamide,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C=C2,,Positive,in vivo
N-phenanthren-2-ylacetamide,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C=C2,,Negative,in vitro
N-phenylacetamide,CC(=O)NC1=CC=CC=C1,103-84-4,Negative,in vitro
N-phenylaniline,C1=CC=C(C=C1)NC2=CC=CC=C2,122-39-4,Positive,in vitro
N-phenyldiazenylaniline,C1=CC=C(C=C1)NN=NC2=CC=CC=C2,136-35-6,Positive,in vitro
N-phenylhydroxylamine,C1=CC=C(C=C1)NO,100-65-2,Positive,in vitro
N-phenylnaphthalen-1-amine,C1=CC=C(C=C1)NC2=CC=CC3=CC=CC=C32,90-30-2,Negative,in vitro
N-phenylnaphthalen-2-amine,C1=CC=C(C=C1)NC2=CC3=CC=CC=C3C=C2,8679,Negative,In Vivo
N-propan-2-ylidenehydroxylamine,CC(=NO)C,67180,Positive,In Vivo
n-PROPYL ISOME,CCCOC(=O)C1C(CC2=CC3=C(C=C2C1C(=O)OCCC)OCO3)C,83-59-0,Negative,In vivo
N-PROPYL-N-NITROSOUREA,CCCN(C(=O)N)N=O,816-57-9,Positive,In vivo
N-Propyl-N-nitrosourea,CCCN(C(=O)N)N=O,816-57-9,Positive,in vitro
N-PROPYL-N'-NITRO-N-NITROSOGUANIDINE,CCCN=C(N)N(N=O)[N+](=O)[O-],13010-07-6,Positive,In vivo
N-Propyl-N'-nitro-N-nitrosoguanidine,CCCN=C(N)N(N=O)[N+](=O)[O-],4245-76-5,Positive,in vitro
N-pyren-1-ylacetamide,CC(=O)NC1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1,255653,Negative,In Vivo
N-tert-butyl-N-methylnitrous amide,CC(C)(C)N(C)N=O,2504-18-9,Negative,in vitro
n-TRITRIACONTANE-16-18-DIONE,CCCCCCCCCCCCCCCC(=O)CC(=O)CCCCCCCCCCCCCCC,24514-86-1,Negative,In vivo
N-VINYLPYRROLIDONE-2,C=CN1CCCC1=O,88-12-0,Positive,In vivo
"N,2-dihydroxybenzamide",C1=CC=C(C(=C1)C(=O)NO)O,89-73-6,Positive,in vitro
"N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",C1CN(P(=O)(OC1)NCCCl)CCCl,3690,Negative,In Vivo
"N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",C1CN(P(=O)(OC1)NCCCl)CCCl,3690,Positive,In Vivo
"N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",C1CN(P(=O)(OC1)NCCCl)CCCl,3778-73-2,Positive,in vivo
"N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",C1CN(P(=O)(OC1)NCCCl)CCCl,3778-73-2,Negative,in vitro
"N,3-dimethyl-5-[methyl(nitroso)amino]-N-nitrosoimidazole-4-carboxamide",CN1C=NC(=C1C(=O)N(C)N=O)N(C)N=O,126866,Positive,In Vivo
"N,3-dimethyl-5-[methyl(nitroso)amino]imidazole-4-carboxamide",CNC(=O)C1=C(N=CN1C)N(C)N=O,126865,Positive,In Vivo
"N,4-dimethyl-N-nitrosobenzenesulfonamide",CC1=CC=C(C=C1)S(=O)(=O)N(C)N=O,80-11-5,Positive,in vitro
"N,N-bis(2-chloroethyl)-2-(4-ethoxyphenyl)ethanamine",CCOC1=CC=C(C=C1)CCN(CCCl)CCCl,,Positive,in vitro
"N,N-bis(2-chloroethyl)-2-diethoxyphosphorylethanamine",CCOP(=O)(CCN(CCCl)CCCl)OCC,,Positive,in vitro
"N,N-bis(2-chloroethyl)-2-methoxyethanamine",COCCN(CCCl)CCCl,26112-92-5,Positive,in vitro
"N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-diazaphosphinan-2-amine",C1CNP(=O)(NC1)N(CCCl)CCCl,,Positive,in vitro
"N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",C1CNP(=O)(OC1)N(CCCl)CCCl,2907,Negative,In Vivo
"N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",C1CNP(=O)(OC1)N(CCCl)CCCl,2907,Positive,In Vivo
"N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",C1CNP(=O)(OC1)N(CCCl)CCCl,50-18-0,Positive,in vivo
"N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",C1CNP(=O)(OC1)N(CCCl)CCCl,50-18-0,Negative,in vitro
"N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine;hydrate",C1CNP(=O)(OC1)N(CCCl)CCCl.O,6055-19-2,Positive,in vivo
"N,N-bis(2-chloroethyl)-2-phenylethanamine",C1=CC=C(C=C1)CCN(CCCl)CCCl,,Positive,in vitro
"N,N-bis(2-chloroethyl)-4-hydroperoxy-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",C1COP(=O)(NC1OO)N(CCCl)CCCl,39800-16-3,Positive,in vitro
"N,N-bis(2-chloroethyl)-4-methoxyaniline",COC1=CC=C(C=C1)N(CCCl)CCCl,1448-52-8,Positive,in vitro
"N,N-bis(2-chloroethyl)-4-methylaniline",CC1=CC=C(C=C1)N(CCCl)CCCl,1204-68-8,Positive,in vitro
"N,N-bis(2-chloroethyl)-5,5-dideuterio-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",[2H]C1(CNP(=O)(OC1)N(CCCl)CCCl)[2H],,Positive,in vitro
"N,N-bis(2-chloroethyl)aniline",C1=CC=C(C=C1)N(CCCl)CCCl,553-27-5,Positive,in vitro
"N,N-bis(2-chloroethyl)naphthalen-2-amine",C1=CC=C2C=C(C=CC2=C1)N(CCCl)CCCl,10307,Positive,In Vivo
"N,N-bis(2-chloroethyl)naphthalen-2-amine",C1=CC=C2C=C(C=CC2=C1)N(CCCl)CCCl,0494-03-01,Positive,in vivo
"N,N-bis(2-chloroethyl)naphthalen-2-amine",C1=CC=C2C=C(C=CC2=C1)N(CCCl)CCCl,0494-03-01,Positive,in vitro
"N,N-Bis(2-hydroxyethyl)-p-phenylenediamine sulfate   COLIPA A50",C1=CC(=CC=C1N)N(CCO)CCO.OS(=O)(=O)O,54381-16-7,Positive,in vitro
"N,N-bis(2-hydroxyethyl)dodecanamide",CCCCCCCCCCCC(=O)N(CCO)CCO,8430,Negative,In Vivo
"N,N-bis(2-hydroxyethyl)nitrous amide",C(CO)N(CCO)N=O,14223,Positive,In Vivo
"N,N-bis(2-hydroxyethyl)nitrous amide",C(CO)N(CCO)N=O,1116-54-7,Positive,in vivo
"N,N-bis(2-hydroxypropyl)nitrous amide",CC(CN(CC(C)O)N=O)O,40828,Positive,In Vivo
"N,N-bis(2-oxopropyl)nitrous amide",CC(=O)CN(CC(=O)C)N=O,43371,Positive,In Vivo
"N,N-bis(4,4,4-trifluorobutyl)nitrous amide",C(CC(F)(F)F)CN(CCCC(F)(F)F)N=O,54990,Positive,In Vivo
"N,N-bis(prop-2-enyl)nitrous amide",C=CCN(CC=C)N=O,27821,Positive,In Vivo
"N,N-bis(prop-2-enyl)nitrous amide",C=CCN(CC=C)N=O,16338-97-9,Positive,in vitro
"N,N-dibenzylnitrous amide",C1=CC=C(C=C1)CN(CC2=CC=CC=C2)N=O,5336-53-8,Negative,in vitro
"N,N-dibutylnitrous amide",CCCCN(CCCC)N=O,13542,Positive,In Vivo
"N,N-dibutylnitrous amide",CCCCN(CCCC)N=O,924-16-3,Negative,in vivo
"N,N-dibutylnitrous amide",CCCCN(CCCC)N=O,924-16-3,Positive,in vivo
"N,N-dibutylnitrous amide",CCCCN(CCCC)N=O,924-16-3,Negative,in vitro
"N,N-Dicyclohexylthiourea",C1CCC(CC1)NC(=S)NC2CCCCC2,1212-29-9,Negative,in vitro
"N,N-diethyl-2-[[4-(hydroxymethyl)-9-oxothioxanthen-1-yl]amino]ethanamine oxide",CC[N+](CC)(CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O)[O-],,Positive,in vitro
"N,N-diethyl-2-[[4-(hydroxymethyl)-9-oxothioxanthen-1-yl]amino]ethanamine oxide;formic acid",CC[N+](CC)(CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O)[O-].C(=O)O,,Positive,in vitro
"N,N-diethyl-3-methylbenzamide",CCN(CC)C(=O)C1=CC=CC(=C1)C,4284,Negative,In Vivo
"N,N-DIETHYL-4-(4'-[PYRIDYL-1'-OXIDE]AZO)ANILINE",CCN(CC)C1=CC=C(C=C1)N=NC2=CC=[N+](C=C2)[O-],7347-49-1,Positive,In vivo
"N,N-diethyl-4-phenyldiazenylaniline",CCN(CC)C1=CC=C(C=C1)N=NC2=CC=CC=C2,2481-94-9,Negative,in vitro
"N,N-DIETHYL-m-TOLUAMIDE",CCN(CC)C(=O)C1=CC=CC(=C1)C,134-62-3,Negative,In vivo
"N,N-diethylhydroxylamine",CCN(CC)O,3710-84-7,Positive,in vitro
"N,N-diethylnitrous amide",CCN(CC)N=O,5921,Positive,In Vivo
"N,N-diethylnitrous amide",CCN(CC)N=O,5921,Negative,In Vivo
"N,N-diethylnitrous amide",CCN(CC)N=O,55-18-5,Negative,in vivo
"N,N-diethylnitrous amide",CCN(CC)N=O,55-18-5,Positive,in vivo
"N,N-diethylnitrous amide",CCN(CC)N=O,55-18-5,Negative,in vitro
"N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine;hydrochloride",CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C.Cl,6014,Negative,In Vivo
"N,N-dimethyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine-2-sulfonamide;methanesulfonic acid",CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C.CS(=O)(=O)O.CS(=O)(=O)O,2347-80-0,Negative,in vivo
"N,N-dimethyl-2-phenyldiazenylaniline",CN(C)C1=CC=CC=C1N=NC2=CC=CC=C2,,Positive,in vitro
"N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine",CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F,146-54-3,Positive,in vivo
"N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine",CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F,146-54-3,Negative,in vitro
"N,N-dimethyl-3-phenothiazin-10-ylpropan-1-amine",CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31,58-40-2,Positive,in vitro
"N,N-dimethyl-4-(quinolin-6-yldiazenyl)aniline",CN(C)C1=CC=C(C=C1)N=NC2=CC3=C(C=C2)N=CC=C3,,Positive,in vitro
"N,N-dimethyl-4-[(3-methylphenyl)diazenyl]aniline",CC1=CC(=CC=C1)N=NC2=CC=C(C=C2)N(C)C,55-80-1,Positive,in vivo
"N,N-dimethyl-4-[(3-methylphenyl)diazenyl]aniline",CC1=CC(=CC=C1)N=NC2=CC=C(C=C2)N(C)C,55-80-1,Negative,in vitro
"N,N-dimethyl-4-[(4-methylphenyl)diazenyl]aniline",CC1=CC=C(C=C1)N=NC2=CC=C(C=C2)N(C)C,3010-57-9,Negative,in vitro
"N,N-DIMETHYL-4-AMINOAZOBENZENE",CN(C)C1=CC=C(C=C1)N=NC2=CC=CC=C2,60-11-7,Positive,In vivo
"N,N-Dimethyl-4-aminoazobenzene",CN(C)C1=CC=C(C=C1)N=NC2=CC=CC=C2,60-11-7,Positive,in vitro
"N,N-dimethyl-4-phenyldiazenylaniline",CN(C)C1=CC=C(C=C1)N=NC2=CC=CC=C2,6053,Positive,In Vivo
"N,N-dimethyl-4-phenyldiazenylaniline",CN(C)C1=CC=C(C=C1)N=NC2=CC=CC=C2,6053,Negative,In Vivo
"N,N-dimethyl-4-phenyldiazenylaniline",CN(C)C1=CC=C(C=C1)N=NC2=CC=CC=C2,60-11-7,Negative,in vivo
"N,N-dimethyl-4-phenyldiazenylaniline",CN(C)C1=CC=C(C=C1)N=NC2=CC=CC=C2,60-11-7,Positive,in vivo
"N,N-dimethyl-4-phenyldiazenylaniline",CN(C)C1=CC=C(C=C1)N=NC2=CC=CC=C2,60-11-7,Negative,in vitro
"N,N-dimethyl-N'-[5-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-1,3,4-oxadiazol-2-yl]methanimidamide",CN(C)/C=N/C1=NN=C(O1)/C=C/C2=CC=C(O2)[N+](=O)[O-],25962-77-0,Positive,in vivo
"N,N-dimethyl-N'-[5-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-1,3,4-oxadiazol-2-yl]methanimidamide",CN(C)/C=N/C1=NN=C(O1)/C=C/C2=CC=C(O2)[N+](=O)[O-],9570442,Positive,In Vivo
"N,N-dimethyl-N'-[5-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-1,3,4-oxadiazol-2-yl]methanimidamide",CN(C)/C=N/C1=NN=C(O1)/C=C/C2=CC=C(O2)[N+](=O)[O-],25962-77-0,Positive,in vitro
"N,N-dimethyl-N'-pyridin-2-yl-N'-(thiophen-2-ylmethyl)ethane-1,2-diamine;hydrochloride",CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2.Cl,135-23-9,Negative,in vivo
"N,N-dimethyl-N'-pyridin-2-yl-N'-(thiophen-2-ylmethyl)ethane-1,2-diamine;hydrochloride",CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2.Cl,8667,Negative,In Vivo
"N,N-dimethyl-N'-pyridin-2-yl-N'-(thiophen-2-ylmethyl)ethane-1,2-diamine;hydrochloride",CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2.Cl,8667,Positive,In Vivo
"N,N-dimethyl-N'-pyridin-2-yl-N'-(thiophen-2-ylmethyl)ethane-1,2-diamine;hydrochloride",CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2.Cl,135-23-9,Negative,in vitro
"N,N-dimethylacetamide",CC(=O)N(C)C,31374,Negative,In Vivo
"N,N-dimethylaniline",CN(C)C1=CC=CC=C1,949,Negative,In Vivo
"N,N-dimethylaniline",CN(C)C1=CC=CC=C1,949,Positive,In Vivo
"N,N-dimethylaniline",CN(C)C1=CC=CC=C1,121-69-7,Positive,in vitro
"N,N-dimethylaziridine-1-carboxamide",CN(C)C(=O)N1CC1,,Positive,in vitro
"N,N-dimethylcarbamoyl chloride",CN(C)C(=O)Cl,6598,Positive,In Vivo
"N,N-dimethylcarbamoyl chloride",CN(C)C(=O)Cl,79-44-7,Positive,in vivo
"N,N-dimethylcarbamoyl chloride",CN(C)C(=O)Cl,79-44-7,Negative,in vitro
"N,N-DIMETHYLDODECYLAMINE-N-OXIDE",CCCCCCCCCCCC[N+](C)(C)[O-],1643-20-5,Negative,In vivo
"N,N-dimethylformamide",CN(C)C=O,6228,Negative,In Vivo
"N,N-dimethylformamide",CN(C)C=O,68-12-2,Negative,in vivo
"N,N-dimethylformamide",CN(C)C=O,68-12-2,Negative,in vitro
"N,N-dimethylnitramide",CN(C)[N+](=O)[O-],20120,Positive,In Vivo
"N,N-dimethylnitrous amide",CN(C)N=O,62-75-9,Positive,in vivo
"N,N-dimethylnitrous amide",CN(C)N=O,6124,Positive,In Vivo
"N,N-dimethylnitrous amide",CN(C)N=O,6124,Negative,In Vivo
"N,N-dimethylnitrous amide",CN(C)N=O,62-75-9,Negative,in vivo
"N,N-dimethylnitrous amide",CN(C)N=O,62-75-9,Positive,in vitro
"N,N-DINITROSOPENTAMETHYLENETETRAMINE",C1N2CN(CN1CN(C2)N=O)N=O,101-25-7,Negative,In vivo
"N,N-dipentylnitrous amide",CCCCCN(CCCCC)N=O,252237,Positive,In Vivo
"N,N-dipentylnitrous amide",CCCCCN(CCCCC)N=O,13256-06-09,Positive,in vitro
"N,N-diphenylnitrous amide",C1=CC=C(C=C1)N(C2=CC=CC=C2)N=O,6838,Negative,In Vivo
"N,N-diphenylnitrous amide",C1=CC=C(C=C1)N(C2=CC=CC=C2)N=O,86-30-6,Negative,in vivo
"N,N-diphenylnitrous amide",C1=CC=C(C=C1)N(C2=CC=CC=C2)N=O,86-30-6,Positive,in vivo
"N,N-diphenylnitrous amide",C1=CC=C(C=C1)N(C2=CC=CC=C2)N=O,6838,Positive,In Vivo
"N,N-diphenylnitrous amide",C1=CC=C(C=C1)N(C2=CC=CC=C2)N=O,86-30-6,Negative,in vitro
"N,N-dipropylnitrous amide",CCCN(CCC)N=O,12130,Positive,In Vivo
"N,N-dipropylnitrous amide",CCCN(CCC)N=O,621-64-7,Positive,in vivo
"N,N-dipropylnitrous amide",CCCN(CCC)N=O,621-64-7,Positive,in vitro
"N,N,3-trimethyl-4-phenyldiazenylaniline",CC1=C(C=CC(=C1)N(C)C)N=NC2=CC=CC=C2,54-88-6,Positive,in vivo
"N,N,3-trimethyl-4-phenyldiazenylaniline",CC1=C(C=CC(=C1)N(C)C)N=NC2=CC=CC=C2,54-88-6,Negative,in vitro
"N,N,3-tris(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",C1CN(P(=O)(OC1)N(CCCl)CCCl)CCCl,22089-22-1,Negative,in vitro
"N,N,N',N'-tetramethyl-1,1-diphenylmethanediamine",CN(C)C(C1=CC=CC=C1)(C2=CC=CC=C2)N(C)C,19111-89-8,Negative,in vitro
"N,N'-[6-(5-Nitro-2-furyl)-s-triazine-2,4-diyl]
bisacetamide",CC(=O)NC1=NC(=NC(=N1)C2=CC=C(O2)[N+](=O)[O-])NC(=O)C,51325-35-0,Positive,in vitro
"N,N'-[6-(5-NITRO-2-FURYL)-s-TRIAZINE-2,4-DIYL]BISACETAMIDE",CC(=O)NC1=NC(=NC(=N1)C2=CC=C(O2)[N+](=O)[O-])NC(=O)C,51325-35-0,Positive,In vivo
"N,N'-bis(1,3,4-thiadiazol-2-yl)methanediamine",C1=NN=C(S1)NCNC2=NN=CS2,26907-37-9,Positive,in vitro
"N,N'-Bis(hydroxyethyl)-2-nitro-p-phenylenediamine COLIPA B034",C1=CC(=C(C=C1NCCO)[N+](=O)[O-])NCCO,84041-77-0,Positive,in vitro
"N,N'-Diacetylbenzidine",CC(=O)NC1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)C,613-35-4,Positive,in vitro
"N,N'-dimethyl-N,N'-dinitrosooxamide",CN(C(=O)C(=O)N(C)N=O)N=O,7601-87-8,Positive,in vitro
"N,N'-DIMETHYL-N,N'-DINITROSOPHTHALAMIDE",CN(C(=O)C1=CC=CC=C1C(=O)N(C)N=O)N=O,3851-16-9,Negative,In vivo
"N'-(2-butoxy-7-chlorobenzo[b][1,5]naphthyridin-10-yl)-N-(2-chloroethyl)propane-1,3-diamine;dihydrochloride",CCCCOC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCCl.Cl.Cl,,Positive,in vitro
"N'-(2-chloroethyl)-N-(6-chloro-2-methoxyacridin-9-yl)-N'-ethylpropane-1,3-diamine;dihydrochloride",CCN(CCCNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC)CCCl.Cl.Cl,146-59-8,Positive,in vivo
"N'-(2-chloroethyl)-N-(6-chloro-2-methoxyacridin-9-yl)-N'-ethylpropane-1,3-diamine;dihydrochloride",CCN(CCCNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC)CCCl.Cl.Cl,146-59-8,Positive,in vitro
"N'-(2-chloroethyl)-N-(7-chloroquinolin-4-yl)-N'-ethylpropane-1,3-diamine;dihydrochloride",CCN(CCCNC1=C2C=CC(=CC2=NC=C1)Cl)CCCl.Cl.Cl,,Positive,in vitro
"N'-(2-chloroethyl)-N'-ethyl-N-(6-methoxyquinolin-4-yl)propane-1,3-diamine;dihydrochloride",CCN(CCCNC1=C2C=C(C=CC2=NC=C1)OC)CCCl.Cl.Cl,,Positive,in vitro
"N'-(2-chloroethyl)-N'-ethylpropane-1,3-diamine;dihydrochloride",CCN(CCCN)CCCl.Cl.Cl,,Positive,in vitro
"N'-(2,4-dimethylphenyl)-N-[(2,4-dimethylphenyl)iminomethyl]-N-methylmethanimidamide",CC1=CC(=C(C=C1)N=CN(C)C=NC2=C(C=C(C=C2)C)C)C,36324,Negative,In Vivo
"N'-(2,4-dimethylphenyl)-N-[(2,4-dimethylphenyl)iminomethyl]-N-methylmethanimidamide",CC1=CC(=C(C=C1)N=CN(C)C=NC2=C(C=C(C=C2)C)C)C,36324,Positive,In Vivo
"N'-(4-chloro-2-methylphenyl)-N,N-dimethylmethanimidamide",CC1=C(C=CC(=C1)Cl)N=CN(C)C,6164-98-3,Negative,in vitro
"N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine;hydrochloride",CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2.Cl,80139,Negative,In Vivo
N'-ACETYL-4-(HYDROXYMETHYL)PHENYLHYDRAZINE,CC(=O)NNC1=CC=C(C=C1)CO,65734-38-5,Negative,In vivo
N'-ACETYL-4-(HYDROXYMETHYL)PHENYLHYDRAZINE,CC(=O)NNC1=CC=C(C=C1)CO,65734-38-5,Positive,In vivo
"N'-acridin-9-yl-N-(2-chloroethyl)propane-1,3-diamine;hydrate;dihydrochloride",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCNCCCl.O.Cl.Cl,,Positive,in vitro
"N'-benzo[c]acridin-7-yl-N-(2-chloroethyl)ethane-1,2-diamine;hydrate;dihydrochloride",C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4N=C32)NCCNCCCl.O.Cl.Cl,,Positive,in vitro
"N'-benzyl-5-methyl-1,2-oxazole-3-carbohydrazide",CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2,59-63-2,Positive,in vivo
"N'-benzyl-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine;hydrochloride",CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2.Cl,9066,Negative,In Vivo
N'-hydroxy-5-nitrofuran-2-carboximidamide,C1=C(OC(=C1)[N+](=O)[O-])/C(=N/O)/N,772-43-0,Positive,in vitro
N'-hydroxymethanimidamide,C(=N/O)\N,624-82-8,Positive,in vitro
"N'-naphthalen-1-ylethane-1,2-diamine;dihydrochloride",C1=CC=C2C(=C1)C=CC=C2NCCN.Cl.Cl,15106,Negative,In Vivo
"N'-naphthalen-1-ylethane-1,2-diamine;dihydrochloride",C1=CC=C2C(=C1)C=CC=C2NCCN.Cl.Cl,1465-25-4,Negative,in vivo
N'-NITROSONORNICOTINE,C1CC(N(C1)N=O)C2=CN=CC=C2,53759-22-1,Positive,In vivo
N'-NITROSONORNICOTINE-1-N-OXIDE,C1CC(N(C1)N=O)C2=C[N+](=CC=C2)[O-],78246-24-9,Negative,In vivo
N'-NITROSONORNICOTINE-1-N-OXIDE,C1CC(N(C1)N=O)C2=C[N+](=CC=C2)[O-],78246-24-9,Positive,In vivo
N'-propan-2-ylpyridine-4-carbohydrazide,CC(C)NNC(=O)C1=CC=NC=C1,54-92-2,Positive,in vivo
N2-gamma-GLUTAMYL-p-HYDRAZINOBENZOIC ACID,C1=CC(=CC=C1C(=O)O)NNC(=O)CCC(C(=O)O)N,---,Positive,In vivo
"N7-Methyldibenzo[c,g]carbazole (NMDBC)",CN1C2=C(C3=CC=CC=C3C=C2)C4=C1C=CC5=CC=CC=C54,27093-62-5,Positive,in vitro
NAFENOPIN,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CCCC3=CC=CC=C23,3771-19-5,Negative,In vivo
NAFENOPIN,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CCCC3=CC=CC=C23,3771-19-5,Positive,In vivo
Naled,COP(=O)(OC)OC(C(Cl)(Cl)Br)Br,300-76-5,Negative,In vivo
NALIDIXIC ACID,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,389-08-2,Negative,In vivo
Nalidixic acid,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,0389-08-02,Positive,in vitro
naphthalen-1-amine,C1=CC=C2C(=C1)C=CC=C2N,8640,Negative,In Vivo
naphthalen-1-amine,C1=CC=C2C(=C1)C=CC=C2N,134-32-7,Negative,in vivo
naphthalen-1-amine,C1=CC=C2C(=C1)C=CC=C2N,134-32-7,Negative,in vitro
naphthalen-1-amine;hydrochloride,C1=CC=C2C(=C1)C=CC=C2N.Cl,552-46-5,Positive,in vitro
naphthalen-1-ol,C1=CC=C2C(=C1)C=CC=C2O,90-15-3,Negative,in vitro
naphthalen-1-yl N-methyl-N-nitrosocarbamate,CN(C(=O)OC1=CC=CC2=CC=CC=C21)N=O,23493,Positive,In Vivo
naphthalen-1-yl N-methyl-N-nitrosocarbamate,CN(C(=O)OC1=CC=CC2=CC=CC=C21)N=O,7090-25-7,Positive,in vitro
naphthalen-1-yl N-methylcarbamate,CNC(=O)OC1=CC=CC2=CC=CC=C21,6129,Negative,In Vivo
naphthalen-1-yl N-methylcarbamate,CNC(=O)OC1=CC=CC2=CC=CC=C21,6129,Positive,In Vivo
naphthalen-1-yl N-methylcarbamate,CNC(=O)OC1=CC=CC2=CC=CC=C21,63-25-2,Negative,in vitro
naphthalen-1-ylthiourea,C1=CC=C2C(=C1)C=CC=C2NC(=S)N,86-88-4,Positive,in vitro
naphthalen-2-amine,C1=CC=C2C=C(C=CC2=C1)N,7057,Positive,In Vivo
naphthalen-2-amine,C1=CC=C2C=C(C=CC2=C1)N,91-59-8,Negative,in vivo
naphthalen-2-amine,C1=CC=C2C=C(C=CC2=C1)N,91-59-8,Positive,in vivo
naphthalen-2-amine,C1=CC=C2C=C(C=CC2=C1)N,91-59-8,Negative,in vitro
naphthalen-2-ol,C1=CC=C2C=C(C=CC2=C1)O,135-19-3,Negative,in vitro
naphthalen-2-ylazanium;chloride,C1=CC=C2C=C(C=CC2=C1)[NH3+].[Cl-],612-52-2,Positive,in vitro
naphthalene,C1=CC=C2C=CC=CC2=C1,931,Negative,In Vivo
naphthalene,C1=CC=C2C=CC=CC2=C1,931,Positive,In Vivo
Naphthalene,C1=CC=C2C=CC=CC2=C1,91-20-3,Negative,In vivo
Naphthalene,C1=CC=C2C=CC=CC2=C1,91-20-3,Positive,in vitro
naphthalene-1-carbonitrile,C1=CC=C2C(=C1)C=CC=C2C#N,86-53-3,Positive,in vitro
"naphthalene-1,5-diamine",C1=CC2=C(C=CC=C2N)C(=C1)N,16720,Positive,In Vivo
"naphthalene-1,5-diamine",C1=CC2=C(C=CC=C2N)C(=C1)N,2243-62-1,Positive,in vivo
"naphthalene-1,5-diamine",C1=CC2=C(C=CC=C2N)C(=C1)N,16720,Negative,In Vivo
naphthalene-2-carbonitrile,C1=CC=C2C=C(C=CC2=C1)C#N,613-46-7,Positive,in vitro
"naphtho[1,2-b][1]benzothiole",C1=CC=C2C(=C1)C=CC3=C2SC4=CC=CC=C34,9198,Positive,In Vivo
"naphtho[1,2-b]phenanthren-5-ol",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)C=C(C5=CC=CC=C54)O,,Negative,in vitro
"naphtho[1,2-b]phenanthrene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=CC5=CC=CC=C54)C=C32,5889,Positive,In Vivo
"naphtho[1,2-b]phenanthrene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=CC5=CC=CC=C54)C=C32,53-70-3,Positive,in vivo
"naphtho[1,2-b]phenanthrene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=CC5=CC=CC=C54)C=C32,53-70-3,Positive,in vitro
Napropamide,CCN(CC)C(=O)C(C)OC1=CC=CC2=CC=CC=C21,15299-99-7,Negative,in vivo
Napropamide,CCN(CC)C(=O)C(C)OC1=CC=CC2=CC=CC=C21,15299-99-7,Positive,in vivo
Napropamide,CCN(CC)C(=O)C(C)OC1=CC=CC2=CC=CC=C21,15299-99-7,Negative,in vitro
NEFIRACETAM,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O,77191-36-7,Negative,In vivo
nickel,[Ni],935,Positive,In Vivo
nickel,[Ni],7440-02-0,Positive,in vivo
NICKEL,[Ni],7440-02-0,Negative,In vivo
NICKEL (II) ACETATE,CC(=O)[O-].CC(=O)[O-].[Ni+2],373-02-4,Negative,In vivo
Nickel carbonyl,[C-]#[O+].[C-]#[O+].[C-]#[O+].[C-]#[O+].[Ni],13463-39-3,Negative,In vivo
NICKEL DIBUTYLDITHIOCARBAMATE,CCCCN(CCCC)C(=S)[S-].CCCCN(CCCC)C(=S)[S-].[Ni+2],13927-77-0,Negative,In vivo
Nickel II sulfate hexahydrate,O.O.O.O.O.O.[O-]S(=O)(=O)[O-].[Ni+2],10101-97-0,Positive,in vitro
Nickel subsulfide,[S-2].[S-2].[Ni].[Ni+2].[Ni+2],12035-72-2,Positive,In vivo
nickel;(sulfanylidene-lambda4-sulfanylidene)nickel,S=S=[Ni].[Ni].[Ni],22833473,Negative,In Vivo
nickel;(sulfanylidene-lambda4-sulfanylidene)nickel,S=S=[Ni].[Ni].[Ni],22833473,Positive,In Vivo
nickel;(sulfanylidene-lambda4-sulfanylidene)nickel,S=S=[Ni].[Ni].[Ni],,Positive,in vivo
nickel;(sulfanylidene-lambda4-sulfanylidene)nickel,S=S=[Ni].[Ni].[Ni],,Positive,in vitro
nickel;nickel(2+);carbonate;tetrahydrate,C(=O)([O-])[O-].O.O.O.O.[Ni].[Ni].[Ni+2],,Positive,in vitro
nickel;sulfanylidenenickel,S=[Ni].S=[Ni].[Ni],25199732,Positive,In Vivo
nickel(2+);diacetate,CC(=O)[O-].CC(=O)[O-].[Ni+2],9756,Negative,In Vivo
nickel(2+);diacetate,CC(=O)[O-].CC(=O)[O-].[Ni+2],9756,Positive,In Vivo
nickel(2+);dichloride;hexahydrate,O.O.O.O.O.O.[Cl-].[Cl-].[Ni+2],,Positive,in vitro
nickel(2+);dihydroxide,[OH-].[OH-].[Ni+2],61534,Positive,In Vivo
nickel(2+);sulfate,[O-]S(=O)(=O)[O-].[Ni+2],24586,Negative,In Vivo
nickel(2+);sulfate,[O-]S(=O)(=O)[O-].[Ni+2],7786-81-4,Positive,in vitro
Niclosamide,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,50-65-7,Positive,in vitro
Nicosulfuron,CN(C)C(=O)C1=C(N=CC=C1)S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC,111991-09-4,Negative,in vivo
Nicosulfuron,CN(C)C(=O)C1=C(N=CC=C1)S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC,111991-09-4,Negative,in vitro
NICOTINAMIDE,C1=CC(=CN=C1)C(=O)N,98-92-0,Negative,In vivo
NICOTINE,CN1CCCC1C2=CN=CC=C2,54-11-5,Negative,In vivo
NICOTINE.HCl,CN1CCCC1C2=CN=CC=C2.Cl,2820-51-1,Negative,In vivo
NICOTINIC ACID,C1=CC(=CN=C1)C(=O)O,59-67-6,Negative,In vivo
NICOTINIC ACID HYDRAZIDE,C1=CC(=CN=C1)C(=O)NN,553-53-7,Negative,In vivo
NICOTINIC ACID HYDRAZIDE,C1=CC(=CN=C1)C(=O)NN,553-53-7,Positive,In vivo
Nifurtimox,CC1CS(=O)(=O)CCN1N=CC2=CC=C(O2)[N+](=O)[O-],23256-30-6,Positive,in vitro
NIGROSINE,C1=CC=C(C=C1)N=NC2=C(C3=C(C(=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC4=CC=C(C=C4)[N+](=O)[O-])N)O.[Na+].[Na+],8005-03-6,Negative,In vivo
"NIOBATE, SODIUM",[O-][Nb](=O)=O.[Na+],12034-09-2,Negative,In vivo
Nithiazide (1-Ethyl-3-(5-Nitrothiazol-2-Yl)Urea,CCNC(=O)NC1=NC=C(S1)[N+](=O)[O-],139-94-6,Negative,in vitro
Nitrapyrin,C1=CC(=NC(=C1)Cl)C(Cl)(Cl)Cl,1929-82-4,Negative,In vivo
Nitrate,[N+](=O)([O-])[O-],14797-55-8,Negative,In vivo
"NITRATE, SODIUM",[N+](=O)([O-])[O-].[Na+],7631-99-4,Negative,In vivo
nitric acid,[N+](=O)(O)[O-],7697-37-2,Negative,in vitro
NITRIC OXIDE,[N]=O,10102-43-9,Negative,In vivo
NITRILOTRIACETIC ACID,C(C(=O)O)N(CC(=O)O)CC(=O)O,139-13-9,Negative,In vivo
"NITRILOTRIACETIC ACID, TRISODIUM SALT, MONOHYDRATE",C(C(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].O.[Na+].[Na+].[Na+],18662-53-8,Positive,In vivo
"Nitrilotriacetic acid/Nitrilotriacetic acid, trisodium salt, monohydrate",C(C(=O)O)N(CC(=O)O)CC(=O)O,139-13-9,Positive,in vitro
Nitrite,N(=O)[O-],14797-65-0,Negative,In vivo
"NITRITE, SODIUM",N(=O)[O-].[Na+],7632-00-0,Negative,In vivo
"NITRITE, SODIUM",N(=O)[O-].[Na+],7632-00-0,Positive,In vivo
"Nitrite, sodium",N(=O)[O-].[Na+],7632-00-0,Positive,in vitro
nitrobenzene,C1=CC=C(C=C1)[N+](=O)[O-],7416,Positive,In Vivo
NITROBENZENE,C1=CC=C(C=C1)[N+](=O)[O-],98-95-3,Positive,In vivo
nitrobenzene,C1=CC=C(C=C1)[N+](=O)[O-],98-95-3,Negative,in vivo
Nitrobenzene,C1=CC=C(C=C1)[N+](=O)[O-],98-95-3,Negative,in vitro
NITROETHANE,CC[N+](=O)[O-],79-24-3,Negative,In vivo
Nitrofen,C1=CC(=CC=C1[N+](=O)[O-])OC2=C(C=C(C=C2)Cl)Cl,1836-75-5,Positive,in vitro
Nitrogen dioxide,N(=O)[O],10102-44-0,Negative,In vivo
Nitrogen dioxide,N(=O)[O],10102-44-0,Positive,in vitro
NITROGEN MUSTARD,CN(CCCl)CCCl,51-75-2,Positive,In vivo
Nitrogen mustard - Chlormethine,CN(CCCl)CCCl,51-75-2,Positive,in vitro
NITROGEN MUSTARD N-OXIDE,C[N+](CCCl)(CCCl)[O-],126-85-2,Positive,In vivo
Nitrogen mustard N-oxide,C[N+](CCCl)(CCCl)[O-],126-85-2,Positive,in vitro
Nitroguanidine,C(=N)(N)N[N+](=O)[O-],556-88-7,Negative,In vivo
nitromethanamine,C(N)[N+](=O)[O-],61148,Positive,In Vivo
nitromethane,C[N+](=O)[O-],6375,Negative,In Vivo
nitromethane,C[N+](=O)[O-],6375,Positive,In Vivo
NITROMETHANE,C[N+](=O)[O-],75-52-5,Negative,In vivo
Nitromethane,C[N+](=O)[O-],75-52-5,Negative,in vitro
nitrooxy(phenyl)mercury,C1=CC=C(C=C1)[Hg]O[N+](=O)[O-],55-68-5,Negative,in vitro
Nitrophenol,C1=CC(=CC=C1[N+](=O)[O-])O,0100-02-07,Negative,In vivo
Nitropropane,CC(C)[N+](=O)[O-],79-46-9,Negative,In vivo
"NITROSO-1,2,3,6-TETRAHYDROPYRIDINE",C1CN(CC=C1)N=O,55556-92-8,Positive,In vivo
"Nitroso-1,2,3,6-tetrahydropyridine",C1CN(CC=C1)N=O,55556-92-8,Positive,in vitro
"NITROSO-2,3-DIHYDROXYPROPYL-2-OXOPROPYLAMINE",CC(=O)CN(CC(CO)O)N=O,92177-50-9,Positive,In vivo
"NITROSO-2,3-DIHYDROXYPROPYL-2-OXOPROPYLAMINE",CC(=O)CN(CC(CO)O)N=O,92177-50-9,Negative,In vivo
"NITROSO-2,6-DIMETHYLMORPHOLINE",CC1CN(CC(O1)C)N=O,1456-28-6,Positive,In vivo
NITROSO-5-METHYLOXAZOLIDONE,CC1CN(C(=O)O1)N=O,79624-33-2,Positive,In vivo
NITROSO-BAYGON,CC(C)OC1=CC=CC=C1OC(=O)N(C)N=O,38777-13-8,Positive,In vivo
Nitroso-Baygon,CC(C)OC1=CC=CC=C1OC(=O)N(C)N=O,38777-13-8,Positive,in vitro
Nitroso-di-n-butylamine,CCCCN(CCCC)N=O,924-16-3,Positive,In vivo
NITROSO-N-METHYL-N-(2-PHENYL)ETHYLAMINE,CN(CCC1=CC=CC=C1)N=O,13256-11-6,Positive,In vivo
Nitroso-N-methylethylamine,CCN(C)N=O,10595-95-6,Positive,In vivo
NITROSOAMYLURETHAN,CCCCCN(C(=O)OCC)N=O,64005-62-5,Positive,In vivo
NITROSOANABASINE,C1CCN(C(C1)C2=CN=CC=C2)N=O,1133-64-8,Positive,In vivo
NITROSOCHLORDIAZEPOXIDE,CN(C1=NC2=C(C=C(C=C2)Cl)C(=[N+](C1)[O-])C3=CC=CC=C3)N=O,51715-17-4,Negative,In vivo
Nitrosodi-N-propylamine,CCCN(CCC)N=O,621-64-7,Positive,In vivo
NITROSODIBUTYLAMINE,CCCCN(CCCC)N=O,924-16-3,Positive,In vivo
Nitrosodibutylamine,CCCCN(CCCC)N=O,924-16-3,Positive,in vitro
Nitrosodiethanolamine,C(CO)N(CCO)N=O,1116-54-7,Positive,In vivo
Nitrosodiethylamine,CCN(CC)N=O,55-18-5,Positive,In vivo
Nitrosodimethylamine,CN(C)N=O,62-75-9,Positive,In vivo
Nitrosodiphenylamine,C1=CC=C(C=C1)N(C2=CC=CC=C2)N=O,86-30-6,Positive,In vivo
NITROSODODECAMETHYLENEIMINE,C1CCCCCCN(CCCCC1)N=O,40580-89-0,Positive,In vivo
Nitrosododecamethyleneimine,C1CCCCCCN(CCCCC1)N=O,40580-89-0,Positive,in vitro
NITROSOETHYLMETHYLAMINE,CCN(C)N=O,10595-95-6,Positive,In vivo
Nitrosoethylmethylamine,CCN(C)N=O,10595-95-6,Positive,in vitro
NITROSOETHYLURETHAN,CCN(C(=O)OCC)N=O,614-95-9,Positive,In vivo
Nitrosoethylurethan,CCN(C(=O)OCC)N=O,614-95-9,Positive,in vitro
NITROSOHEPTAMETHYLENEIMINE,C1CCCN(CCC1)N=O,20917-49-1,Positive,In vivo
Nitrosoheptamethyleneimine,C1CCCN(CCC1)N=O,20917-49-1,Positive,in vitro
NITROSOHYDROXYPROLINE,C1C(CN(C1C(=O)O)N=O)O,30310-80-6,Negative,In vivo
NITROSOIMINODIACETIC ACID,C(C(=O)O)N(CC(=O)O)N=O,25081-31-6,Negative,In vivo
NITROSOMETHYL-3-CARBOXYPROPYLAMINE,CN(CCCC(=O)O)N=O,61445-55-4,Positive,In vivo
NITROSOMETHYLANILINE,CN(C1=CC=CC=C1)N=O,614-00-6,Negative,In vivo
NITROSOMETHYLANILINE,CN(C1=CC=CC=C1)N=O,614-00-6,Positive,In vivo
NITROSOMETHYLPHENIDATE,COC(=O)C(C1CCCCN1N=O)C2=CC=CC=C2,55557-03-4,Negative,In vivo
NITROSOMETHYLUNDECYLAMINE,CCCCCCCCCCCN(C)N=O,68107-26-6,Positive,In vivo
NITROSOPIPECOLIC ACID,C1CCN(C(C1)C(=O)O)N=O,4515-18-8,Negative,In vivo
NITROSOPROLINE,C1CC(N(C1)N=O)C(=O)O,7519-36-0,Negative,In vivo
Nitrosopyrrolidine,C1CCN(C1)N=O,930-55-2,Positive,In vivo
nitrous acid,N(=O)O,7782-77-6,Positive,in vitro
nitrous oxide,[N-]=[N+]=O,10024-97-2,Negative,in vivo
nitrous oxide,[N-]=[N+]=O,10024-97-2,Positive,in vitro
NIVALENOL,CC1=CC2C(C(C1=O)O)(C3(C(C(C(C34CO4)O2)O)O)C)CO,23282-20-4,Negative,In vivo
NNK,CN(CCCC(=O)C1=CN=CC=C1)N=O,64091-91-4,Positive,in vitro
NONABROMOBIPHENYL,C1=C(C(=C(C(=C1Br)Br)Br)C2=C(C(=C(C(=C2Br)Br)Br)Br)Br)Br,27753-52-2,Positive,In vivo
Nonabromodiphenyl ether,C1=C(C(=C(C(=C1Br)Br)Br)Br)OC2=C(C(=C(C(=C2Br)Br)Br)Br)Br,63936-56-1,Negative,In vivo
Norethisterone acetate,CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C,51-98-9,Positive,in vitro
NORETHYNODREL,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3CCC(=O)C4,68-23-5,Negative,In vivo
Norflurazon,CNC1=C(C(=O)N(N=C1)C2=CC=CC(=C2)C(F)(F)F)Cl,27314-13-2,Negative,In vivo
NORHARMAN,C1=CC=C2C(=C1)C3=C(N2)C=NC=C3,244-63-3,Negative,In vivo
NORLESTRIN,CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C.CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,8015-12-1,Negative,In vivo
NORLESTRIN,CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C.CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,8015-12-1,Positive,In vivo
"NOVADELOX (18% BENZOYL PEROXIDE, 78% CALCIUM SULPHATE, 4% MAGNESIUM CARBONATE)",C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2,94-36-0,Negative,In vivo
NuStar,C[Si](CN1C=NC=N1)(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F,85509-19-9,Negative,In vivo
o-AMINOAZOTOLUENE,CC1=CC=CC=C1N=NC2=CC(=C(C=C2)N)C,97-56-3,Positive,In vivo
o-Anisidine (free base and HCl salt),COC1=CC=CC=C1N,90-04-0,Positive,in vitro
o-Anthranilic acid,C1=CC=C(C(=C1)C(=O)O)N,118-92-3,Negative,in vitro
o-ETHOXYBENZAMIDE,CCOC1=CC=CC=C1C(=O)N,938-73-8,Positive,In vivo
O-methylhydroxylamine,CON,67-62-9,Positive,in vitro
O-methylhydroxylamine;hydrochloride,CON.Cl,593-56-6,Positive,in vitro
O-naphthalen-2-yl N-methyl-N-(3-methylphenyl)carbamothioate,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,2398-96-1,Negative,in vitro
o-Nitroanisole,COC1=CC=CC=C1[N+](=O)[O-],91-23-6,Positive,in vitro
o-NITROSOTOLUENE,CC1=CC=CC=C1N=O,611-23-4,Positive,In vivo
o-Nitrotoluene,CC1=CC=CC=C1[N+](=O)[O-],88-72-2,Positive,in vitro
o-Phenylenediamine (free base and 2HCl salt),C1=CC=C(C(=C1)N)N,95-54-5,Positive,in vitro
o-PHENYLENEDIAMINE.2HCl,C1=CC=C(C(=C1)N)N.Cl.Cl,615-28-1,Negative,In vivo
o-PHENYLENEDIAMINE.2HCl,C1=CC=C(C(=C1)N)N.Cl.Cl,615-28-1,Positive,In vivo
o-PHENYLPHENOL,C1=CC=C(C=C1)C2=CC=CC=C2O,90-43-7,Negative,In vivo
o-PHENYLPHENOL,C1=CC=C(C=C1)C2=CC=CC=C2O,90-43-7,Positive,In vivo
o-Phenylphenol (2-phenylphenol),C1=CC=C(C=C1)C2=CC=CC=C2O,90-43-7,Positive,in vitro
"o-PHENYLPHENOL, SODIUM",C1=CC=C(C=C1)C2=CC=CC=C2[O-].[Na+],132-27-4,Negative,In vivo
"o-PHENYLPHENOL, SODIUM",C1=CC=C(C=C1)C2=CC=CC=C2[O-].[Na+],132-27-4,Positive,In vivo
o-TOLUENESULFONAMIDE,CC1=CC=CC=C1S(=O)(=O)N,88-19-7,Negative,In vivo
o-TOLUENESULFONAMIDE,CC1=CC=CC=C1S(=O)(=O)N,88-19-7,Positive,In vivo
o-Toluenesulfonamide,CC1=CC=CC=C1S(=O)(=O)N,88-19-7,Negative,in vitro
o-Toluidine (free base and HCl salt),CC1=CC=CC=C1N,95-53-4,Positive,in vitro
o-TOLUIDINE.HCl,CC1=CC=CC=C1N.Cl,636-21-5,Negative,In vivo
o-TOLUIDINE.HCl,CC1=CC=CC=C1N.Cl,636-21-5,Positive,In vivo
"O,O-DIETHYL-O-(3,5,6-TRICHLORO-2-PYRIDYL)PHOSPHOROTHIOATE",CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl,2921-88-2,Negative,In vivo
"O,O-Dimethyl phosphorochloridothioate",COP(=S)(OC)Cl,2524-03-0,Positive,in vitro
"O,O-DIMETHYL S-2(ACETYLAMINO)ETHYL DITHIOPHOSPHATE, TECHNICAL GRADE",CC(=O)NCCSP(=S)(OC)OC,13265-60-6,Negative,In vivo
"O,S-DIBENZOYL THIAMINE.HCl",CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOC(=O)C2=CC=CC=C2)SC(=O)C3=CC=CC=C3)C.Cl,35660-60-7,Negative,In vivo
OCHRATOXIN A,CC1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)NC(CC3=CC=CC=C3)C(=O)O)Cl,303-47-9,Positive,In vivo
OCHRATOXIN A,CC1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)NC(CC3=CC=CC=C3)C(=O)O)Cl,303-47-9,Negative,In vivo
Ochratoxin A,CC1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)NC(CC3=CC=CC=C3)C(=O)O)Cl,303-47-9,Positive,in vitro
Octabromodiphenyl ether,C1=C(C(=C(C(=C1Br)Br)Br)Br)OC2=CC(=C(C(=C2Br)Br)Br)Br,32536-52-0,Negative,In vivo
octadecanoic acid,CCCCCCCCCCCCCCCCCC(=O)O,57-11-4,Negative,in vitro
"Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine (HMX)",C1N(CN(CN(CN1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],2691-41-0,Negative,In vivo
Oil orange SS,CC1=CC=CC=C1N=NC2=C(C=CC3=CC=CC=C32)O,2646-17-5,Positive,in vitro
Olaquindox,CC1=C([N+](=O)C2=CC=CC=C2N1[O-])C(=O)NCCO,23696-28-8,Positive,in vitro
"OLEATE, SODIUM",CCCCCCCCC=CCCCCCCCC(=O)[O-].[Na+],143-19-1,Negative,In vivo
OLTIPRAZ,CC1=C(SSC1=S)C2=NC=CN=C2,64224-21-1,Negative,In vivo
OMEPRAZOLE,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,73590-58-6,Positive,In vivo
Orthosulfamuron,CN(C)C(=O)C1=CC=CC=C1NS(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC,213464-77-8,Negative,in vivo
Orthosulfamuron,CN(C)C(=O)C1=CC=CC=C1NS(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC,213464-77-8,Negative,in vitro
Oryzalin,CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])S(=O)(=O)N)[N+](=O)[O-],19044-88-3,Positive,in vivo
Oryzalin,CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])S(=O)(=O)N)[N+](=O)[O-],19044-88-3,Negative,in vivo
Oryzalin,CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])S(=O)(=O)N)[N+](=O)[O-],19044-88-3,Negative,in vitro
OSUTIDINE,CNCC1=CC=C(O1)CSCCNC(=NCC(C2=CC=C(C=C2)O)O)NS(=O)(=O)C,140695-21-2,Negative,In vivo
Oxadiazon,CC(C)OC1=C(C=C(C(=C1)N2C(=O)OC(=N2)C(C)(C)C)Cl)Cl,19666-30-9,Negative,in vivo
Oxadiazon,CC(C)OC1=C(C=C(C(=C1)N2C(=O)OC(=N2)C(C)(C)C)Cl)Cl,19666-30-9,Negative,in vitro
oxaldehyde,C(=O)C=O,7860,Negative,In Vivo
Oxamyl,CNC(=O)O/N=C(/C(=O)N(C)C)\SC,23135-22-0,Negative,in vivo
Oxamyl,CNC(=O)O/N=C(/C(=O)N(C)C)\SC,23135-22-0,Negative,in vitro
"oxathiane 2,2-dioxide",C1CCS(=O)(=O)OC1,1633-83-6,Positive,in vitro
"oxathiolane 2,2-dioxide",C1COS(=O)(=O)C1,14264,Positive,In Vivo
"oxathiolane 2,2-dioxide",C1COS(=O)(=O)C1,1120-71-4,Positive,in vivo
"oxathiolane 2,2-dioxide",C1COS(=O)(=O)C1,1120-71-4,Positive,in vitro
Oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,604-75-1,Negative,in vitro
oxepan-2-one,C1CCC(=O)OCC1,502-44-3,Negative,in vitro
oxetan-2-one,C1COC1=O,57-57-8,Positive,in vivo
oxetan-2-one,C1COC1=O,57-57-8,Negative,in vivo
oxetan-2-one,C1COC1=O,2365,Positive,In Vivo
oxetan-2-one,C1COC1=O,57-57-8,Positive,in vitro
oxido-phenyl-phenyliminoazanium,C1=CC=C(C=C1)N=[N+](C2=CC=CC=C2)[O-],495-48-7,Negative,in vivo
oxido-phenyl-phenyliminoazanium,C1=CC=C(C=C1)N=[N+](C2=CC=CC=C2)[O-],495-48-7,Positive,in vitro
oxiran-2-yl carbamate,C1C(O1)OC(=O)N,108032,Positive,In Vivo
oxiran-2-ylmethanol,C1C(O1)CO,11164,Positive,In Vivo
oxiran-2-ylmethanol,C1C(O1)CO,556-52-5,Negative,in vitro
oxirane,C1CO1,75-21-8,Positive,in vivo
oxirane,C1CO1,6354,Positive,In Vivo
oxirane,C1CO1,6354,Negative,In Vivo
oxirane,C1CO1,75-21-8,Positive,in vitro
oxirane-2-carbaldehyde,C1C(O1)C=O,13002,Positive,In Vivo
oxirane-2-carbaldehyde,C1C(O1)C=O,765-34-4,Positive,in vivo
oxirane-2-carbaldehyde,C1C(O1)C=O,765-34-4,Positive,in vitro
oxo-oxoalumanyloxy-[oxo(oxoalumanyloxy)silyl]oxysilane;dihydrate,O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O,56841936,Positive,In Vivo
oxoberyllium,[Be]=O,1304-56-9,Positive,in vivo
oxoberyllium,[Be]=O,14775,Positive,In Vivo
oxocadmium,O=[Cd],14782,Negative,In Vivo
oxocadmium,O=[Cd],1306-19-0,Positive,in vivo
oxocadmium,O=[Cd],14782,Positive,In Vivo
oxocobalt,O=[Co],14786,Negative,In Vivo
oxocobalt,O=[Co],14786,Positive,In Vivo
oxolan-2-one,C1CC(=O)OC1,7302,Negative,In Vivo
oxolan-2-one,C1CC(=O)OC1,96-48-0,Negative,in vivo
oxolan-2-one,C1CC(=O)OC1,96-48-0,Positive,in vitro
oxolane,C1CCOC1,8028,Negative,In Vivo
oxolane,C1CCOC1,8028,Positive,In Vivo
"oxolane-2,5-dione",C1CC(=O)OC1=O,7922,Negative,In Vivo
"oxolane-2,5-dione",C1CC(=O)OC1=O,108-30-5,Positive,in vivo
"oxolane-2,5-dione",C1CC(=O)OC1=O,108-30-5,Negative,in vitro
oxolead,O=[Pb],1317-36-8,Positive,in vitro
OXOLINIC ACID,CCN1C=C(C(=O)C2=CC3=C(C=C21)OCO3)C(=O)O,14698-29-4,Positive,In vivo
Oxolinic acid,CCN1C=C(C(=O)C2=CC3=C(C=C21)OCO3)C(=O)O,14698-29-4,Positive,in vitro
oxonickel,O=[Ni],14805,Negative,In Vivo
oxonickel,O=[Ni],14805,Positive,In Vivo
oxovanadium;dihydrochloride,O=[V].Cl.Cl,,Positive,in vitro
oxovanadium(2+);sulfate,[O-]S(=O)(=O)[O-].O=[V+2],34007,Negative,In Vivo
oxozirconium;octahydrate;dihydrochloride,O.O.O.O.O.O.O.O.O=[Zr].Cl.Cl,13520-92-8,Negative,in vitro
OXPRENOLOL.HCl,CC(C)NCC(COC1=CC=CC=C1OCC=C)O.Cl,6452-73-9,Negative,In vivo
Oxydemeton-methyl,CCS(=O)CCSP(=O)(OC)OC,301-12-2,Negative,in vivo
Oxydemeton-methyl,CCS(=O)CCSP(=O)(OC)OC,301-12-2,Positive,in vivo
Oxydemeton-methyl,CCS(=O)CCSP(=O)(OC)OC,0301-12-2,Positive,in vitro
Oxyfluorfen,CCOC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],42874-03-3,Negative,in vivo
Oxyfluorfen,CCOC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],42874-03-03,Negative,In vivo
Oxyfluorfen,CCOC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],42874-03-03,Negative,in vitro
Oxymetholone,CC12CCC3C(C1CCC2(C)O)CCC4C3(CC(=CO)C(=O)C4)C,434-07-1,Negative,in vitro
ozone,[O-][O+]=O,24823,Positive,In Vivo
ozone,[O-][O+]=O,10028-15-6,Negative,in vivo
ozone,[O-][O+]=O,24823,Negative,In Vivo
Ozone,[O-][O+]=O,10028-15-6,Positive,in vitro
p- Phenylenediamine (COLIPA: A7) (free base and 2HCl salt),C1=CC(=CC=C1N)N,106-50-3,Positive,in vitro
p-Anisidine (free base and HCl salt),COC1=CC=C(C=C1)N,104-94-9,Positive,in vitro
p-Chloroaniline (free base and HCl salt),C1=CC(=CC=C1N)Cl,106-47-8,Positive,in vitro
p-Chlorobenzotrichloride,C1=CC(=CC=C1C(Cl)(Cl)Cl)Cl,5216-25-1,Positive,in vitro
"p-CHLOROPHENYL-2,4,5-TRICHLOROPHENYL SULFIDE",C1=CC(=CC=C1SC2=CC(=C(C=C2Cl)Cl)Cl)Cl,2227-13-6,Negative,In vivo
p-CHLOROPHENYL-p-CHLOROBENZENE SULFONATE,C1=CC(=CC=C1OS(=O)(=O)C2=CC=C(C=C2)Cl)Cl,80-33-1,Negative,In vivo
p-Cresidine,CC1=CC(=C(C=C1)OC)N,120-71-8,Positive,in vitro
p-DDD,C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,72-54-8,Negative,in vitro
p-HYDRAZINOBENZOIC ACID,C1=CC(=CC=C1C(=O)O)NN,619-67-0,Negative,In vivo
p-HYDRAZINOBENZOIC ACID.HCl,C1=CC(=CC=C1C(=O)O)NN.Cl,24589-77-3,Positive,In vivo
p-ISOPROPOXYDIPHENYLAMINE,CC(C)OC1=CC=C(C=C1)NC2=CC=CC=C2,101-73-5,Negative,In vivo
p-Methylaminophenol sulphate  COLIPA A22,CNC1=CC=C(C=C1)O.OS(=O)(=O)O,55-55-0,Positive,in vitro
p-METHYLSTYRENE,CC1=CC=C(C=C1)C=C,622-97-9,Negative,In vivo
p-NITROANILINE,C1=CC(=CC=C1N)[N+](=O)[O-],100-01-6,Negative,In vivo
p-Nitroaniline,C1=CC(=CC=C1N)[N+](=O)[O-],0100-01-06,Positive,in vitro
p-Nitroanisole,COC1=CC=C(C=C1)[N+](=O)[O-],100-17-4,Positive,in vitro
p-Nitrobenzoic acid,C1=CC(=CC=C1C(=O)O)[N+](=O)[O-],62-23-7,Positive,in vitro
p-Nitrophenol,C1=CC(=CC=C1[N+](=O)[O-])O,100-02-7,Positive,in vitro
p-Nitrosodiphenylamine,C1=CC=C(C=C1)NC2=CC=C(C=C2)N=O ,0156-10-5,Positive,in vitro
p-Nitrotoluene,CC1=CC=C(C=C1)[N+](=O)[O-],99-99-0,Positive,in vitro
p-PHENYLENEDIAMINE,C1=CC(=CC=C1N)N,106-50-3,Negative,In vivo
p-PHENYLPHENOL,C1=CC=C(C=C1)C2=CC=C(C=C2)O,92-69-3,Negative,In vivo
p-Quinone dioxime,C1=CC=C(C=C1)C(=O)C2=C(C=CC(=C2C(=O)C3=CC=CC=C3)N=O)NO ,,Positive,in vitro
p-ROSANILINE.HCl,C1=CC(=N)C=CC1=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N.Cl,569-61-9,Negative,In vivo
p-Toluidine HCl,CC1=CC=C(C=C1)N.Cl,540-23-8,Positive,in vitro
p-TOLUIDINE.HCl,CC1=CC=C(C=C1)N.Cl,540-23-8,Negative,In vivo
p-TOLUIDINE.HCl,CC1=CC=C(C=C1)N.Cl,540-23-8,Positive,In vivo
p-TOLYLUREA,CC1=CC=C(C=C1)NC(=O)N,622-51-5,Negative,In vivo
p-TOLYLUREA,CC1=CC=C(C=C1)NC(=O)N,622-51-5,Positive,In vivo
"p,p-Ethyl-DDD [AKA perthane]",CCC1=CC=C(C=C1)C(C2=CC=C(C=C2)CC)C(Cl)Cl,72-56-0,Negative,in vitro
"p,p'-DDD",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,72-54-8,Negative,In vivo
"p,p'-DDD",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,72-54-8,Positive,In vivo
"p,p'-DDE",C1=CC(=CC=C1C(=C(Cl)Cl)C2=CC=C(C=C2)Cl)Cl,72-55-9,Positive,In vivo
"p,p'-DDE",C1=CC(=CC=C1C(=C(Cl)Cl)C2=CC=C(C=C2)Cl)Cl,72-55-9,Negative,In vivo
Paclobutrazol,CC(C)(C)[C@H]([C@@H](CC1=CC=C(C=C1)Cl)N2C=NC=N2)O,76738-62-0,Negative,in vivo
Paclobutrazol,CC(C)(C)[C@H]([C@@H](CC1=CC=C(C=C1)Cl)N2C=NC=N2)O,76738-62-0,Negative,in vitro
PALONIDIPINE.HCl,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)(C)CN(C)CC2=CC=CC=C2)C3=C(C=CC(=C3)[N+](=O)[O-])F)C(=O)OC.Cl,96515-74-1,Negative,In vivo
Paraquat,C[N+]1=CC=C(C=C1)C2=CC=[N+](C=C2)C.[Cl-].[Cl-],1910-42-5,Negative,In vivo
Parathion,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-],56-38-2,Negative,In vivo
Parathion-methyl,COP(=S)(OC)OC1=CC=C(C=C1)[N+](=O)[O-],298-00-0,Positive,in vitro
PATULIN,C1C=C2C(=CC(=O)O2)C(O1)O,149-29-1,Negative,In vivo
Patulin,C1C=C2C(=CC(=O)O2)C(O1)O,149-29-1,Positive,in vitro
"PEG-3-2',2'-di-p-phenylelenediamine COLIPA A146",C1=CC(=C(C=C1N)OCCOCCOCCOC2=C(C=CC(=C2)N)N)N.Cl.Cl.Cl.Cl,144644-13-3,Negative,in vitro
Penconazole,CCCC(CN1C=NC=N1)C2=C(C=C(C=C2)Cl)Cl,66246-88-6,Negative,in vivo
Penconazole,CCCC(CN1C=NC=N1)C2=C(C=C(C=C2)Cl)Cl,66246-88-6,Negative,in vitro
Pencycuron,O=C(NC2=CC=CC=C2)N(C3CCCC3)CC1=CC=C(Cl)C=C1,66063-05-6,Negative,in vivo
Pencycuron,O=C(NC2=CC=CC=C2)N(C3CCCC3)CC1=CC=C(Cl)C=C1,66063-05-06,Negative,in vitro
Pendimethalin,CCC(CC)NC1=C(C=C(C(=C1[N+](=O)[O-])C)C)[N+](=O)[O-],40487-42-1,Negative,In vivo
Penflufen,O=C(Nc1ccccc1C(C)CC(C)C)c2c(F)n(C)nc2C,494793-67-8,Negative,in vivo
Penflufen,O=C(Nc1ccccc1C(C)CC(C)C)c2c(F)n(C)nc2C,494793-67-8,Negative,in vitro
Penoxsulam,COC1=CN=C(N2C1=NC(=N2)NS(=O)(=O)C3=C(C=CC=C3OCC(F)F)C(F)(F)F)OC,219714-96-2,Negative,in vivo
Penoxsulam,COC1=CN=C(N2C1=NC(=N2)NS(=O)(=O)C3=C(C=CC=C3OCC(F)F)C(F)(F)F)OC,219714-96-2,Negative,in vitro
Pentabromodiphenyl ether,C1=CC(=C(C=C1Br)Br)OC2=CC(=C(C=C2Br)Br)Br,32534-81-9,Negative,In vivo
Pentabromodiphenyl ether (BDE-99),C1=CC(=C(C=C1Br)Br)OC2=CC(=C(C=C2Br)Br)Br,60348-60-9,Negative,In vivo
pentachloro-lambda5-stibane,Cl[Sb](Cl)(Cl)(Cl)Cl,7647-18-9,Positive,in vitro
Pentachloroanisole,COC1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl,1825-21-4,Negative,in vitro
Pentachlorobenzene,C1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl,608-93-5,Negative,In vivo
Pentachlorocyclopentadiene,C1(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl,25329-35-5,Negative,In vivo
pentachloromolybdenum,Cl[Mo](Cl)(Cl)(Cl)Cl,10241-05-01,Negative,in vitro
pentachloroniobium,Cl[Nb](Cl)(Cl)(Cl)Cl,10026-12-7,Negative,in vitro
PENTACHLORONITROBENZENE,C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)[N+](=O)[O-],82-68-8,Positive,In vivo
Pentachloronitrobenzene (PCNB),C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)[N+](=O)[O-],82-68-8,Negative,In vivo
Pentachlorophenol,C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)O,87-86-5,Positive,In vivo
"pentacyclo[10.7.1.02,11.03,8.016,20]icosa-1(19),2(11),3,5,7,9,12,14,16(20),17-decaene",C1=CC=C2C(=C1)C=CC3=C2C4=CC=CC5=C4C3=CC=C5,9152,Positive,In Vivo
"pentacyclo[10.7.1.02,11.03,8.016,20]icosa-1(19),2(11),3,5,7,9,12,14,16(20),17-decaene",C1=CC=C2C(=C1)C=CC3=C2C4=CC=CC5=C4C3=CC=C5,205-82-3,Positive,in vivo
"pentacyclo[10.7.1.02,7.08,20.013,18]icosa-1(19),2(7),3,5,8(20),9,11,13,15,17-decaene",C1=CC=C2C3=C4C(=CC=C3)C5=CC=CC=C5C4=CC2=C1,9153,Positive,In Vivo
"pentacyclo[10.7.1.02,7.08,20.013,18]icosa-1(19),2(7),3,5,8(20),9,11,13,15,17-decaene",C1=CC=C2C3=C4C(=CC=C3)C5=CC=CC=C5C4=CC2=C1,205-99-2,Positive,in vivo
"pentacyclo[11.6.1.02,11.03,8.017,20]icosa-1(20),2(11),3,5,7,9,12,14,16,18-decaene",C1=CC=C2C(=C1)C=CC3=C2C4=C5C(=CC=CC5=C3)C=C4,211-91-6,Positive,in vivo
"pentacyclo[12.3.1.04,17.07,16.010,15]octadeca-1(18),2,4(17),5,7(16),8,10(15),11,13-nonaene",C1=CC2=C3C(=C1)C=C4C=CC5=C4C3=C(C=C2)C=C5,33743,Positive,In Vivo
"pentacyclo[12.3.1.04,17.07,16.010,15]octadeca-1(18),2,4(17),5,7(16),8,10(15),11,13-nonaene",C1=CC2=C3C(=C1)C=C4C=CC5=C4C3=C(C=C2)C=C5,27208-37-3,Positive,in vivo
"pentacyclo[12.3.1.04,17.07,16.010,15]octadeca-1(18),2,4(17),5,7(16),8,10(15),11,13-nonaene",C1=CC2=C3C(=C1)C=C4C=CC5=C4C3=C(C=C2)C=C5,27208-37-3,Positive,in vitro
"pentacyclo[12.8.0.03,12.04,9.017,22]docosa-1,3(12),4,6,8,13,15,17(22)-octaene",C1CCC2=C(C1)C=CC3=CC4=C(C=C23)C5=CC=CC=C5CC4,16310-69-3,Positive,in vitro
"pentacyclo[12.8.0.03,12.04,9.017,22]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)C5=CC=CC=C5C=C4,9176,Positive,In Vivo
"pentacyclo[12.8.0.03,12.04,9.017,22]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)C5=CC=CC=C5C=C4,224-41-9,Positive,in vitro
"pentacyclo[12.8.0.03,12.04,9.017,22]docosa-1(14),2,4,6,8,10,12,15,17(22)-nonaene",C1CCC2=C(C1)C=CC3=C2C=C4C(=C3)C=CC5=CC=CC=C54,27810,Positive,In Vivo
"pentacyclo[13.2.1.03,7.08,17.011,16]octadeca-1,3(7),8(17),9,11(16),12,14-heptaen-4-one",C1CC(=O)C2=C1C3=C4C(=C2)CC5=CC=CC(=C54)C=C3,126355,Positive,In Vivo
Pentafluoroethane,C(C(F)(F)F)(F)F,354-33-6,Negative,In vivo
pentanal,CCCCC=O,110-62-3,Positive,in vitro
PENTANAL METHYLFORMYLHYDRAZONE,CCCCC=NN(C)C=O,57590-20-2,Positive,In vivo
pentanedial,C(CC=O)CC=O,3485,Negative,In Vivo
pentanedial,C(CC=O)CC=O,3485,Positive,In Vivo
pentanedial,C(CC=O)CC=O,111-30-8,Negative,in vitro
Penthiopyrad,CC(C)CC(C)C1=C(C=CS1)NC(=O)C2=CN(N=C2C(F)(F)F)C,183675-82-3,Negative,in vivo
Penthiopyrad,CC(C)CC(C)C1=C(C=CS1)NC(=O)C2=CN(N=C2C(F)(F)F)C,183675-82-3,Negative,in vitro
Pentostatin,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,53910-25-1,Positive,in vitro
"pentyl 2-(2,4,5-trichlorophenoxy)acetate",CCCCCOC(=O)COC1=CC(=C(C=C1Cl)Cl)Cl,120-39-8,Negative,in vitro
"pentyl 2-[2-chloro-5-(1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)-4-fluorophenoxy]acetate",CCCCCOC(=O)COC1=C(C=C(C(=C1)N2C(=O)C3=C(C2=O)CCCC3)F)Cl,443048,Negative,In Vivo
Perchlorate (ClO4) and Perchlorate Salts,[NH4+].[O-]Cl(=O)(=O)=O,7790-98-9,Negative,In vivo
Perfluorobutanoic Acid (PFBA),C(=O)(C(C(C(F)(F)F)(F)F)(F)F)O,375-22-4,Negative,In vivo
Perfluorodecanoic Acid (PFDA),C(=O)(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,335-76-2,Negative,In vivo
Perfluorohexanesulfonic Acid (PFHxS),C(C(C(C(F)(F)S(=O)(=O)O)(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F,355-46-4,Negative,In vivo
Perfluorohexanoic Acid (PFHxA),C(=O)(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)O,307-24-4,Negative,In vivo
PERHEXILINE MALEATE,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3.C(=CC(=O)O)C(=O)O,6724-53-4,Negative,In vivo
Permethrin,CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,52645-53-1,Negative,In vivo
Peroxyacetyl nitrate,CC(=O)OO[N+](=O)[O-],2278-22-0,Positive,in vitro
perylene,C1=CC2=C3C(=C1)C4=CC=CC5=C4C(=CC=C5)C3=CC=C2,198-55-0,Negative,in vivo
perylene,C1=CC2=C3C(=C1)C4=CC=CC5=C4C(=CC=C5)C3=CC=C2,198-55-0,Negative,in vitro
PETASITENINE,CC1CC2(C(O2)C)C(=O)OC3CCN(CC=C(C3=O)COC(=O)C1(C)O)C,60102-37-6,Positive,In vivo
PHENACETIN,CCOC1=CC=C(C=C1)NC(=O)C,62-44-2,Negative,In vivo
PHENACETIN,CCOC1=CC=C(C=C1)NC(=O)C,62-44-2,Positive,In vivo
Phenacetin,CCOC1=CC=C(C=C1)NC(=O)C,62-44-2,Positive,in vitro
phenalen-1-one,C1=CC2=C3C(=C1)C=CC(=O)C3=CC=C2,11050,Negative,In Vivo
phenalen-1-one,C1=CC2=C3C(=C1)C=CC(=O)C3=CC=C2,11050,Positive,In Vivo
Phenanthrene,C1=CC=C2C(=C1)C=CC3=CC=CC=C32,85-01-8,Negative,In vivo
phenanthrene,C1=CC=C2C(=C1)C=CC3=CC=CC=C32,85-01-8,Positive,in vivo
phenanthrene,C1=CC=C2C(=C1)C=CC3=CC=CC=C32,995,Negative,In Vivo
phenanthrene,C1=CC=C2C(=C1)C=CC3=CC=CC=C32,85-01-8,Negative,in vitro
"phenanthrene-9,10-dione",C1=CC=C2C(=C1)C3=CC=CC=C3C(=O)C2=O,84-11-7,Negative,in vitro
phenanthridine,C1=CC=C2C(=C1)C=NC3=CC=CC=C23,9189,Negative,In Vivo
phenanthridine,C1=CC=C2C(=C1)C=NC3=CC=CC=C23,229-87-8,Positive,in vitro
PHENAZONE,CC1=CC(=O)N(N1C)C2=CC=CC=C2,60-80-0,Positive,In vivo
Phenazone,CC1=CC(=O)N(N1C)C2=CC=CC=C2,60-80-0,Negative,in vitro
Phenazopyridine (free base and HCl salt),C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N,94-78-0,Positive,in vitro
Phenelzine,C1=CC=C(C=C1)CCNN,51-71-8,Positive,in vitro
PHENETHYL ISOTHIOCYANATE,C1=CC=C(C=C1)CCN=C=S,2257-09-2,Negative,In vivo
Phenformin.HCl,C1=CC=C(C=C1)CCN=C(N)N=C(N)N.Cl,834-28-6,Negative,in vitro
Phenmedipham,CC1=CC(=CC=C1)NC(=O)OC2=CC=CC(=C2)NC(=O)OC,13684-63-4,Negative,In vivo
PHENOBARBITAL,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,50-06-6,Negative,In vivo
PHENOBARBITAL,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,50-06-6,Positive,In vivo
Phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,50-06-6,Positive,in vitro
"PHENOBARBITAL, SODIUM",CCC1(C(=O)NC(=NC1=O)[O-])C2=CC=CC=C2.[Na+],57-30-7,Negative,In vivo
"PHENOBARBITAL, SODIUM",CCC1(C(=O)NC(=NC1=O)[O-])C2=CC=CC=C2.[Na+],57-30-7,Positive,In vivo
phenol,C1=CC=C(C=C1)O,996,Negative,In Vivo
Phenol,C1=CC=C(C=C1)O,108-95-2,Negative,In vivo
Phenol,C1=CC=C(C=C1)O,108-95-2,Positive,in vitro
PHENOLPHTHALEIN,C1=CC=C2C(=C1)C(=O)OC2(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O,77-09-8,Negative,In vivo
PHENOTHIAZINE,C1=CC=C2C(=C1)NC3=CC=CC=C3S2,92-84-2,Negative,In vivo
Phenoxybenzamine (free base and HCl salt),CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,59-96-1,Positive,in vitro
PHENYL ISOTHIOCYANATE,C1=CC=C(C=C1)N=C=S,103-72-0,Negative,In vivo
PHENYL-beta-NAPHTHYLAMINE,C1=CC=C(C=C1)NC2=CC3=CC=CC=C3C=C2,135-88-6,Negative,In vivo
phenyl(sulfinyl)methanamine,C1=CC=C(C=C1)C(=S=O)N,20199-04-06,Positive,in vitro
PHENYLBUTAZONE,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,50-33-9,Negative,In vivo
Phenylbutazone,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,50-33-9,Positive,in vitro
Phenylenediamine,C1=CC(=CC(=C1)N)N,108-45-2,Negative,In vivo
PHENYLETHYL-3-METHYLCAFFEATE,COC1=C(C=CC(=C1)C=CC(=O)OCCC2=CC=CC=C2)O,71835-85-3,Negative,In vivo
PHENYLGLYCIDYL ETHER,C1C(O1)COC2=CC=CC=C2,122-60-1,Positive,In vivo
Phenylglycidyl ether,C1C(O1)COC2=CC=CC=C2,122-60-1,Positive,in vitro
PHENYLHYDRAZINE,C1=CC=C(C=C1)NN,100-63-0,Negative,In vivo
phenylhydrazine,C1=CC=C(C=C1)NN,7516,Positive,In Vivo
phenylhydrazine,C1=CC=C(C=C1)NN,100-63-0,Positive,in vitro
Phenylhydrazine (free base and HCl salt),C1=CC=C(C=C1)NN,100-63-0,Positive,in vitro
PHENYLHYDRAZINE.HCl,C1=CC=C(C=C1)NN.Cl,59-88-1,Negative,In vivo
PHENYLHYDRAZINE.HCl,C1=CC=C(C=C1)NN.Cl,59-88-1,Positive,In vivo
PHENYLMERCURIC ACETATE,CC(=O)O[Hg]C1=CC=CC=C1,62-38-4,Negative,In vivo
phenylmercury;hydrate,C1=CC=C(C=C1)[Hg].O,,Positive,in vitro
phenylmethanol,C1=CC=C(C=C1)CO,244,Negative,In Vivo
phenylmethanol,C1=CC=C(C=C1)CO,100-51-6,Negative,in vitro
phenylthiourea,C1=CC=C(C=C1)NC(=S)N,676454,Negative,In Vivo
phenylthiourea,C1=CC=C(C=C1)NC(=S)N,103-85-5,Negative,in vivo
PhIP.HCl,CN1C2=C(N=CC(=C2)C3=CC=CC=C3)N=C1N.Cl,---,Positive,In vivo
Phorate Thimet,CCOP(=S)(OCC)SCSCC,298-02-2,Negative,in vitro
PHORBOL,CC1C(C2(C(C2(C)C)C3C1(C4C=C(C(=O)C4(CC(=C3)CO)O)C)O)O)O,17673-25-5,Negative,In vivo
PHORBOL,CC1C(C2(C(C2(C)C)C3C1(C4C=C(C(=O)C4(CC(=C3)CO)O)C)O)O)O,17673-25-5,Positive,In vivo
Phosalone,CCOP(=S)(OCC)SCN1C2=C(C=C(C=C2)Cl)OC1=O,2310-17-0,Negative,in vivo
Phosalone,CCOP(=S)(OCC)SCN1C2=C(C=C(C=C2)Cl)OC1=O,2310-17-0,Negative,in vitro
Phosgene,C(=O)(Cl)Cl,75-44-5,Negative,In vivo
Phosmet,COP(=S)(OC)SCN1C(=O)C2=CC=CC=C2C1=O,732-11-6,Negative,in vivo
Phosmet,COP(=S)(OC)SCN1C(=O)C2=CC=CC=C2C1=O,0732-11-6,Negative,In vivo
Phosmet,COP(=S)(OC)SCN1C(=O)C2=CC=CC=C2C1=O,0732-11-6,Positive,in vitro
Phosphamidon,CCN(CC)C(=O)C(=C(C)OP(=O)(OC)OC)Cl,13171-21-6,Positive,in vitro
Phosphine,P,24404,Negative,In Vivo
Phosphine,P,7803-51-2,Negative,in vivo
Phosphine,P,7803-51-2,Positive,in vivo
Phosphine,P,7803-51-2,Negative,in vitro
Phosphoric acid,OP(=O)(O)O,7664-38-2,Negative,In vivo
phosphoric acid,OP(=O)(O)O,7664-38-2,Negative,in vitro
Photodieldrin,C12C3C(C4C1C5(C(C3(C4(C5(Cl)Cl)Cl)Cl)Cl)Cl)C6C2O6,13366-73-9,Positive,in vitro
Phthalic anhydride,C1=CC=C2C(=C1)C(=O)OC2=O,85-44-9,Negative,In vivo
Phthalic anhydride,C1=CC=C2C(=C1)C(=O)OC2=O,85-44-9,Negative,in vitro
picene,C1=CC=C2C(=C1)C=CC3=C2C=CC4=C3C=CC5=CC=CC=C54,9162,Positive,In Vivo
Picloram,C1(=C(C(=NC(=C1Cl)Cl)C(=O)O)Cl)N,1918-02-1,Negative,in vivo
Picloram,C1(=C(C(=NC(=C1Cl)Cl)C(=O)O)Cl)N,1918-02-01,Negative,In vivo
Picloram,C1(=C(C(=NC(=C1Cl)Cl)C(=O)O)Cl)N,1918-02-01,Negative,in vitro
"PICLORAM, TECHNICAL GRADE",C1(=C(C(=NC(=C1Cl)Cl)C(=O)O)Cl)N,1918-02-1,Negative,In vivo
Picolinafen,C1=CC(=CC(=C1)OC2=CC=CC(=N2)C(=O)NC3=CC=C(C=C3)F)C(F)(F)F,137641-05-5,Negative,in vivo
Picolinafen,C1=CC(=CC(=C1)OC2=CC=CC(=N2)C(=O)NC3=CC=C(C=C3)F)C(F)(F)F,137641-05-5,Negative,in vitro
Picramic acid and Sodium picramate COLIPA B028,C1=C(C=C(C(=C1N)O)[N+](=O)[O-])[N+](=O)[O-],96-91-3,Negative,in vitro
Picric acid,C1=C(C=C(C(=C1[N+](=O)[O-])O)[N+](=O)[O-])[N+](=O)[O-],88-89-1,Positive,in vitro
PILDRALAZINE.2HCl,CC(CN(C)C1=NN=C(C=C1)NN)O.Cl.Cl,56393-22-7,Negative,In vivo
PILOCARPINE,CCC1C(COC1=O)CC2=CN=CN2C,92-13-7,Negative,In vivo
PIMARICIN,CC1CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC3C(O3)C=CC(=O)O1)O)O)O)C(=O)O)OC4C(C(C(C(O4)C)O)N)O,7681-93-8,Negative,In vivo
Pinoxaden,CCC1=CC(=CC(=C1C2=C(N3CCOCCN3C2=O)OC(=O)C(C)(C)C)CC)C,243973-20-8,Negative,in vivo
Pinoxaden,CCC1=CC(=CC(=C1C2=C(N3CCOCCN3C2=O)OC(=O)C(C)(C)C)CC)C,243973-20-8,Negative,in vitro
piperazine;dihydrochloride,C1CNCCN1.Cl.Cl ,142-64-3,Positive,in vitro
piperidine,C1CCNCC1,110-89-4,Negative,in vitro
piperidine-2-carboxylic acid,C1CCNC(C1)C(=O)O,535-75-1,Negative,in vitro
PIPERONYL BUTOXIDE,CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2,51-03-6,Positive,In vivo
PIPERONYL BUTOXIDE,CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2,51-03-6,Negative,In vivo
Piperonyl butoxide,CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2,51-03-6,Negative,in vitro
PIPERONYL BUTOXIDE IN SOLVENT,CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2,51-03-6,Negative,In vivo
Pirimicarb,CC1=C(N=C(N=C1OC(=O)N(C)C)N(C)C)C,23103-98-2,Negative,in vivo
Pirimicarb,CC1=C(N=C(N=C1OC(=O)N(C)C)N(C)C)C,23103-98-2,Negative,in vitro
Pirimiphos-methyl,CCN(CC)C1=NC(=CC(=N1)OP(=S)(OC)OC)C,29232-93-7,Negative,in vivo
Pirimiphos-methyl,CCN(CC)C1=NC(=CC(=N1)OP(=S)(OC)OC)C,29232-93-7,Negative,in vitro
PIRMENOL.HCl,CC1CCCC(N1CCCC(C2=CC=CC=C2)(C3=CC=CC=N3)O)C.Cl,61477-94-9,Negative,In vivo
Pivalolactone,CC1(COC1=O)C,1955-45-9,Positive,in vitro
platinum;hydrochloride,Cl.[Pt],,Positive,in vitro
POLICOSANOL,CCCO,142583-61-7,Negative,In vivo
POLYBROMINATED BIPHENYLS,C1=CC(=C(C(=C1C2=CC(=C(C(=C2)Br)Br)Br)Br)Br)Br,59536-65-1,Negative,In vivo
"POLYDEXTROSE, ACID FORM",C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)O)O)O)O)O)O)O)O,68424-04-4,Negative,In vivo
POLYOXYETHYLENE(10)NONYLPHENYL ETHER,CCCCCCCCCC1=CC=C(C=C1)OCCO,26027-38-3,Negative,In vivo
Polysorbate 80,[H]C(COCCOC(=O)CCCCCCCCCCC)(OCCO)[C@@]1([H])OCC([H])(OCCO)[C@@]1([H])OCCO,9005-65-6,Positive,in vitro
POLYVINYLPYRIDINE-N-OXIDE,C=CC1=CC=CC=[N+]1[O-],9045-81-2,Negative,In vivo
POTASSIUM BICARBONATE,C(=O)(O)[O-].[K+],298-14-6,Positive,In vivo
POTASSIUM CHLORIDE,[Cl-].[K+],7447-40-7,Negative,In vivo
Potassium chromate,[O-][Cr](=O)(=O)[O-].[K+].[K+],7789-00-6,Positive,in vitro
Potassium cyanide,[C-]#N.[K+],151-50-8,Negative,In vivo
Potassium dichromate,[O-][Cr](=O)(=O)O[Cr](=O)(=O)[O-].[K+].[K+],7778-50-9,Positive,in vitro
POTASSIUM IODIDE,[K+].[I-],7681-11-0,Negative,In vivo
POTASSIUM IODIDE,[K+].[I-],7681-11-0,Positive,In vivo
Potassium phosphonates,[O-]P([O-])[O-].[K+].[K+].[K+],,Negative,in vivo
Potassium phosphonates,[O-]P([O-])[O-].[K+].[K+].[K+],,Negative,in vitro
Potassium silver cyanide,[C-]#N.[C-]#N.[K+].[Ag+],506-61-6,Negative,In vivo
"potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+],23676814,Negative,In Vivo
"potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[K+],113-98-4,Negative,in vitro
potassium;(2S)-2-amino-5-hydroxy-5-oxopentanoate,C(CC(=O)O)[C@@H](C(=O)[O-])N.[K+],24595-14-0,Negative,in vitro
"potassium;1-methyl-7-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-4-oxo-1,8-naphthyridine-3-carboxylate",CN1C=C(C(=O)C2=C1N=C(C=C2)/C=C/C3=CC=C(O3)[N+](=O)[O-])C(=O)[O-].[K+],5284417,Positive,In Vivo
"potassium;3-(1-hydroxy-9,10-dioxoanthracen-2-yl)oxypropane-1-sulfonate",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)OCCCS(=O)(=O)[O-])O.[K+],,Positive,in vitro
"potassium;6-methyl-2,2-dioxooxathiazin-4-olate",CC1=CC(=NS(=O)(=O)O1)[O-].[K+],23683747,Negative,In Vivo
potassium;6-oxo-1H-pyridazin-3-olate,C1=CC(=NNC1=O)[O-].[K+],23695319,Negative,In Vivo
potassium;bromate,[O-]Br(=O)=O.[K+],23673461,Positive,In Vivo
potassium;bromate,[O-]Br(=O)=O.[K+],23673461,Negative,In Vivo
potassium;bromate,[O-]Br(=O)=O.[K+],7758-01-02,Positive,in vitro
potassium;chloride,[Cl-].[K+],4873,Negative,In Vivo
potassium;cyanate,C(#N)[O-].[K+],590-28-3,Positive,in vitro
potassium;cyanide,[C-]#N.[K+],151-50-8,Negative,in vitro
potassium;fluoride,[F-].[K+],7789-23-3,Negative,in vitro
potassium;iodide,[K+].[I-],4875,Positive,In Vivo
"potassium;N,N-bis(2-hydroxyethyl)carbamodithioate",C(CO)N(CCO)C(=S)[S-].[K+],23662398,Positive,In Vivo
"potassium;N,N-bis(2-hydroxyethyl)carbamodithioate",C(CO)N(CCO)C(=S)[S-].[K+],23662398,Negative,In Vivo
potassium;permanganate,[O-][Mn](=O)(=O)=O.[K+],7722-64-7,Negative,in vitro
PRACTOLOL,CC(C)NCC(COC1=CC=C(C=C1)NC(=O)C)O,6673-35-4,Negative,In vivo
PRANLUKAST HYDRATE,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5.C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5.O,150821-03-7,Negative,In vivo
PRAZEPAM,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4,2955-38-6,Negative,In vivo
PRAZIQUANTEL,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,55268-74-1,Negative,In vivo
PREDNIMUSTINE,CC12CC(C3C(C1CCC2(C(=O)COC(=O)CCCC4=CC=C(C=C4)N(CCCl)CCCl)O)CCC5=CC(=O)C=CC35C)O,29069-24-7,Negative,In vivo
PREDNIMUSTINE,CC12CC(C3C(C1CCC2(C(=O)COC(=O)CCCC4=CC=C(C=C4)N(CCCl)CCCl)O)CCC5=CC(=O)C=CC35C)O,29069-24-7,Positive,In vivo
PREDNISOLONE,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,50-24-8,Negative,In vivo
PREDNISOLONE,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,50-24-8,Positive,In vivo
PREDNISONE,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,53-03-2,Negative,In vivo
PREMARIN,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O,12126-59-9,Negative,In vivo
Primaclone (primidone),CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,125-33-7,Negative,in vitro
Primaquine,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,90-34-6,Positive,in vitro
PROCARBAZINE,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,671-16-9,Positive,In vivo
PROCARBAZINE.HCl,CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl,366-70-1,Positive,In vivo
Prochloraz,CCCN(CCOC1=C(C=C(C=C1Cl)Cl)Cl)C(=O)N2C=CN=C2,67747-09-5,Negative,in vivo
Prochloraz,CCCN(CCOC1=C(C=C(C=C1Cl)Cl)Cl)C(=O)N2C=CN=C2,67747-09-05,Positive,In vivo
Prochloraz,CCCN(CCOC1=C(C=C(C=C1Cl)Cl)Cl)C(=O)N2C=CN=C2,67747-09-05,Negative,in vitro
Proflavin [Acriflavine],C[N+]1=C2C=C(C=CC2=CC3=C1C=C(C=C3)N)N.C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N.[Cl-],8048-52-0,Positive,in vitro
Progesterone,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,57-83-0,Negative,in vitro
Prohexadione-calcium,CCC(=C1C(=O)CC(CC1=O)C(=O)O)[O-].CCC(=C1C(=O)CC(CC1=O)C(=O)O)[O-].[Ca+2],127277-53-6,Negative,in vivo
Prohexadione-calcium,CCC(=C1C(=O)CC(CC1=O)C(=O)O)[O-].CCC(=C1C(=O)CC(CC1=O)C(=O)O)[O-].[Ca+2],127277-53-6,Negative,in vitro
Prometon,CC(C)NC1=NC(=NC(=N1)OC)NC(C)C,1610-18-0,Negative,In vivo
Prometryn,CC(C)NC1=NC(=NC(=N1)SC)NC(C)C,7287-19-6,Negative,In vivo
Pronamide,CC(C)(C#C)NC(=O)C1=CC(=CC(=C1)Cl)Cl,23950-58-5,Negative,In vivo
PRONETHALOL.HCl,CC(C)NCC(C1=CC2=CC=CC=C2C=C1)O.Cl,51-02-5,Negative,In vivo
prop-1-en-2-ylbenzene,CC(=C)C1=CC=CC=C1,7407,Negative,In Vivo
prop-1-en-2-ylbenzene,CC(=C)C1=CC=CC=C1,7407,Positive,In Vivo
prop-1-en-2-ylbenzene,CC(=C)C1=CC=CC=C1,98-83-9,Positive,in vitro
prop-1-ene,CC=C,8252,Negative,In Vivo
prop-2-en-1-ol,C=CCO,7858,Negative,In Vivo
prop-2-enal,C=CC=O,7847,Negative,In Vivo
prop-2-enal,C=CC=O,0107-02-08,Positive,in vitro
prop-2-enamide,C=CC(=O)N,6579,Negative,In Vivo
prop-2-enamide,C=CC(=O)N,6579,Positive,In Vivo
prop-2-enamide,C=CC(=O)N,79-06-1,Negative,in vivo
prop-2-enenitrile,C=CC#N,7855,Positive,In Vivo
prop-2-enenitrile,C=CC#N,107-13-1,Positive,in vivo
prop-2-enenitrile,C=CC#N,7855,Negative,In Vivo
prop-2-enenitrile,C=CC#N,107-13-1,Negative,in vitro
prop-2-enoic acid,C=CC(=O)O,6581,Negative,In Vivo
prop-2-enyl 3-methylbutanoate,CC(C)CC(=O)OCC=C,17816,Positive,In Vivo
prop-2-enyl 3-methylbutanoate,CC(C)CC(=O)OCC=C,2835-39-4,Positive,in vivo
prop-2-enyl carbamate,C=CCOC(=O)N,2114-11-6,Positive,in vivo
prop-2-yn-1-ol,C#CCO,7859,Positive,In Vivo
prop-2-yn-1-ol,C#CCO,7859,Negative,In Vivo
Propachlor,CC(C)N(C1=CC=CC=C1)C(=O)CCl,1918-16-7,Negative,In vivo
Propamocarb hydrochloride,CCCOC(=O)NCCC[NH+](C)C.[Cl-],25606-41-1,Negative,in vivo
Propamocarb hydrochloride,CCCOC(=O)NCCC[NH+](C)C.[Cl-],25606-41-1,Negative,in vitro
propan-1-ol,CCCO,1031,Negative,In Vivo
propan-1-ol,CCCO,71-23-8,Negative,in vitro
propan-2-ol,CC(C)O,3776,Negative,In Vivo
propan-2-ol,CC(C)O,67-63-0,Negative,in vitro
propan-2-one,CC(=O)C,67-64-1,Negative,in vitro
propan-2-yl 2-[ethoxy-(propan-2-ylamino)phosphinothioyl]oxybenzoate,CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C,25311-71-1,Negative,in vitro
propan-2-yl carbamate,CC(C)OC(=O)N,1746-77-6,Positive,in vivo
propan-2-yl methanesulfonate,CC(C)OS(=O)(=O)C,0926-06-07,Positive,in vivo
propan-2-yl methanesulfonate,CC(C)OS(=O)(=O)C,13551,Positive,In Vivo
propan-2-yl methanesulfonate,CC(C)OS(=O)(=O)C,0926-06-07,Negative,in vitro
propan-2-yl N-(2-methoxy-5-phenylanilino)carbamate,CC(C)OC(=O)NNC1=C(C=CC(=C1)C2=CC=CC=C2)OC,176879,Negative,In Vivo
propan-2-yl N-(3-chlorophenyl)carbamate,CC(C)OC(=O)NC1=CC(=CC=C1)Cl,2728,Negative,In Vivo
propan-2-yl N-(3-chlorophenyl)carbamate,CC(C)OC(=O)NC1=CC(=CC=C1)Cl,101-21-3,Negative,in vivo
propan-2-yl N-(3-chlorophenyl)carbamate,CC(C)OC(=O)NC1=CC(=CC=C1)Cl,2728,Positive,In Vivo
propan-2-yl N-(3-chlorophenyl)carbamate,CC(C)OC(=O)NC1=CC(=CC=C1)Cl,101-21-3,Positive,in vitro
propan-2-yl N-phenylcarbamate,CC(C)OC(=O)NC1=CC=CC=C1,122-42-9,Positive,in vitro
propanal,CCC=O,123-38-6,Positive,in vitro
PROPANE SULTONE,C1COS(=O)(=O)C1,1120-71-4,Positive,In vivo
"propane-1,2-diol",CC(CO)O,57-55-6,Negative,in vitro
propanedial,C(C=O)C=O,10964,Negative,In Vivo
Propanil,CCC(=O)NC1=CC(=C(C=C1)Cl)Cl,709-98-8,Negative,In vivo
propanoic acid,CCC(=O)O,79-09-4,Negative,in vitro
Propaquizafop,C/C(C)=N\OCCOC(=O)[C@@H](C)Oc1ccc(cc1)Oc2cnc3cc(Cl)ccc3n2,111479-05-1,Negative,in vivo
Propaquizafop,C/C(C)=N\OCCOC(=O)[C@@H](C)Oc1ccc(cc1)Oc2cnc3cc(Cl)ccc3n2,111479-05-1,Positive,in vivo
Propaquizafop,C/C(C)=N\OCCOC(=O)[C@@H](C)Oc1ccc(cc1)Oc2cnc3cc(Cl)ccc3n2,111479-05-1,Negative,in vitro
Propargite,CC(C)(C)C1=CC=C(C=C1)OC2CCCCC2OS(=O)OCC#C,2312-35-8,Negative,in vivo
Propargite,CC(C)(C)C1=CC=C(C=C1)OC2CCCCC2OS(=O)OCC#C,2312-35-8,Negative,in vitro
Propargyl alcohol,C#CCO,107-19-7,Negative,In vivo
Propargyl alcohol ,C#CCO,107-19-7,Positive,in vitro
PROPAZINE,CC(C)NC1=NC(=NC(=N1)Cl)NC(C)C,139-40-2,Negative,In vivo
Propham,CC(C)OC(=O)NC1=CC=CC=C1,122-42-9,Negative,In vivo
Propiconazole,CCCC1COC(O1)(CN2C=NC=N2)C3=C(C=C(C=C3)Cl)Cl,60207-90-1,Negative,In vivo
Propiolactone,C1COC1=O,57-57-8,Negative,In vivo
Propionaldehyde,CCC=O,123-38-6,Negative,In vivo
PROPRANOLOL.HCl,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl,318-98-9,Negative,In vivo
"propyl 3,4,5-trihydroxybenzoate",CCCOC(=O)C1=CC(=C(C(=C1)O)O)O,4947,Negative,In Vivo
propyl 4-hydroxybenzoate,CCCOC(=O)C1=CC=C(C=C1)O,94-13-3,Negative,in vitro
propyl carbamate,CCCOC(=O)N,12306,Positive,In Vivo
PROPYL GALLATE,CCCOC(=O)C1=CC(=C(C(=C1)O)O)O,121-79-9,Negative,In vivo
propyl methanesulfonate,CCCOS(=O)(=O)C,1912-31-8,Positive,in vivo
propyl methanesulfonate,CCCOS(=O)(=O)C,1912-31-8,Positive,in vitro
"PROPYL N-ETHYL-N-BUTYLTHIOCARBAMATE, COMMERCIAL GRADE (78%)",CCCCN(CC)C(=O)SCCC,1114-71-2,Negative,In vivo
propylaminoazanium;chloride,CCCN[NH3+].[Cl-],42006,Positive,In Vivo
PROPYLENE,CC=C,115-07-1,Negative,In vivo
Propylene glycol,CC(CO)O,57-55-6,Negative,In vivo
Propylene glycol mono-t-butyl ether,CC(COC(C)(C)C)O,57018-52-7,Negative,in vitro
Propylene glycol monoethyl ether,CCC(O)OCC,52125-53-8,Negative,In vivo
Propylene glycol monomethyl ether (PGME),CC(COC)O,107-98-2,Negative,In vivo
Propylene oxide,CC1CO1,75-56-9,Positive,In vivo
Propyleneimine,CC1CN1,75-55-8,Negative,In vivo
PROPYLHYDRAZINE.HCl,CCCNN.Cl,56795-66-5,Negative,In vivo
PROPYLHYDRAZINE.HCl,CCCNN.Cl,56795-66-5,Positive,In vivo
PROPYLTHIOURACIL,CCCC1=CC(=O)NC(=S)N1,51-52-5,Positive,In vivo
PROPYLTHIOURACIL,CCCC1=CC(=O)NC(=S)N1,51-52-5,Negative,In vivo
PROQUAZONE,CC1=CC2=C(C=C1)C(=NC(=O)N2C(C)C)C3=CC=CC=C3,22760-18-5,Negative,In vivo
Proquinazid,CCCN1C(=O)C2=C(C=CC(=C2)I)N=C1OCCC,189278-12-4,Negative,in vivo
Proquinazid,CCCN1C(=O)C2=C(C=CC(=C2)I)N=C1OCCC,189278-12-4,Negative,in vitro
PRORESID,CCNNC(=O)C1C(C(C2=CC3=C(C=C2C1C4=CC(=C(C(=C4)OC)OC)OC)OCO3)O)CO,1508-45-8,Negative,In vivo
Prosulfocarb,CCCN(CCC)C(=O)SCc1ccccc1,52888-80-9,Negative,in vivo
Prosulfocarb,CCCN(CCC)C(=O)SCc1ccccc1,52888-80-9,Negative,in vitro
Prosulfuron,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=CC=CC=C2CCC(F)(F)F,94125-34-5,Negative,in vivo
Prosulfuron,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=CC=CC=C2CCC(F)(F)F,94125-34-5,Negative,in vitro
Prothioconazole,C1CC1(C(CC2=CC=CC=C2Cl)(CN3C(=S)N=CN3)O)Cl,178928-70-6,Negative,in vivo
Prothioconazole,C1CC1(C(CC2=CC=CC=C2Cl)(CN3C(=S)N=CN3)O)Cl,178928-70-6,Negative,in vitro
PROTOCATECHUIC ACID,C1=CC(=C(C=C1C(=O)O)O)O,99-50-3,Negative,In vivo
PURPURIN,C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3O)O)O,81-54-9,Positive,In vivo
Pursuit,CCC1=CC(=C(N=C1)C2=NC(C(=O)N2)(C)C(C)C)C(=O)O,81335-77-5,Negative,In vivo
Pydrin,CC(C)C(C1=CC=C(C=C1)Cl)C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3,51630-58-1,Negative,In vivo
Pymetrozine,CC1=NNC(=O)N(C1)/N=C/C2=CN=CC=C2,123312-89-0,Negative,in vivo
Pymetrozine,CC1=NNC(=O)N(C1)/N=C/C2=CN=CC=C2,123312-89-0,Positive,in vivo
Pymetrozine,CC1=NNC(=O)N(C1)/N=C/C2=CN=CC=C2,123312-89-0,Negative,in vitro
Pyraflufen-ethyl,CCOC(=O)COC1=C(C=C(C(=C1)C2=NN(C(=C2Cl)OC(F)F)C)F)Cl,129630-19-9,Negative,in vivo
Pyraflufen-ethyl,CCOC(=O)COC1=C(C=C(C(=C1)C2=NN(C(=C2Cl)OC(F)F)C)F)Cl,129630-19-9,Negative,in vitro
pyrazine-2-carboxamide,C1=CN=C(C=N1)C(=O)N,1046,Negative,In Vivo
pyren-1-amine,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)N,1606-67-3,Positive,in vitro
pyren-1-ylmethanol,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)CO,104977,Negative,In Vivo
pyren-1-ylmethyl hydrogen sulfate,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)COS(=O)(=O)O,131320,Positive,In Vivo
pyrene,C1=CC2=C3C(=C1)C=CC4=CC=CC(=C43)C=C2,31423,Negative,In Vivo
pyrene,C1=CC2=C3C(=C1)C=CC4=CC=CC(=C43)C=C2,129-00-0,Negative,in vivo
Pyrene,C1=CC2=C3C(=C1)C=CC4=CC=CC(=C43)C=C2,129-00-0,Positive,in vitro
Pyrethrins,CC1=C(C(=O)CC1OC(=O)C2C(C2(C)C)C=C(C)C)CC=CC=C.CC1=C(C(=O)CC1OC(=O)C2C(C2(C)C)C=C(C)C(=O)OC)CC=CC=C,8003-34-7,Negative,in vitro
Pyridaben,O=C1N(C(C)(C)C)N=CC(SCC2=CC=C(C(C)(C)C)C=C2)=C1Cl,96489-71-3,Negative,in vivo
Pyridaben,O=C1N(C(C)(C)C)N=CC(SCC2=CC=C(C(C)(C)C)C=C2)=C1Cl,96489-71-3,Negative,in vitro
Pyridalyl,C1=CC(=NC=C1C(F)(F)F)OCCCOC2=C(C=C(C=C2Cl)OCC=C(Cl)Cl)Cl,179101-81-6,Negative,in vivo
Pyridalyl,C1=CC(=NC=C1C(F)(F)F)OCCCOC2=C(C=C(C=C2Cl)OCC=C(Cl)Cl)Cl,179101-81-6,Negative,in vitro
Pyridate,CCCCCCCCSC(=O)OC1=CC(=NN=C1C2=CC=CC=C2)Cl,55512-33-9,Negative,in vivo
Pyridate,CCCCCCCCSC(=O)OC1=CC(=NN=C1C2=CC=CC=C2)Cl,55512-33-9,Negative,in vitro
pyridine,C1=CC=NC=C1,1049,Positive,In Vivo
Pyridine,C1=CC=NC=C1,110-86-1,Negative,In vivo
Pyridine,C1=CC=NC=C1,110-86-1,Negative,in vitro
pyridine-3-carbohydrazide,C1=CC(=CN=C1)C(=O)NN,11112,Positive,In Vivo
pyridine-3-carboxamide,C1=CC(=CN=C1)C(=O)N,98-92-0,Positive,in vitro
pyridine-4-carbohydrazide,C1=CN=CC=C1C(=O)NN,54-85-3,Negative,in vivo
pyridine-4-carbohydrazide,C1=CN=CC=C1C(=O)NN,3767,Positive,In Vivo
pyridine-4-carbohydrazide,C1=CN=CC=C1C(=O)NN,54-85-3,Positive,in vivo
pyridine-4-carbohydrazide,C1=CN=CC=C1C(=O)NN,3767,Negative,In Vivo
pyridine-4-carbohydrazide,C1=CN=CC=C1C(=O)NN,54-85-3,Positive,in vitro
PYRILAMINE MALEATE,CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,59-33-6,Negative,In vivo
PYRILAMINE MALEATE,CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,59-33-6,Positive,In vivo
Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,58-14-0,Positive,in vitro
Pyrimethanil,CC1=NC(NC2=CC=CC=C2)=NC(C)=C1,53112-28-0,Negative,in vivo
Pyrimethanil,CC1=NC(NC2=CC=CC=C2)=NC(C)=C1,53112-28-0,Negative,in vitro
Pyriofenone,CC1=CC(=C(C(=C1C(=O)C2=C(C(=CN=C2OC)Cl)C)OC)OC)OC,688046-61-9,Negative,in vivo
Pyriofenone,CC1=CC(=C(C(=C1C(=O)C2=C(C(=CN=C2OC)Cl)C)OC)OC)OC,688046-61-9,Negative,in vitro
Pyriproxyfen,CC(OC3=NC=CC=C3)COC2=CC=C(C=C2)OC1=CC=CC=C1,95737-68-1,Negative,in vivo
Pyriproxyfen,CC(OC3=NC=CC=C3)COC2=CC=C(C=C2)OC1=CC=CC=C1,95737-68-1,Negative,in vitro
Pyrogallol,C1=CC(=C(C(=C1)O)O)O,87-66-1,Positive,in vitro
Pyroxsulam,COC1=CC(=NC2=NC(=NN12)NS(=O)(=O)C3=C(C=CN=C3OC)C(F)(F)F)OC,422556-08-9,Negative,in vivo
Pyroxsulam,COC1=CC(=NC2=NC(=NN12)NS(=O)(=O)C3=C(C=CN=C3OC)C(F)(F)F)OC,422556-08-9,Negative,in vitro
pyrrolidine,C1CCNC1,123-75-1,Negative,in vitro
pyrrolidine-2-carbothioic S-acid,C1CC(NC1)C(=O)S,1823322-47-9,Negative,in vitro
QUERCETIN,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,117-39-5,Negative,In vivo
QUERCETIN,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,117-39-5,Positive,In vivo
Quercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,117-39-5,Positive,in vitro
QUERCETIN DIHYDRATE,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O.O.O,6151-25-3,Negative,In vivo
Quinacrine mustard (free base and 2HCl salt),C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O.O.O,6151-25-3,Positive,in vitro
Quinacrine/ Quinacrine dihydrochloride,CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,83-89-6,Positive,in vitro
Quinalphos,CCOP(=S)(OCC)OC1=NC2=CC=CC=C2N=C1,13593-03-08,Negative,In vivo
QUINAPRIL.HCl,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O.Cl,82586-55-8,Negative,In vivo
Quinine (free base and 2HCl salt),COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,130-95-0,Positive,in vitro
Quinmerac,CC1=CC2=C(C(=C(C=C2)Cl)C(=O)O)N=C1,90717-03-6,Negative,in vivo
Quinmerac,CC1=CC2=C(C(=C(C=C2)Cl)C(=O)O)N=C1,90717-03-06,Negative,in vitro
Quinoclamine,NC1=C(Cl)C(=O)c2ccccc2C1=O,2797-51-5,Negative,in vivo
Quinoclamine,NC1=C(Cl)C(=O)c2ccccc2C1=O,2797-51-5,Negative,in vitro
quinolin-1-ium-8-ol;sulfate,C1=CC2=C(C(=C1)O)[NH+]=CC=C2.C1=CC2=C(C(=C1)O)[NH+]=CC=C2.[O-]S(=O)(=O)[O-],,Negative,in vitro
quinolin-5-ol,C1=CC2=C(C=CC=N2)C(=C1)O,578-67-6,Positive,in vitro
quinolin-6-ol,C1=CC2=C(C=CC(=C2)O)N=C1,580-16-5,Negative,in vitro
quinolin-7-ol,C1=CC2=C(C=C(C=C2)O)N=C1,580-20-1,Negative,in vitro
quinolin-8-amine,C1=CC2=C(C(=C1)N)N=CC=C2,578-66-5,Negative,in vitro
quinolin-8-ol,C1=CC2=C(C(=C1)O)N=CC=C2,1923,Negative,In Vivo
quinolin-8-ol,C1=CC2=C(C(=C1)O)N=CC=C2,148-24-3,Negative,in vivo
quinolin-8-ol,C1=CC2=C(C(=C1)O)N=CC=C2,148-24-3,Negative,in vitro
quinoline,C1=CC=C2C(=C1)C=CC=N2,7047,Negative,In Vivo
quinoline,C1=CC=C2C(=C1)C=CC=N2,7047,Positive,In Vivo
Quinoline,C1=CC=C2C(=C1)C=CC=N2,91-22-5,Positive,In vivo
Quinoline,C1=CC=C2C(=C1)C=CC=N2,91-22-5,Positive,in vitro
"Quinolinium, 4-formyl-1-methyl-, salt with 4-methylbenzenesulfonic acid COLIPA A157",CC1=CC=C(C=C1)S(=O)(=O)[O-].C[N+]1=CC=C(C2=CC=CC=C21)C=O,223398-02-5,Positive,in vitro
Quinone,C1=CC(=O)C=CC1=O,106-51-4,Negative,In vivo
quinoxaline,C1=CC=C2C(=C1)N=CC=N2,91-19-0,Negative,in vivo
Quizalofop-P-ethyl,CCOC(=O)[C@@H](C)OC1=CC=C(C=C1)OC2=CN=C3C=C(C=CC3=N2)Cl,100646-51-3,Negative,in vivo
Quizalofop-P-ethyl,CCOC(=O)[C@@H](C)OC1=CC=C(C=C1)OC2=CN=C3C=C(C=CC3=N2)Cl,100646-51-3,Negative,in vitro
Quizalofop-P-tefuryl,CC(C(=O)OCC1CCCO1)OC2=CC=C(C=C2)OC3=CN=C4C=C(C=CC4=N3)Cl,119738-06-6,Negative,in vivo
Quizalofop-P-tefuryl,CC(C(=O)OCC1CCCO1)OC2=CC=C(C=C2)OC3=CN=C4C=C(C=CC4=N3)Cl,119738-06-6,Negative,in vitro
R(-)-2-METHYL-N-NITROSOPIPERIDINE,CC1CCCCN1N=O,14026-03-0,Positive,In vivo
"Radium 226,228",[Ra],7440-14-4,Negative,In vivo
Radon 222,[Rn],14859-67-7,Negative,In vivo
RAMOSETRON.HCl,CN1C=C(C2=CC=CC=C21)C(=O)C3CCC4=C(C3)NC=N4.Cl,132907-72-3,Negative,In vivo
RESERPINE,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,50-55-5,Negative,In vivo
Reserpine,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,50-55-5,Negative,in vitro
Resmethrin,CC(=CC1C(C1(C)C)C(=O)OCC2=COC(=C2)CC3=CC=CC=C3)C,10453-86-8,Negative,In vivo
"Resorcinol  1,3-dihydroxybenezene",C1=CC(=CC(=C1)O)O,108-46-3,Positive,in vitro
RETINOIC ACID,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,302-79-4,Negative,In vivo
RETINOL ACETATE,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCOC(=O)C)C)C,127-47-9,Negative,In vivo
RETINOL ACETATE,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCOC(=O)C)C)C,127-47-9,Positive,In vivo
RETINOL PALMITATE,CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C,79-81-2,Negative,In vivo
RETRORSINE,CC=C1CC(C(C(=O)OCC2=CCN3C2C(CC3)OC1=O)(CO)O)C,480-54-6,Positive,In vivo
rhodium(3+);trinitrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Rh+3],10139-58-9,Positive,in vitro
Riddelliine,CC=C1CC(=C)C(C(=O)OCC2=CCN3C2C(CC3)OC1=O)(CO)O,23246-96-0,Positive,in vitro
RIFAMPICIN,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,13292-46-1,Negative,In vivo
RIFAMPICIN,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,13292-46-1,Positive,In vivo
Rimsulfuron,O=S(C1=NC=CC=C1S(CC)(=O)=O)(NC(NC2=NC(OC)=CC(OC)=N2)=O)=O,122931-48-0,Negative,in vivo
Rimsulfuron,O=S(C1=NC=CC=C1S(CC)(=O)=O)(NC(NC2=NC(OC)=CC(OC)=N2)=O)=O,122931-48-0,Negative,in vitro
RIPAZEPAM,CCN1C2=C(C(=N1)C)NC(=O)CN=C2C3=CC=CC=C3,26308-28-1,Positive,In vivo
RIPAZEPAM,CCN1C2=C(C(=N1)C)NC(=O)CN=C2C3=CC=CC=C3,26308-28-1,Negative,In vivo
Ropinorole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,91374-21-9,Negative,in vitro
ROSANILINE.HCl,CC1=CC(=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N)C=CC1=N.Cl,632-99-5,Negative,In vivo
Rosuvastatin,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,287714-41-4,Negative,in vitro
ROTENONE,CC(=C)C1CC2=C(O1)C=CC3=C2OC4COC5=CC(=C(C=C5C4C3=O)OC)OC,83-79-4,Negative,In vivo
Rotenone,CC(=C)C1CC2=C(O1)C=CC3=C2OC4COC5=CC(=C(C=C5C4C3=O)OC)OC,83-79-4,Positive,in vitro
rubidium(1+);dichloride,[Cl-].[Cl-].[Rb+],,Negative,in vitro
ruthenium(3+);trichloride,[Cl-].[Cl-].[Cl-].[Ru+3],,Negative,in vitro
RUTIN SULFATE,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O.OS(=O)(=O)O,12768-44-4,Negative,In vivo
RUTIN TRIHYDRATE,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O.O.O.O,153-18-4,Negative,In vivo
"S-(2,3,3-trichloroprop-2-enyl) N,N-di(propan-2-yl)carbamothioate",CC(C)N(C(C)C)C(=O)SCC(=C(Cl)Cl)Cl,2303-17-5,Positive,in vitro
"S-[(Z)-2,3-dichloroprop-2-enyl] N,N-di(propan-2-yl)carbamothioate",CC(C)N(C(C)C)C(=O)SC/C(=C/Cl)/Cl,5284376,Positive,In Vivo
"S-[(Z)-2,3-dichloroprop-2-enyl] N,N-di(propan-2-yl)carbamothioate",CC(C)N(C(C)C)C(=O)SC/C(=C/Cl)/Cl,5284376,Negative,In Vivo
"S-[(Z)-2,3-dichloroprop-2-enyl] N,N-di(propan-2-yl)carbamothioate",CC(C)N(C(C)C)C(=O)SC/C(=C/Cl)/Cl,2303-16-4,Positive,in vitro
S-abscisic acid,CC1=CC(=O)CC([C@]1(/C=C/C(=C\C(=O)O)/C)O)(C)C,21293-29-8,Negative,in vivo
S-abscisic acid,CC1=CC(=O)CC([C@]1(/C=C/C(=C\C(=O)O)/C)O)(C)C,21293-29-8,Negative,in vitro
S-ethyl N-cyclohexyl-N-ethylcarbamothioate,CCN(C1CCCCC1)C(=O)SCC,14337,Negative,In Vivo
"S-ethyl N,N-bis(2-methylpropyl)carbamothioate",CCSC(=O)N(CC(C)C)CC(C)C,16181,Negative,In Vivo
"S-ethyl N,N-dipropylcarbamothioate",CCCN(CCC)C(=O)SCC,12968,Negative,In Vivo
"S-ethyl N,N-dipropylcarbamothioate",CCCN(CCC)C(=O)SCC,759-94-4,Negative,in vitro
S-ETHYL-l-CYSTEINE,CCSCC(C(=O)O)N,2629-59-6,Negative,In vivo
"S-methyl 1,2,3-benzothiadiazole-7-carbothioate",CSC(=O)C1=C2C(=CC=C1)N=NS2,86412,Negative,In Vivo
"S-methyl 1,2,3-benzothiadiazole-7-carbothioate",CSC(=O)C1=C2C(=CC=C1)N=NS2,86412,Positive,In Vivo
S(+)-2-METHYL-N-NITROSOPIPERIDINE,CC1CCCCN1N=O,36702-44-0,Positive,In vivo
SACCHARIN,C1=CC=C2C(=C1)C(=O)NS2(=O)=O,81-07-2,Negative,In vivo
"SACCHARIN, CALCIUM",C1=CC=C2C(=C1)C(=NS2(=O)=O)[O-].C1=CC=C2C(=C1)C(=NS2(=O)=O)[O-].[Ca+2],6485-34-3,Negative,In vivo
"SACCHARIN, SODIUM",C1=CC=C2C(=C1)C(=O)[N-]S2(=O)=O.[Na+],128-44-9,Negative,In vivo
"SACCHARIN, SODIUM",C1=CC=C2C(=C1)C(=O)[N-]S2(=O)=O.[Na+],128-44-9,Positive,In vivo
Saccharin/Sodium Saccharin,C1=CC=C2C(=C1)C(=O)NS2(=O)=O,81-07-2,Negative,in vitro
Safflower yellow,C1=CC(=CC=C1C=CC(=O)C2=C(C(=C(C=C2O)O)O)OC3C(C(C(C(O3)CO)O)O)O)O,1401-20-3,Positive,in vitro
SAFROLE,C=CCC1=CC2=C(C=C1)OCO2,94-59-7,Negative,In vivo
SAFROLE,C=CCC1=CC2=C(C=C1)OCO2,94-59-7,Positive,In vivo
Safrole,C=CCC1=CC2=C(C=C1)OCO2,94-59-7,Positive,in vitro
SALBUTAMOL,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,18559-94-9,Positive,In vivo
Salicylazosulfapyridine Sulfasalazine,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,599-79-1,Negative,in vitro
Salicylic Acid   ,C1=CC=C(C(=C1)C(=O)O)O,69-72-7,Positive,in vitro
SARCOPHYTOL A,CC1=CCCC(=CC=C(C(CC(=CCC1)C)O)C(C)C)C,72629-69-7,Negative,In vivo
Savey,CC1C(SC(=O)N1C(=O)NC2CCCCC2)C3=CC=C(C=C3)Cl,78587-05-0,Negative,In vivo
Sedaxane,FC(F)c4nn(C)cc4C(=O)Nc3ccccc3C2CC2C1CC1,874967-67-6,Negative,in vivo
Sedaxane,FC(F)c4nn(C)cc4C(=O)Nc3ccccc3C2CC2C1CC1,874967-67-6,Negative,in vitro
selanylidenenickel,[Ni]=[Se],62394,Positive,In Vivo
selenic acid,O[Se](=O)(=O)O,7783-08-06,Negative,in vitro
Selenious acid,O[Se](=O)O,7783-00-8,Negative,In vivo
Selenious acid,O[Se](=O)O,7783-00-8,Positive,in vitro
selenium,[Se],7782-49-2,Positive,in vitro
Selenium and Compounds,[Se],7782-49-2,Negative,In vivo
SELENIUM DIETHYLDITHIOCARBAMATE,CCN(CC)C(=S)S[Se]SC(=S)N(CC)CC,5456-28-0,Positive,In vivo
SELENIUM DIMETHYLDITHIOCARBAMATE,CN(C)C(=S)S[Se](SC(=S)N(C)C)(SC(=S)N(C)C)SC(=S)N(C)C,144-34-3,Negative,In vivo
selenium dioxide,O=[Se]=O,7446-08-04,Negative,in vitro
Selenium disulfide,S=[Se]=S,7488-56-4,Positive,in vivo
Selenium sulfide,S=[Se],24011,Negative,In Vivo
Selenium sulfide,S=[Se],24011,Positive,In Vivo
Selenium sulfide,S=[Se],7446-34-6,Negative,In vivo
Selenium sulphide,S=[Se],7446-34-6,Positive,in vitro
Selenourea,C(=N)(N)[Se],0630-10-4,Negative,In vivo
Semustine,CC1CCC(CC1)NC(=O)N(CCCl)N=O ,13909-09-6,Positive,in vitro
SENKIRKINE,CC=C1CC(C(C(=O)OCC2=CCN(CCC(C2=O)OC1=O)C)(C)O)C,2318-18-5,Positive,In vivo
Senkirkine,CC=C1CC(C(C(=O)OCC2=CCN(CCC(C2=O)OC1=O)C)(C)O)C,2318-18-5,Positive,in vitro
SERTRALINE.HCl,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl.Cl,79559-97-0,Negative,In vivo
SESAMOL,C1OC2=C(O1)C=C(C=C2)O,533-31-3,Positive,In vivo
Sethoxydim,CCCC(=NOCC)C1=C(CC(CC1=O)CC(C)SCC)O,74051-80-2,Negative,In vivo
silicon,[Si],5461123,Positive,In Vivo
Silver,[Ag],7440-22-4,Negative,In vivo
Silver cyanide,[C-]#N.[Ag+],506-64-9,Negative,In vivo
silver;(4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide,C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+],22199-08-02,Negative,in vitro
silver;nitrate,[N+](=O)([O-])[O-].[Ag+],7761-88-8,Negative,in vitro
SIMAZINE,CCNC1=NC(=NC(=N1)Cl)NCC,122-34-9,Negative,In vivo
Sintofen (aka cintofen),O=C(O)C2=NN(c1ccc(Cl)cc1)c3cccc(OCCOC)c3C2=O,130561-48-7,Negative,in vivo
Sintofen (aka cintofen),O=C(O)C2=NN(c1ccc(Cl)cc1)c3cccc(OCCOC)c3C2=O,130561-48-7,Negative,in vitro
Sodium 5-nitroguaiacolate,COC1=C(C=C(C=C1)[N+](=O)[O-])[O-].[Na+],67233-85-6,Negative,in vivo
Sodium 5-nitroguaiacolate,COC1=C(C=C(C=C1)[N+](=O)[O-])[O-].[Na+],67233-85-6,Negative,in vitro
Sodium arsenite,[O-][As]=O.[Na+],7784-46-5,Positive,in vitro
Sodium azide,[N-]=[N+]=[N-].[Na+],26628-22-8,Negative,In vivo
SODIUM BICARBONATE,C(=O)(O)[O-].[Na+],144-55-8,Negative,In vivo
SODIUM BITHIONOLATE,C1=C(C=C(C(=C1SC2=C(C(=CC(=C2)Cl)Cl)[O-])[O-])Cl)Cl.[Na+].[Na+],6385-58-6,Negative,In vivo
SODIUM CHLORIDE,[Na+].[Cl-],7647-14-5,Negative,In vivo
SODIUM CHLORITE,[O-]Cl=O.[Na+],7758-19-2,Negative,In vivo
Sodium chlorite,[O-]Cl=O.[Na+],7758-19-2,Positive,in vitro
Sodium cyanide,[C-]#N.[Na+],143-33-9,Negative,In vivo
Sodium dehydroacetate,CC1=CC(=O)[C-](C(=O)O1)C(=O)C.[Na+] ,4418-26-2,Negative,in vitro
Sodium dichromate,[O-][Cr](=O)(=O)O[Cr](=O)(=O)[O-].[Na+].[Na+] ,7789-12-0,Positive,in vitro
Sodium diclofenac,C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+],15307-79-6,Negative,in vitro
Sodium diethyldithiocarbamate,CCN(CC)C(=S)[S-].[Na+],148-18-5,Negative,In vivo
Sodium dimethyldithiocarbamate,CN(C)C(=S)[S-].[Na+],10588-01-9 ,Negative,in vitro
Sodium fluoride,[F-].[Na+],7681-49-4,Positive,in vitro
Sodium fluoroacetate,C(C(=O)[O-])F.[Na+],62-74-8,Negative,In vivo
Sodium hypochlorite,[O-]Cl.[Na+],7681-52-9,Negative,in vivo
Sodium hypochlorite,[O-]Cl.[Na+],7681-52-9,Negative,in vitro
Sodium Metabisulfite,[O-]S(=O)S(=O)(=O)[O-].[Na+].[Na+],7681-57-4,Negative,in vivo
Sodium Metabisulfite,[O-]S(=O)S(=O)(=O)[O-].[Na+].[Na+],656671,Negative,In Vivo
SODIUM METAPHOSPHATE,[O-]P(=O)=O.[Na+],10361-03-2,Negative,In vivo
Sodium o-nitrophenolate,C1=CC=C(C(=C1)[N+](=O)[O-])[O-].[Na+],824-39-5,Negative,in vivo
Sodium o-nitrophenolate,C1=CC=C(C(=C1)[N+](=O)[O-])[O-].[Na+],824-39-5,Negative,in vitro
Sodium p-nitrophenolate,C1=CC(=CC=C1[N+](=O)[O-])[O-].[Na+],824-78-2,Negative,in vivo
Sodium p-nitrophenolate,C1=CC(=CC=C1[N+](=O)[O-])[O-].[Na+],824-78-2,Negative,in vitro
Sodium silver thiosulfate,[O-]S(=O)(=S)[O-].[O-]S(=O)(=S)[O-].[Na+].[Na+].[Na+].[Ag+],16027-55-14,Negative,in vivo
sodium;(12-methylbenzo[a]anthracen-7-yl)methyl sulfate,CC1=C2C(=C(C3=CC=CC=C13)COS(=O)(=O)[O-])C=CC4=CC=CC=C42.[Na+],23688094,Negative,In Vivo
sodium;(12-methylbenzo[a]anthracen-7-yl)methyl sulfate,CC1=C2C(=C(C3=CC=CC=C13)COS(=O)(=O)[O-])C=CC4=CC=CC=C42.[Na+],23688094,Positive,In Vivo
sodium;(2-carboxylatophenyl)sulfanyl-ethylmercury,CC[Hg]SC1=CC=CC=C1C(=O)[O-].[Na+],54-64-8,Positive,in vitro
"sodium;(2R)-2-[(1R)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate",C([C@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O)O.[Na+],23683938,Negative,In Vivo
"sodium;(2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate",C([C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O)O.[Na+],23667548,Negative,In Vivo
"sodium;(2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate",C([C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O)O.[Na+],0134-03-02,Positive,in vitro
"sodium;(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(N-hydroxy-4-phenylanilino)oxane-2-carboxylate",C1=CC=C(C=C1)C2=CC=C(C=C2)N([C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)[O-])O)O)O)O.[Na+],,Positive,in vitro
sodium;(2S)-2-amino-4-hydroxy-4-oxobutanoate,C([C@@H](C(=O)[O-])N)C(=O)O.[Na+],23672344,Negative,In Vivo
sodium;(2S)-2-amino-5-hydroxy-5-oxopentanoate,C(CC(=O)O)[C@@H](C(=O)[O-])N.[Na+],142-47-2,Negative,in vivo
sodium;(2S)-2-amino-5-hydroxy-5-oxopentanoate,C(CC(=O)O)[C@@H](C(=O)[O-])N.[Na+],23672308,Negative,In Vivo
sodium;(4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide,C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Na+],547-32-0,Negative,in vitro
"sodium;(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)[O-].[Na+],,Negative,in vitro
"sodium;(E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate",CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+],23679527,Negative,In Vivo
"sodium;(E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate",CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+],23679527,Positive,In Vivo
sodium;(E)-3-bromo-4-(4-methoxyphenyl)-4-oxobut-2-enoate,COC1=CC=C(C=C1)C(=O)/C(=C\C(=O)[O-])/Br.[Na+],23665583,Negative,In Vivo
sodium;(E)-3-bromo-4-(4-methoxyphenyl)-4-oxobut-2-enoate,COC1=CC=C(C=C1)C(=O)/C(=C\C(=O)[O-])/Br.[Na+],21739-91-3,Positive,in vivo
sodium;(E)-3-bromo-4-(4-methoxyphenyl)-4-oxobut-2-enoate,COC1=CC=C(C=C1)C(=O)/C(=C\C(=O)[O-])/Br.[Na+],23665583,Positive,In Vivo
sodium;(E)-3-bromo-4-(4-methoxyphenyl)-4-oxobut-2-enoate,COC1=CC=C(C=C1)C(=O)/C(=C\C(=O)[O-])/Br.[Na+],21739-91-3,Positive,in vitro
sodium;(Z)-octadec-9-enoate,CCCCCCCC/C=C\CCCCCCCC(=O)[O-].[Na+],23665730,Negative,In Vivo
"sodium;[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-methylamino]methanesulfonate",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+],522325,Negative,In Vivo
"sodium;[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-methylamino]methanesulfonate;hydrate",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].O.[Na+],23674183,Positive,In Vivo
"sodium;[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-methylamino]methanesulfonate;hydrate",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].O.[Na+],23674183,Negative,In Vivo
"sodium;[(9S,13S,14S)-13-methyl-17-oxo-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-yl] sulfate",C[C@]12CC[C@H]3C(=CCC4=C3C=CC(=C4)OS(=O)(=O)[O-])[C@@H]1CCC2=O.[Na+],23676225,Positive,In Vivo
"sodium;1,1-dioxo-1,2-benzothiazol-2-id-3-one",C1=CC=C2C(=C1)C(=O)[N-]S2(=O)=O.[Na+],656582,Negative,In Vivo
"sodium;1,1-dioxo-1,2-benzothiazol-2-id-3-one",C1=CC=C2C(=C1)C(=O)[N-]S2(=O)=O.[Na+],128-44-9,Negative,in vivo
"sodium;1,1-dioxo-1,2-benzothiazol-2-id-3-one",C1=CC=C2C(=C1)C(=O)[N-]S2(=O)=O.[Na+],128-44-9,Positive,in vivo
"sodium;1,1-dioxo-1,2-benzothiazol-2-id-3-one",C1=CC=C2C(=C1)C(=O)[N-]S2(=O)=O.[Na+],128-44-9,Negative,in vitro
"sodium;1,3-diaza-5-azanidacyclohexane-2,4,6-trione",C1(=O)NC(=O)[N-]C(=O)N1.[Na+],2624-17-1,Negative,in vitro
"sodium;1,4-dihydroxy-9,10-dioxoanthracene-2-sulfonate",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3O)S(=O)(=O)[O-])O.[Na+],22297-70-7,Positive,in vitro
"sodium;2-(2,4-dichlorophenoxy)acetate",C1=CC(=C(C=C1Cl)Cl)OCC(=O)[O-].[Na+],2702-72-9,Negative,in vitro
sodium;2-[(2-hydroxynaphthalen-1-yl)diazenyl]naphthalene-1-sulfonate,C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C4=CC=CC=C4C=C3)S(=O)(=O)[O-])O.[Na+],135487615,Negative,In Vivo
sodium;2-[(2-hydroxynaphthalen-1-yl)diazenyl]naphthalene-1-sulfonate,C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C4=CC=CC=C4C=C3)S(=O)(=O)[O-])O.[Na+],1248-18-6,Negative,in vitro
"sodium;2-[nitroso-[(4R)-4-[(3R,5S,7R,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate",C[C@H](CCC(=O)N(CCS(=O)(=O)[O-])N=O)[C@H]1CCC2[C@@]1([C@H](CC3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C.[Na+],23694677,Positive,In Vivo
"sodium;2-anilino-5-(2,4-dinitroanilino)benzenesulfonate",C1=CC=C(C=C1)NC2=C(C=C(C=C2)NC3=C(C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-])S(=O)(=O)[O-].[Na+],5284435,Negative,In Vivo
"sodium;2-anilino-5-(2,4-dinitroanilino)benzenesulfonate",C1=CC=C(C=C1)NC2=C(C=C(C=C2)NC3=C(C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-])S(=O)(=O)[O-].[Na+],5284435,Positive,In Vivo
sodium;2-benzamidoacetate,C1=CC=C(C=C1)C(=O)NCC(=O)[O-].[Na+],532-94-5,Negative,in vitro
sodium;2-ethylhexyl sulfate,CCCCC(CC)COS(=O)(=O)[O-].[Na+],23662383,Negative,In Vivo
sodium;2-ethylhexyl sulfate,CCCCC(CC)COS(=O)(=O)[O-].[Na+],23662383,Positive,In Vivo
sodium;2-phenylphenolate,C1=CC=C(C=C1)C2=CC=CC=C2[O-].[Na+],23675735,Negative,In Vivo
sodium;2-phenylphenolate,C1=CC=C(C=C1)C2=CC=CC=C2[O-].[Na+],23675735,Positive,In Vivo
"sodium;2,2-dichloropropanoate",CC(C(=O)[O-])(Cl)Cl.[Na+],127-20-8,Negative,in vitro
"sodium;2,3,4,5,6-pentachlorophenolate",C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)[O-].[Na+],131-52-2,Positive,in vitro
"sodium;2,6-bis[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoate",COC1=CC(=NC(=N1)OC2=C(C(=CC=C2)OC3=NC(=CC(=N3)OC)OC)C(=O)[O-])OC.[Na+],23682789,Negative,In Vivo
"sodium;3-[[4-[(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methyl]-N-ethylanilino]methyl]benzenesulfonate",CCN(CC1=CC(=CC=C1)S(=O)(=O)O)C2=CC=C(C=C2)C(=C3C=CC(=[N+](C)C)C=C3)C4=CC=C(C=C4)N(CC)CC5=CC(=CC=C5)S(=O)(=O)[O-].[Na+],23691992,Negative,In Vivo
"sodium;3-[[4-[(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methyl]-N-ethylanilino]methyl]benzenesulfonate",CCN(CC1=CC(=CC=C1)S(=O)(=O)O)C2=CC=C(C=C2)C(=C3C=CC(=[N+](C)C)C=C3)C4=CC=C(C=C4)N(CC)CC5=CC(=CC=C5)S(=O)(=O)[O-].[Na+],1694-09-03,Positive,in vivo
"sodium;3-[[4-[(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methyl]-N-ethylanilino]methyl]benzenesulfonate",CCN(CC1=CC(=CC=C1)S(=O)(=O)O)C2=CC=C(C=C2)C(=C3C=CC(=[N+](C)C)C=C3)C4=CC=C(C=C4)N(CC)CC5=CC(=CC=C5)S(=O)(=O)[O-].[Na+],23691992,Positive,In Vivo
"sodium;3-[[4-[(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methyl]-N-ethylanilino]methyl]benzenesulfonate",CCN(CC1=CC(=CC=C1)S(=O)(=O)O)C2=CC=C(C=C2)C(=C3C=CC(=[N+](C)C)C=C3)C4=CC=C(C=C4)N(CC)CC5=CC(=CC=C5)S(=O)(=O)[O-].[Na+],1694-09-03,Negative,in vitro
"sodium;3-acetyl-6-methylpyran-3-ide-2,4-dione",CC1=CC(=O)[C-](C(=O)O1)C(=O)C.[Na+],,Negative,in vitro
"sodium;3,4-dimethylbenzenesulfonate",CC1=C(C=C(C=C1)S(=O)(=O)[O-])C.[Na+],23668192,Negative,In Vivo
"sodium;3,4,5-trihydroxybenzoate",C1=C(C=C(C(=C1O)O)O)C(=O)[O-].[Na+],2053-21-6,Positive,in vitro
"sodium;4-(2,4-dichlorophenoxy)butanoate",C1=CC(=C(C=C1Cl)Cl)OCCCC(=O)[O-].[Na+],10433-59-7,Negative,in vitro
sodium;4-(7-oxobenzo[a]phenalen-3-yl)oxybenzenesulfonate,C1=CC=C2C(=C1)C3=C4C(=C(C=C3)OC5=CC=C(C=C5)S(=O)(=O)[O-])C=CC=C4C2=O.[Na+],,Positive,in vitro
sodium;4-[(2-hydroxynaphthalen-1-yl)diazenyl]benzenesulfonate,C1=CC=C2C(=C1)C=CC(=C2N=NC3=CC=C(C=C3)S(=O)(=O)[O-])O.[Na+],135442941,Negative,In Vivo
"sodium;4-[(2,4-diamino-5-methylphenyl)diazenyl]benzenesulfonate",CC1=CC(=C(C=C1N)N)N=NC2=CC=C(C=C2)S(=O)(=O)[O-].[Na+],,Positive,in vitro
"sodium;4-[(2,4-diaminophenyl)diazenyl]benzenesulfonate",C1=CC(=CC=C1N=NC2=C(C=C(C=C2)N)N)S(=O)(=O)[O-].[Na+],10190-66-6,Positive,in vitro
sodium;4-[(4-hydroxynaphthalen-1-yl)diazenyl]benzenesulfonate,C1=CC=C2C(=C1)C(=CC=C2O)N=NC3=CC=C(C=C3)S(=O)(=O)[O-].[Na+],523-44-4,Negative,in vitro
"sodium;4-[[4-(diethylamino)phenyl]-(4-diethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]benzene-1,3-disulfonate",CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=C(C=C(C=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+],8507,Positive,In Vivo
"sodium;4-[[4-(diethylamino)phenyl]-(4-diethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]benzene-1,3-disulfonate",CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=C(C=C(C=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+],129-17-9,Positive,in vitro
"sodium;4-[[4-(dimethylamino)phenyl]-(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]-3-hydroxynaphthalene-2,7-disulfonate",CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=C4C=CC(=CC4=CC(=C3O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+],91525,Negative,In Vivo
"sodium;4-[[4-(dimethylamino)phenyl]-(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]-3-hydroxynaphthalene-2,7-disulfonate",CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=C4C=CC(=CC4=CC(=C3O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+],3087-16-9,Negative,in vitro
sodium;4-[[4-(dimethylamino)phenyl]diazenyl]benzenesulfonate,CN(C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)S(=O)(=O)[O-].[Na+],547-58-0,Negative,in vivo
sodium;4-[[4-(dimethylamino)phenyl]diazenyl]benzenesulfonate,CN(C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)S(=O)(=O)[O-].[Na+],547-58-0,Negative,in vitro
"sodium;4-[3-(diethylamino)-6-diethylazaniumylidenexanthen-9-yl]benzene-1,3-disulfonate",CCN(CC)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](CC)CC)C=C3O2)C4=C(C=C(C=C4)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+],9916275,Negative,In Vivo
sodium;4-[4-[bis(2-chloroethyl)amino]phenyl]butanoate,C1=CC(=CC=C1CCCC(=O)[O-])N(CCCl)CCCl.[Na+],1030-06-04,Positive,in vitro
sodium;5-benzo[e]benzotriazol-2-yl-2-[(E)-2-phenylethenyl]benzenesulfonate,C1=CC=C(C=C1)/C=C/C2=C(C=C(C=C2)N3N=C4C=CC5=CC=CC=C5C4=N3)S(=O)(=O)[O-].[Na+],6416-68-8,Negative,in vivo
"sodium;5-ethyl-4,6-dioxo-5-phenyl-1H-pyrimidin-2-olate",CCC1(C(=O)NC(=NC1=O)[O-])C2=CC=CC=C2.[Na+],23674889,Negative,In Vivo
"sodium;5-ethyl-4,6-dioxo-5-phenyl-1H-pyrimidin-2-olate",CCC1(C(=O)NC(=NC1=O)[O-])C2=CC=CC=C2.[Na+],57-30-7,Negative,in vivo
"sodium;5-ethyl-4,6-dioxo-5-phenyl-1H-pyrimidin-2-olate",CCC1(C(=O)NC(=NC1=O)[O-])C2=CC=CC=C2.[Na+],23674889,Positive,In Vivo
"sodium;5-ethyl-4,6-dioxo-5-phenyl-1H-pyrimidin-2-olate",CCC1(C(=O)NC(=NC1=O)[O-])C2=CC=CC=C2.[Na+],57-30-7,Negative,in vitro
"sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione",C1=CC=C(C=C1)C2(C(=O)[N-]C(=O)N2)C3=CC=CC=C3.[Na+],630-93-3,Positive,in vitro
sodium;6-hydroxy-5-phenyldiazenylnaphthalene-2-sulfonate,C1=CC=C(C=C1)N=NC2=C(C=CC3=C2C=CC(=C3)S(=O)(=O)[O-])O.[Na+],1934-20-9,Negative,in vitro
sodium;acetate,CC(=O)[O-].[Na+],13291-89-9,Negative,in vitro
sodium;azide,[N-]=[N+]=[N-].[Na+],26628-22-8,Negative,in vivo
sodium;azide,[N-]=[N+]=[N-].[Na+],33557,Negative,In Vivo
sodium;azide,[N-]=[N+]=[N-].[Na+],26628-22-8,Negative,in vitro
sodium;benzoate,C1=CC=C(C=C1)C(=O)[O-].[Na+],532-32-1,Negative,in vitro
sodium;chlorate,[O-]Cl(=O)=O.[Na+],516902,Negative,In Vivo
sodium;chlorate,[O-]Cl(=O)=O.[Na+],516902,Positive,In Vivo
sodium;chloride,[Na+].[Cl-],7647-14-5,Negative,in vivo
sodium;chloride,[Na+].[Cl-],7647-14-5,Negative,in vitro
sodium;chlorite,[O-]Cl=O.[Na+],23668197,Negative,In Vivo
sodium;diethyl 2-[(oxidoamino)-phenylmethylidene]propanedioate,CCOC(=O)C(=C(C1=CC=CC=C1)N[O-])C(=O)OCC.[Na+],23667633,Negative,In Vivo
sodium;diethyl 2-[(oxidoamino)-phenylmethylidene]propanedioate,CCOC(=O)C(=C(C1=CC=CC=C1)N[O-])C(=O)OCC.[Na+],23667633,Positive,In Vivo
sodium;ethyl-(4-sulfinatooxyphenyl)sulfanylmercury,CC[Hg]SC1=CC=C(C=C1)OS(=O)[O-].[Na+],5964-24-9,Positive,in vitro
sodium;fluoride,[F-].[Na+],5235,Negative,In Vivo
sodium;fluoride,[F-].[Na+],7681-49-4,Negative,in vivo
sodium;fluoride,[F-].[Na+],7681-49-4,Negative,in vitro
sodium;hydrogen selenite,O[Se](=O)[O-].[Na+],7782-82-3,Positive,in vitro
sodium;hydrogen sulfite,OS(=O)[O-].[Na+],7631-90-5,Negative,in vivo
sodium;hydrogen sulfite,OS(=O)[O-].[Na+],7631-90-5,Negative,in vitro
sodium;hydroxide,[OH-].[Na+],1310-73-2,Negative,in vitro
sodium;hydroxy(methyl)arsinate,C[As](=O)(O)[O-].[Na+],2163-80-6,Negative,in vitro
sodium;hypochlorite,[O-]Cl.[Na+],23665760,Negative,In Vivo
sodium;hypochlorite,[O-]Cl.[Na+],23665760,Positive,In Vivo
sodium;hypochlorite,[O-]Cl.[Na+],7681-52-9,Positive,in vitro
sodium;N-[4-(dimethylamino)phenyl]iminosulfamate,CN(C)C1=CC=C(C=C1)N=NS(=O)(=O)[O-].[Na+],23668198,Negative,In Vivo
sodium;N-[4-(dimethylamino)phenyl]iminosulfamate,CN(C)C1=CC=C(C=C1)N=NS(=O)(=O)[O-].[Na+],140-56-7,Negative,in vivo
sodium;N-[4-(dimethylamino)phenyl]iminosulfamate,CN(C)C1=CC=C(C=C1)N=NS(=O)(=O)[O-].[Na+],140-56-7,Positive,in vitro
sodium;N-cyclohexylsulfamate,C1CCC(CC1)NS(=O)(=O)[O-].[Na+],23665706,Negative,In Vivo
sodium;N-cyclohexylsulfamate,C1CCC(CC1)NS(=O)(=O)[O-].[Na+],0139-05-09,Negative,in vivo
sodium;N-cyclohexylsulfamate,C1CCC(CC1)NS(=O)(=O)[O-].[Na+],0139-05-09,Negative,in vitro
"sodium;N,N-diethylcarbamodithioate",CCN(CC)C(=S)[S-].[Na+],533728,Negative,In Vivo
"sodium;N,N-diethylcarbamodithioate",CCN(CC)C(=S)[S-].[Na+],148-18-5,Negative,in vivo
sodium;nitrate,[N+](=O)([O-])[O-].[Na+],24268,Negative,In Vivo
sodium;nitrate,[N+](=O)([O-])[O-].[Na+],7631-99-4,Positive,in vitro
sodium;nitrite,N(=O)[O-].[Na+],23668193,Negative,In Vivo
sodium;nitrite,N(=O)[O-].[Na+],7632-00-0,Negative,in vivo
sodium;nitrite,N(=O)[O-].[Na+],7632-00-0,Negative,in vitro
sodium;oxidooxy(oxo)borane,B(=O)O[O-].[Na+],7632-04-04,Positive,in vitro
sodium;oxoarsinite,[O-][As]=O.[Na+],443495,Negative,In Vivo
sodium;oxoarsinite,[O-][As]=O.[Na+],443495,Positive,In Vivo
sodium;oxoarsinite,[O-][As]=O.[Na+],7784-46-5,Positive,in vitro
sodium;propanedial,[CH-](C=O)C=O.[Na+],23712862,Negative,In Vivo
sodium;propanedial,[CH-](C=O)C=O.[Na+],23712862,Positive,In Vivo
sodium;thiocyanate,C(#N)[S-].[Na+],516871,Negative,In Vivo
SORBIC ACID,CC=CC=CC(=O)O,110-44-1,Negative,In vivo
SOTALOL.HCl,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.Cl,959-24-0,Negative,In vivo
SOYBEAN LECITHIN,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCC=CCCCCC,8002-43-5,Negative,In vivo
Spinetoram,CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@@H]3[C@H](C2CC(=O)O1)CC[C@H]4[C@H]3CC(C4)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OCC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C,935545-74-7,Negative,in vivo
Spinetoram,CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@@H]3[C@H](C2CC(=O)O1)CC[C@H]4[C@H]3CC(C4)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OCC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C,935545-74-7,Negative,in vitro
Spirodiclofen,O=C2OC1(C(OC(C(CC)(C)C)=O)=C2C3=CC(Cl)=CC(Cl)=C3)CCCCC1,148477-71-8,Negative,in vivo
Spirodiclofen,O=C2OC1(C(OC(C(CC)(C)C)=O)=C2C3=CC(Cl)=CC(Cl)=C3)CCCCC1,148477-71-8,Negative,in vitro
Spiromesifen,O=C(CC(C)(C)C)OC1=C(C3=C(C)C=C(C)C=C3C)C(OC21CCCC2)=O,283594-90-1,Negative,in vivo
Spiromesifen,O=C(CC(C)(C)C)OC1=C(C3=C(C)C=C(C)C=C3C)C(OC21CCCC2)=O,283594-90-1,Negative,in vitro
Spirotetramat,CCOC(=O)OC1=C(C(=O)NC12CCC(CC2)OC)C3=C(C=CC(=C3)C)C,203313-25-1,Negative,in vivo
Spirotetramat,CCOC(=O)OC1=C(C(=O)NC12CCC(CC2)OC)C3=C(C=CC(=C3)C)C,203313-25-1,Negative,in vitro
Spiroxamine,CCCN(CC)CC1COC2(O1)CCC(CC2)C(C)(C)C,118134-30-8,Negative,in vivo
Spiroxamine,CCCN(CC)CC1COC2(O1)CCC(CC2)C(C)(C)C,118134-30-8,Negative,in vitro
Stannous chloride,Cl[Sn]Cl,7772-99-8,Positive,in vitro
STERIGMATOCYSTIN,COC1=C2C(=C3C4C=COC4OC3=C1)OC5=CC=CC(=C5C2=O)O,10048-13-2,Positive,In vivo
Sterigmatocystin,COC1=C2C(=C3C4C=COC4OC3=C1)OC5=CC=CC(=C5C2=O)O,10048-13-2,Positive,in vitro
STEVIOSIDE,CC12CCCC(C1CCC34C2CCC(C3)(C(=C)C4)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)(C)C(=O)OC7C(C(C(C(O7)CO)O)O)O,57817-89-7,Negative,In vivo
stibanylidynenickel,[Ni]#[Sb],61553,Positive,In Vivo
STREPTOZOTOCIN,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,18883-66-4,Positive,In vivo
Streptozotocin,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,18883-66-4,Positive,in vitro
STROBANE,CC1(C(=C)C2(C(C1(C(C2(Cl)Cl)(Cl)Cl)Cl)Cl)Cl)C,8001-50-1,Positive,In vivo
Strontium,[Sr],7440-24-6,Negative,In vivo
strontium;dichloride,[Cl-].[Cl-].[Sr+2],,Negative,in vitro
strontium;dioxido(dioxo)chromium,[O-][Cr](=O)(=O)[O-].[Sr+2],7789-06-02,Positive,in vivo
strontium;dioxido(dioxo)chromium,[O-][Cr](=O)(=O)[O-].[Sr+2],24599,Positive,In Vivo
strontium;dioxido(dioxo)chromium,[O-][Cr](=O)(=O)[O-].[Sr+2],7789-06-02,Positive,in vitro
Strychnine,C1CN2CC3=CCOC4CC(=O)N5C6C4C3CC2C61C7=CC=CC=C75,57-24-9,Negative,In vivo
styrene,C=CC1=CC=CC=C1,7501,Negative,In Vivo
styrene,C=CC1=CC=CC=C1,7501,Positive,In Vivo
STYRENE,C=CC1=CC=CC=C1,100-42-5,Positive,In vivo
Styrene,C=CC1=CC=CC=C1,100-42-5,Negative,In vivo
styrene,C=CC1=CC=CC=C1,100-42-5,Negative,in vitro
STYRENE OXIDE,C1C(O1)C2=CC=CC=C2,96-09-3,Positive,In vivo
Styrene oxide / Epoxyethyl Benzene,C1C(O1)C2=CC=CC=C2,96-09-3,Positive,in vitro
SUCRALOSE,C(C1C(C(C(C(O1)OC2(C(C(C(O2)CCl)O)O)CCl)O)O)Cl)O,56038-13-2,Negative,In vivo
SUCROSE,C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)CO)O)O)O)O,57-50-1,Negative,In vivo
SUCROSE ACETATE ISOBUTYRATE,CC(C)C(=O)OCC1C(C(C(O1)(COC(=O)C)OC2C(C(C(C(O2)COC(=O)C)OC(=O)C(C)C)OC(=O)C(C)C)OC(=O)C(C)C)OC(=O)C(C)C)OC(=O)C(C)C,126-13-6,Negative,In vivo
Sulcotrione,O=C2CCCC(=O)C2C(=O)c1ccc(cc1Cl)S(C)(=O)=O,99105-77-8,Negative,in vivo
Sulcotrione,O=C2CCCC(=O)C2C(=O)c1ccc(cc1Cl)S(C)(=O)=O,99105-77-8,Positive,in vivo
Sulcotrione,O=C2CCCC(=O)C2C(=O)c1ccc(cc1Cl)S(C)(=O)=O,99105-77-8,Negative,in vitro
Sulfallate,CCN(CC)C(=S)SCC(=C)Cl,95-06-7,Positive,in vitro
SULFAMETHAZINE,CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C,57-68-1,Positive,In vivo
sulfanylidenecadmium,S=[Cd],14783,Negative,In Vivo
sulfanylidenecadmium,S=[Cd],1306-23-6,Positive,in vivo
sulfanylidenecadmium,S=[Cd],14783,Positive,In Vivo
sulfanylidenecadmium,S=[Cd],1306-23-6,Positive,in vitro
sulfanylidenenickel,S=[Ni],28094,Positive,In Vivo
Sulfisoxazole,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,127-69-5,Negative,in vitro
"SULFITE, POTASSIUM METABI-",OS(=O)[O-].[K+],4429-42-9,Negative,In vivo
Sulfosulfuron,CCS(=O)(=O)C1=C(N2C=CC=CC2=N1)S(=O)(=O)NC(=O)NC3=NC(=CC(=N3)OC)OC,141776-32-1,Negative,in vivo
Sulfosulfuron,CCS(=O)(=O)C1=C(N2C=CC=CC2=N1)S(=O)(=O)NC(=O)NC3=NC(=CC(=N3)OC)OC,141776-32-1,Negative,in vitro
Sulfoxaflor,CC(C1=CN=C(C=C1)C(F)(F)F)S(=NC#N)(=O)C,946578-00-3,Negative,in vivo
Sulfoxaflor,CC(C1=CN=C(C=C1)C(F)(F)F)S(=NC#N)(=O)C,946578-00-3,Negative,in vitro
sulfur dioxide,O=S=O,7446-09-05,Positive,in vitro
Sulfur mustard,C(CCl)SCCCl,505-60-2,Positive,in vitro
Sulfuryl fluoride,O=S(=O)(F)F,2699-79-8,Negative,in vivo
Sulfuryl fluoride,O=S(=O)(F)F,2699-79-8,Negative,in vitro
SULINDAC SULFONE,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)(=O)C)C=CC(=C2)F)CC(=O)O,59973-80-7,Negative,In vivo
SUXIBUZONE,CCCCC1(C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)COC(=O)CCC(=O)O,27470-51-5,Negative,In vivo
SX PURPLE,C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C(C=CC4=CC(=CC(=C43)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+].[Na+],2611-82-7,Negative,In vivo
SX PURPLE,C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C(C=CC4=CC(=CC(=C43)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+].[Na+],2611-82-7,Positive,In vivo
SYMPHYTINE,CC=C(C)C(=O)OC1CCN2C1C(=CC2)COC(=O)C(C(C)C)(C(C)O)O,22571-95-5,Positive,In vivo
Systhane,CCCCC(CN1C=NC=N1)(C#N)C2=CC=C(C=C2)Cl,88671-89-0,Negative,In vivo
T-2 TOXIN,CC1=CC2C(CC1OC(=O)CC(C)C)(C3(C(C(C(C34CO4)O2)O)OC(=O)C)C)COC(=O)C,21259-20-1,Positive,In vivo
TACE,COC1=CC=C(C=C1)C(=C(C2=CC=C(C=C2)OC)Cl)C3=CC=C(C=C3)OC,569-57-3,Negative,In vivo
Tafethion,CCOP(=S)(OCC)SCSP(=S)(OCC)OCC,563-12-2,Positive,in vitro
TALTIRELIN TETRAHYDRATE,CN1C(=O)CC(NC1=O)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)N.O.O.O.O,---,Negative,In vivo
TAMOXIFEN CITRATE,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,54965-24-1,Negative,In vivo
TAMOXIFEN CITRATE,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,54965-24-1,Positive,In vivo
"TANNIC ACIDS, PHARMACEUTICAL GRADE (85.69% TANNIC ACIDS, 8.84% GALLIC ACIDS)",C1=C(C=C(C(=C1O)O)O)C(=O)OC2=CC(=CC(=C2O)O)C(=O)OCC3C(C(C(C(O3)OC(=O)C4=CC(=C(C(=C4)OC(=O)C5=CC(=C(C(=C5)O)O)O)O)O)OC(=O)C6=CC(=C(C(=C6)OC(=O)C7=CC(=C(C(=C7)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8)OC(=O)C9=CC(=C(C(=C9)O)O)O)O)O)OC(=O)C1=CC(=C(C(=C1)OC(=O)C1=CC(=C(C(=C1)O)O)O)O)O,1401-55-4,Negative,In vivo
tantalum,[Ta],23956,Negative,In Vivo
Tau-fluvalinate,CC(C)[C@H](C(=O)OC(C#N)C1=CC(=CC=C1)OC2=CC=CC=C2)NC3=C(C=C(C=C3)C(F)(F)F)Cl,102851-06-9,Negative,in vivo
Tau-fluvalinate,CC(C)[C@H](C(=O)OC(C#N)C1=CC(=CC=C1)OC2=CC=CC=C2)NC3=C(C=C(C=C3)C(F)(F)F)Cl,102851-06-9,Negative,in vitro
TAURINE,C(CS(=O)(=O)O)N,107-35-7,Negative,In vivo
Tebuconazole,OC(C(C)(C)C)(CN2N=CN=C2)CCC1=CC=C(Cl)C=C1,107534-96-3,Negative,in vivo
Tebuconazole,OC(C(C)(C)C)(CN2N=CN=C2)CCC1=CC=C(Cl)C=C1,107534-96-3,Negative,in vitro
Tebufenozide,O=C(N(C(C)(C)C)NC(C2=CC=C(CC)C=C2)=O)C1=CC(C)=CC(C)=C1,112410-23-8,Negative,in vivo
Tebufenozide,O=C(N(C(C)(C)C)NC(C2=CC=C(CC)C=C2)=O)C1=CC(C)=CC(C)=C1,112410-23-8,Negative,in vitro
Tebufenpyrad,O=C(NCC2=CC=C(C(C)(C)C)C=C2)C1=C(Cl)C(CC)=NN1C,119168-77-3,Negative,in vivo
Tebufenpyrad,O=C(NCC2=CC=C(C(C)(C)C)C=C2)C1=C(Cl)C(CC)=NN1C,119168-77-3,Negative,in vitro
Tebuthiuron,CC(C)(C)C1=NN=C(S1)N(C)C(=O)NC,34014-18-1,Negative,In vivo
Teflubenzuron,O=C(NC(NC2=C(F)C(Cl)=C(F)C(Cl)=C2)=O)C1=C(F)C=CC=C1F,83121-18-0,Negative,in vivo
Teflubenzuron,O=C(NC(NC2=C(F)C(Cl)=C(F)C(Cl)=C2)=O)C1=C(F)C=CC=C1F,83121-18-0,Negative,in vitro
Tefluthrin,O=C(OCC2=C(F)C(F)=C(C)C(F)=C2F)C1C(C)(C)C1/C=C(Cl)/C(F)(F)F,79538-32-2,Negative,in vivo
Tefluthrin,O=C(OCC2=C(F)C(F)=C(C)C(F)=C2F)C1C(C)(C)C1/C=C(Cl)/C(F)(F)F,79538-32-2,Negative,in vitro
TEGAFUR,C1CC(OC1)N2C=C(C(=O)NC2=O)F,37076-68-9,Negative,In vivo
tellanylidenenickel,[Ni]=[Te],62780,Positive,In Vivo
Tellurium tetrachloride,Cl[Te](Cl)(Cl)Cl,10026-07-0,Positive,in vitro
TELODRIN,C12C(C(OC1Cl)Cl)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl,297-78-9,Negative,In vivo
"TELONE II, TECHNICAL GRADE (WITHOUT EPICHLOROHYDRIN)",C(C=CCl)Cl,542-75-6,Negative,In vivo
"TELONE II, TECHNICAL GRADE (WITHOUT EPICHLOROHYDRIN)",C(C=CCl)Cl,542-75-6,Positive,In vivo
"TEMAZEPAM, PHARMACEUTICAL GRADE",CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,846-50-4,Negative,In vivo
Tembotrione,CS(=O)(=O)C1=C(C(=C(C=C1)C(=O)C2C(=O)CCCC2=O)Cl)COCC(F)(F)F,335104-84-2,Negative,in vivo
Tembotrione,CS(=O)(=O)C1=C(C(=C(C=C1)C(=O)C2C(=O)CCCC2=O)Cl)COCC(F)(F)F,335104-84-2,Negative,in vitro
Temposil,CNC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.[Ca],8013-88-5,Negative,in vitro
Terbacil,CC1=C(C(=O)N(C(=O)N1)C(C)(C)C)Cl,5902-51-2,Negative,In vivo
TERBUTALINE,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,23031-25-6,Positive,In vivo
Terbuthylazine,CCNC1=NC(=NC(=N1)Cl)NC(C)(C)C,5915-41-3,Negative,in vivo
Terbuthylazine,CCNC1=NC(=NC(=N1)Cl)NC(C)(C)C,5915-41-3,Negative,in vitro
Terbutryn,CCNC1=NC(=NC(=N1)SC)NC(C)(C)C,886-50-0,Negative,In vivo
terephthalic acid,C1=CC(=CC=C1C(=O)O)C(=O)O,100-21-0,Negative,in vitro
"tert-butyl 4-[[(E)-(1,3-dimethyl-5-phenoxypyrazol-4-yl)methylideneamino]oxymethyl]benzoate",CC1=NN(C(=C1/C=N/OCC2=CC=C(C=C2)C(=O)OC(C)(C)C)OC3=CC=CC=C3)C,9576412,Negative,In Vivo
tert-Butyl alcohol,CC(C)(C)O,75-65-0,Negative,in vitro
tert-Butyl Alcohol (tBA),CC(C)(C)O,75-65-0,Positive,In vivo
tert-butyl-[2-hydroxy-3-(2-methyl-1-oxoisoquinolin-4-yl)oxypropyl]azanium;chloride,CC(C)(C)[NH2+]CC(COC1=CN(C(=O)C2=CC=CC=C21)C)O.[Cl-],44155,Negative,In Vivo
tert-butylperoxymethanol,CC(C)(C)OOCO,17742-78-8,Positive,in vitro
tert-butylsulfanylmethylsulfanyl-diethoxy-sulfanylidene-lambda5-phosphane,CCOP(=S)(OCC)SCSC(C)(C)C,13071-79-9,Positive,in vitro
"Tertbuthylazine N-tert-butyl-6-chloro-N'-ethyl-1,3,5-triazine-2,4-diamine",CCNC1=NC(=NC(=N1)Cl)NC(C)(C)C,5915-41-3,Negative,in vitro
Tertiary-butylhydroquinone,CC(C)(C)C1=C(C=CC(=C1)O)O,1948-33-0,Positive,in vitro
Tetrabromodiphenyl ether,C1=CC(=CC(=C1)Br)OC2=C(C(=C(C=C2)Br)Br)Br,40088-47-9,Negative,In vivo
Tetrabromodiphenyl ether (BDE-47),C1=CC(=C(C=C1Br)Br)OC2=C(C=C(C=C2)Br)Br,5436-43-1,Negative,In vivo
Tetrachlorobenzene,C1=C(C(=CC(=C1Cl)Cl)Cl)Cl,95-94-3,Negative,In vivo
Tetrachlorocyclopentadiene,C1C(=C(C(=C1Cl)Cl)Cl)Cl,695-77-2,Negative,In vivo
Tetrachlorodibenzo-p-dioxin,C1=C2C(=CC(=C1Cl)Cl)OC3=CC(=C(C=C3O2)Cl)Cl,1746-01-06,Negative,In vivo
TETRACHLOROETHYLENE,C(=C(Cl)Cl)(Cl)Cl,127-18-4,Positive,In vivo
Tetrachloroethylene (Perchloroethylene),C(=C(Cl)Cl)(Cl)Cl,127-18-4,Positive,In vivo
tetrachlorogermane,Cl[Ge](Cl)(Cl)Cl,10038-98-9,Positive,in vitro
tetrachloromethane,C(Cl)(Cl)(Cl)Cl,5943,Negative,In Vivo
tetrachloromethane,C(Cl)(Cl)(Cl)Cl,56-23-5,Negative,in vivo
tetrachloromethane,C(Cl)(Cl)(Cl)Cl,5943,Positive,In Vivo
tetrachloromethane,C(Cl)(Cl)(Cl)Cl,56-23-5,Positive,in vivo
tetrachloromethane,C(Cl)(Cl)(Cl)Cl,56-23-5,Negative,in vitro
Tetrachlorophenol,C1=C(C(=C(C(=C1Cl)Cl)Cl)O)Cl,58-90-2,Negative,In vivo
tetrachloroplatinum,Cl[Pt](Cl)(Cl)Cl,13454-96-1,Positive,in vitro
tetrachlorostannane,Cl[Sn](Cl)(Cl)Cl,7646-78-8,Negative,in vitro
tetrachlorothorium,Cl[Th](Cl)(Cl)Cl,10026-08-01,Negative,in vitro
Tetrachlorovinphos,COP(=O)(OC)OC(=CCl)C1=CC(=C(C=C1Cl)Cl)Cl,0961-11-5,Negative,In vivo
Tetrachlorvinphos,COP(=O)(OC)OC(=CCl)C1=CC(=C(C=C1Cl)Cl)Cl,961-11-5,Positive,in vitro
Tetraconazole,C1=CC(=C(C=C1Cl)Cl)C(CN2C=NC=N2)COC(C(F)F)(F)F,112281-77-3,Negative,in vivo
Tetraconazole,C1=CC(=C(C=C1Cl)Cl)C(CN2C=NC=N2)COC(C(F)F)(F)F,112281-77-3,Negative,in vitro
Tetraethyl lead,CC[Pb](CC)(CC)CC,78-00-2,Negative,In vivo
Tetraethyldithiopyrophosphate,CCOP(=S)(OCC)OP(=S)(OCC)OCC,3689-24-5,Negative,In vivo
tetraethylplumbane,CC[Pb](CC)(CC)CC,6511,Negative,In Vivo
tetraethylplumbane,CC[Pb](CC)(CC)CC,6511,Positive,In Vivo
tetraethylplumbane,CC[Pb](CC)(CC)CC,78-00-2,Positive,in vitro
TETRAETHYLTHIURAM DISULFIDE,CCN(CC)C(=S)SSC(=S)N(CC)CC,97-77-8,Negative,In vivo
TETRAFLUORO-m-PHENYLENEDIAMINE.2HCl,C1(=C(C(=C(C(=C1F)F)F)N)F)N.Cl.Cl,63886-77-1,Negative,In vivo
TETRAFLUORO-m-PHENYLENEDIAMINE.2HCl,C1(=C(C(=C(C(=C1F)F)F)N)F)N.Cl.Cl,63886-77-1,Positive,In vivo
Tetrafluoroethane,C(C(F)(F)F)F,811-97-2,Negative,In vivo
"TETRAHYDRO-2-NITROSO-2H-1,2-OXAZINE",C1CCON(C1)N=O,40548-68-3,Positive,In vivo
Tetrahydro-6-nitroquinoxaline  COLIPA B104,C1CNC2=C(N1)C=CC(=C2)[N+](=O)[O-],41959-35-7,Positive,in vitro
Tetrahydrofuran,C1CCOC1,109-99-9,Negative,In vivo
Tetrahydrofuran,C1CCOC1,109-99-9,Negative,in vitro
tetrakis(hydroxymethyl)phosphanium;chloride,C(O)[P+](CO)(CO)CO.[Cl-],31298,Negative,In Vivo
tetrakis(hydroxymethyl)phosphanium;sulfate,C(O)[P+](CO)(CO)CO.C(O)[P+](CO)(CO)CO.[O-]S(=O)(=O)[O-],41478,Negative,In Vivo
Tetrakishydroxymethylphosphonium chloride/Tetrakishydroxymethylphosphonium sulfate,C(O)[P+](CO)(CO)CO.[Cl-],124-64-1,Positive,in vitro
TETRAMETHYLTHIURAM DISULFIDE,CN(C)C(=S)SSC(=S)N(C)C,137-26-8,Negative,In vivo
TETRAMETHYLTHIURAM MONOSULFIDE,CN(C)C(=S)SC(=S)N(C)C,97-74-5,Negative,In vivo
Tetramethylthiuram monosulfide,CN(C)C(=S)SC(=S)N(C)C,97-74-5,Positive,in vitro
tetranitromethane,C([N+](=O)[O-])([N+](=O)[O-])([N+](=O)[O-])[N+](=O)[O-],10509,Positive,In Vivo
Tetranitromethane,C([N+](=O)[O-])([N+](=O)[O-])([N+](=O)[O-])[N+](=O)[O-],509-14-8,Positive,in vitro
tetraoxoosmium,O=[Os](=O)(=O)=O,20816-12-0,Positive,in vitro
tetrapotassium;iron(6+);hexacyanide,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[K+].[K+].[K+].[K+].[Fe+6],,Negative,in vitro
"tetrasodium;(3E)-5-amino-3-[[4-[4-[(2E)-2-(8-amino-1-oxo-3,6-disulfonatonaphthalen-2-ylidene)hydrazinyl]-3-hydroxyphenyl]-2-hydroxyphenyl]hydrazinylidene]-4-oxonaphthalene-2,7-disulfonate;copper",C1=CC(=C(C=C1C2=CC(=C(C=C2)N/N=C/3\C(=O)C4=C(C=C3S(=O)(=O)[O-])C=C(C=C4N)S(=O)(=O)[O-])O)O)N/N=C/5\C(=O)C6=C(C=C5S(=O)(=O)[O-])C=C(C=C6N)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Cu].[Cu],9570455,Positive,In Vivo
"tetrasodium;(3E)-5-amino-3-[[4-[4-[(2E)-2-(8-amino-1-oxo-3,6-disulfonatonaphthalen-2-ylidene)hydrazinyl]-3-hydroxyphenyl]-2-hydroxyphenyl]hydrazinylidene]-4-oxonaphthalene-2,7-disulfonate;copper",C1=CC(=C(C=C1C2=CC(=C(C=C2)N/N=C/3\C(=O)C4=C(C=C3S(=O)(=O)[O-])C=C(C=C4N)S(=O)(=O)[O-])O)O)N/N=C/5\C(=O)C6=C(C=C5S(=O)(=O)[O-])C=C(C=C6N)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Cu].[Cu],9570455,Negative,In Vivo
"tetrasodium;(3Z)-5-amino-3-[[4-[4-[(2Z)-2-(8-amino-1-oxo-3,6-disulfonatonaphthalen-2-ylidene)hydrazinyl]-3-methoxyphenyl]-2-methoxyphenyl]hydrazinylidene]-4-oxonaphthalene-2,7-disulfonate",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N/N=C\3/C(=O)C4=C(C=C3S(=O)(=O)[O-])C=C(C=C4N)S(=O)(=O)[O-])OC)N/N=C\5/C(=O)C6=C(C=C5S(=O)(=O)[O-])C=C(C=C6N)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],6321380,Positive,In Vivo
"tetrasodium;(3Z)-5-amino-3-[[4-[4-[(2Z)-2-(8-amino-1-oxo-3,6-disulfonatonaphthalen-2-ylidene)hydrazinyl]-3-methylphenyl]-2-methylphenyl]hydrazinylidene]-4-oxonaphthalene-2,7-disulfonate",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N/N=C\3/C(=O)C4=C(C=C3S(=O)(=O)[O-])C=C(C=C4N)S(=O)(=O)[O-])C)N/N=C\5/C(=O)C6=C(C=C5S(=O)(=O)[O-])C=C(C=C6N)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,Positive,in vivo
"tetrasodium;(3Z)-5-amino-3-[[4-[4-[(2Z)-2-(8-amino-1-oxo-3,6-disulfonatonaphthalen-2-ylidene)hydrazinyl]-3-methylphenyl]-2-methylphenyl]hydrazinylidene]-4-oxonaphthalene-2,7-disulfonate",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N/N=C\3/C(=O)C4=C(C=C3S(=O)(=O)[O-])C=C(C=C4N)S(=O)(=O)[O-])C)N/N=C\5/C(=O)C6=C(C=C5S(=O)(=O)[O-])C=C(C=C6N)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],9562061,Positive,In Vivo
"tetrasodium;(3Z)-5-amino-3-[[4-[4-[(2Z)-2-(8-amino-1-oxo-3,6-disulfonatonaphthalen-2-ylidene)hydrazinyl]-3-methylphenyl]-2-methylphenyl]hydrazinylidene]-4-oxonaphthalene-2,7-disulfonate",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N/N=C\3/C(=O)C4=C(C=C3S(=O)(=O)[O-])C=C(C=C4N)S(=O)(=O)[O-])C)N/N=C\5/C(=O)C6=C(C=C5S(=O)(=O)[O-])C=C(C=C6N)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,Negative,in vitro
"tetrasodium;(3Z)-5-amino-3-[[4-[4-[(2Z)-2-(8-amino-1-oxo-3,6-disulfonatonaphthalen-2-ylidene)hydrazinyl]phenyl]phenyl]hydrazinylidene]-4-oxonaphthalene-2,7-disulfonate",C1=CC(=CC=C1C2=CC=C(C=C2)N/N=C\3/C(=O)C4=C(C=C3S(=O)(=O)[O-])C=C(C=C4N)S(=O)(=O)[O-])N/N=C\5/C(=O)C6=C(C=C5S(=O)(=O)[O-])C=C(C=C6N)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,Positive,in vivo
"tetrasodium;(3Z)-5-amino-3-[[4-[4-[(2Z)-2-(8-amino-1-oxo-3,6-disulfonatonaphthalen-2-ylidene)hydrazinyl]phenyl]phenyl]hydrazinylidene]-4-oxonaphthalene-2,7-disulfonate",C1=CC(=CC=C1C2=CC=C(C=C2)N/N=C\3/C(=O)C4=C(C=C3S(=O)(=O)[O-])C=C(C=C4N)S(=O)(=O)[O-])N/N=C\5/C(=O)C6=C(C=C5S(=O)(=O)[O-])C=C(C=C6N)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],9570116,Positive,In Vivo
"tetrasodium;(6E)-4-amino-6-[[4-[4-[(2E)-2-(8-amino-1-oxo-5,7-disulfonatonaphthalen-2-ylidene)hydrazinyl]-3-methylphenyl]-2-methylphenyl]hydrazinylidene]-5-oxonaphthalene-1,3-disulfonate",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N/N=C\3/C(=O)C4=C(C(=CC(=C4N)S(=O)(=O)[O-])S(=O)(=O)[O-])C=C3)C)N/N=C\5/C(=O)C6=C(C(=CC(=C6N)S(=O)(=O)[O-])S(=O)(=O)[O-])C=C5.[Na+].[Na+].[Na+].[Na+],9566057,Positive,In Vivo
tetrasodium;[4-[(E)-4-(4-phosphonatooxyphenyl)hex-3-en-3-yl]phenyl] phosphate,CC/C(=C(/CC)\C1=CC=C(C=C1)OP(=O)([O-])[O-])/C2=CC=C(C=C2)OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+],4719-75-9,Positive,in vivo
"Thallium (I), soluble salts",[Tl],7440-28-0,Negative,In vivo
Thallium acetate,CC(=O)[O-].[Tl+],563-68-8,Negative,In vivo
Thallium carbonate,C(=O)([O-])[O-].[Tl+].[Tl+],6533-73-9,Negative,In vivo
Thallium chloride,Cl[Tl],7791-12-0,Negative,In vivo
Thallium nitrate,[N+](=O)([O-])[O-].[Tl+],10102-45-1,Negative,In vivo
Thallium oxide,O=[Tl]O[Tl]=O,1314-32-5,Negative,In vivo
Thallium selenite,[O-][Se](=O)[O-].[Tl+].[Tl+],12039-52-0,Negative,In vivo
thallium(1+);acetate,CC(=O)[O-].[Tl+],563-68-8,Positive,in vitro
Thallium(I) sulfate,[O-]S(=O)(=O)[O-].[Tl+].[Tl+],7446-18-6,Negative,In vivo
THENYLDIAMINE,CN(C)CCN(CC1=CSC=C1)C2=CC=CC=N2,91-79-2,Negative,In vivo
Thiabendazole,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,148-79-8,Negative,in vivo
Thiabendazole,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,148-79-8,Positive,in vitro
Thiamethoxam,CN\1COCN(/C1=N/[N+](=O)[O-])CC2=CN=C(S2)Cl,153719-23-4,Negative,in vivo
Thiamethoxam,CN\1COCN(/C1=N/[N+](=O)[O-])CC2=CN=C(S2)Cl,153719-23-4,Negative,in vitro
THIAMPHENICOL,CS(=O)(=O)C1=CC=C(C=C1)C(C(CO)NC(=O)C(Cl)Cl)O,15318-45-3,Negative,In vivo
Thiencarbazone-methyl,CC1=C(C(=CS1)C(=O)OC)S(=O)(=O)NC(=O)N2C(=O)N(C(=N2)OC)C,317815-83-1,Negative,in vivo
Thiencarbazone-methyl,CC1=C(C(=CS1)C(=O)OC)S(=O)(=O)NC(=O)N2C(=O)N(C(=N2)OC)C,317815-83-1,Negative,in vitro
Thifensulfuron-methyl,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=C(SC=C2)C(=O)OC,79277-27-3,Negative,in vivo
Thifensulfuron-methyl,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=C(SC=C2)C(=O)OC,79277-27-3,Negative,in vitro
THIO-TEPA,C1CN1P(=S)(N2CC2)N3CC3,52-24-4,Positive,In vivo
Thio-tepa,C1CN1P(=S)(N2CC2)N3CC3,52-24-4,Positive,in vitro
THIOACETAMIDE,CC(=S)N,62-55-5,Positive,In vivo
Thioacetamide,CC(=S)N,62-55-5,Negative,in vitro
thioarsorosomethane,C[As]=S,2533-82-6,Positive,in vitro
Thiobencarb,CCN(CC)C(=O)SCC1=CC=C(C=C1)Cl,28249-77-6,Negative,In vivo
"THIOCYANATE, SODIUM",C(#N)[S-].[Na+],540-72-7,Negative,In vivo
Thiodicarb,CC(=NOC(=O)N(C)SN(C)C(=O)ON=C(C)SC)SC,59669-26-0,Negative,in vivo
Thiodicarb,CC(=NOC(=O)N(C)SN(C)C(=O)ON=C(C)SC)SC,59669-26-0,Negative,in vitro
Thiophanate-methyl,COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC,23564-05-08,Negative,In vivo
THIOSEMICARBAZIDE,C(=S)(N)NN,79-19-6,Negative,In vivo
THIOURACIL,C1=CNC(=S)NC1=O,141-90-2,Negative,In vivo
THIOURACIL,C1=CNC(=S)NC1=O,141-90-2,Positive,In vivo
thiourea,C(=S)(N)N,62-56-6,Negative,in vivo
thiourea,C(=S)(N)N,62-56-6,Positive,in vivo
thiourea,C(=S)(N)N,2723790,Positive,In Vivo
Thiourea,C(=S)(N)N,62-56-6,Negative,in vitro
Thiram,CN(C)C(=S)SSC(=S)N(C)C,137-26-8,Negative,In vivo
Thiram (tetramethulthiuram disulfide),CN(C)C(=S)SSC(=S)N(C)C,137-26-8,Positive,in vitro
Thymol,CC1=CC(=C(C=C1)C(C)C)O,89-83-8,Negative,in vivo
Thymol,CC1=CC(=C(C=C1)C(C)C)O,89-83-8,Positive,in vivo
Thymol,CC1=CC(=C(C=C1)C(C)C)O,89-83-8,Negative,in vitro
TILIDINE FUMARATE,CCOC(=O)C1(CCC=CC1N(C)C)C2=CC=CC=C2.C(=CC(=O)O)C(=O)O,55567-81-2,Negative,In vivo
TILISOLOL.HCl,CC(C)(C)NCC(COC1=CN(C(=O)C2=CC=CC=C21)C)O.Cl,62774-96-3,Negative,In vivo
TIN (II) CHLORIDE,Cl[Sn]Cl,7772-99-8,Negative,In vivo
Tinidazole,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,19387-91-8,Negative,in vitro
Tolclofos-methyl,S=P(OC)(OC)OC1=C(Cl)C=C(C)C=C1Cl,57018-04-9,Negative,in vivo
Tolclofos-methyl,S=P(OC)(OC)OC1=C(Cl)C=C(C)C=C1Cl,57018-04-09,Negative,in vitro
Tolterodine,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,124937-51-5,Negative,in vitro
toluene,CC1=CC=CC=C1,1140,Negative,In Vivo
toluene,CC1=CC=CC=C1,108-88-3,Negative,in vivo
TOLUENE,CC1=CC=CC=C1,108-88-3,Positive,In vivo
Toluene,CC1=CC=CC=C1,108-88-3,Negative,in vitro
"TOLUENE DIISOCYANATE, COMMERCIAL GRADE (2,4 (80%)- AND 2,6 (20%)-)",CC1=C(C=C(C=C1)N=C=O)N=C=O,26471-62-5,Negative,In vivo
Tolylfluanid,CC1=CC=C(C=C1)N(SC(F)(Cl)Cl)S(=O)(=O)N(C)C,731-27-1,Negative,in vivo
Tolylfluanid,CC1=CC=C(C=C1)N(SC(F)(Cl)Cl)S(=O)(=O)N(C)C,731-27-1,Positive,in vivo
Tolylfluanid,CC1=CC=C(C=C1)N(SC(F)(Cl)Cl)S(=O)(=O)N(C)C,731-27-1,Negative,in vitro
Topiramate,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,97240-79-4,Negative,in vitro
Topramezone,CC1=C(C=CC(=C1C2=NOCC2)S(=O)(=O)C)C(=O)C3=CNN(C3=O)C,210631-68-8,Negative,in vivo
Topramezone,CC1=C(C=CC(=C1C2=NOCC2)S(=O)(=O)C)C(=O)C3=CNN(C3=O)C,210631-68-8,Negative,in vitro
TOREMIFENE CITRATE,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,89778-27-8,Negative,In vivo
Toremifene/Toremifene citrate,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,89778-27-8,Positive,in vitro
TOXAPHENE,C=C1C(C2(C(C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)(CCl)CCl,8001-35-2,Positive,In vivo
Toxaphene,C=C1C(C2(C(C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)(CCl)CCl,8001-35-2,Positive,in vitro
TRAGACANTH GUM,CC.CC.CC.CC.CC,9000-65-1,Negative,In vivo
Tralkoxydim,CCC(=C1C(=O)CC(CC1=O)C2=C(C=C(C=C2C)C)C)NOCC,87820-88-0,Negative,in vivo
Tralkoxydim,CCC(=C1C(=O)CC(CC1=O)C2=C(C=C(C=C2C)C)C)NOCC,87820-88-0,Negative,in vitro
Tralomethrin,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C(C(Br)(Br)Br)Br)C,66841-25-6,Negative,In vivo
"trans-1,4-DICHLOROBUTENE-2",C(C=CCCl)Cl,110-57-6,Positive,In vivo
"trans-1,4-Dichlorobutene-2",C(C=CCCl)Cl,110-57-6,Positive,in vitro
"trans-2-[(Dimethylamino)methylimino]-5-
[2-(5-nitro-2-furyl)vinyl]-1,3,4-oxadiazole",CN(C)C=NC1=NN=C(O1)C=CC2=CC=C(O2)[N+](=O)[O-],55738-54-0,Positive,in vitro
"trans-2-[(DIMETHYLAMINO)METHYLIMINO]-5-[2-(5-NITRO-2-FURYL)VINYL]-1,3,4-OXADIAZOLE",CN(C)C=NC1=NN=C(O1)C=CC2=CC=C(O2)[N+](=O)[O-],55738-54-0,Positive,In vivo
"trans-5-AMINO-3[2-(5-NITRO-2-FURYL)VINYL]-1,2,4-OXADIAZOLE",C1=C(OC(=C1)[N+](=O)[O-])C=CC2=NOC(=N2)N,28754-68-9,Positive,In vivo
TRENIMON,C1CN1C2=CC(=O)C(=C(C2=O)N3CC3)N4CC4,68-76-8,Positive,In vivo
Treosulfan,CS(=O)(=O)OCC(C(COS(=O)(=O)C)O)O,299-75-2,Positive,in vitro
Tri-allate,CC(C)N(C(C)C)C(=O)SCC(=C(Cl)Cl)Cl,2303-17-5,Negative,in vivo
Tri-allate,CC(C)N(C(C)C)C(=O)SCC(=C(Cl)Cl)Cl,2303-17-5,Negative,in vitro
Triadimenol,CC(C)(C)C(C(N1C=NC=N1)OC2=CC=C(C=C2)Cl)O,55219-65-3,Negative,in vivo
Triadimenol,CC(C)(C)C(C(N1C=NC=N1)OC2=CC=C(C=C2)Cl)O,55219-65-3,Negative,in vitro
Triallate,CC(C)N(C(C)C)C(=O)SCC(=C(Cl)Cl)Cl,2303-17-5,Negative,In vivo
Triallate,CC(C)N(C(C)C)C(=O)SCC(=C(Cl)Cl)Cl,2303-17-5,Negative,in vitro
TRIAMCINOLONE ACETONIDE,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C,76-25-5,Positive,In vivo
Triasulfuron,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=CC=CC=C2OCCCl,82097-50-5,Negative,in vivo
Triasulfuron,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=CC=CC=C2OCCCl,82097-50-5,Negative,in vitro
triazene,NN=N,15056-34-5,Positive,in vitro
Triaziquinone,C1CN1C2=CC(=O)C(=C(C2=O)N3CC3)N4CC4,8059-32-3,Positive,in vitro
Triaziquone (Trenimon),C1CN1C2=CC(=O)C(=C(C2=O)N3CC3)N4CC4,68-76-8,Positive,in vitro
Triazoxide,Clc1ccc2nc(n[n+]([O-])c2c1)n3ccnc3,72459-58-6,Negative,in vivo
Triazoxide,Clc1ccc2nc(n[n+]([O-])c2c1)n3ccnc3,72459-58-6,Negative,in vitro
Tribenuron-methyl,CC1=NC(=NC(=N1)OC)N(C)C(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC,101200-48-0,Negative,in vivo
Tribenuron-methyl,CC1=NC(=NC(=N1)OC)N(C)C(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC,101200-48-0,Negative,in vitro
Tribromobenzene,C1=CC(=C(C=C1Br)Br)Br,615-54-3,Negative,In vivo
Tribromochloromethane,C(Cl)(Br)(Br)Br,594-15-0,Negative,In vivo
Tribromodiphenyl ether,C1=CC=C(C(=C1)OC2=CC(=C(C=C2)Br)Br)Br,49690-94-0,Negative,In vivo
Tribromomethane (bromoform),C(Br)(Br)Br,75-25-2,Positive,in vitro
tributyl phosphate,CCCCOP(=O)(OCCCC)OCCCC,31357,Negative,In Vivo
TRIBUTYL PHOSPHATE,CCCCOP(=O)(OCCCC)OCCCC,126-73-8,Negative,In vivo
tributyl phosphate,CCCCOP(=O)(OCCCC)OCCCC,31357,Positive,In Vivo
TRIBUTYL PHOSPHATE,CCCCOP(=O)(OCCCC)OCCCC,126-73-8,Positive,In vivo
tributyl(tributylstannyloxy)stannane,CCCC[Sn](CCCC)(CCCC)O[Sn](CCCC)(CCCC)CCCC,16682746,Positive,In Vivo
tributyl(tributylstannyloxy)stannane,CCCC[Sn](CCCC)(CCCC)O[Sn](CCCC)(CCCC)CCCC,56-35-9,Positive,in vitro
Tributyltin oxide (TBTO),CCCC[Sn](CCCC)(CCCC)O[Sn](CCCC)(CCCC)CCCC,56-35-9,Negative,In vivo
Tricaprylin,CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,538-23-8,Positive,in vitro
Trichlorfon,COP(=O)(C(C(Cl)(Cl)Cl)O)OC,52-68-6,Negative,in vivo
Trichlorfon,COP(=O)(C(C(Cl)(Cl)Cl)O)OC,52-68-6,Positive,in vitro
"Trichloro-1,2,2-trifluoroethane (CFC-113)",C(C(F)(Cl)Cl)(F)(F)Cl,76-13-1,Negative,In vivo
trichloro(fluoro)methane,C(F)(Cl)(Cl)Cl,6389,Negative,In Vivo
trichloro(nitro)methane,C([N+](=O)[O-])(Cl)(Cl)Cl,6423,Negative,In Vivo
trichloro(nitro)methane,C([N+](=O)[O-])(Cl)(Cl)Cl,6423,Positive,In Vivo
TRICHLOROACETIC ACID,C(=O)(C(Cl)(Cl)Cl)O,76-03-9,Positive,In vivo
TRICHLOROACETIC ACID,C(=O)(C(Cl)(Cl)Cl)O,76-03-9,Negative,In vivo
trichloroalumane,[Al](Cl)(Cl)Cl,7446-70-0,Negative,in vitro
trichloroarsane,Cl[As](Cl)Cl,7784-34-1,Positive,in vitro
Trichlorobenzene,C1=CC(=C(C=C1Cl)Cl)Cl,120-82-1,Negative,In vivo
trichlorobismuthane,Cl[Bi](Cl)Cl,7787-60-2,Negative,in vitro
trichlorocerium,Cl[Ce](Cl)Cl,,Negative,in vitro
trichlorochromium,Cl[Cr](Cl)Cl,10025-73-7,Negative,in vitro
trichlorochromium;hexahydrate,O.O.O.O.O.O.Cl[Cr](Cl)Cl,,Positive,in vitro
Trichlorocyclopentadiene,C1C=C(C(=C1Cl)Cl)Cl,77323-84-3,Negative,In vivo
Trichloroethane,CC(Cl)(Cl)Cl,71-55-6,Negative,In vivo
Trichloroethane,CC(Cl)(Cl)Cl,79-00-5,Positive,In vivo
TRICHLOROETHYLENE,C(=C(Cl)Cl)Cl,79-01-6,Negative,In vivo
TRICHLOROETHYLENE,C(=C(Cl)Cl)Cl,79-01-6,Positive,In vivo
TRICHLOROFLUOROMETHANE,C(F)(Cl)(Cl)Cl,75-69-4,Negative,In vivo
Trichlorofluoromethane,C(F)(Cl)(Cl)Cl,75-69-4,Negative,in vitro
trichloroiron,Cl[Fe](Cl)Cl,24380,Negative,In Vivo
trichloroiron,Cl[Fe](Cl)Cl,7705-08-0,Negative,in vitro
trichlorolanthanum,Cl[La](Cl)Cl,10099-58-8,Negative,in vitro
trichloromethylbenzene,C1=CC=C(C=C1)C(Cl)(Cl)Cl,7367,Positive,In Vivo
trichloromethylbenzene,C1=CC=C(C=C1)C(Cl)(Cl)Cl,98-07-7,Positive,in vivo
trichloromethylbenzene,C1=CC=C(C=C1)C(Cl)(Cl)Cl,98-07-7,Positive,in vitro
Trichlorophenol,C1=CC(=C(C(=C1O)Cl)Cl)Cl,95-95-4,Negative,In vivo
Trichlorophenol,C1=CC(=C(C(=C1O)Cl)Cl)Cl,88-06-2,Positive,In vivo
"Trichlorophenoxy) propionic acid (2,4,5-TP)",CC(C(=O)O)OC1=CC(=C(C=C1Cl)Cl)Cl,93-72-1,Negative,In vivo
"Trichlorophenoxyacetic acid (2,4,5-T)",C1=C(C(=CC(=C1Cl)Cl)Cl)OCC(=O)O,93-76-5,Negative,In vivo
Trichloropropane,CCC(Cl)(Cl)Cl,598-77-6,Negative,In vivo
Trichloropropane,CCC(Cl)(Cl)Cl,96-18-4,Positive,In vivo
trichlororhodium,Cl[Rh](Cl)Cl,,Positive,in vitro
trichlorostibane,Cl[Sb](Cl)Cl,10025-91-9,Positive,in vitro
trichloroterbium,Cl[Tb](Cl)Cl,10042-88-3,Negative,in vitro
trichlorotitanium,Cl[Ti](Cl)Cl,,Negative,in vitro
Triclopyr,C1=C(C(=NC(=C1Cl)Cl)OCC(=O)O)Cl,55335-06-3,Negative,in vivo
Triclopyr,C1=C(C(=NC(=C1Cl)Cl)OCC(=O)O)Cl,55335-06-03,Negative,in vitro
Tricresyl phosphate,CC1=CC=C(C=C1)OP(=O)(OC2=CC=C(C=C2)C)OC3=CC=C(C=C3)C,78-32-0,Negative,in vitro
"tricyclo[5.2.1.02,6]deca-3,8-diene",C1C=CC2C1C3CC2C=C3,77-73-6,Negative,in vitro
tridecasodium;hypochlorite;tetraphosphate,[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]Cl.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],61532,Negative,In Vivo
Tridiphane,C1C(O1)(CC(Cl)(Cl)Cl)C2=CC(=CC(=C2)Cl)Cl,58138-08-02,Negative,In vivo
TRIETHANOLAMINE,C(CO)N(CCO)CCO,102-71-6,Negative,In vivo
TRIETHANOLAMINE,C(CO)N(CCO)CCO,102-71-6,Positive,In vivo
Triethanolamine,C(CO)N(CCO)CCO,102-71-6,Negative,in vitro
triethoxy-[2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl]silane,CCO[Si](CCC1CCC2C(C1)O2)(OCC)OCC,154915,Negative,In Vivo
triethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane,CCO[Si](CCCOCC1CO1)(OCC)OCC,102856,Negative,In Vivo
Triethylamine,CCN(CC)CC,121-44-8,Negative,In vivo
Triethylene glycol monobutyl ether,CCCCOCCOCCOCCO,143-22-6,Negative,In vivo
Triethylene glycol monoethyl ether,CCOCCOCCOCCO,112-50-5,Negative,In vivo
Triethylenemelamine,C1CN1C2=NC(=NC(=N2)N3CC3)N4CC4,51-18-3,Positive,in vitro
Triflumizole,CCCOCC(=NC1=C(C=C(C=C1)Cl)C(F)(F)F)N2C=CN=C2,99387-89-0,Negative,in vivo
Triflumizole,CCCOCC(=NC1=C(C=C(C=C1)Cl)C(F)(F)F)N2C=CN=C2,99387-89-0,Negative,in vitro
Triflumuron,O=C(C1=CC=CC=C1Cl)NC(NC(C=C2)=CC=C2OC(F)(F)F)=O,64628-44-0,Negative,in vivo
Triflumuron,O=C(C1=CC=CC=C1Cl)NC(NC(C=C2)=CC=C2OC(F)(F)F)=O,64628-44-0,Negative,in vitro
Trifluralin,CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],1582-09-8,Negative,in vivo
Trifluralin,CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],1582-09-8,Positive,in vivo
Trifluralin,CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],1582-09-08,Positive,In vivo
Trifluralin,CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],1582-09-08,Negative,in vitro
Triflusulfuron-methyl,CC1=C(C(=CC=C1)C(=O)OC)S(=O)(=O)NC(=O)NC2=NC(=NC(=N2)OCC(F)(F)F)N(C)C,126535-15-7,Negative,in vivo
Triflusulfuron-methyl,CC1=C(C(=CC=C1)C(=O)OC)S(=O)(=O)NC(=O)NC2=NC(=NC(=N2)OCC(F)(F)F)N(C)C,126535-15-7,Negative,in vitro
"trilithium;2-hydroxypropane-1,2,3-tricarboxylate",[Li+].[Li+].[Li+].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O,919-16-4,Positive,in vitro
trimagnesium;dioxido(oxo)silane;hydroxy-oxido-oxosilane,O[Si](=O)[O-].O[Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[Mg+2].[Mg+2].[Mg+2],26924,Negative,In Vivo
trimagnesium;dioxido(oxo)silane;hydroxy-oxido-oxosilane,O[Si](=O)[O-].O[Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[Mg+2].[Mg+2].[Mg+2],26924,Positive,In Vivo
trimagnesium;disodium;dihydroxy(oxo)silane;iron(3+),O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Fe+3].[Fe+3],86278622,Positive,In Vivo
trimagnesium;disodium;dihydroxy(oxo)silane;iron(3+),O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Fe+3].[Fe+3],12001-28-4,Positive,in vivo
trimagnesium;disodium;dihydroxy(oxo)silane;iron(3+),O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Fe+3].[Fe+3],86278622,Negative,In Vivo
trimagnesium;disodium;dihydroxy(oxo)silane;iron(3+),O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.O[Si](=O)O.[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Fe+3].[Fe+3],12001-28-4,Negative,in vitro
trimagnesium;hydroxy(trioxido)silane;hydrate,O.O[Si]([O-])([O-])[O-].O[Si]([O-])([O-])[O-].[Mg+2].[Mg+2].[Mg+2],25477,Negative,In Vivo
trimagnesium;hydroxy(trioxido)silane;hydrate,O.O[Si]([O-])([O-])[O-].O[Si]([O-])([O-])[O-].[Mg+2].[Mg+2].[Mg+2],25477,Positive,In Vivo
trimagnesium;hydroxy(trioxido)silane;hydrate,O.O[Si]([O-])([O-])[O-].O[Si]([O-])([O-])[O-].[Mg+2].[Mg+2].[Mg+2],12001-29-5,Positive,in vivo
trimagnesium;hydroxy(trioxido)silane;hydrate,O.O[Si]([O-])([O-])[O-].O[Si]([O-])([O-])[O-].[Mg+2].[Mg+2].[Mg+2],12001-29-5,Negative,in vitro
trimethoxy-[2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl]silane,CO[Si](CCC1CCC2C(C1)O2)(OC)OC,18819,Positive,In Vivo
trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane,CO[Si](CCCOCC1CO1)(OC)OC,17317,Negative,In Vivo
trimethyl phosphate,COP(=O)(OC)OC,10541,Negative,In Vivo
trimethyl phosphate,COP(=O)(OC)OC,10541,Positive,In Vivo
trimethyl phosphate,COP(=O)(OC)OC,512-56-1,Positive,in vivo
trimethyl phosphate,COP(=O)(OC)OC,512-56-1,Positive,in vitro
TRIMETHYLARSINE OXIDE,C[As](=O)(C)C,4964-14-1,Positive,In vivo
Trimethylbenzene,CC1=C(C(=CC=C1)C)C,95-63-6,Negative,In vivo
Trimethylbenzene,CC1=C(C(=CC=C1)C)C,526-73-8,Negative,In vivo
Trimethylbenzene,CC1=C(C(=CC=C1)C)C,108-67-8,Negative,In vivo
Trimethylpentane,CC(C)CC(C)(C)C,540-84-1,Negative,In vivo
TRIMETHYLPHOSPHATE,COP(=O)(OC)OC,512-56-1,Negative,In vivo
Trimethylphosphate,COP(=O)(OC)OC,512-56-1,Positive,in vitro
Trinexapac-ethyl,CCOC(=O)C1CC(=O)C(=C(C2CC2)O)C(=O)C1,95266-40-3,Negative,in vivo
Trinexapac-ethyl,CCOC(=O)C1CC(=O)C(=C(C2CC2)O)C(=O)C1,95266-40-3,Negative,in vitro
Trinitrobenzene,C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],99-35-4,Negative,In vivo
TRINITROGLYCERIN,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],55-63-0,Positive,In vivo
Trinitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],55-63-0,Positive,in vitro
Trinitrotoluene (TNT),CC1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],118-96-7,Positive,In vivo
trioxochromium,O=[Cr](=O)=O,1333-82-0,Positive,in vivo
trioxochromium,O=[Cr](=O)=O,14915,Positive,In Vivo
trioxochromium,O=[Cr](=O)=O,1333-82-0,Positive,in vitro
trioxomolybdenum,O=[Mo](=O)=O,14802,Positive,In Vivo
trioxomolybdenum,O=[Mo](=O)=O,14802,Negative,In Vivo
TRIPHENYLTIN ACETATE,CC(=O)O[Sn](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3,900-95-8,Negative,In vivo
Triphenyltin hydroxide,C1=CC=C(C=C1)[Sn](C2=CC=CC=C2)C3=CC=CC=C3.O,6327657,Negative,In Vivo
Triphenyltin hydroxide,C1=CC=C(C=C1)[Sn](C2=CC=CC=C2)C3=CC=CC=C3.O,76-87-9,Negative,in vivo
Triphenyltin hydroxide,C1=CC=C(C=C1)[Sn](C2=CC=CC=C2)C3=CC=CC=C3.O,76-87-9,Negative,in vitro
tripotassium;arsorite,[O-][As]([O-])[O-].[K+].[K+].[K+],1332-10-1,Negative,in vitro
tripotassium;iron(3+);hexacyanide,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[K+].[K+].[K+].[Fe+3],13746-66-2,Negative,in vitro
TRIPROLIDINE.HCl MONOHYDRATE,CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3.O.Cl,6138-79-0,Negative,In vivo
"TRIS-(1,3-DICHLORO-2-PROPYL)PHOSPHATE",C(C(CCl)OP(=O)(OC(CCl)CCl)OC(CCl)CCl)Cl,13674-87-8,Positive,In vivo
"TRIS-1,2,3-(CHLOROMETHOXY)PROPANE",C(C(COCCl)OCCl)OCCl,38571-73-2,Positive,In vivo
"tris(1,3-dichloropropan-2-yl) phosphate",C(C(CCl)OP(=O)(OC(CCl)CCl)OC(CCl)CCl)Cl,26177,Positive,In Vivo
tris(2-chloroethyl) phosphate,C(CCl)OP(=O)(OCCCl)OCCCl,8295,Negative,In Vivo
tris(2-chloroethyl) phosphate,C(CCl)OP(=O)(OCCCl)OCCCl,8295,Positive,In Vivo
tris(2-chloroethyl) phosphate,C(CCl)OP(=O)(OCCCl)OCCCl,115-96-8,Negative,in vitro
TRIS(2-CHLOROETHYL)PHOSPHATE,C(CCl)OP(=O)(OCCCl)OCCCl,115-96-8,Positive,In vivo
tris(2-ethylhexyl) phosphate,CCCCC(CC)COP(=O)(OCC(CC)CCCC)OCC(CC)CCCC,6537,Negative,In Vivo
tris(2-ethylhexyl) phosphate,CCCCC(CC)COP(=O)(OCC(CC)CCCC)OCC(CC)CCCC,6537,Positive,In Vivo
TRIS(2-HYDROXYPROPYL)AMINE,CC(CN(CC(C)O)CC(C)O)O,122-20-3,Negative,In vivo
tris(2-methyl-2-phenylpropyl)-tris(2-methyl-2-phenylpropyl)stannyloxystannane,CC(C)(C[Sn](CC(C)(C)C1=CC=CC=C1)(CC(C)(C)C2=CC=CC=C2)O[Sn](CC(C)(C)C3=CC=CC=C3)(CC(C)(C)C4=CC=CC=C4)CC(C)(C)C5=CC=CC=C5)C6=CC=CC=C6,16683004,Negative,In Vivo
"tris(2,3-dibromopropyl) phosphate",C(C(CBr)Br)OP(=O)(OCC(CBr)Br)OCC(CBr)Br,126-72-7,Positive,in vivo
"tris(2,3-dibromopropyl) phosphate",C(C(CBr)Br)OP(=O)(OCC(CBr)Br)OCC(CBr)Br,31356,Positive,In Vivo
"tris(2,3-dibromopropyl) phosphate",C(C(CBr)Br)OP(=O)(OCC(CBr)Br)OCC(CBr)Br,126-72-7,Positive,in vitro
"TRIS(2,3-DIBROMOPROPYL)PHOSPHATE",C(C(CBr)Br)OP(=O)(OCC(CBr)Br)OCC(CBr)Br,126-72-7,Positive,In vivo
"Tris(2,3-dibromopropyl)phosphate",C(C(CBr)Br)OP(=O)(OCC(CBr)Br)OCC(CBr)Br,126-72-7,Positive,in vitro
tris(aziridin-1-yl)-sulfanylidene-lambda5-phosphane,C1CN1P(=S)(N2CC2)N3CC3,5453,Positive,In Vivo
tris(aziridin-1-yl)-sulfanylidene-lambda5-phosphane,C1CN1P(=S)(N2CC2)N3CC3,52-24-4,Positive,in vivo
tris(aziridin-1-yl)-sulfanylidene-lambda5-phosphane,C1CN1P(=S)(N2CC2)N3CC3,52-24-4,Positive,in vitro
Tris2-ethylhexylphosphate,CCCCC(CC)COP(=O)(OCC(CC)CCCC)OCC(CC)CCCC,78-42-2,Negative,in vitro
trisodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxymethyl)amino]acetate,C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)O)CC(=O)[O-].[Na+].[Na+].[Na+],9008,Negative,In Vivo
trisodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxymethyl)amino]acetate,C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)O)CC(=O)[O-].[Na+].[Na+].[Na+],,Negative,in vivo
trisodium;2-[bis(carboxylatomethyl)amino]acetate,C(C(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+],21152,Positive,In Vivo
trisodium;2-[bis(carboxylatomethyl)amino]acetate;hydrate,C(C(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].O.[Na+].[Na+].[Na+],29194,Negative,In Vivo
trisodium;2-[bis(carboxylatomethyl)amino]acetate;hydrate,C(C(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].O.[Na+].[Na+].[Na+],18662-53-8,Positive,in vivo
trisodium;2-[bis(carboxylatomethyl)amino]acetate;hydrate,C(C(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].O.[Na+].[Na+].[Na+],29194,Positive,In Vivo
"trisodium;2,4,6-trioxido-1,3,5,2lambda5,4lambda5,6lambda5-trioxatriphosphinane 2,4,6-trioxide",[O-]P1(=O)OP(=O)(OP(=O)(O1)[O-])[O-].[Na+].[Na+].[Na+],24579,Negative,In Vivo
"trisodium;3-hydroxy-4-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2,7-disulfonate",C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C4C=CC(=CC4=CC(=C3O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],13506,Negative,In Vivo
"trisodium;3-hydroxy-4-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2,7-disulfonate",C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C4C=CC(=CC4=CC(=C3O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],915-67-3,Negative,in vivo
"trisodium;3-hydroxy-4-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2,7-disulfonate",C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C4C=CC(=CC4=CC(=C3O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],915-67-3,Negative,in vitro
"trisodium;4-[(2,4-diamino-5-methylphenyl)diazenyl]benzenesulfonate;4-[[2,4-diamino-5-[(4-sulfonatophenyl)diazenyl]phenyl]diazenyl]benzenesulfonate",CC1=CC(=C(C=C1N)N)N=NC2=CC=C(C=C2)S(=O)(=O)[O-].C1=CC(=CC=C1N=NC2=CC(=C(C=C2N)N)N=NC3=CC=C(C=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],8062-14-4,Positive,in vitro
trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4H-pyrazole-3-carboxylate,C1=CC(=CC=C1N=NC2C(=NN(C2=O)C3=CC=C(C=C3)S(=O)(=O)[O-])C(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],164825,Negative,In Vivo
trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4H-pyrazole-3-carboxylate,C1=CC(=CC=C1N=NC2C(=NN(C2=O)C3=CC=C(C=C3)S(=O)(=O)[O-])C(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],1934-21-0,Negative,in vitro
"trisodium;7-hydroxy-8-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-1,3-disulfonate",C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C(C=CC4=CC(=CC(=C43)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+].[Na+],17466,Negative,In Vivo
"trisodium;7-hydroxy-8-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-1,3-disulfonate",C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)[O-])N=NC3=C(C=CC4=CC(=CC(=C43)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+].[Na+],2611-82-7,Negative,in vitro
Triticonazole,OC1(CN2N=CN=C2)C(C)(C)CCC1=CC3=CC=C(Cl)C=C3,131983-72-7,Negative,in vivo
Triticonazole,OC1(CN2N=CN=C2)C(C)(C)CCC1=CC3=CC=C(Cl)C=C3,131983-72-7,Negative,in vitro
Trofosfamide,C1CN(P(=O)(OC1)N(CCCl)CCCl)CCCl,22089-22-1,Positive,in vitro
Trp-P-1 ACETATE,CC1=C2C(=C(N=C1N)C)C3=CC=CC=C3N2.CC(=O)O,75104-43-7,Positive,In vivo
Trp-P-2 ACETATE,CC1=C2C3=CC=CC=C3NC2=CC(=N1)N.CC(=O)O,72254-58-1,Positive,In vivo
"TUNGSTATE, SODIUM",[O-][W](=O)(=O)[O-].[Na+].[Na+],13472-45-2,Negative,In vivo
tungsten,[W],23964,Positive,In Vivo
TURMERIC (>98% CURCUMIN),COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O,458-37-7,Negative,In vivo
Turmeric oleoresin 79%-85% curcumin,COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O ,458-37-7,Negative,in vitro
TYLOSIN LACTATE,CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)C)COC4C(C(C(C(O4)C)O)OC)OC.CC(C(=O)O)O,11034-63-2,Negative,In vivo
"U-71,184",CC1=CNC2=C1C34CC3CN(C4=CC2=O)C(=O)C5=CC6=C(N5)C=CC(=C6)NC(=O)C7=CC8=CC=CC=C8N7,101222-80-4,Positive,in vitro
"U-73,975",CC1=CNC2=C1C34CC3CN(C4=CC2=O)C(=O)C5=CC6=C(N5)C=CC(=C6)NC(=O)C7=CC8=CC=CC=C8O7,123219-86-3,Positive,in vitro
URACIL,C1=CNC(=O)NC1=O,66-22-8,Positive,In vivo
Uracil mustard,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,66-75-1,Positive,in vitro
"Uranium, soluble salts",[U],7440-61-1,Negative,In vivo
URAPIDIL,CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC,34661-75-1,Negative,In vivo
urea,C(=O)(N)N,57-13-6,Negative,in vivo
Urea,C(=O)(N)N,57-13-6,Negative,in vitro
URETHANE,CCOC(=O)N,51-79-6,Positive,In vivo
URETHANE,CCOC(=O)N,51-79-6,Negative,In vivo
Valexon / Phoxim,CCOP(=S)(OCC)ON=C(C#N)C1=CC=CC=C1,14816-18-3,Positive,in vitro
Valiphenal,CC(C)[C@@H](C(=O)NC(CC(=O)OC)C1=CC=C(C=C1)Cl)NC(=O)OC(C)C,283159-90-0,Negative,in vivo
Valiphenal,CC(C)[C@@H](C(=O)NC(CC(=O)OC)C1=CC=C(C=C1)Cl)NC(=O)OC(C)C,283159-90-0,Negative,in vitro
VANADYL SULFATE,[O-]S(=O)(=O)[O-].O=[V+2],27774-13-6,Negative,In vivo
VANGUARD GF,CN(C)C(=S)SSC(=S)N(C)C,mixture,Negative,In vivo
Vernam,CCCN(CCC)C(=O)SCCC,1929-77-7,Negative,In vivo
VINBLASTINE,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,865-21-4,Negative,In vivo
Vinblastine sulphate,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O,143-67-9,Positive,in vitro
Vinclozolin,CC1(C(=O)N(C(=O)O1)C2=CC(=CC(=C2)Cl)Cl)C=C,50471-44-8,Negative,In vivo
VINYL ACETATE,CC(=O)OC=C,108-05-4,Positive,In vivo
Vinyl acetate,CC(=O)OC=C,0108-05-04,Negative,In vivo
Vinyl acetate,CC(=O)OC=C,108-05-4,Positive,in vitro
Vinyl bromide,C=CBr,593-60-2,Negative,In vivo
VINYL BROMIDE,C=CBr,593-60-2,Positive,In vivo
Vinyl bromide,C=CBr,593-60-2,Positive,in vitro
VINYL CARBAMATE,C=COC(=O)N,15805-73-9,Positive,In vivo
Vinyl carbamate,C=COC(=O)N,15805-73-9,Positive,in vitro
Vinyl carbamate epoxide,C1C(O1)OC(=O)N,82617-23-0,Positive,in vitro
VINYL CHLORIDE,C=CCl,75-01-4,Positive,In vivo
Vinyl chloride / Chloroethylene,C=CCl,75-01-4,Positive,in vitro
VINYL FLUORIDE,C=CF,75-02-5,Positive,In vivo
VINYLIDENE CHLORIDE,C=C(Cl)Cl,75-35-4,Negative,In vivo
VINYLIDENE CHLORIDE,C=C(Cl)Cl,75-35-4,Positive,In vivo
VOGLIBOSE,C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO,83480-29-9,Negative,In vivo
Warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,81-81-2,Negative,In vivo
WATANIDIPINE.2HCl,CC1=C(C(C(=C(N1)C)C(=O)OCCC2=CC=C(C=C2)N3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5)C6=CC(=CC=C6)[N+](=O)[O-])C(=O)OC.Cl.Cl,133743-71-2,Negative,In vivo
White phosphorus,[P],7723-14-0,Negative,In vivo
"Wyeth 14,643 4-Chloro-6-2,3-xylidino-2-pyrimidinylthio acetic acid",CC1=C(C(=CC=C1)NC2=CC(=NC(=N2)SCC(=O)O)Cl)C,50892-23-4,Positive,in vitro
XIBENOLOL.HCl,CC1=C(C(=CC=C1)OCC(CNC(C)(C)C)O)C.Cl,15263-30-6,Negative,In vivo
Xylenes,Cc1c(C)cccc1,1330-20-7,Negative,In vivo
"Z-ETHYL-O,N,N-AZOXYETHANE",CCN=[N+](CC)[O-],16301-26-1,Positive,In vivo
"Z-ETHYL-O,N,N-AZOXYMETHANE",CCN=[N+](CC)[O-],57497-29-7,Positive,In vivo
"Z-METHYL-O,N,N-AZOXYETHANE",CCN=[N+](C)[O-],57497-34-4,Positive,In vivo
Zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,107753-78-6,Negative,in vitro
Zermattite,O.O[Si](O)(O)O.O[Si](O)(O)O.[Mg].[Mg].[Mg],6335834,Negative,In Vivo
Zeta-cypermethrin,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,52315-07-8,Negative,in vivo
Zeta-cypermethrin,CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,52315-07-08,Negative,in vitro
Zinc,[Zn],7440-66-6,Negative,In vivo
ZINC (II) ACETATE DIHYDRATE,CC(=O)[O-].CC(=O)[O-].O.O.[Zn+2],5970-45-6,Negative,In vivo
Zinc cyanide,[C-]#N.[C-]#N.[Zn+2],557-21-1,Negative,In vivo
ZINC DIBUTYLDITHIOCARBAMATE,CCN(CC)C(=S)[S-].CCN(CC)C(=S)[S-].[Zn+2],136-23-2,Negative,In vivo
ZINC DIETHYLDITHIOCARBAMATE,CCN(CC)C(=S)[S-].CCN(CC)C(=S)[S-].[Zn+2],14324-55-1,Negative,In vivo
ZINC DIMETHYLDITHIOCARBAMATE,CN(C)C(=S)[S-].CN(C)C(=S)[S-].[Zn+2],137-30-4,Negative,In vivo
ZINC DIMETHYLDITHIOCARBAMATE,CN(C)C(=S)[S-].CN(C)C(=S)[S-].[Zn+2],137-30-4,Positive,In vivo
Zinc dimethyldithiocarbamate (Ziram),CN(C)C(=S)[S-].CN(C)C(=S)[S-].[Zn+2],137-30-4,Positive,in vitro
ZINC ETHYLENEBISTHIOCARBAMATE,C(CNC(=S)[S-])NC(=S)[S-].[Zn+2],12122-67-7,Negative,In vivo
ZINC ETHYLENEBISTHIOCARBAMATE,C(CNC(=S)[S-])NC(=S)[S-].[Zn+2],12122-67-7,Positive,In vivo
Zinc ethylenebisthiocarbamate Zineb,C(CNC(=S)[S-])NC(=S)[S-].[Zn+2],12122-67-7,Positive,in vitro
Zinc phosphide,[P-3].[P-3].[Zn+2].[Zn+2].[Zn+2],1314-84-7,Negative,in vivo
Zinc phosphide,[P-3].[P-3].[Zn+2].[Zn+2].[Zn+2],1314-84-7,Positive,in vivo
Zinc phosphide,[P-3].[P-3].[Zn+2].[Zn+2].[Zn+2],1314-84-7,Negative,in vitro
Zinc sulfate/Zinc heptahydrate,[O-]S(=O)(=O)[O-].[Zn+2],7733-02-0,Negative,in vitro
zinc;dioxido(dioxo)chromium,[O-][Cr](=O)(=O)[O-].[Zn+2],26089,Positive,In Vivo
zinc;dioxido(dioxo)chromium,[O-][Cr](=O)(=O)[O-].[Zn+2],13530-65-9,Positive,in vivo
zinc;dioxido(dioxo)chromium,[O-][Cr](=O)(=O)[O-].[Zn+2],13530-65-9,Positive,in vitro
zinc;N-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate,C(CNC(=S)[S-])NC(=S)[S-].[Zn+2],5284484,Negative,In Vivo
zinc;N-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate,C(CNC(=S)[S-])NC(=S)[S-].[Zn+2],9006-42-2,Negative,in vitro
zinc;sulfate,[O-]S(=O)(=O)[O-].[Zn+2],7733-02-0,Negative,in vitro
Zineb,C(CNC(=S)[S-])NC(=S)[S-].[Zn+2],12122-67-7,Negative,In vivo
ZIRCONIUM (IV) SULFATE,[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Zr+4],14644-61-2,Negative,In vivo
Zonisamide,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,68291-97-4,Negative,in vitro